STUDYID|DOMAIN|USUBJID|SESEQ|ETCD|TAETORD|EPOCH|SESTDTC|SEENDTC|SESTDY|SEENDY
Study ID|SE|d713606e-c808-49d6-878b-242fa5423a99|1|SCRN|3|SCREENING|2022-01-30|2022-07-25|121|297
Study ID|SE|d713606e-c808-49d6-878b-242fa5423a99|2|P|5|TREATMENT|2021-12-22|2022-03-22|82|172
Study ID|SE|d713606e-c808-49d6-878b-242fa5423a99|3|REST|6|WASHOUT|2022-03-09|2022-04-19|159|200
Study ID|SE|d713606e-c808-49d6-878b-242fa5423a99|4|5|6|TREATMENT|2021-11-20|2021-11-27|50|57
Study ID|SE|d713606e-c808-49d6-878b-242fa5423a99|5|REST|7|WASHOUT|2021-10-29|2021-10-31|28|30
Study ID|SE|d713606e-c808-49d6-878b-242fa5423a99|6|10|4|TREATMENT|2021-11-25|2022-04-28|55|209
Study ID|SE|d713606e-c808-49d6-878b-242fa5423a99|7|FU|5|FOLLOW-UP|2021-10-06|2021-10-26|5|25
Study ID|SE|19276962-2753-41ca-93c0-b62eebf73043|1|SCRN|1|SCREENING|2021-11-28|2021-12-08|37|47
Study ID|SE|19276962-2753-41ca-93c0-b62eebf73043|2|P|1|TREATMENT|2022-06-04|2022-08-17|225|299
Study ID|SE|19276962-2753-41ca-93c0-b62eebf73043|3|REST|7|WASHOUT|2022-04-24|2022-05-19|184|209
Study ID|SE|19276962-2753-41ca-93c0-b62eebf73043|4|5|4|TREATMENT|2022-01-17|2022-01-26|87|96
Study ID|SE|19276962-2753-41ca-93c0-b62eebf73043|5|REST|4|WASHOUT|2022-02-26|2022-07-28|127|279
Study ID|SE|19276962-2753-41ca-93c0-b62eebf73043|6|10|2|TREATMENT|2022-05-14|2022-07-03|204|254
Study ID|SE|19276962-2753-41ca-93c0-b62eebf73043|7|FU|2|FOLLOW-UP|2021-10-24|2021-11-07|2|16
Study ID|SE|fba486eb-0c9f-4093-83ec-7b3a3119e949|1|SCRN|4|SCREENING|2021-08-29|2022-02-08|9|172
Study ID|SE|fba486eb-0c9f-4093-83ec-7b3a3119e949|2|5|1|TREATMENT|2021-09-11|2022-02-07|22|171
Study ID|SE|fba486eb-0c9f-4093-83ec-7b3a3119e949|3|REST|5|WASHOUT|2021-08-22|2021-09-01|2|12
Study ID|SE|fba486eb-0c9f-4093-83ec-7b3a3119e949|4|10|4|TREATMENT|2021-08-22|2021-09-09|2|20
Study ID|SE|fba486eb-0c9f-4093-83ec-7b3a3119e949|5|REST|2|WASHOUT|2021-08-30|2021-12-08|10|110
Study ID|SE|fba486eb-0c9f-4093-83ec-7b3a3119e949|6|P|6|TREATMENT|2021-09-13|2022-01-09|24|142
Study ID|SE|fba486eb-0c9f-4093-83ec-7b3a3119e949|7|FU|7|FOLLOW-UP|2021-09-12|2021-11-05|23|77
Study ID|SE|9b1d13e0-4298-471e-b0f4-e66662712e84|1|SCRN|5|SCREENING|2022-01-04|2022-01-12|67|75
Study ID|SE|9b1d13e0-4298-471e-b0f4-e66662712e84|2|5|3|TREATMENT|2022-03-06|2022-05-23|128|206
Study ID|SE|9b1d13e0-4298-471e-b0f4-e66662712e84|3|REST|7|WASHOUT|2022-03-30|2022-06-08|152|222
Study ID|SE|9b1d13e0-4298-471e-b0f4-e66662712e84|4|P|4|TREATMENT|2022-03-17|2022-06-10|139|224
Study ID|SE|9b1d13e0-4298-471e-b0f4-e66662712e84|5|REST|1|WASHOUT|2022-03-11|2022-08-12|133|287
Study ID|SE|9b1d13e0-4298-471e-b0f4-e66662712e84|6|10|2|TREATMENT|2022-04-03|2022-08-14|156|289
Study ID|SE|9b1d13e0-4298-471e-b0f4-e66662712e84|7|FU|6|FOLLOW-UP|2022-01-04|2022-07-09|67|253
Study ID|SE|e7827662-389f-439b-bd52-bcc90880dae5|1|SCRN|4|SCREENING|2022-02-23|2022-05-01|169|236
Study ID|SE|e7827662-389f-439b-bd52-bcc90880dae5|2|5|3|TREATMENT|2022-03-08|2022-04-27|182|232
Study ID|SE|e7827662-389f-439b-bd52-bcc90880dae5|3|REST|5|WASHOUT|2021-09-13|2021-12-07|6|91
Study ID|SE|e7827662-389f-439b-bd52-bcc90880dae5|4|10|2|TREATMENT|2021-11-11|2022-06-29|65|295
Study ID|SE|e7827662-389f-439b-bd52-bcc90880dae5|5|REST|2|WASHOUT|2021-12-03|2022-04-27|87|232
Study ID|SE|e7827662-389f-439b-bd52-bcc90880dae5|6|P|1|TREATMENT|2021-09-18|2022-05-31|11|266
Study ID|SE|e7827662-389f-439b-bd52-bcc90880dae5|7|FU|6|FOLLOW-UP|2021-10-23|2021-10-25|46|48
Study ID|SE|a1870039-6e2b-4170-8c6b-bd813a0f62f2|1|SCRN|5|SCREENING|2021-10-22|2021-11-14|9|32
Study ID|SE|a1870039-6e2b-4170-8c6b-bd813a0f62f2|2|P|3|TREATMENT|2022-03-13|2022-07-25|151|285
Study ID|SE|a1870039-6e2b-4170-8c6b-bd813a0f62f2|3|REST|3|WASHOUT|2021-10-18|2021-10-31|5|18
Study ID|SE|a1870039-6e2b-4170-8c6b-bd813a0f62f2|4|5|2|TREATMENT|2021-10-24|2022-01-16|11|95
Study ID|SE|a1870039-6e2b-4170-8c6b-bd813a0f62f2|5|REST|5|WASHOUT|2022-02-14|2022-02-26|124|136
Study ID|SE|a1870039-6e2b-4170-8c6b-bd813a0f62f2|6|10|5|TREATMENT|2021-11-08|2022-01-15|26|94
Study ID|SE|a1870039-6e2b-4170-8c6b-bd813a0f62f2|7|FU|2|FOLLOW-UP|2021-11-10|2022-06-07|28|237
Study ID|SE|42b8617e-b2c0-4f9d-af9c-4c9618d9676b|1|SCRN|3|SCREENING|2021-10-25|2022-03-03|7|136
Study ID|SE|42b8617e-b2c0-4f9d-af9c-4c9618d9676b|2|5|1|TREATMENT|2022-01-21|2022-02-12|95|117
Study ID|SE|42b8617e-b2c0-4f9d-af9c-4c9618d9676b|3|REST|5|WASHOUT|2022-02-24|2022-06-12|129|237
Study ID|SE|42b8617e-b2c0-4f9d-af9c-4c9618d9676b|4|P|2|TREATMENT|2021-11-02|2022-02-26|15|131
Study ID|SE|42b8617e-b2c0-4f9d-af9c-4c9618d9676b|5|REST|2|WASHOUT|2021-10-25|2022-01-17|7|91
Study ID|SE|42b8617e-b2c0-4f9d-af9c-4c9618d9676b|6|10|5|TREATMENT|2021-10-30|2021-12-07|12|50
Study ID|SE|42b8617e-b2c0-4f9d-af9c-4c9618d9676b|7|FU|1|FOLLOW-UP|2021-11-14|2021-11-28|27|41
Study ID|SE|ab5335fb-bc0d-460f-abe5-5d613b1b6afb|1|SCRN|2|SCREENING|2022-03-23|2022-04-05|174|187
Study ID|SE|ab5335fb-bc0d-460f-abe5-5d613b1b6afb|2|5|1|TREATMENT|2021-10-18|2022-07-10|18|283
Study ID|SE|ab5335fb-bc0d-460f-abe5-5d613b1b6afb|3|REST|5|WASHOUT|2022-03-25|2022-06-08|176|251
Study ID|SE|ab5335fb-bc0d-460f-abe5-5d613b1b6afb|4|P|4|TREATMENT|2022-03-05|2022-03-23|156|174
Study ID|SE|ab5335fb-bc0d-460f-abe5-5d613b1b6afb|5|REST|6|WASHOUT|2021-10-12|2022-02-13|12|136
Study ID|SE|ab5335fb-bc0d-460f-abe5-5d613b1b6afb|6|10|4|TREATMENT|2021-11-18|2022-02-15|49|138
Study ID|SE|ab5335fb-bc0d-460f-abe5-5d613b1b6afb|7|FU|3|FOLLOW-UP|2021-11-03|2021-12-19|34|80
Study ID|SE|f975203f-2a45-4166-b937-afb03fb17d1e|1|SCRN|7|SCREENING|2022-06-19|2022-06-26|261|268
Study ID|SE|f975203f-2a45-4166-b937-afb03fb17d1e|2|5|3|TREATMENT|2022-03-29|2022-06-02|179|244
Study ID|SE|f975203f-2a45-4166-b937-afb03fb17d1e|3|REST|7|WASHOUT|2021-11-09|2022-06-22|39|264
Study ID|SE|f975203f-2a45-4166-b937-afb03fb17d1e|4|10|6|TREATMENT|2021-10-25|2022-05-18|24|229
Study ID|SE|f975203f-2a45-4166-b937-afb03fb17d1e|5|REST|6|WASHOUT|2022-02-19|2022-04-12|141|193
Study ID|SE|f975203f-2a45-4166-b937-afb03fb17d1e|6|P|7|TREATMENT|2022-01-21|2022-04-21|112|202
Study ID|SE|f975203f-2a45-4166-b937-afb03fb17d1e|7|FU|7|FOLLOW-UP|2022-03-09|2022-03-31|159|181
Study ID|SE|8faca3ae-52d5-4e2a-896d-9a5b86ea1a1a|1|SCRN|4|SCREENING|2021-10-24|2021-12-18|70|125
Study ID|SE|8faca3ae-52d5-4e2a-896d-9a5b86ea1a1a|2|P|1|TREATMENT|2021-10-27|2022-02-26|73|195
Study ID|SE|8faca3ae-52d5-4e2a-896d-9a5b86ea1a1a|3|REST|4|WASHOUT|2021-12-26|2022-04-02|133|230
Study ID|SE|8faca3ae-52d5-4e2a-896d-9a5b86ea1a1a|4|5|6|TREATMENT|2021-09-02|2021-09-15|18|31
Study ID|SE|8faca3ae-52d5-4e2a-896d-9a5b86ea1a1a|5|REST|6|WASHOUT|2021-09-09|2022-02-06|25|175
Study ID|SE|8faca3ae-52d5-4e2a-896d-9a5b86ea1a1a|6|10|6|TREATMENT|2021-09-12|2022-02-25|28|194
Study ID|SE|8faca3ae-52d5-4e2a-896d-9a5b86ea1a1a|7|FU|2|FOLLOW-UP|2021-08-26|2022-02-22|11|191
Study ID|SE|b3a504cf-317b-429e-bb1b-39c4b1568a5f|1|SCRN|1|SCREENING|2021-10-23|2022-05-06|62|257
Study ID|SE|b3a504cf-317b-429e-bb1b-39c4b1568a5f|2|5|5|TREATMENT|2021-12-26|2022-04-25|126|246
Study ID|SE|b3a504cf-317b-429e-bb1b-39c4b1568a5f|3|REST|1|WASHOUT|2022-04-19|2022-05-06|240|257
Study ID|SE|b3a504cf-317b-429e-bb1b-39c4b1568a5f|4|10|1|TREATMENT|2022-03-20|2022-03-31|210|221
Study ID|SE|b3a504cf-317b-429e-bb1b-39c4b1568a5f|5|REST|2|WASHOUT|2022-03-02|2022-05-30|192|281
Study ID|SE|b3a504cf-317b-429e-bb1b-39c4b1568a5f|6|P|5|TREATMENT|2021-08-28|2022-04-10|6|231
Study ID|SE|b3a504cf-317b-429e-bb1b-39c4b1568a5f|7|FU|7|FOLLOW-UP|2022-03-25|2022-05-24|215|275
Study ID|SE|bc1b5635-3292-4053-8401-e257c00b5db2|1|SCRN|6|SCREENING|2022-03-27|2022-05-26|209|269
Study ID|SE|bc1b5635-3292-4053-8401-e257c00b5db2|2|P|5|TREATMENT|2021-11-02|2021-11-23|64|85
Study ID|SE|bc1b5635-3292-4053-8401-e257c00b5db2|3|REST|5|WASHOUT|2021-09-11|2022-01-25|12|148
Study ID|SE|bc1b5635-3292-4053-8401-e257c00b5db2|4|5|5|TREATMENT|2021-09-06|2021-09-21|7|22
Study ID|SE|bc1b5635-3292-4053-8401-e257c00b5db2|5|REST|1|WASHOUT|2021-09-23|2022-03-21|24|203
Study ID|SE|bc1b5635-3292-4053-8401-e257c00b5db2|6|10|7|TREATMENT|2021-09-22|2021-10-15|23|46
Study ID|SE|bc1b5635-3292-4053-8401-e257c00b5db2|7|FU|4|FOLLOW-UP|2021-09-15|2021-09-23|16|24
Study ID|SE|2deec466-9b3f-4b48-ac64-56beeb018888|1|SCRN|7|SCREENING|2022-02-28|2022-07-04|159|285
Study ID|SE|2deec466-9b3f-4b48-ac64-56beeb018888|2|5|5|TREATMENT|2022-02-20|2022-05-06|151|226
Study ID|SE|2deec466-9b3f-4b48-ac64-56beeb018888|3|REST|3|WASHOUT|2021-11-30|2021-12-09|69|78
Study ID|SE|2deec466-9b3f-4b48-ac64-56beeb018888|4|10|3|TREATMENT|2022-01-17|2022-05-25|117|245
Study ID|SE|2deec466-9b3f-4b48-ac64-56beeb018888|5|REST|5|WASHOUT|2021-10-15|2022-03-29|23|188
Study ID|SE|2deec466-9b3f-4b48-ac64-56beeb018888|6|P|6|TREATMENT|2021-11-22|2022-03-07|61|166
Study ID|SE|2deec466-9b3f-4b48-ac64-56beeb018888|7|FU|6|FOLLOW-UP|2021-10-08|2021-10-28|16|36
Study ID|SE|d5eff634-c07e-4933-9551-0f596a0a6aa3|1|SCRN|1|SCREENING|2021-10-22|2021-11-16|70|95
Study ID|SE|d5eff634-c07e-4933-9551-0f596a0a6aa3|2|P|7|TREATMENT|2021-08-15|2021-08-18|2|5
Study ID|SE|d5eff634-c07e-4933-9551-0f596a0a6aa3|3|REST|5|WASHOUT|2022-01-16|2022-02-23|156|194
Study ID|SE|d5eff634-c07e-4933-9551-0f596a0a6aa3|4|5|4|TREATMENT|2021-11-14|2022-03-05|93|204
Study ID|SE|d5eff634-c07e-4933-9551-0f596a0a6aa3|5|REST|4|WASHOUT|2021-09-08|2021-10-22|26|70
Study ID|SE|d5eff634-c07e-4933-9551-0f596a0a6aa3|6|10|6|TREATMENT|2022-02-06|2022-02-13|177|184
Study ID|SE|d5eff634-c07e-4933-9551-0f596a0a6aa3|7|FU|4|FOLLOW-UP|2021-09-27|2022-03-21|45|220
Study ID|SE|b831f8dd-ec31-4fae-9e3d-1c64e6fcacb1|1|SCRN|2|SCREENING|2022-01-19|2022-08-02|101|296
Study ID|SE|b831f8dd-ec31-4fae-9e3d-1c64e6fcacb1|2|P|6|TREATMENT|2021-11-02|2021-12-09|23|60
Study ID|SE|b831f8dd-ec31-4fae-9e3d-1c64e6fcacb1|3|REST|1|WASHOUT|2021-10-12|2022-03-01|2|142
Study ID|SE|b831f8dd-ec31-4fae-9e3d-1c64e6fcacb1|4|5|7|TREATMENT|2021-11-30|2022-06-06|51|239
Study ID|SE|b831f8dd-ec31-4fae-9e3d-1c64e6fcacb1|5|REST|3|WASHOUT|2022-01-20|2022-02-03|102|116
Study ID|SE|b831f8dd-ec31-4fae-9e3d-1c64e6fcacb1|6|10|5|TREATMENT|2021-12-12|2021-12-21|63|72
Study ID|SE|b831f8dd-ec31-4fae-9e3d-1c64e6fcacb1|7|FU|2|FOLLOW-UP|2021-10-19|2021-10-25|9|15
Study ID|SE|47665624-a6d0-4756-8af7-b3643cf402fc|1|SCRN|5|SCREENING|2021-10-19|2021-10-20|19|20
Study ID|SE|47665624-a6d0-4756-8af7-b3643cf402fc|2|P|7|TREATMENT|2021-10-08|2021-10-24|8|24
Study ID|SE|47665624-a6d0-4756-8af7-b3643cf402fc|3|REST|6|WASHOUT|2022-01-17|2022-05-29|109|241
Study ID|SE|47665624-a6d0-4756-8af7-b3643cf402fc|4|5|5|TREATMENT|2022-01-07|2022-04-23|99|205
Study ID|SE|47665624-a6d0-4756-8af7-b3643cf402fc|5|REST|5|WASHOUT|2022-01-30|2022-04-12|122|194
Study ID|SE|47665624-a6d0-4756-8af7-b3643cf402fc|6|10|6|TREATMENT|2022-06-08|2022-07-19|251|292
Study ID|SE|47665624-a6d0-4756-8af7-b3643cf402fc|7|FU|1|FOLLOW-UP|2022-01-23|2022-02-07|115|130
Study ID|SE|80a01467-5aa8-45f7-919a-0e1e0046d252|1|SCRN|4|SCREENING|2021-09-25|2021-09-28|13|16
Study ID|SE|80a01467-5aa8-45f7-919a-0e1e0046d252|2|5|7|TREATMENT|2022-05-14|2022-05-27|244|257
Study ID|SE|80a01467-5aa8-45f7-919a-0e1e0046d252|3|REST|6|WASHOUT|2021-12-30|2022-03-11|109|180
Study ID|SE|80a01467-5aa8-45f7-919a-0e1e0046d252|4|P|2|TREATMENT|2021-09-18|2021-09-20|6|8
Study ID|SE|80a01467-5aa8-45f7-919a-0e1e0046d252|5|REST|1|WASHOUT|2021-11-07|2022-03-19|56|188
Study ID|SE|80a01467-5aa8-45f7-919a-0e1e0046d252|6|10|7|TREATMENT|2021-11-07|2022-02-24|56|165
Study ID|SE|80a01467-5aa8-45f7-919a-0e1e0046d252|7|FU|5|FOLLOW-UP|2021-11-03|2021-12-05|52|84
Study ID|SE|5b2e3107-b84c-43dc-a5fc-43f02e7def1c|1|SCRN|2|SCREENING|2021-12-15|2022-04-01|50|157
Study ID|SE|5b2e3107-b84c-43dc-a5fc-43f02e7def1c|2|5|2|TREATMENT|2022-05-07|2022-05-19|193|205
Study ID|SE|5b2e3107-b84c-43dc-a5fc-43f02e7def1c|3|REST|4|WASHOUT|2022-02-26|2022-06-09|123|226
Study ID|SE|5b2e3107-b84c-43dc-a5fc-43f02e7def1c|4|P|5|TREATMENT|2022-04-24|2022-06-27|180|244
Study ID|SE|5b2e3107-b84c-43dc-a5fc-43f02e7def1c|5|REST|2|WASHOUT|2022-01-26|2022-03-30|92|155
Study ID|SE|5b2e3107-b84c-43dc-a5fc-43f02e7def1c|6|10|5|TREATMENT|2021-11-07|2022-03-06|12|131
Study ID|SE|5b2e3107-b84c-43dc-a5fc-43f02e7def1c|7|FU|3|FOLLOW-UP|2022-01-19|2022-08-01|85|279
Study ID|SE|848bf545-6441-48fa-80cc-b97aba0d77c3|1|SCRN|7|SCREENING|2021-12-21|2022-01-01|74|85
Study ID|SE|848bf545-6441-48fa-80cc-b97aba0d77c3|2|P|6|TREATMENT|2021-10-18|2022-01-18|10|102
Study ID|SE|848bf545-6441-48fa-80cc-b97aba0d77c3|3|REST|2|WASHOUT|2021-10-13|2021-10-17|5|9
Study ID|SE|848bf545-6441-48fa-80cc-b97aba0d77c3|4|5|6|TREATMENT|2022-01-24|2022-02-24|108|139
Study ID|SE|848bf545-6441-48fa-80cc-b97aba0d77c3|5|REST|2|WASHOUT|2022-03-01|2022-07-13|144|278
Study ID|SE|848bf545-6441-48fa-80cc-b97aba0d77c3|6|10|4|TREATMENT|2021-10-22|2022-03-13|14|156
Study ID|SE|848bf545-6441-48fa-80cc-b97aba0d77c3|7|FU|3|FOLLOW-UP|2022-03-08|2022-03-19|151|162
Study ID|SE|4c476a2e-71de-47b8-845d-73d5963ebf61|1|SCRN|1|SCREENING|2022-01-27|2022-03-19|98|149
Study ID|SE|4c476a2e-71de-47b8-845d-73d5963ebf61|2|P|7|TREATMENT|2022-03-06|2022-05-30|136|221
Study ID|SE|4c476a2e-71de-47b8-845d-73d5963ebf61|3|REST|2|WASHOUT|2022-03-17|2022-04-09|147|170
Study ID|SE|4c476a2e-71de-47b8-845d-73d5963ebf61|4|5|7|TREATMENT|2022-01-07|2022-05-13|78|204
Study ID|SE|4c476a2e-71de-47b8-845d-73d5963ebf61|5|REST|5|WASHOUT|2021-11-07|2022-07-14|17|266
Study ID|SE|4c476a2e-71de-47b8-845d-73d5963ebf61|6|10|7|TREATMENT|2022-02-18|2022-08-02|120|285
Study ID|SE|4c476a2e-71de-47b8-845d-73d5963ebf61|7|FU|6|FOLLOW-UP|2022-02-08|2022-03-30|110|160
Study ID|SE|fd8e4cff-6799-40e2-84ee-a222b5d564ad|1|SCRN|4|SCREENING|2021-11-21|2021-12-27|50|86
Study ID|SE|fd8e4cff-6799-40e2-84ee-a222b5d564ad|2|5|5|TREATMENT|2021-11-02|2021-11-12|31|41
Study ID|SE|fd8e4cff-6799-40e2-84ee-a222b5d564ad|3|REST|4|WASHOUT|2022-02-18|2022-03-10|139|159
Study ID|SE|fd8e4cff-6799-40e2-84ee-a222b5d564ad|4|10|4|TREATMENT|2022-02-20|2022-05-11|141|221
Study ID|SE|fd8e4cff-6799-40e2-84ee-a222b5d564ad|5|REST|2|WASHOUT|2021-10-26|2021-12-31|24|90
Study ID|SE|fd8e4cff-6799-40e2-84ee-a222b5d564ad|6|P|5|TREATMENT|2022-01-25|2022-02-26|115|147
Study ID|SE|fd8e4cff-6799-40e2-84ee-a222b5d564ad|7|FU|5|FOLLOW-UP|2021-11-25|2021-12-13|54|72
Study ID|SE|afc20884-6463-4dd3-a61c-c73566fde2d2|1|SCRN|2|SCREENING|2021-10-27|2021-11-24|13|41
Study ID|SE|afc20884-6463-4dd3-a61c-c73566fde2d2|2|5|1|TREATMENT|2022-01-30|2022-07-25|108|284
Study ID|SE|afc20884-6463-4dd3-a61c-c73566fde2d2|3|REST|3|WASHOUT|2021-11-23|2022-02-06|40|115
Study ID|SE|afc20884-6463-4dd3-a61c-c73566fde2d2|4|P|5|TREATMENT|2022-03-25|2022-06-02|162|231
Study ID|SE|afc20884-6463-4dd3-a61c-c73566fde2d2|5|REST|3|WASHOUT|2021-12-31|2022-03-05|78|142
Study ID|SE|afc20884-6463-4dd3-a61c-c73566fde2d2|6|10|7|TREATMENT|2021-11-28|2022-07-28|45|287
Study ID|SE|afc20884-6463-4dd3-a61c-c73566fde2d2|7|FU|5|FOLLOW-UP|2022-01-08|2022-03-16|86|153
Study ID|SE|cafdfd6a-907b-4504-893d-b2353295e18c|1|SCRN|7|SCREENING|2021-10-24|2022-03-29|35|191
Study ID|SE|cafdfd6a-907b-4504-893d-b2353295e18c|2|P|5|TREATMENT|2022-03-19|2022-04-23|181|216
Study ID|SE|cafdfd6a-907b-4504-893d-b2353295e18c|3|REST|1|WASHOUT|2021-10-31|2021-11-05|42|47
Study ID|SE|cafdfd6a-907b-4504-893d-b2353295e18c|4|5|6|TREATMENT|2021-10-13|2022-05-21|24|244
Study ID|SE|cafdfd6a-907b-4504-893d-b2353295e18c|5|REST|5|WASHOUT|2021-09-24|2021-11-20|5|62
Study ID|SE|cafdfd6a-907b-4504-893d-b2353295e18c|6|10|6|TREATMENT|2021-10-27|2022-04-09|38|202
Study ID|SE|cafdfd6a-907b-4504-893d-b2353295e18c|7|FU|7|FOLLOW-UP|2021-10-20|2022-01-05|31|108
Study ID|SE|6be30d43-dc8c-4406-b5b2-6461039ac501|1|SCRN|4|SCREENING|2021-11-24|2021-12-19|38|63
Study ID|SE|6be30d43-dc8c-4406-b5b2-6461039ac501|2|5|2|TREATMENT|2022-03-08|2022-05-18|142|213
Study ID|SE|6be30d43-dc8c-4406-b5b2-6461039ac501|3|REST|1|WASHOUT|2022-01-17|2022-04-09|92|174
Study ID|SE|6be30d43-dc8c-4406-b5b2-6461039ac501|4|10|3|TREATMENT|2021-11-08|2021-12-11|22|55
Study ID|SE|6be30d43-dc8c-4406-b5b2-6461039ac501|5|REST|2|WASHOUT|2021-10-19|2021-10-20|2|3
Study ID|SE|6be30d43-dc8c-4406-b5b2-6461039ac501|6|P|4|TREATMENT|2022-06-03|2022-06-29|229|255
Study ID|SE|6be30d43-dc8c-4406-b5b2-6461039ac501|7|FU|4|FOLLOW-UP|2021-11-01|2021-11-28|15|42
Study ID|SE|2fa374c2-4d57-4de3-a86b-a3a374e6ab68|1|SCRN|2|SCREENING|2021-12-30|2022-06-21|104|277
Study ID|SE|2fa374c2-4d57-4de3-a86b-a3a374e6ab68|2|5|2|TREATMENT|2021-11-09|2022-02-06|53|142
Study ID|SE|2fa374c2-4d57-4de3-a86b-a3a374e6ab68|3|REST|3|WASHOUT|2021-10-05|2021-10-06|18|19
Study ID|SE|2fa374c2-4d57-4de3-a86b-a3a374e6ab68|4|10|1|TREATMENT|2022-04-27|2022-05-22|222|247
Study ID|SE|2fa374c2-4d57-4de3-a86b-a3a374e6ab68|5|REST|1|WASHOUT|2021-11-11|2022-04-16|55|211
Study ID|SE|2fa374c2-4d57-4de3-a86b-a3a374e6ab68|6|P|7|TREATMENT|2021-09-20|2021-10-01|3|14
Study ID|SE|2fa374c2-4d57-4de3-a86b-a3a374e6ab68|7|FU|2|FOLLOW-UP|2022-01-10|2022-01-19|115|124
Study ID|SE|22adef60-8485-404f-99a6-70b3983d9d63|1|SCRN|4|SCREENING|2021-12-04|2022-01-19|54|100
Study ID|SE|22adef60-8485-404f-99a6-70b3983d9d63|2|5|4|TREATMENT|2021-12-27|2022-02-04|77|116
Study ID|SE|22adef60-8485-404f-99a6-70b3983d9d63|3|REST|4|WASHOUT|2021-12-24|2022-02-03|74|115
Study ID|SE|22adef60-8485-404f-99a6-70b3983d9d63|4|10|5|TREATMENT|2021-11-06|2021-12-02|26|52
Study ID|SE|22adef60-8485-404f-99a6-70b3983d9d63|5|REST|1|WASHOUT|2021-10-31|2022-05-06|20|207
Study ID|SE|22adef60-8485-404f-99a6-70b3983d9d63|6|P|2|TREATMENT|2021-10-18|2021-12-10|7|60
Study ID|SE|22adef60-8485-404f-99a6-70b3983d9d63|7|FU|4|FOLLOW-UP|2022-01-07|2022-02-19|88|131
Study ID|SE|88be6386-17bc-4005-93f7-547e970c0162|1|SCRN|7|SCREENING|2021-12-01|2021-12-02|86|87
Study ID|SE|88be6386-17bc-4005-93f7-547e970c0162|2|5|2|TREATMENT|2021-09-11|2021-10-13|5|37
Study ID|SE|88be6386-17bc-4005-93f7-547e970c0162|3|REST|6|WASHOUT|2021-11-20|2022-02-28|75|175
Study ID|SE|88be6386-17bc-4005-93f7-547e970c0162|4|10|7|TREATMENT|2021-09-26|2022-05-21|20|257
Study ID|SE|88be6386-17bc-4005-93f7-547e970c0162|5|REST|7|WASHOUT|2021-09-17|2021-09-24|11|18
Study ID|SE|88be6386-17bc-4005-93f7-547e970c0162|6|P|7|TREATMENT|2021-09-26|2022-02-28|20|175
Study ID|SE|88be6386-17bc-4005-93f7-547e970c0162|7|FU|1|FOLLOW-UP|2021-11-11|2021-12-01|66|86
Study ID|SE|3ae36993-0a7f-4299-9f2b-0af624d27fb4|1|SCRN|4|SCREENING|2021-11-26|2022-01-13|68|116
Study ID|SE|3ae36993-0a7f-4299-9f2b-0af624d27fb4|2|5|5|TREATMENT|2021-11-13|2022-05-05|55|228
Study ID|SE|3ae36993-0a7f-4299-9f2b-0af624d27fb4|3|REST|2|WASHOUT|2021-11-05|2022-01-01|47|104
Study ID|SE|3ae36993-0a7f-4299-9f2b-0af624d27fb4|4|10|1|TREATMENT|2021-10-25|2022-01-12|36|115
Study ID|SE|3ae36993-0a7f-4299-9f2b-0af624d27fb4|5|REST|5|WASHOUT|2021-09-26|2022-01-14|7|117
Study ID|SE|3ae36993-0a7f-4299-9f2b-0af624d27fb4|6|P|7|TREATMENT|2021-10-21|2021-11-13|32|55
Study ID|SE|3ae36993-0a7f-4299-9f2b-0af624d27fb4|7|FU|4|FOLLOW-UP|2021-12-04|2022-04-09|76|202
Study ID|SE|67f55a16-dc5c-4ff7-b9e0-453bd287538e|1|SCRN|1|SCREENING|2021-12-05|2022-07-23|59|289
Study ID|SE|67f55a16-dc5c-4ff7-b9e0-453bd287538e|2|5|4|TREATMENT|2022-01-07|2022-01-25|92|110
Study ID|SE|67f55a16-dc5c-4ff7-b9e0-453bd287538e|3|REST|7|WASHOUT|2022-01-31|2022-04-29|116|204
Study ID|SE|67f55a16-dc5c-4ff7-b9e0-453bd287538e|4|10|3|TREATMENT|2022-04-10|2022-07-01|185|267
Study ID|SE|67f55a16-dc5c-4ff7-b9e0-453bd287538e|5|REST|2|WASHOUT|2021-10-12|2021-10-16|5|9
Study ID|SE|67f55a16-dc5c-4ff7-b9e0-453bd287538e|6|P|1|TREATMENT|2021-10-24|2022-04-23|17|198
Study ID|SE|67f55a16-dc5c-4ff7-b9e0-453bd287538e|7|FU|5|FOLLOW-UP|2022-01-30|2022-06-16|115|252
Study ID|SE|b6a9a102-8ce6-48c6-ae0f-59c6a078f608|1|SCRN|1|SCREENING|2021-09-07|2021-12-19|30|133
Study ID|SE|b6a9a102-8ce6-48c6-ae0f-59c6a078f608|2|5|4|TREATMENT|2021-09-23|2021-10-24|46|77
Study ID|SE|b6a9a102-8ce6-48c6-ae0f-59c6a078f608|3|REST|2|WASHOUT|2021-08-23|2021-12-05|15|119
Study ID|SE|b6a9a102-8ce6-48c6-ae0f-59c6a078f608|4|P|4|TREATMENT|2021-08-13|2021-09-04|5|27
Study ID|SE|b6a9a102-8ce6-48c6-ae0f-59c6a078f608|5|REST|2|WASHOUT|2021-09-21|2021-10-07|44|60
Study ID|SE|b6a9a102-8ce6-48c6-ae0f-59c6a078f608|6|10|7|TREATMENT|2021-11-24|2022-01-25|108|170
Study ID|SE|b6a9a102-8ce6-48c6-ae0f-59c6a078f608|7|FU|4|FOLLOW-UP|2021-09-18|2021-12-23|41|137
Study ID|SE|15a62d52-47e5-41a0-a12a-a88965957b79|1|SCRN|5|SCREENING|2021-10-13|2022-03-25|19|182
Study ID|SE|15a62d52-47e5-41a0-a12a-a88965957b79|2|5|6|TREATMENT|2021-11-11|2022-02-06|48|135
Study ID|SE|15a62d52-47e5-41a0-a12a-a88965957b79|3|REST|5|WASHOUT|2022-01-02|2022-07-13|100|292
Study ID|SE|15a62d52-47e5-41a0-a12a-a88965957b79|4|P|5|TREATMENT|2022-02-24|2022-06-14|153|263
Study ID|SE|15a62d52-47e5-41a0-a12a-a88965957b79|5|REST|7|WASHOUT|2022-01-07|2022-04-03|105|191
Study ID|SE|15a62d52-47e5-41a0-a12a-a88965957b79|6|10|1|TREATMENT|2021-10-09|2021-11-06|15|43
Study ID|SE|15a62d52-47e5-41a0-a12a-a88965957b79|7|FU|1|FOLLOW-UP|2021-09-28|2022-03-19|4|176
Study ID|SE|eb675e48-769a-46e2-be7a-41aa1f53046a|1|SCRN|6|SCREENING|2022-05-13|2022-05-18|218|223
Study ID|SE|eb675e48-769a-46e2-be7a-41aa1f53046a|2|5|5|TREATMENT|2021-11-09|2022-03-08|33|152
Study ID|SE|eb675e48-769a-46e2-be7a-41aa1f53046a|3|REST|3|WASHOUT|2021-11-13|2021-11-18|37|42
Study ID|SE|eb675e48-769a-46e2-be7a-41aa1f53046a|4|P|3|TREATMENT|2022-01-27|2022-05-22|112|227
Study ID|SE|eb675e48-769a-46e2-be7a-41aa1f53046a|5|REST|4|WASHOUT|2021-11-16|2021-11-22|40|46
Study ID|SE|eb675e48-769a-46e2-be7a-41aa1f53046a|6|10|4|TREATMENT|2021-12-22|2022-04-06|76|181
Study ID|SE|eb675e48-769a-46e2-be7a-41aa1f53046a|7|FU|6|FOLLOW-UP|2022-01-13|2022-03-15|98|159
Study ID|SE|2eafa16a-62cc-4f6c-b84c-e9fb97d7b423|1|SCRN|1|SCREENING|2021-11-19|2022-06-28|21|242
Study ID|SE|2eafa16a-62cc-4f6c-b84c-e9fb97d7b423|2|P|6|TREATMENT|2021-11-23|2022-04-23|25|176
Study ID|SE|2eafa16a-62cc-4f6c-b84c-e9fb97d7b423|3|REST|2|WASHOUT|2021-12-04|2021-12-05|36|37
Study ID|SE|2eafa16a-62cc-4f6c-b84c-e9fb97d7b423|4|5|2|TREATMENT|2022-04-30|2022-07-31|183|275
Study ID|SE|2eafa16a-62cc-4f6c-b84c-e9fb97d7b423|5|REST|1|WASHOUT|2021-11-08|2021-12-24|10|56
Study ID|SE|2eafa16a-62cc-4f6c-b84c-e9fb97d7b423|6|10|5|TREATMENT|2021-11-28|2021-12-15|30|47
Study ID|SE|2eafa16a-62cc-4f6c-b84c-e9fb97d7b423|7|FU|1|FOLLOW-UP|2022-01-10|2022-05-13|73|196
Study ID|SE|f3614c5a-73d1-4268-b164-2eff0b860d10|1|SCRN|2|SCREENING|2022-01-29|2022-03-02|166|198
Study ID|SE|f3614c5a-73d1-4268-b164-2eff0b860d10|2|5|1|TREATMENT|2021-11-23|2021-11-29|99|105
Study ID|SE|f3614c5a-73d1-4268-b164-2eff0b860d10|3|REST|2|WASHOUT|2021-09-13|2021-10-06|28|51
Study ID|SE|f3614c5a-73d1-4268-b164-2eff0b860d10|4|P|3|TREATMENT|2021-08-25|2021-09-01|9|16
Study ID|SE|f3614c5a-73d1-4268-b164-2eff0b860d10|5|REST|1|WASHOUT|2021-08-19|2021-11-01|3|77
Study ID|SE|f3614c5a-73d1-4268-b164-2eff0b860d10|6|10|4|TREATMENT|2021-10-20|2021-12-26|65|132
Study ID|SE|f3614c5a-73d1-4268-b164-2eff0b860d10|7|FU|2|FOLLOW-UP|2021-11-01|2022-04-30|77|257
Study ID|SE|4ee388d9-9a78-4a48-aee5-eee7065d8a24|1|SCRN|2|SCREENING|2021-09-22|2021-10-29|22|59
Study ID|SE|4ee388d9-9a78-4a48-aee5-eee7065d8a24|2|5|4|TREATMENT|2021-12-10|2022-04-02|101|214
Study ID|SE|4ee388d9-9a78-4a48-aee5-eee7065d8a24|3|REST|3|WASHOUT|2022-03-30|2022-05-19|211|261
Study ID|SE|4ee388d9-9a78-4a48-aee5-eee7065d8a24|4|10|3|TREATMENT|2021-12-12|2022-04-24|103|236
Study ID|SE|4ee388d9-9a78-4a48-aee5-eee7065d8a24|5|REST|5|WASHOUT|2021-10-05|2021-10-18|35|48
Study ID|SE|4ee388d9-9a78-4a48-aee5-eee7065d8a24|6|P|3|TREATMENT|2021-09-21|2021-09-30|21|30
Study ID|SE|4ee388d9-9a78-4a48-aee5-eee7065d8a24|7|FU|4|FOLLOW-UP|2021-09-12|2021-09-16|12|16
Study ID|SE|2ac651d5-c732-44e4-8f9e-7fbe3078bced|1|SCRN|4|SCREENING|2022-01-07|2022-01-22|125|140
Study ID|SE|2ac651d5-c732-44e4-8f9e-7fbe3078bced|2|5|1|TREATMENT|2021-11-20|2022-03-23|77|200
Study ID|SE|2ac651d5-c732-44e4-8f9e-7fbe3078bced|3|REST|3|WASHOUT|2021-10-19|2021-12-31|45|118
Study ID|SE|2ac651d5-c732-44e4-8f9e-7fbe3078bced|4|10|2|TREATMENT|2022-05-06|2022-06-07|244|276
Study ID|SE|2ac651d5-c732-44e4-8f9e-7fbe3078bced|5|REST|2|WASHOUT|2022-03-03|2022-03-22|180|199
Study ID|SE|2ac651d5-c732-44e4-8f9e-7fbe3078bced|6|P|3|TREATMENT|2021-11-09|2022-01-28|66|146
Study ID|SE|2ac651d5-c732-44e4-8f9e-7fbe3078bced|7|FU|4|FOLLOW-UP|2021-09-08|2021-09-15|4|11
Study ID|SE|19c4b5d7-3f8e-4d71-91a5-1c54ef1e6363|1|SCRN|5|SCREENING|2021-10-31|2022-04-16|15|182
Study ID|SE|19c4b5d7-3f8e-4d71-91a5-1c54ef1e6363|2|P|2|TREATMENT|2021-10-27|2021-10-30|11|14
Study ID|SE|19c4b5d7-3f8e-4d71-91a5-1c54ef1e6363|3|REST|5|WASHOUT|2022-04-12|2022-05-08|178|204
Study ID|SE|19c4b5d7-3f8e-4d71-91a5-1c54ef1e6363|4|5|7|TREATMENT|2021-11-14|2021-12-14|29|59
Study ID|SE|19c4b5d7-3f8e-4d71-91a5-1c54ef1e6363|5|REST|6|WASHOUT|2021-10-29|2021-11-08|13|23
Study ID|SE|19c4b5d7-3f8e-4d71-91a5-1c54ef1e6363|6|10|4|TREATMENT|2021-11-16|2022-01-14|31|90
Study ID|SE|19c4b5d7-3f8e-4d71-91a5-1c54ef1e6363|7|FU|3|FOLLOW-UP|2021-10-29|2022-01-27|13|103
Study ID|SE|a6419434-b962-48b4-b026-86a708cdf45f|1|SCRN|2|SCREENING|2021-10-31|2022-02-10|25|127
Study ID|SE|a6419434-b962-48b4-b026-86a708cdf45f|2|5|7|TREATMENT|2021-10-09|2022-01-02|3|88
Study ID|SE|a6419434-b962-48b4-b026-86a708cdf45f|3|REST|5|WASHOUT|2021-12-25|2022-03-28|80|173
Study ID|SE|a6419434-b962-48b4-b026-86a708cdf45f|4|P|3|TREATMENT|2021-11-26|2022-03-26|51|171
Study ID|SE|a6419434-b962-48b4-b026-86a708cdf45f|5|REST|1|WASHOUT|2021-11-27|2022-07-25|52|292
Study ID|SE|a6419434-b962-48b4-b026-86a708cdf45f|6|10|1|TREATMENT|2021-10-13|2021-10-25|7|19
Study ID|SE|a6419434-b962-48b4-b026-86a708cdf45f|7|FU|7|FOLLOW-UP|2022-02-03|2022-04-23|120|199
Study ID|SE|43b05d09-d9d8-4c7e-86ef-02a98a379637|1|SCRN|4|SCREENING|2021-12-19|2021-12-24|67|72
Study ID|SE|43b05d09-d9d8-4c7e-86ef-02a98a379637|2|P|7|TREATMENT|2022-04-07|2022-04-09|176|178
Study ID|SE|43b05d09-d9d8-4c7e-86ef-02a98a379637|3|REST|2|WASHOUT|2021-10-26|2022-08-08|13|299
Study ID|SE|43b05d09-d9d8-4c7e-86ef-02a98a379637|4|5|5|TREATMENT|2021-10-23|2022-08-02|10|293
Study ID|SE|43b05d09-d9d8-4c7e-86ef-02a98a379637|5|REST|2|WASHOUT|2021-11-01|2021-11-18|19|36
Study ID|SE|43b05d09-d9d8-4c7e-86ef-02a98a379637|6|10|3|TREATMENT|2021-10-24|2021-11-07|11|25
Study ID|SE|43b05d09-d9d8-4c7e-86ef-02a98a379637|7|FU|2|FOLLOW-UP|2022-01-08|2022-04-16|87|185
Study ID|SE|617f2f04-58b4-4709-a5be-1b1fbd267629|1|SCRN|3|SCREENING|2021-09-13|2021-09-18|2|7
Study ID|SE|617f2f04-58b4-4709-a5be-1b1fbd267629|2|5|5|TREATMENT|2021-11-25|2022-05-20|75|251
Study ID|SE|617f2f04-58b4-4709-a5be-1b1fbd267629|3|REST|7|WASHOUT|2021-10-23|2022-04-02|42|203
Study ID|SE|617f2f04-58b4-4709-a5be-1b1fbd267629|4|P|6|TREATMENT|2022-05-13|2022-06-02|244|264
Study ID|SE|617f2f04-58b4-4709-a5be-1b1fbd267629|5|REST|2|WASHOUT|2021-09-27|2022-03-11|16|181
Study ID|SE|617f2f04-58b4-4709-a5be-1b1fbd267629|6|10|7|TREATMENT|2021-12-09|2022-06-21|89|283
Study ID|SE|617f2f04-58b4-4709-a5be-1b1fbd267629|7|FU|2|FOLLOW-UP|2022-01-25|2022-05-11|136|242
Study ID|SE|8df00fbb-03af-45c1-8059-728b4e005ccc|1|SCRN|1|SCREENING|2021-10-17|2021-11-19|37|70
Study ID|SE|8df00fbb-03af-45c1-8059-728b4e005ccc|2|P|1|TREATMENT|2022-04-17|2022-05-18|219|250
Study ID|SE|8df00fbb-03af-45c1-8059-728b4e005ccc|3|REST|3|WASHOUT|2021-12-20|2022-03-12|101|183
Study ID|SE|8df00fbb-03af-45c1-8059-728b4e005ccc|4|5|2|TREATMENT|2021-11-29|2022-06-08|80|271
Study ID|SE|8df00fbb-03af-45c1-8059-728b4e005ccc|5|REST|4|WASHOUT|2022-04-13|2022-05-01|215|233
Study ID|SE|8df00fbb-03af-45c1-8059-728b4e005ccc|6|10|3|TREATMENT|2021-09-19|2022-02-18|9|161
Study ID|SE|8df00fbb-03af-45c1-8059-728b4e005ccc|7|FU|3|FOLLOW-UP|2022-01-20|2022-04-09|132|211
Study ID|SE|a3dacbc1-5539-4c71-bb6d-5f76f67a6ac0|1|SCRN|2|SCREENING|2022-05-14|2022-08-21|199|298
Study ID|SE|a3dacbc1-5539-4c71-bb6d-5f76f67a6ac0|2|P|4|TREATMENT|2022-01-07|2022-05-16|72|201
Study ID|SE|a3dacbc1-5539-4c71-bb6d-5f76f67a6ac0|3|REST|5|WASHOUT|2021-12-27|2022-03-23|61|147
Study ID|SE|a3dacbc1-5539-4c71-bb6d-5f76f67a6ac0|4|5|6|TREATMENT|2022-01-12|2022-06-02|77|218
Study ID|SE|a3dacbc1-5539-4c71-bb6d-5f76f67a6ac0|5|REST|4|WASHOUT|2021-11-21|2022-06-22|25|238
Study ID|SE|a3dacbc1-5539-4c71-bb6d-5f76f67a6ac0|6|10|2|TREATMENT|2022-01-26|2022-02-13|91|109
Study ID|SE|a3dacbc1-5539-4c71-bb6d-5f76f67a6ac0|7|FU|2|FOLLOW-UP|2022-03-08|2022-03-15|132|139
Study ID|SE|9c2bc89e-2ac0-412d-8a6b-f2e0b8dd2ca3|1|SCRN|1|SCREENING|2021-09-14|2021-12-18|7|102
Study ID|SE|9c2bc89e-2ac0-412d-8a6b-f2e0b8dd2ca3|2|5|5|TREATMENT|2021-09-17|2022-03-31|10|205
Study ID|SE|9c2bc89e-2ac0-412d-8a6b-f2e0b8dd2ca3|3|REST|4|WASHOUT|2021-09-10|2021-09-14|3|7
Study ID|SE|9c2bc89e-2ac0-412d-8a6b-f2e0b8dd2ca3|4|P|5|TREATMENT|2022-05-15|2022-06-24|250|290
Study ID|SE|9c2bc89e-2ac0-412d-8a6b-f2e0b8dd2ca3|5|REST|2|WASHOUT|2021-11-09|2021-11-29|63|83
Study ID|SE|9c2bc89e-2ac0-412d-8a6b-f2e0b8dd2ca3|6|10|3|TREATMENT|2021-12-23|2022-02-05|107|151
Study ID|SE|9c2bc89e-2ac0-412d-8a6b-f2e0b8dd2ca3|7|FU|4|FOLLOW-UP|2021-10-19|2022-01-20|42|135
Study ID|SE|31f9ea80-527d-4eb4-ad98-6688f6347d39|1|SCRN|2|SCREENING|2021-09-29|2021-11-30|38|100
Study ID|SE|31f9ea80-527d-4eb4-ad98-6688f6347d39|2|5|3|TREATMENT|2021-08-25|2021-08-28|3|6
Study ID|SE|31f9ea80-527d-4eb4-ad98-6688f6347d39|3|REST|5|WASHOUT|2021-12-06|2021-12-19|106|119
Study ID|SE|31f9ea80-527d-4eb4-ad98-6688f6347d39|4|P|7|TREATMENT|2021-11-09|2021-11-12|79|82
Study ID|SE|31f9ea80-527d-4eb4-ad98-6688f6347d39|5|REST|7|WASHOUT|2021-09-29|2021-10-18|38|57
Study ID|SE|31f9ea80-527d-4eb4-ad98-6688f6347d39|6|10|2|TREATMENT|2021-09-03|2022-05-20|12|271
Study ID|SE|31f9ea80-527d-4eb4-ad98-6688f6347d39|7|FU|6|FOLLOW-UP|2021-10-13|2021-11-04|52|74
Study ID|SE|5e138a4b-9752-4d7c-8e14-5287394d5e66|1|SCRN|7|SCREENING|2022-02-02|2022-04-03|117|177
Study ID|SE|5e138a4b-9752-4d7c-8e14-5287394d5e66|2|5|2|TREATMENT|2022-04-15|2022-07-26|189|291
Study ID|SE|5e138a4b-9752-4d7c-8e14-5287394d5e66|3|REST|6|WASHOUT|2021-10-25|2022-03-30|17|173
Study ID|SE|5e138a4b-9752-4d7c-8e14-5287394d5e66|4|P|7|TREATMENT|2022-03-07|2022-07-09|150|274
Study ID|SE|5e138a4b-9752-4d7c-8e14-5287394d5e66|5|REST|7|WASHOUT|2021-11-08|2022-02-02|31|117
Study ID|SE|5e138a4b-9752-4d7c-8e14-5287394d5e66|6|10|5|TREATMENT|2021-10-10|2021-11-15|2|38
Study ID|SE|5e138a4b-9752-4d7c-8e14-5287394d5e66|7|FU|4|FOLLOW-UP|2022-01-21|2022-02-26|105|141
Study ID|SE|fff8406a-d54f-42c4-84df-3dc1c8a00753|1|SCRN|3|SCREENING|2021-10-04|2021-10-10|58|64
Study ID|SE|fff8406a-d54f-42c4-84df-3dc1c8a00753|2|5|5|TREATMENT|2021-08-12|2021-09-02|5|26
Study ID|SE|fff8406a-d54f-42c4-84df-3dc1c8a00753|3|REST|7|WASHOUT|2021-08-23|2022-04-05|16|241
Study ID|SE|fff8406a-d54f-42c4-84df-3dc1c8a00753|4|P|4|TREATMENT|2021-09-23|2021-12-30|47|145
Study ID|SE|fff8406a-d54f-42c4-84df-3dc1c8a00753|5|REST|7|WASHOUT|2021-10-06|2022-05-16|60|282
Study ID|SE|fff8406a-d54f-42c4-84df-3dc1c8a00753|6|10|6|TREATMENT|2021-09-03|2021-10-07|27|61
Study ID|SE|fff8406a-d54f-42c4-84df-3dc1c8a00753|7|FU|3|FOLLOW-UP|2021-09-08|2021-09-10|32|34
Study ID|SE|22095a9b-6771-4df2-aa8f-1830ecffbbb2|1|SCRN|1|SCREENING|2021-09-28|2021-09-29|28|29
Study ID|SE|22095a9b-6771-4df2-aa8f-1830ecffbbb2|2|5|3|TREATMENT|2021-10-06|2021-10-24|36|54
Study ID|SE|22095a9b-6771-4df2-aa8f-1830ecffbbb2|3|REST|7|WASHOUT|2021-10-31|2022-04-04|61|216
Study ID|SE|22095a9b-6771-4df2-aa8f-1830ecffbbb2|4|P|4|TREATMENT|2022-01-08|2022-04-19|130|231
Study ID|SE|22095a9b-6771-4df2-aa8f-1830ecffbbb2|5|REST|7|WASHOUT|2021-09-02|2021-09-04|2|4
Study ID|SE|22095a9b-6771-4df2-aa8f-1830ecffbbb2|6|10|1|TREATMENT|2021-12-19|2022-02-25|110|178
Study ID|SE|22095a9b-6771-4df2-aa8f-1830ecffbbb2|7|FU|6|FOLLOW-UP|2021-10-03|2021-12-02|33|93
Study ID|SE|626e1e91-37a9-4d83-999c-e073773869f5|1|SCRN|4|SCREENING|2021-10-11|2021-10-31|51|71
Study ID|SE|626e1e91-37a9-4d83-999c-e073773869f5|2|5|3|TREATMENT|2021-08-28|2021-11-04|7|75
Study ID|SE|626e1e91-37a9-4d83-999c-e073773869f5|3|REST|4|WASHOUT|2022-01-05|2022-01-21|137|153
Study ID|SE|626e1e91-37a9-4d83-999c-e073773869f5|4|P|1|TREATMENT|2021-10-03|2021-11-05|43|76
Study ID|SE|626e1e91-37a9-4d83-999c-e073773869f5|5|REST|4|WASHOUT|2022-01-26|2022-06-16|158|299
Study ID|SE|626e1e91-37a9-4d83-999c-e073773869f5|6|10|6|TREATMENT|2021-12-26|2022-01-20|127|152
Study ID|SE|626e1e91-37a9-4d83-999c-e073773869f5|7|FU|6|FOLLOW-UP|2021-08-24|2021-08-25|3|4
Study ID|SE|0303e1ae-d354-4808-9f64-f02c8ac612b3|1|SCRN|6|SCREENING|2021-09-25|2022-01-20|37|154
Study ID|SE|0303e1ae-d354-4808-9f64-f02c8ac612b3|2|5|7|TREATMENT|2021-10-27|2022-02-25|69|190
Study ID|SE|0303e1ae-d354-4808-9f64-f02c8ac612b3|3|REST|1|WASHOUT|2021-12-22|2022-02-21|125|186
Study ID|SE|0303e1ae-d354-4808-9f64-f02c8ac612b3|4|10|2|TREATMENT|2021-08-22|2021-08-25|3|6
Study ID|SE|0303e1ae-d354-4808-9f64-f02c8ac612b3|5|REST|7|WASHOUT|2021-10-11|2021-12-31|53|134
Study ID|SE|0303e1ae-d354-4808-9f64-f02c8ac612b3|6|P|6|TREATMENT|2022-03-16|2022-04-08|209|232
Study ID|SE|0303e1ae-d354-4808-9f64-f02c8ac612b3|7|FU|2|FOLLOW-UP|2021-10-05|2022-01-30|47|164
Study ID|SE|1281079e-bc3d-48c8-b66d-a5ac44b50c84|1|SCRN|4|SCREENING|2021-10-11|2021-10-16|2|7
Study ID|SE|1281079e-bc3d-48c8-b66d-a5ac44b50c84|2|5|2|TREATMENT|2021-12-22|2022-05-10|74|213
Study ID|SE|1281079e-bc3d-48c8-b66d-a5ac44b50c84|3|REST|7|WASHOUT|2021-10-19|2022-01-20|10|103
Study ID|SE|1281079e-bc3d-48c8-b66d-a5ac44b50c84|4|P|4|TREATMENT|2021-11-05|2021-11-10|27|32
Study ID|SE|1281079e-bc3d-48c8-b66d-a5ac44b50c84|5|REST|3|WASHOUT|2021-11-20|2021-12-09|42|61
Study ID|SE|1281079e-bc3d-48c8-b66d-a5ac44b50c84|6|10|5|TREATMENT|2022-01-02|2022-05-07|85|210
Study ID|SE|1281079e-bc3d-48c8-b66d-a5ac44b50c84|7|FU|7|FOLLOW-UP|2022-04-23|2022-05-08|196|211
Study ID|SE|75a8da56-f2e9-4b0c-aa93-848992cff6f5|1|SCRN|7|SCREENING|2021-11-15|2021-11-19|18|22
Study ID|SE|75a8da56-f2e9-4b0c-aa93-848992cff6f5|2|5|5|TREATMENT|2022-01-27|2022-07-22|91|267
Study ID|SE|75a8da56-f2e9-4b0c-aa93-848992cff6f5|3|REST|4|WASHOUT|2021-12-11|2022-02-07|44|102
Study ID|SE|75a8da56-f2e9-4b0c-aa93-848992cff6f5|4|P|2|TREATMENT|2021-12-06|2021-12-22|39|55
Study ID|SE|75a8da56-f2e9-4b0c-aa93-848992cff6f5|5|REST|2|WASHOUT|2021-12-05|2022-04-01|38|155
Study ID|SE|75a8da56-f2e9-4b0c-aa93-848992cff6f5|6|10|6|TREATMENT|2021-11-10|2021-11-22|13|25
Study ID|SE|75a8da56-f2e9-4b0c-aa93-848992cff6f5|7|FU|2|FOLLOW-UP|2022-06-27|2022-08-17|242|293
Study ID|SE|28957af8-b000-4d8f-8557-8580445d7f2f|1|SCRN|7|SCREENING|2022-01-31|2022-06-18|159|297
Study ID|SE|28957af8-b000-4d8f-8557-8580445d7f2f|2|5|5|TREATMENT|2022-03-09|2022-04-24|196|242
Study ID|SE|28957af8-b000-4d8f-8557-8580445d7f2f|3|REST|3|WASHOUT|2021-11-07|2022-05-08|74|256
Study ID|SE|28957af8-b000-4d8f-8557-8580445d7f2f|4|10|4|TREATMENT|2021-10-13|2022-03-10|49|197
Study ID|SE|28957af8-b000-4d8f-8557-8580445d7f2f|5|REST|5|WASHOUT|2021-11-18|2021-12-10|85|107
Study ID|SE|28957af8-b000-4d8f-8557-8580445d7f2f|6|P|6|TREATMENT|2021-12-06|2022-06-02|103|281
Study ID|SE|28957af8-b000-4d8f-8557-8580445d7f2f|7|FU|4|FOLLOW-UP|2021-08-28|2021-10-02|3|38
Study ID|SE|61a0979d-56bb-41c0-9b78-6d99b39f776f|1|SCRN|2|SCREENING|2021-11-22|2022-01-04|87|130
Study ID|SE|61a0979d-56bb-41c0-9b78-6d99b39f776f|2|5|3|TREATMENT|2021-10-27|2021-11-20|61|85
Study ID|SE|61a0979d-56bb-41c0-9b78-6d99b39f776f|3|REST|5|WASHOUT|2021-10-31|2022-01-05|65|131
Study ID|SE|61a0979d-56bb-41c0-9b78-6d99b39f776f|4|P|5|TREATMENT|2022-01-01|2022-03-07|127|192
Study ID|SE|61a0979d-56bb-41c0-9b78-6d99b39f776f|5|REST|7|WASHOUT|2021-11-24|2022-03-29|89|214
Study ID|SE|61a0979d-56bb-41c0-9b78-6d99b39f776f|6|10|4|TREATMENT|2022-01-16|2022-02-10|142|167
Study ID|SE|61a0979d-56bb-41c0-9b78-6d99b39f776f|7|FU|5|FOLLOW-UP|2021-09-26|2021-10-26|30|60
Study ID|SE|6aaeef9d-a806-4440-8b57-98a81398d67d|1|SCRN|4|SCREENING|2021-12-18|2022-02-21|111|176
Study ID|SE|6aaeef9d-a806-4440-8b57-98a81398d67d|2|P|6|TREATMENT|2022-02-14|2022-04-28|169|242
Study ID|SE|6aaeef9d-a806-4440-8b57-98a81398d67d|3|REST|7|WASHOUT|2021-10-11|2021-12-30|43|123
Study ID|SE|6aaeef9d-a806-4440-8b57-98a81398d67d|4|5|3|TREATMENT|2021-10-04|2022-02-01|36|156
Study ID|SE|6aaeef9d-a806-4440-8b57-98a81398d67d|5|REST|1|WASHOUT|2021-09-02|2021-11-23|4|86
Study ID|SE|6aaeef9d-a806-4440-8b57-98a81398d67d|6|10|5|TREATMENT|2021-09-24|2021-10-02|26|34
Study ID|SE|6aaeef9d-a806-4440-8b57-98a81398d67d|7|FU|1|FOLLOW-UP|2021-09-13|2021-10-07|15|39
Study ID|SE|65b0ce2c-b9c5-4c7f-a8aa-4bd6d555304b|1|SCRN|6|SCREENING|2022-01-13|2022-03-28|100|174
Study ID|SE|65b0ce2c-b9c5-4c7f-a8aa-4bd6d555304b|2|5|2|TREATMENT|2022-03-07|2022-03-13|153|159
Study ID|SE|65b0ce2c-b9c5-4c7f-a8aa-4bd6d555304b|3|REST|4|WASHOUT|2021-10-31|2022-06-17|26|255
Study ID|SE|65b0ce2c-b9c5-4c7f-a8aa-4bd6d555304b|4|10|2|TREATMENT|2022-03-29|2022-04-19|175|196
Study ID|SE|65b0ce2c-b9c5-4c7f-a8aa-4bd6d555304b|5|REST|7|WASHOUT|2022-04-12|2022-06-24|189|262
Study ID|SE|65b0ce2c-b9c5-4c7f-a8aa-4bd6d555304b|6|P|7|TREATMENT|2021-11-18|2022-04-27|44|204
Study ID|SE|65b0ce2c-b9c5-4c7f-a8aa-4bd6d555304b|7|FU|5|FOLLOW-UP|2021-10-17|2021-10-18|12|13
Study ID|SE|d3acc9bf-719d-4f9f-9ee8-542bb9778058|1|SCRN|3|SCREENING|2021-11-24|2022-02-23|32|123
Study ID|SE|d3acc9bf-719d-4f9f-9ee8-542bb9778058|2|5|7|TREATMENT|2022-01-14|2022-04-13|83|172
Study ID|SE|d3acc9bf-719d-4f9f-9ee8-542bb9778058|3|REST|6|WASHOUT|2021-10-29|2021-11-13|6|21
Study ID|SE|d3acc9bf-719d-4f9f-9ee8-542bb9778058|4|10|4|TREATMENT|2021-10-29|2021-12-27|6|65
Study ID|SE|d3acc9bf-719d-4f9f-9ee8-542bb9778058|5|REST|6|WASHOUT|2022-06-30|2022-07-28|250|278
Study ID|SE|d3acc9bf-719d-4f9f-9ee8-542bb9778058|6|P|2|TREATMENT|2021-11-23|2022-06-12|31|232
Study ID|SE|d3acc9bf-719d-4f9f-9ee8-542bb9778058|7|FU|2|FOLLOW-UP|2021-12-06|2022-03-16|44|144
Study ID|SE|9a35b233-5288-4376-9c63-5b86f8f6672d|1|SCRN|3|SCREENING|2021-11-15|2021-12-17|21|53
Study ID|SE|9a35b233-5288-4376-9c63-5b86f8f6672d|2|P|6|TREATMENT|2022-01-31|2022-02-10|98|108
Study ID|SE|9a35b233-5288-4376-9c63-5b86f8f6672d|3|REST|7|WASHOUT|2021-12-21|2022-03-19|57|145
Study ID|SE|9a35b233-5288-4376-9c63-5b86f8f6672d|4|5|1|TREATMENT|2021-11-08|2021-11-17|14|23
Study ID|SE|9a35b233-5288-4376-9c63-5b86f8f6672d|5|REST|5|WASHOUT|2022-01-09|2022-03-19|76|145
Study ID|SE|9a35b233-5288-4376-9c63-5b86f8f6672d|6|10|5|TREATMENT|2022-01-04|2022-02-12|71|110
Study ID|SE|9a35b233-5288-4376-9c63-5b86f8f6672d|7|FU|5|FOLLOW-UP|2022-01-26|2022-04-03|93|160
Study ID|SE|e3d54bd1-a96e-4415-8c47-3476c9c7236b|1|SCRN|3|SCREENING|2021-11-02|2021-12-15|9|52
Study ID|SE|e3d54bd1-a96e-4415-8c47-3476c9c7236b|2|5|1|TREATMENT|2022-02-05|2022-02-26|104|125
Study ID|SE|e3d54bd1-a96e-4415-8c47-3476c9c7236b|3|REST|7|WASHOUT|2021-11-14|2022-02-14|21|113
Study ID|SE|e3d54bd1-a96e-4415-8c47-3476c9c7236b|4|10|2|TREATMENT|2021-11-15|2022-04-07|22|165
Study ID|SE|e3d54bd1-a96e-4415-8c47-3476c9c7236b|5|REST|4|WASHOUT|2021-12-23|2022-02-20|60|119
Study ID|SE|e3d54bd1-a96e-4415-8c47-3476c9c7236b|6|P|6|TREATMENT|2022-04-02|2022-05-04|160|192
Study ID|SE|e3d54bd1-a96e-4415-8c47-3476c9c7236b|7|FU|1|FOLLOW-UP|2022-02-11|2022-08-18|110|298
Study ID|SE|abaea736-f6c5-4354-b783-5931177c9c7b|1|SCRN|4|SCREENING|2022-04-07|2022-07-28|180|292
Study ID|SE|abaea736-f6c5-4354-b783-5931177c9c7b|2|P|4|TREATMENT|2022-03-01|2022-04-23|143|196
Study ID|SE|abaea736-f6c5-4354-b783-5931177c9c7b|3|REST|1|WASHOUT|2022-03-09|2022-06-02|151|236
Study ID|SE|abaea736-f6c5-4354-b783-5931177c9c7b|4|5|5|TREATMENT|2021-11-04|2022-05-25|26|228
Study ID|SE|abaea736-f6c5-4354-b783-5931177c9c7b|5|REST|2|WASHOUT|2021-11-25|2021-12-11|47|63
Study ID|SE|abaea736-f6c5-4354-b783-5931177c9c7b|6|10|2|TREATMENT|2022-03-04|2022-07-28|146|292
Study ID|SE|abaea736-f6c5-4354-b783-5931177c9c7b|7|FU|4|FOLLOW-UP|2022-01-13|2022-02-07|96|121
Study ID|SE|7d60d223-5bcf-4607-96a8-602c2de91f32|1|SCRN|1|SCREENING|2022-02-12|2022-02-23|181|192
Study ID|SE|7d60d223-5bcf-4607-96a8-602c2de91f32|2|P|6|TREATMENT|2021-12-31|2022-01-15|138|153
Study ID|SE|7d60d223-5bcf-4607-96a8-602c2de91f32|3|REST|3|WASHOUT|2021-11-11|2021-11-17|88|94
Study ID|SE|7d60d223-5bcf-4607-96a8-602c2de91f32|4|5|6|TREATMENT|2021-12-30|2022-02-10|137|179
Study ID|SE|7d60d223-5bcf-4607-96a8-602c2de91f32|5|REST|3|WASHOUT|2021-11-04|2022-01-01|81|139
Study ID|SE|7d60d223-5bcf-4607-96a8-602c2de91f32|6|10|6|TREATMENT|2021-09-06|2021-09-08|22|24
Study ID|SE|7d60d223-5bcf-4607-96a8-602c2de91f32|7|FU|6|FOLLOW-UP|2021-09-07|2021-09-19|23|35
Study ID|SE|8a49d289-4d0d-45a6-aafd-79d3a1469c30|1|SCRN|3|SCREENING|2022-02-28|2022-04-13|129|173
Study ID|SE|8a49d289-4d0d-45a6-aafd-79d3a1469c30|2|5|5|TREATMENT|2021-12-29|2022-01-04|68|74
Study ID|SE|8a49d289-4d0d-45a6-aafd-79d3a1469c30|3|REST|1|WASHOUT|2021-12-01|2022-05-02|40|192
Study ID|SE|8a49d289-4d0d-45a6-aafd-79d3a1469c30|4|10|4|TREATMENT|2021-11-05|2022-05-31|14|221
Study ID|SE|8a49d289-4d0d-45a6-aafd-79d3a1469c30|5|REST|5|WASHOUT|2022-01-06|2022-03-07|76|136
Study ID|SE|8a49d289-4d0d-45a6-aafd-79d3a1469c30|6|P|4|TREATMENT|2021-11-05|2022-04-25|14|185
Study ID|SE|8a49d289-4d0d-45a6-aafd-79d3a1469c30|7|FU|1|FOLLOW-UP|2021-11-22|2022-02-14|31|115
Study ID|SE|38fc7d5f-a83a-41e0-9cc2-00962bb1e016|1|SCRN|7|SCREENING|2021-09-16|2021-12-23|24|122
Study ID|SE|38fc7d5f-a83a-41e0-9cc2-00962bb1e016|2|5|1|TREATMENT|2021-10-28|2022-01-17|66|147
Study ID|SE|38fc7d5f-a83a-41e0-9cc2-00962bb1e016|3|REST|2|WASHOUT|2021-09-13|2021-09-16|21|24
Study ID|SE|38fc7d5f-a83a-41e0-9cc2-00962bb1e016|4|10|5|TREATMENT|2022-01-13|2022-06-06|143|287
Study ID|SE|38fc7d5f-a83a-41e0-9cc2-00962bb1e016|5|REST|7|WASHOUT|2021-08-26|2021-11-05|3|74
Study ID|SE|38fc7d5f-a83a-41e0-9cc2-00962bb1e016|6|P|4|TREATMENT|2021-11-22|2022-03-10|91|199
Study ID|SE|38fc7d5f-a83a-41e0-9cc2-00962bb1e016|7|FU|2|FOLLOW-UP|2022-02-01|2022-06-03|162|284
Study ID|SE|8cb8b17b-558f-4b2f-b773-38119cbeed97|1|SCRN|1|SCREENING|2021-10-13|2021-12-03|54|105
Study ID|SE|8cb8b17b-558f-4b2f-b773-38119cbeed97|2|5|5|TREATMENT|2021-09-17|2022-03-31|28|223
Study ID|SE|8cb8b17b-558f-4b2f-b773-38119cbeed97|3|REST|3|WASHOUT|2021-12-23|2022-05-07|125|260
Study ID|SE|8cb8b17b-558f-4b2f-b773-38119cbeed97|4|P|3|TREATMENT|2021-11-15|2021-12-26|87|128
Study ID|SE|8cb8b17b-558f-4b2f-b773-38119cbeed97|5|REST|1|WASHOUT|2021-12-09|2022-05-02|111|255
Study ID|SE|8cb8b17b-558f-4b2f-b773-38119cbeed97|6|10|7|TREATMENT|2021-10-08|2022-06-09|49|293
Study ID|SE|8cb8b17b-558f-4b2f-b773-38119cbeed97|7|FU|6|FOLLOW-UP|2021-09-29|2021-10-13|40|54
Study ID|SE|326bc136-7ef2-48a6-bf25-72481da70ba6|1|SCRN|1|SCREENING|2021-11-09|2022-03-11|77|199
Study ID|SE|326bc136-7ef2-48a6-bf25-72481da70ba6|2|5|2|TREATMENT|2021-10-15|2021-10-28|52|65
Study ID|SE|326bc136-7ef2-48a6-bf25-72481da70ba6|3|REST|6|WASHOUT|2021-12-02|2022-04-15|100|234
Study ID|SE|326bc136-7ef2-48a6-bf25-72481da70ba6|4|10|1|TREATMENT|2021-11-01|2021-11-17|69|85
Study ID|SE|326bc136-7ef2-48a6-bf25-72481da70ba6|5|REST|5|WASHOUT|2021-09-23|2021-10-23|30|60
Study ID|SE|326bc136-7ef2-48a6-bf25-72481da70ba6|6|P|7|TREATMENT|2021-09-16|2021-10-01|23|38
Study ID|SE|326bc136-7ef2-48a6-bf25-72481da70ba6|7|FU|5|FOLLOW-UP|2021-12-19|2022-04-11|117|230
Study ID|SE|31859576-209e-409e-b331-46285e48e2b4|1|SCRN|5|SCREENING|2022-03-22|2022-07-31|168|299
Study ID|SE|31859576-209e-409e-b331-46285e48e2b4|2|P|1|TREATMENT|2021-10-13|2021-10-17|8|12
Study ID|SE|31859576-209e-409e-b331-46285e48e2b4|3|REST|3|WASHOUT|2021-11-20|2022-06-30|46|268
Study ID|SE|31859576-209e-409e-b331-46285e48e2b4|4|5|5|TREATMENT|2022-01-18|2022-04-11|105|188
Study ID|SE|31859576-209e-409e-b331-46285e48e2b4|5|REST|1|WASHOUT|2021-12-21|2022-04-01|77|178
Study ID|SE|31859576-209e-409e-b331-46285e48e2b4|6|10|7|TREATMENT|2021-10-31|2022-06-30|26|268
Study ID|SE|31859576-209e-409e-b331-46285e48e2b4|7|FU|7|FOLLOW-UP|2021-10-09|2022-01-10|4|97
Study ID|SE|3432d463-0704-492c-aab8-f47f1eefdf0f|1|SCRN|1|SCREENING|2021-10-21|2022-01-28|47|146
Study ID|SE|3432d463-0704-492c-aab8-f47f1eefdf0f|2|5|7|TREATMENT|2021-12-01|2022-05-29|88|267
Study ID|SE|3432d463-0704-492c-aab8-f47f1eefdf0f|3|REST|6|WASHOUT|2022-01-07|2022-02-20|125|169
Study ID|SE|3432d463-0704-492c-aab8-f47f1eefdf0f|4|P|6|TREATMENT|2021-10-12|2021-11-17|38|74
Study ID|SE|3432d463-0704-492c-aab8-f47f1eefdf0f|5|REST|5|WASHOUT|2021-10-27|2021-12-25|53|112
Study ID|SE|3432d463-0704-492c-aab8-f47f1eefdf0f|6|10|1|TREATMENT|2022-04-14|2022-06-20|222|289
Study ID|SE|3432d463-0704-492c-aab8-f47f1eefdf0f|7|FU|6|FOLLOW-UP|2021-09-18|2021-10-14|14|40
Study ID|SE|e5cf09f7-8ebb-4b96-bb18-a6e0281d8e4f|1|SCRN|6|SCREENING|2021-10-22|2021-11-21|12|42
Study ID|SE|e5cf09f7-8ebb-4b96-bb18-a6e0281d8e4f|2|P|5|TREATMENT|2021-11-27|2022-06-18|48|251
Study ID|SE|e5cf09f7-8ebb-4b96-bb18-a6e0281d8e4f|3|REST|4|WASHOUT|2021-12-19|2022-06-03|70|236
Study ID|SE|e5cf09f7-8ebb-4b96-bb18-a6e0281d8e4f|4|5|2|TREATMENT|2021-12-31|2022-02-24|82|137
Study ID|SE|e5cf09f7-8ebb-4b96-bb18-a6e0281d8e4f|5|REST|6|WASHOUT|2021-10-13|2021-10-19|3|9
Study ID|SE|e5cf09f7-8ebb-4b96-bb18-a6e0281d8e4f|6|10|3|TREATMENT|2022-03-05|2022-03-15|146|156
Study ID|SE|e5cf09f7-8ebb-4b96-bb18-a6e0281d8e4f|7|FU|2|FOLLOW-UP|2022-03-27|2022-07-25|168|288
Study ID|SE|4ec49792-4081-4e07-a478-009f715fe92f|1|SCRN|4|SCREENING|2021-08-29|2021-11-14|3|80
Study ID|SE|4ec49792-4081-4e07-a478-009f715fe92f|2|5|1|TREATMENT|2021-09-03|2021-11-25|8|91
Study ID|SE|4ec49792-4081-4e07-a478-009f715fe92f|3|REST|4|WASHOUT|2021-10-02|2021-12-05|37|101
Study ID|SE|4ec49792-4081-4e07-a478-009f715fe92f|4|10|6|TREATMENT|2021-11-09|2021-12-29|75|125
Study ID|SE|4ec49792-4081-4e07-a478-009f715fe92f|5|REST|2|WASHOUT|2022-01-15|2022-02-15|142|173
Study ID|SE|4ec49792-4081-4e07-a478-009f715fe92f|6|P|5|TREATMENT|2022-01-03|2022-03-26|130|212
Study ID|SE|4ec49792-4081-4e07-a478-009f715fe92f|7|FU|4|FOLLOW-UP|2021-10-31|2022-02-01|66|159
Study ID|SE|395bc1a2-3aa9-4efa-b468-899beabd1001|1|SCRN|6|SCREENING|2021-10-30|2022-01-30|73|165
Study ID|SE|395bc1a2-3aa9-4efa-b468-899beabd1001|2|5|1|TREATMENT|2021-10-16|2022-03-18|59|212
Study ID|SE|395bc1a2-3aa9-4efa-b468-899beabd1001|3|REST|3|WASHOUT|2021-11-17|2022-01-15|91|150
Study ID|SE|395bc1a2-3aa9-4efa-b468-899beabd1001|4|10|7|TREATMENT|2021-10-17|2021-12-13|60|117
Study ID|SE|395bc1a2-3aa9-4efa-b468-899beabd1001|5|REST|6|WASHOUT|2021-10-20|2022-02-26|63|192
Study ID|SE|395bc1a2-3aa9-4efa-b468-899beabd1001|6|P|6|TREATMENT|2021-08-23|2021-09-02|5|15
Study ID|SE|395bc1a2-3aa9-4efa-b468-899beabd1001|7|FU|5|FOLLOW-UP|2021-09-29|2021-10-17|42|60
Study ID|SE|1c47e5f6-4e35-409c-a891-ab52f28a0400|1|SCRN|3|SCREENING|2021-12-08|2022-02-28|58|140
Study ID|SE|1c47e5f6-4e35-409c-a891-ab52f28a0400|2|5|2|TREATMENT|2021-10-18|2021-11-07|7|27
Study ID|SE|1c47e5f6-4e35-409c-a891-ab52f28a0400|3|REST|1|WASHOUT|2021-10-15|2021-12-07|4|57
Study ID|SE|1c47e5f6-4e35-409c-a891-ab52f28a0400|4|P|7|TREATMENT|2022-01-21|2022-02-27|102|139
Study ID|SE|1c47e5f6-4e35-409c-a891-ab52f28a0400|5|REST|7|WASHOUT|2021-12-05|2022-05-02|55|203
Study ID|SE|1c47e5f6-4e35-409c-a891-ab52f28a0400|6|10|5|TREATMENT|2021-10-18|2022-04-26|7|197
Study ID|SE|1c47e5f6-4e35-409c-a891-ab52f28a0400|7|FU|1|FOLLOW-UP|2021-11-07|2021-12-18|27|68
Study ID|SE|f102dfe2-cca3-4f55-a66b-858ca672663f|1|SCRN|4|SCREENING|2021-11-09|2021-12-28|22|71
Study ID|SE|f102dfe2-cca3-4f55-a66b-858ca672663f|2|5|1|TREATMENT|2022-02-15|2022-02-24|120|129
Study ID|SE|f102dfe2-cca3-4f55-a66b-858ca672663f|3|REST|5|WASHOUT|2021-10-27|2021-11-19|9|32
Study ID|SE|f102dfe2-cca3-4f55-a66b-858ca672663f|4|P|7|TREATMENT|2021-11-14|2022-01-02|27|76
Study ID|SE|f102dfe2-cca3-4f55-a66b-858ca672663f|5|REST|4|WASHOUT|2022-03-18|2022-08-05|151|291
Study ID|SE|f102dfe2-cca3-4f55-a66b-858ca672663f|6|10|1|TREATMENT|2021-10-31|2022-07-04|13|259
Study ID|SE|f102dfe2-cca3-4f55-a66b-858ca672663f|7|FU|1|FOLLOW-UP|2022-02-19|2022-05-29|124|223
Study ID|SE|a306acbd-a329-497f-9d5d-2787ea6700be|1|SCRN|6|SCREENING|2021-10-25|2022-05-06|66|259
Study ID|SE|a306acbd-a329-497f-9d5d-2787ea6700be|2|5|7|TREATMENT|2021-12-20|2022-03-27|122|219
Study ID|SE|a306acbd-a329-497f-9d5d-2787ea6700be|3|REST|2|WASHOUT|2021-12-19|2022-05-15|121|268
Study ID|SE|a306acbd-a329-497f-9d5d-2787ea6700be|4|10|5|TREATMENT|2021-09-15|2021-11-08|26|80
Study ID|SE|a306acbd-a329-497f-9d5d-2787ea6700be|5|REST|2|WASHOUT|2022-05-07|2022-05-21|260|274
Study ID|SE|a306acbd-a329-497f-9d5d-2787ea6700be|6|P|5|TREATMENT|2021-09-18|2021-09-19|29|30
Study ID|SE|a306acbd-a329-497f-9d5d-2787ea6700be|7|FU|5|FOLLOW-UP|2021-10-18|2021-12-31|59|133
Study ID|SE|ee62f692-ae79-49c2-9495-a50194feba65|1|SCRN|7|SCREENING|2022-06-30|2022-07-21|264|285
Study ID|SE|ee62f692-ae79-49c2-9495-a50194feba65|2|P|6|TREATMENT|2022-01-09|2022-03-21|92|163
Study ID|SE|ee62f692-ae79-49c2-9495-a50194feba65|3|REST|4|WASHOUT|2021-11-30|2021-12-09|52|61
Study ID|SE|ee62f692-ae79-49c2-9495-a50194feba65|4|5|4|TREATMENT|2021-12-23|2022-01-01|75|84
Study ID|SE|ee62f692-ae79-49c2-9495-a50194feba65|5|REST|1|WASHOUT|2021-10-25|2021-11-06|16|28
Study ID|SE|ee62f692-ae79-49c2-9495-a50194feba65|6|10|4|TREATMENT|2021-10-31|2021-11-04|22|26
Study ID|SE|ee62f692-ae79-49c2-9495-a50194feba65|7|FU|7|FOLLOW-UP|2021-11-05|2021-11-20|27|42
Study ID|SE|6848c047-d167-4a31-b2dc-0175ab0e9fb5|1|SCRN|4|SCREENING|2021-12-18|2022-06-21|56|241
Study ID|SE|6848c047-d167-4a31-b2dc-0175ab0e9fb5|2|5|7|TREATMENT|2022-02-02|2022-06-19|102|239
Study ID|SE|6848c047-d167-4a31-b2dc-0175ab0e9fb5|3|REST|3|WASHOUT|2021-11-03|2022-03-30|11|158
Study ID|SE|6848c047-d167-4a31-b2dc-0175ab0e9fb5|4|P|7|TREATMENT|2022-03-22|2022-06-11|150|231
Study ID|SE|6848c047-d167-4a31-b2dc-0175ab0e9fb5|5|REST|6|WASHOUT|2021-12-24|2022-04-16|62|175
Study ID|SE|6848c047-d167-4a31-b2dc-0175ab0e9fb5|6|10|7|TREATMENT|2021-11-08|2021-11-09|16|17
Study ID|SE|6848c047-d167-4a31-b2dc-0175ab0e9fb5|7|FU|7|FOLLOW-UP|2021-12-19|2022-01-11|57|80
Study ID|SE|3634f8d0-a8c2-476a-a10f-be394a45de2f|1|SCRN|5|SCREENING|2021-12-31|2022-06-03|106|260
Study ID|SE|3634f8d0-a8c2-476a-a10f-be394a45de2f|2|P|1|TREATMENT|2021-11-18|2021-11-30|63|75
Study ID|SE|3634f8d0-a8c2-476a-a10f-be394a45de2f|3|REST|7|WASHOUT|2021-10-04|2021-11-14|18|59
Study ID|SE|3634f8d0-a8c2-476a-a10f-be394a45de2f|4|5|2|TREATMENT|2021-10-23|2022-01-15|37|121
Study ID|SE|3634f8d0-a8c2-476a-a10f-be394a45de2f|5|REST|6|WASHOUT|2021-09-23|2021-11-20|7|65
Study ID|SE|3634f8d0-a8c2-476a-a10f-be394a45de2f|6|10|3|TREATMENT|2021-11-11|2022-05-02|56|228
Study ID|SE|3634f8d0-a8c2-476a-a10f-be394a45de2f|7|FU|2|FOLLOW-UP|2021-10-12|2021-11-24|26|69
Study ID|SE|8406f0e0-f958-4cbf-b2f8-209bdc55cec5|1|SCRN|2|SCREENING|2021-11-26|2022-06-17|75|278
Study ID|SE|8406f0e0-f958-4cbf-b2f8-209bdc55cec5|2|5|3|TREATMENT|2021-12-28|2022-02-18|107|159
Study ID|SE|8406f0e0-f958-4cbf-b2f8-209bdc55cec5|3|REST|3|WASHOUT|2022-02-19|2022-02-28|160|169
Study ID|SE|8406f0e0-f958-4cbf-b2f8-209bdc55cec5|4|10|2|TREATMENT|2022-02-14|2022-02-16|155|157
Study ID|SE|8406f0e0-f958-4cbf-b2f8-209bdc55cec5|5|REST|1|WASHOUT|2022-01-17|2022-02-10|127|151
Study ID|SE|8406f0e0-f958-4cbf-b2f8-209bdc55cec5|6|P|5|TREATMENT|2022-02-24|2022-04-15|165|215
Study ID|SE|8406f0e0-f958-4cbf-b2f8-209bdc55cec5|7|FU|1|FOLLOW-UP|2021-10-04|2021-11-03|22|52
Study ID|SE|a625107a-976d-4442-9bcd-06fb6630e271|1|SCRN|4|SCREENING|2021-11-15|2022-03-02|49|156
Study ID|SE|a625107a-976d-4442-9bcd-06fb6630e271|2|5|2|TREATMENT|2022-04-07|2022-05-02|192|217
Study ID|SE|a625107a-976d-4442-9bcd-06fb6630e271|3|REST|5|WASHOUT|2021-11-14|2021-11-24|48|58
Study ID|SE|a625107a-976d-4442-9bcd-06fb6630e271|4|P|6|TREATMENT|2021-10-06|2021-12-27|9|91
Study ID|SE|a625107a-976d-4442-9bcd-06fb6630e271|5|REST|2|WASHOUT|2021-12-29|2022-01-01|93|96
Study ID|SE|a625107a-976d-4442-9bcd-06fb6630e271|6|10|7|TREATMENT|2022-02-01|2022-05-17|127|232
Study ID|SE|a625107a-976d-4442-9bcd-06fb6630e271|7|FU|6|FOLLOW-UP|2022-01-06|2022-02-11|101|137
Study ID|SE|4de184be-ccc0-4545-8c9b-138a71194fcc|1|SCRN|6|SCREENING|2021-10-03|2021-11-23|34|85
Study ID|SE|4de184be-ccc0-4545-8c9b-138a71194fcc|2|5|5|TREATMENT|2021-09-02|2021-09-27|3|28
Study ID|SE|4de184be-ccc0-4545-8c9b-138a71194fcc|3|REST|3|WASHOUT|2021-10-17|2021-11-11|48|73
Study ID|SE|4de184be-ccc0-4545-8c9b-138a71194fcc|4|P|5|TREATMENT|2021-11-05|2022-04-05|67|218
Study ID|SE|4de184be-ccc0-4545-8c9b-138a71194fcc|5|REST|2|WASHOUT|2021-11-18|2021-12-02|80|94
Study ID|SE|4de184be-ccc0-4545-8c9b-138a71194fcc|6|10|1|TREATMENT|2022-03-02|2022-06-02|184|276
Study ID|SE|4de184be-ccc0-4545-8c9b-138a71194fcc|7|FU|1|FOLLOW-UP|2021-10-13|2021-10-17|44|48
Study ID|SE|2b3bad9f-1020-4540-8fb5-a28b1834a028|1|SCRN|2|SCREENING|2021-12-06|2022-06-07|61|244
Study ID|SE|2b3bad9f-1020-4540-8fb5-a28b1834a028|2|P|5|TREATMENT|2022-05-11|2022-05-12|217|218
Study ID|SE|2b3bad9f-1020-4540-8fb5-a28b1834a028|3|REST|7|WASHOUT|2021-10-25|2021-11-14|19|39
Study ID|SE|2b3bad9f-1020-4540-8fb5-a28b1834a028|4|5|1|TREATMENT|2022-02-12|2022-03-13|129|158
Study ID|SE|2b3bad9f-1020-4540-8fb5-a28b1834a028|5|REST|5|WASHOUT|2021-10-08|2021-10-19|2|13
Study ID|SE|2b3bad9f-1020-4540-8fb5-a28b1834a028|6|10|2|TREATMENT|2022-03-15|2022-05-28|160|234
Study ID|SE|2b3bad9f-1020-4540-8fb5-a28b1834a028|7|FU|7|FOLLOW-UP|2022-05-04|2022-06-29|210|266
Study ID|SE|6f06fdd7-9b4c-475a-9a2f-fa63b6880f6b|1|SCRN|3|SCREENING|2021-09-29|2021-10-08|18|27
Study ID|SE|6f06fdd7-9b4c-475a-9a2f-fa63b6880f6b|2|5|2|TREATMENT|2021-11-05|2022-02-26|55|168
Study ID|SE|6f06fdd7-9b4c-475a-9a2f-fa63b6880f6b|3|REST|3|WASHOUT|2021-09-21|2021-10-23|10|42
Study ID|SE|6f06fdd7-9b4c-475a-9a2f-fa63b6880f6b|4|10|5|TREATMENT|2021-11-28|2022-02-17|78|159
Study ID|SE|6f06fdd7-9b4c-475a-9a2f-fa63b6880f6b|5|REST|3|WASHOUT|2021-12-27|2022-04-10|107|211
Study ID|SE|6f06fdd7-9b4c-475a-9a2f-fa63b6880f6b|6|P|1|TREATMENT|2021-10-15|2021-11-14|34|64
Study ID|SE|6f06fdd7-9b4c-475a-9a2f-fa63b6880f6b|7|FU|6|FOLLOW-UP|2021-10-05|2022-02-25|24|167
Study ID|SE|34327bcd-ee05-4828-a302-a9edc20e9e42|1|SCRN|7|SCREENING|2021-11-29|2022-03-22|113|226
Study ID|SE|34327bcd-ee05-4828-a302-a9edc20e9e42|2|5|6|TREATMENT|2021-08-16|2021-10-04|8|57
Study ID|SE|34327bcd-ee05-4828-a302-a9edc20e9e42|3|REST|7|WASHOUT|2021-08-28|2022-01-31|20|176
Study ID|SE|34327bcd-ee05-4828-a302-a9edc20e9e42|4|P|7|TREATMENT|2021-08-10|2021-08-17|2|9
Study ID|SE|34327bcd-ee05-4828-a302-a9edc20e9e42|5|REST|7|WASHOUT|2021-08-23|2022-02-14|15|190
Study ID|SE|34327bcd-ee05-4828-a302-a9edc20e9e42|6|10|5|TREATMENT|2021-08-13|2021-08-15|5|7
Study ID|SE|34327bcd-ee05-4828-a302-a9edc20e9e42|7|FU|6|FOLLOW-UP|2021-11-30|2022-01-01|114|146
Study ID|SE|528a5210-4439-40ce-a1e7-0597f7aa9350|1|SCRN|5|SCREENING|2022-01-05|2022-07-01|104|281
Study ID|SE|528a5210-4439-40ce-a1e7-0597f7aa9350|2|5|3|TREATMENT|2021-09-25|2021-10-25|2|32
Study ID|SE|528a5210-4439-40ce-a1e7-0597f7aa9350|3|REST|6|WASHOUT|2021-12-02|2022-03-02|70|160
Study ID|SE|528a5210-4439-40ce-a1e7-0597f7aa9350|4|10|4|TREATMENT|2022-01-29|2022-02-01|128|131
Study ID|SE|528a5210-4439-40ce-a1e7-0597f7aa9350|5|REST|4|WASHOUT|2022-05-14|2022-07-14|233|294
Study ID|SE|528a5210-4439-40ce-a1e7-0597f7aa9350|6|P|3|TREATMENT|2021-12-10|2022-02-05|78|135
Study ID|SE|528a5210-4439-40ce-a1e7-0597f7aa9350|7|FU|7|FOLLOW-UP|2022-05-21|2022-06-27|240|277
Study ID|SE|a15a4209-7a42-4c07-b6fe-4a49bf5357c6|1|SCRN|4|SCREENING|2021-09-03|2021-12-09|11|108
Study ID|SE|a15a4209-7a42-4c07-b6fe-4a49bf5357c6|2|5|6|TREATMENT|2022-03-30|2022-04-01|219|221
Study ID|SE|a15a4209-7a42-4c07-b6fe-4a49bf5357c6|3|REST|3|WASHOUT|2021-09-25|2022-03-01|33|190
Study ID|SE|a15a4209-7a42-4c07-b6fe-4a49bf5357c6|4|P|1|TREATMENT|2021-12-19|2021-12-25|118|124
Study ID|SE|a15a4209-7a42-4c07-b6fe-4a49bf5357c6|5|REST|2|WASHOUT|2022-02-07|2022-02-16|168|177
Study ID|SE|a15a4209-7a42-4c07-b6fe-4a49bf5357c6|6|10|1|TREATMENT|2021-12-16|2022-02-15|115|176
Study ID|SE|a15a4209-7a42-4c07-b6fe-4a49bf5357c6|7|FU|2|FOLLOW-UP|2021-10-31|2022-03-05|69|194
Study ID|SE|caf6881d-791f-42f0-afd7-885216350fd9|1|SCRN|2|SCREENING|2022-02-23|2022-04-29|185|250
Study ID|SE|caf6881d-791f-42f0-afd7-885216350fd9|2|5|2|TREATMENT|2021-08-25|2021-11-10|3|80
Study ID|SE|caf6881d-791f-42f0-afd7-885216350fd9|3|REST|7|WASHOUT|2022-02-11|2022-05-28|173|279
Study ID|SE|caf6881d-791f-42f0-afd7-885216350fd9|4|10|1|TREATMENT|2021-11-14|2022-03-02|84|192
Study ID|SE|caf6881d-791f-42f0-afd7-885216350fd9|5|REST|7|WASHOUT|2021-12-11|2021-12-31|111|131
Study ID|SE|caf6881d-791f-42f0-afd7-885216350fd9|6|P|5|TREATMENT|2021-09-13|2022-01-05|22|136
Study ID|SE|caf6881d-791f-42f0-afd7-885216350fd9|7|FU|6|FOLLOW-UP|2021-10-01|2022-03-20|40|210
Study ID|SE|49d7b534-90c3-4790-8ed3-4bed04676ece|1|SCRN|3|SCREENING|2022-01-19|2022-02-02|141|155
Study ID|SE|49d7b534-90c3-4790-8ed3-4bed04676ece|2|P|7|TREATMENT|2021-09-02|2021-09-07|2|7
Study ID|SE|49d7b534-90c3-4790-8ed3-4bed04676ece|3|REST|1|WASHOUT|2021-10-16|2021-12-10|46|101
Study ID|SE|49d7b534-90c3-4790-8ed3-4bed04676ece|4|5|6|TREATMENT|2021-11-10|2021-12-26|71|117
Study ID|SE|49d7b534-90c3-4790-8ed3-4bed04676ece|5|REST|7|WASHOUT|2021-11-03|2022-01-23|64|145
Study ID|SE|49d7b534-90c3-4790-8ed3-4bed04676ece|6|10|3|TREATMENT|2021-10-08|2021-12-22|38|113
Study ID|SE|49d7b534-90c3-4790-8ed3-4bed04676ece|7|FU|2|FOLLOW-UP|2021-10-10|2022-04-06|40|218
Study ID|SE|9d1a0f42-d590-4b1f-9368-22ee3a5e8403|1|SCRN|3|SCREENING|2021-10-08|2021-10-12|45|49
Study ID|SE|9d1a0f42-d590-4b1f-9368-22ee3a5e8403|2|P|7|TREATMENT|2021-09-12|2022-02-02|19|162
Study ID|SE|9d1a0f42-d590-4b1f-9368-22ee3a5e8403|3|REST|3|WASHOUT|2021-12-26|2022-03-17|124|205
Study ID|SE|9d1a0f42-d590-4b1f-9368-22ee3a5e8403|4|5|5|TREATMENT|2022-04-14|2022-05-01|233|250
Study ID|SE|9d1a0f42-d590-4b1f-9368-22ee3a5e8403|5|REST|5|WASHOUT|2021-10-20|2021-11-19|57|87
Study ID|SE|9d1a0f42-d590-4b1f-9368-22ee3a5e8403|6|10|4|TREATMENT|2021-08-30|2021-12-13|6|111
Study ID|SE|9d1a0f42-d590-4b1f-9368-22ee3a5e8403|7|FU|5|FOLLOW-UP|2022-01-25|2022-05-07|154|256
Study ID|SE|38b834d2-d543-40b8-b25e-cec32309b253|1|SCRN|6|SCREENING|2021-10-21|2022-01-06|24|101
Study ID|SE|38b834d2-d543-40b8-b25e-cec32309b253|2|P|2|TREATMENT|2021-12-26|2022-01-18|90|113
Study ID|SE|38b834d2-d543-40b8-b25e-cec32309b253|3|REST|3|WASHOUT|2022-01-19|2022-02-18|114|144
Study ID|SE|38b834d2-d543-40b8-b25e-cec32309b253|4|5|6|TREATMENT|2021-12-31|2022-04-04|95|189
Study ID|SE|38b834d2-d543-40b8-b25e-cec32309b253|5|REST|2|WASHOUT|2022-01-02|2022-05-11|97|226
Study ID|SE|38b834d2-d543-40b8-b25e-cec32309b253|6|10|1|TREATMENT|2021-10-02|2021-10-03|5|6
Study ID|SE|38b834d2-d543-40b8-b25e-cec32309b253|7|FU|4|FOLLOW-UP|2021-11-02|2022-01-15|36|110
Study ID|SE|80c7f221-8a14-44aa-b7aa-cf75bb6348b1|1|SCRN|6|SCREENING|2022-01-11|2022-02-22|87|129
Study ID|SE|80c7f221-8a14-44aa-b7aa-cf75bb6348b1|2|P|2|TREATMENT|2022-01-20|2022-02-21|96|128
Study ID|SE|80c7f221-8a14-44aa-b7aa-cf75bb6348b1|3|REST|2|WASHOUT|2021-10-24|2021-11-17|8|32
Study ID|SE|80c7f221-8a14-44aa-b7aa-cf75bb6348b1|4|5|1|TREATMENT|2021-10-28|2022-05-27|12|223
Study ID|SE|80c7f221-8a14-44aa-b7aa-cf75bb6348b1|5|REST|6|WASHOUT|2021-11-30|2022-07-03|45|260
Study ID|SE|80c7f221-8a14-44aa-b7aa-cf75bb6348b1|6|10|1|TREATMENT|2022-06-06|2022-08-05|233|293
Study ID|SE|80c7f221-8a14-44aa-b7aa-cf75bb6348b1|7|FU|5|FOLLOW-UP|2021-10-21|2021-10-29|5|13
Study ID|SE|76f7cfaf-118f-4158-bcd1-99a21bb06da2|1|SCRN|1|SCREENING|2021-11-24|2022-02-18|53|139
Study ID|SE|76f7cfaf-118f-4158-bcd1-99a21bb06da2|2|5|7|TREATMENT|2022-02-24|2022-04-19|145|199
Study ID|SE|76f7cfaf-118f-4158-bcd1-99a21bb06da2|3|REST|3|WASHOUT|2021-10-22|2021-11-22|20|51
Study ID|SE|76f7cfaf-118f-4158-bcd1-99a21bb06da2|4|P|1|TREATMENT|2021-10-10|2021-11-29|8|58
Study ID|SE|76f7cfaf-118f-4158-bcd1-99a21bb06da2|5|REST|1|WASHOUT|2022-05-17|2022-06-07|227|248
Study ID|SE|76f7cfaf-118f-4158-bcd1-99a21bb06da2|6|10|2|TREATMENT|2021-11-11|2021-12-18|40|77
Study ID|SE|76f7cfaf-118f-4158-bcd1-99a21bb06da2|7|FU|1|FOLLOW-UP|2021-10-10|2021-11-20|8|49
Study ID|SE|aeedb489-9c1e-480b-9baf-7e723060cd28|1|SCRN|7|SCREENING|2021-10-25|2022-03-19|68|213
Study ID|SE|aeedb489-9c1e-480b-9baf-7e723060cd28|2|P|2|TREATMENT|2022-03-10|2022-03-30|204|224
Study ID|SE|aeedb489-9c1e-480b-9baf-7e723060cd28|3|REST|1|WASHOUT|2022-04-09|2022-05-04|234|259
Study ID|SE|aeedb489-9c1e-480b-9baf-7e723060cd28|4|5|4|TREATMENT|2021-11-30|2022-02-03|104|169
Study ID|SE|aeedb489-9c1e-480b-9baf-7e723060cd28|5|REST|6|WASHOUT|2022-02-23|2022-03-15|189|209
Study ID|SE|aeedb489-9c1e-480b-9baf-7e723060cd28|6|10|3|TREATMENT|2021-08-26|2022-05-30|8|285
Study ID|SE|aeedb489-9c1e-480b-9baf-7e723060cd28|7|FU|2|FOLLOW-UP|2021-10-05|2021-12-01|48|105
Study ID|SE|7d1d8119-224d-4ca8-94d9-d78a917ae454|1|SCRN|1|SCREENING|2021-08-23|2022-03-23|6|218
Study ID|SE|7d1d8119-224d-4ca8-94d9-d78a917ae454|2|P|2|TREATMENT|2022-03-10|2022-04-03|205|229
Study ID|SE|7d1d8119-224d-4ca8-94d9-d78a917ae454|3|REST|3|WASHOUT|2021-10-01|2021-12-01|45|106
Study ID|SE|7d1d8119-224d-4ca8-94d9-d78a917ae454|4|5|5|TREATMENT|2021-09-02|2022-01-13|16|149
Study ID|SE|7d1d8119-224d-4ca8-94d9-d78a917ae454|5|REST|4|WASHOUT|2022-03-22|2022-03-31|217|226
Study ID|SE|7d1d8119-224d-4ca8-94d9-d78a917ae454|6|10|6|TREATMENT|2021-11-13|2022-01-09|88|145
Study ID|SE|7d1d8119-224d-4ca8-94d9-d78a917ae454|7|FU|7|FOLLOW-UP|2021-10-01|2021-10-17|45|61
Study ID|SE|f15ef6ad-be4b-4dca-8862-feb841db6887|1|SCRN|3|SCREENING|2021-09-23|2022-01-25|17|141
Study ID|SE|f15ef6ad-be4b-4dca-8862-feb841db6887|2|5|7|TREATMENT|2022-01-02|2022-06-22|118|289
Study ID|SE|f15ef6ad-be4b-4dca-8862-feb841db6887|3|REST|4|WASHOUT|2021-09-20|2022-01-22|14|138
Study ID|SE|f15ef6ad-be4b-4dca-8862-feb841db6887|4|10|5|TREATMENT|2022-03-11|2022-06-22|186|289
Study ID|SE|f15ef6ad-be4b-4dca-8862-feb841db6887|5|REST|2|WASHOUT|2021-09-27|2021-10-14|21|38
Study ID|SE|f15ef6ad-be4b-4dca-8862-feb841db6887|6|P|7|TREATMENT|2021-12-07|2022-06-01|92|268
Study ID|SE|f15ef6ad-be4b-4dca-8862-feb841db6887|7|FU|1|FOLLOW-UP|2021-11-21|2021-12-09|76|94
Study ID|SE|967139c3-a1f7-4745-bc11-41e641e8bcfd|1|SCRN|7|SCREENING|2021-08-28|2022-05-20|22|287
Study ID|SE|967139c3-a1f7-4745-bc11-41e641e8bcfd|2|5|2|TREATMENT|2021-08-08|2021-08-18|2|12
Study ID|SE|967139c3-a1f7-4745-bc11-41e641e8bcfd|3|REST|2|WASHOUT|2021-09-18|2021-10-11|43|66
Study ID|SE|967139c3-a1f7-4745-bc11-41e641e8bcfd|4|P|2|TREATMENT|2021-10-14|2022-02-05|69|183
Study ID|SE|967139c3-a1f7-4745-bc11-41e641e8bcfd|5|REST|6|WASHOUT|2021-08-18|2021-10-24|12|79
Study ID|SE|967139c3-a1f7-4745-bc11-41e641e8bcfd|6|10|4|TREATMENT|2021-08-11|2021-09-08|5|33
Study ID|SE|967139c3-a1f7-4745-bc11-41e641e8bcfd|7|FU|4|FOLLOW-UP|2021-11-10|2022-03-14|96|220
Study ID|SE|467a1f4e-ae0d-4f87-ba06-e60d270111d1|1|SCRN|3|SCREENING|2021-11-03|2021-11-23|6|26
Study ID|SE|467a1f4e-ae0d-4f87-ba06-e60d270111d1|2|P|4|TREATMENT|2022-01-25|2022-06-12|89|227
Study ID|SE|467a1f4e-ae0d-4f87-ba06-e60d270111d1|3|REST|3|WASHOUT|2021-11-18|2022-05-01|21|185
Study ID|SE|467a1f4e-ae0d-4f87-ba06-e60d270111d1|4|5|3|TREATMENT|2022-03-07|2022-05-03|130|187
Study ID|SE|467a1f4e-ae0d-4f87-ba06-e60d270111d1|5|REST|1|WASHOUT|2021-12-24|2022-06-10|57|225
Study ID|SE|467a1f4e-ae0d-4f87-ba06-e60d270111d1|6|10|6|TREATMENT|2021-11-13|2021-11-17|16|20
Study ID|SE|467a1f4e-ae0d-4f87-ba06-e60d270111d1|7|FU|3|FOLLOW-UP|2022-02-03|2022-02-14|98|109
Study ID|SE|bec02309-a085-460f-be3d-cc290c5c3266|1|SCRN|6|SCREENING|2021-12-23|2022-04-11|58|167
Study ID|SE|bec02309-a085-460f-be3d-cc290c5c3266|2|P|4|TREATMENT|2021-11-20|2022-01-21|25|87
Study ID|SE|bec02309-a085-460f-be3d-cc290c5c3266|3|REST|3|WASHOUT|2022-02-23|2022-05-02|120|188
Study ID|SE|bec02309-a085-460f-be3d-cc290c5c3266|4|5|6|TREATMENT|2021-12-20|2022-05-05|55|191
Study ID|SE|bec02309-a085-460f-be3d-cc290c5c3266|5|REST|4|WASHOUT|2021-11-05|2022-03-23|10|148
Study ID|SE|bec02309-a085-460f-be3d-cc290c5c3266|6|10|7|TREATMENT|2021-10-29|2022-07-07|3|254
Study ID|SE|bec02309-a085-460f-be3d-cc290c5c3266|7|FU|2|FOLLOW-UP|2021-11-01|2021-11-03|6|8
Study ID|SE|2151a119-37d1-4532-a75d-6e4945ad235c|1|SCRN|2|SCREENING|2021-10-12|2022-04-26|58|254
Study ID|SE|2151a119-37d1-4532-a75d-6e4945ad235c|2|P|6|TREATMENT|2021-11-04|2021-11-26|81|103
Study ID|SE|2151a119-37d1-4532-a75d-6e4945ad235c|3|REST|5|WASHOUT|2021-09-19|2021-10-31|35|77
Study ID|SE|2151a119-37d1-4532-a75d-6e4945ad235c|4|5|7|TREATMENT|2022-02-17|2022-03-24|186|221
Study ID|SE|2151a119-37d1-4532-a75d-6e4945ad235c|5|REST|3|WASHOUT|2021-09-10|2021-10-03|26|49
Study ID|SE|2151a119-37d1-4532-a75d-6e4945ad235c|6|10|6|TREATMENT|2021-11-06|2022-01-04|83|142
Study ID|SE|2151a119-37d1-4532-a75d-6e4945ad235c|7|FU|7|FOLLOW-UP|2021-08-23|2021-09-05|8|21
Study ID|SE|76925097-8b5d-4db0-a753-80df265aa961|1|SCRN|6|SCREENING|2021-11-01|2022-04-10|19|179
Study ID|SE|76925097-8b5d-4db0-a753-80df265aa961|2|5|4|TREATMENT|2021-12-19|2021-12-29|67|77
Study ID|SE|76925097-8b5d-4db0-a753-80df265aa961|3|REST|2|WASHOUT|2022-01-13|2022-02-07|92|117
Study ID|SE|76925097-8b5d-4db0-a753-80df265aa961|4|P|5|TREATMENT|2022-02-10|2022-02-12|120|122
Study ID|SE|76925097-8b5d-4db0-a753-80df265aa961|5|REST|1|WASHOUT|2021-12-05|2022-02-21|53|131
Study ID|SE|76925097-8b5d-4db0-a753-80df265aa961|6|10|1|TREATMENT|2022-01-24|2022-04-29|103|198
Study ID|SE|76925097-8b5d-4db0-a753-80df265aa961|7|FU|2|FOLLOW-UP|2022-03-05|2022-06-07|143|237
Study ID|SE|a15b3809-05c6-497d-baa3-575910ca6be0|1|SCRN|4|SCREENING|2021-12-24|2022-06-20|80|258
Study ID|SE|a15b3809-05c6-497d-baa3-575910ca6be0|2|P|3|TREATMENT|2021-10-24|2022-01-10|19|97
Study ID|SE|a15b3809-05c6-497d-baa3-575910ca6be0|3|REST|4|WASHOUT|2021-10-10|2022-04-18|5|195
Study ID|SE|a15b3809-05c6-497d-baa3-575910ca6be0|4|5|2|TREATMENT|2021-10-31|2022-01-19|26|106
Study ID|SE|a15b3809-05c6-497d-baa3-575910ca6be0|5|REST|2|WASHOUT|2021-12-10|2022-03-28|66|174
Study ID|SE|a15b3809-05c6-497d-baa3-575910ca6be0|6|10|2|TREATMENT|2022-01-26|2022-02-16|113|134
Study ID|SE|a15b3809-05c6-497d-baa3-575910ca6be0|7|FU|4|FOLLOW-UP|2021-11-06|2022-03-17|32|163
Study ID|SE|be96372a-43f4-4186-ba38-af187089e655|1|SCRN|6|SCREENING|2022-04-18|2022-05-25|253|290
Study ID|SE|be96372a-43f4-4186-ba38-af187089e655|2|5|6|TREATMENT|2021-11-01|2022-03-12|85|216
Study ID|SE|be96372a-43f4-4186-ba38-af187089e655|3|REST|7|WASHOUT|2021-08-13|2022-02-08|5|184
Study ID|SE|be96372a-43f4-4186-ba38-af187089e655|4|P|3|TREATMENT|2021-08-31|2021-10-18|23|71
Study ID|SE|be96372a-43f4-4186-ba38-af187089e655|5|REST|4|WASHOUT|2022-02-15|2022-02-18|191|194
Study ID|SE|be96372a-43f4-4186-ba38-af187089e655|6|10|6|TREATMENT|2022-02-09|2022-04-26|185|261
Study ID|SE|be96372a-43f4-4186-ba38-af187089e655|7|FU|4|FOLLOW-UP|2021-12-18|2022-03-14|132|218
Study ID|SE|c5e627be-f1e3-495b-81f6-13b445cdca13|1|SCRN|3|SCREENING|2021-10-17|2021-11-16|8|38
Study ID|SE|c5e627be-f1e3-495b-81f6-13b445cdca13|2|5|5|TREATMENT|2022-02-18|2022-04-16|132|189
Study ID|SE|c5e627be-f1e3-495b-81f6-13b445cdca13|3|REST|6|WASHOUT|2022-03-17|2022-05-04|159|207
Study ID|SE|c5e627be-f1e3-495b-81f6-13b445cdca13|4|P|6|TREATMENT|2021-11-16|2022-02-02|38|116
Study ID|SE|c5e627be-f1e3-495b-81f6-13b445cdca13|5|REST|3|WASHOUT|2021-11-10|2022-05-22|32|225
Study ID|SE|c5e627be-f1e3-495b-81f6-13b445cdca13|6|10|7|TREATMENT|2021-10-12|2021-10-29|3|20
Study ID|SE|c5e627be-f1e3-495b-81f6-13b445cdca13|7|FU|2|FOLLOW-UP|2022-01-25|2022-04-21|108|194
Study ID|SE|99b8c1a3-deb5-432e-8589-679a52b0861e|1|SCRN|7|SCREENING|2021-10-05|2022-01-26|30|143
Study ID|SE|99b8c1a3-deb5-432e-8589-679a52b0861e|2|P|6|TREATMENT|2021-09-07|2021-09-08|2|3
Study ID|SE|99b8c1a3-deb5-432e-8589-679a52b0861e|3|REST|7|WASHOUT|2021-09-16|2021-11-02|11|58
Study ID|SE|99b8c1a3-deb5-432e-8589-679a52b0861e|4|5|1|TREATMENT|2021-09-22|2021-11-14|17|70
Study ID|SE|99b8c1a3-deb5-432e-8589-679a52b0861e|5|REST|4|WASHOUT|2021-09-20|2022-06-13|15|281
Study ID|SE|99b8c1a3-deb5-432e-8589-679a52b0861e|6|10|2|TREATMENT|2021-09-07|2021-12-04|2|90
Study ID|SE|99b8c1a3-deb5-432e-8589-679a52b0861e|7|FU|6|FOLLOW-UP|2021-10-28|2022-03-12|53|188
Study ID|SE|2392bd8f-d606-464b-abf0-f66f06c8613a|1|SCRN|1|SCREENING|2022-01-06|2022-01-26|111|131
Study ID|SE|2392bd8f-d606-464b-abf0-f66f06c8613a|2|5|5|TREATMENT|2021-10-13|2022-03-26|26|190
Study ID|SE|2392bd8f-d606-464b-abf0-f66f06c8613a|3|REST|6|WASHOUT|2021-09-28|2022-01-07|11|112
Study ID|SE|2392bd8f-d606-464b-abf0-f66f06c8613a|4|P|2|TREATMENT|2021-09-20|2021-10-04|3|17
Study ID|SE|2392bd8f-d606-464b-abf0-f66f06c8613a|5|REST|3|WASHOUT|2021-10-09|2021-11-18|22|62
Study ID|SE|2392bd8f-d606-464b-abf0-f66f06c8613a|6|10|6|TREATMENT|2021-09-19|2021-09-22|2|5
Study ID|SE|2392bd8f-d606-464b-abf0-f66f06c8613a|7|FU|1|FOLLOW-UP|2021-10-11|2021-12-15|24|89
Study ID|SE|84bda3cd-0134-47c0-b64f-97b25fc0fa04|1|SCRN|1|SCREENING|2021-10-22|2021-11-17|64|90
Study ID|SE|84bda3cd-0134-47c0-b64f-97b25fc0fa04|2|P|4|TREATMENT|2021-10-10|2021-11-06|52|79
Study ID|SE|84bda3cd-0134-47c0-b64f-97b25fc0fa04|3|REST|7|WASHOUT|2021-08-29|2022-03-12|10|205
Study ID|SE|84bda3cd-0134-47c0-b64f-97b25fc0fa04|4|5|4|TREATMENT|2021-10-27|2021-11-05|69|78
Study ID|SE|84bda3cd-0134-47c0-b64f-97b25fc0fa04|5|REST|4|WASHOUT|2021-09-08|2022-06-14|20|299
Study ID|SE|84bda3cd-0134-47c0-b64f-97b25fc0fa04|6|10|7|TREATMENT|2021-09-24|2022-03-11|36|204
Study ID|SE|84bda3cd-0134-47c0-b64f-97b25fc0fa04|7|FU|3|FOLLOW-UP|2021-09-28|2022-01-09|40|143
Study ID|SE|3ed72845-5bef-446c-974d-2b7521c3eecf|1|SCRN|2|SCREENING|2022-02-13|2022-02-19|155|161
Study ID|SE|3ed72845-5bef-446c-974d-2b7521c3eecf|2|5|4|TREATMENT|2021-09-22|2021-09-28|11|17
Study ID|SE|3ed72845-5bef-446c-974d-2b7521c3eecf|3|REST|6|WASHOUT|2021-09-13|2021-09-15|2|4
Study ID|SE|3ed72845-5bef-446c-974d-2b7521c3eecf|4|P|4|TREATMENT|2021-11-10|2021-11-23|60|73
Study ID|SE|3ed72845-5bef-446c-974d-2b7521c3eecf|5|REST|4|WASHOUT|2022-04-12|2022-04-29|213|230
Study ID|SE|3ed72845-5bef-446c-974d-2b7521c3eecf|6|10|5|TREATMENT|2021-10-02|2021-10-04|21|23
Study ID|SE|3ed72845-5bef-446c-974d-2b7521c3eecf|7|FU|5|FOLLOW-UP|2021-11-02|2021-11-17|52|67
Study ID|SE|b135e6c7-dd3e-47cc-9859-19398f2f6be0|1|SCRN|2|SCREENING|2022-02-06|2022-03-24|150|196
Study ID|SE|b135e6c7-dd3e-47cc-9859-19398f2f6be0|2|P|7|TREATMENT|2021-09-11|2021-10-08|2|29
Study ID|SE|b135e6c7-dd3e-47cc-9859-19398f2f6be0|3|REST|5|WASHOUT|2021-09-14|2021-10-26|5|47
Study ID|SE|b135e6c7-dd3e-47cc-9859-19398f2f6be0|4|5|2|TREATMENT|2021-09-17|2021-10-05|8|26
Study ID|SE|b135e6c7-dd3e-47cc-9859-19398f2f6be0|5|REST|3|WASHOUT|2021-11-14|2022-03-13|66|185
Study ID|SE|b135e6c7-dd3e-47cc-9859-19398f2f6be0|6|10|1|TREATMENT|2021-12-09|2022-06-26|91|290
Study ID|SE|b135e6c7-dd3e-47cc-9859-19398f2f6be0|7|FU|1|FOLLOW-UP|2022-04-17|2022-05-12|220|245
Study ID|SE|4fdaf1de-23fd-4cfe-b96f-d0e8ed253a6b|1|SCRN|6|SCREENING|2021-12-19|2022-07-10|76|279
Study ID|SE|4fdaf1de-23fd-4cfe-b96f-d0e8ed253a6b|2|P|5|TREATMENT|2022-02-09|2022-05-06|128|214
Study ID|SE|4fdaf1de-23fd-4cfe-b96f-d0e8ed253a6b|3|REST|1|WASHOUT|2022-01-13|2022-07-06|101|275
Study ID|SE|4fdaf1de-23fd-4cfe-b96f-d0e8ed253a6b|4|5|5|TREATMENT|2021-10-08|2022-02-13|4|132
Study ID|SE|4fdaf1de-23fd-4cfe-b96f-d0e8ed253a6b|5|REST|2|WASHOUT|2022-02-25|2022-06-09|144|248
Study ID|SE|4fdaf1de-23fd-4cfe-b96f-d0e8ed253a6b|6|10|2|TREATMENT|2021-11-01|2022-02-03|28|122
Study ID|SE|4fdaf1de-23fd-4cfe-b96f-d0e8ed253a6b|7|FU|2|FOLLOW-UP|2021-11-23|2022-06-03|50|242
Study ID|SE|614ca6ee-fba6-431f-8036-5c576b03c829|1|SCRN|5|SCREENING|2022-07-28|2022-08-09|278|290
Study ID|SE|614ca6ee-fba6-431f-8036-5c576b03c829|2|5|4|TREATMENT|2022-07-04|2022-08-18|254|299
Study ID|SE|614ca6ee-fba6-431f-8036-5c576b03c829|3|REST|1|WASHOUT|2022-01-29|2022-05-21|98|210
Study ID|SE|614ca6ee-fba6-431f-8036-5c576b03c829|4|P|2|TREATMENT|2022-05-01|2022-07-26|190|276
Study ID|SE|614ca6ee-fba6-431f-8036-5c576b03c829|5|REST|7|WASHOUT|2021-12-04|2022-01-03|42|72
Study ID|SE|614ca6ee-fba6-431f-8036-5c576b03c829|6|10|2|TREATMENT|2022-03-02|2022-03-13|130|141
Study ID|SE|614ca6ee-fba6-431f-8036-5c576b03c829|7|FU|7|FOLLOW-UP|2021-12-08|2022-01-09|46|78
Study ID|SE|9ffc41b2-93bb-4a00-99e8-51f41ad10f1f|1|SCRN|2|SCREENING|2021-09-19|2022-02-18|16|168
Study ID|SE|9ffc41b2-93bb-4a00-99e8-51f41ad10f1f|2|5|1|TREATMENT|2021-12-26|2022-01-21|114|140
Study ID|SE|9ffc41b2-93bb-4a00-99e8-51f41ad10f1f|3|REST|2|WASHOUT|2022-02-26|2022-03-04|176|182
Study ID|SE|9ffc41b2-93bb-4a00-99e8-51f41ad10f1f|4|10|3|TREATMENT|2022-03-21|2022-03-22|199|200
Study ID|SE|9ffc41b2-93bb-4a00-99e8-51f41ad10f1f|5|REST|2|WASHOUT|2021-10-08|2021-12-18|35|106
Study ID|SE|9ffc41b2-93bb-4a00-99e8-51f41ad10f1f|6|P|5|TREATMENT|2021-09-22|2022-03-02|19|180
Study ID|SE|9ffc41b2-93bb-4a00-99e8-51f41ad10f1f|7|FU|2|FOLLOW-UP|2022-01-19|2022-02-15|138|165
Study ID|SE|eb0c4506-7c3a-45c7-8a21-226a052ff830|1|SCRN|5|SCREENING|2022-01-25|2022-03-06|133|173
Study ID|SE|eb0c4506-7c3a-45c7-8a21-226a052ff830|2|P|4|TREATMENT|2022-03-22|2022-04-16|189|214
Study ID|SE|eb0c4506-7c3a-45c7-8a21-226a052ff830|3|REST|1|WASHOUT|2021-10-22|2022-03-22|38|189
Study ID|SE|eb0c4506-7c3a-45c7-8a21-226a052ff830|4|5|6|TREATMENT|2021-10-03|2021-10-08|19|24
Study ID|SE|eb0c4506-7c3a-45c7-8a21-226a052ff830|5|REST|7|WASHOUT|2021-10-04|2021-10-05|20|21
Study ID|SE|eb0c4506-7c3a-45c7-8a21-226a052ff830|6|10|6|TREATMENT|2021-11-27|2022-02-18|74|157
Study ID|SE|eb0c4506-7c3a-45c7-8a21-226a052ff830|7|FU|3|FOLLOW-UP|2021-11-10|2022-01-06|57|114
Study ID|SE|0fb43761-7a6d-436f-8bcf-cf2d3ace4f9d|1|SCRN|5|SCREENING|2021-08-16|2021-09-06|3|24
Study ID|SE|0fb43761-7a6d-436f-8bcf-cf2d3ace4f9d|2|5|6|TREATMENT|2021-08-15|2021-08-18|2|5
Study ID|SE|0fb43761-7a6d-436f-8bcf-cf2d3ace4f9d|3|REST|4|WASHOUT|2021-08-22|2022-01-22|9|162
Study ID|SE|0fb43761-7a6d-436f-8bcf-cf2d3ace4f9d|4|P|6|TREATMENT|2022-02-11|2022-05-19|182|279
Study ID|SE|0fb43761-7a6d-436f-8bcf-cf2d3ace4f9d|5|REST|1|WASHOUT|2021-10-10|2021-10-22|58|70
Study ID|SE|0fb43761-7a6d-436f-8bcf-cf2d3ace4f9d|6|10|7|TREATMENT|2021-08-16|2021-08-20|3|7
Study ID|SE|0fb43761-7a6d-436f-8bcf-cf2d3ace4f9d|7|FU|6|FOLLOW-UP|2021-08-22|2021-08-31|9|18
Study ID|SE|9e31425e-d439-40d6-a518-c76b9d0c221b|1|SCRN|4|SCREENING|2022-03-29|2022-05-17|185|234
Study ID|SE|9e31425e-d439-40d6-a518-c76b9d0c221b|2|5|7|TREATMENT|2022-03-11|2022-06-23|167|271
Study ID|SE|9e31425e-d439-40d6-a518-c76b9d0c221b|3|REST|5|WASHOUT|2021-09-29|2022-04-13|4|200
Study ID|SE|9e31425e-d439-40d6-a518-c76b9d0c221b|4|P|6|TREATMENT|2021-12-27|2022-06-30|93|278
Study ID|SE|9e31425e-d439-40d6-a518-c76b9d0c221b|5|REST|3|WASHOUT|2021-12-21|2021-12-29|87|95
Study ID|SE|9e31425e-d439-40d6-a518-c76b9d0c221b|6|10|7|TREATMENT|2021-10-22|2022-06-19|27|267
Study ID|SE|9e31425e-d439-40d6-a518-c76b9d0c221b|7|FU|4|FOLLOW-UP|2021-11-26|2021-11-30|62|66
Study ID|SE|0b28391a-5735-42c9-8c0f-fe2f499180ad|1|SCRN|7|SCREENING|2022-03-02|2022-05-23|141|223
Study ID|SE|0b28391a-5735-42c9-8c0f-fe2f499180ad|2|P|2|TREATMENT|2021-11-11|2022-03-29|30|168
Study ID|SE|0b28391a-5735-42c9-8c0f-fe2f499180ad|3|REST|5|WASHOUT|2021-11-14|2022-06-23|33|254
Study ID|SE|0b28391a-5735-42c9-8c0f-fe2f499180ad|4|5|6|TREATMENT|2021-11-22|2022-05-02|41|202
Study ID|SE|0b28391a-5735-42c9-8c0f-fe2f499180ad|5|REST|7|WASHOUT|2022-03-19|2022-03-27|158|166
Study ID|SE|0b28391a-5735-42c9-8c0f-fe2f499180ad|6|10|1|TREATMENT|2022-01-03|2022-04-25|83|195
Study ID|SE|0b28391a-5735-42c9-8c0f-fe2f499180ad|7|FU|2|FOLLOW-UP|2021-12-11|2021-12-26|60|75
Study ID|SE|d4bdfcb0-f9b0-40b4-8a2b-ee14ecc4a788|1|SCRN|1|SCREENING|2021-09-24|2021-11-26|8|71
Study ID|SE|d4bdfcb0-f9b0-40b4-8a2b-ee14ecc4a788|2|P|5|TREATMENT|2022-02-13|2022-02-28|150|165
Study ID|SE|d4bdfcb0-f9b0-40b4-8a2b-ee14ecc4a788|3|REST|5|WASHOUT|2021-09-19|2021-11-15|3|60
Study ID|SE|d4bdfcb0-f9b0-40b4-8a2b-ee14ecc4a788|4|5|3|TREATMENT|2022-02-08|2022-05-04|145|230
Study ID|SE|d4bdfcb0-f9b0-40b4-8a2b-ee14ecc4a788|5|REST|2|WASHOUT|2021-11-09|2021-12-13|54|88
Study ID|SE|d4bdfcb0-f9b0-40b4-8a2b-ee14ecc4a788|6|10|6|TREATMENT|2021-12-25|2022-02-04|100|141
Study ID|SE|d4bdfcb0-f9b0-40b4-8a2b-ee14ecc4a788|7|FU|1|FOLLOW-UP|2021-10-06|2021-11-18|20|63
Study ID|SE|072bccd8-4efe-4b27-b304-52dad87c879d|1|SCRN|5|SCREENING|2021-09-02|2021-09-08|7|13
Study ID|SE|072bccd8-4efe-4b27-b304-52dad87c879d|2|5|2|TREATMENT|2021-09-04|2021-09-18|9|23
Study ID|SE|072bccd8-4efe-4b27-b304-52dad87c879d|3|REST|1|WASHOUT|2021-10-13|2021-10-15|48|50
Study ID|SE|072bccd8-4efe-4b27-b304-52dad87c879d|4|P|2|TREATMENT|2021-09-01|2021-09-10|6|15
Study ID|SE|072bccd8-4efe-4b27-b304-52dad87c879d|5|REST|4|WASHOUT|2022-02-01|2022-06-08|159|286
Study ID|SE|072bccd8-4efe-4b27-b304-52dad87c879d|6|10|2|TREATMENT|2021-10-02|2021-10-05|37|40
Study ID|SE|072bccd8-4efe-4b27-b304-52dad87c879d|7|FU|3|FOLLOW-UP|2021-10-08|2022-04-13|43|230
Study ID|SE|1d852bb3-1772-4eb1-85a6-79cbb41f2f29|1|SCRN|6|SCREENING|2022-02-07|2022-06-11|115|239
Study ID|SE|1d852bb3-1772-4eb1-85a6-79cbb41f2f29|2|5|4|TREATMENT|2021-11-22|2022-06-07|38|235
Study ID|SE|1d852bb3-1772-4eb1-85a6-79cbb41f2f29|3|REST|1|WASHOUT|2021-11-23|2022-04-15|39|182
Study ID|SE|1d852bb3-1772-4eb1-85a6-79cbb41f2f29|4|P|5|TREATMENT|2022-01-22|2022-01-28|99|105
Study ID|SE|1d852bb3-1772-4eb1-85a6-79cbb41f2f29|5|REST|4|WASHOUT|2022-06-30|2022-07-15|258|273
Study ID|SE|1d852bb3-1772-4eb1-85a6-79cbb41f2f29|6|10|5|TREATMENT|2022-01-22|2022-02-25|99|133
Study ID|SE|1d852bb3-1772-4eb1-85a6-79cbb41f2f29|7|FU|6|FOLLOW-UP|2021-10-23|2021-11-27|8|43
Study ID|SE|a7a714e9-49e2-4e73-ad90-0fecf0d35cf5|1|SCRN|7|SCREENING|2021-09-30|2021-11-19|15|65
Study ID|SE|a7a714e9-49e2-4e73-ad90-0fecf0d35cf5|2|5|1|TREATMENT|2021-10-24|2022-06-29|39|287
Study ID|SE|a7a714e9-49e2-4e73-ad90-0fecf0d35cf5|3|REST|1|WASHOUT|2021-10-06|2021-12-03|21|79
Study ID|SE|a7a714e9-49e2-4e73-ad90-0fecf0d35cf5|4|10|1|TREATMENT|2021-12-13|2022-02-06|89|144
Study ID|SE|a7a714e9-49e2-4e73-ad90-0fecf0d35cf5|5|REST|4|WASHOUT|2021-09-24|2021-10-20|9|35
Study ID|SE|a7a714e9-49e2-4e73-ad90-0fecf0d35cf5|6|P|5|TREATMENT|2022-01-26|2022-03-13|133|179
Study ID|SE|a7a714e9-49e2-4e73-ad90-0fecf0d35cf5|7|FU|5|FOLLOW-UP|2022-01-01|2022-07-06|108|294
Study ID|SE|948c63c5-3146-42c3-b999-794f4f7eb5ac|1|SCRN|2|SCREENING|2021-08-23|2021-08-26|10|13
Study ID|SE|948c63c5-3146-42c3-b999-794f4f7eb5ac|2|5|3|TREATMENT|2022-02-02|2022-03-04|173|203
Study ID|SE|948c63c5-3146-42c3-b999-794f4f7eb5ac|3|REST|5|WASHOUT|2021-09-05|2022-01-22|23|162
Study ID|SE|948c63c5-3146-42c3-b999-794f4f7eb5ac|4|10|2|TREATMENT|2021-10-24|2021-10-31|72|79
Study ID|SE|948c63c5-3146-42c3-b999-794f4f7eb5ac|5|REST|1|WASHOUT|2021-09-02|2021-09-09|20|27
Study ID|SE|948c63c5-3146-42c3-b999-794f4f7eb5ac|6|P|1|TREATMENT|2021-10-15|2022-04-29|63|259
Study ID|SE|948c63c5-3146-42c3-b999-794f4f7eb5ac|7|FU|7|FOLLOW-UP|2022-02-03|2022-06-05|174|296
Study ID|SE|b5eaeff7-2cda-4196-a352-bb42cf321606|1|SCRN|1|SCREENING|2022-05-11|2022-06-03|250|273
Study ID|SE|b5eaeff7-2cda-4196-a352-bb42cf321606|2|P|7|TREATMENT|2022-01-07|2022-02-27|126|177
Study ID|SE|b5eaeff7-2cda-4196-a352-bb42cf321606|3|REST|1|WASHOUT|2022-06-09|2022-06-28|279|298
Study ID|SE|b5eaeff7-2cda-4196-a352-bb42cf321606|4|5|2|TREATMENT|2021-09-05|2021-09-07|2|4
Study ID|SE|b5eaeff7-2cda-4196-a352-bb42cf321606|5|REST|5|WASHOUT|2021-09-17|2022-01-30|14|149
Study ID|SE|b5eaeff7-2cda-4196-a352-bb42cf321606|6|10|6|TREATMENT|2021-09-16|2022-04-25|13|234
Study ID|SE|b5eaeff7-2cda-4196-a352-bb42cf321606|7|FU|3|FOLLOW-UP|2021-10-12|2022-01-09|39|128
Study ID|SE|41c087e5-1dfb-4285-96a3-fd59076e5717|1|SCRN|6|SCREENING|2021-12-16|2022-02-12|84|142
Study ID|SE|41c087e5-1dfb-4285-96a3-fd59076e5717|2|5|7|TREATMENT|2022-03-26|2022-05-13|184|232
Study ID|SE|41c087e5-1dfb-4285-96a3-fd59076e5717|3|REST|7|WASHOUT|2021-12-13|2021-12-20|81|88
Study ID|SE|41c087e5-1dfb-4285-96a3-fd59076e5717|4|P|1|TREATMENT|2022-01-28|2022-04-23|127|212
Study ID|SE|41c087e5-1dfb-4285-96a3-fd59076e5717|5|REST|7|WASHOUT|2021-12-07|2022-01-31|75|130
Study ID|SE|41c087e5-1dfb-4285-96a3-fd59076e5717|6|10|6|TREATMENT|2022-03-14|2022-05-25|172|244
Study ID|SE|41c087e5-1dfb-4285-96a3-fd59076e5717|7|FU|5|FOLLOW-UP|2022-01-25|2022-01-29|124|128
Study ID|SE|1ff7c459-01b3-4598-838c-7f3f9eacc752|1|SCRN|5|SCREENING|2021-09-04|2022-01-31|14|163
Study ID|SE|1ff7c459-01b3-4598-838c-7f3f9eacc752|2|P|3|TREATMENT|2021-09-05|2022-02-15|15|178
Study ID|SE|1ff7c459-01b3-4598-838c-7f3f9eacc752|3|REST|7|WASHOUT|2021-12-18|2022-04-22|119|244
Study ID|SE|1ff7c459-01b3-4598-838c-7f3f9eacc752|4|5|7|TREATMENT|2022-03-02|2022-03-29|193|220
Study ID|SE|1ff7c459-01b3-4598-838c-7f3f9eacc752|5|REST|1|WASHOUT|2022-01-20|2022-04-08|152|230
Study ID|SE|1ff7c459-01b3-4598-838c-7f3f9eacc752|6|10|4|TREATMENT|2021-11-23|2022-03-28|94|219
Study ID|SE|1ff7c459-01b3-4598-838c-7f3f9eacc752|7|FU|5|FOLLOW-UP|2022-06-10|2022-06-16|293|299
Study ID|SE|f30f326c-bba6-4e50-98c4-2654c1cbea4d|1|SCRN|7|SCREENING|2021-11-28|2021-12-19|39|60
Study ID|SE|f30f326c-bba6-4e50-98c4-2654c1cbea4d|2|5|6|TREATMENT|2021-11-04|2021-12-30|15|71
Study ID|SE|f30f326c-bba6-4e50-98c4-2654c1cbea4d|3|REST|6|WASHOUT|2021-12-28|2022-03-06|69|137
Study ID|SE|f30f326c-bba6-4e50-98c4-2654c1cbea4d|4|10|5|TREATMENT|2021-12-08|2021-12-18|49|59
Study ID|SE|f30f326c-bba6-4e50-98c4-2654c1cbea4d|5|REST|7|WASHOUT|2021-11-13|2022-01-08|24|80
Study ID|SE|f30f326c-bba6-4e50-98c4-2654c1cbea4d|6|P|2|TREATMENT|2022-03-31|2022-07-19|162|272
Study ID|SE|f30f326c-bba6-4e50-98c4-2654c1cbea4d|7|FU|7|FOLLOW-UP|2022-04-01|2022-06-30|163|253
Study ID|SE|88f49917-6cc4-4bfc-bbcc-d0ef408649f2|1|SCRN|3|SCREENING|2021-12-22|2022-02-03|110|153
Study ID|SE|88f49917-6cc4-4bfc-bbcc-d0ef408649f2|2|P|3|TREATMENT|2021-11-24|2022-04-11|82|220
Study ID|SE|88f49917-6cc4-4bfc-bbcc-d0ef408649f2|3|REST|5|WASHOUT|2021-10-25|2022-01-08|52|127
Study ID|SE|88f49917-6cc4-4bfc-bbcc-d0ef408649f2|4|5|7|TREATMENT|2021-09-05|2021-09-06|2|3
Study ID|SE|88f49917-6cc4-4bfc-bbcc-d0ef408649f2|5|REST|3|WASHOUT|2021-10-21|2021-10-23|48|50
Study ID|SE|88f49917-6cc4-4bfc-bbcc-d0ef408649f2|6|10|6|TREATMENT|2021-12-09|2022-02-12|97|162
Study ID|SE|88f49917-6cc4-4bfc-bbcc-d0ef408649f2|7|FU|6|FOLLOW-UP|2021-09-10|2021-09-18|7|15
Study ID|SE|38d60c2e-c043-47cf-9ef7-5e1346d65d5d|1|SCRN|6|SCREENING|2021-12-27|2022-05-08|135|267
Study ID|SE|38d60c2e-c043-47cf-9ef7-5e1346d65d5d|2|P|5|TREATMENT|2021-09-03|2022-02-10|20|180
Study ID|SE|38d60c2e-c043-47cf-9ef7-5e1346d65d5d|3|REST|6|WASHOUT|2021-11-28|2022-01-05|106|144
Study ID|SE|38d60c2e-c043-47cf-9ef7-5e1346d65d5d|4|5|3|TREATMENT|2021-10-01|2021-12-16|48|124
Study ID|SE|38d60c2e-c043-47cf-9ef7-5e1346d65d5d|5|REST|1|WASHOUT|2021-08-22|2021-08-23|8|9
Study ID|SE|38d60c2e-c043-47cf-9ef7-5e1346d65d5d|6|10|3|TREATMENT|2021-12-14|2022-03-26|122|224
Study ID|SE|38d60c2e-c043-47cf-9ef7-5e1346d65d5d|7|FU|6|FOLLOW-UP|2021-11-18|2022-01-31|96|170
Study ID|SE|5dc6b4b8-9cce-42ce-8186-5d9515e52929|1|SCRN|7|SCREENING|2021-11-17|2021-11-27|24|34
Study ID|SE|5dc6b4b8-9cce-42ce-8186-5d9515e52929|2|P|7|TREATMENT|2021-11-21|2022-02-22|28|121
Study ID|SE|5dc6b4b8-9cce-42ce-8186-5d9515e52929|3|REST|2|WASHOUT|2022-03-26|2022-06-01|153|220
Study ID|SE|5dc6b4b8-9cce-42ce-8186-5d9515e52929|4|5|1|TREATMENT|2021-10-30|2021-11-23|6|30
Study ID|SE|5dc6b4b8-9cce-42ce-8186-5d9515e52929|5|REST|6|WASHOUT|2022-04-07|2022-07-26|165|275
Study ID|SE|5dc6b4b8-9cce-42ce-8186-5d9515e52929|6|10|6|TREATMENT|2022-01-09|2022-08-02|77|282
Study ID|SE|5dc6b4b8-9cce-42ce-8186-5d9515e52929|7|FU|6|FOLLOW-UP|2022-01-10|2022-03-05|78|132
Study ID|SE|a756e1c5-dd35-47cf-b3e2-610b6595dc15|1|SCRN|6|SCREENING|2021-11-07|2021-11-22|16|31
Study ID|SE|a756e1c5-dd35-47cf-b3e2-610b6595dc15|2|P|1|TREATMENT|2021-10-26|2021-12-07|4|46
Study ID|SE|a756e1c5-dd35-47cf-b3e2-610b6595dc15|3|REST|3|WASHOUT|2021-10-25|2021-11-01|3|10
Study ID|SE|a756e1c5-dd35-47cf-b3e2-610b6595dc15|4|5|7|TREATMENT|2021-11-05|2022-07-03|14|254
Study ID|SE|a756e1c5-dd35-47cf-b3e2-610b6595dc15|5|REST|1|WASHOUT|2022-01-10|2022-01-19|80|89
Study ID|SE|a756e1c5-dd35-47cf-b3e2-610b6595dc15|6|10|2|TREATMENT|2022-02-11|2022-08-07|112|289
Study ID|SE|a756e1c5-dd35-47cf-b3e2-610b6595dc15|7|FU|7|FOLLOW-UP|2022-02-02|2022-08-05|103|287
Study ID|SE|4f75fe33-11e7-4c44-8a39-6391188b1db5|1|SCRN|1|SCREENING|2021-09-24|2021-11-16|31|84
Study ID|SE|4f75fe33-11e7-4c44-8a39-6391188b1db5|2|P|4|TREATMENT|2021-11-23|2022-03-06|91|194
Study ID|SE|4f75fe33-11e7-4c44-8a39-6391188b1db5|3|REST|5|WASHOUT|2021-09-10|2022-06-18|17|298
Study ID|SE|4f75fe33-11e7-4c44-8a39-6391188b1db5|4|5|7|TREATMENT|2021-11-04|2022-02-23|72|183
Study ID|SE|4f75fe33-11e7-4c44-8a39-6391188b1db5|5|REST|7|WASHOUT|2021-11-04|2022-01-29|72|158
Study ID|SE|4f75fe33-11e7-4c44-8a39-6391188b1db5|6|10|2|TREATMENT|2021-10-09|2021-10-19|46|56
Study ID|SE|4f75fe33-11e7-4c44-8a39-6391188b1db5|7|FU|1|FOLLOW-UP|2021-12-21|2022-03-28|119|216
Study ID|SE|d1bd1be2-7172-44b3-b1d5-32a3d377b4d6|1|SCRN|4|SCREENING|2021-11-24|2022-01-17|82|136
Study ID|SE|d1bd1be2-7172-44b3-b1d5-32a3d377b4d6|2|5|3|TREATMENT|2021-10-22|2021-10-23|49|50
Study ID|SE|d1bd1be2-7172-44b3-b1d5-32a3d377b4d6|3|REST|1|WASHOUT|2021-09-18|2021-10-21|15|48
Study ID|SE|d1bd1be2-7172-44b3-b1d5-32a3d377b4d6|4|P|7|TREATMENT|2021-10-20|2022-04-17|47|226
Study ID|SE|d1bd1be2-7172-44b3-b1d5-32a3d377b4d6|5|REST|2|WASHOUT|2021-09-11|2021-09-13|8|10
Study ID|SE|d1bd1be2-7172-44b3-b1d5-32a3d377b4d6|6|10|6|TREATMENT|2021-10-02|2022-01-24|29|143
Study ID|SE|d1bd1be2-7172-44b3-b1d5-32a3d377b4d6|7|FU|7|FOLLOW-UP|2021-11-14|2022-03-01|72|179
Study ID|SE|053425cd-706f-4d2e-847c-5a779ae9b2ab|1|SCRN|3|SCREENING|2021-11-21|2022-06-28|30|249
Study ID|SE|053425cd-706f-4d2e-847c-5a779ae9b2ab|2|5|1|TREATMENT|2021-10-26|2022-04-02|4|162
Study ID|SE|053425cd-706f-4d2e-847c-5a779ae9b2ab|3|REST|6|WASHOUT|2022-04-12|2022-08-15|172|297
Study ID|SE|053425cd-706f-4d2e-847c-5a779ae9b2ab|4|10|5|TREATMENT|2021-12-19|2021-12-25|58|64
Study ID|SE|053425cd-706f-4d2e-847c-5a779ae9b2ab|5|REST|7|WASHOUT|2022-01-22|2022-07-25|92|276
Study ID|SE|053425cd-706f-4d2e-847c-5a779ae9b2ab|6|P|6|TREATMENT|2021-11-19|2022-07-25|28|276
Study ID|SE|053425cd-706f-4d2e-847c-5a779ae9b2ab|7|FU|2|FOLLOW-UP|2022-05-02|2022-07-18|192|269
Study ID|SE|4bd332b3-6cd8-4e28-94ef-0b1a0be0a002|1|SCRN|3|SCREENING|2022-03-28|2022-04-02|227|232
Study ID|SE|4bd332b3-6cd8-4e28-94ef-0b1a0be0a002|2|P|4|TREATMENT|2021-10-14|2021-11-30|62|109
Study ID|SE|4bd332b3-6cd8-4e28-94ef-0b1a0be0a002|3|REST|1|WASHOUT|2021-09-01|2021-12-09|19|118
Study ID|SE|4bd332b3-6cd8-4e28-94ef-0b1a0be0a002|4|5|4|TREATMENT|2022-03-21|2022-04-27|220|257
Study ID|SE|4bd332b3-6cd8-4e28-94ef-0b1a0be0a002|5|REST|6|WASHOUT|2022-04-14|2022-05-17|244|277
Study ID|SE|4bd332b3-6cd8-4e28-94ef-0b1a0be0a002|6|10|4|TREATMENT|2021-12-06|2022-02-25|115|196
Study ID|SE|4bd332b3-6cd8-4e28-94ef-0b1a0be0a002|7|FU|5|FOLLOW-UP|2021-09-01|2022-03-30|19|229
Study ID|SE|e01de567-61df-4da1-8dcd-7190d1b9d889|1|SCRN|3|SCREENING|2022-01-15|2022-04-01|81|157
Study ID|SE|e01de567-61df-4da1-8dcd-7190d1b9d889|2|5|3|TREATMENT|2021-12-03|2022-05-31|38|217
Study ID|SE|e01de567-61df-4da1-8dcd-7190d1b9d889|3|REST|5|WASHOUT|2022-08-15|2022-08-21|293|299
Study ID|SE|e01de567-61df-4da1-8dcd-7190d1b9d889|4|P|7|TREATMENT|2021-10-29|2021-11-02|3|7
Study ID|SE|e01de567-61df-4da1-8dcd-7190d1b9d889|5|REST|2|WASHOUT|2021-11-09|2022-03-23|14|148
Study ID|SE|e01de567-61df-4da1-8dcd-7190d1b9d889|6|10|7|TREATMENT|2021-11-07|2021-11-26|12|31
Study ID|SE|e01de567-61df-4da1-8dcd-7190d1b9d889|7|FU|6|FOLLOW-UP|2021-11-24|2022-05-21|29|207
Study ID|SE|7569cb98-81bf-4117-b076-8e27f6a12eee|1|SCRN|1|SCREENING|2021-09-05|2021-09-16|4|15
Study ID|SE|7569cb98-81bf-4117-b076-8e27f6a12eee|2|5|5|TREATMENT|2021-10-13|2021-10-17|42|46
Study ID|SE|7569cb98-81bf-4117-b076-8e27f6a12eee|3|REST|5|WASHOUT|2021-10-15|2022-05-22|44|263
Study ID|SE|7569cb98-81bf-4117-b076-8e27f6a12eee|4|10|6|TREATMENT|2022-02-28|2022-04-25|180|236
Study ID|SE|7569cb98-81bf-4117-b076-8e27f6a12eee|5|REST|5|WASHOUT|2021-11-22|2022-01-05|82|126
Study ID|SE|7569cb98-81bf-4117-b076-8e27f6a12eee|6|P|6|TREATMENT|2021-09-29|2021-10-04|28|33
Study ID|SE|7569cb98-81bf-4117-b076-8e27f6a12eee|7|FU|4|FOLLOW-UP|2022-01-11|2022-01-23|132|144
Study ID|SE|ffc9571a-170d-44d9-be33-4e602e45fb1f|1|SCRN|2|SCREENING|2021-10-04|2021-10-13|41|50
Study ID|SE|ffc9571a-170d-44d9-be33-4e602e45fb1f|2|P|1|TREATMENT|2021-09-29|2022-01-16|36|145
Study ID|SE|ffc9571a-170d-44d9-be33-4e602e45fb1f|3|REST|3|WASHOUT|2022-02-01|2022-06-05|161|285
Study ID|SE|ffc9571a-170d-44d9-be33-4e602e45fb1f|4|5|1|TREATMENT|2021-09-27|2021-10-19|34|56
Study ID|SE|ffc9571a-170d-44d9-be33-4e602e45fb1f|5|REST|2|WASHOUT|2021-09-11|2021-10-01|18|38
Study ID|SE|ffc9571a-170d-44d9-be33-4e602e45fb1f|6|10|2|TREATMENT|2021-10-22|2022-04-15|59|234
Study ID|SE|ffc9571a-170d-44d9-be33-4e602e45fb1f|7|FU|1|FOLLOW-UP|2021-11-18|2021-12-11|86|109
Study ID|SE|1a307872-c540-43e0-b6cf-6c7abd48bd34|1|SCRN|2|SCREENING|2021-11-21|2022-05-01|41|202
Study ID|SE|1a307872-c540-43e0-b6cf-6c7abd48bd34|2|5|2|TREATMENT|2021-11-10|2022-07-25|30|287
Study ID|SE|1a307872-c540-43e0-b6cf-6c7abd48bd34|3|REST|5|WASHOUT|2022-01-27|2022-05-05|108|206
Study ID|SE|1a307872-c540-43e0-b6cf-6c7abd48bd34|4|10|4|TREATMENT|2021-12-10|2022-01-27|60|108
Study ID|SE|1a307872-c540-43e0-b6cf-6c7abd48bd34|5|REST|1|WASHOUT|2021-10-21|2021-11-02|10|22
Study ID|SE|1a307872-c540-43e0-b6cf-6c7abd48bd34|6|P|1|TREATMENT|2021-10-19|2021-10-28|8|17
Study ID|SE|1a307872-c540-43e0-b6cf-6c7abd48bd34|7|FU|1|FOLLOW-UP|2021-10-18|2021-10-19|7|8
Study ID|SE|ae0d4887-73ee-47ff-98df-69e53708973a|1|SCRN|1|SCREENING|2021-09-16|2021-09-17|2|3
Study ID|SE|ae0d4887-73ee-47ff-98df-69e53708973a|2|P|5|TREATMENT|2021-12-19|2022-01-10|96|118
Study ID|SE|ae0d4887-73ee-47ff-98df-69e53708973a|3|REST|6|WASHOUT|2021-11-20|2021-12-24|67|101
Study ID|SE|ae0d4887-73ee-47ff-98df-69e53708973a|4|5|1|TREATMENT|2022-02-22|2022-03-29|161|196
Study ID|SE|ae0d4887-73ee-47ff-98df-69e53708973a|5|REST|4|WASHOUT|2022-02-27|2022-04-27|166|225
Study ID|SE|ae0d4887-73ee-47ff-98df-69e53708973a|6|10|4|TREATMENT|2021-10-29|2022-05-27|45|255
Study ID|SE|ae0d4887-73ee-47ff-98df-69e53708973a|7|FU|5|FOLLOW-UP|2022-03-22|2022-04-06|189|204
Study ID|SE|a9d0cb3a-b2bf-442c-a297-b01e8e701c6b|1|SCRN|2|SCREENING|2022-04-10|2022-04-18|209|217
Study ID|SE|a9d0cb3a-b2bf-442c-a297-b01e8e701c6b|2|5|1|TREATMENT|2021-11-21|2022-02-20|69|160
Study ID|SE|a9d0cb3a-b2bf-442c-a297-b01e8e701c6b|3|REST|1|WASHOUT|2021-10-07|2021-12-06|24|84
Study ID|SE|a9d0cb3a-b2bf-442c-a297-b01e8e701c6b|4|10|5|TREATMENT|2021-10-25|2021-12-05|42|83
Study ID|SE|a9d0cb3a-b2bf-442c-a297-b01e8e701c6b|5|REST|5|WASHOUT|2021-12-08|2022-05-03|86|232
Study ID|SE|a9d0cb3a-b2bf-442c-a297-b01e8e701c6b|6|P|7|TREATMENT|2021-10-07|2022-02-22|24|162
Study ID|SE|a9d0cb3a-b2bf-442c-a297-b01e8e701c6b|7|FU|6|FOLLOW-UP|2022-01-29|2022-05-12|138|241
Study ID|SE|5988e1e7-9658-4677-be9d-c61a0cb2cc95|1|SCRN|5|SCREENING|2021-12-21|2022-01-31|117|158
Study ID|SE|5988e1e7-9658-4677-be9d-c61a0cb2cc95|2|P|2|TREATMENT|2022-04-23|2022-05-23|240|270
Study ID|SE|5988e1e7-9658-4677-be9d-c61a0cb2cc95|3|REST|7|WASHOUT|2022-05-13|2022-06-07|260|285
Study ID|SE|5988e1e7-9658-4677-be9d-c61a0cb2cc95|4|5|2|TREATMENT|2021-11-06|2022-04-21|72|238
Study ID|SE|5988e1e7-9658-4677-be9d-c61a0cb2cc95|5|REST|1|WASHOUT|2021-12-05|2022-02-01|101|159
Study ID|SE|5988e1e7-9658-4677-be9d-c61a0cb2cc95|6|10|5|TREATMENT|2021-09-14|2021-11-16|19|82
Study ID|SE|5988e1e7-9658-4677-be9d-c61a0cb2cc95|7|FU|3|FOLLOW-UP|2021-09-08|2021-10-06|13|41
Study ID|SE|fc101382-4916-4ee4-bf00-6398e8aece08|1|SCRN|3|SCREENING|2021-10-28|2021-11-02|16|21
Study ID|SE|fc101382-4916-4ee4-bf00-6398e8aece08|2|P|3|TREATMENT|2021-10-26|2022-06-30|14|261
Study ID|SE|fc101382-4916-4ee4-bf00-6398e8aece08|3|REST|7|WASHOUT|2022-01-21|2022-03-15|101|154
Study ID|SE|fc101382-4916-4ee4-bf00-6398e8aece08|4|5|5|TREATMENT|2022-01-24|2022-06-25|104|256
Study ID|SE|fc101382-4916-4ee4-bf00-6398e8aece08|5|REST|5|WASHOUT|2022-06-06|2022-08-01|237|293
Study ID|SE|fc101382-4916-4ee4-bf00-6398e8aece08|6|10|2|TREATMENT|2021-12-19|2022-04-18|68|188
Study ID|SE|fc101382-4916-4ee4-bf00-6398e8aece08|7|FU|2|FOLLOW-UP|2021-10-14|2021-10-15|2|3
Study ID|SE|93dc1418-6279-4db0-b55b-a26645a9b30c|1|SCRN|4|SCREENING|2021-10-16|2022-03-21|10|166
Study ID|SE|93dc1418-6279-4db0-b55b-a26645a9b30c|2|5|6|TREATMENT|2021-11-14|2021-11-28|39|53
Study ID|SE|93dc1418-6279-4db0-b55b-a26645a9b30c|3|REST|6|WASHOUT|2021-12-12|2022-06-08|67|245
Study ID|SE|93dc1418-6279-4db0-b55b-a26645a9b30c|4|10|5|TREATMENT|2022-03-16|2022-05-31|161|237
Study ID|SE|93dc1418-6279-4db0-b55b-a26645a9b30c|5|REST|1|WASHOUT|2021-12-14|2022-01-22|69|108
Study ID|SE|93dc1418-6279-4db0-b55b-a26645a9b30c|6|P|5|TREATMENT|2021-10-24|2022-07-02|18|269
Study ID|SE|93dc1418-6279-4db0-b55b-a26645a9b30c|7|FU|4|FOLLOW-UP|2021-10-16|2022-02-11|10|128
Study ID|SE|166f2758-b6c5-4439-9201-22007ca181c7|1|SCRN|1|SCREENING|2021-11-02|2021-12-21|53|102
Study ID|SE|166f2758-b6c5-4439-9201-22007ca181c7|2|P|5|TREATMENT|2021-09-28|2021-10-12|18|32
Study ID|SE|166f2758-b6c5-4439-9201-22007ca181c7|3|REST|3|WASHOUT|2021-09-24|2021-10-04|14|24
Study ID|SE|166f2758-b6c5-4439-9201-22007ca181c7|4|5|3|TREATMENT|2021-10-04|2022-06-15|24|278
Study ID|SE|166f2758-b6c5-4439-9201-22007ca181c7|5|REST|3|WASHOUT|2021-09-15|2021-09-29|5|19
Study ID|SE|166f2758-b6c5-4439-9201-22007ca181c7|6|10|7|TREATMENT|2021-09-22|2022-06-29|12|292
Study ID|SE|166f2758-b6c5-4439-9201-22007ca181c7|7|FU|4|FOLLOW-UP|2021-10-19|2021-11-19|39|70
Study ID|SE|dfe799ef-40f8-4293-ae08-fefc54ae3bd1|1|SCRN|3|SCREENING|2021-12-21|2021-12-23|100|102
Study ID|SE|dfe799ef-40f8-4293-ae08-fefc54ae3bd1|2|5|2|TREATMENT|2021-11-15|2021-11-21|64|70
Study ID|SE|dfe799ef-40f8-4293-ae08-fefc54ae3bd1|3|REST|3|WASHOUT|2021-09-28|2021-09-30|16|18
Study ID|SE|dfe799ef-40f8-4293-ae08-fefc54ae3bd1|4|P|3|TREATMENT|2021-12-12|2022-05-28|91|258
Study ID|SE|dfe799ef-40f8-4293-ae08-fefc54ae3bd1|5|REST|7|WASHOUT|2021-12-10|2021-12-28|89|107
Study ID|SE|dfe799ef-40f8-4293-ae08-fefc54ae3bd1|6|10|1|TREATMENT|2021-10-17|2021-11-22|35|71
Study ID|SE|dfe799ef-40f8-4293-ae08-fefc54ae3bd1|7|FU|6|FOLLOW-UP|2022-03-01|2022-05-05|170|235
Study ID|SE|a385105b-f0f8-4f28-9f0d-83590bdbb515|1|SCRN|2|SCREENING|2022-03-31|2022-07-05|176|272
Study ID|SE|a385105b-f0f8-4f28-9f0d-83590bdbb515|2|5|6|TREATMENT|2021-12-16|2021-12-30|71|85
Study ID|SE|a385105b-f0f8-4f28-9f0d-83590bdbb515|3|REST|2|WASHOUT|2022-03-23|2022-05-15|168|221
Study ID|SE|a385105b-f0f8-4f28-9f0d-83590bdbb515|4|10|6|TREATMENT|2021-10-30|2021-11-29|24|54
Study ID|SE|a385105b-f0f8-4f28-9f0d-83590bdbb515|5|REST|3|WASHOUT|2021-10-18|2021-11-19|12|44
Study ID|SE|a385105b-f0f8-4f28-9f0d-83590bdbb515|6|P|5|TREATMENT|2022-03-10|2022-06-08|155|245
Study ID|SE|a385105b-f0f8-4f28-9f0d-83590bdbb515|7|FU|3|FOLLOW-UP|2022-03-15|2022-07-01|160|268
Study ID|SE|808520d3-3b76-49bc-b3af-bc2fe89292ce|1|SCRN|7|SCREENING|2022-02-16|2022-05-12|175|260
Study ID|SE|808520d3-3b76-49bc-b3af-bc2fe89292ce|2|P|7|TREATMENT|2022-05-05|2022-06-13|253|292
Study ID|SE|808520d3-3b76-49bc-b3af-bc2fe89292ce|3|REST|7|WASHOUT|2021-11-12|2021-12-07|79|104
Study ID|SE|808520d3-3b76-49bc-b3af-bc2fe89292ce|4|5|4|TREATMENT|2021-09-27|2021-11-29|33|96
Study ID|SE|808520d3-3b76-49bc-b3af-bc2fe89292ce|5|REST|2|WASHOUT|2021-11-20|2022-01-13|87|141
Study ID|SE|808520d3-3b76-49bc-b3af-bc2fe89292ce|6|10|6|TREATMENT|2021-12-10|2022-02-11|107|170
Study ID|SE|808520d3-3b76-49bc-b3af-bc2fe89292ce|7|FU|1|FOLLOW-UP|2021-11-26|2022-01-15|93|143
Study ID|SE|7a0b128e-56a8-4dc2-9fff-5da61f895cc7|1|SCRN|4|SCREENING|2022-04-03|2022-05-23|167|217
Study ID|SE|7a0b128e-56a8-4dc2-9fff-5da61f895cc7|2|5|2|TREATMENT|2022-04-22|2022-06-18|186|243
Study ID|SE|7a0b128e-56a8-4dc2-9fff-5da61f895cc7|3|REST|2|WASHOUT|2021-11-23|2022-02-04|36|109
Study ID|SE|7a0b128e-56a8-4dc2-9fff-5da61f895cc7|4|P|1|TREATMENT|2021-10-28|2021-10-30|10|12
Study ID|SE|7a0b128e-56a8-4dc2-9fff-5da61f895cc7|5|REST|2|WASHOUT|2022-02-01|2022-06-25|106|250
Study ID|SE|7a0b128e-56a8-4dc2-9fff-5da61f895cc7|6|10|6|TREATMENT|2022-05-29|2022-06-11|223|236
Study ID|SE|7a0b128e-56a8-4dc2-9fff-5da61f895cc7|7|FU|1|FOLLOW-UP|2021-10-21|2021-10-23|3|5
Study ID|SE|958d143a-5381-49c5-8bd4-57e1369c3c83|1|SCRN|5|SCREENING|2022-01-26|2022-03-25|128|186
Study ID|SE|958d143a-5381-49c5-8bd4-57e1369c3c83|2|5|6|TREATMENT|2021-10-27|2022-02-09|37|142
Study ID|SE|958d143a-5381-49c5-8bd4-57e1369c3c83|3|REST|7|WASHOUT|2021-11-07|2021-11-13|48|54
Study ID|SE|958d143a-5381-49c5-8bd4-57e1369c3c83|4|P|3|TREATMENT|2022-01-16|2022-04-07|118|199
Study ID|SE|958d143a-5381-49c5-8bd4-57e1369c3c83|5|REST|6|WASHOUT|2021-10-25|2021-11-15|35|56
Study ID|SE|958d143a-5381-49c5-8bd4-57e1369c3c83|6|10|7|TREATMENT|2021-10-08|2021-12-09|18|80
Study ID|SE|958d143a-5381-49c5-8bd4-57e1369c3c83|7|FU|3|FOLLOW-UP|2022-02-01|2022-04-05|134|197
Study ID|SE|1b08fa0e-c785-4e2b-ade6-764dc0199b46|1|SCRN|6|SCREENING|2022-02-02|2022-04-07|152|216
Study ID|SE|1b08fa0e-c785-4e2b-ade6-764dc0199b46|2|5|1|TREATMENT|2021-09-15|2022-02-05|12|155
Study ID|SE|1b08fa0e-c785-4e2b-ade6-764dc0199b46|3|REST|2|WASHOUT|2021-09-28|2021-11-08|25|66
Study ID|SE|1b08fa0e-c785-4e2b-ade6-764dc0199b46|4|10|1|TREATMENT|2021-11-16|2022-04-25|74|234
Study ID|SE|1b08fa0e-c785-4e2b-ade6-764dc0199b46|5|REST|6|WASHOUT|2021-10-16|2022-02-25|43|175
Study ID|SE|1b08fa0e-c785-4e2b-ade6-764dc0199b46|6|P|7|TREATMENT|2021-09-29|2021-12-11|26|99
Study ID|SE|1b08fa0e-c785-4e2b-ade6-764dc0199b46|7|FU|6|FOLLOW-UP|2021-11-13|2022-06-22|71|292
Study ID|SE|9e430cf4-27f1-4fd8-abbb-1971b7f6698b|1|SCRN|7|SCREENING|2021-12-29|2022-03-03|89|153
Study ID|SE|9e430cf4-27f1-4fd8-abbb-1971b7f6698b|2|5|6|TREATMENT|2021-12-16|2022-03-22|76|172
Study ID|SE|9e430cf4-27f1-4fd8-abbb-1971b7f6698b|3|REST|6|WASHOUT|2021-12-20|2022-03-01|80|151
Study ID|SE|9e430cf4-27f1-4fd8-abbb-1971b7f6698b|4|10|4|TREATMENT|2021-10-05|2021-12-11|4|71
Study ID|SE|9e430cf4-27f1-4fd8-abbb-1971b7f6698b|5|REST|6|WASHOUT|2022-01-11|2022-01-22|102|113
Study ID|SE|9e430cf4-27f1-4fd8-abbb-1971b7f6698b|6|P|5|TREATMENT|2022-05-11|2022-06-27|222|269
Study ID|SE|9e430cf4-27f1-4fd8-abbb-1971b7f6698b|7|FU|7|FOLLOW-UP|2021-11-11|2021-11-15|41|45
Study ID|SE|fc84f14d-27bf-4f2e-beb1-af50ddf975b8|1|SCRN|2|SCREENING|2021-12-05|2022-06-23|46|246
Study ID|SE|fc84f14d-27bf-4f2e-beb1-af50ddf975b8|2|5|1|TREATMENT|2022-05-21|2022-08-11|213|295
Study ID|SE|fc84f14d-27bf-4f2e-beb1-af50ddf975b8|3|REST|6|WASHOUT|2022-02-23|2022-05-27|126|219
Study ID|SE|fc84f14d-27bf-4f2e-beb1-af50ddf975b8|4|10|7|TREATMENT|2021-12-01|2022-03-20|42|151
Study ID|SE|fc84f14d-27bf-4f2e-beb1-af50ddf975b8|5|REST|5|WASHOUT|2022-05-06|2022-06-21|198|244
Study ID|SE|fc84f14d-27bf-4f2e-beb1-af50ddf975b8|6|P|5|TREATMENT|2021-12-24|2022-02-24|65|127
Study ID|SE|fc84f14d-27bf-4f2e-beb1-af50ddf975b8|7|FU|4|FOLLOW-UP|2021-11-12|2022-01-06|23|78
Study ID|SE|e2242eef-d92e-40e2-a481-3da17eef3d9f|1|SCRN|7|SCREENING|2021-09-27|2021-11-06|36|76
Study ID|SE|e2242eef-d92e-40e2-a481-3da17eef3d9f|2|5|1|TREATMENT|2021-10-25|2022-02-09|64|171
Study ID|SE|e2242eef-d92e-40e2-a481-3da17eef3d9f|3|REST|7|WASHOUT|2021-08-28|2021-09-18|6|27
Study ID|SE|e2242eef-d92e-40e2-a481-3da17eef3d9f|4|P|5|TREATMENT|2021-09-12|2021-09-23|21|32
Study ID|SE|e2242eef-d92e-40e2-a481-3da17eef3d9f|5|REST|2|WASHOUT|2021-08-30|2022-05-13|8|264
Study ID|SE|e2242eef-d92e-40e2-a481-3da17eef3d9f|6|10|3|TREATMENT|2021-09-09|2021-11-14|18|84
Study ID|SE|e2242eef-d92e-40e2-a481-3da17eef3d9f|7|FU|7|FOLLOW-UP|2021-08-26|2021-11-01|4|71
Study ID|SE|fb8e4e6b-79e5-4a38-bb3b-8b9dea8d70b0|1|SCRN|1|SCREENING|2021-09-08|2022-02-27|14|186
Study ID|SE|fb8e4e6b-79e5-4a38-bb3b-8b9dea8d70b0|2|P|7|TREATMENT|2021-09-17|2021-09-22|23|28
Study ID|SE|fb8e4e6b-79e5-4a38-bb3b-8b9dea8d70b0|3|REST|5|WASHOUT|2021-08-29|2021-09-29|4|35
Study ID|SE|fb8e4e6b-79e5-4a38-bb3b-8b9dea8d70b0|4|5|2|TREATMENT|2021-09-10|2022-04-10|16|228
Study ID|SE|fb8e4e6b-79e5-4a38-bb3b-8b9dea8d70b0|5|REST|4|WASHOUT|2022-05-06|2022-05-08|254|256
Study ID|SE|fb8e4e6b-79e5-4a38-bb3b-8b9dea8d70b0|6|10|5|TREATMENT|2021-12-18|2022-03-21|115|208
Study ID|SE|fb8e4e6b-79e5-4a38-bb3b-8b9dea8d70b0|7|FU|6|FOLLOW-UP|2022-03-16|2022-04-23|203|241
Study ID|SE|c416dd33-f0c5-4097-8be0-a8baef1f41ab|1|SCRN|6|SCREENING|2021-09-26|2022-02-08|25|160
Study ID|SE|c416dd33-f0c5-4097-8be0-a8baef1f41ab|2|5|7|TREATMENT|2022-01-28|2022-04-15|149|226
Study ID|SE|c416dd33-f0c5-4097-8be0-a8baef1f41ab|3|REST|5|WASHOUT|2021-09-26|2021-12-28|25|118
Study ID|SE|c416dd33-f0c5-4097-8be0-a8baef1f41ab|4|P|2|TREATMENT|2021-11-17|2022-03-12|77|192
Study ID|SE|c416dd33-f0c5-4097-8be0-a8baef1f41ab|5|REST|3|WASHOUT|2022-02-02|2022-06-06|154|278
Study ID|SE|c416dd33-f0c5-4097-8be0-a8baef1f41ab|6|10|4|TREATMENT|2021-09-13|2022-01-04|12|125
Study ID|SE|c416dd33-f0c5-4097-8be0-a8baef1f41ab|7|FU|5|FOLLOW-UP|2021-10-23|2021-12-07|52|97
Study ID|SE|33606058-1c76-4b31-bb71-b25bc019dacc|1|SCRN|7|SCREENING|2022-02-21|2022-08-19|116|295
Study ID|SE|33606058-1c76-4b31-bb71-b25bc019dacc|2|5|7|TREATMENT|2022-01-31|2022-05-12|95|196
Study ID|SE|33606058-1c76-4b31-bb71-b25bc019dacc|3|REST|2|WASHOUT|2021-12-11|2021-12-26|44|59
Study ID|SE|33606058-1c76-4b31-bb71-b25bc019dacc|4|10|3|TREATMENT|2022-02-02|2022-02-04|97|99
Study ID|SE|33606058-1c76-4b31-bb71-b25bc019dacc|5|REST|1|WASHOUT|2021-12-20|2022-03-20|53|143
Study ID|SE|33606058-1c76-4b31-bb71-b25bc019dacc|6|P|2|TREATMENT|2021-10-31|2021-11-30|3|33
Study ID|SE|33606058-1c76-4b31-bb71-b25bc019dacc|7|FU|3|FOLLOW-UP|2021-12-19|2021-12-27|52|60
Study ID|SE|b3117024-d79c-4ba6-bc57-cd5e32352abb|1|SCRN|6|SCREENING|2022-04-08|2022-06-13|192|258
Study ID|SE|b3117024-d79c-4ba6-bc57-cd5e32352abb|2|5|5|TREATMENT|2021-10-22|2021-11-06|24|39
Study ID|SE|b3117024-d79c-4ba6-bc57-cd5e32352abb|3|REST|4|WASHOUT|2021-10-02|2022-02-10|4|135
Study ID|SE|b3117024-d79c-4ba6-bc57-cd5e32352abb|4|P|3|TREATMENT|2021-10-02|2021-10-07|4|9
Study ID|SE|b3117024-d79c-4ba6-bc57-cd5e32352abb|5|REST|5|WASHOUT|2021-12-31|2022-02-27|94|152
Study ID|SE|b3117024-d79c-4ba6-bc57-cd5e32352abb|6|10|5|TREATMENT|2021-10-05|2021-11-29|7|62
Study ID|SE|b3117024-d79c-4ba6-bc57-cd5e32352abb|7|FU|2|FOLLOW-UP|2021-12-11|2022-06-23|74|268
Study ID|SE|5f681c2a-5efd-4774-bfb8-d031fbdd917d|1|SCRN|4|SCREENING|2021-11-16|2022-01-11|53|109
Study ID|SE|5f681c2a-5efd-4774-bfb8-d031fbdd917d|2|5|2|TREATMENT|2022-04-01|2022-04-27|189|215
Study ID|SE|5f681c2a-5efd-4774-bfb8-d031fbdd917d|3|REST|6|WASHOUT|2021-11-23|2022-01-21|60|119
Study ID|SE|5f681c2a-5efd-4774-bfb8-d031fbdd917d|4|10|1|TREATMENT|2022-01-09|2022-01-15|107|113
Study ID|SE|5f681c2a-5efd-4774-bfb8-d031fbdd917d|5|REST|1|WASHOUT|2021-10-07|2022-05-13|13|231
Study ID|SE|5f681c2a-5efd-4774-bfb8-d031fbdd917d|6|P|6|TREATMENT|2021-10-19|2021-11-10|25|47
Study ID|SE|5f681c2a-5efd-4774-bfb8-d031fbdd917d|7|FU|1|FOLLOW-UP|2021-10-10|2022-04-04|16|192
Study ID|SE|a9e04609-9af3-4587-8ac0-a8d62854939a|1|SCRN|3|SCREENING|2022-02-20|2022-06-02|115|217
Study ID|SE|a9e04609-9af3-4587-8ac0-a8d62854939a|2|5|4|TREATMENT|2022-01-28|2022-03-31|92|154
Study ID|SE|a9e04609-9af3-4587-8ac0-a8d62854939a|3|REST|3|WASHOUT|2021-11-12|2021-12-08|15|41
Study ID|SE|a9e04609-9af3-4587-8ac0-a8d62854939a|4|P|2|TREATMENT|2022-03-01|2022-07-21|124|266
Study ID|SE|a9e04609-9af3-4587-8ac0-a8d62854939a|5|REST|4|WASHOUT|2022-02-22|2022-03-28|117|151
Study ID|SE|a9e04609-9af3-4587-8ac0-a8d62854939a|6|10|2|TREATMENT|2021-11-15|2021-12-09|18|42
Study ID|SE|a9e04609-9af3-4587-8ac0-a8d62854939a|7|FU|5|FOLLOW-UP|2021-11-04|2022-04-13|7|167
Study ID|SE|0913ad12-1f57-4c53-953c-53b2c77d6916|1|SCRN|2|SCREENING|2021-10-13|2022-07-11|3|274
Study ID|SE|0913ad12-1f57-4c53-953c-53b2c77d6916|2|5|5|TREATMENT|2022-01-11|2022-03-25|93|166
Study ID|SE|0913ad12-1f57-4c53-953c-53b2c77d6916|3|REST|3|WASHOUT|2021-12-18|2022-05-19|69|221
Study ID|SE|0913ad12-1f57-4c53-953c-53b2c77d6916|4|P|4|TREATMENT|2021-10-13|2022-06-03|3|236
Study ID|SE|0913ad12-1f57-4c53-953c-53b2c77d6916|5|REST|6|WASHOUT|2022-01-08|2022-04-04|90|176
Study ID|SE|0913ad12-1f57-4c53-953c-53b2c77d6916|6|10|1|TREATMENT|2022-05-24|2022-06-08|226|241
Study ID|SE|0913ad12-1f57-4c53-953c-53b2c77d6916|7|FU|4|FOLLOW-UP|2021-11-23|2022-06-08|44|241
Study ID|SE|5621f735-4c04-4865-ae76-417f931fc416|1|SCRN|1|SCREENING|2022-04-03|2022-07-20|173|281
Study ID|SE|5621f735-4c04-4865-ae76-417f931fc416|2|P|2|TREATMENT|2022-01-18|2022-07-26|98|287
Study ID|SE|5621f735-4c04-4865-ae76-417f931fc416|3|REST|7|WASHOUT|2022-02-27|2022-06-13|138|244
Study ID|SE|5621f735-4c04-4865-ae76-417f931fc416|4|5|6|TREATMENT|2022-02-27|2022-04-10|138|180
Study ID|SE|5621f735-4c04-4865-ae76-417f931fc416|5|REST|5|WASHOUT|2021-11-10|2022-06-13|29|244
Study ID|SE|5621f735-4c04-4865-ae76-417f931fc416|6|10|4|TREATMENT|2021-10-25|2022-01-30|13|110
Study ID|SE|5621f735-4c04-4865-ae76-417f931fc416|7|FU|2|FOLLOW-UP|2021-10-15|2021-11-12|3|31
Study ID|SE|d2815dac-314a-4b51-a2a8-7c34342d8762|1|SCRN|2|SCREENING|2022-02-11|2022-02-16|117|122
Study ID|SE|d2815dac-314a-4b51-a2a8-7c34342d8762|2|5|1|TREATMENT|2022-03-26|2022-07-22|160|278
Study ID|SE|d2815dac-314a-4b51-a2a8-7c34342d8762|3|REST|1|WASHOUT|2021-11-01|2021-11-25|15|39
Study ID|SE|d2815dac-314a-4b51-a2a8-7c34342d8762|4|10|1|TREATMENT|2021-11-15|2021-11-29|29|43
Study ID|SE|d2815dac-314a-4b51-a2a8-7c34342d8762|5|REST|5|WASHOUT|2022-04-11|2022-04-19|176|184
Study ID|SE|d2815dac-314a-4b51-a2a8-7c34342d8762|6|P|3|TREATMENT|2022-01-05|2022-04-04|80|169
Study ID|SE|d2815dac-314a-4b51-a2a8-7c34342d8762|7|FU|5|FOLLOW-UP|2021-11-25|2022-06-02|39|228
Study ID|SE|1e4a58b7-6c40-49c2-8366-ab18bde326ba|1|SCRN|5|SCREENING|2021-11-13|2021-12-14|54|85
Study ID|SE|1e4a58b7-6c40-49c2-8366-ab18bde326ba|2|5|3|TREATMENT|2021-10-06|2021-10-07|16|17
Study ID|SE|1e4a58b7-6c40-49c2-8366-ab18bde326ba|3|REST|5|WASHOUT|2022-06-13|2022-06-24|266|277
Study ID|SE|1e4a58b7-6c40-49c2-8366-ab18bde326ba|4|10|1|TREATMENT|2022-02-10|2022-02-12|143|145
Study ID|SE|1e4a58b7-6c40-49c2-8366-ab18bde326ba|5|REST|2|WASHOUT|2021-10-22|2022-03-06|32|167
Study ID|SE|1e4a58b7-6c40-49c2-8366-ab18bde326ba|6|P|2|TREATMENT|2021-09-24|2021-10-28|4|38
Study ID|SE|1e4a58b7-6c40-49c2-8366-ab18bde326ba|7|FU|7|FOLLOW-UP|2021-12-16|2022-03-15|87|176
Study ID|SE|6142ec67-5b3f-4b25-ab15-4b89681287aa|1|SCRN|4|SCREENING|2021-09-25|2022-02-15|32|175
Study ID|SE|6142ec67-5b3f-4b25-ab15-4b89681287aa|2|5|5|TREATMENT|2021-12-03|2021-12-15|101|113
Study ID|SE|6142ec67-5b3f-4b25-ab15-4b89681287aa|3|REST|6|WASHOUT|2021-12-25|2022-03-31|123|219
Study ID|SE|6142ec67-5b3f-4b25-ab15-4b89681287aa|4|10|4|TREATMENT|2021-08-26|2021-08-27|2|3
Study ID|SE|6142ec67-5b3f-4b25-ab15-4b89681287aa|5|REST|5|WASHOUT|2021-11-12|2022-01-28|80|157
Study ID|SE|6142ec67-5b3f-4b25-ab15-4b89681287aa|6|P|4|TREATMENT|2021-11-19|2022-05-23|87|272
Study ID|SE|6142ec67-5b3f-4b25-ab15-4b89681287aa|7|FU|6|FOLLOW-UP|2021-09-18|2021-11-02|25|70
Study ID|SE|f3d1a010-45e4-4136-985b-2c267cc61bc0|1|SCRN|5|SCREENING|2021-08-21|2021-09-06|5|21
Study ID|SE|f3d1a010-45e4-4136-985b-2c267cc61bc0|2|5|7|TREATMENT|2021-10-21|2022-01-18|66|155
Study ID|SE|f3d1a010-45e4-4136-985b-2c267cc61bc0|3|REST|4|WASHOUT|2021-11-03|2021-12-28|79|134
Study ID|SE|f3d1a010-45e4-4136-985b-2c267cc61bc0|4|P|2|TREATMENT|2021-10-28|2021-12-03|73|109
Study ID|SE|f3d1a010-45e4-4136-985b-2c267cc61bc0|5|REST|4|WASHOUT|2021-12-08|2022-04-15|114|242
Study ID|SE|f3d1a010-45e4-4136-985b-2c267cc61bc0|6|10|3|TREATMENT|2021-12-10|2021-12-23|116|129
Study ID|SE|f3d1a010-45e4-4136-985b-2c267cc61bc0|7|FU|4|FOLLOW-UP|2021-09-17|2022-05-06|32|263
Study ID|SE|02731faf-c909-4245-bde8-9ed89623636c|1|SCRN|3|SCREENING|2021-10-14|2022-03-02|30|169
Study ID|SE|02731faf-c909-4245-bde8-9ed89623636c|2|5|5|TREATMENT|2021-09-19|2021-09-21|5|7
Study ID|SE|02731faf-c909-4245-bde8-9ed89623636c|3|REST|1|WASHOUT|2021-11-10|2022-02-05|57|144
Study ID|SE|02731faf-c909-4245-bde8-9ed89623636c|4|P|6|TREATMENT|2021-10-09|2022-01-01|25|109
Study ID|SE|02731faf-c909-4245-bde8-9ed89623636c|5|REST|6|WASHOUT|2021-09-28|2021-10-30|14|46
Study ID|SE|02731faf-c909-4245-bde8-9ed89623636c|6|10|2|TREATMENT|2021-09-28|2022-02-12|14|151
Study ID|SE|02731faf-c909-4245-bde8-9ed89623636c|7|FU|1|FOLLOW-UP|2021-10-09|2021-12-09|25|86
Study ID|SE|f41c7623-dc71-40b6-af05-cb27bcc5bc0d|1|SCRN|7|SCREENING|2022-01-12|2022-01-28|83|99
Study ID|SE|f41c7623-dc71-40b6-af05-cb27bcc5bc0d|2|5|2|TREATMENT|2022-03-10|2022-03-31|140|161
Study ID|SE|f41c7623-dc71-40b6-af05-cb27bcc5bc0d|3|REST|5|WASHOUT|2021-12-18|2022-02-22|58|124
Study ID|SE|f41c7623-dc71-40b6-af05-cb27bcc5bc0d|4|10|2|TREATMENT|2021-12-06|2022-07-28|46|280
Study ID|SE|f41c7623-dc71-40b6-af05-cb27bcc5bc0d|5|REST|3|WASHOUT|2021-12-23|2022-01-24|63|95
Study ID|SE|f41c7623-dc71-40b6-af05-cb27bcc5bc0d|6|P|6|TREATMENT|2022-02-14|2022-08-04|116|287
Study ID|SE|f41c7623-dc71-40b6-af05-cb27bcc5bc0d|7|FU|6|FOLLOW-UP|2021-12-12|2021-12-13|52|53
Study ID|SE|3ca6f491-6adb-461e-8c77-6964298881b8|1|SCRN|2|SCREENING|2022-03-02|2022-06-02|181|273
Study ID|SE|3ca6f491-6adb-461e-8c77-6964298881b8|2|5|6|TREATMENT|2021-09-16|2022-01-16|14|136
Study ID|SE|3ca6f491-6adb-461e-8c77-6964298881b8|3|REST|4|WASHOUT|2021-10-21|2021-11-07|49|66
Study ID|SE|3ca6f491-6adb-461e-8c77-6964298881b8|4|10|2|TREATMENT|2021-09-24|2021-09-30|22|28
Study ID|SE|3ca6f491-6adb-461e-8c77-6964298881b8|5|REST|3|WASHOUT|2022-04-16|2022-04-17|226|227
Study ID|SE|3ca6f491-6adb-461e-8c77-6964298881b8|6|P|7|TREATMENT|2022-01-08|2022-03-31|128|210
Study ID|SE|3ca6f491-6adb-461e-8c77-6964298881b8|7|FU|6|FOLLOW-UP|2021-09-22|2022-03-09|20|188
Study ID|SE|348c5733-3f80-4958-aed9-788cae022359|1|SCRN|5|SCREENING|2022-02-16|2022-06-04|145|253
Study ID|SE|348c5733-3f80-4958-aed9-788cae022359|2|5|7|TREATMENT|2021-09-30|2021-10-02|6|8
Study ID|SE|348c5733-3f80-4958-aed9-788cae022359|3|REST|7|WASHOUT|2022-02-03|2022-07-20|132|299
Study ID|SE|348c5733-3f80-4958-aed9-788cae022359|4|P|1|TREATMENT|2022-01-23|2022-07-03|121|282
Study ID|SE|348c5733-3f80-4958-aed9-788cae022359|5|REST|5|WASHOUT|2022-05-24|2022-05-30|242|248
Study ID|SE|348c5733-3f80-4958-aed9-788cae022359|6|10|7|TREATMENT|2021-12-07|2021-12-13|74|80
Study ID|SE|348c5733-3f80-4958-aed9-788cae022359|7|FU|1|FOLLOW-UP|2022-02-16|2022-06-23|145|272
Study ID|SE|25afbbe4-4844-47b1-a1f2-719a1d539a7e|1|SCRN|2|SCREENING|2021-08-24|2022-05-16|4|269
Study ID|SE|25afbbe4-4844-47b1-a1f2-719a1d539a7e|2|5|5|TREATMENT|2021-10-28|2022-01-24|69|157
Study ID|SE|25afbbe4-4844-47b1-a1f2-719a1d539a7e|3|REST|5|WASHOUT|2022-04-05|2022-04-12|228|235
Study ID|SE|25afbbe4-4844-47b1-a1f2-719a1d539a7e|4|P|6|TREATMENT|2021-10-15|2022-03-04|56|196
Study ID|SE|25afbbe4-4844-47b1-a1f2-719a1d539a7e|5|REST|3|WASHOUT|2021-10-10|2021-12-08|51|110
Study ID|SE|25afbbe4-4844-47b1-a1f2-719a1d539a7e|6|10|3|TREATMENT|2022-02-04|2022-04-09|168|232
Study ID|SE|25afbbe4-4844-47b1-a1f2-719a1d539a7e|7|FU|6|FOLLOW-UP|2022-04-09|2022-04-19|232|242
Study ID|SE|ebdeac60-a9e0-40b5-a156-2e65c3d34ece|1|SCRN|6|SCREENING|2021-12-14|2021-12-27|58|71
Study ID|SE|ebdeac60-a9e0-40b5-a156-2e65c3d34ece|2|5|5|TREATMENT|2022-02-15|2022-07-22|121|278
Study ID|SE|ebdeac60-a9e0-40b5-a156-2e65c3d34ece|3|REST|7|WASHOUT|2021-10-22|2022-07-26|5|282
Study ID|SE|ebdeac60-a9e0-40b5-a156-2e65c3d34ece|4|P|6|TREATMENT|2021-10-23|2021-11-06|6|20
Study ID|SE|ebdeac60-a9e0-40b5-a156-2e65c3d34ece|5|REST|7|WASHOUT|2022-01-22|2022-03-01|97|135
Study ID|SE|ebdeac60-a9e0-40b5-a156-2e65c3d34ece|6|10|3|TREATMENT|2021-11-09|2021-12-04|23|48
Study ID|SE|ebdeac60-a9e0-40b5-a156-2e65c3d34ece|7|FU|4|FOLLOW-UP|2022-07-31|2022-08-10|287|297
Study ID|SE|0a056ab2-3769-4bb4-ab9f-581f1f302e5e|1|SCRN|1|SCREENING|2021-09-06|2021-11-24|6|85
Study ID|SE|0a056ab2-3769-4bb4-ab9f-581f1f302e5e|2|5|1|TREATMENT|2021-09-10|2021-09-24|10|24
Study ID|SE|0a056ab2-3769-4bb4-ab9f-581f1f302e5e|3|REST|6|WASHOUT|2022-02-01|2022-04-22|154|234
Study ID|SE|0a056ab2-3769-4bb4-ab9f-581f1f302e5e|4|10|7|TREATMENT|2021-11-12|2022-04-11|73|223
Study ID|SE|0a056ab2-3769-4bb4-ab9f-581f1f302e5e|5|REST|5|WASHOUT|2021-09-22|2021-09-25|22|25
Study ID|SE|0a056ab2-3769-4bb4-ab9f-581f1f302e5e|6|P|5|TREATMENT|2021-10-10|2021-11-08|40|69
Study ID|SE|0a056ab2-3769-4bb4-ab9f-581f1f302e5e|7|FU|4|FOLLOW-UP|2021-10-20|2022-03-09|50|190
Study ID|SE|0dc6f54f-28d3-4e98-9202-ecde1228feba|1|SCRN|1|SCREENING|2021-12-21|2022-02-12|125|178
Study ID|SE|0dc6f54f-28d3-4e98-9202-ecde1228feba|2|5|7|TREATMENT|2021-11-30|2022-04-13|104|238
Study ID|SE|0dc6f54f-28d3-4e98-9202-ecde1228feba|3|REST|5|WASHOUT|2022-03-31|2022-05-23|225|278
Study ID|SE|0dc6f54f-28d3-4e98-9202-ecde1228feba|4|P|2|TREATMENT|2021-09-13|2022-03-30|26|224
Study ID|SE|0dc6f54f-28d3-4e98-9202-ecde1228feba|5|REST|2|WASHOUT|2021-09-04|2021-09-11|17|24
Study ID|SE|0dc6f54f-28d3-4e98-9202-ecde1228feba|6|10|2|TREATMENT|2021-10-19|2021-11-10|62|84
Study ID|SE|0dc6f54f-28d3-4e98-9202-ecde1228feba|7|FU|1|FOLLOW-UP|2022-02-10|2022-04-23|176|248
Study ID|SE|a918255d-29fb-4e33-b0b7-df6fc4790307|1|SCRN|1|SCREENING|2021-10-31|2022-07-24|33|299
Study ID|SE|a918255d-29fb-4e33-b0b7-df6fc4790307|2|P|3|TREATMENT|2022-02-06|2022-07-04|131|279
Study ID|SE|a918255d-29fb-4e33-b0b7-df6fc4790307|3|REST|2|WASHOUT|2021-10-16|2022-04-07|18|191
Study ID|SE|a918255d-29fb-4e33-b0b7-df6fc4790307|4|5|2|TREATMENT|2021-11-06|2021-12-26|39|89
Study ID|SE|a918255d-29fb-4e33-b0b7-df6fc4790307|5|REST|1|WASHOUT|2022-01-25|2022-03-20|119|173
Study ID|SE|a918255d-29fb-4e33-b0b7-df6fc4790307|6|10|6|TREATMENT|2022-02-19|2022-04-01|144|185
Study ID|SE|a918255d-29fb-4e33-b0b7-df6fc4790307|7|FU|4|FOLLOW-UP|2021-12-30|2022-01-28|93|122
Study ID|SE|cca42372-642c-4914-89be-334f5e371202|1|SCRN|4|SCREENING|2022-01-12|2022-03-09|125|181
Study ID|SE|cca42372-642c-4914-89be-334f5e371202|2|5|4|TREATMENT|2021-10-02|2021-11-30|23|82
Study ID|SE|cca42372-642c-4914-89be-334f5e371202|3|REST|6|WASHOUT|2022-02-21|2022-02-28|165|172
Study ID|SE|cca42372-642c-4914-89be-334f5e371202|4|P|3|TREATMENT|2022-01-30|2022-04-25|143|228
Study ID|SE|cca42372-642c-4914-89be-334f5e371202|5|REST|7|WASHOUT|2021-10-24|2021-11-21|45|73
Study ID|SE|cca42372-642c-4914-89be-334f5e371202|6|10|2|TREATMENT|2021-10-04|2022-01-06|25|119
Study ID|SE|cca42372-642c-4914-89be-334f5e371202|7|FU|6|FOLLOW-UP|2021-09-20|2021-10-27|11|48
Study ID|SE|ef11d251-ad64-4ee8-8924-97229080b97f|1|SCRN|1|SCREENING|2021-12-29|2022-05-18|87|227
Study ID|SE|ef11d251-ad64-4ee8-8924-97229080b97f|2|5|2|TREATMENT|2022-03-08|2022-03-18|156|166
Study ID|SE|ef11d251-ad64-4ee8-8924-97229080b97f|3|REST|5|WASHOUT|2021-11-30|2022-07-09|58|279
Study ID|SE|ef11d251-ad64-4ee8-8924-97229080b97f|4|10|5|TREATMENT|2022-03-24|2022-04-23|172|202
Study ID|SE|ef11d251-ad64-4ee8-8924-97229080b97f|5|REST|6|WASHOUT|2021-12-25|2021-12-31|83|89
Study ID|SE|ef11d251-ad64-4ee8-8924-97229080b97f|6|P|1|TREATMENT|2022-01-12|2022-02-01|101|121
Study ID|SE|ef11d251-ad64-4ee8-8924-97229080b97f|7|FU|1|FOLLOW-UP|2022-02-26|2022-07-10|146|280
Study ID|SE|c81be2c6-6a71-42ed-821c-2539d90f9da6|1|SCRN|5|SCREENING|2021-12-08|2022-02-01|85|140
Study ID|SE|c81be2c6-6a71-42ed-821c-2539d90f9da6|2|5|6|TREATMENT|2021-09-19|2021-10-13|5|29
Study ID|SE|c81be2c6-6a71-42ed-821c-2539d90f9da6|3|REST|3|WASHOUT|2021-11-10|2021-11-24|57|71
Study ID|SE|c81be2c6-6a71-42ed-821c-2539d90f9da6|4|P|4|TREATMENT|2022-04-12|2022-05-20|210|248
Study ID|SE|c81be2c6-6a71-42ed-821c-2539d90f9da6|5|REST|1|WASHOUT|2021-11-08|2022-01-23|55|131
Study ID|SE|c81be2c6-6a71-42ed-821c-2539d90f9da6|6|10|1|TREATMENT|2022-04-15|2022-06-21|213|280
Study ID|SE|c81be2c6-6a71-42ed-821c-2539d90f9da6|7|FU|2|FOLLOW-UP|2022-04-28|2022-05-30|226|258
Study ID|SE|195e00af-25ec-43b2-98a0-b7dbb0918556|1|SCRN|5|SCREENING|2021-09-22|2022-04-04|32|226
Study ID|SE|195e00af-25ec-43b2-98a0-b7dbb0918556|2|5|5|TREATMENT|2021-09-15|2021-09-22|25|32
Study ID|SE|195e00af-25ec-43b2-98a0-b7dbb0918556|3|REST|1|WASHOUT|2022-03-05|2022-04-17|196|239
Study ID|SE|195e00af-25ec-43b2-98a0-b7dbb0918556|4|10|6|TREATMENT|2021-08-23|2021-11-11|2|82
Study ID|SE|195e00af-25ec-43b2-98a0-b7dbb0918556|5|REST|1|WASHOUT|2021-11-26|2022-04-20|97|242
Study ID|SE|195e00af-25ec-43b2-98a0-b7dbb0918556|6|P|7|TREATMENT|2021-11-05|2022-06-07|76|290
Study ID|SE|195e00af-25ec-43b2-98a0-b7dbb0918556|7|FU|1|FOLLOW-UP|2021-09-19|2021-09-25|29|35
Study ID|SE|166f2644-d223-48de-a053-7a7931229ea9|1|SCRN|3|SCREENING|2021-09-27|2021-10-04|4|11
Study ID|SE|166f2644-d223-48de-a053-7a7931229ea9|2|5|1|TREATMENT|2021-09-30|2021-12-04|7|72
Study ID|SE|166f2644-d223-48de-a053-7a7931229ea9|3|REST|1|WASHOUT|2022-01-10|2022-05-09|109|228
Study ID|SE|166f2644-d223-48de-a053-7a7931229ea9|4|P|5|TREATMENT|2021-10-09|2022-05-06|16|225
Study ID|SE|166f2644-d223-48de-a053-7a7931229ea9|5|REST|2|WASHOUT|2021-09-25|2021-12-25|2|93
Study ID|SE|166f2644-d223-48de-a053-7a7931229ea9|6|10|7|TREATMENT|2022-03-29|2022-07-14|187|294
Study ID|SE|166f2644-d223-48de-a053-7a7931229ea9|7|FU|1|FOLLOW-UP|2021-10-13|2022-03-17|20|175
Study ID|SE|50f00565-e065-4bb5-906f-43b4994f05d9|1|SCRN|3|SCREENING|2021-09-20|2022-01-21|29|152
Study ID|SE|50f00565-e065-4bb5-906f-43b4994f05d9|2|5|7|TREATMENT|2021-09-29|2021-11-24|38|94
Study ID|SE|50f00565-e065-4bb5-906f-43b4994f05d9|3|REST|2|WASHOUT|2021-08-30|2021-10-10|8|49
Study ID|SE|50f00565-e065-4bb5-906f-43b4994f05d9|4|10|7|TREATMENT|2021-09-30|2021-10-26|39|65
Study ID|SE|50f00565-e065-4bb5-906f-43b4994f05d9|5|REST|3|WASHOUT|2021-10-29|2021-11-19|68|89
Study ID|SE|50f00565-e065-4bb5-906f-43b4994f05d9|6|P|4|TREATMENT|2022-01-19|2022-02-10|150|172
Study ID|SE|50f00565-e065-4bb5-906f-43b4994f05d9|7|FU|6|FOLLOW-UP|2021-12-20|2022-01-31|120|162
Study ID|SE|25be6337-0010-4c3f-a40d-73f1970be014|1|SCRN|5|SCREENING|2021-08-31|2021-10-01|11|42
Study ID|SE|25be6337-0010-4c3f-a40d-73f1970be014|2|5|3|TREATMENT|2021-11-06|2022-01-03|78|136
Study ID|SE|25be6337-0010-4c3f-a40d-73f1970be014|3|REST|6|WASHOUT|2021-09-30|2021-11-25|41|97
Study ID|SE|25be6337-0010-4c3f-a40d-73f1970be014|4|10|7|TREATMENT|2021-12-14|2022-02-06|116|170
Study ID|SE|25be6337-0010-4c3f-a40d-73f1970be014|5|REST|1|WASHOUT|2021-11-09|2022-01-24|81|157
Study ID|SE|25be6337-0010-4c3f-a40d-73f1970be014|6|P|2|TREATMENT|2021-08-22|2021-08-22|2|2
Study ID|SE|25be6337-0010-4c3f-a40d-73f1970be014|7|FU|7|FOLLOW-UP|2021-09-06|2021-09-08|17|19
Study ID|SE|51665699-7b2e-4584-ba77-1495e49154c8|1|SCRN|7|SCREENING|2021-11-22|2022-01-18|50|107
Study ID|SE|51665699-7b2e-4584-ba77-1495e49154c8|2|5|7|TREATMENT|2022-02-21|2022-05-30|141|239
Study ID|SE|51665699-7b2e-4584-ba77-1495e49154c8|3|REST|1|WASHOUT|2021-10-06|2021-10-19|3|16
Study ID|SE|51665699-7b2e-4584-ba77-1495e49154c8|4|P|1|TREATMENT|2022-02-01|2022-04-21|121|200
Study ID|SE|51665699-7b2e-4584-ba77-1495e49154c8|5|REST|4|WASHOUT|2022-06-07|2022-07-26|247|296
Study ID|SE|51665699-7b2e-4584-ba77-1495e49154c8|6|10|5|TREATMENT|2021-11-25|2021-12-23|53|81
Study ID|SE|51665699-7b2e-4584-ba77-1495e49154c8|7|FU|4|FOLLOW-UP|2021-11-04|2022-05-20|32|229
Study ID|SE|677139a9-de5a-46e8-9b01-78b89bb5721c|1|SCRN|4|SCREENING|2021-10-20|2021-10-26|21|27
Study ID|SE|677139a9-de5a-46e8-9b01-78b89bb5721c|2|P|4|TREATMENT|2022-03-28|2022-07-14|180|288
Study ID|SE|677139a9-de5a-46e8-9b01-78b89bb5721c|3|REST|5|WASHOUT|2022-02-19|2022-05-08|143|221
Study ID|SE|677139a9-de5a-46e8-9b01-78b89bb5721c|4|5|5|TREATMENT|2021-11-04|2021-12-17|36|79
Study ID|SE|677139a9-de5a-46e8-9b01-78b89bb5721c|5|REST|2|WASHOUT|2022-04-06|2022-07-23|189|297
Study ID|SE|677139a9-de5a-46e8-9b01-78b89bb5721c|6|10|6|TREATMENT|2021-12-02|2022-04-09|64|192
Study ID|SE|677139a9-de5a-46e8-9b01-78b89bb5721c|7|FU|2|FOLLOW-UP|2022-01-06|2022-07-12|99|286
Study ID|SE|875a63c3-b499-4a5a-8b56-ca6d10bf9c26|1|SCRN|3|SCREENING|2022-03-25|2022-05-15|228|279
Study ID|SE|875a63c3-b499-4a5a-8b56-ca6d10bf9c26|2|P|4|TREATMENT|2022-03-13|2022-05-17|216|281
Study ID|SE|875a63c3-b499-4a5a-8b56-ca6d10bf9c26|3|REST|5|WASHOUT|2021-09-17|2021-10-18|39|70
Study ID|SE|875a63c3-b499-4a5a-8b56-ca6d10bf9c26|4|5|6|TREATMENT|2021-10-29|2022-03-06|81|209
Study ID|SE|875a63c3-b499-4a5a-8b56-ca6d10bf9c26|5|REST|4|WASHOUT|2021-10-15|2021-10-16|67|68
Study ID|SE|875a63c3-b499-4a5a-8b56-ca6d10bf9c26|6|10|6|TREATMENT|2021-12-18|2022-03-22|131|225
Study ID|SE|875a63c3-b499-4a5a-8b56-ca6d10bf9c26|7|FU|7|FOLLOW-UP|2021-09-07|2021-09-08|29|30
Study ID|SE|07f84376-6ab5-43a9-8ee5-51f2f8046eb2|1|SCRN|4|SCREENING|2022-01-02|2022-05-05|135|258
Study ID|SE|07f84376-6ab5-43a9-8ee5-51f2f8046eb2|2|P|6|TREATMENT|2021-11-24|2022-01-13|96|146
Study ID|SE|07f84376-6ab5-43a9-8ee5-51f2f8046eb2|3|REST|1|WASHOUT|2021-10-14|2021-11-01|55|73
Study ID|SE|07f84376-6ab5-43a9-8ee5-51f2f8046eb2|4|5|3|TREATMENT|2021-09-09|2021-10-29|20|70
Study ID|SE|07f84376-6ab5-43a9-8ee5-51f2f8046eb2|5|REST|2|WASHOUT|2021-10-17|2022-01-06|58|139
Study ID|SE|07f84376-6ab5-43a9-8ee5-51f2f8046eb2|6|10|3|TREATMENT|2021-09-06|2021-10-29|17|70
Study ID|SE|07f84376-6ab5-43a9-8ee5-51f2f8046eb2|7|FU|1|FOLLOW-UP|2021-10-09|2021-12-17|50|119
Study ID|SE|b179358d-b542-479f-8a24-8cd656f8b29c|1|SCRN|5|SCREENING|2021-10-30|2021-12-24|2|57
Study ID|SE|b179358d-b542-479f-8a24-8cd656f8b29c|2|5|4|TREATMENT|2021-11-14|2021-11-30|17|33
Study ID|SE|b179358d-b542-479f-8a24-8cd656f8b29c|3|REST|3|WASHOUT|2021-12-11|2022-01-16|44|80
Study ID|SE|b179358d-b542-479f-8a24-8cd656f8b29c|4|10|7|TREATMENT|2021-10-30|2021-11-19|2|22
Study ID|SE|b179358d-b542-479f-8a24-8cd656f8b29c|5|REST|5|WASHOUT|2021-12-05|2022-07-31|38|276
Study ID|SE|b179358d-b542-479f-8a24-8cd656f8b29c|6|P|2|TREATMENT|2021-11-08|2021-11-18|11|21
Study ID|SE|b179358d-b542-479f-8a24-8cd656f8b29c|7|FU|4|FOLLOW-UP|2022-01-05|2022-04-14|69|168
Study ID|SE|f2b14285-7731-41ba-803d-a13079c8d7e2|1|SCRN|2|SCREENING|2021-12-31|2022-06-03|93|247
Study ID|SE|f2b14285-7731-41ba-803d-a13079c8d7e2|2|5|2|TREATMENT|2021-10-03|2021-10-11|4|12
Study ID|SE|f2b14285-7731-41ba-803d-a13079c8d7e2|3|REST|3|WASHOUT|2021-12-20|2022-04-12|82|195
Study ID|SE|f2b14285-7731-41ba-803d-a13079c8d7e2|4|P|7|TREATMENT|2021-10-09|2022-01-12|10|105
Study ID|SE|f2b14285-7731-41ba-803d-a13079c8d7e2|5|REST|5|WASHOUT|2021-11-16|2021-12-19|48|81
Study ID|SE|f2b14285-7731-41ba-803d-a13079c8d7e2|6|10|3|TREATMENT|2022-02-03|2022-03-14|127|166
Study ID|SE|f2b14285-7731-41ba-803d-a13079c8d7e2|7|FU|2|FOLLOW-UP|2021-10-30|2022-02-04|31|128
Study ID|SE|01dab730-8fa8-48b8-9db4-549d17fe9364|1|SCRN|6|SCREENING|2021-11-23|2022-01-23|81|142
Study ID|SE|01dab730-8fa8-48b8-9db4-549d17fe9364|2|5|7|TREATMENT|2021-10-21|2022-02-02|48|152
Study ID|SE|01dab730-8fa8-48b8-9db4-549d17fe9364|3|REST|5|WASHOUT|2021-11-08|2022-02-21|66|171
Study ID|SE|01dab730-8fa8-48b8-9db4-549d17fe9364|4|P|7|TREATMENT|2021-11-17|2022-01-15|75|134
Study ID|SE|01dab730-8fa8-48b8-9db4-549d17fe9364|5|REST|2|WASHOUT|2021-09-15|2021-10-02|12|29
Study ID|SE|01dab730-8fa8-48b8-9db4-549d17fe9364|6|10|7|TREATMENT|2021-11-14|2022-01-05|72|124
Study ID|SE|01dab730-8fa8-48b8-9db4-549d17fe9364|7|FU|7|FOLLOW-UP|2021-10-02|2021-10-04|29|31
Study ID|SE|91824814-dbc7-42f2-933a-843c745307f0|1|SCRN|2|SCREENING|2021-10-16|2022-01-17|33|126
Study ID|SE|91824814-dbc7-42f2-933a-843c745307f0|2|5|5|TREATMENT|2022-01-11|2022-04-05|120|204
Study ID|SE|91824814-dbc7-42f2-933a-843c745307f0|3|REST|2|WASHOUT|2021-09-19|2021-10-10|6|27
Study ID|SE|91824814-dbc7-42f2-933a-843c745307f0|4|10|2|TREATMENT|2021-10-14|2021-12-29|31|107
Study ID|SE|91824814-dbc7-42f2-933a-843c745307f0|5|REST|3|WASHOUT|2021-11-27|2022-05-17|75|246
Study ID|SE|91824814-dbc7-42f2-933a-843c745307f0|6|P|5|TREATMENT|2022-02-14|2022-05-05|154|234
Study ID|SE|91824814-dbc7-42f2-933a-843c745307f0|7|FU|5|FOLLOW-UP|2021-10-11|2022-03-05|28|173
Study ID|SE|0a8847a0-ad08-43f0-8f7c-09194197ded3|1|SCRN|1|SCREENING|2021-11-06|2021-11-16|23|33
Study ID|SE|0a8847a0-ad08-43f0-8f7c-09194197ded3|2|5|7|TREATMENT|2021-10-25|2021-11-14|11|31
Study ID|SE|0a8847a0-ad08-43f0-8f7c-09194197ded3|3|REST|6|WASHOUT|2021-12-03|2021-12-20|50|67
Study ID|SE|0a8847a0-ad08-43f0-8f7c-09194197ded3|4|P|6|TREATMENT|2021-11-25|2022-05-01|42|199
Study ID|SE|0a8847a0-ad08-43f0-8f7c-09194197ded3|5|REST|2|WASHOUT|2021-10-24|2021-10-25|10|11
Study ID|SE|0a8847a0-ad08-43f0-8f7c-09194197ded3|6|10|7|TREATMENT|2021-11-16|2022-02-10|33|119
Study ID|SE|0a8847a0-ad08-43f0-8f7c-09194197ded3|7|FU|3|FOLLOW-UP|2021-11-05|2022-01-17|22|95
Study ID|SE|3ef841f6-b1d8-41c0-a708-ed1a2866d92b|1|SCRN|6|SCREENING|2021-11-19|2022-03-28|80|209
Study ID|SE|3ef841f6-b1d8-41c0-a708-ed1a2866d92b|2|5|7|TREATMENT|2021-09-04|2021-09-11|4|11
Study ID|SE|3ef841f6-b1d8-41c0-a708-ed1a2866d92b|3|REST|4|WASHOUT|2021-12-15|2022-03-23|106|204
Study ID|SE|3ef841f6-b1d8-41c0-a708-ed1a2866d92b|4|P|3|TREATMENT|2021-10-31|2022-03-30|61|211
Study ID|SE|3ef841f6-b1d8-41c0-a708-ed1a2866d92b|5|REST|4|WASHOUT|2021-11-05|2022-02-02|66|155
Study ID|SE|3ef841f6-b1d8-41c0-a708-ed1a2866d92b|6|10|1|TREATMENT|2022-02-11|2022-03-30|164|211
Study ID|SE|3ef841f6-b1d8-41c0-a708-ed1a2866d92b|7|FU|2|FOLLOW-UP|2021-09-28|2021-12-10|28|101
Study ID|SE|ec732f35-e389-42ea-b5c1-5795312935ac|1|SCRN|6|SCREENING|2022-01-10|2022-03-05|132|186
Study ID|SE|ec732f35-e389-42ea-b5c1-5795312935ac|2|5|6|TREATMENT|2021-09-27|2021-10-06|27|36
Study ID|SE|ec732f35-e389-42ea-b5c1-5795312935ac|3|REST|5|WASHOUT|2021-09-17|2022-01-08|17|130
Study ID|SE|ec732f35-e389-42ea-b5c1-5795312935ac|4|10|4|TREATMENT|2021-10-17|2021-10-21|47|51
Study ID|SE|ec732f35-e389-42ea-b5c1-5795312935ac|5|REST|1|WASHOUT|2021-09-19|2021-10-02|19|32
Study ID|SE|ec732f35-e389-42ea-b5c1-5795312935ac|6|P|3|TREATMENT|2021-09-09|2021-10-24|9|54
Study ID|SE|ec732f35-e389-42ea-b5c1-5795312935ac|7|FU|6|FOLLOW-UP|2021-12-17|2022-03-14|108|195
Study ID|SE|ae055ad4-6e9a-47f9-8914-6bab08f739fc|1|SCRN|2|SCREENING|2021-11-21|2022-03-01|76|176
Study ID|SE|ae055ad4-6e9a-47f9-8914-6bab08f739fc|2|5|6|TREATMENT|2021-10-07|2021-10-22|31|46
Study ID|SE|ae055ad4-6e9a-47f9-8914-6bab08f739fc|3|REST|4|WASHOUT|2021-12-20|2022-04-30|105|236
Study ID|SE|ae055ad4-6e9a-47f9-8914-6bab08f739fc|4|10|5|TREATMENT|2021-09-25|2021-11-16|19|71
Study ID|SE|ae055ad4-6e9a-47f9-8914-6bab08f739fc|5|REST|6|WASHOUT|2021-10-20|2022-02-21|44|168
Study ID|SE|ae055ad4-6e9a-47f9-8914-6bab08f739fc|6|P|7|TREATMENT|2021-10-01|2021-10-04|25|28
Study ID|SE|ae055ad4-6e9a-47f9-8914-6bab08f739fc|7|FU|2|FOLLOW-UP|2021-10-10|2021-12-14|34|99
Study ID|SE|7d95af47-fe69-49d0-b3c2-0b4b011bdf97|1|SCRN|6|SCREENING|2021-11-20|2022-04-14|78|223
Study ID|SE|7d95af47-fe69-49d0-b3c2-0b4b011bdf97|2|5|5|TREATMENT|2021-09-05|2021-09-05|2|2
Study ID|SE|7d95af47-fe69-49d0-b3c2-0b4b011bdf97|3|REST|2|WASHOUT|2021-11-24|2022-06-23|82|293
Study ID|SE|7d95af47-fe69-49d0-b3c2-0b4b011bdf97|4|10|5|TREATMENT|2021-10-12|2022-01-06|39|125
Study ID|SE|7d95af47-fe69-49d0-b3c2-0b4b011bdf97|5|REST|6|WASHOUT|2021-11-19|2021-12-24|77|112
Study ID|SE|7d95af47-fe69-49d0-b3c2-0b4b011bdf97|6|P|3|TREATMENT|2021-09-14|2021-12-02|11|90
Study ID|SE|7d95af47-fe69-49d0-b3c2-0b4b011bdf97|7|FU|6|FOLLOW-UP|2021-12-01|2022-05-22|89|261
Study ID|SE|ba667dad-f75a-4736-b891-0bf204438374|1|SCRN|1|SCREENING|2021-09-06|2021-11-14|25|94
Study ID|SE|ba667dad-f75a-4736-b891-0bf204438374|2|5|1|TREATMENT|2022-03-28|2022-05-02|228|263
Study ID|SE|ba667dad-f75a-4736-b891-0bf204438374|3|REST|1|WASHOUT|2021-09-25|2021-12-27|44|137
Study ID|SE|ba667dad-f75a-4736-b891-0bf204438374|4|P|7|TREATMENT|2021-11-30|2022-01-06|110|147
Study ID|SE|ba667dad-f75a-4736-b891-0bf204438374|5|REST|7|WASHOUT|2021-08-26|2021-10-09|14|58
Study ID|SE|ba667dad-f75a-4736-b891-0bf204438374|6|10|6|TREATMENT|2021-09-25|2021-09-28|44|47
Study ID|SE|ba667dad-f75a-4736-b891-0bf204438374|7|FU|3|FOLLOW-UP|2021-09-26|2022-02-04|45|176
Study ID|SE|86bf2d3a-e791-4eec-8ef8-6aa975a23d46|1|SCRN|7|SCREENING|2022-03-21|2022-04-24|153|187
Study ID|SE|86bf2d3a-e791-4eec-8ef8-6aa975a23d46|2|5|1|TREATMENT|2021-10-28|2022-02-23|9|127
Study ID|SE|86bf2d3a-e791-4eec-8ef8-6aa975a23d46|3|REST|3|WASHOUT|2021-12-21|2022-03-30|63|162
Study ID|SE|86bf2d3a-e791-4eec-8ef8-6aa975a23d46|4|10|4|TREATMENT|2022-03-06|2022-04-16|138|179
Study ID|SE|86bf2d3a-e791-4eec-8ef8-6aa975a23d46|5|REST|6|WASHOUT|2021-10-23|2022-01-20|4|93
Study ID|SE|86bf2d3a-e791-4eec-8ef8-6aa975a23d46|6|P|3|TREATMENT|2022-03-31|2022-04-28|163|191
Study ID|SE|86bf2d3a-e791-4eec-8ef8-6aa975a23d46|7|FU|7|FOLLOW-UP|2022-04-23|2022-05-17|186|210
Study ID|SE|e223e6f1-4f84-4ae8-9621-67d13737279a|1|SCRN|2|SCREENING|2021-12-17|2021-12-19|55|57
Study ID|SE|e223e6f1-4f84-4ae8-9621-67d13737279a|2|P|2|TREATMENT|2022-02-26|2022-03-30|126|158
Study ID|SE|e223e6f1-4f84-4ae8-9621-67d13737279a|3|REST|4|WASHOUT|2022-01-13|2022-04-04|82|163
Study ID|SE|e223e6f1-4f84-4ae8-9621-67d13737279a|4|5|6|TREATMENT|2021-11-08|2022-02-26|16|126
Study ID|SE|e223e6f1-4f84-4ae8-9621-67d13737279a|5|REST|7|WASHOUT|2022-01-26|2022-03-03|95|131
Study ID|SE|e223e6f1-4f84-4ae8-9621-67d13737279a|6|10|7|TREATMENT|2021-12-14|2022-04-08|52|167
Study ID|SE|e223e6f1-4f84-4ae8-9621-67d13737279a|7|FU|1|FOLLOW-UP|2021-11-19|2022-02-25|27|125
Study ID|SE|6b71d31d-4466-4699-a4d8-38998456913a|1|SCRN|1|SCREENING|2021-12-10|2022-04-06|54|171
Study ID|SE|6b71d31d-4466-4699-a4d8-38998456913a|2|5|2|TREATMENT|2022-04-30|2022-06-20|195|246
Study ID|SE|6b71d31d-4466-4699-a4d8-38998456913a|3|REST|3|WASHOUT|2021-12-27|2022-05-22|71|217
Study ID|SE|6b71d31d-4466-4699-a4d8-38998456913a|4|P|3|TREATMENT|2021-11-19|2021-11-25|33|39
Study ID|SE|6b71d31d-4466-4699-a4d8-38998456913a|5|REST|1|WASHOUT|2021-11-11|2021-11-13|25|27
Study ID|SE|6b71d31d-4466-4699-a4d8-38998456913a|6|10|6|TREATMENT|2022-01-16|2022-01-21|91|96
Study ID|SE|6b71d31d-4466-4699-a4d8-38998456913a|7|FU|1|FOLLOW-UP|2021-11-01|2021-11-04|15|18
Study ID|SE|6a8b54cc-5569-4c3a-8f25-d0a357c23c1b|1|SCRN|7|SCREENING|2022-02-05|2022-04-16|167|237
Study ID|SE|6a8b54cc-5569-4c3a-8f25-d0a357c23c1b|2|5|4|TREATMENT|2021-12-16|2021-12-23|116|123
Study ID|SE|6a8b54cc-5569-4c3a-8f25-d0a357c23c1b|3|REST|3|WASHOUT|2021-12-16|2022-03-10|116|200
Study ID|SE|6a8b54cc-5569-4c3a-8f25-d0a357c23c1b|4|P|4|TREATMENT|2021-08-25|2022-01-08|3|139
Study ID|SE|6a8b54cc-5569-4c3a-8f25-d0a357c23c1b|5|REST|5|WASHOUT|2021-10-07|2021-12-28|46|128
Study ID|SE|6a8b54cc-5569-4c3a-8f25-d0a357c23c1b|6|10|3|TREATMENT|2022-01-16|2022-05-08|147|259
Study ID|SE|6a8b54cc-5569-4c3a-8f25-d0a357c23c1b|7|FU|3|FOLLOW-UP|2021-10-05|2021-10-29|44|68
Study ID|SE|d7453b4b-c700-4116-88e0-5ec07255fcc1|1|SCRN|3|SCREENING|2021-10-01|2021-10-27|31|57
Study ID|SE|d7453b4b-c700-4116-88e0-5ec07255fcc1|2|P|5|TREATMENT|2021-10-13|2021-10-17|43|47
Study ID|SE|d7453b4b-c700-4116-88e0-5ec07255fcc1|3|REST|7|WASHOUT|2021-10-09|2021-10-22|39|52
Study ID|SE|d7453b4b-c700-4116-88e0-5ec07255fcc1|4|5|6|TREATMENT|2021-09-17|2022-03-24|17|205
Study ID|SE|d7453b4b-c700-4116-88e0-5ec07255fcc1|5|REST|1|WASHOUT|2021-09-20|2022-03-03|20|184
Study ID|SE|d7453b4b-c700-4116-88e0-5ec07255fcc1|6|10|5|TREATMENT|2021-10-21|2022-05-28|51|270
Study ID|SE|d7453b4b-c700-4116-88e0-5ec07255fcc1|7|FU|3|FOLLOW-UP|2021-09-18|2021-10-20|18|50
Study ID|SE|97846c4a-bc01-4a2b-9d5a-15f44d085c04|1|SCRN|6|SCREENING|2022-06-21|2022-06-27|268|274
Study ID|SE|97846c4a-bc01-4a2b-9d5a-15f44d085c04|2|5|3|TREATMENT|2021-10-19|2022-07-11|23|288
Study ID|SE|97846c4a-bc01-4a2b-9d5a-15f44d085c04|3|REST|5|WASHOUT|2021-12-17|2022-02-09|82|136
Study ID|SE|97846c4a-bc01-4a2b-9d5a-15f44d085c04|4|P|6|TREATMENT|2021-11-17|2022-04-12|52|198
Study ID|SE|97846c4a-bc01-4a2b-9d5a-15f44d085c04|5|REST|2|WASHOUT|2021-10-02|2021-10-05|6|9
Study ID|SE|97846c4a-bc01-4a2b-9d5a-15f44d085c04|6|10|2|TREATMENT|2021-12-12|2022-05-05|77|221
Study ID|SE|97846c4a-bc01-4a2b-9d5a-15f44d085c04|7|FU|4|FOLLOW-UP|2021-12-30|2022-01-15|95|111
Study ID|SE|6ac67159-7286-4911-9ffa-136fbe29e4f3|1|SCRN|2|SCREENING|2021-12-06|2021-12-25|49|68
Study ID|SE|6ac67159-7286-4911-9ffa-136fbe29e4f3|2|P|7|TREATMENT|2022-02-08|2022-08-12|113|298
Study ID|SE|6ac67159-7286-4911-9ffa-136fbe29e4f3|3|REST|1|WASHOUT|2021-10-29|2022-04-21|11|185
Study ID|SE|6ac67159-7286-4911-9ffa-136fbe29e4f3|4|5|2|TREATMENT|2021-11-24|2022-06-02|37|227
Study ID|SE|6ac67159-7286-4911-9ffa-136fbe29e4f3|5|REST|4|WASHOUT|2021-10-23|2021-10-27|5|9
Study ID|SE|6ac67159-7286-4911-9ffa-136fbe29e4f3|6|10|7|TREATMENT|2022-03-17|2022-04-11|150|175
Study ID|SE|6ac67159-7286-4911-9ffa-136fbe29e4f3|7|FU|4|FOLLOW-UP|2021-11-02|2021-11-10|15|23
Study ID|SE|71bb085e-762e-4807-bf68-38c734740c69|1|SCRN|5|SCREENING|2021-08-29|2021-09-04|9|15
Study ID|SE|71bb085e-762e-4807-bf68-38c734740c69|2|5|2|TREATMENT|2021-08-24|2021-09-08|4|19
Study ID|SE|71bb085e-762e-4807-bf68-38c734740c69|3|REST|7|WASHOUT|2021-09-01|2021-12-21|12|123
Study ID|SE|71bb085e-762e-4807-bf68-38c734740c69|4|P|4|TREATMENT|2021-08-26|2022-01-14|6|147
Study ID|SE|71bb085e-762e-4807-bf68-38c734740c69|5|REST|6|WASHOUT|2021-09-04|2021-09-13|15|24
Study ID|SE|71bb085e-762e-4807-bf68-38c734740c69|6|10|4|TREATMENT|2022-03-17|2022-05-08|209|261
Study ID|SE|71bb085e-762e-4807-bf68-38c734740c69|7|FU|5|FOLLOW-UP|2022-03-28|2022-05-28|220|281
Study ID|SE|c44e84f0-4142-417a-b150-0f869ba0b626|1|SCRN|2|SCREENING|2021-10-29|2022-04-30|8|191
Study ID|SE|c44e84f0-4142-417a-b150-0f869ba0b626|2|P|7|TREATMENT|2021-11-02|2021-12-27|12|67
Study ID|SE|c44e84f0-4142-417a-b150-0f869ba0b626|3|REST|2|WASHOUT|2022-02-01|2022-05-27|103|218
Study ID|SE|c44e84f0-4142-417a-b150-0f869ba0b626|4|5|1|TREATMENT|2021-11-08|2022-01-17|18|88
Study ID|SE|c44e84f0-4142-417a-b150-0f869ba0b626|5|REST|2|WASHOUT|2021-10-29|2021-11-04|8|14
Study ID|SE|c44e84f0-4142-417a-b150-0f869ba0b626|6|10|2|TREATMENT|2022-03-13|2022-07-12|143|264
Study ID|SE|c44e84f0-4142-417a-b150-0f869ba0b626|7|FU|3|FOLLOW-UP|2021-10-29|2022-04-14|8|175
Study ID|SE|beafde56-2984-4fbf-ae59-57666400ec13|1|SCRN|2|SCREENING|2021-08-15|2021-11-18|5|100
Study ID|SE|beafde56-2984-4fbf-ae59-57666400ec13|2|P|7|TREATMENT|2021-09-01|2021-09-10|22|31
Study ID|SE|beafde56-2984-4fbf-ae59-57666400ec13|3|REST|5|WASHOUT|2021-09-05|2022-02-22|26|196
Study ID|SE|beafde56-2984-4fbf-ae59-57666400ec13|4|5|2|TREATMENT|2021-12-18|2022-03-22|130|224
Study ID|SE|beafde56-2984-4fbf-ae59-57666400ec13|5|REST|2|WASHOUT|2021-12-28|2022-05-20|140|283
Study ID|SE|beafde56-2984-4fbf-ae59-57666400ec13|6|10|4|TREATMENT|2021-10-16|2021-10-24|67|75
Study ID|SE|beafde56-2984-4fbf-ae59-57666400ec13|7|FU|4|FOLLOW-UP|2021-08-13|2021-09-02|3|23
Study ID|SE|1bd533cc-d6ad-4b46-b65f-22521af557c5|1|SCRN|4|SCREENING|2021-11-17|2021-11-23|22|28
Study ID|SE|1bd533cc-d6ad-4b46-b65f-22521af557c5|2|5|5|TREATMENT|2022-01-14|2022-02-14|80|111
Study ID|SE|1bd533cc-d6ad-4b46-b65f-22521af557c5|3|REST|1|WASHOUT|2021-12-05|2022-04-15|40|171
Study ID|SE|1bd533cc-d6ad-4b46-b65f-22521af557c5|4|P|6|TREATMENT|2021-12-16|2022-03-26|51|151
Study ID|SE|1bd533cc-d6ad-4b46-b65f-22521af557c5|5|REST|4|WASHOUT|2021-12-24|2022-08-12|59|290
Study ID|SE|1bd533cc-d6ad-4b46-b65f-22521af557c5|6|10|3|TREATMENT|2021-12-24|2022-03-15|59|140
Study ID|SE|1bd533cc-d6ad-4b46-b65f-22521af557c5|7|FU|2|FOLLOW-UP|2022-04-25|2022-08-13|181|291
Study ID|SE|ea38ac51-e63c-4105-a611-7f82e602e40d|1|SCRN|4|SCREENING|2021-09-13|2022-05-19|22|270
Study ID|SE|ea38ac51-e63c-4105-a611-7f82e602e40d|2|5|4|TREATMENT|2021-09-29|2021-10-01|38|40
Study ID|SE|ea38ac51-e63c-4105-a611-7f82e602e40d|3|REST|1|WASHOUT|2021-11-02|2022-01-28|72|159
Study ID|SE|ea38ac51-e63c-4105-a611-7f82e602e40d|4|P|1|TREATMENT|2022-01-17|2022-03-11|148|201
Study ID|SE|ea38ac51-e63c-4105-a611-7f82e602e40d|5|REST|4|WASHOUT|2021-12-20|2021-12-29|120|129
Study ID|SE|ea38ac51-e63c-4105-a611-7f82e602e40d|6|10|4|TREATMENT|2021-09-13|2021-11-09|22|79
Study ID|SE|ea38ac51-e63c-4105-a611-7f82e602e40d|7|FU|4|FOLLOW-UP|2021-11-12|2022-06-15|82|297
Study ID|SE|d0ffcc8c-51e8-4e39-bff1-70ee52985b9e|1|SCRN|4|SCREENING|2021-09-22|2021-12-15|3|87
Study ID|SE|d0ffcc8c-51e8-4e39-bff1-70ee52985b9e|2|5|5|TREATMENT|2021-11-09|2022-03-13|51|175
Study ID|SE|d0ffcc8c-51e8-4e39-bff1-70ee52985b9e|3|REST|4|WASHOUT|2021-09-22|2021-09-25|3|6
Study ID|SE|d0ffcc8c-51e8-4e39-bff1-70ee52985b9e|4|P|2|TREATMENT|2021-11-06|2022-01-27|48|130
Study ID|SE|d0ffcc8c-51e8-4e39-bff1-70ee52985b9e|5|REST|7|WASHOUT|2022-02-23|2022-03-18|157|180
Study ID|SE|d0ffcc8c-51e8-4e39-bff1-70ee52985b9e|6|10|3|TREATMENT|2021-11-09|2021-12-04|51|76
Study ID|SE|d0ffcc8c-51e8-4e39-bff1-70ee52985b9e|7|FU|5|FOLLOW-UP|2021-12-20|2022-04-10|92|203
Study ID|SE|1d54d4f1-bde4-4686-96bf-d1d78ab25874|1|SCRN|4|SCREENING|2021-11-15|2022-01-11|68|125
Study ID|SE|1d54d4f1-bde4-4686-96bf-d1d78ab25874|2|5|1|TREATMENT|2021-12-14|2022-06-10|97|275
Study ID|SE|1d54d4f1-bde4-4686-96bf-d1d78ab25874|3|REST|6|WASHOUT|2022-01-05|2022-07-03|119|298
Study ID|SE|1d54d4f1-bde4-4686-96bf-d1d78ab25874|4|P|2|TREATMENT|2022-04-02|2022-07-01|206|296
Study ID|SE|1d54d4f1-bde4-4686-96bf-d1d78ab25874|5|REST|6|WASHOUT|2022-02-27|2022-04-19|172|223
Study ID|SE|1d54d4f1-bde4-4686-96bf-d1d78ab25874|6|10|1|TREATMENT|2021-10-12|2021-11-20|34|73
Study ID|SE|1d54d4f1-bde4-4686-96bf-d1d78ab25874|7|FU|3|FOLLOW-UP|2021-09-29|2022-04-05|21|209
Study ID|SE|d0902968-a6cd-4b8d-bcf8-4da11b088679|1|SCRN|7|SCREENING|2021-10-19|2021-11-30|39|81
Study ID|SE|d0902968-a6cd-4b8d-bcf8-4da11b088679|2|5|3|TREATMENT|2021-09-28|2022-02-10|18|153
Study ID|SE|d0902968-a6cd-4b8d-bcf8-4da11b088679|3|REST|5|WASHOUT|2021-09-12|2021-11-25|2|76
Study ID|SE|d0902968-a6cd-4b8d-bcf8-4da11b088679|4|10|3|TREATMENT|2021-11-16|2021-12-14|67|95
Study ID|SE|d0902968-a6cd-4b8d-bcf8-4da11b088679|5|REST|2|WASHOUT|2022-03-29|2022-04-16|200|218
Study ID|SE|d0902968-a6cd-4b8d-bcf8-4da11b088679|6|P|2|TREATMENT|2021-09-23|2021-10-15|13|35
Study ID|SE|d0902968-a6cd-4b8d-bcf8-4da11b088679|7|FU|7|FOLLOW-UP|2021-11-19|2022-02-19|70|162
Study ID|SE|dc30ce6d-7caf-4baa-a7ef-368c1213ba44|1|SCRN|3|SCREENING|2022-03-09|2022-04-08|175|205
Study ID|SE|dc30ce6d-7caf-4baa-a7ef-368c1213ba44|2|5|3|TREATMENT|2021-11-01|2021-12-29|47|105
Study ID|SE|dc30ce6d-7caf-4baa-a7ef-368c1213ba44|3|REST|5|WASHOUT|2021-09-22|2021-09-26|7|11
Study ID|SE|dc30ce6d-7caf-4baa-a7ef-368c1213ba44|4|10|5|TREATMENT|2022-04-14|2022-07-07|211|295
Study ID|SE|dc30ce6d-7caf-4baa-a7ef-368c1213ba44|5|REST|7|WASHOUT|2021-12-28|2022-01-28|104|135
Study ID|SE|dc30ce6d-7caf-4baa-a7ef-368c1213ba44|6|P|1|TREATMENT|2022-02-20|2022-03-29|158|195
Study ID|SE|dc30ce6d-7caf-4baa-a7ef-368c1213ba44|7|FU|1|FOLLOW-UP|2021-10-01|2021-10-03|16|18
Study ID|SE|72574893-e8f5-44d2-8e9b-ef6b0d1f5f7b|1|SCRN|5|SCREENING|2021-09-17|2021-09-18|2|3
Study ID|SE|72574893-e8f5-44d2-8e9b-ef6b0d1f5f7b|2|P|6|TREATMENT|2021-12-22|2022-07-03|98|291
Study ID|SE|72574893-e8f5-44d2-8e9b-ef6b0d1f5f7b|3|REST|7|WASHOUT|2021-12-01|2022-07-07|77|295
Study ID|SE|72574893-e8f5-44d2-8e9b-ef6b0d1f5f7b|4|5|5|TREATMENT|2022-03-03|2022-06-27|169|285
Study ID|SE|72574893-e8f5-44d2-8e9b-ef6b0d1f5f7b|5|REST|3|WASHOUT|2022-06-17|2022-06-28|275|286
Study ID|SE|72574893-e8f5-44d2-8e9b-ef6b0d1f5f7b|6|10|3|TREATMENT|2022-02-10|2022-02-13|148|151
Study ID|SE|72574893-e8f5-44d2-8e9b-ef6b0d1f5f7b|7|FU|4|FOLLOW-UP|2022-01-01|2022-01-10|108|117
Study ID|SE|e246564a-8c28-4bba-b70d-12cc38919ed9|1|SCRN|6|SCREENING|2021-10-17|2021-10-22|32|37
Study ID|SE|e246564a-8c28-4bba-b70d-12cc38919ed9|2|5|4|TREATMENT|2021-10-06|2022-02-24|21|162
Study ID|SE|e246564a-8c28-4bba-b70d-12cc38919ed9|3|REST|4|WASHOUT|2021-12-11|2022-02-04|87|142
Study ID|SE|e246564a-8c28-4bba-b70d-12cc38919ed9|4|P|2|TREATMENT|2022-02-03|2022-03-05|141|171
Study ID|SE|e246564a-8c28-4bba-b70d-12cc38919ed9|5|REST|5|WASHOUT|2022-02-11|2022-02-19|149|157
Study ID|SE|e246564a-8c28-4bba-b70d-12cc38919ed9|6|10|6|TREATMENT|2021-10-21|2021-10-27|36|42
Study ID|SE|e246564a-8c28-4bba-b70d-12cc38919ed9|7|FU|4|FOLLOW-UP|2021-10-13|2021-10-16|28|31
Study ID|SE|c04a3991-7665-487f-916f-f695b3a91afa|1|SCRN|7|SCREENING|2022-01-08|2022-05-26|150|288
Study ID|SE|c04a3991-7665-487f-916f-f695b3a91afa|2|5|7|TREATMENT|2022-04-20|2022-06-02|252|295
Study ID|SE|c04a3991-7665-487f-916f-f695b3a91afa|3|REST|2|WASHOUT|2021-10-13|2021-10-16|63|66
Study ID|SE|c04a3991-7665-487f-916f-f695b3a91afa|4|10|6|TREATMENT|2021-08-16|2021-12-06|5|117
Study ID|SE|c04a3991-7665-487f-916f-f695b3a91afa|5|REST|5|WASHOUT|2022-03-19|2022-04-17|220|249
Study ID|SE|c04a3991-7665-487f-916f-f695b3a91afa|6|P|2|TREATMENT|2021-10-02|2022-03-23|52|224
Study ID|SE|c04a3991-7665-487f-916f-f695b3a91afa|7|FU|6|FOLLOW-UP|2021-09-02|2021-09-20|22|40
Study ID|SE|808e1ec0-c263-4209-a16c-28d78a445acd|1|SCRN|2|SCREENING|2022-02-04|2022-03-19|126|169
Study ID|SE|808e1ec0-c263-4209-a16c-28d78a445acd|2|5|1|TREATMENT|2021-10-03|2021-10-04|2|3
Study ID|SE|808e1ec0-c263-4209-a16c-28d78a445acd|3|REST|7|WASHOUT|2021-12-17|2022-01-27|77|118
Study ID|SE|808e1ec0-c263-4209-a16c-28d78a445acd|4|10|1|TREATMENT|2021-12-13|2022-01-18|73|109
Study ID|SE|808e1ec0-c263-4209-a16c-28d78a445acd|5|REST|5|WASHOUT|2021-10-14|2022-01-06|13|97
Study ID|SE|808e1ec0-c263-4209-a16c-28d78a445acd|6|P|3|TREATMENT|2022-04-19|2022-07-18|200|290
Study ID|SE|808e1ec0-c263-4209-a16c-28d78a445acd|7|FU|2|FOLLOW-UP|2022-01-18|2022-02-22|109|144
Study ID|SE|9725ad20-8ca3-48e7-824e-7dba1da8abdd|1|SCRN|3|SCREENING|2021-09-03|2022-03-23|20|221
Study ID|SE|9725ad20-8ca3-48e7-824e-7dba1da8abdd|2|5|4|TREATMENT|2021-08-30|2021-09-03|16|20
Study ID|SE|9725ad20-8ca3-48e7-824e-7dba1da8abdd|3|REST|5|WASHOUT|2021-11-09|2021-12-04|87|112
Study ID|SE|9725ad20-8ca3-48e7-824e-7dba1da8abdd|4|10|2|TREATMENT|2022-01-14|2022-01-19|153|158
Study ID|SE|9725ad20-8ca3-48e7-824e-7dba1da8abdd|5|REST|2|WASHOUT|2021-09-05|2021-09-14|22|31
Study ID|SE|9725ad20-8ca3-48e7-824e-7dba1da8abdd|6|P|5|TREATMENT|2021-09-08|2021-11-18|25|96
Study ID|SE|9725ad20-8ca3-48e7-824e-7dba1da8abdd|7|FU|6|FOLLOW-UP|2022-01-09|2022-02-06|148|176
Study ID|SE|12fe384b-bcd1-4b63-855a-0c5e220b6caa|1|SCRN|7|SCREENING|2021-11-09|2022-04-03|19|164
Study ID|SE|12fe384b-bcd1-4b63-855a-0c5e220b6caa|2|5|6|TREATMENT|2021-10-24|2021-12-18|3|58
Study ID|SE|12fe384b-bcd1-4b63-855a-0c5e220b6caa|3|REST|7|WASHOUT|2021-12-08|2022-02-07|48|109
Study ID|SE|12fe384b-bcd1-4b63-855a-0c5e220b6caa|4|10|4|TREATMENT|2021-10-24|2022-02-07|3|109
Study ID|SE|12fe384b-bcd1-4b63-855a-0c5e220b6caa|5|REST|2|WASHOUT|2021-11-22|2022-03-01|32|131
Study ID|SE|12fe384b-bcd1-4b63-855a-0c5e220b6caa|6|P|3|TREATMENT|2022-02-12|2022-05-08|114|199
Study ID|SE|12fe384b-bcd1-4b63-855a-0c5e220b6caa|7|FU|5|FOLLOW-UP|2022-02-17|2022-04-29|119|190
Study ID|SE|42351b79-f2f3-4c6f-9d70-2fab11eca35a|1|SCRN|2|SCREENING|2021-12-08|2021-12-09|60|61
Study ID|SE|42351b79-f2f3-4c6f-9d70-2fab11eca35a|2|5|3|TREATMENT|2022-03-01|2022-05-29|143|232
Study ID|SE|42351b79-f2f3-4c6f-9d70-2fab11eca35a|3|REST|5|WASHOUT|2021-11-12|2022-03-08|34|150
Study ID|SE|42351b79-f2f3-4c6f-9d70-2fab11eca35a|4|P|1|TREATMENT|2021-11-10|2022-02-15|32|129
Study ID|SE|42351b79-f2f3-4c6f-9d70-2fab11eca35a|5|REST|1|WASHOUT|2021-12-09|2022-06-14|61|248
Study ID|SE|42351b79-f2f3-4c6f-9d70-2fab11eca35a|6|10|4|TREATMENT|2021-10-11|2021-11-13|2|35
Study ID|SE|42351b79-f2f3-4c6f-9d70-2fab11eca35a|7|FU|7|FOLLOW-UP|2022-01-30|2022-02-08|113|122
Study ID|SE|1850f6e3-d8dd-48a2-a4c1-7676bb1fafd5|1|SCRN|7|SCREENING|2021-09-01|2021-09-03|20|22
Study ID|SE|1850f6e3-d8dd-48a2-a4c1-7676bb1fafd5|2|5|7|TREATMENT|2022-01-14|2022-04-15|155|246
Study ID|SE|1850f6e3-d8dd-48a2-a4c1-7676bb1fafd5|3|REST|3|WASHOUT|2022-03-25|2022-05-03|225|264
Study ID|SE|1850f6e3-d8dd-48a2-a4c1-7676bb1fafd5|4|P|5|TREATMENT|2022-03-11|2022-04-21|211|252
Study ID|SE|1850f6e3-d8dd-48a2-a4c1-7676bb1fafd5|5|REST|6|WASHOUT|2022-03-30|2022-06-06|230|298
Study ID|SE|1850f6e3-d8dd-48a2-a4c1-7676bb1fafd5|6|10|1|TREATMENT|2022-04-21|2022-05-06|252|267
Study ID|SE|1850f6e3-d8dd-48a2-a4c1-7676bb1fafd5|7|FU|1|FOLLOW-UP|2021-10-17|2022-04-29|66|260
Study ID|SE|cdf46a68-d9ca-4645-a48a-93ffb1cab1b7|1|SCRN|3|SCREENING|2021-12-05|2022-04-17|60|193
Study ID|SE|cdf46a68-d9ca-4645-a48a-93ffb1cab1b7|2|5|3|TREATMENT|2021-10-26|2022-04-05|20|181
Study ID|SE|cdf46a68-d9ca-4645-a48a-93ffb1cab1b7|3|REST|2|WASHOUT|2021-10-17|2021-10-25|11|19
Study ID|SE|cdf46a68-d9ca-4645-a48a-93ffb1cab1b7|4|P|4|TREATMENT|2021-12-26|2022-03-07|81|152
Study ID|SE|cdf46a68-d9ca-4645-a48a-93ffb1cab1b7|5|REST|3|WASHOUT|2021-11-09|2022-07-02|34|269
Study ID|SE|cdf46a68-d9ca-4645-a48a-93ffb1cab1b7|6|10|3|TREATMENT|2022-04-30|2022-05-10|206|216
Study ID|SE|cdf46a68-d9ca-4645-a48a-93ffb1cab1b7|7|FU|1|FOLLOW-UP|2021-10-29|2022-03-09|23|154
Study ID|SE|8ca35852-d560-4920-a83c-0ce950d886ec|1|SCRN|2|SCREENING|2021-10-28|2021-11-16|44|63
Study ID|SE|8ca35852-d560-4920-a83c-0ce950d886ec|2|P|5|TREATMENT|2021-11-21|2022-06-05|68|264
Study ID|SE|8ca35852-d560-4920-a83c-0ce950d886ec|3|REST|7|WASHOUT|2021-09-18|2022-03-05|4|172
Study ID|SE|8ca35852-d560-4920-a83c-0ce950d886ec|4|5|4|TREATMENT|2021-12-09|2022-06-20|86|279
Study ID|SE|8ca35852-d560-4920-a83c-0ce950d886ec|5|REST|5|WASHOUT|2022-03-07|2022-03-25|174|192
Study ID|SE|8ca35852-d560-4920-a83c-0ce950d886ec|6|10|6|TREATMENT|2021-09-22|2021-09-23|8|9
Study ID|SE|8ca35852-d560-4920-a83c-0ce950d886ec|7|FU|4|FOLLOW-UP|2022-03-14|2022-06-20|181|279
Study ID|SE|b1c9bc78-2257-44c2-8b8b-6426cf6d3e7c|1|SCRN|6|SCREENING|2021-08-13|2022-04-26|5|261
Study ID|SE|b1c9bc78-2257-44c2-8b8b-6426cf6d3e7c|2|5|3|TREATMENT|2021-09-24|2021-12-17|47|131
Study ID|SE|b1c9bc78-2257-44c2-8b8b-6426cf6d3e7c|3|REST|1|WASHOUT|2021-12-06|2022-02-18|120|194
Study ID|SE|b1c9bc78-2257-44c2-8b8b-6426cf6d3e7c|4|P|5|TREATMENT|2021-10-02|2022-05-25|55|290
Study ID|SE|b1c9bc78-2257-44c2-8b8b-6426cf6d3e7c|5|REST|6|WASHOUT|2021-11-06|2022-04-10|90|245
Study ID|SE|b1c9bc78-2257-44c2-8b8b-6426cf6d3e7c|6|10|6|TREATMENT|2022-02-19|2022-04-17|195|252
Study ID|SE|b1c9bc78-2257-44c2-8b8b-6426cf6d3e7c|7|FU|4|FOLLOW-UP|2021-12-31|2022-01-27|145|172
Study ID|SE|3f85e60b-02d4-49f7-b18e-165a3111bea7|1|SCRN|3|SCREENING|2022-01-05|2022-02-20|94|140
Study ID|SE|3f85e60b-02d4-49f7-b18e-165a3111bea7|2|P|1|TREATMENT|2021-10-07|2022-03-01|4|149
Study ID|SE|3f85e60b-02d4-49f7-b18e-165a3111bea7|3|REST|6|WASHOUT|2021-11-08|2021-11-11|36|39
Study ID|SE|3f85e60b-02d4-49f7-b18e-165a3111bea7|4|5|3|TREATMENT|2021-11-22|2021-12-12|50|70
Study ID|SE|3f85e60b-02d4-49f7-b18e-165a3111bea7|5|REST|7|WASHOUT|2021-10-15|2021-12-17|12|75
Study ID|SE|3f85e60b-02d4-49f7-b18e-165a3111bea7|6|10|1|TREATMENT|2021-11-03|2021-11-10|31|38
Study ID|SE|3f85e60b-02d4-49f7-b18e-165a3111bea7|7|FU|7|FOLLOW-UP|2021-10-30|2022-06-07|27|247
Study ID|SE|cde9f3d9-ddee-4509-8eb7-a564be85aaff|1|SCRN|5|SCREENING|2021-12-10|2021-12-16|51|57
Study ID|SE|cde9f3d9-ddee-4509-8eb7-a564be85aaff|2|5|4|TREATMENT|2021-11-02|2022-04-30|13|192
Study ID|SE|cde9f3d9-ddee-4509-8eb7-a564be85aaff|3|REST|5|WASHOUT|2021-10-23|2021-10-27|3|7
Study ID|SE|cde9f3d9-ddee-4509-8eb7-a564be85aaff|4|P|2|TREATMENT|2022-01-04|2022-04-09|76|171
Study ID|SE|cde9f3d9-ddee-4509-8eb7-a564be85aaff|5|REST|6|WASHOUT|2021-12-20|2022-03-22|61|153
Study ID|SE|cde9f3d9-ddee-4509-8eb7-a564be85aaff|6|10|4|TREATMENT|2021-11-10|2022-07-17|21|270
Study ID|SE|cde9f3d9-ddee-4509-8eb7-a564be85aaff|7|FU|4|FOLLOW-UP|2021-10-23|2021-12-09|3|50
Study ID|SE|3107c700-6a04-4e10-ad7c-cd8a0311386d|1|SCRN|6|SCREENING|2021-10-09|2022-04-06|41|220
Study ID|SE|3107c700-6a04-4e10-ad7c-cd8a0311386d|2|5|3|TREATMENT|2021-09-23|2022-01-18|25|142
Study ID|SE|3107c700-6a04-4e10-ad7c-cd8a0311386d|3|REST|2|WASHOUT|2021-09-15|2022-04-10|17|224
Study ID|SE|3107c700-6a04-4e10-ad7c-cd8a0311386d|4|P|7|TREATMENT|2021-10-10|2022-05-10|42|254
Study ID|SE|3107c700-6a04-4e10-ad7c-cd8a0311386d|5|REST|3|WASHOUT|2021-09-10|2021-10-11|12|43
Study ID|SE|3107c700-6a04-4e10-ad7c-cd8a0311386d|6|10|3|TREATMENT|2022-01-31|2022-02-13|155|168
Study ID|SE|3107c700-6a04-4e10-ad7c-cd8a0311386d|7|FU|4|FOLLOW-UP|2021-11-20|2022-05-27|83|271
Study ID|SE|ff8ce288-b923-44e6-ae07-5dac29048b6d|1|SCRN|2|SCREENING|2022-01-27|2022-05-03|102|198
Study ID|SE|ff8ce288-b923-44e6-ae07-5dac29048b6d|2|5|5|TREATMENT|2022-04-20|2022-08-07|185|294
Study ID|SE|ff8ce288-b923-44e6-ae07-5dac29048b6d|3|REST|2|WASHOUT|2022-04-09|2022-04-29|174|194
Study ID|SE|ff8ce288-b923-44e6-ae07-5dac29048b6d|4|10|4|TREATMENT|2022-03-29|2022-04-12|163|177
Study ID|SE|ff8ce288-b923-44e6-ae07-5dac29048b6d|5|REST|4|WASHOUT|2021-11-01|2021-11-03|15|17
Study ID|SE|ff8ce288-b923-44e6-ae07-5dac29048b6d|6|P|3|TREATMENT|2022-03-14|2022-04-29|148|194
Study ID|SE|ff8ce288-b923-44e6-ae07-5dac29048b6d|7|FU|6|FOLLOW-UP|2022-04-20|2022-07-12|185|268
Study ID|SE|83270fc0-01ac-4d5a-807d-bb4a7bde1c7f|1|SCRN|2|SCREENING|2021-11-26|2021-12-17|54|75
Study ID|SE|83270fc0-01ac-4d5a-807d-bb4a7bde1c7f|2|5|4|TREATMENT|2022-01-06|2022-05-31|95|240
Study ID|SE|83270fc0-01ac-4d5a-807d-bb4a7bde1c7f|3|REST|6|WASHOUT|2022-02-01|2022-02-04|121|124
Study ID|SE|83270fc0-01ac-4d5a-807d-bb4a7bde1c7f|4|P|5|TREATMENT|2021-11-08|2022-04-25|36|204
Study ID|SE|83270fc0-01ac-4d5a-807d-bb4a7bde1c7f|5|REST|7|WASHOUT|2021-12-22|2022-03-10|80|158
Study ID|SE|83270fc0-01ac-4d5a-807d-bb4a7bde1c7f|6|10|2|TREATMENT|2021-10-27|2022-02-10|24|130
Study ID|SE|83270fc0-01ac-4d5a-807d-bb4a7bde1c7f|7|FU|4|FOLLOW-UP|2022-06-03|2022-07-18|243|288
Study ID|SE|764b8b95-3ff5-4ed7-992b-0eddc8f2f042|1|SCRN|7|SCREENING|2022-02-01|2022-05-07|125|220
Study ID|SE|764b8b95-3ff5-4ed7-992b-0eddc8f2f042|2|5|5|TREATMENT|2021-10-17|2021-12-09|18|71
Study ID|SE|764b8b95-3ff5-4ed7-992b-0eddc8f2f042|3|REST|5|WASHOUT|2021-12-25|2021-12-31|87|93
Study ID|SE|764b8b95-3ff5-4ed7-992b-0eddc8f2f042|4|10|5|TREATMENT|2021-10-13|2022-06-26|14|270
Study ID|SE|764b8b95-3ff5-4ed7-992b-0eddc8f2f042|5|REST|4|WASHOUT|2022-01-05|2022-01-26|98|119
Study ID|SE|764b8b95-3ff5-4ed7-992b-0eddc8f2f042|6|P|3|TREATMENT|2021-12-07|2022-06-03|69|247
Study ID|SE|764b8b95-3ff5-4ed7-992b-0eddc8f2f042|7|FU|5|FOLLOW-UP|2021-11-25|2022-01-02|57|95
Study ID|SE|9c54af9a-3b79-4bc6-807e-71b15c34adf8|1|SCRN|2|SCREENING|2022-02-22|2022-06-25|134|257
Study ID|SE|9c54af9a-3b79-4bc6-807e-71b15c34adf8|2|P|3|TREATMENT|2022-02-27|2022-06-18|139|250
Study ID|SE|9c54af9a-3b79-4bc6-807e-71b15c34adf8|3|REST|7|WASHOUT|2022-01-14|2022-03-16|95|156
Study ID|SE|9c54af9a-3b79-4bc6-807e-71b15c34adf8|4|5|2|TREATMENT|2021-12-09|2022-05-04|59|205
Study ID|SE|9c54af9a-3b79-4bc6-807e-71b15c34adf8|5|REST|3|WASHOUT|2022-01-26|2022-02-21|107|133
Study ID|SE|9c54af9a-3b79-4bc6-807e-71b15c34adf8|6|10|1|TREATMENT|2022-01-08|2022-02-28|89|140
Study ID|SE|9c54af9a-3b79-4bc6-807e-71b15c34adf8|7|FU|3|FOLLOW-UP|2021-11-21|2022-01-19|41|100
Study ID|SE|a8c7879f-9b99-4eef-8bae-5f2045165742|1|SCRN|5|SCREENING|2021-12-06|2022-06-16|40|232
Study ID|SE|a8c7879f-9b99-4eef-8bae-5f2045165742|2|P|6|TREATMENT|2021-11-23|2022-08-19|27|296
Study ID|SE|a8c7879f-9b99-4eef-8bae-5f2045165742|3|REST|6|WASHOUT|2022-03-14|2022-04-17|138|172
Study ID|SE|a8c7879f-9b99-4eef-8bae-5f2045165742|4|5|3|TREATMENT|2021-11-14|2022-06-27|18|243
Study ID|SE|a8c7879f-9b99-4eef-8bae-5f2045165742|5|REST|1|WASHOUT|2021-11-03|2022-03-26|7|150
Study ID|SE|a8c7879f-9b99-4eef-8bae-5f2045165742|6|10|1|TREATMENT|2022-02-10|2022-05-18|106|203
Study ID|SE|a8c7879f-9b99-4eef-8bae-5f2045165742|7|FU|2|FOLLOW-UP|2021-11-08|2021-12-09|12|43
Study ID|SE|3335ac20-54bb-4eab-a1a3-bad43caa109b|1|SCRN|2|SCREENING|2021-10-15|2021-11-17|6|39
Study ID|SE|3335ac20-54bb-4eab-a1a3-bad43caa109b|2|5|2|TREATMENT|2022-02-08|2022-07-17|122|281
Study ID|SE|3335ac20-54bb-4eab-a1a3-bad43caa109b|3|REST|6|WASHOUT|2021-11-23|2021-12-03|45|55
Study ID|SE|3335ac20-54bb-4eab-a1a3-bad43caa109b|4|10|2|TREATMENT|2022-05-15|2022-07-08|218|272
Study ID|SE|3335ac20-54bb-4eab-a1a3-bad43caa109b|5|REST|6|WASHOUT|2022-01-06|2022-06-13|89|247
Study ID|SE|3335ac20-54bb-4eab-a1a3-bad43caa109b|6|P|6|TREATMENT|2022-01-18|2022-02-15|101|129
Study ID|SE|3335ac20-54bb-4eab-a1a3-bad43caa109b|7|FU|7|FOLLOW-UP|2021-10-18|2021-10-20|9|11
Study ID|SE|d756c97e-423f-4dd4-b738-c969a1b08461|1|SCRN|6|SCREENING|2021-12-03|2021-12-15|110|122
Study ID|SE|d756c97e-423f-4dd4-b738-c969a1b08461|2|5|2|TREATMENT|2021-10-02|2021-10-03|48|49
Study ID|SE|d756c97e-423f-4dd4-b738-c969a1b08461|3|REST|5|WASHOUT|2022-05-16|2022-05-20|274|278
Study ID|SE|d756c97e-423f-4dd4-b738-c969a1b08461|4|P|3|TREATMENT|2021-11-29|2021-12-03|106|110
Study ID|SE|d756c97e-423f-4dd4-b738-c969a1b08461|5|REST|4|WASHOUT|2022-02-25|2022-03-17|194|214
Study ID|SE|d756c97e-423f-4dd4-b738-c969a1b08461|6|10|7|TREATMENT|2021-10-08|2021-10-29|54|75
Study ID|SE|d756c97e-423f-4dd4-b738-c969a1b08461|7|FU|7|FOLLOW-UP|2021-10-07|2021-10-18|53|64
Study ID|SE|94d170c2-fc3e-45f0-869b-471e4f0c613a|1|SCRN|6|SCREENING|2022-02-28|2022-04-28|180|239
Study ID|SE|94d170c2-fc3e-45f0-869b-471e4f0c613a|2|P|7|TREATMENT|2021-11-21|2022-01-06|81|127
Study ID|SE|94d170c2-fc3e-45f0-869b-471e4f0c613a|3|REST|1|WASHOUT|2021-11-03|2022-02-12|63|164
Study ID|SE|94d170c2-fc3e-45f0-869b-471e4f0c613a|4|5|3|TREATMENT|2021-09-06|2022-04-10|5|221
Study ID|SE|94d170c2-fc3e-45f0-869b-471e4f0c613a|5|REST|3|WASHOUT|2021-10-24|2021-11-11|53|71
Study ID|SE|94d170c2-fc3e-45f0-869b-471e4f0c613a|6|10|7|TREATMENT|2022-05-10|2022-06-20|251|292
Study ID|SE|94d170c2-fc3e-45f0-869b-471e4f0c613a|7|FU|1|FOLLOW-UP|2021-09-04|2021-09-20|3|19
Study ID|SE|9a166b73-8cb2-43fa-aeab-7d2ef06fe7e7|1|SCRN|3|SCREENING|2022-02-21|2022-03-02|183|192
Study ID|SE|9a166b73-8cb2-43fa-aeab-7d2ef06fe7e7|2|5|3|TREATMENT|2021-11-30|2021-12-19|100|119
Study ID|SE|9a166b73-8cb2-43fa-aeab-7d2ef06fe7e7|3|REST|3|WASHOUT|2021-10-07|2021-11-18|46|88
Study ID|SE|9a166b73-8cb2-43fa-aeab-7d2ef06fe7e7|4|10|2|TREATMENT|2021-08-24|2021-12-31|2|131
Study ID|SE|9a166b73-8cb2-43fa-aeab-7d2ef06fe7e7|5|REST|7|WASHOUT|2021-09-22|2021-11-22|31|92
Study ID|SE|9a166b73-8cb2-43fa-aeab-7d2ef06fe7e7|6|P|2|TREATMENT|2021-11-19|2022-03-30|89|220
Study ID|SE|9a166b73-8cb2-43fa-aeab-7d2ef06fe7e7|7|FU|1|FOLLOW-UP|2021-12-23|2022-01-20|123|151
Study ID|SE|a04b7049-49aa-4c99-8705-4962cad4040a|1|SCRN|4|SCREENING|2021-10-29|2022-05-01|72|256
Study ID|SE|a04b7049-49aa-4c99-8705-4962cad4040a|2|P|4|TREATMENT|2021-09-28|2022-01-18|41|153
Study ID|SE|a04b7049-49aa-4c99-8705-4962cad4040a|3|REST|3|WASHOUT|2021-09-29|2021-12-04|42|108
Study ID|SE|a04b7049-49aa-4c99-8705-4962cad4040a|4|5|1|TREATMENT|2021-08-22|2021-08-28|4|10
Study ID|SE|a04b7049-49aa-4c99-8705-4962cad4040a|5|REST|4|WASHOUT|2021-09-02|2021-09-20|15|33
Study ID|SE|a04b7049-49aa-4c99-8705-4962cad4040a|6|10|3|TREATMENT|2021-10-31|2021-11-04|74|78
Study ID|SE|a04b7049-49aa-4c99-8705-4962cad4040a|7|FU|2|FOLLOW-UP|2021-08-20|2021-12-09|2|113
Study ID|SE|3cf1a0ae-c84b-47be-a432-b5e4293bfc26|1|SCRN|1|SCREENING|2021-10-21|2022-01-19|12|102
Study ID|SE|3cf1a0ae-c84b-47be-a432-b5e4293bfc26|2|5|2|TREATMENT|2021-10-20|2021-11-11|11|33
Study ID|SE|3cf1a0ae-c84b-47be-a432-b5e4293bfc26|3|REST|5|WASHOUT|2021-10-20|2021-11-02|11|24
Study ID|SE|3cf1a0ae-c84b-47be-a432-b5e4293bfc26|4|10|7|TREATMENT|2021-10-23|2022-05-17|14|220
Study ID|SE|3cf1a0ae-c84b-47be-a432-b5e4293bfc26|5|REST|1|WASHOUT|2021-10-11|2021-10-21|2|12
Study ID|SE|3cf1a0ae-c84b-47be-a432-b5e4293bfc26|6|P|1|TREATMENT|2021-10-14|2021-11-08|5|30
Study ID|SE|3cf1a0ae-c84b-47be-a432-b5e4293bfc26|7|FU|6|FOLLOW-UP|2021-12-22|2022-04-17|74|190
Study ID|SE|9819ea3f-0f7d-4e01-8c85-c9aa2db89060|1|SCRN|6|SCREENING|2022-04-11|2022-06-02|204|256
Study ID|SE|9819ea3f-0f7d-4e01-8c85-c9aa2db89060|2|5|7|TREATMENT|2021-09-22|2021-11-11|3|53
Study ID|SE|9819ea3f-0f7d-4e01-8c85-c9aa2db89060|3|REST|5|WASHOUT|2022-02-04|2022-05-20|138|243
Study ID|SE|9819ea3f-0f7d-4e01-8c85-c9aa2db89060|4|10|7|TREATMENT|2021-11-16|2022-05-06|58|229
Study ID|SE|9819ea3f-0f7d-4e01-8c85-c9aa2db89060|5|REST|7|WASHOUT|2021-11-01|2021-12-06|43|78
Study ID|SE|9819ea3f-0f7d-4e01-8c85-c9aa2db89060|6|P|5|TREATMENT|2021-09-23|2021-10-19|4|30
Study ID|SE|9819ea3f-0f7d-4e01-8c85-c9aa2db89060|7|FU|1|FOLLOW-UP|2021-09-23|2022-05-24|4|247
Study ID|SE|31705791-d8b5-4b87-9a86-b3e24475463d|1|SCRN|4|SCREENING|2021-09-15|2021-10-06|12|33
Study ID|SE|31705791-d8b5-4b87-9a86-b3e24475463d|2|5|1|TREATMENT|2021-09-14|2021-10-04|11|31
Study ID|SE|31705791-d8b5-4b87-9a86-b3e24475463d|3|REST|3|WASHOUT|2022-01-11|2022-02-20|130|170
Study ID|SE|31705791-d8b5-4b87-9a86-b3e24475463d|4|P|2|TREATMENT|2021-09-05|2021-09-11|2|8
Study ID|SE|31705791-d8b5-4b87-9a86-b3e24475463d|5|REST|6|WASHOUT|2021-11-11|2022-02-12|69|162
Study ID|SE|31705791-d8b5-4b87-9a86-b3e24475463d|6|10|1|TREATMENT|2021-10-25|2021-12-23|52|111
Study ID|SE|31705791-d8b5-4b87-9a86-b3e24475463d|7|FU|7|FOLLOW-UP|2021-11-14|2022-02-25|72|175
Study ID|SE|aafbdfe9-c0bf-4729-98b5-6d4a48cd0100|1|SCRN|5|SCREENING|2022-03-28|2022-07-27|152|273
Study ID|SE|aafbdfe9-c0bf-4729-98b5-6d4a48cd0100|2|5|5|TREATMENT|2022-02-02|2022-05-13|98|198
Study ID|SE|aafbdfe9-c0bf-4729-98b5-6d4a48cd0100|3|REST|2|WASHOUT|2021-11-20|2021-12-06|24|40
Study ID|SE|aafbdfe9-c0bf-4729-98b5-6d4a48cd0100|4|P|2|TREATMENT|2021-12-15|2021-12-31|49|65
Study ID|SE|aafbdfe9-c0bf-4729-98b5-6d4a48cd0100|5|REST|1|WASHOUT|2022-01-04|2022-03-21|69|145
Study ID|SE|aafbdfe9-c0bf-4729-98b5-6d4a48cd0100|6|10|6|TREATMENT|2021-12-27|2022-01-28|61|93
Study ID|SE|aafbdfe9-c0bf-4729-98b5-6d4a48cd0100|7|FU|4|FOLLOW-UP|2022-01-28|2022-05-10|93|195
Study ID|SE|52373cda-1ccf-427a-baea-1fa13a0a431c|1|SCRN|7|SCREENING|2021-10-13|2021-11-19|45|82
Study ID|SE|52373cda-1ccf-427a-baea-1fa13a0a431c|2|5|6|TREATMENT|2021-09-04|2021-09-07|6|9
Study ID|SE|52373cda-1ccf-427a-baea-1fa13a0a431c|3|REST|7|WASHOUT|2021-09-08|2021-10-10|10|42
Study ID|SE|52373cda-1ccf-427a-baea-1fa13a0a431c|4|P|2|TREATMENT|2021-11-19|2022-03-03|82|186
Study ID|SE|52373cda-1ccf-427a-baea-1fa13a0a431c|5|REST|7|WASHOUT|2021-09-01|2022-01-10|3|134
Study ID|SE|52373cda-1ccf-427a-baea-1fa13a0a431c|6|10|1|TREATMENT|2021-09-14|2021-09-19|16|21
Study ID|SE|52373cda-1ccf-427a-baea-1fa13a0a431c|7|FU|1|FOLLOW-UP|2021-12-31|2022-04-03|124|217
Study ID|SE|609f31d1-1a82-4f98-acb3-4d6674d56ada|1|SCRN|2|SCREENING|2021-10-01|2022-01-27|10|128
Study ID|SE|609f31d1-1a82-4f98-acb3-4d6674d56ada|2|5|1|TREATMENT|2021-11-09|2022-01-29|49|130
Study ID|SE|609f31d1-1a82-4f98-acb3-4d6674d56ada|3|REST|3|WASHOUT|2021-12-28|2022-04-17|98|208
Study ID|SE|609f31d1-1a82-4f98-acb3-4d6674d56ada|4|10|1|TREATMENT|2021-12-18|2021-12-30|88|100
Study ID|SE|609f31d1-1a82-4f98-acb3-4d6674d56ada|5|REST|7|WASHOUT|2021-12-23|2022-03-25|93|185
Study ID|SE|609f31d1-1a82-4f98-acb3-4d6674d56ada|6|P|4|TREATMENT|2021-12-19|2022-07-04|89|286
Study ID|SE|609f31d1-1a82-4f98-acb3-4d6674d56ada|7|FU|7|FOLLOW-UP|2022-04-26|2022-07-15|217|297
Study ID|SE|8fcf9829-8812-434a-a31d-123cbbacbdf5|1|SCRN|4|SCREENING|2021-10-23|2021-10-29|7|13
Study ID|SE|8fcf9829-8812-434a-a31d-123cbbacbdf5|2|5|7|TREATMENT|2022-04-06|2022-07-20|172|277
Study ID|SE|8fcf9829-8812-434a-a31d-123cbbacbdf5|3|REST|6|WASHOUT|2021-10-20|2021-12-12|4|57
Study ID|SE|8fcf9829-8812-434a-a31d-123cbbacbdf5|4|P|6|TREATMENT|2022-02-03|2022-04-23|110|189
Study ID|SE|8fcf9829-8812-434a-a31d-123cbbacbdf5|5|REST|1|WASHOUT|2021-11-22|2022-03-15|37|150
Study ID|SE|8fcf9829-8812-434a-a31d-123cbbacbdf5|6|10|7|TREATMENT|2021-11-13|2021-11-22|28|37
Study ID|SE|8fcf9829-8812-434a-a31d-123cbbacbdf5|7|FU|5|FOLLOW-UP|2021-11-26|2021-12-25|41|70
Study ID|SE|a259b1eb-481b-4ef5-8509-c110c0aec4f9|1|SCRN|2|SCREENING|2021-10-27|2021-11-16|32|52
Study ID|SE|a259b1eb-481b-4ef5-8509-c110c0aec4f9|2|5|2|TREATMENT|2021-10-13|2022-01-02|18|99
Study ID|SE|a259b1eb-481b-4ef5-8509-c110c0aec4f9|3|REST|2|WASHOUT|2021-10-08|2022-06-01|13|249
Study ID|SE|a259b1eb-481b-4ef5-8509-c110c0aec4f9|4|P|7|TREATMENT|2022-03-15|2022-07-05|171|283
Study ID|SE|a259b1eb-481b-4ef5-8509-c110c0aec4f9|5|REST|3|WASHOUT|2021-12-19|2021-12-26|85|92
Study ID|SE|a259b1eb-481b-4ef5-8509-c110c0aec4f9|6|10|2|TREATMENT|2021-09-27|2021-09-29|2|4
Study ID|SE|a259b1eb-481b-4ef5-8509-c110c0aec4f9|7|FU|6|FOLLOW-UP|2021-10-30|2022-05-29|35|246
Study ID|SE|1cf3ce30-295f-4ff8-8556-2fe8cb8b0bc7|1|SCRN|6|SCREENING|2021-10-13|2022-04-01|36|206
Study ID|SE|1cf3ce30-295f-4ff8-8556-2fe8cb8b0bc7|2|5|2|TREATMENT|2021-09-27|2021-12-05|20|89
Study ID|SE|1cf3ce30-295f-4ff8-8556-2fe8cb8b0bc7|3|REST|6|WASHOUT|2022-05-05|2022-05-27|240|262
Study ID|SE|1cf3ce30-295f-4ff8-8556-2fe8cb8b0bc7|4|10|5|TREATMENT|2022-03-24|2022-05-04|198|239
Study ID|SE|1cf3ce30-295f-4ff8-8556-2fe8cb8b0bc7|5|REST|2|WASHOUT|2022-03-10|2022-03-26|184|200
Study ID|SE|1cf3ce30-295f-4ff8-8556-2fe8cb8b0bc7|6|P|6|TREATMENT|2021-09-27|2021-11-14|20|68
Study ID|SE|1cf3ce30-295f-4ff8-8556-2fe8cb8b0bc7|7|FU|2|FOLLOW-UP|2021-09-12|2021-09-14|5|7
Study ID|SE|28e37863-8010-4475-a326-ca687a0b1c77|1|SCRN|5|SCREENING|2021-12-29|2022-06-22|88|263
Study ID|SE|28e37863-8010-4475-a326-ca687a0b1c77|2|P|6|TREATMENT|2022-02-14|2022-03-17|135|166
Study ID|SE|28e37863-8010-4475-a326-ca687a0b1c77|3|REST|4|WASHOUT|2021-10-29|2021-11-06|27|35
Study ID|SE|28e37863-8010-4475-a326-ca687a0b1c77|4|5|2|TREATMENT|2021-10-09|2022-05-18|7|228
Study ID|SE|28e37863-8010-4475-a326-ca687a0b1c77|5|REST|6|WASHOUT|2022-05-21|2022-07-24|231|295
Study ID|SE|28e37863-8010-4475-a326-ca687a0b1c77|6|10|6|TREATMENT|2021-12-19|2022-01-16|78|106
Study ID|SE|28e37863-8010-4475-a326-ca687a0b1c77|7|FU|2|FOLLOW-UP|2021-10-08|2021-10-26|6|24
Study ID|SE|e59eba09-9366-4808-b6df-5d6974f6ff34|1|SCRN|1|SCREENING|2021-08-23|2021-12-10|10|119
Study ID|SE|e59eba09-9366-4808-b6df-5d6974f6ff34|2|5|1|TREATMENT|2021-08-25|2021-09-17|12|35
Study ID|SE|e59eba09-9366-4808-b6df-5d6974f6ff34|3|REST|3|WASHOUT|2022-01-28|2022-05-30|168|290
Study ID|SE|e59eba09-9366-4808-b6df-5d6974f6ff34|4|P|2|TREATMENT|2021-09-28|2021-11-13|46|92
Study ID|SE|e59eba09-9366-4808-b6df-5d6974f6ff34|5|REST|7|WASHOUT|2021-08-17|2021-08-26|4|13
Study ID|SE|e59eba09-9366-4808-b6df-5d6974f6ff34|6|10|1|TREATMENT|2022-03-01|2022-06-02|200|293
Study ID|SE|e59eba09-9366-4808-b6df-5d6974f6ff34|7|FU|2|FOLLOW-UP|2021-11-22|2021-11-30|101|109
Study ID|SE|61d5efed-8673-4e45-8d71-455182e69f36|1|SCRN|4|SCREENING|2021-10-24|2022-05-02|32|222
Study ID|SE|61d5efed-8673-4e45-8d71-455182e69f36|2|5|5|TREATMENT|2021-11-05|2021-11-19|44|58
Study ID|SE|61d5efed-8673-4e45-8d71-455182e69f36|3|REST|4|WASHOUT|2021-10-02|2021-10-17|10|25
Study ID|SE|61d5efed-8673-4e45-8d71-455182e69f36|4|10|1|TREATMENT|2021-11-14|2022-04-29|53|219
Study ID|SE|61d5efed-8673-4e45-8d71-455182e69f36|5|REST|4|WASHOUT|2022-03-23|2022-04-07|182|197
Study ID|SE|61d5efed-8673-4e45-8d71-455182e69f36|6|P|1|TREATMENT|2022-02-02|2022-05-08|133|228
Study ID|SE|61d5efed-8673-4e45-8d71-455182e69f36|7|FU|5|FOLLOW-UP|2021-10-19|2021-10-31|27|39
Study ID|SE|93cb4676-6d85-47d2-8abe-9e2894c1988e|1|SCRN|3|SCREENING|2021-10-05|2022-01-26|18|131
Study ID|SE|93cb4676-6d85-47d2-8abe-9e2894c1988e|2|P|1|TREATMENT|2021-09-23|2022-02-06|6|142
Study ID|SE|93cb4676-6d85-47d2-8abe-9e2894c1988e|3|REST|7|WASHOUT|2022-02-28|2022-06-08|164|264
Study ID|SE|93cb4676-6d85-47d2-8abe-9e2894c1988e|4|5|6|TREATMENT|2021-12-26|2022-04-21|100|216
Study ID|SE|93cb4676-6d85-47d2-8abe-9e2894c1988e|5|REST|5|WASHOUT|2021-11-19|2022-03-23|63|187
Study ID|SE|93cb4676-6d85-47d2-8abe-9e2894c1988e|6|10|4|TREATMENT|2021-10-26|2021-11-19|39|63
Study ID|SE|93cb4676-6d85-47d2-8abe-9e2894c1988e|7|FU|3|FOLLOW-UP|2022-04-29|2022-06-13|224|269
Study ID|SE|0230d010-e393-4a25-9d74-1f04f04a62f4|1|SCRN|5|SCREENING|2021-09-25|2021-09-29|27|31
Study ID|SE|0230d010-e393-4a25-9d74-1f04f04a62f4|2|5|4|TREATMENT|2022-02-12|2022-03-17|167|200
Study ID|SE|0230d010-e393-4a25-9d74-1f04f04a62f4|3|REST|6|WASHOUT|2021-12-24|2022-02-11|117|166
Study ID|SE|0230d010-e393-4a25-9d74-1f04f04a62f4|4|P|1|TREATMENT|2021-09-05|2021-10-27|7|59
Study ID|SE|0230d010-e393-4a25-9d74-1f04f04a62f4|5|REST|6|WASHOUT|2021-11-05|2022-03-10|68|193
Study ID|SE|0230d010-e393-4a25-9d74-1f04f04a62f4|6|10|3|TREATMENT|2021-11-23|2021-12-08|86|101
Study ID|SE|0230d010-e393-4a25-9d74-1f04f04a62f4|7|FU|3|FOLLOW-UP|2021-09-06|2021-09-25|8|27
Study ID|SE|98dc4659-5b52-461c-b74a-a9475a5a5d6a|1|SCRN|2|SCREENING|2021-09-20|2022-02-25|31|189
Study ID|SE|98dc4659-5b52-461c-b74a-a9475a5a5d6a|2|P|6|TREATMENT|2021-09-07|2021-12-22|18|124
Study ID|SE|98dc4659-5b52-461c-b74a-a9475a5a5d6a|3|REST|5|WASHOUT|2022-02-23|2022-03-11|187|203
Study ID|SE|98dc4659-5b52-461c-b74a-a9475a5a5d6a|4|5|4|TREATMENT|2021-11-19|2022-01-20|91|153
Study ID|SE|98dc4659-5b52-461c-b74a-a9475a5a5d6a|5|REST|4|WASHOUT|2021-08-28|2021-09-23|8|34
Study ID|SE|98dc4659-5b52-461c-b74a-a9475a5a5d6a|6|10|7|TREATMENT|2021-11-14|2022-04-14|86|237
Study ID|SE|98dc4659-5b52-461c-b74a-a9475a5a5d6a|7|FU|2|FOLLOW-UP|2021-11-01|2021-12-20|73|122
Study ID|SE|36277ed8-38e6-4056-b51d-928ec80926e7|1|SCRN|1|SCREENING|2021-09-12|2021-09-22|25|35
Study ID|SE|36277ed8-38e6-4056-b51d-928ec80926e7|2|5|7|TREATMENT|2021-12-21|2022-03-07|125|201
Study ID|SE|36277ed8-38e6-4056-b51d-928ec80926e7|3|REST|3|WASHOUT|2021-10-13|2022-01-03|56|138
Study ID|SE|36277ed8-38e6-4056-b51d-928ec80926e7|4|P|2|TREATMENT|2021-12-28|2022-05-07|132|262
Study ID|SE|36277ed8-38e6-4056-b51d-928ec80926e7|5|REST|2|WASHOUT|2021-12-26|2022-01-21|130|156
Study ID|SE|36277ed8-38e6-4056-b51d-928ec80926e7|6|10|5|TREATMENT|2021-08-29|2021-09-17|11|30
Study ID|SE|36277ed8-38e6-4056-b51d-928ec80926e7|7|FU|6|FOLLOW-UP|2021-08-27|2022-05-12|9|267
Study ID|SE|0d0321a6-ccd7-468b-963d-27c9faef7f5e|1|SCRN|4|SCREENING|2021-12-12|2022-05-02|84|225
Study ID|SE|0d0321a6-ccd7-468b-963d-27c9faef7f5e|2|P|6|TREATMENT|2021-10-14|2021-11-02|25|44
Study ID|SE|0d0321a6-ccd7-468b-963d-27c9faef7f5e|3|REST|3|WASHOUT|2021-09-24|2022-04-02|5|195
Study ID|SE|0d0321a6-ccd7-468b-963d-27c9faef7f5e|4|5|5|TREATMENT|2022-02-07|2022-04-22|141|215
Study ID|SE|0d0321a6-ccd7-468b-963d-27c9faef7f5e|5|REST|3|WASHOUT|2022-02-28|2022-07-12|162|296
Study ID|SE|0d0321a6-ccd7-468b-963d-27c9faef7f5e|6|10|7|TREATMENT|2021-11-12|2021-11-15|54|57
Study ID|SE|0d0321a6-ccd7-468b-963d-27c9faef7f5e|7|FU|7|FOLLOW-UP|2021-12-22|2022-05-13|94|236
Study ID|SE|73c43d89-0f5f-41fc-8b2f-123abce98d5f|1|SCRN|6|SCREENING|2022-02-07|2022-04-19|108|179
Study ID|SE|73c43d89-0f5f-41fc-8b2f-123abce98d5f|2|5|4|TREATMENT|2021-11-06|2021-11-26|15|35
Study ID|SE|73c43d89-0f5f-41fc-8b2f-123abce98d5f|3|REST|3|WASHOUT|2022-02-03|2022-03-07|104|136
Study ID|SE|73c43d89-0f5f-41fc-8b2f-123abce98d5f|4|10|7|TREATMENT|2021-12-11|2022-04-15|50|175
Study ID|SE|73c43d89-0f5f-41fc-8b2f-123abce98d5f|5|REST|4|WASHOUT|2021-12-19|2022-01-24|58|94
Study ID|SE|73c43d89-0f5f-41fc-8b2f-123abce98d5f|6|P|2|TREATMENT|2022-05-19|2022-06-09|209|230
Study ID|SE|73c43d89-0f5f-41fc-8b2f-123abce98d5f|7|FU|1|FOLLOW-UP|2021-12-05|2022-07-13|44|264
Study ID|SE|6f8b89c1-09b9-45a1-ad04-191a1d7b31d9|1|SCRN|4|SCREENING|2021-08-09|2021-08-13|3|7
Study ID|SE|6f8b89c1-09b9-45a1-ad04-191a1d7b31d9|2|5|2|TREATMENT|2021-08-11|2022-03-19|5|225
Study ID|SE|6f8b89c1-09b9-45a1-ad04-191a1d7b31d9|3|REST|2|WASHOUT|2022-01-10|2022-05-02|157|269
Study ID|SE|6f8b89c1-09b9-45a1-ad04-191a1d7b31d9|4|10|1|TREATMENT|2021-08-29|2021-12-26|23|142
Study ID|SE|6f8b89c1-09b9-45a1-ad04-191a1d7b31d9|5|REST|6|WASHOUT|2021-11-19|2022-05-19|105|286
Study ID|SE|6f8b89c1-09b9-45a1-ad04-191a1d7b31d9|6|P|7|TREATMENT|2022-02-20|2022-04-29|198|266
Study ID|SE|6f8b89c1-09b9-45a1-ad04-191a1d7b31d9|7|FU|1|FOLLOW-UP|2022-04-09|2022-04-11|246|248
Study ID|SE|380a12da-1c9d-436f-920e-574406d171fe|1|SCRN|5|SCREENING|2021-10-03|2022-04-24|25|228
Study ID|SE|380a12da-1c9d-436f-920e-574406d171fe|2|5|2|TREATMENT|2022-04-25|2022-06-11|229|276
Study ID|SE|380a12da-1c9d-436f-920e-574406d171fe|3|REST|2|WASHOUT|2021-09-17|2022-05-03|9|237
Study ID|SE|380a12da-1c9d-436f-920e-574406d171fe|4|P|2|TREATMENT|2022-01-16|2022-04-04|130|208
Study ID|SE|380a12da-1c9d-436f-920e-574406d171fe|5|REST|3|WASHOUT|2021-09-22|2021-10-11|14|33
Study ID|SE|380a12da-1c9d-436f-920e-574406d171fe|6|10|4|TREATMENT|2022-01-08|2022-06-02|122|267
Study ID|SE|380a12da-1c9d-436f-920e-574406d171fe|7|FU|2|FOLLOW-UP|2022-03-29|2022-03-30|202|203
Study ID|SE|a9d6d2e3-38a5-47ca-bbb9-c0e41e8432b7|1|SCRN|7|SCREENING|2021-09-26|2022-06-23|24|294
Study ID|SE|a9d6d2e3-38a5-47ca-bbb9-c0e41e8432b7|2|5|2|TREATMENT|2021-09-26|2022-04-24|24|234
Study ID|SE|a9d6d2e3-38a5-47ca-bbb9-c0e41e8432b7|3|REST|6|WASHOUT|2022-01-15|2022-04-24|135|234
Study ID|SE|a9d6d2e3-38a5-47ca-bbb9-c0e41e8432b7|4|10|6|TREATMENT|2021-10-30|2022-01-02|58|122
Study ID|SE|a9d6d2e3-38a5-47ca-bbb9-c0e41e8432b7|5|REST|3|WASHOUT|2021-09-08|2021-11-27|6|86
Study ID|SE|a9d6d2e3-38a5-47ca-bbb9-c0e41e8432b7|6|P|1|TREATMENT|2021-09-24|2021-10-23|22|51
Study ID|SE|a9d6d2e3-38a5-47ca-bbb9-c0e41e8432b7|7|FU|6|FOLLOW-UP|2021-09-22|2021-09-28|20|26
Study ID|SE|c9483c30-fed5-45b9-85cf-299559cd97b7|1|SCRN|6|SCREENING|2021-11-23|2022-04-22|103|253
Study ID|SE|c9483c30-fed5-45b9-85cf-299559cd97b7|2|5|3|TREATMENT|2021-09-02|2021-12-10|21|120
Study ID|SE|c9483c30-fed5-45b9-85cf-299559cd97b7|3|REST|5|WASHOUT|2021-12-28|2022-03-31|138|231
Study ID|SE|c9483c30-fed5-45b9-85cf-299559cd97b7|4|10|1|TREATMENT|2022-04-29|2022-05-17|260|278
Study ID|SE|c9483c30-fed5-45b9-85cf-299559cd97b7|5|REST|3|WASHOUT|2021-09-12|2022-03-07|31|207
Study ID|SE|c9483c30-fed5-45b9-85cf-299559cd97b7|6|P|3|TREATMENT|2021-10-02|2021-12-31|51|141
Study ID|SE|c9483c30-fed5-45b9-85cf-299559cd97b7|7|FU|4|FOLLOW-UP|2021-09-23|2022-01-26|42|167
Study ID|SE|70b6a549-03e7-415f-9af2-ab9183c1a78f|1|SCRN|6|SCREENING|2021-12-24|2022-02-15|95|148
Study ID|SE|70b6a549-03e7-415f-9af2-ab9183c1a78f|2|5|1|TREATMENT|2021-11-06|2021-11-16|47|57
Study ID|SE|70b6a549-03e7-415f-9af2-ab9183c1a78f|3|REST|6|WASHOUT|2021-09-30|2022-03-24|10|185
Study ID|SE|70b6a549-03e7-415f-9af2-ab9183c1a78f|4|10|3|TREATMENT|2021-10-06|2021-12-02|16|73
Study ID|SE|70b6a549-03e7-415f-9af2-ab9183c1a78f|5|REST|6|WASHOUT|2021-10-27|2021-12-15|37|86
Study ID|SE|70b6a549-03e7-415f-9af2-ab9183c1a78f|6|P|3|TREATMENT|2021-09-24|2022-06-30|4|283
Study ID|SE|70b6a549-03e7-415f-9af2-ab9183c1a78f|7|FU|1|FOLLOW-UP|2022-05-04|2022-07-16|226|299
Study ID|SE|f3c55f64-987f-4ab7-bb31-821dc6fc0d96|1|SCRN|3|SCREENING|2021-11-07|2022-01-23|23|100
Study ID|SE|f3c55f64-987f-4ab7-bb31-821dc6fc0d96|2|5|5|TREATMENT|2021-10-19|2022-03-31|4|167
Study ID|SE|f3c55f64-987f-4ab7-bb31-821dc6fc0d96|3|REST|4|WASHOUT|2021-12-03|2022-04-27|49|194
Study ID|SE|f3c55f64-987f-4ab7-bb31-821dc6fc0d96|4|10|4|TREATMENT|2021-11-14|2021-11-29|30|45
Study ID|SE|f3c55f64-987f-4ab7-bb31-821dc6fc0d96|5|REST|4|WASHOUT|2021-11-09|2022-05-22|25|219
Study ID|SE|f3c55f64-987f-4ab7-bb31-821dc6fc0d96|6|P|4|TREATMENT|2021-12-26|2022-01-20|72|97
Study ID|SE|f3c55f64-987f-4ab7-bb31-821dc6fc0d96|7|FU|4|FOLLOW-UP|2021-10-18|2021-11-10|3|26
Study ID|SE|ecc23866-885e-403c-bf01-5cce2a7c010f|1|SCRN|3|SCREENING|2021-11-08|2021-12-30|17|69
Study ID|SE|ecc23866-885e-403c-bf01-5cce2a7c010f|2|5|7|TREATMENT|2021-12-09|2022-02-20|48|121
Study ID|SE|ecc23866-885e-403c-bf01-5cce2a7c010f|3|REST|2|WASHOUT|2021-12-10|2022-05-16|49|206
Study ID|SE|ecc23866-885e-403c-bf01-5cce2a7c010f|4|P|5|TREATMENT|2022-04-01|2022-07-07|161|258
Study ID|SE|ecc23866-885e-403c-bf01-5cce2a7c010f|5|REST|5|WASHOUT|2022-06-23|2022-08-11|244|293
Study ID|SE|ecc23866-885e-403c-bf01-5cce2a7c010f|6|10|6|TREATMENT|2021-12-01|2021-12-13|40|52
Study ID|SE|ecc23866-885e-403c-bf01-5cce2a7c010f|7|FU|6|FOLLOW-UP|2022-02-11|2022-03-09|112|138
Study ID|SE|665c979c-d076-44e0-9f76-4869bc22b09e|1|SCRN|5|SCREENING|2021-12-09|2022-06-27|82|282
Study ID|SE|665c979c-d076-44e0-9f76-4869bc22b09e|2|5|1|TREATMENT|2021-10-27|2021-12-23|39|96
Study ID|SE|665c979c-d076-44e0-9f76-4869bc22b09e|3|REST|1|WASHOUT|2022-03-03|2022-04-12|166|206
Study ID|SE|665c979c-d076-44e0-9f76-4869bc22b09e|4|P|6|TREATMENT|2021-10-05|2022-01-03|17|107
Study ID|SE|665c979c-d076-44e0-9f76-4869bc22b09e|5|REST|5|WASHOUT|2021-10-29|2022-01-31|41|135
Study ID|SE|665c979c-d076-44e0-9f76-4869bc22b09e|6|10|1|TREATMENT|2021-12-04|2021-12-27|77|100
Study ID|SE|665c979c-d076-44e0-9f76-4869bc22b09e|7|FU|4|FOLLOW-UP|2021-10-18|2021-11-10|30|53
Study ID|SE|1533f51f-0564-49ad-bf8c-472538fa03a4|1|SCRN|6|SCREENING|2021-11-13|2022-03-15|56|178
Study ID|SE|1533f51f-0564-49ad-bf8c-472538fa03a4|2|5|6|TREATMENT|2021-10-20|2022-01-29|32|133
Study ID|SE|1533f51f-0564-49ad-bf8c-472538fa03a4|3|REST|1|WASHOUT|2021-12-09|2022-07-09|82|294
Study ID|SE|1533f51f-0564-49ad-bf8c-472538fa03a4|4|P|1|TREATMENT|2022-02-23|2022-04-27|158|221
Study ID|SE|1533f51f-0564-49ad-bf8c-472538fa03a4|5|REST|1|WASHOUT|2021-09-22|2021-12-17|4|90
Study ID|SE|1533f51f-0564-49ad-bf8c-472538fa03a4|6|10|7|TREATMENT|2021-11-01|2022-02-22|44|157
Study ID|SE|1533f51f-0564-49ad-bf8c-472538fa03a4|7|FU|7|FOLLOW-UP|2022-02-15|2022-03-10|150|173
Study ID|SE|d15001d4-14c3-440c-bac4-6fb4414fb410|1|SCRN|1|SCREENING|2022-05-21|2022-06-26|216|252
Study ID|SE|d15001d4-14c3-440c-bac4-6fb4414fb410|2|P|6|TREATMENT|2021-12-10|2022-01-24|54|99
Study ID|SE|d15001d4-14c3-440c-bac4-6fb4414fb410|3|REST|4|WASHOUT|2021-10-25|2021-11-13|8|27
Study ID|SE|d15001d4-14c3-440c-bac4-6fb4414fb410|4|5|5|TREATMENT|2021-11-26|2021-12-31|40|75
Study ID|SE|d15001d4-14c3-440c-bac4-6fb4414fb410|5|REST|2|WASHOUT|2021-10-19|2021-10-23|2|6
Study ID|SE|d15001d4-14c3-440c-bac4-6fb4414fb410|6|10|6|TREATMENT|2022-02-01|2022-03-25|107|159
Study ID|SE|d15001d4-14c3-440c-bac4-6fb4414fb410|7|FU|5|FOLLOW-UP|2022-02-12|2022-07-27|118|283
Study ID|SE|9b8601b3-75d2-47ad-8256-b10ee9e99123|1|SCRN|7|SCREENING|2021-11-12|2021-11-30|32|50
Study ID|SE|9b8601b3-75d2-47ad-8256-b10ee9e99123|2|5|4|TREATMENT|2021-12-27|2022-02-04|77|116
Study ID|SE|9b8601b3-75d2-47ad-8256-b10ee9e99123|3|REST|2|WASHOUT|2021-10-30|2021-11-03|19|23
Study ID|SE|9b8601b3-75d2-47ad-8256-b10ee9e99123|4|P|1|TREATMENT|2022-01-23|2022-05-18|104|219
Study ID|SE|9b8601b3-75d2-47ad-8256-b10ee9e99123|5|REST|1|WASHOUT|2021-10-14|2021-10-20|3|9
Study ID|SE|9b8601b3-75d2-47ad-8256-b10ee9e99123|6|10|1|TREATMENT|2022-04-03|2022-07-10|174|272
Study ID|SE|9b8601b3-75d2-47ad-8256-b10ee9e99123|7|FU|4|FOLLOW-UP|2021-10-13|2021-10-15|2|4
Study ID|SE|dc90d8f8-a9d3-4869-8b00-9a75bcc1e302|1|SCRN|2|SCREENING|2022-01-27|2022-02-18|157|179
Study ID|SE|dc90d8f8-a9d3-4869-8b00-9a75bcc1e302|2|5|7|TREATMENT|2021-10-08|2021-11-26|46|95
Study ID|SE|dc90d8f8-a9d3-4869-8b00-9a75bcc1e302|3|REST|1|WASHOUT|2021-12-18|2022-06-10|117|291
Study ID|SE|dc90d8f8-a9d3-4869-8b00-9a75bcc1e302|4|P|3|TREATMENT|2021-09-13|2022-01-24|21|154
Study ID|SE|dc90d8f8-a9d3-4869-8b00-9a75bcc1e302|5|REST|4|WASHOUT|2021-09-19|2021-10-21|27|59
Study ID|SE|dc90d8f8-a9d3-4869-8b00-9a75bcc1e302|6|10|5|TREATMENT|2021-12-21|2022-02-20|120|181
Study ID|SE|dc90d8f8-a9d3-4869-8b00-9a75bcc1e302|7|FU|1|FOLLOW-UP|2021-11-02|2022-05-31|71|281
Study ID|SE|1f338414-9f49-4dec-bcc2-a20311ab653a|1|SCRN|6|SCREENING|2021-10-01|2022-01-21|8|120
Study ID|SE|1f338414-9f49-4dec-bcc2-a20311ab653a|2|5|5|TREATMENT|2021-12-11|2022-02-11|79|141
Study ID|SE|1f338414-9f49-4dec-bcc2-a20311ab653a|3|REST|6|WASHOUT|2021-11-13|2021-12-01|51|69
Study ID|SE|1f338414-9f49-4dec-bcc2-a20311ab653a|4|P|6|TREATMENT|2021-09-28|2021-10-19|5|26
Study ID|SE|1f338414-9f49-4dec-bcc2-a20311ab653a|5|REST|1|WASHOUT|2021-10-18|2021-12-07|25|75
Study ID|SE|1f338414-9f49-4dec-bcc2-a20311ab653a|6|10|1|TREATMENT|2022-03-15|2022-05-29|173|248
Study ID|SE|1f338414-9f49-4dec-bcc2-a20311ab653a|7|FU|5|FOLLOW-UP|2021-12-10|2021-12-11|78|79
Study ID|SE|12728dc0-3f6a-4d2c-b396-b6bcdb2927d1|1|SCRN|2|SCREENING|2021-09-08|2021-11-07|13|73
Study ID|SE|12728dc0-3f6a-4d2c-b396-b6bcdb2927d1|2|5|2|TREATMENT|2021-09-15|2022-03-05|20|191
Study ID|SE|12728dc0-3f6a-4d2c-b396-b6bcdb2927d1|3|REST|6|WASHOUT|2021-12-17|2022-02-22|113|180
Study ID|SE|12728dc0-3f6a-4d2c-b396-b6bcdb2927d1|4|10|3|TREATMENT|2022-01-12|2022-04-05|139|222
Study ID|SE|12728dc0-3f6a-4d2c-b396-b6bcdb2927d1|5|REST|2|WASHOUT|2022-02-12|2022-03-19|170|205
Study ID|SE|12728dc0-3f6a-4d2c-b396-b6bcdb2927d1|6|P|5|TREATMENT|2021-09-20|2021-09-28|25|33
Study ID|SE|12728dc0-3f6a-4d2c-b396-b6bcdb2927d1|7|FU|1|FOLLOW-UP|2021-09-18|2022-05-24|23|271
Study ID|SE|24a85a44-fd7a-45d8-bcb5-cf65e095b4e5|1|SCRN|3|SCREENING|2021-12-18|2021-12-29|65|76
Study ID|SE|24a85a44-fd7a-45d8-bcb5-cf65e095b4e5|2|P|3|TREATMENT|2021-10-25|2021-11-02|11|19
Study ID|SE|24a85a44-fd7a-45d8-bcb5-cf65e095b4e5|3|REST|7|WASHOUT|2021-10-18|2022-03-29|4|166
Study ID|SE|24a85a44-fd7a-45d8-bcb5-cf65e095b4e5|4|5|2|TREATMENT|2022-06-07|2022-07-20|236|279
Study ID|SE|24a85a44-fd7a-45d8-bcb5-cf65e095b4e5|5|REST|2|WASHOUT|2022-02-20|2022-03-02|129|139
Study ID|SE|24a85a44-fd7a-45d8-bcb5-cf65e095b4e5|6|10|7|TREATMENT|2022-02-28|2022-06-30|137|259
Study ID|SE|24a85a44-fd7a-45d8-bcb5-cf65e095b4e5|7|FU|2|FOLLOW-UP|2021-11-26|2022-01-08|43|86
Study ID|SE|7dcec4d6-6b65-4340-8f44-54730c0671f4|1|SCRN|2|SCREENING|2022-05-02|2022-05-22|228|248
Study ID|SE|7dcec4d6-6b65-4340-8f44-54730c0671f4|2|5|5|TREATMENT|2022-05-21|2022-05-26|247|252
Study ID|SE|7dcec4d6-6b65-4340-8f44-54730c0671f4|3|REST|2|WASHOUT|2021-11-11|2021-11-14|56|59
Study ID|SE|7dcec4d6-6b65-4340-8f44-54730c0671f4|4|P|2|TREATMENT|2021-11-08|2021-12-02|53|77
Study ID|SE|7dcec4d6-6b65-4340-8f44-54730c0671f4|5|REST|3|WASHOUT|2021-12-19|2022-03-14|94|179
Study ID|SE|7dcec4d6-6b65-4340-8f44-54730c0671f4|6|10|4|TREATMENT|2021-11-28|2022-06-02|73|259
Study ID|SE|7dcec4d6-6b65-4340-8f44-54730c0671f4|7|FU|7|FOLLOW-UP|2022-01-21|2022-03-14|127|179
Study ID|SE|129a67f2-3c33-4322-9257-08f9b1b2adb5|1|SCRN|6|SCREENING|2021-09-21|2021-12-02|14|86
Study ID|SE|129a67f2-3c33-4322-9257-08f9b1b2adb5|2|5|2|TREATMENT|2021-10-14|2022-04-19|37|224
Study ID|SE|129a67f2-3c33-4322-9257-08f9b1b2adb5|3|REST|5|WASHOUT|2022-01-10|2022-04-16|125|221
Study ID|SE|129a67f2-3c33-4322-9257-08f9b1b2adb5|4|P|4|TREATMENT|2021-09-27|2022-01-30|20|145
Study ID|SE|129a67f2-3c33-4322-9257-08f9b1b2adb5|5|REST|5|WASHOUT|2021-09-26|2022-03-23|19|197
Study ID|SE|129a67f2-3c33-4322-9257-08f9b1b2adb5|6|10|6|TREATMENT|2021-10-06|2021-10-30|29|53
Study ID|SE|129a67f2-3c33-4322-9257-08f9b1b2adb5|7|FU|1|FOLLOW-UP|2021-10-25|2021-11-27|48|81
Study ID|SE|24cab1dd-d866-4de2-ab08-4d9242db328a|1|SCRN|3|SCREENING|2022-05-10|2022-06-29|213|263
Study ID|SE|24cab1dd-d866-4de2-ab08-4d9242db328a|2|5|3|TREATMENT|2021-10-19|2021-12-23|10|75
Study ID|SE|24cab1dd-d866-4de2-ab08-4d9242db328a|3|REST|4|WASHOUT|2021-11-25|2022-03-01|47|143
Study ID|SE|24cab1dd-d866-4de2-ab08-4d9242db328a|4|P|2|TREATMENT|2021-11-04|2022-05-04|26|207
Study ID|SE|24cab1dd-d866-4de2-ab08-4d9242db328a|5|REST|6|WASHOUT|2021-12-02|2022-04-29|54|202
Study ID|SE|24cab1dd-d866-4de2-ab08-4d9242db328a|6|10|6|TREATMENT|2021-11-06|2022-03-27|28|169
Study ID|SE|24cab1dd-d866-4de2-ab08-4d9242db328a|7|FU|6|FOLLOW-UP|2022-07-30|2022-08-04|294|299
Study ID|SE|bbbc30c5-fb5f-4424-90ce-32f90a80ea4a|1|SCRN|7|SCREENING|2021-09-04|2021-09-22|25|43
Study ID|SE|bbbc30c5-fb5f-4424-90ce-32f90a80ea4a|2|5|6|TREATMENT|2022-01-19|2022-03-07|162|209
Study ID|SE|bbbc30c5-fb5f-4424-90ce-32f90a80ea4a|3|REST|5|WASHOUT|2021-09-18|2021-10-12|39|63
Study ID|SE|bbbc30c5-fb5f-4424-90ce-32f90a80ea4a|4|P|4|TREATMENT|2021-09-02|2022-04-03|23|236
Study ID|SE|bbbc30c5-fb5f-4424-90ce-32f90a80ea4a|5|REST|6|WASHOUT|2021-09-06|2021-11-08|27|90
Study ID|SE|bbbc30c5-fb5f-4424-90ce-32f90a80ea4a|6|10|4|TREATMENT|2021-08-13|2021-08-19|3|9
Study ID|SE|bbbc30c5-fb5f-4424-90ce-32f90a80ea4a|7|FU|2|FOLLOW-UP|2021-11-04|2021-11-22|86|104
Study ID|SE|1ca6d30a-3042-4e3b-85bf-d07738068c8d|1|SCRN|3|SCREENING|2021-12-11|2022-01-18|70|108
Study ID|SE|1ca6d30a-3042-4e3b-85bf-d07738068c8d|2|5|7|TREATMENT|2021-11-03|2021-11-27|32|56
Study ID|SE|1ca6d30a-3042-4e3b-85bf-d07738068c8d|3|REST|4|WASHOUT|2022-02-11|2022-04-21|132|201
Study ID|SE|1ca6d30a-3042-4e3b-85bf-d07738068c8d|4|P|1|TREATMENT|2021-10-04|2021-10-06|2|4
Study ID|SE|1ca6d30a-3042-4e3b-85bf-d07738068c8d|5|REST|1|WASHOUT|2021-12-07|2022-05-23|66|233
Study ID|SE|1ca6d30a-3042-4e3b-85bf-d07738068c8d|6|10|1|TREATMENT|2022-03-13|2022-03-17|162|166
Study ID|SE|1ca6d30a-3042-4e3b-85bf-d07738068c8d|7|FU|1|FOLLOW-UP|2021-12-31|2022-01-07|90|97
Study ID|SE|0ab2aea5-1905-4e6d-abfd-c1cfd6c3c6e0|1|SCRN|3|SCREENING|2022-05-03|2022-06-14|187|229
Study ID|SE|0ab2aea5-1905-4e6d-abfd-c1cfd6c3c6e0|2|5|4|TREATMENT|2022-01-24|2022-05-30|88|214
Study ID|SE|0ab2aea5-1905-4e6d-abfd-c1cfd6c3c6e0|3|REST|7|WASHOUT|2021-12-14|2022-02-15|47|110
Study ID|SE|0ab2aea5-1905-4e6d-abfd-c1cfd6c3c6e0|4|10|6|TREATMENT|2021-12-22|2022-06-03|55|218
Study ID|SE|0ab2aea5-1905-4e6d-abfd-c1cfd6c3c6e0|5|REST|7|WASHOUT|2021-11-14|2021-11-29|17|32
Study ID|SE|0ab2aea5-1905-4e6d-abfd-c1cfd6c3c6e0|6|P|4|TREATMENT|2021-12-04|2022-01-14|37|78
Study ID|SE|0ab2aea5-1905-4e6d-abfd-c1cfd6c3c6e0|7|FU|4|FOLLOW-UP|2022-02-13|2022-06-24|108|239
Study ID|SE|d5e867a2-5911-4645-bbd0-df9f0d79d8bc|1|SCRN|4|SCREENING|2021-09-28|2021-10-14|8|24
Study ID|SE|d5e867a2-5911-4645-bbd0-df9f0d79d8bc|2|5|3|TREATMENT|2021-10-14|2022-03-12|24|173
Study ID|SE|d5e867a2-5911-4645-bbd0-df9f0d79d8bc|3|REST|2|WASHOUT|2021-09-30|2021-11-15|10|56
Study ID|SE|d5e867a2-5911-4645-bbd0-df9f0d79d8bc|4|P|3|TREATMENT|2021-10-20|2021-10-25|30|35
Study ID|SE|d5e867a2-5911-4645-bbd0-df9f0d79d8bc|5|REST|4|WASHOUT|2021-10-07|2022-01-12|17|114
Study ID|SE|d5e867a2-5911-4645-bbd0-df9f0d79d8bc|6|10|6|TREATMENT|2021-11-26|2021-12-25|67|96
Study ID|SE|d5e867a2-5911-4645-bbd0-df9f0d79d8bc|7|FU|1|FOLLOW-UP|2021-12-27|2022-02-01|98|134
Study ID|SE|7f7be32a-b13e-4866-a1c2-00da92af3f92|1|SCRN|6|SCREENING|2021-10-19|2021-10-22|2|5
Study ID|SE|7f7be32a-b13e-4866-a1c2-00da92af3f92|2|5|5|TREATMENT|2021-11-04|2021-11-27|18|41
Study ID|SE|7f7be32a-b13e-4866-a1c2-00da92af3f92|3|REST|4|WASHOUT|2022-01-12|2022-05-19|87|214
Study ID|SE|7f7be32a-b13e-4866-a1c2-00da92af3f92|4|P|4|TREATMENT|2021-10-28|2021-12-15|11|59
Study ID|SE|7f7be32a-b13e-4866-a1c2-00da92af3f92|5|REST|4|WASHOUT|2021-10-28|2021-12-04|11|48
Study ID|SE|7f7be32a-b13e-4866-a1c2-00da92af3f92|6|10|1|TREATMENT|2022-03-28|2022-05-10|162|205
Study ID|SE|7f7be32a-b13e-4866-a1c2-00da92af3f92|7|FU|7|FOLLOW-UP|2021-11-01|2022-01-30|15|105
Study ID|SE|8824d842-e09b-4dc2-96bd-080b228c8a6c|1|SCRN|7|SCREENING|2021-12-03|2022-04-28|91|237
Study ID|SE|8824d842-e09b-4dc2-96bd-080b228c8a6c|2|P|2|TREATMENT|2021-09-28|2021-11-09|25|67
Study ID|SE|8824d842-e09b-4dc2-96bd-080b228c8a6c|3|REST|3|WASHOUT|2021-10-14|2021-10-18|41|45
Study ID|SE|8824d842-e09b-4dc2-96bd-080b228c8a6c|4|5|6|TREATMENT|2021-10-06|2021-10-12|33|39
Study ID|SE|8824d842-e09b-4dc2-96bd-080b228c8a6c|5|REST|6|WASHOUT|2022-01-18|2022-04-17|137|226
Study ID|SE|8824d842-e09b-4dc2-96bd-080b228c8a6c|6|10|7|TREATMENT|2022-01-03|2022-02-06|122|156
Study ID|SE|8824d842-e09b-4dc2-96bd-080b228c8a6c|7|FU|4|FOLLOW-UP|2021-10-15|2022-04-29|42|238
Study ID|SE|6f6d16b9-f088-4b48-a9d7-5620b38212f4|1|SCRN|2|SCREENING|2021-10-25|2021-10-31|13|19
Study ID|SE|6f6d16b9-f088-4b48-a9d7-5620b38212f4|2|P|4|TREATMENT|2022-02-17|2022-06-10|128|241
Study ID|SE|6f6d16b9-f088-4b48-a9d7-5620b38212f4|3|REST|3|WASHOUT|2021-11-06|2021-11-10|25|29
Study ID|SE|6f6d16b9-f088-4b48-a9d7-5620b38212f4|4|5|3|TREATMENT|2022-01-07|2022-01-29|87|109
Study ID|SE|6f6d16b9-f088-4b48-a9d7-5620b38212f4|5|REST|6|WASHOUT|2021-10-28|2021-11-12|16|31
Study ID|SE|6f6d16b9-f088-4b48-a9d7-5620b38212f4|6|10|3|TREATMENT|2022-01-03|2022-07-29|83|290
Study ID|SE|6f6d16b9-f088-4b48-a9d7-5620b38212f4|7|FU|7|FOLLOW-UP|2022-03-26|2022-04-20|165|190
Study ID|SE|f5e4e708-55f2-4281-a8ed-b42ef27f6671|1|SCRN|7|SCREENING|2022-05-28|2022-06-26|224|253
Study ID|SE|f5e4e708-55f2-4281-a8ed-b42ef27f6671|2|5|7|TREATMENT|2022-05-26|2022-07-08|222|265
Study ID|SE|f5e4e708-55f2-4281-a8ed-b42ef27f6671|3|REST|3|WASHOUT|2021-10-25|2022-07-23|9|280
Study ID|SE|f5e4e708-55f2-4281-a8ed-b42ef27f6671|4|P|7|TREATMENT|2021-11-08|2022-05-11|23|207
Study ID|SE|f5e4e708-55f2-4281-a8ed-b42ef27f6671|5|REST|7|WASHOUT|2021-12-02|2021-12-22|47|67
Study ID|SE|f5e4e708-55f2-4281-a8ed-b42ef27f6671|6|10|1|TREATMENT|2021-10-24|2021-11-09|8|24
Study ID|SE|f5e4e708-55f2-4281-a8ed-b42ef27f6671|7|FU|1|FOLLOW-UP|2022-03-31|2022-07-13|166|270
Study ID|SE|2bc210d1-2103-45a9-912d-c3b940211dec|1|SCRN|3|SCREENING|2021-10-07|2021-10-11|8|12
Study ID|SE|2bc210d1-2103-45a9-912d-c3b940211dec|2|P|3|TREATMENT|2021-10-31|2021-11-01|32|33
Study ID|SE|2bc210d1-2103-45a9-912d-c3b940211dec|3|REST|4|WASHOUT|2021-10-25|2021-12-09|26|71
Study ID|SE|2bc210d1-2103-45a9-912d-c3b940211dec|4|5|3|TREATMENT|2021-10-11|2021-10-16|12|17
Study ID|SE|2bc210d1-2103-45a9-912d-c3b940211dec|5|REST|5|WASHOUT|2022-02-04|2022-06-01|128|245
Study ID|SE|2bc210d1-2103-45a9-912d-c3b940211dec|6|10|3|TREATMENT|2022-05-25|2022-07-25|238|299
Study ID|SE|2bc210d1-2103-45a9-912d-c3b940211dec|7|FU|7|FOLLOW-UP|2021-11-02|2021-12-03|34|65
Study ID|SE|0f8419dd-1497-4496-8cd5-77cc5af2a2bb|1|SCRN|1|SCREENING|2021-09-11|2021-11-14|8|72
Study ID|SE|0f8419dd-1497-4496-8cd5-77cc5af2a2bb|2|P|6|TREATMENT|2021-11-01|2021-12-14|59|102
Study ID|SE|0f8419dd-1497-4496-8cd5-77cc5af2a2bb|3|REST|5|WASHOUT|2022-03-27|2022-03-30|205|208
Study ID|SE|0f8419dd-1497-4496-8cd5-77cc5af2a2bb|4|5|1|TREATMENT|2022-01-24|2022-06-01|143|271
Study ID|SE|0f8419dd-1497-4496-8cd5-77cc5af2a2bb|5|REST|4|WASHOUT|2021-11-01|2022-02-20|59|170
Study ID|SE|0f8419dd-1497-4496-8cd5-77cc5af2a2bb|6|10|7|TREATMENT|2021-10-04|2021-12-16|31|104
Study ID|SE|0f8419dd-1497-4496-8cd5-77cc5af2a2bb|7|FU|5|FOLLOW-UP|2021-09-22|2022-01-16|19|135
Study ID|SE|94ba310d-113e-45d2-a7f2-3bb52a0f83e6|1|SCRN|7|SCREENING|2022-04-08|2022-04-23|220|235
Study ID|SE|94ba310d-113e-45d2-a7f2-3bb52a0f83e6|2|5|7|TREATMENT|2021-11-09|2022-05-21|70|263
Study ID|SE|94ba310d-113e-45d2-a7f2-3bb52a0f83e6|3|REST|2|WASHOUT|2022-01-03|2022-01-29|125|151
Study ID|SE|94ba310d-113e-45d2-a7f2-3bb52a0f83e6|4|10|6|TREATMENT|2021-11-04|2022-01-14|65|136
Study ID|SE|94ba310d-113e-45d2-a7f2-3bb52a0f83e6|5|REST|4|WASHOUT|2021-10-29|2021-12-02|59|93
Study ID|SE|94ba310d-113e-45d2-a7f2-3bb52a0f83e6|6|P|5|TREATMENT|2021-12-06|2022-03-28|97|209
Study ID|SE|94ba310d-113e-45d2-a7f2-3bb52a0f83e6|7|FU|7|FOLLOW-UP|2021-10-11|2021-12-16|41|107
Study ID|SE|cacf3cf3-3c48-423c-9b15-1563573b9e00|1|SCRN|1|SCREENING|2022-04-08|2022-05-19|167|208
Study ID|SE|cacf3cf3-3c48-423c-9b15-1563573b9e00|2|P|3|TREATMENT|2022-03-22|2022-04-06|150|165
Study ID|SE|cacf3cf3-3c48-423c-9b15-1563573b9e00|3|REST|2|WASHOUT|2021-12-13|2022-07-22|51|272
Study ID|SE|cacf3cf3-3c48-423c-9b15-1563573b9e00|4|5|3|TREATMENT|2021-11-09|2022-04-07|17|166
Study ID|SE|cacf3cf3-3c48-423c-9b15-1563573b9e00|5|REST|6|WASHOUT|2021-11-03|2021-12-10|11|48
Study ID|SE|cacf3cf3-3c48-423c-9b15-1563573b9e00|6|10|2|TREATMENT|2021-12-02|2021-12-09|40|47
Study ID|SE|cacf3cf3-3c48-423c-9b15-1563573b9e00|7|FU|1|FOLLOW-UP|2021-10-27|2021-11-02|4|10
Study ID|SE|98603ea2-3f67-4f4b-87f5-5b5705b3538d|1|SCRN|5|SCREENING|2021-11-20|2022-07-08|50|280
Study ID|SE|98603ea2-3f67-4f4b-87f5-5b5705b3538d|2|5|3|TREATMENT|2021-10-20|2022-03-23|19|173
Study ID|SE|98603ea2-3f67-4f4b-87f5-5b5705b3538d|3|REST|3|WASHOUT|2022-02-06|2022-03-03|128|153
Study ID|SE|98603ea2-3f67-4f4b-87f5-5b5705b3538d|4|P|4|TREATMENT|2022-02-07|2022-07-12|129|284
Study ID|SE|98603ea2-3f67-4f4b-87f5-5b5705b3538d|5|REST|1|WASHOUT|2021-10-13|2021-10-17|12|16
Study ID|SE|98603ea2-3f67-4f4b-87f5-5b5705b3538d|6|10|2|TREATMENT|2021-10-08|2021-11-06|7|36
Study ID|SE|98603ea2-3f67-4f4b-87f5-5b5705b3538d|7|FU|7|FOLLOW-UP|2021-12-27|2022-02-12|87|134
Study ID|SE|bd3d322d-1da9-41ad-865e-f25599f98687|1|SCRN|4|SCREENING|2022-04-27|2022-04-30|219|222
Study ID|SE|bd3d322d-1da9-41ad-865e-f25599f98687|2|5|2|TREATMENT|2021-09-23|2021-11-10|3|51
Study ID|SE|bd3d322d-1da9-41ad-865e-f25599f98687|3|REST|5|WASHOUT|2022-03-20|2022-04-01|181|193
Study ID|SE|bd3d322d-1da9-41ad-865e-f25599f98687|4|10|3|TREATMENT|2021-11-07|2021-11-19|48|60
Study ID|SE|bd3d322d-1da9-41ad-865e-f25599f98687|5|REST|4|WASHOUT|2021-11-01|2022-05-05|42|227
Study ID|SE|bd3d322d-1da9-41ad-865e-f25599f98687|6|P|6|TREATMENT|2022-02-18|2022-02-27|151|160
Study ID|SE|bd3d322d-1da9-41ad-865e-f25599f98687|7|FU|3|FOLLOW-UP|2021-10-22|2021-12-03|32|74
Study ID|SE|eafb6349-037c-413d-a4d1-13d105700f04|1|SCRN|6|SCREENING|2021-12-17|2022-01-13|108|135
Study ID|SE|eafb6349-037c-413d-a4d1-13d105700f04|2|P|2|TREATMENT|2022-01-01|2022-01-06|123|128
Study ID|SE|eafb6349-037c-413d-a4d1-13d105700f04|3|REST|2|WASHOUT|2021-09-20|2021-09-25|20|25
Study ID|SE|eafb6349-037c-413d-a4d1-13d105700f04|4|5|5|TREATMENT|2021-10-20|2022-04-15|50|227
Study ID|SE|eafb6349-037c-413d-a4d1-13d105700f04|5|REST|1|WASHOUT|2022-05-18|2022-06-16|260|289
Study ID|SE|eafb6349-037c-413d-a4d1-13d105700f04|6|10|7|TREATMENT|2021-09-02|2021-09-03|2|3
Study ID|SE|eafb6349-037c-413d-a4d1-13d105700f04|7|FU|1|FOLLOW-UP|2022-01-02|2022-05-10|124|252
Study ID|SE|040ec88f-f136-4e8c-ab55-70d2f1d87728|1|SCRN|5|SCREENING|2022-05-03|2022-06-05|239|272
Study ID|SE|040ec88f-f136-4e8c-ab55-70d2f1d87728|2|5|5|TREATMENT|2021-09-22|2021-10-03|16|27
Study ID|SE|040ec88f-f136-4e8c-ab55-70d2f1d87728|3|REST|5|WASHOUT|2022-01-16|2022-03-06|132|181
Study ID|SE|040ec88f-f136-4e8c-ab55-70d2f1d87728|4|10|3|TREATMENT|2021-10-28|2021-11-09|52|64
Study ID|SE|040ec88f-f136-4e8c-ab55-70d2f1d87728|5|REST|7|WASHOUT|2021-10-19|2022-04-22|43|228
Study ID|SE|040ec88f-f136-4e8c-ab55-70d2f1d87728|6|P|3|TREATMENT|2022-02-23|2022-06-26|170|293
Study ID|SE|040ec88f-f136-4e8c-ab55-70d2f1d87728|7|FU|4|FOLLOW-UP|2021-10-22|2021-12-15|46|100
Study ID|SE|3d2eaf49-98cb-450e-a0f4-8e188a3e9743|1|SCRN|4|SCREENING|2021-11-21|2022-04-09|61|200
Study ID|SE|3d2eaf49-98cb-450e-a0f4-8e188a3e9743|2|5|3|TREATMENT|2021-09-24|2021-09-29|3|8
Study ID|SE|3d2eaf49-98cb-450e-a0f4-8e188a3e9743|3|REST|6|WASHOUT|2021-10-18|2021-12-05|27|75
Study ID|SE|3d2eaf49-98cb-450e-a0f4-8e188a3e9743|4|10|3|TREATMENT|2022-01-22|2022-06-19|123|271
Study ID|SE|3d2eaf49-98cb-450e-a0f4-8e188a3e9743|5|REST|3|WASHOUT|2022-01-12|2022-04-23|113|214
Study ID|SE|3d2eaf49-98cb-450e-a0f4-8e188a3e9743|6|P|6|TREATMENT|2021-12-06|2022-01-05|76|106
Study ID|SE|3d2eaf49-98cb-450e-a0f4-8e188a3e9743|7|FU|1|FOLLOW-UP|2022-02-04|2022-04-16|136|207
Study ID|SE|9222e497-21a6-488c-b8a0-11f0fb12eaf3|1|SCRN|2|SCREENING|2021-11-05|2022-03-25|13|153
Study ID|SE|9222e497-21a6-488c-b8a0-11f0fb12eaf3|2|P|1|TREATMENT|2021-12-25|2022-02-09|63|109
Study ID|SE|9222e497-21a6-488c-b8a0-11f0fb12eaf3|3|REST|2|WASHOUT|2021-11-05|2022-01-21|13|90
Study ID|SE|9222e497-21a6-488c-b8a0-11f0fb12eaf3|4|5|5|TREATMENT|2022-03-01|2022-05-06|129|195
Study ID|SE|9222e497-21a6-488c-b8a0-11f0fb12eaf3|5|REST|7|WASHOUT|2021-10-27|2021-11-14|4|22
Study ID|SE|9222e497-21a6-488c-b8a0-11f0fb12eaf3|6|10|2|TREATMENT|2021-12-02|2022-03-14|40|142
Study ID|SE|9222e497-21a6-488c-b8a0-11f0fb12eaf3|7|FU|2|FOLLOW-UP|2021-11-25|2022-04-01|33|160
Study ID|SE|573ab644-6f30-4f50-a499-22968a99d3db|1|SCRN|3|SCREENING|2021-11-25|2022-02-07|93|167
Study ID|SE|573ab644-6f30-4f50-a499-22968a99d3db|2|5|3|TREATMENT|2021-09-01|2021-09-03|8|10
Study ID|SE|573ab644-6f30-4f50-a499-22968a99d3db|3|REST|3|WASHOUT|2021-08-26|2021-11-01|2|69
Study ID|SE|573ab644-6f30-4f50-a499-22968a99d3db|4|P|6|TREATMENT|2022-02-10|2022-05-13|170|262
Study ID|SE|573ab644-6f30-4f50-a499-22968a99d3db|5|REST|4|WASHOUT|2021-10-12|2021-10-28|49|65
Study ID|SE|573ab644-6f30-4f50-a499-22968a99d3db|6|10|1|TREATMENT|2021-09-04|2021-11-03|11|71
Study ID|SE|573ab644-6f30-4f50-a499-22968a99d3db|7|FU|5|FOLLOW-UP|2021-10-05|2022-04-16|42|235
Study ID|SE|9f896e27-284d-437c-9e61-a7b9b1e1dcc9|1|SCRN|3|SCREENING|2021-11-14|2022-01-14|29|90
Study ID|SE|9f896e27-284d-437c-9e61-a7b9b1e1dcc9|2|5|4|TREATMENT|2022-01-04|2022-05-23|80|219
Study ID|SE|9f896e27-284d-437c-9e61-a7b9b1e1dcc9|3|REST|4|WASHOUT|2022-03-10|2022-03-27|145|162
Study ID|SE|9f896e27-284d-437c-9e61-a7b9b1e1dcc9|4|10|1|TREATMENT|2022-01-18|2022-01-21|94|97
Study ID|SE|9f896e27-284d-437c-9e61-a7b9b1e1dcc9|5|REST|2|WASHOUT|2021-10-31|2021-11-12|15|27
Study ID|SE|9f896e27-284d-437c-9e61-a7b9b1e1dcc9|6|P|1|TREATMENT|2021-11-05|2022-07-24|20|281
Study ID|SE|9f896e27-284d-437c-9e61-a7b9b1e1dcc9|7|FU|3|FOLLOW-UP|2022-07-04|2022-07-17|261|274
Study ID|SE|ac59aed4-fda2-4cf1-bb80-8075cb35b853|1|SCRN|4|SCREENING|2021-09-23|2021-11-18|21|77
Study ID|SE|ac59aed4-fda2-4cf1-bb80-8075cb35b853|2|P|3|TREATMENT|2021-11-22|2021-12-23|81|112
Study ID|SE|ac59aed4-fda2-4cf1-bb80-8075cb35b853|3|REST|7|WASHOUT|2022-01-14|2022-02-15|134|166
Study ID|SE|ac59aed4-fda2-4cf1-bb80-8075cb35b853|4|5|4|TREATMENT|2021-12-18|2022-03-25|107|204
Study ID|SE|ac59aed4-fda2-4cf1-bb80-8075cb35b853|5|REST|2|WASHOUT|2021-09-26|2022-01-23|24|143
Study ID|SE|ac59aed4-fda2-4cf1-bb80-8075cb35b853|6|10|7|TREATMENT|2022-01-07|2022-02-10|127|161
Study ID|SE|ac59aed4-fda2-4cf1-bb80-8075cb35b853|7|FU|4|FOLLOW-UP|2021-09-07|2022-01-01|5|121
Study ID|SE|09a644bd-a8cd-45a1-bde7-2711c8f7be76|1|SCRN|2|SCREENING|2021-11-25|2022-05-22|91|269
Study ID|SE|09a644bd-a8cd-45a1-bde7-2711c8f7be76|2|5|6|TREATMENT|2021-11-02|2021-11-10|68|76
Study ID|SE|09a644bd-a8cd-45a1-bde7-2711c8f7be76|3|REST|2|WASHOUT|2021-09-29|2022-02-11|34|169
Study ID|SE|09a644bd-a8cd-45a1-bde7-2711c8f7be76|4|10|5|TREATMENT|2021-08-30|2021-09-14|4|19
Study ID|SE|09a644bd-a8cd-45a1-bde7-2711c8f7be76|5|REST|1|WASHOUT|2021-09-14|2021-10-23|19|58
Study ID|SE|09a644bd-a8cd-45a1-bde7-2711c8f7be76|6|P|3|TREATMENT|2021-12-15|2022-01-03|111|130
Study ID|SE|09a644bd-a8cd-45a1-bde7-2711c8f7be76|7|FU|7|FOLLOW-UP|2021-11-08|2022-02-02|74|160
Study ID|SE|fb28d99b-b4af-4d3e-9b66-25f3a7ba0b60|1|SCRN|6|SCREENING|2021-12-21|2022-01-03|66|79
Study ID|SE|fb28d99b-b4af-4d3e-9b66-25f3a7ba0b60|2|P|6|TREATMENT|2022-02-02|2022-04-15|109|181
Study ID|SE|fb28d99b-b4af-4d3e-9b66-25f3a7ba0b60|3|REST|7|WASHOUT|2021-11-16|2021-12-01|31|46
Study ID|SE|fb28d99b-b4af-4d3e-9b66-25f3a7ba0b60|4|5|7|TREATMENT|2021-10-30|2021-10-31|14|15
Study ID|SE|fb28d99b-b4af-4d3e-9b66-25f3a7ba0b60|5|REST|3|WASHOUT|2021-11-03|2022-01-25|18|101
Study ID|SE|fb28d99b-b4af-4d3e-9b66-25f3a7ba0b60|6|10|3|TREATMENT|2022-03-22|2022-03-31|157|166
Study ID|SE|fb28d99b-b4af-4d3e-9b66-25f3a7ba0b60|7|FU|6|FOLLOW-UP|2021-11-15|2022-08-03|30|291
Study ID|SE|953c03ac-2ac5-4419-80d4-8dfaa9d764ed|1|SCRN|1|SCREENING|2021-11-15|2021-11-16|72|73
Study ID|SE|953c03ac-2ac5-4419-80d4-8dfaa9d764ed|2|5|4|TREATMENT|2022-05-10|2022-06-06|248|275
Study ID|SE|953c03ac-2ac5-4419-80d4-8dfaa9d764ed|3|REST|3|WASHOUT|2021-10-05|2021-11-30|31|87
Study ID|SE|953c03ac-2ac5-4419-80d4-8dfaa9d764ed|4|P|6|TREATMENT|2021-10-09|2021-12-15|35|102
Study ID|SE|953c03ac-2ac5-4419-80d4-8dfaa9d764ed|5|REST|6|WASHOUT|2021-12-11|2022-02-11|98|160
Study ID|SE|953c03ac-2ac5-4419-80d4-8dfaa9d764ed|6|10|7|TREATMENT|2021-11-05|2022-04-11|62|219
Study ID|SE|953c03ac-2ac5-4419-80d4-8dfaa9d764ed|7|FU|1|FOLLOW-UP|2022-04-14|2022-05-09|222|247
Study ID|SE|35dc4735-9b9c-4dc3-bbd6-c500edecd2e2|1|SCRN|6|SCREENING|2022-04-11|2022-04-23|209|221
Study ID|SE|35dc4735-9b9c-4dc3-bbd6-c500edecd2e2|2|5|6|TREATMENT|2021-11-27|2022-07-07|74|296
Study ID|SE|35dc4735-9b9c-4dc3-bbd6-c500edecd2e2|3|REST|5|WASHOUT|2021-10-14|2021-11-01|30|48
Study ID|SE|35dc4735-9b9c-4dc3-bbd6-c500edecd2e2|4|10|1|TREATMENT|2021-09-29|2021-10-11|15|27
Study ID|SE|35dc4735-9b9c-4dc3-bbd6-c500edecd2e2|5|REST|4|WASHOUT|2022-02-07|2022-04-27|146|225
Study ID|SE|35dc4735-9b9c-4dc3-bbd6-c500edecd2e2|6|P|1|TREATMENT|2022-03-30|2022-05-07|197|235
Study ID|SE|35dc4735-9b9c-4dc3-bbd6-c500edecd2e2|7|FU|4|FOLLOW-UP|2022-01-02|2022-01-20|110|128
Study ID|SE|68a9c486-1ea0-4faf-b116-0d99639f5ac0|1|SCRN|5|SCREENING|2021-10-31|2022-02-13|14|119
Study ID|SE|68a9c486-1ea0-4faf-b116-0d99639f5ac0|2|5|3|TREATMENT|2021-10-26|2021-11-07|9|21
Study ID|SE|68a9c486-1ea0-4faf-b116-0d99639f5ac0|3|REST|3|WASHOUT|2021-12-04|2022-02-09|48|115
Study ID|SE|68a9c486-1ea0-4faf-b116-0d99639f5ac0|4|P|7|TREATMENT|2022-06-05|2022-07-29|231|285
Study ID|SE|68a9c486-1ea0-4faf-b116-0d99639f5ac0|5|REST|3|WASHOUT|2022-01-18|2022-04-04|93|169
Study ID|SE|68a9c486-1ea0-4faf-b116-0d99639f5ac0|6|10|7|TREATMENT|2021-10-19|2021-10-21|2|4
Study ID|SE|68a9c486-1ea0-4faf-b116-0d99639f5ac0|7|FU|5|FOLLOW-UP|2022-01-01|2022-02-25|76|131
Study ID|SE|0fef3c1c-47d7-420c-9130-7e4daf02e4a5|1|SCRN|5|SCREENING|2022-03-20|2022-05-16|163|220
Study ID|SE|0fef3c1c-47d7-420c-9130-7e4daf02e4a5|2|5|7|TREATMENT|2021-10-18|2021-12-05|10|58
Study ID|SE|0fef3c1c-47d7-420c-9130-7e4daf02e4a5|3|REST|3|WASHOUT|2022-05-01|2022-05-08|205|212
Study ID|SE|0fef3c1c-47d7-420c-9130-7e4daf02e4a5|4|10|7|TREATMENT|2021-10-27|2022-03-07|19|150
Study ID|SE|0fef3c1c-47d7-420c-9130-7e4daf02e4a5|5|REST|1|WASHOUT|2021-12-14|2022-05-23|67|227
Study ID|SE|0fef3c1c-47d7-420c-9130-7e4daf02e4a5|6|P|2|TREATMENT|2022-01-02|2022-03-05|86|148
Study ID|SE|0fef3c1c-47d7-420c-9130-7e4daf02e4a5|7|FU|7|FOLLOW-UP|2022-05-06|2022-06-06|210|241
Study ID|SE|cb2a7cd4-3814-458f-8d9f-1d9d501a5493|1|SCRN|7|SCREENING|2022-02-11|2022-05-01|157|236
Study ID|SE|cb2a7cd4-3814-458f-8d9f-1d9d501a5493|2|P|4|TREATMENT|2021-09-10|2021-12-15|3|99
Study ID|SE|cb2a7cd4-3814-458f-8d9f-1d9d501a5493|3|REST|2|WASHOUT|2021-09-28|2021-11-14|21|68
Study ID|SE|cb2a7cd4-3814-458f-8d9f-1d9d501a5493|4|5|6|TREATMENT|2021-11-02|2021-11-14|56|68
Study ID|SE|cb2a7cd4-3814-458f-8d9f-1d9d501a5493|5|REST|7|WASHOUT|2021-09-28|2021-10-04|21|27
Study ID|SE|cb2a7cd4-3814-458f-8d9f-1d9d501a5493|6|10|3|TREATMENT|2021-09-09|2021-10-08|2|31
Study ID|SE|cb2a7cd4-3814-458f-8d9f-1d9d501a5493|7|FU|7|FOLLOW-UP|2022-06-09|2022-06-26|275|292
Study ID|SE|fe5681d0-ae8f-4138-a471-b3987b3ecef2|1|SCRN|1|SCREENING|2021-12-15|2022-05-08|57|201
Study ID|SE|fe5681d0-ae8f-4138-a471-b3987b3ecef2|2|5|1|TREATMENT|2021-10-22|2022-07-18|3|272
Study ID|SE|fe5681d0-ae8f-4138-a471-b3987b3ecef2|3|REST|4|WASHOUT|2022-05-17|2022-06-06|210|230
Study ID|SE|fe5681d0-ae8f-4138-a471-b3987b3ecef2|4|P|4|TREATMENT|2021-11-23|2022-01-21|35|94
Study ID|SE|fe5681d0-ae8f-4138-a471-b3987b3ecef2|5|REST|7|WASHOUT|2021-11-30|2022-07-04|42|258
Study ID|SE|fe5681d0-ae8f-4138-a471-b3987b3ecef2|6|10|3|TREATMENT|2022-01-13|2022-01-14|86|87
Study ID|SE|fe5681d0-ae8f-4138-a471-b3987b3ecef2|7|FU|7|FOLLOW-UP|2022-03-18|2022-05-19|150|212
Study ID|SE|78099927-98e6-481e-975c-6db28590527d|1|SCRN|1|SCREENING|2021-09-30|2021-11-22|51|104
Study ID|SE|78099927-98e6-481e-975c-6db28590527d|2|5|2|TREATMENT|2021-08-31|2021-10-19|21|70
Study ID|SE|78099927-98e6-481e-975c-6db28590527d|3|REST|7|WASHOUT|2021-12-27|2022-05-23|139|286
Study ID|SE|78099927-98e6-481e-975c-6db28590527d|4|P|4|TREATMENT|2021-11-05|2021-11-08|87|90
Study ID|SE|78099927-98e6-481e-975c-6db28590527d|5|REST|2|WASHOUT|2021-08-13|2021-09-03|3|24
Study ID|SE|78099927-98e6-481e-975c-6db28590527d|6|10|7|TREATMENT|2021-08-17|2021-11-03|7|85
Study ID|SE|78099927-98e6-481e-975c-6db28590527d|7|FU|5|FOLLOW-UP|2021-08-27|2021-09-03|17|24
Study ID|SE|63867bf1-8945-43c8-9889-45315844a1ba|1|SCRN|5|SCREENING|2022-02-03|2022-05-31|156|273
Study ID|SE|63867bf1-8945-43c8-9889-45315844a1ba|2|P|6|TREATMENT|2021-09-04|2021-09-09|4|9
Study ID|SE|63867bf1-8945-43c8-9889-45315844a1ba|3|REST|3|WASHOUT|2021-09-25|2021-09-27|25|27
Study ID|SE|63867bf1-8945-43c8-9889-45315844a1ba|4|5|5|TREATMENT|2021-10-08|2021-10-16|38|46
Study ID|SE|63867bf1-8945-43c8-9889-45315844a1ba|5|REST|2|WASHOUT|2021-11-07|2021-12-09|68|100
Study ID|SE|63867bf1-8945-43c8-9889-45315844a1ba|6|10|2|TREATMENT|2022-03-13|2022-04-17|194|229
Study ID|SE|63867bf1-8945-43c8-9889-45315844a1ba|7|FU|2|FOLLOW-UP|2021-10-05|2021-12-01|35|92
Study ID|SE|746358fc-dc62-47e8-840d-c41f56096bf1|1|SCRN|5|SCREENING|2022-01-24|2022-05-28|127|251
Study ID|SE|746358fc-dc62-47e8-840d-c41f56096bf1|2|5|3|TREATMENT|2021-11-13|2022-01-04|55|107
Study ID|SE|746358fc-dc62-47e8-840d-c41f56096bf1|3|REST|7|WASHOUT|2022-01-28|2022-04-18|131|211
Study ID|SE|746358fc-dc62-47e8-840d-c41f56096bf1|4|10|2|TREATMENT|2021-11-15|2021-11-17|57|59
Study ID|SE|746358fc-dc62-47e8-840d-c41f56096bf1|5|REST|5|WASHOUT|2021-10-27|2021-11-01|38|43
Study ID|SE|746358fc-dc62-47e8-840d-c41f56096bf1|6|P|6|TREATMENT|2021-10-01|2021-10-03|12|14
Study ID|SE|746358fc-dc62-47e8-840d-c41f56096bf1|7|FU|3|FOLLOW-UP|2021-10-22|2022-03-08|33|170
Study ID|SE|bba7936a-2e13-460c-b5d6-4e05d61ff34e|1|SCRN|5|SCREENING|2021-08-19|2021-11-28|7|108
Study ID|SE|bba7936a-2e13-460c-b5d6-4e05d61ff34e|2|P|4|TREATMENT|2021-09-08|2022-03-27|27|227
Study ID|SE|bba7936a-2e13-460c-b5d6-4e05d61ff34e|3|REST|6|WASHOUT|2022-01-12|2022-05-19|153|280
Study ID|SE|bba7936a-2e13-460c-b5d6-4e05d61ff34e|4|5|4|TREATMENT|2021-09-18|2022-03-04|37|204
Study ID|SE|bba7936a-2e13-460c-b5d6-4e05d61ff34e|5|REST|6|WASHOUT|2021-12-31|2022-04-08|141|239
Study ID|SE|bba7936a-2e13-460c-b5d6-4e05d61ff34e|6|10|4|TREATMENT|2021-09-10|2021-10-04|29|53
Study ID|SE|bba7936a-2e13-460c-b5d6-4e05d61ff34e|7|FU|1|FOLLOW-UP|2021-08-29|2021-09-14|17|33
Study ID|SE|4913facb-a897-4a54-bf00-03e8de26dea9|1|SCRN|7|SCREENING|2021-12-25|2022-02-27|76|140
Study ID|SE|4913facb-a897-4a54-bf00-03e8de26dea9|2|5|6|TREATMENT|2021-12-31|2022-04-18|82|190
Study ID|SE|4913facb-a897-4a54-bf00-03e8de26dea9|3|REST|2|WASHOUT|2021-12-01|2022-01-06|52|88
Study ID|SE|4913facb-a897-4a54-bf00-03e8de26dea9|4|10|1|TREATMENT|2021-12-20|2022-05-12|71|214
Study ID|SE|4913facb-a897-4a54-bf00-03e8de26dea9|5|REST|7|WASHOUT|2021-11-04|2021-12-10|25|61
Study ID|SE|4913facb-a897-4a54-bf00-03e8de26dea9|6|P|2|TREATMENT|2021-10-19|2021-11-17|9|38
Study ID|SE|4913facb-a897-4a54-bf00-03e8de26dea9|7|FU|5|FOLLOW-UP|2021-12-13|2021-12-20|64|71
Study ID|SE|b9fc69bf-5074-43b3-bb5b-ef5a9274bb9f|1|SCRN|1|SCREENING|2021-10-31|2022-07-12|11|265
Study ID|SE|b9fc69bf-5074-43b3-bb5b-ef5a9274bb9f|2|P|2|TREATMENT|2022-02-01|2022-04-07|104|169
Study ID|SE|b9fc69bf-5074-43b3-bb5b-ef5a9274bb9f|3|REST|6|WASHOUT|2022-02-28|2022-08-06|131|290
Study ID|SE|b9fc69bf-5074-43b3-bb5b-ef5a9274bb9f|4|5|5|TREATMENT|2021-10-22|2021-10-23|2|3
Study ID|SE|b9fc69bf-5074-43b3-bb5b-ef5a9274bb9f|5|REST|4|WASHOUT|2022-05-21|2022-05-22|213|214
Study ID|SE|b9fc69bf-5074-43b3-bb5b-ef5a9274bb9f|6|10|1|TREATMENT|2022-05-05|2022-07-02|197|255
Study ID|SE|b9fc69bf-5074-43b3-bb5b-ef5a9274bb9f|7|FU|3|FOLLOW-UP|2022-06-10|2022-07-05|233|258
Study ID|SE|18d9c429-a7fa-484d-8ad1-aff9c485ccd5|1|SCRN|6|SCREENING|2022-06-07|2022-07-08|257|288
Study ID|SE|18d9c429-a7fa-484d-8ad1-aff9c485ccd5|2|P|3|TREATMENT|2021-11-21|2022-03-17|59|175
Study ID|SE|18d9c429-a7fa-484d-8ad1-aff9c485ccd5|3|REST|3|WASHOUT|2021-10-30|2021-11-17|37|55
Study ID|SE|18d9c429-a7fa-484d-8ad1-aff9c485ccd5|4|5|2|TREATMENT|2022-01-04|2022-01-09|103|108
Study ID|SE|18d9c429-a7fa-484d-8ad1-aff9c485ccd5|5|REST|6|WASHOUT|2022-02-26|2022-06-06|156|256
Study ID|SE|18d9c429-a7fa-484d-8ad1-aff9c485ccd5|6|10|1|TREATMENT|2021-10-18|2022-06-03|25|253
Study ID|SE|18d9c429-a7fa-484d-8ad1-aff9c485ccd5|7|FU|5|FOLLOW-UP|2021-12-03|2022-07-08|71|288
Study ID|SE|f96f2f97-2dde-4b49-92d6-e2318b5b8dd6|1|SCRN|7|SCREENING|2022-02-14|2022-03-27|192|233
Study ID|SE|f96f2f97-2dde-4b49-92d6-e2318b5b8dd6|2|5|1|TREATMENT|2021-09-30|2021-11-19|55|105
Study ID|SE|f96f2f97-2dde-4b49-92d6-e2318b5b8dd6|3|REST|6|WASHOUT|2021-08-13|2021-08-14|7|8
Study ID|SE|f96f2f97-2dde-4b49-92d6-e2318b5b8dd6|4|P|2|TREATMENT|2022-02-28|2022-03-30|206|236
Study ID|SE|f96f2f97-2dde-4b49-92d6-e2318b5b8dd6|5|REST|5|WASHOUT|2021-08-30|2022-01-11|24|158
Study ID|SE|f96f2f97-2dde-4b49-92d6-e2318b5b8dd6|6|10|1|TREATMENT|2021-10-29|2022-03-08|84|214
Study ID|SE|f96f2f97-2dde-4b49-92d6-e2318b5b8dd6|7|FU|5|FOLLOW-UP|2022-01-24|2022-02-09|171|187
Study ID|SE|9aa605b0-f301-4a30-a77f-b8ea80c5404e|1|SCRN|1|SCREENING|2022-05-03|2022-07-04|188|250
Study ID|SE|9aa605b0-f301-4a30-a77f-b8ea80c5404e|2|P|1|TREATMENT|2021-11-07|2022-01-04|11|69
Study ID|SE|9aa605b0-f301-4a30-a77f-b8ea80c5404e|3|REST|5|WASHOUT|2022-01-10|2022-01-14|75|79
Study ID|SE|9aa605b0-f301-4a30-a77f-b8ea80c5404e|4|5|1|TREATMENT|2021-11-27|2022-04-20|31|175
Study ID|SE|9aa605b0-f301-4a30-a77f-b8ea80c5404e|5|REST|2|WASHOUT|2022-02-27|2022-07-14|123|260
Study ID|SE|9aa605b0-f301-4a30-a77f-b8ea80c5404e|6|10|5|TREATMENT|2022-03-26|2022-06-11|150|227
Study ID|SE|9aa605b0-f301-4a30-a77f-b8ea80c5404e|7|FU|1|FOLLOW-UP|2021-11-02|2021-12-13|6|47
Study ID|SE|7d3a3c79-4678-477a-a2e4-006e877825e9|1|SCRN|2|SCREENING|2021-11-20|2021-12-07|36|53
Study ID|SE|7d3a3c79-4678-477a-a2e4-006e877825e9|2|P|3|TREATMENT|2022-07-04|2022-07-25|262|283
Study ID|SE|7d3a3c79-4678-477a-a2e4-006e877825e9|3|REST|5|WASHOUT|2022-03-20|2022-04-09|156|176
Study ID|SE|7d3a3c79-4678-477a-a2e4-006e877825e9|4|5|5|TREATMENT|2021-10-25|2021-11-09|10|25
Study ID|SE|7d3a3c79-4678-477a-a2e4-006e877825e9|5|REST|3|WASHOUT|2021-10-24|2021-11-02|9|18
Study ID|SE|7d3a3c79-4678-477a-a2e4-006e877825e9|6|10|4|TREATMENT|2022-01-10|2022-03-04|87|140
Study ID|SE|7d3a3c79-4678-477a-a2e4-006e877825e9|7|FU|3|FOLLOW-UP|2021-11-23|2022-04-06|39|173
Study ID|SE|c1890918-1c35-4e9c-91c4-3eda13542117|1|SCRN|5|SCREENING|2022-01-08|2022-02-27|109|159
Study ID|SE|c1890918-1c35-4e9c-91c4-3eda13542117|2|5|6|TREATMENT|2022-03-17|2022-06-08|177|260
Study ID|SE|c1890918-1c35-4e9c-91c4-3eda13542117|3|REST|5|WASHOUT|2021-09-23|2021-09-23|2|2
Study ID|SE|c1890918-1c35-4e9c-91c4-3eda13542117|4|10|7|TREATMENT|2021-11-23|2022-04-23|63|214
Study ID|SE|c1890918-1c35-4e9c-91c4-3eda13542117|5|REST|2|WASHOUT|2021-11-07|2021-12-09|47|79
Study ID|SE|c1890918-1c35-4e9c-91c4-3eda13542117|6|P|2|TREATMENT|2021-11-28|2022-02-06|68|138
Study ID|SE|c1890918-1c35-4e9c-91c4-3eda13542117|7|FU|5|FOLLOW-UP|2022-03-14|2022-05-07|174|228
Study ID|SE|0c945d4a-80ce-4068-861c-44af5f738490|1|SCRN|1|SCREENING|2021-09-25|2021-09-30|4|9
Study ID|SE|0c945d4a-80ce-4068-861c-44af5f738490|2|5|1|TREATMENT|2022-01-22|2022-07-10|123|292
Study ID|SE|0c945d4a-80ce-4068-861c-44af5f738490|3|REST|5|WASHOUT|2021-10-26|2021-10-30|35|39
Study ID|SE|0c945d4a-80ce-4068-861c-44af5f738490|4|P|6|TREATMENT|2021-10-06|2022-01-18|15|119
Study ID|SE|0c945d4a-80ce-4068-861c-44af5f738490|5|REST|5|WASHOUT|2022-06-05|2022-06-29|257|281
Study ID|SE|0c945d4a-80ce-4068-861c-44af5f738490|6|10|6|TREATMENT|2022-02-07|2022-05-10|139|231
Study ID|SE|0c945d4a-80ce-4068-861c-44af5f738490|7|FU|6|FOLLOW-UP|2021-09-30|2022-02-10|9|142
Study ID|SE|e79af959-1fd9-4849-9443-43591b71e62a|1|SCRN|6|SCREENING|2022-01-12|2022-04-07|88|173
Study ID|SE|e79af959-1fd9-4849-9443-43591b71e62a|2|5|3|TREATMENT|2022-03-21|2022-08-03|156|291
Study ID|SE|e79af959-1fd9-4849-9443-43591b71e62a|3|REST|7|WASHOUT|2022-03-21|2022-06-25|156|252
Study ID|SE|e79af959-1fd9-4849-9443-43591b71e62a|4|P|3|TREATMENT|2021-12-05|2022-05-25|50|221
Study ID|SE|e79af959-1fd9-4849-9443-43591b71e62a|5|REST|6|WASHOUT|2021-10-20|2021-10-22|4|6
Study ID|SE|e79af959-1fd9-4849-9443-43591b71e62a|6|10|3|TREATMENT|2021-11-15|2021-12-11|30|56
Study ID|SE|e79af959-1fd9-4849-9443-43591b71e62a|7|FU|2|FOLLOW-UP|2021-11-26|2022-02-04|41|111
Study ID|SE|4d43d548-e243-4110-952f-14ada154970c|1|SCRN|1|SCREENING|2022-01-06|2022-03-31|94|178
Study ID|SE|4d43d548-e243-4110-952f-14ada154970c|2|5|7|TREATMENT|2021-11-07|2021-12-20|34|77
Study ID|SE|4d43d548-e243-4110-952f-14ada154970c|3|REST|5|WASHOUT|2022-03-28|2022-05-08|175|216
Study ID|SE|4d43d548-e243-4110-952f-14ada154970c|4|10|2|TREATMENT|2021-10-30|2022-04-23|26|201
Study ID|SE|4d43d548-e243-4110-952f-14ada154970c|5|REST|1|WASHOUT|2021-10-28|2021-12-17|24|74
Study ID|SE|4d43d548-e243-4110-952f-14ada154970c|6|P|6|TREATMENT|2022-03-22|2022-05-25|169|233
Study ID|SE|4d43d548-e243-4110-952f-14ada154970c|7|FU|1|FOLLOW-UP|2021-12-20|2022-04-05|77|183
Study ID|SE|30320185-e97c-4242-ae4d-cb24611b7750|1|SCRN|1|SCREENING|2022-01-23|2022-03-06|154|196
Study ID|SE|30320185-e97c-4242-ae4d-cb24611b7750|2|5|5|TREATMENT|2022-04-14|2022-04-15|235|236
Study ID|SE|30320185-e97c-4242-ae4d-cb24611b7750|3|REST|6|WASHOUT|2021-12-30|2022-05-10|130|261
Study ID|SE|30320185-e97c-4242-ae4d-cb24611b7750|4|P|1|TREATMENT|2021-10-17|2021-10-31|56|70
Study ID|SE|30320185-e97c-4242-ae4d-cb24611b7750|5|REST|2|WASHOUT|2022-02-02|2022-02-08|164|170
Study ID|SE|30320185-e97c-4242-ae4d-cb24611b7750|6|10|7|TREATMENT|2021-08-30|2021-09-03|8|12
Study ID|SE|30320185-e97c-4242-ae4d-cb24611b7750|7|FU|3|FOLLOW-UP|2021-08-31|2021-09-27|9|36
Study ID|SE|5d0127ff-c151-45eb-b3b7-926bfe449838|1|SCRN|3|SCREENING|2022-02-20|2022-03-14|161|183
Study ID|SE|5d0127ff-c151-45eb-b3b7-926bfe449838|2|P|7|TREATMENT|2021-10-03|2021-12-02|21|81
Study ID|SE|5d0127ff-c151-45eb-b3b7-926bfe449838|3|REST|4|WASHOUT|2022-01-17|2022-06-20|127|281
Study ID|SE|5d0127ff-c151-45eb-b3b7-926bfe449838|4|5|1|TREATMENT|2021-09-19|2022-02-21|7|162
Study ID|SE|5d0127ff-c151-45eb-b3b7-926bfe449838|5|REST|2|WASHOUT|2022-04-30|2022-05-24|230|254
Study ID|SE|5d0127ff-c151-45eb-b3b7-926bfe449838|6|10|6|TREATMENT|2021-10-29|2021-10-30|47|48
Study ID|SE|5d0127ff-c151-45eb-b3b7-926bfe449838|7|FU|6|FOLLOW-UP|2021-11-10|2022-02-03|59|144
Study ID|SE|25c04c0b-c392-474c-a3d5-82711041ca1e|1|SCRN|2|SCREENING|2021-12-17|2021-12-22|51|56
Study ID|SE|25c04c0b-c392-474c-a3d5-82711041ca1e|2|5|1|TREATMENT|2021-11-12|2021-12-11|16|45
Study ID|SE|25c04c0b-c392-474c-a3d5-82711041ca1e|3|REST|5|WASHOUT|2021-11-11|2022-05-01|15|186
Study ID|SE|25c04c0b-c392-474c-a3d5-82711041ca1e|4|P|2|TREATMENT|2021-11-25|2022-04-01|29|156
Study ID|SE|25c04c0b-c392-474c-a3d5-82711041ca1e|5|REST|4|WASHOUT|2021-11-08|2022-06-17|12|233
Study ID|SE|25c04c0b-c392-474c-a3d5-82711041ca1e|6|10|4|TREATMENT|2021-12-25|2021-12-30|59|64
Study ID|SE|25c04c0b-c392-474c-a3d5-82711041ca1e|7|FU|5|FOLLOW-UP|2021-11-14|2021-11-27|18|31
Study ID|SE|bcceaae7-1012-4528-be14-489633f52157|1|SCRN|5|SCREENING|2022-05-12|2022-05-19|259|266
Study ID|SE|bcceaae7-1012-4528-be14-489633f52157|2|P|5|TREATMENT|2021-11-26|2022-03-02|92|188
Study ID|SE|bcceaae7-1012-4528-be14-489633f52157|3|REST|7|WASHOUT|2022-01-19|2022-04-20|146|237
Study ID|SE|bcceaae7-1012-4528-be14-489633f52157|4|5|7|TREATMENT|2021-09-07|2021-09-28|12|33
Study ID|SE|bcceaae7-1012-4528-be14-489633f52157|5|REST|4|WASHOUT|2021-11-03|2021-12-15|69|111
Study ID|SE|bcceaae7-1012-4528-be14-489633f52157|6|10|3|TREATMENT|2022-01-27|2022-02-11|154|169
Study ID|SE|bcceaae7-1012-4528-be14-489633f52157|7|FU|1|FOLLOW-UP|2021-10-13|2022-03-17|48|203
Study ID|SE|8c6ca613-79a4-447f-89e4-ea0774da639c|1|SCRN|5|SCREENING|2021-09-09|2022-01-24|10|147
Study ID|SE|8c6ca613-79a4-447f-89e4-ea0774da639c|2|5|1|TREATMENT|2022-02-06|2022-03-07|160|189
Study ID|SE|8c6ca613-79a4-447f-89e4-ea0774da639c|3|REST|7|WASHOUT|2021-12-25|2022-02-04|117|158
Study ID|SE|8c6ca613-79a4-447f-89e4-ea0774da639c|4|P|6|TREATMENT|2021-10-21|2021-11-12|52|74
Study ID|SE|8c6ca613-79a4-447f-89e4-ea0774da639c|5|REST|4|WASHOUT|2021-10-17|2022-01-24|48|147
Study ID|SE|8c6ca613-79a4-447f-89e4-ea0774da639c|6|10|3|TREATMENT|2021-11-22|2021-11-28|84|90
Study ID|SE|8c6ca613-79a4-447f-89e4-ea0774da639c|7|FU|3|FOLLOW-UP|2021-10-13|2021-10-27|44|58
Study ID|SE|cec457ac-fa41-4b67-9fd8-f0754d6c23a1|1|SCRN|5|SCREENING|2022-01-27|2022-02-25|154|183
Study ID|SE|cec457ac-fa41-4b67-9fd8-f0754d6c23a1|2|P|7|TREATMENT|2022-01-19|2022-02-22|146|180
Study ID|SE|cec457ac-fa41-4b67-9fd8-f0754d6c23a1|3|REST|1|WASHOUT|2021-09-11|2021-09-22|16|27
Study ID|SE|cec457ac-fa41-4b67-9fd8-f0754d6c23a1|4|5|2|TREATMENT|2022-01-14|2022-04-16|141|233
Study ID|SE|cec457ac-fa41-4b67-9fd8-f0754d6c23a1|5|REST|3|WASHOUT|2021-11-19|2022-01-29|85|156
Study ID|SE|cec457ac-fa41-4b67-9fd8-f0754d6c23a1|6|10|5|TREATMENT|2021-11-25|2021-12-14|91|110
Study ID|SE|cec457ac-fa41-4b67-9fd8-f0754d6c23a1|7|FU|2|FOLLOW-UP|2022-01-05|2022-01-10|132|137
Study ID|SE|b162843c-5086-4bd5-ae65-072fb1dc8140|1|SCRN|3|SCREENING|2021-10-08|2021-10-16|40|48
Study ID|SE|b162843c-5086-4bd5-ae65-072fb1dc8140|2|P|1|TREATMENT|2021-09-06|2021-10-26|8|58
Study ID|SE|b162843c-5086-4bd5-ae65-072fb1dc8140|3|REST|6|WASHOUT|2021-10-22|2021-12-06|54|99
Study ID|SE|b162843c-5086-4bd5-ae65-072fb1dc8140|4|5|5|TREATMENT|2022-01-22|2022-04-22|146|236
Study ID|SE|b162843c-5086-4bd5-ae65-072fb1dc8140|5|REST|5|WASHOUT|2021-09-19|2021-10-06|21|38
Study ID|SE|b162843c-5086-4bd5-ae65-072fb1dc8140|6|10|4|TREATMENT|2021-09-24|2021-10-27|26|59
Study ID|SE|b162843c-5086-4bd5-ae65-072fb1dc8140|7|FU|7|FOLLOW-UP|2022-01-09|2022-01-23|133|147
Study ID|SE|eb87675c-9d36-455b-b08d-3ff38da1bdcf|1|SCRN|2|SCREENING|2021-12-02|2021-12-18|38|54
Study ID|SE|eb87675c-9d36-455b-b08d-3ff38da1bdcf|2|5|7|TREATMENT|2021-11-08|2022-03-19|14|145
Study ID|SE|eb87675c-9d36-455b-b08d-3ff38da1bdcf|3|REST|1|WASHOUT|2021-10-30|2021-11-26|5|32
Study ID|SE|eb87675c-9d36-455b-b08d-3ff38da1bdcf|4|10|4|TREATMENT|2022-02-18|2022-04-29|116|186
Study ID|SE|eb87675c-9d36-455b-b08d-3ff38da1bdcf|5|REST|5|WASHOUT|2022-01-02|2022-01-06|69|73
Study ID|SE|eb87675c-9d36-455b-b08d-3ff38da1bdcf|6|P|3|TREATMENT|2021-10-29|2022-05-15|4|202
Study ID|SE|eb87675c-9d36-455b-b08d-3ff38da1bdcf|7|FU|4|FOLLOW-UP|2021-10-31|2021-12-23|6|59
Study ID|SE|db09cf52-bd36-44dd-ae61-446ebfe27d96|1|SCRN|3|SCREENING|2021-09-23|2021-10-24|10|41
Study ID|SE|db09cf52-bd36-44dd-ae61-446ebfe27d96|2|5|6|TREATMENT|2022-01-20|2022-03-18|129|186
Study ID|SE|db09cf52-bd36-44dd-ae61-446ebfe27d96|3|REST|1|WASHOUT|2021-12-31|2022-07-06|109|296
Study ID|SE|db09cf52-bd36-44dd-ae61-446ebfe27d96|4|P|7|TREATMENT|2021-09-27|2021-10-03|14|20
Study ID|SE|db09cf52-bd36-44dd-ae61-446ebfe27d96|5|REST|7|WASHOUT|2021-11-22|2022-04-17|70|216
Study ID|SE|db09cf52-bd36-44dd-ae61-446ebfe27d96|6|10|3|TREATMENT|2022-03-08|2022-06-04|176|264
Study ID|SE|db09cf52-bd36-44dd-ae61-446ebfe27d96|7|FU|6|FOLLOW-UP|2021-09-19|2021-12-20|6|98
Study ID|SE|81ac7f9e-c4d4-46e2-8539-0ad8ad46df96|1|SCRN|1|SCREENING|2021-10-16|2022-01-05|38|119
Study ID|SE|81ac7f9e-c4d4-46e2-8539-0ad8ad46df96|2|P|7|TREATMENT|2021-11-08|2021-12-25|61|108
Study ID|SE|81ac7f9e-c4d4-46e2-8539-0ad8ad46df96|3|REST|5|WASHOUT|2021-09-20|2022-02-05|12|150
Study ID|SE|81ac7f9e-c4d4-46e2-8539-0ad8ad46df96|4|5|5|TREATMENT|2022-01-06|2022-03-29|120|202
Study ID|SE|81ac7f9e-c4d4-46e2-8539-0ad8ad46df96|5|REST|2|WASHOUT|2021-09-21|2022-06-29|13|294
Study ID|SE|81ac7f9e-c4d4-46e2-8539-0ad8ad46df96|6|10|1|TREATMENT|2021-11-03|2022-01-05|56|119
Study ID|SE|81ac7f9e-c4d4-46e2-8539-0ad8ad46df96|7|FU|3|FOLLOW-UP|2021-12-28|2022-05-01|111|235
Study ID|SE|c7bcaf1a-6382-4247-ba8f-1b2eab6a072f|1|SCRN|2|SCREENING|2022-02-17|2022-04-01|120|163
Study ID|SE|c7bcaf1a-6382-4247-ba8f-1b2eab6a072f|2|5|5|TREATMENT|2021-10-28|2022-01-14|8|86
Study ID|SE|c7bcaf1a-6382-4247-ba8f-1b2eab6a072f|3|REST|2|WASHOUT|2022-01-05|2022-04-18|77|180
Study ID|SE|c7bcaf1a-6382-4247-ba8f-1b2eab6a072f|4|10|4|TREATMENT|2021-12-13|2022-02-20|54|123
Study ID|SE|c7bcaf1a-6382-4247-ba8f-1b2eab6a072f|5|REST|1|WASHOUT|2021-11-07|2022-08-01|18|285
Study ID|SE|c7bcaf1a-6382-4247-ba8f-1b2eab6a072f|6|P|1|TREATMENT|2022-02-28|2022-04-15|131|177
Study ID|SE|c7bcaf1a-6382-4247-ba8f-1b2eab6a072f|7|FU|2|FOLLOW-UP|2021-10-25|2021-10-30|5|10
Study ID|SE|05997ac8-3c85-45ab-aae5-2fa752d4dcbb|1|SCRN|7|SCREENING|2021-10-27|2022-05-07|79|271
Study ID|SE|05997ac8-3c85-45ab-aae5-2fa752d4dcbb|2|P|6|TREATMENT|2021-09-17|2021-10-08|39|60
Study ID|SE|05997ac8-3c85-45ab-aae5-2fa752d4dcbb|3|REST|2|WASHOUT|2021-08-31|2021-12-19|22|132
Study ID|SE|05997ac8-3c85-45ab-aae5-2fa752d4dcbb|4|5|6|TREATMENT|2021-08-15|2021-10-20|6|72
Study ID|SE|05997ac8-3c85-45ab-aae5-2fa752d4dcbb|5|REST|3|WASHOUT|2022-02-28|2022-05-06|203|270
Study ID|SE|05997ac8-3c85-45ab-aae5-2fa752d4dcbb|6|10|5|TREATMENT|2021-08-24|2022-01-03|15|147
Study ID|SE|05997ac8-3c85-45ab-aae5-2fa752d4dcbb|7|FU|7|FOLLOW-UP|2021-08-21|2021-09-03|12|25
Study ID|SE|615e5774-576d-4bf2-bf4a-d037187fc9dc|1|SCRN|5|SCREENING|2021-09-01|2021-09-03|7|9
Study ID|SE|615e5774-576d-4bf2-bf4a-d037187fc9dc|2|P|5|TREATMENT|2022-02-21|2022-02-23|180|182
Study ID|SE|615e5774-576d-4bf2-bf4a-d037187fc9dc|3|REST|5|WASHOUT|2021-10-26|2022-02-09|62|168
Study ID|SE|615e5774-576d-4bf2-bf4a-d037187fc9dc|4|5|7|TREATMENT|2021-10-14|2021-11-14|50|81
Study ID|SE|615e5774-576d-4bf2-bf4a-d037187fc9dc|5|REST|4|WASHOUT|2021-10-14|2021-10-19|50|55
Study ID|SE|615e5774-576d-4bf2-bf4a-d037187fc9dc|6|10|2|TREATMENT|2021-08-28|2021-11-04|3|71
Study ID|SE|615e5774-576d-4bf2-bf4a-d037187fc9dc|7|FU|7|FOLLOW-UP|2022-04-20|2022-06-14|238|293
Study ID|SE|4b45ad63-686b-48d9-a170-e68e3986e094|1|SCRN|1|SCREENING|2021-10-27|2021-11-08|20|32
Study ID|SE|4b45ad63-686b-48d9-a170-e68e3986e094|2|5|1|TREATMENT|2021-11-05|2022-04-08|29|183
Study ID|SE|4b45ad63-686b-48d9-a170-e68e3986e094|3|REST|2|WASHOUT|2021-10-12|2021-10-21|5|14
Study ID|SE|4b45ad63-686b-48d9-a170-e68e3986e094|4|P|6|TREATMENT|2022-01-26|2022-03-29|111|173
Study ID|SE|4b45ad63-686b-48d9-a170-e68e3986e094|5|REST|7|WASHOUT|2021-11-05|2022-03-01|29|145
Study ID|SE|4b45ad63-686b-48d9-a170-e68e3986e094|6|10|7|TREATMENT|2022-05-01|2022-05-24|206|229
Study ID|SE|4b45ad63-686b-48d9-a170-e68e3986e094|7|FU|4|FOLLOW-UP|2021-10-15|2021-12-16|8|70
Study ID|SE|de28132b-7820-42e2-b6ed-73122f687503|1|SCRN|2|SCREENING|2021-10-21|2021-10-30|14|23
Study ID|SE|de28132b-7820-42e2-b6ed-73122f687503|2|P|5|TREATMENT|2022-01-01|2022-03-02|86|146
Study ID|SE|de28132b-7820-42e2-b6ed-73122f687503|3|REST|5|WASHOUT|2021-12-07|2022-04-05|61|180
Study ID|SE|de28132b-7820-42e2-b6ed-73122f687503|4|5|4|TREATMENT|2022-04-22|2022-05-07|197|212
Study ID|SE|de28132b-7820-42e2-b6ed-73122f687503|5|REST|1|WASHOUT|2021-11-23|2021-12-25|47|79
Study ID|SE|de28132b-7820-42e2-b6ed-73122f687503|6|10|1|TREATMENT|2022-02-27|2022-06-16|143|252
Study ID|SE|de28132b-7820-42e2-b6ed-73122f687503|7|FU|1|FOLLOW-UP|2022-03-24|2022-04-26|168|201
Study ID|SE|ddf32ab2-063e-4e0c-a39b-1b62fafcd9c0|1|SCRN|3|SCREENING|2021-12-30|2022-03-01|109|170
Study ID|SE|ddf32ab2-063e-4e0c-a39b-1b62fafcd9c0|2|5|2|TREATMENT|2021-09-15|2021-09-16|3|4
Study ID|SE|ddf32ab2-063e-4e0c-a39b-1b62fafcd9c0|3|REST|7|WASHOUT|2022-03-22|2022-04-06|191|206
Study ID|SE|ddf32ab2-063e-4e0c-a39b-1b62fafcd9c0|4|P|7|TREATMENT|2022-01-21|2022-04-19|131|219
Study ID|SE|ddf32ab2-063e-4e0c-a39b-1b62fafcd9c0|5|REST|7|WASHOUT|2022-02-04|2022-02-21|145|162
Study ID|SE|ddf32ab2-063e-4e0c-a39b-1b62fafcd9c0|6|10|1|TREATMENT|2021-10-01|2021-11-12|19|61
Study ID|SE|ddf32ab2-063e-4e0c-a39b-1b62fafcd9c0|7|FU|7|FOLLOW-UP|2021-11-21|2022-04-27|70|227
Study ID|SE|1012002b-2a83-4649-97a1-7abae8449749|1|SCRN|3|SCREENING|2021-09-07|2021-10-05|16|44
Study ID|SE|1012002b-2a83-4649-97a1-7abae8449749|2|P|6|TREATMENT|2021-09-10|2021-09-11|19|20
Study ID|SE|1012002b-2a83-4649-97a1-7abae8449749|3|REST|1|WASHOUT|2021-09-11|2021-10-23|20|62
Study ID|SE|1012002b-2a83-4649-97a1-7abae8449749|4|5|7|TREATMENT|2021-10-12|2022-05-08|51|259
Study ID|SE|1012002b-2a83-4649-97a1-7abae8449749|5|REST|7|WASHOUT|2021-09-03|2021-09-28|12|37
Study ID|SE|1012002b-2a83-4649-97a1-7abae8449749|6|10|1|TREATMENT|2022-02-10|2022-04-08|172|229
Study ID|SE|1012002b-2a83-4649-97a1-7abae8449749|7|FU|4|FOLLOW-UP|2021-11-19|2022-01-08|89|139
Study ID|SE|4f2dee02-6b3f-488e-aab1-9ae321997823|1|SCRN|5|SCREENING|2021-10-19|2022-01-12|51|136
Study ID|SE|4f2dee02-6b3f-488e-aab1-9ae321997823|2|5|3|TREATMENT|2021-11-02|2022-04-25|65|239
Study ID|SE|4f2dee02-6b3f-488e-aab1-9ae321997823|3|REST|1|WASHOUT|2021-10-31|2022-03-09|63|192
Study ID|SE|4f2dee02-6b3f-488e-aab1-9ae321997823|4|P|1|TREATMENT|2021-10-16|2021-12-24|48|117
Study ID|SE|4f2dee02-6b3f-488e-aab1-9ae321997823|5|REST|7|WASHOUT|2021-09-07|2021-12-24|9|117
Study ID|SE|4f2dee02-6b3f-488e-aab1-9ae321997823|6|10|3|TREATMENT|2021-09-07|2021-09-20|9|22
Study ID|SE|4f2dee02-6b3f-488e-aab1-9ae321997823|7|FU|2|FOLLOW-UP|2021-10-22|2022-04-15|54|229
Study ID|SE|b30d18a1-37bc-4b36-800a-dc7fef2b9121|1|SCRN|6|SCREENING|2022-04-07|2022-04-29|212|234
Study ID|SE|b30d18a1-37bc-4b36-800a-dc7fef2b9121|2|P|4|TREATMENT|2021-10-05|2021-10-22|28|45
Study ID|SE|b30d18a1-37bc-4b36-800a-dc7fef2b9121|3|REST|4|WASHOUT|2021-09-11|2021-12-04|4|88
Study ID|SE|b30d18a1-37bc-4b36-800a-dc7fef2b9121|4|5|1|TREATMENT|2021-09-24|2021-10-05|17|28
Study ID|SE|b30d18a1-37bc-4b36-800a-dc7fef2b9121|5|REST|2|WASHOUT|2022-03-20|2022-06-30|194|296
Study ID|SE|b30d18a1-37bc-4b36-800a-dc7fef2b9121|6|10|7|TREATMENT|2022-01-12|2022-02-04|127|150
Study ID|SE|b30d18a1-37bc-4b36-800a-dc7fef2b9121|7|FU|5|FOLLOW-UP|2021-10-02|2021-10-03|25|26
Study ID|SE|d1e3fd18-c1ac-471c-95fd-210c5f45c90f|1|SCRN|4|SCREENING|2021-12-03|2021-12-08|81|86
Study ID|SE|d1e3fd18-c1ac-471c-95fd-210c5f45c90f|2|P|4|TREATMENT|2021-09-23|2021-10-17|10|34
Study ID|SE|d1e3fd18-c1ac-471c-95fd-210c5f45c90f|3|REST|6|WASHOUT|2021-09-19|2021-10-09|6|26
Study ID|SE|d1e3fd18-c1ac-471c-95fd-210c5f45c90f|4|5|5|TREATMENT|2022-01-01|2022-01-06|110|115
Study ID|SE|d1e3fd18-c1ac-471c-95fd-210c5f45c90f|5|REST|5|WASHOUT|2022-03-03|2022-04-19|171|218
Study ID|SE|d1e3fd18-c1ac-471c-95fd-210c5f45c90f|6|10|3|TREATMENT|2021-09-20|2021-11-13|7|61
Study ID|SE|d1e3fd18-c1ac-471c-95fd-210c5f45c90f|7|FU|7|FOLLOW-UP|2022-04-03|2022-05-04|202|233
Study ID|SE|460242c7-6626-4d89-95d7-122a274cacbc|1|SCRN|2|SCREENING|2021-09-24|2021-10-09|24|39
Study ID|SE|460242c7-6626-4d89-95d7-122a274cacbc|2|5|2|TREATMENT|2022-01-23|2022-02-22|145|175
Study ID|SE|460242c7-6626-4d89-95d7-122a274cacbc|3|REST|1|WASHOUT|2021-11-26|2021-12-19|87|110
Study ID|SE|460242c7-6626-4d89-95d7-122a274cacbc|4|P|3|TREATMENT|2021-11-18|2022-01-26|79|148
Study ID|SE|460242c7-6626-4d89-95d7-122a274cacbc|5|REST|6|WASHOUT|2021-09-18|2021-10-02|18|32
Study ID|SE|460242c7-6626-4d89-95d7-122a274cacbc|6|10|5|TREATMENT|2021-09-06|2022-01-19|6|141
Study ID|SE|460242c7-6626-4d89-95d7-122a274cacbc|7|FU|7|FOLLOW-UP|2022-04-29|2022-05-07|241|249
Study ID|SE|80564fe6-89a7-48ca-970c-8fd6cfb2faa9|1|SCRN|1|SCREENING|2021-09-10|2021-10-06|23|49
Study ID|SE|80564fe6-89a7-48ca-970c-8fd6cfb2faa9|2|5|5|TREATMENT|2022-04-05|2022-06-02|230|288
Study ID|SE|80564fe6-89a7-48ca-970c-8fd6cfb2faa9|3|REST|4|WASHOUT|2021-09-30|2022-03-08|43|202
Study ID|SE|80564fe6-89a7-48ca-970c-8fd6cfb2faa9|4|10|1|TREATMENT|2022-04-01|2022-05-31|226|286
Study ID|SE|80564fe6-89a7-48ca-970c-8fd6cfb2faa9|5|REST|2|WASHOUT|2021-09-05|2021-11-26|18|100
Study ID|SE|80564fe6-89a7-48ca-970c-8fd6cfb2faa9|6|P|7|TREATMENT|2021-10-07|2021-12-06|50|110
Study ID|SE|80564fe6-89a7-48ca-970c-8fd6cfb2faa9|7|FU|3|FOLLOW-UP|2021-12-11|2022-03-27|115|221
Study ID|SE|a0290e05-7c42-4d9b-a5eb-c8ad65bcfd2b|1|SCRN|3|SCREENING|2021-09-30|2022-01-18|26|136
Study ID|SE|a0290e05-7c42-4d9b-a5eb-c8ad65bcfd2b|2|5|2|TREATMENT|2022-02-28|2022-04-04|177|212
Study ID|SE|a0290e05-7c42-4d9b-a5eb-c8ad65bcfd2b|3|REST|5|WASHOUT|2021-09-30|2021-10-14|26|40
Study ID|SE|a0290e05-7c42-4d9b-a5eb-c8ad65bcfd2b|4|P|6|TREATMENT|2021-09-06|2021-10-23|2|49
Study ID|SE|a0290e05-7c42-4d9b-a5eb-c8ad65bcfd2b|5|REST|7|WASHOUT|2021-10-03|2022-05-31|29|269
Study ID|SE|a0290e05-7c42-4d9b-a5eb-c8ad65bcfd2b|6|10|4|TREATMENT|2021-09-21|2021-10-15|17|41
Study ID|SE|a0290e05-7c42-4d9b-a5eb-c8ad65bcfd2b|7|FU|6|FOLLOW-UP|2022-02-07|2022-05-26|156|264
Study ID|SE|5a5ac5e2-564e-4cde-b25b-bf9a69399310|1|SCRN|5|SCREENING|2021-10-27|2022-06-30|3|249
Study ID|SE|5a5ac5e2-564e-4cde-b25b-bf9a69399310|2|P|5|TREATMENT|2021-12-13|2022-03-07|50|134
Study ID|SE|5a5ac5e2-564e-4cde-b25b-bf9a69399310|3|REST|1|WASHOUT|2021-11-25|2022-01-23|32|91
Study ID|SE|5a5ac5e2-564e-4cde-b25b-bf9a69399310|4|5|5|TREATMENT|2022-04-27|2022-06-20|185|239
Study ID|SE|5a5ac5e2-564e-4cde-b25b-bf9a69399310|5|REST|7|WASHOUT|2021-11-01|2021-12-17|8|54
Study ID|SE|5a5ac5e2-564e-4cde-b25b-bf9a69399310|6|10|4|TREATMENT|2021-11-11|2021-11-15|18|22
Study ID|SE|5a5ac5e2-564e-4cde-b25b-bf9a69399310|7|FU|2|FOLLOW-UP|2021-12-22|2022-08-08|59|288
Study ID|SE|bf7ab21f-d573-471a-9b64-2c0b952994dd|1|SCRN|1|SCREENING|2021-12-07|2022-01-03|75|102
Study ID|SE|bf7ab21f-d573-471a-9b64-2c0b952994dd|2|5|3|TREATMENT|2022-06-01|2022-07-15|251|295
Study ID|SE|bf7ab21f-d573-471a-9b64-2c0b952994dd|3|REST|4|WASHOUT|2021-12-25|2022-04-17|93|206
Study ID|SE|bf7ab21f-d573-471a-9b64-2c0b952994dd|4|10|1|TREATMENT|2021-11-23|2022-03-22|61|180
Study ID|SE|bf7ab21f-d573-471a-9b64-2c0b952994dd|5|REST|7|WASHOUT|2021-10-05|2022-03-04|12|162
Study ID|SE|bf7ab21f-d573-471a-9b64-2c0b952994dd|6|P|4|TREATMENT|2021-12-08|2022-02-14|76|144
Study ID|SE|bf7ab21f-d573-471a-9b64-2c0b952994dd|7|FU|3|FOLLOW-UP|2021-09-26|2021-11-02|3|40
Study ID|SE|f7cfadf0-f78d-4548-ad04-8d37e6d031f1|1|SCRN|1|SCREENING|2021-09-30|2021-10-16|21|37
Study ID|SE|f7cfadf0-f78d-4548-ad04-8d37e6d031f1|2|5|5|TREATMENT|2021-12-30|2022-02-16|112|160
Study ID|SE|f7cfadf0-f78d-4548-ad04-8d37e6d031f1|3|REST|2|WASHOUT|2021-09-15|2021-09-23|6|14
Study ID|SE|f7cfadf0-f78d-4548-ad04-8d37e6d031f1|4|P|4|TREATMENT|2022-04-25|2022-06-12|228|276
Study ID|SE|f7cfadf0-f78d-4548-ad04-8d37e6d031f1|5|REST|4|WASHOUT|2021-11-14|2021-11-21|66|73
Study ID|SE|f7cfadf0-f78d-4548-ad04-8d37e6d031f1|6|10|2|TREATMENT|2021-09-22|2021-10-17|13|38
Study ID|SE|f7cfadf0-f78d-4548-ad04-8d37e6d031f1|7|FU|1|FOLLOW-UP|2022-03-13|2022-05-09|185|242
Study ID|SE|e2a9612c-3b14-4b8c-ac88-39ac9de31c2f|1|SCRN|4|SCREENING|2021-12-13|2022-02-08|109|166
Study ID|SE|e2a9612c-3b14-4b8c-ac88-39ac9de31c2f|2|P|4|TREATMENT|2021-11-01|2021-12-13|67|109
Study ID|SE|e2a9612c-3b14-4b8c-ac88-39ac9de31c2f|3|REST|7|WASHOUT|2021-08-31|2021-11-17|5|83
Study ID|SE|e2a9612c-3b14-4b8c-ac88-39ac9de31c2f|4|5|4|TREATMENT|2021-12-04|2022-01-06|100|133
Study ID|SE|e2a9612c-3b14-4b8c-ac88-39ac9de31c2f|5|REST|6|WASHOUT|2021-10-01|2021-12-14|36|110
Study ID|SE|e2a9612c-3b14-4b8c-ac88-39ac9de31c2f|6|10|4|TREATMENT|2021-09-13|2021-09-16|18|21
Study ID|SE|e2a9612c-3b14-4b8c-ac88-39ac9de31c2f|7|FU|7|FOLLOW-UP|2021-12-11|2022-02-08|107|166
Study ID|SE|ef8e1969-22b2-4191-bb95-209af30b5096|1|SCRN|2|SCREENING|2021-11-25|2022-01-26|65|127
Study ID|SE|ef8e1969-22b2-4191-bb95-209af30b5096|2|P|4|TREATMENT|2021-09-23|2021-10-19|2|28
Study ID|SE|ef8e1969-22b2-4191-bb95-209af30b5096|3|REST|7|WASHOUT|2021-11-30|2022-03-28|70|188
Study ID|SE|ef8e1969-22b2-4191-bb95-209af30b5096|4|5|6|TREATMENT|2022-01-05|2022-03-05|106|165
Study ID|SE|ef8e1969-22b2-4191-bb95-209af30b5096|5|REST|1|WASHOUT|2021-11-03|2022-07-10|43|292
Study ID|SE|ef8e1969-22b2-4191-bb95-209af30b5096|6|10|6|TREATMENT|2022-02-05|2022-03-09|137|169
Study ID|SE|ef8e1969-22b2-4191-bb95-209af30b5096|7|FU|5|FOLLOW-UP|2021-12-14|2022-01-28|84|129
Study ID|SE|aaab833d-2546-4606-a806-4fbed4c00eeb|1|SCRN|6|SCREENING|2021-11-02|2021-11-08|12|18
Study ID|SE|aaab833d-2546-4606-a806-4fbed4c00eeb|2|P|4|TREATMENT|2021-10-30|2021-11-15|9|25
Study ID|SE|aaab833d-2546-4606-a806-4fbed4c00eeb|3|REST|3|WASHOUT|2022-03-06|2022-08-01|136|284
Study ID|SE|aaab833d-2546-4606-a806-4fbed4c00eeb|4|5|3|TREATMENT|2022-01-01|2022-08-14|72|297
Study ID|SE|aaab833d-2546-4606-a806-4fbed4c00eeb|5|REST|6|WASHOUT|2021-11-13|2021-12-18|23|58
Study ID|SE|aaab833d-2546-4606-a806-4fbed4c00eeb|6|10|6|TREATMENT|2021-10-27|2021-11-08|6|18
Study ID|SE|aaab833d-2546-4606-a806-4fbed4c00eeb|7|FU|4|FOLLOW-UP|2021-10-24|2022-01-14|3|85
Study ID|SE|ceebe624-3386-406a-a055-e7d4952cd37e|1|SCRN|7|SCREENING|2021-12-24|2022-04-20|58|175
Study ID|SE|ceebe624-3386-406a-a055-e7d4952cd37e|2|5|5|TREATMENT|2021-11-20|2022-07-29|24|275
Study ID|SE|ceebe624-3386-406a-a055-e7d4952cd37e|3|REST|4|WASHOUT|2022-03-16|2022-07-11|140|257
Study ID|SE|ceebe624-3386-406a-a055-e7d4952cd37e|4|10|2|TREATMENT|2022-05-10|2022-05-20|195|205
Study ID|SE|ceebe624-3386-406a-a055-e7d4952cd37e|5|REST|5|WASHOUT|2021-12-25|2022-06-20|59|236
Study ID|SE|ceebe624-3386-406a-a055-e7d4952cd37e|6|P|5|TREATMENT|2021-11-12|2022-07-29|16|275
Study ID|SE|ceebe624-3386-406a-a055-e7d4952cd37e|7|FU|5|FOLLOW-UP|2022-01-31|2022-02-02|96|98
Study ID|SE|131a7b87-c5fb-4176-841a-b4d1af976105|1|SCRN|3|SCREENING|2021-09-27|2021-10-04|33|40
Study ID|SE|131a7b87-c5fb-4176-841a-b4d1af976105|2|5|5|TREATMENT|2022-03-02|2022-03-27|189|214
Study ID|SE|131a7b87-c5fb-4176-841a-b4d1af976105|3|REST|3|WASHOUT|2021-11-10|2021-12-07|77|104
Study ID|SE|131a7b87-c5fb-4176-841a-b4d1af976105|4|P|4|TREATMENT|2022-02-24|2022-04-17|183|235
Study ID|SE|131a7b87-c5fb-4176-841a-b4d1af976105|5|REST|5|WASHOUT|2022-01-11|2022-01-15|139|143
Study ID|SE|131a7b87-c5fb-4176-841a-b4d1af976105|6|10|6|TREATMENT|2022-01-03|2022-02-07|131|166
Study ID|SE|131a7b87-c5fb-4176-841a-b4d1af976105|7|FU|2|FOLLOW-UP|2022-01-31|2022-04-05|159|223
Study ID|SE|1ce2e510-e54a-46a7-8bed-d9c786d428de|1|SCRN|6|SCREENING|2021-10-22|2022-01-01|76|147
Study ID|SE|1ce2e510-e54a-46a7-8bed-d9c786d428de|2|5|3|TREATMENT|2021-08-11|2021-10-22|4|76
Study ID|SE|1ce2e510-e54a-46a7-8bed-d9c786d428de|3|REST|1|WASHOUT|2021-12-15|2022-01-24|130|170
Study ID|SE|1ce2e510-e54a-46a7-8bed-d9c786d428de|4|10|4|TREATMENT|2021-12-17|2022-05-02|132|268
Study ID|SE|1ce2e510-e54a-46a7-8bed-d9c786d428de|5|REST|3|WASHOUT|2021-09-05|2021-11-23|29|108
Study ID|SE|1ce2e510-e54a-46a7-8bed-d9c786d428de|6|P|1|TREATMENT|2021-10-02|2021-12-01|56|116
Study ID|SE|1ce2e510-e54a-46a7-8bed-d9c786d428de|7|FU|1|FOLLOW-UP|2021-08-12|2021-08-30|5|23
Study ID|SE|c7c28c4a-e559-497a-8181-fe015050b12f|1|SCRN|1|SCREENING|2021-10-27|2021-11-15|53|72
Study ID|SE|c7c28c4a-e559-497a-8181-fe015050b12f|2|P|4|TREATMENT|2021-11-07|2021-12-08|64|95
Study ID|SE|c7c28c4a-e559-497a-8181-fe015050b12f|3|REST|3|WASHOUT|2021-10-08|2022-02-16|34|165
Study ID|SE|c7c28c4a-e559-497a-8181-fe015050b12f|4|5|3|TREATMENT|2021-09-15|2021-10-07|11|33
Study ID|SE|c7c28c4a-e559-497a-8181-fe015050b12f|5|REST|7|WASHOUT|2021-09-11|2021-10-03|7|29
Study ID|SE|c7c28c4a-e559-497a-8181-fe015050b12f|6|10|2|TREATMENT|2021-11-04|2021-11-27|61|84
Study ID|SE|c7c28c4a-e559-497a-8181-fe015050b12f|7|FU|5|FOLLOW-UP|2021-12-26|2022-01-01|113|119
Study ID|SE|79564b04-8e29-4939-8810-6c637d1d4504|1|SCRN|5|SCREENING|2021-11-02|2022-05-30|24|233
Study ID|SE|79564b04-8e29-4939-8810-6c637d1d4504|2|5|2|TREATMENT|2022-01-11|2022-02-15|94|129
Study ID|SE|79564b04-8e29-4939-8810-6c637d1d4504|3|REST|5|WASHOUT|2022-04-20|2022-06-17|193|251
Study ID|SE|79564b04-8e29-4939-8810-6c637d1d4504|4|10|1|TREATMENT|2021-12-04|2022-02-01|56|115
Study ID|SE|79564b04-8e29-4939-8810-6c637d1d4504|5|REST|7|WASHOUT|2022-01-23|2022-02-05|106|119
Study ID|SE|79564b04-8e29-4939-8810-6c637d1d4504|6|P|7|TREATMENT|2021-12-20|2022-02-18|72|132
Study ID|SE|79564b04-8e29-4939-8810-6c637d1d4504|7|FU|1|FOLLOW-UP|2022-02-15|2022-08-04|129|299
Study ID|SE|f9cf9898-ea99-474b-a173-15b8e0068065|1|SCRN|7|SCREENING|2021-10-31|2022-03-27|2|149
Study ID|SE|f9cf9898-ea99-474b-a173-15b8e0068065|2|5|5|TREATMENT|2022-04-21|2022-05-25|174|208
Study ID|SE|f9cf9898-ea99-474b-a173-15b8e0068065|3|REST|7|WASHOUT|2021-11-29|2022-07-13|31|257
Study ID|SE|f9cf9898-ea99-474b-a173-15b8e0068065|4|P|2|TREATMENT|2021-11-28|2021-12-04|30|36
Study ID|SE|f9cf9898-ea99-474b-a173-15b8e0068065|5|REST|7|WASHOUT|2022-06-27|2022-08-03|241|278
Study ID|SE|f9cf9898-ea99-474b-a173-15b8e0068065|6|10|7|TREATMENT|2021-12-06|2021-12-07|38|39
Study ID|SE|f9cf9898-ea99-474b-a173-15b8e0068065|7|FU|5|FOLLOW-UP|2021-11-06|2021-12-09|8|41
Study ID|SE|c7990059-5e9d-41da-8832-f19ebf5ce11a|1|SCRN|6|SCREENING|2021-11-01|2022-07-20|22|283
Study ID|SE|c7990059-5e9d-41da-8832-f19ebf5ce11a|2|P|2|TREATMENT|2021-11-21|2021-11-29|42|50
Study ID|SE|c7990059-5e9d-41da-8832-f19ebf5ce11a|3|REST|7|WASHOUT|2021-12-10|2022-04-01|61|173
Study ID|SE|c7990059-5e9d-41da-8832-f19ebf5ce11a|4|5|1|TREATMENT|2021-10-18|2021-11-25|8|46
Study ID|SE|c7990059-5e9d-41da-8832-f19ebf5ce11a|5|REST|6|WASHOUT|2021-12-30|2022-02-10|81|123
Study ID|SE|c7990059-5e9d-41da-8832-f19ebf5ce11a|6|10|5|TREATMENT|2022-01-03|2022-07-07|85|270
Study ID|SE|c7990059-5e9d-41da-8832-f19ebf5ce11a|7|FU|1|FOLLOW-UP|2021-10-21|2021-10-24|11|14
Study ID|SE|b1f6503d-502b-47b3-9266-ba6cfa45c138|1|SCRN|6|SCREENING|2021-10-19|2022-02-16|11|131
Study ID|SE|b1f6503d-502b-47b3-9266-ba6cfa45c138|2|P|7|TREATMENT|2022-06-08|2022-06-17|243|252
Study ID|SE|b1f6503d-502b-47b3-9266-ba6cfa45c138|3|REST|7|WASHOUT|2021-11-30|2021-12-13|53|66
Study ID|SE|b1f6503d-502b-47b3-9266-ba6cfa45c138|4|5|6|TREATMENT|2021-11-23|2022-03-13|46|156
Study ID|SE|b1f6503d-502b-47b3-9266-ba6cfa45c138|5|REST|1|WASHOUT|2022-04-02|2022-06-11|176|246
Study ID|SE|b1f6503d-502b-47b3-9266-ba6cfa45c138|6|10|4|TREATMENT|2022-06-07|2022-07-03|242|268
Study ID|SE|b1f6503d-502b-47b3-9266-ba6cfa45c138|7|FU|1|FOLLOW-UP|2022-01-31|2022-05-20|115|224
Study ID|SE|1f200d28-91a8-43dd-acdc-76276cc05e00|1|SCRN|6|SCREENING|2021-10-08|2022-01-01|18|103
Study ID|SE|1f200d28-91a8-43dd-acdc-76276cc05e00|2|5|5|TREATMENT|2022-07-09|2022-07-11|292|294
Study ID|SE|1f200d28-91a8-43dd-acdc-76276cc05e00|3|REST|5|WASHOUT|2021-10-10|2021-12-29|20|100
Study ID|SE|1f200d28-91a8-43dd-acdc-76276cc05e00|4|P|4|TREATMENT|2021-10-07|2021-10-15|17|25
Study ID|SE|1f200d28-91a8-43dd-acdc-76276cc05e00|5|REST|3|WASHOUT|2021-11-15|2022-02-28|56|161
Study ID|SE|1f200d28-91a8-43dd-acdc-76276cc05e00|6|10|3|TREATMENT|2021-11-20|2022-02-19|61|152
Study ID|SE|1f200d28-91a8-43dd-acdc-76276cc05e00|7|FU|3|FOLLOW-UP|2021-09-27|2021-10-20|7|30
Study ID|SE|9ed5969e-2bab-4e80-96e2-5200f770ba03|1|SCRN|2|SCREENING|2021-11-09|2022-03-20|38|169
Study ID|SE|9ed5969e-2bab-4e80-96e2-5200f770ba03|2|P|5|TREATMENT|2021-10-25|2021-12-15|23|74
Study ID|SE|9ed5969e-2bab-4e80-96e2-5200f770ba03|3|REST|4|WASHOUT|2021-12-11|2022-03-03|70|152
Study ID|SE|9ed5969e-2bab-4e80-96e2-5200f770ba03|4|5|7|TREATMENT|2021-10-08|2021-10-11|6|9
Study ID|SE|9ed5969e-2bab-4e80-96e2-5200f770ba03|5|REST|6|WASHOUT|2021-10-16|2021-11-08|14|37
Study ID|SE|9ed5969e-2bab-4e80-96e2-5200f770ba03|6|10|2|TREATMENT|2022-02-26|2022-07-12|147|283
Study ID|SE|9ed5969e-2bab-4e80-96e2-5200f770ba03|7|FU|7|FOLLOW-UP|2021-11-02|2021-11-25|31|54
Study ID|SE|0c4ce5af-6958-46b5-9475-1b3a4fc0d33f|1|SCRN|4|SCREENING|2021-08-23|2021-08-24|6|7
Study ID|SE|0c4ce5af-6958-46b5-9475-1b3a4fc0d33f|2|P|7|TREATMENT|2021-08-19|2021-08-19|2|2
Study ID|SE|0c4ce5af-6958-46b5-9475-1b3a4fc0d33f|3|REST|1|WASHOUT|2021-08-31|2021-09-22|14|36
Study ID|SE|0c4ce5af-6958-46b5-9475-1b3a4fc0d33f|4|5|3|TREATMENT|2021-11-07|2021-12-26|82|131
Study ID|SE|0c4ce5af-6958-46b5-9475-1b3a4fc0d33f|5|REST|5|WASHOUT|2021-09-08|2021-10-25|22|69
Study ID|SE|0c4ce5af-6958-46b5-9475-1b3a4fc0d33f|6|10|7|TREATMENT|2022-01-17|2022-03-18|153|213
Study ID|SE|0c4ce5af-6958-46b5-9475-1b3a4fc0d33f|7|FU|1|FOLLOW-UP|2021-11-22|2021-11-30|97|105
Study ID|SE|69c9c9dd-3ab0-4a43-94c8-9c40b580b4f2|1|SCRN|1|SCREENING|2021-10-07|2021-10-21|13|27
Study ID|SE|69c9c9dd-3ab0-4a43-94c8-9c40b580b4f2|2|5|3|TREATMENT|2021-12-14|2022-04-09|81|197
Study ID|SE|69c9c9dd-3ab0-4a43-94c8-9c40b580b4f2|3|REST|3|WASHOUT|2021-10-30|2021-11-20|36|57
Study ID|SE|69c9c9dd-3ab0-4a43-94c8-9c40b580b4f2|4|P|3|TREATMENT|2021-11-07|2022-02-24|44|153
Study ID|SE|69c9c9dd-3ab0-4a43-94c8-9c40b580b4f2|5|REST|7|WASHOUT|2021-09-28|2022-05-20|4|238
Study ID|SE|69c9c9dd-3ab0-4a43-94c8-9c40b580b4f2|6|10|2|TREATMENT|2022-01-09|2022-04-09|107|197
Study ID|SE|69c9c9dd-3ab0-4a43-94c8-9c40b580b4f2|7|FU|5|FOLLOW-UP|2022-03-21|2022-06-02|178|251
Study ID|SE|54911800-8507-499a-a7a0-7f2d2fb091d3|1|SCRN|2|SCREENING|2021-10-14|2022-02-25|59|193
Study ID|SE|54911800-8507-499a-a7a0-7f2d2fb091d3|2|P|1|TREATMENT|2021-08-31|2021-09-11|15|26
Study ID|SE|54911800-8507-499a-a7a0-7f2d2fb091d3|3|REST|7|WASHOUT|2021-10-13|2021-11-04|58|80
Study ID|SE|54911800-8507-499a-a7a0-7f2d2fb091d3|4|5|7|TREATMENT|2021-11-29|2022-04-03|105|230
Study ID|SE|54911800-8507-499a-a7a0-7f2d2fb091d3|5|REST|1|WASHOUT|2021-12-25|2022-01-15|131|152
Study ID|SE|54911800-8507-499a-a7a0-7f2d2fb091d3|6|10|3|TREATMENT|2021-09-30|2022-06-10|45|298
Study ID|SE|54911800-8507-499a-a7a0-7f2d2fb091d3|7|FU|6|FOLLOW-UP|2021-09-17|2022-01-20|32|157
Study ID|SE|62d81c3b-7e47-4ca1-9b1b-5ae8ba53e4d5|1|SCRN|2|SCREENING|2021-11-24|2022-05-04|42|203
Study ID|SE|62d81c3b-7e47-4ca1-9b1b-5ae8ba53e4d5|2|5|5|TREATMENT|2022-03-12|2022-03-23|150|161
Study ID|SE|62d81c3b-7e47-4ca1-9b1b-5ae8ba53e4d5|3|REST|1|WASHOUT|2022-04-15|2022-04-23|184|192
Study ID|SE|62d81c3b-7e47-4ca1-9b1b-5ae8ba53e4d5|4|P|6|TREATMENT|2021-10-16|2021-10-17|3|4
Study ID|SE|62d81c3b-7e47-4ca1-9b1b-5ae8ba53e4d5|5|REST|2|WASHOUT|2022-02-09|2022-06-08|119|238
Study ID|SE|62d81c3b-7e47-4ca1-9b1b-5ae8ba53e4d5|6|10|3|TREATMENT|2021-10-28|2022-06-30|15|260
Study ID|SE|62d81c3b-7e47-4ca1-9b1b-5ae8ba53e4d5|7|FU|6|FOLLOW-UP|2021-11-05|2021-11-15|23|33
Study ID|SE|5c3a10c5-ff6d-4848-8fba-89ed56deebcd|1|SCRN|4|SCREENING|2021-11-01|2022-02-01|12|104
Study ID|SE|5c3a10c5-ff6d-4848-8fba-89ed56deebcd|2|P|5|TREATMENT|2021-11-28|2022-03-25|39|156
Study ID|SE|5c3a10c5-ff6d-4848-8fba-89ed56deebcd|3|REST|1|WASHOUT|2021-11-10|2021-11-11|21|22
Study ID|SE|5c3a10c5-ff6d-4848-8fba-89ed56deebcd|4|5|7|TREATMENT|2021-11-14|2021-12-04|25|45
Study ID|SE|5c3a10c5-ff6d-4848-8fba-89ed56deebcd|5|REST|2|WASHOUT|2022-01-12|2022-01-14|84|86
Study ID|SE|5c3a10c5-ff6d-4848-8fba-89ed56deebcd|6|10|7|TREATMENT|2022-01-02|2022-01-25|74|97
Study ID|SE|5c3a10c5-ff6d-4848-8fba-89ed56deebcd|7|FU|2|FOLLOW-UP|2021-10-23|2021-10-26|3|6
Study ID|SE|100085d7-f49a-468d-a92d-0304e65f71b6|1|SCRN|5|SCREENING|2021-12-18|2022-04-08|119|230
Study ID|SE|100085d7-f49a-468d-a92d-0304e65f71b6|2|P|5|TREATMENT|2021-08-27|2021-09-07|6|17
Study ID|SE|100085d7-f49a-468d-a92d-0304e65f71b6|3|REST|6|WASHOUT|2021-10-11|2022-06-02|51|285
Study ID|SE|100085d7-f49a-468d-a92d-0304e65f71b6|4|5|7|TREATMENT|2021-08-31|2021-09-10|10|20
Study ID|SE|100085d7-f49a-468d-a92d-0304e65f71b6|5|REST|6|WASHOUT|2022-01-10|2022-06-07|142|290
Study ID|SE|100085d7-f49a-468d-a92d-0304e65f71b6|6|10|3|TREATMENT|2021-09-03|2021-09-13|13|23
Study ID|SE|100085d7-f49a-468d-a92d-0304e65f71b6|7|FU|3|FOLLOW-UP|2021-11-11|2022-01-16|82|148
Study ID|SE|9cbde452-5eb2-4af6-b986-456a7d96594a|1|SCRN|5|SCREENING|2021-11-05|2021-12-16|77|118
Study ID|SE|9cbde452-5eb2-4af6-b986-456a7d96594a|2|P|1|TREATMENT|2021-09-10|2021-09-23|21|34
Study ID|SE|9cbde452-5eb2-4af6-b986-456a7d96594a|3|REST|5|WASHOUT|2021-12-07|2022-01-06|109|139
Study ID|SE|9cbde452-5eb2-4af6-b986-456a7d96594a|4|5|2|TREATMENT|2021-09-05|2021-11-14|16|86
Study ID|SE|9cbde452-5eb2-4af6-b986-456a7d96594a|5|REST|6|WASHOUT|2021-11-30|2022-03-12|102|204
Study ID|SE|9cbde452-5eb2-4af6-b986-456a7d96594a|6|10|4|TREATMENT|2021-10-17|2022-01-18|58|151
Study ID|SE|9cbde452-5eb2-4af6-b986-456a7d96594a|7|FU|6|FOLLOW-UP|2021-08-30|2021-09-02|10|13
Study ID|SE|8e171a3f-46df-4df0-9a45-ef1577574095|1|SCRN|2|SCREENING|2022-01-14|2022-01-22|121|129
Study ID|SE|8e171a3f-46df-4df0-9a45-ef1577574095|2|P|4|TREATMENT|2021-10-07|2022-04-29|22|226
Study ID|SE|8e171a3f-46df-4df0-9a45-ef1577574095|3|REST|3|WASHOUT|2021-11-04|2022-01-07|50|114
Study ID|SE|8e171a3f-46df-4df0-9a45-ef1577574095|4|5|6|TREATMENT|2021-12-15|2022-05-02|91|229
Study ID|SE|8e171a3f-46df-4df0-9a45-ef1577574095|5|REST|2|WASHOUT|2021-12-24|2022-01-06|100|113
Study ID|SE|8e171a3f-46df-4df0-9a45-ef1577574095|6|10|5|TREATMENT|2022-01-14|2022-03-06|121|172
Study ID|SE|8e171a3f-46df-4df0-9a45-ef1577574095|7|FU|6|FOLLOW-UP|2022-01-02|2022-05-14|109|241
Study ID|SE|099b7ac3-d3ae-4370-a687-a9829c374dd3|1|SCRN|7|SCREENING|2022-03-28|2022-04-09|157|169
Study ID|SE|099b7ac3-d3ae-4370-a687-a9829c374dd3|2|5|4|TREATMENT|2021-12-19|2022-05-14|58|204
Study ID|SE|099b7ac3-d3ae-4370-a687-a9829c374dd3|3|REST|6|WASHOUT|2021-10-26|2021-11-04|4|13
Study ID|SE|099b7ac3-d3ae-4370-a687-a9829c374dd3|4|10|3|TREATMENT|2021-10-25|2021-12-03|3|42
Study ID|SE|099b7ac3-d3ae-4370-a687-a9829c374dd3|5|REST|1|WASHOUT|2021-11-24|2021-12-05|33|44
Study ID|SE|099b7ac3-d3ae-4370-a687-a9829c374dd3|6|P|1|TREATMENT|2022-01-01|2022-02-23|71|124
Study ID|SE|099b7ac3-d3ae-4370-a687-a9829c374dd3|7|FU|5|FOLLOW-UP|2022-04-19|2022-07-04|179|255
Study ID|SE|7d023693-f052-4b93-8706-1cfc6754f05b|1|SCRN|6|SCREENING|2021-11-20|2022-04-26|84|241
Study ID|SE|7d023693-f052-4b93-8706-1cfc6754f05b|2|5|5|TREATMENT|2021-08-30|2021-08-30|2|2
Study ID|SE|7d023693-f052-4b93-8706-1cfc6754f05b|3|REST|6|WASHOUT|2021-10-31|2021-12-20|64|114
Study ID|SE|7d023693-f052-4b93-8706-1cfc6754f05b|4|P|5|TREATMENT|2021-09-25|2021-12-14|28|108
Study ID|SE|7d023693-f052-4b93-8706-1cfc6754f05b|5|REST|1|WASHOUT|2022-02-14|2022-03-19|170|203
Study ID|SE|7d023693-f052-4b93-8706-1cfc6754f05b|6|10|1|TREATMENT|2021-09-02|2021-09-04|5|7
Study ID|SE|7d023693-f052-4b93-8706-1cfc6754f05b|7|FU|5|FOLLOW-UP|2021-11-25|2021-11-27|89|91
Study ID|SE|975abcca-91ce-4b91-b607-3967668b0432|1|SCRN|6|SCREENING|2021-12-06|2021-12-12|50|56
Study ID|SE|975abcca-91ce-4b91-b607-3967668b0432|2|P|2|TREATMENT|2021-11-06|2022-04-16|20|181
Study ID|SE|975abcca-91ce-4b91-b607-3967668b0432|3|REST|4|WASHOUT|2021-11-23|2022-01-24|37|99
Study ID|SE|975abcca-91ce-4b91-b607-3967668b0432|4|5|4|TREATMENT|2022-01-21|2022-04-22|96|187
Study ID|SE|975abcca-91ce-4b91-b607-3967668b0432|5|REST|5|WASHOUT|2022-05-01|2022-05-09|196|204
Study ID|SE|975abcca-91ce-4b91-b607-3967668b0432|6|10|5|TREATMENT|2021-12-14|2022-02-27|58|133
Study ID|SE|975abcca-91ce-4b91-b607-3967668b0432|7|FU|2|FOLLOW-UP|2022-01-05|2022-05-20|80|215
Study ID|SE|3831851f-30ba-47d0-8ce2-565af7ed3055|1|SCRN|2|SCREENING|2021-12-09|2022-01-13|113|148
Study ID|SE|3831851f-30ba-47d0-8ce2-565af7ed3055|2|P|6|TREATMENT|2021-09-11|2021-11-04|24|78
Study ID|SE|3831851f-30ba-47d0-8ce2-565af7ed3055|3|REST|4|WASHOUT|2021-09-27|2021-09-29|40|42
Study ID|SE|3831851f-30ba-47d0-8ce2-565af7ed3055|4|5|5|TREATMENT|2021-08-24|2021-10-05|6|48
Study ID|SE|3831851f-30ba-47d0-8ce2-565af7ed3055|5|REST|7|WASHOUT|2021-09-02|2021-11-11|15|85
Study ID|SE|3831851f-30ba-47d0-8ce2-565af7ed3055|6|10|2|TREATMENT|2021-09-02|2021-09-06|15|19
Study ID|SE|3831851f-30ba-47d0-8ce2-565af7ed3055|7|FU|1|FOLLOW-UP|2021-08-28|2021-10-12|10|55
Study ID|SE|e691e72d-cc4a-4256-913c-9889f5282c2b|1|SCRN|4|SCREENING|2021-11-20|2021-11-22|25|27
Study ID|SE|e691e72d-cc4a-4256-913c-9889f5282c2b|2|5|6|TREATMENT|2021-11-10|2022-08-17|15|295
Study ID|SE|e691e72d-cc4a-4256-913c-9889f5282c2b|3|REST|6|WASHOUT|2022-02-19|2022-07-15|116|262
Study ID|SE|e691e72d-cc4a-4256-913c-9889f5282c2b|4|P|5|TREATMENT|2022-02-26|2022-03-10|123|135
Study ID|SE|e691e72d-cc4a-4256-913c-9889f5282c2b|5|REST|5|WASHOUT|2021-11-21|2022-02-06|26|103
Study ID|SE|e691e72d-cc4a-4256-913c-9889f5282c2b|6|10|2|TREATMENT|2022-01-13|2022-03-03|79|128
Study ID|SE|e691e72d-cc4a-4256-913c-9889f5282c2b|7|FU|6|FOLLOW-UP|2022-02-23|2022-05-17|120|203
Study ID|SE|eff0d0b0-90a4-49be-8963-0e1e14b65c99|1|SCRN|7|SCREENING|2021-11-17|2021-11-26|42|51
Study ID|SE|eff0d0b0-90a4-49be-8963-0e1e14b65c99|2|P|3|TREATMENT|2022-05-20|2022-06-26|226|263
Study ID|SE|eff0d0b0-90a4-49be-8963-0e1e14b65c99|3|REST|3|WASHOUT|2022-01-22|2022-03-04|108|149
Study ID|SE|eff0d0b0-90a4-49be-8963-0e1e14b65c99|4|5|6|TREATMENT|2021-12-03|2022-05-27|58|233
Study ID|SE|eff0d0b0-90a4-49be-8963-0e1e14b65c99|5|REST|5|WASHOUT|2021-12-29|2022-02-23|84|140
Study ID|SE|eff0d0b0-90a4-49be-8963-0e1e14b65c99|6|10|1|TREATMENT|2021-11-30|2022-02-27|55|144
Study ID|SE|eff0d0b0-90a4-49be-8963-0e1e14b65c99|7|FU|6|FOLLOW-UP|2022-02-21|2022-05-17|138|223
Study ID|SE|923bf4b4-2489-4fb8-bde3-b5747b98a128|1|SCRN|6|SCREENING|2021-10-17|2021-11-03|53|70
Study ID|SE|923bf4b4-2489-4fb8-bde3-b5747b98a128|2|P|2|TREATMENT|2021-11-19|2021-12-22|86|119
Study ID|SE|923bf4b4-2489-4fb8-bde3-b5747b98a128|3|REST|3|WASHOUT|2021-10-17|2022-04-06|53|224
Study ID|SE|923bf4b4-2489-4fb8-bde3-b5747b98a128|4|5|7|TREATMENT|2022-01-30|2022-05-02|158|250
Study ID|SE|923bf4b4-2489-4fb8-bde3-b5747b98a128|5|REST|4|WASHOUT|2022-04-12|2022-06-06|230|285
Study ID|SE|923bf4b4-2489-4fb8-bde3-b5747b98a128|6|10|7|TREATMENT|2022-01-23|2022-03-21|151|208
Study ID|SE|923bf4b4-2489-4fb8-bde3-b5747b98a128|7|FU|4|FOLLOW-UP|2021-10-02|2022-02-26|38|185
Study ID|SE|754a5564-4735-449b-b57c-8909371e4ea1|1|SCRN|7|SCREENING|2021-10-25|2021-10-30|8|13
Study ID|SE|754a5564-4735-449b-b57c-8909371e4ea1|2|5|2|TREATMENT|2022-01-15|2022-04-10|90|175
Study ID|SE|754a5564-4735-449b-b57c-8909371e4ea1|3|REST|6|WASHOUT|2022-02-10|2022-02-28|116|134
Study ID|SE|754a5564-4735-449b-b57c-8909371e4ea1|4|10|3|TREATMENT|2021-10-31|2022-01-02|14|77
Study ID|SE|754a5564-4735-449b-b57c-8909371e4ea1|5|REST|7|WASHOUT|2022-01-19|2022-05-05|94|200
Study ID|SE|754a5564-4735-449b-b57c-8909371e4ea1|6|P|6|TREATMENT|2022-02-19|2022-05-17|125|212
Study ID|SE|754a5564-4735-449b-b57c-8909371e4ea1|7|FU|4|FOLLOW-UP|2021-11-09|2021-11-14|23|28
Study ID|SE|a2f1f1f7-ee92-4e60-97a7-6b506252b2dd|1|SCRN|3|SCREENING|2021-12-20|2022-07-23|83|298
Study ID|SE|a2f1f1f7-ee92-4e60-97a7-6b506252b2dd|2|5|6|TREATMENT|2021-11-14|2022-02-23|47|148
Study ID|SE|a2f1f1f7-ee92-4e60-97a7-6b506252b2dd|3|REST|1|WASHOUT|2022-05-20|2022-06-20|234|265
Study ID|SE|a2f1f1f7-ee92-4e60-97a7-6b506252b2dd|4|10|4|TREATMENT|2021-11-23|2022-02-14|56|139
Study ID|SE|a2f1f1f7-ee92-4e60-97a7-6b506252b2dd|5|REST|5|WASHOUT|2022-04-02|2022-06-26|186|271
Study ID|SE|a2f1f1f7-ee92-4e60-97a7-6b506252b2dd|6|P|3|TREATMENT|2021-09-30|2021-09-30|2|2
Study ID|SE|a2f1f1f7-ee92-4e60-97a7-6b506252b2dd|7|FU|1|FOLLOW-UP|2021-10-22|2021-12-16|24|79
Study ID|SE|12e2e175-84e0-48bf-8a02-1cbdb8b7a646|1|SCRN|3|SCREENING|2021-11-01|2021-11-04|10|13
Study ID|SE|12e2e175-84e0-48bf-8a02-1cbdb8b7a646|2|5|7|TREATMENT|2022-05-15|2022-08-14|205|296
Study ID|SE|12e2e175-84e0-48bf-8a02-1cbdb8b7a646|3|REST|3|WASHOUT|2021-11-03|2021-11-05|12|14
Study ID|SE|12e2e175-84e0-48bf-8a02-1cbdb8b7a646|4|P|1|TREATMENT|2021-12-28|2022-01-12|67|82
Study ID|SE|12e2e175-84e0-48bf-8a02-1cbdb8b7a646|5|REST|2|WASHOUT|2021-10-26|2021-11-22|4|31
Study ID|SE|12e2e175-84e0-48bf-8a02-1cbdb8b7a646|6|10|7|TREATMENT|2022-04-20|2022-08-03|180|285
Study ID|SE|12e2e175-84e0-48bf-8a02-1cbdb8b7a646|7|FU|6|FOLLOW-UP|2022-03-01|2022-06-26|130|247
Study ID|SE|1f46fe9b-33e4-4555-9195-7acaf5d149be|1|SCRN|5|SCREENING|2022-05-23|2022-06-25|264|297
Study ID|SE|1f46fe9b-33e4-4555-9195-7acaf5d149be|2|5|6|TREATMENT|2021-09-12|2022-04-05|11|216
Study ID|SE|1f46fe9b-33e4-4555-9195-7acaf5d149be|3|REST|4|WASHOUT|2022-01-09|2022-01-23|130|144
Study ID|SE|1f46fe9b-33e4-4555-9195-7acaf5d149be|4|P|6|TREATMENT|2022-01-12|2022-02-02|133|154
Study ID|SE|1f46fe9b-33e4-4555-9195-7acaf5d149be|5|REST|1|WASHOUT|2021-12-12|2022-03-11|102|191
Study ID|SE|1f46fe9b-33e4-4555-9195-7acaf5d149be|6|10|7|TREATMENT|2021-09-12|2021-12-25|11|115
Study ID|SE|1f46fe9b-33e4-4555-9195-7acaf5d149be|7|FU|1|FOLLOW-UP|2021-10-21|2021-11-03|50|63
Study ID|SE|caf416eb-7ca0-45be-bbff-f39131db02ef|1|SCRN|2|SCREENING|2022-02-21|2022-05-20|154|242
Study ID|SE|caf416eb-7ca0-45be-bbff-f39131db02ef|2|5|2|TREATMENT|2022-03-01|2022-07-04|162|287
Study ID|SE|caf416eb-7ca0-45be-bbff-f39131db02ef|3|REST|2|WASHOUT|2021-10-07|2021-10-15|17|25
Study ID|SE|caf416eb-7ca0-45be-bbff-f39131db02ef|4|P|3|TREATMENT|2021-09-27|2021-10-04|7|14
Study ID|SE|caf416eb-7ca0-45be-bbff-f39131db02ef|5|REST|3|WASHOUT|2021-10-25|2021-12-08|35|79
Study ID|SE|caf416eb-7ca0-45be-bbff-f39131db02ef|6|10|2|TREATMENT|2021-11-09|2021-12-11|50|82
Study ID|SE|caf416eb-7ca0-45be-bbff-f39131db02ef|7|FU|2|FOLLOW-UP|2021-10-26|2022-06-09|36|262
Study ID|SE|1d94fa8d-4e72-4d3b-8d50-b5a276fdbdf9|1|SCRN|1|SCREENING|2021-11-13|2021-11-22|15|24
Study ID|SE|1d94fa8d-4e72-4d3b-8d50-b5a276fdbdf9|2|5|4|TREATMENT|2022-06-10|2022-07-19|224|263
Study ID|SE|1d94fa8d-4e72-4d3b-8d50-b5a276fdbdf9|3|REST|7|WASHOUT|2022-05-14|2022-05-29|197|212
Study ID|SE|1d94fa8d-4e72-4d3b-8d50-b5a276fdbdf9|4|10|7|TREATMENT|2021-12-10|2022-08-11|42|286
Study ID|SE|1d94fa8d-4e72-4d3b-8d50-b5a276fdbdf9|5|REST|4|WASHOUT|2022-01-29|2022-05-05|92|188
Study ID|SE|1d94fa8d-4e72-4d3b-8d50-b5a276fdbdf9|6|P|5|TREATMENT|2021-11-29|2022-02-12|31|106
Study ID|SE|1d94fa8d-4e72-4d3b-8d50-b5a276fdbdf9|7|FU|6|FOLLOW-UP|2021-11-27|2022-02-13|29|107
Study ID|SE|00ae1afd-197f-472e-b400-614a5c0859e8|1|SCRN|4|SCREENING|2021-09-16|2021-09-22|19|25
Study ID|SE|00ae1afd-197f-472e-b400-614a5c0859e8|2|P|7|TREATMENT|2022-01-21|2022-02-22|146|178
Study ID|SE|00ae1afd-197f-472e-b400-614a5c0859e8|3|REST|5|WASHOUT|2022-05-27|2022-06-17|272|293
Study ID|SE|00ae1afd-197f-472e-b400-614a5c0859e8|4|5|2|TREATMENT|2021-10-18|2022-04-01|51|216
Study ID|SE|00ae1afd-197f-472e-b400-614a5c0859e8|5|REST|1|WASHOUT|2021-12-01|2022-04-15|95|230
Study ID|SE|00ae1afd-197f-472e-b400-614a5c0859e8|6|10|5|TREATMENT|2022-01-22|2022-02-25|147|181
Study ID|SE|00ae1afd-197f-472e-b400-614a5c0859e8|7|FU|1|FOLLOW-UP|2021-10-08|2021-10-14|41|47
Study ID|SE|ccd0534d-432b-4bbf-82d2-075fad3a74b7|1|SCRN|6|SCREENING|2021-10-08|2021-10-09|3|4
Study ID|SE|ccd0534d-432b-4bbf-82d2-075fad3a74b7|2|P|4|TREATMENT|2021-12-11|2022-02-28|67|146
Study ID|SE|ccd0534d-432b-4bbf-82d2-075fad3a74b7|3|REST|5|WASHOUT|2021-10-08|2021-10-11|3|6
Study ID|SE|ccd0534d-432b-4bbf-82d2-075fad3a74b7|4|5|3|TREATMENT|2022-01-01|2022-05-21|88|228
Study ID|SE|ccd0534d-432b-4bbf-82d2-075fad3a74b7|5|REST|7|WASHOUT|2022-01-12|2022-07-12|99|280
Study ID|SE|ccd0534d-432b-4bbf-82d2-075fad3a74b7|6|10|4|TREATMENT|2021-10-10|2021-10-12|5|7
Study ID|SE|ccd0534d-432b-4bbf-82d2-075fad3a74b7|7|FU|2|FOLLOW-UP|2021-12-24|2022-01-25|80|112
Study ID|SE|0d66f896-f5ed-4f9d-8568-47d4708f5348|1|SCRN|5|SCREENING|2021-10-28|2021-11-28|40|71
Study ID|SE|0d66f896-f5ed-4f9d-8568-47d4708f5348|2|5|3|TREATMENT|2021-10-18|2021-10-24|30|36
Study ID|SE|0d66f896-f5ed-4f9d-8568-47d4708f5348|3|REST|4|WASHOUT|2022-02-21|2022-07-04|156|289
Study ID|SE|0d66f896-f5ed-4f9d-8568-47d4708f5348|4|10|4|TREATMENT|2022-02-08|2022-02-28|143|163
Study ID|SE|0d66f896-f5ed-4f9d-8568-47d4708f5348|5|REST|4|WASHOUT|2022-04-01|2022-05-29|195|253
Study ID|SE|0d66f896-f5ed-4f9d-8568-47d4708f5348|6|P|3|TREATMENT|2022-01-19|2022-07-13|123|298
Study ID|SE|0d66f896-f5ed-4f9d-8568-47d4708f5348|7|FU|4|FOLLOW-UP|2022-03-08|2022-04-13|171|207
Study ID|SE|2f83788c-5f95-47c0-91aa-a8577b6864ae|1|SCRN|2|SCREENING|2021-10-09|2022-03-28|12|182
Study ID|SE|2f83788c-5f95-47c0-91aa-a8577b6864ae|2|P|7|TREATMENT|2021-11-26|2022-01-06|60|101
Study ID|SE|2f83788c-5f95-47c0-91aa-a8577b6864ae|3|REST|6|WASHOUT|2021-11-09|2022-01-03|43|98
Study ID|SE|2f83788c-5f95-47c0-91aa-a8577b6864ae|4|5|3|TREATMENT|2022-06-12|2022-06-18|258|264
Study ID|SE|2f83788c-5f95-47c0-91aa-a8577b6864ae|5|REST|1|WASHOUT|2021-09-30|2021-10-01|3|4
Study ID|SE|2f83788c-5f95-47c0-91aa-a8577b6864ae|6|10|7|TREATMENT|2022-01-16|2022-03-03|111|157
Study ID|SE|2f83788c-5f95-47c0-91aa-a8577b6864ae|7|FU|1|FOLLOW-UP|2022-01-13|2022-02-20|108|146
Study ID|SE|67ea82d1-7c31-47dd-a86d-735cb8959645|1|SCRN|7|SCREENING|2021-11-09|2021-12-09|16|46
Study ID|SE|67ea82d1-7c31-47dd-a86d-735cb8959645|2|P|4|TREATMENT|2021-11-24|2022-03-29|31|156
Study ID|SE|67ea82d1-7c31-47dd-a86d-735cb8959645|3|REST|2|WASHOUT|2022-06-04|2022-08-11|223|291
Study ID|SE|67ea82d1-7c31-47dd-a86d-735cb8959645|4|5|6|TREATMENT|2021-11-18|2022-01-12|25|80
Study ID|SE|67ea82d1-7c31-47dd-a86d-735cb8959645|5|REST|1|WASHOUT|2021-11-04|2021-11-20|11|27
Study ID|SE|67ea82d1-7c31-47dd-a86d-735cb8959645|6|10|5|TREATMENT|2022-03-16|2022-04-10|143|168
Study ID|SE|67ea82d1-7c31-47dd-a86d-735cb8959645|7|FU|3|FOLLOW-UP|2021-10-30|2022-08-09|6|289
Study ID|SE|a120fa16-f4c5-44cc-b4b7-d48d3e6ea808|1|SCRN|4|SCREENING|2021-11-14|2021-12-15|60|91
Study ID|SE|a120fa16-f4c5-44cc-b4b7-d48d3e6ea808|2|5|4|TREATMENT|2022-03-03|2022-05-31|169|258
Study ID|SE|a120fa16-f4c5-44cc-b4b7-d48d3e6ea808|3|REST|6|WASHOUT|2022-02-15|2022-03-02|153|168
Study ID|SE|a120fa16-f4c5-44cc-b4b7-d48d3e6ea808|4|10|2|TREATMENT|2021-12-18|2022-01-28|94|135
Study ID|SE|a120fa16-f4c5-44cc-b4b7-d48d3e6ea808|5|REST|3|WASHOUT|2021-09-25|2021-10-19|10|34
Study ID|SE|a120fa16-f4c5-44cc-b4b7-d48d3e6ea808|6|P|3|TREATMENT|2021-09-24|2021-09-25|9|10
Study ID|SE|a120fa16-f4c5-44cc-b4b7-d48d3e6ea808|7|FU|6|FOLLOW-UP|2021-10-09|2021-11-11|24|57
Study ID|SE|da347bd5-04a6-4702-9bdf-d423296bd37a|1|SCRN|6|SCREENING|2021-09-25|2021-10-19|36|60
Study ID|SE|da347bd5-04a6-4702-9bdf-d423296bd37a|2|P|1|TREATMENT|2022-02-20|2022-03-22|184|214
Study ID|SE|da347bd5-04a6-4702-9bdf-d423296bd37a|3|REST|7|WASHOUT|2021-12-09|2022-01-06|111|139
Study ID|SE|da347bd5-04a6-4702-9bdf-d423296bd37a|4|5|2|TREATMENT|2021-12-26|2022-01-08|128|141
Study ID|SE|da347bd5-04a6-4702-9bdf-d423296bd37a|5|REST|4|WASHOUT|2021-09-16|2021-10-15|27|56
Study ID|SE|da347bd5-04a6-4702-9bdf-d423296bd37a|6|10|4|TREATMENT|2022-02-15|2022-02-20|179|184
Study ID|SE|da347bd5-04a6-4702-9bdf-d423296bd37a|7|FU|3|FOLLOW-UP|2021-11-22|2022-03-19|94|211
Study ID|SE|c6935776-c0dc-45a8-b6ef-4f0b0df78049|1|SCRN|6|SCREENING|2021-09-21|2021-12-16|2|88
Study ID|SE|c6935776-c0dc-45a8-b6ef-4f0b0df78049|2|P|1|TREATMENT|2021-10-18|2022-06-17|29|271
Study ID|SE|c6935776-c0dc-45a8-b6ef-4f0b0df78049|3|REST|5|WASHOUT|2022-05-21|2022-06-27|244|281
Study ID|SE|c6935776-c0dc-45a8-b6ef-4f0b0df78049|4|5|7|TREATMENT|2021-09-30|2022-05-07|11|230
Study ID|SE|c6935776-c0dc-45a8-b6ef-4f0b0df78049|5|REST|3|WASHOUT|2021-10-10|2022-05-24|21|247
Study ID|SE|c6935776-c0dc-45a8-b6ef-4f0b0df78049|6|10|5|TREATMENT|2022-01-04|2022-01-24|107|127
Study ID|SE|c6935776-c0dc-45a8-b6ef-4f0b0df78049|7|FU|3|FOLLOW-UP|2021-11-22|2021-12-30|64|102
Study ID|SE|e078c95e-c244-42b3-a2df-de4a04c44045|1|SCRN|4|SCREENING|2021-11-28|2022-02-11|63|138
Study ID|SE|e078c95e-c244-42b3-a2df-de4a04c44045|2|5|5|TREATMENT|2021-11-02|2022-01-21|37|117
Study ID|SE|e078c95e-c244-42b3-a2df-de4a04c44045|3|REST|5|WASHOUT|2022-03-18|2022-05-11|173|227
Study ID|SE|e078c95e-c244-42b3-a2df-de4a04c44045|4|10|1|TREATMENT|2021-12-18|2022-01-30|83|126
Study ID|SE|e078c95e-c244-42b3-a2df-de4a04c44045|5|REST|7|WASHOUT|2021-12-08|2022-01-02|73|98
Study ID|SE|e078c95e-c244-42b3-a2df-de4a04c44045|6|P|3|TREATMENT|2021-09-29|2022-04-13|3|199
Study ID|SE|e078c95e-c244-42b3-a2df-de4a04c44045|7|FU|2|FOLLOW-UP|2021-10-15|2021-10-16|19|20
Study ID|SE|9741b905-8565-460d-8dca-06ccf0ce4e46|1|SCRN|2|SCREENING|2021-10-06|2022-04-26|30|232
Study ID|SE|9741b905-8565-460d-8dca-06ccf0ce4e46|2|5|5|TREATMENT|2021-10-12|2021-11-24|36|79
Study ID|SE|9741b905-8565-460d-8dca-06ccf0ce4e46|3|REST|5|WASHOUT|2021-10-10|2021-10-19|34|43
Study ID|SE|9741b905-8565-460d-8dca-06ccf0ce4e46|4|10|2|TREATMENT|2021-10-27|2022-03-09|51|184
Study ID|SE|9741b905-8565-460d-8dca-06ccf0ce4e46|5|REST|4|WASHOUT|2021-11-11|2022-06-01|66|268
Study ID|SE|9741b905-8565-460d-8dca-06ccf0ce4e46|6|P|4|TREATMENT|2021-12-10|2021-12-29|95|114
Study ID|SE|9741b905-8565-460d-8dca-06ccf0ce4e46|7|FU|3|FOLLOW-UP|2021-12-11|2021-12-15|96|100
Study ID|SE|a1d554e2-e153-4703-ac09-a261b054d818|1|SCRN|2|SCREENING|2021-11-18|2022-01-10|79|132
Study ID|SE|a1d554e2-e153-4703-ac09-a261b054d818|2|5|6|TREATMENT|2021-09-10|2021-09-18|10|18
Study ID|SE|a1d554e2-e153-4703-ac09-a261b054d818|3|REST|2|WASHOUT|2021-11-23|2022-06-01|84|274
Study ID|SE|a1d554e2-e153-4703-ac09-a261b054d818|4|P|1|TREATMENT|2021-11-18|2022-04-05|79|217
Study ID|SE|a1d554e2-e153-4703-ac09-a261b054d818|5|REST|3|WASHOUT|2022-05-22|2022-06-18|264|291
Study ID|SE|a1d554e2-e153-4703-ac09-a261b054d818|6|10|5|TREATMENT|2021-12-12|2022-01-09|103|131
Study ID|SE|a1d554e2-e153-4703-ac09-a261b054d818|7|FU|3|FOLLOW-UP|2021-09-14|2021-09-15|14|15
Study ID|SE|2bfaca0e-7432-4006-82f9-df89cd638dec|1|SCRN|7|SCREENING|2021-12-22|2022-06-10|70|240
Study ID|SE|2bfaca0e-7432-4006-82f9-df89cd638dec|2|5|3|TREATMENT|2022-02-22|2022-04-23|132|192
Study ID|SE|2bfaca0e-7432-4006-82f9-df89cd638dec|3|REST|1|WASHOUT|2021-11-07|2021-11-19|25|37
Study ID|SE|2bfaca0e-7432-4006-82f9-df89cd638dec|4|P|6|TREATMENT|2021-10-31|2022-03-20|18|158
Study ID|SE|2bfaca0e-7432-4006-82f9-df89cd638dec|5|REST|7|WASHOUT|2021-11-13|2021-11-14|31|32
Study ID|SE|2bfaca0e-7432-4006-82f9-df89cd638dec|6|10|3|TREATMENT|2021-10-16|2021-10-25|3|12
Study ID|SE|2bfaca0e-7432-4006-82f9-df89cd638dec|7|FU|5|FOLLOW-UP|2021-10-15|2022-02-28|2|138
Study ID|SE|73e211f4-249d-4736-b234-bfbc04721709|1|SCRN|6|SCREENING|2021-09-06|2022-01-07|19|142
Study ID|SE|73e211f4-249d-4736-b234-bfbc04721709|2|P|1|TREATMENT|2021-09-29|2021-10-01|42|44
Study ID|SE|73e211f4-249d-4736-b234-bfbc04721709|3|REST|3|WASHOUT|2021-10-13|2022-05-30|56|285
Study ID|SE|73e211f4-249d-4736-b234-bfbc04721709|4|5|7|TREATMENT|2021-10-08|2022-05-15|51|270
Study ID|SE|73e211f4-249d-4736-b234-bfbc04721709|5|REST|1|WASHOUT|2022-01-15|2022-02-23|150|189
Study ID|SE|73e211f4-249d-4736-b234-bfbc04721709|6|10|6|TREATMENT|2021-11-06|2022-02-27|80|193
Study ID|SE|73e211f4-249d-4736-b234-bfbc04721709|7|FU|4|FOLLOW-UP|2021-10-18|2021-11-30|61|104
Study ID|SE|8d0d1112-a65d-4ad9-bce5-7f5c11bec70d|1|SCRN|7|SCREENING|2022-01-22|2022-03-03|102|142
Study ID|SE|8d0d1112-a65d-4ad9-bce5-7f5c11bec70d|2|5|4|TREATMENT|2021-11-09|2021-11-14|28|33
Study ID|SE|8d0d1112-a65d-4ad9-bce5-7f5c11bec70d|3|REST|2|WASHOUT|2021-10-19|2021-11-28|7|47
Study ID|SE|8d0d1112-a65d-4ad9-bce5-7f5c11bec70d|4|10|5|TREATMENT|2021-12-15|2022-04-15|64|185
Study ID|SE|8d0d1112-a65d-4ad9-bce5-7f5c11bec70d|5|REST|5|WASHOUT|2021-10-17|2021-11-28|5|47
Study ID|SE|8d0d1112-a65d-4ad9-bce5-7f5c11bec70d|6|P|7|TREATMENT|2021-12-03|2022-03-03|52|142
Study ID|SE|8d0d1112-a65d-4ad9-bce5-7f5c11bec70d|7|FU|5|FOLLOW-UP|2022-03-29|2022-04-06|168|176
Study ID|SE|50303234-a96f-4a05-a979-d5f199e465c6|1|SCRN|1|SCREENING|2022-02-12|2022-04-18|118|183
Study ID|SE|50303234-a96f-4a05-a979-d5f199e465c6|2|5|1|TREATMENT|2021-11-02|2021-11-05|16|19
Study ID|SE|50303234-a96f-4a05-a979-d5f199e465c6|3|REST|6|WASHOUT|2022-01-16|2022-02-11|91|117
Study ID|SE|50303234-a96f-4a05-a979-d5f199e465c6|4|10|5|TREATMENT|2022-02-13|2022-03-05|119|139
Study ID|SE|50303234-a96f-4a05-a979-d5f199e465c6|5|REST|1|WASHOUT|2022-03-30|2022-07-31|164|287
Study ID|SE|50303234-a96f-4a05-a979-d5f199e465c6|6|P|1|TREATMENT|2021-11-30|2022-04-11|44|176
Study ID|SE|50303234-a96f-4a05-a979-d5f199e465c6|7|FU|1|FOLLOW-UP|2022-03-21|2022-05-31|155|226
Study ID|SE|1ed4eb06-a61b-4ee8-a2ee-3e8ddcc09a16|1|SCRN|3|SCREENING|2021-10-09|2021-11-16|45|83
Study ID|SE|1ed4eb06-a61b-4ee8-a2ee-3e8ddcc09a16|2|5|3|TREATMENT|2021-12-07|2022-02-01|104|160
Study ID|SE|1ed4eb06-a61b-4ee8-a2ee-3e8ddcc09a16|3|REST|2|WASHOUT|2021-11-18|2021-11-21|85|88
Study ID|SE|1ed4eb06-a61b-4ee8-a2ee-3e8ddcc09a16|4|P|2|TREATMENT|2021-09-27|2021-12-05|33|102
Study ID|SE|1ed4eb06-a61b-4ee8-a2ee-3e8ddcc09a16|5|REST|6|WASHOUT|2021-10-05|2021-10-29|41|65
Study ID|SE|1ed4eb06-a61b-4ee8-a2ee-3e8ddcc09a16|6|10|1|TREATMENT|2021-12-12|2021-12-30|109|127
Study ID|SE|1ed4eb06-a61b-4ee8-a2ee-3e8ddcc09a16|7|FU|2|FOLLOW-UP|2022-01-29|2022-02-05|157|164
Study ID|SE|4386650d-d299-4d8d-a657-58c847fb8c00|1|SCRN|2|SCREENING|2021-11-28|2022-04-19|41|183
Study ID|SE|4386650d-d299-4d8d-a657-58c847fb8c00|2|5|4|TREATMENT|2022-06-19|2022-08-01|244|287
Study ID|SE|4386650d-d299-4d8d-a657-58c847fb8c00|3|REST|6|WASHOUT|2021-12-28|2022-01-11|71|85
Study ID|SE|4386650d-d299-4d8d-a657-58c847fb8c00|4|P|4|TREATMENT|2021-12-07|2022-02-27|50|132
Study ID|SE|4386650d-d299-4d8d-a657-58c847fb8c00|5|REST|4|WASHOUT|2021-11-27|2022-01-07|40|81
Study ID|SE|4386650d-d299-4d8d-a657-58c847fb8c00|6|10|4|TREATMENT|2021-10-29|2022-01-25|11|99
Study ID|SE|4386650d-d299-4d8d-a657-58c847fb8c00|7|FU|5|FOLLOW-UP|2022-03-05|2022-03-15|138|148
Study ID|SE|363b577d-5a9b-4cd5-a353-5ac7547e0b69|1|SCRN|6|SCREENING|2021-12-13|2022-03-30|97|204
Study ID|SE|363b577d-5a9b-4cd5-a353-5ac7547e0b69|2|5|5|TREATMENT|2021-10-10|2021-10-27|33|50
Study ID|SE|363b577d-5a9b-4cd5-a353-5ac7547e0b69|3|REST|7|WASHOUT|2022-02-25|2022-03-28|171|202
Study ID|SE|363b577d-5a9b-4cd5-a353-5ac7547e0b69|4|10|4|TREATMENT|2021-09-17|2021-11-16|10|70
Study ID|SE|363b577d-5a9b-4cd5-a353-5ac7547e0b69|5|REST|7|WASHOUT|2021-10-15|2021-11-09|38|63
Study ID|SE|363b577d-5a9b-4cd5-a353-5ac7547e0b69|6|P|7|TREATMENT|2022-03-28|2022-05-18|202|253
Study ID|SE|363b577d-5a9b-4cd5-a353-5ac7547e0b69|7|FU|5|FOLLOW-UP|2021-09-14|2021-09-26|7|19
Study ID|SE|0dae606b-1594-45a8-a22b-f01abc193c6f|1|SCRN|2|SCREENING|2022-01-30|2022-03-14|116|159
Study ID|SE|0dae606b-1594-45a8-a22b-f01abc193c6f|2|5|3|TREATMENT|2021-10-10|2021-10-16|4|10
Study ID|SE|0dae606b-1594-45a8-a22b-f01abc193c6f|3|REST|1|WASHOUT|2022-01-28|2022-05-13|114|219
Study ID|SE|0dae606b-1594-45a8-a22b-f01abc193c6f|4|10|3|TREATMENT|2022-03-05|2022-03-28|150|173
Study ID|SE|0dae606b-1594-45a8-a22b-f01abc193c6f|5|REST|4|WASHOUT|2021-11-15|2021-12-01|40|56
Study ID|SE|0dae606b-1594-45a8-a22b-f01abc193c6f|6|P|2|TREATMENT|2021-12-07|2022-04-17|62|193
Study ID|SE|0dae606b-1594-45a8-a22b-f01abc193c6f|7|FU|1|FOLLOW-UP|2022-06-09|2022-07-11|246|278
Study ID|SE|29b7909c-0caf-4a3d-98dd-f1dc96294bcf|1|SCRN|6|SCREENING|2021-09-15|2022-03-26|16|208
Study ID|SE|29b7909c-0caf-4a3d-98dd-f1dc96294bcf|2|P|6|TREATMENT|2021-10-07|2021-10-08|38|39
Study ID|SE|29b7909c-0caf-4a3d-98dd-f1dc96294bcf|3|REST|1|WASHOUT|2021-10-18|2022-03-19|49|201
Study ID|SE|29b7909c-0caf-4a3d-98dd-f1dc96294bcf|4|5|1|TREATMENT|2021-09-26|2022-03-04|27|186
Study ID|SE|29b7909c-0caf-4a3d-98dd-f1dc96294bcf|5|REST|6|WASHOUT|2021-10-11|2021-12-30|42|122
Study ID|SE|29b7909c-0caf-4a3d-98dd-f1dc96294bcf|6|10|4|TREATMENT|2021-12-27|2022-04-25|119|238
Study ID|SE|29b7909c-0caf-4a3d-98dd-f1dc96294bcf|7|FU|4|FOLLOW-UP|2022-01-22|2022-03-02|145|184
Study ID|SE|caa5f408-9834-4b2e-b07a-acc62f7e6606|1|SCRN|7|SCREENING|2022-05-02|2022-06-21|186|236
Study ID|SE|caa5f408-9834-4b2e-b07a-acc62f7e6606|2|P|7|TREATMENT|2021-12-26|2022-02-26|59|121
Study ID|SE|caa5f408-9834-4b2e-b07a-acc62f7e6606|3|REST|1|WASHOUT|2022-03-11|2022-04-07|134|161
Study ID|SE|caa5f408-9834-4b2e-b07a-acc62f7e6606|4|5|5|TREATMENT|2021-11-09|2022-02-02|12|97
Study ID|SE|caa5f408-9834-4b2e-b07a-acc62f7e6606|5|REST|7|WASHOUT|2021-12-25|2022-02-08|58|103
Study ID|SE|caa5f408-9834-4b2e-b07a-acc62f7e6606|6|10|1|TREATMENT|2022-02-20|2022-06-17|115|232
Study ID|SE|caa5f408-9834-4b2e-b07a-acc62f7e6606|7|FU|3|FOLLOW-UP|2021-12-25|2022-01-15|58|79
Study ID|SE|04820ebc-945e-4625-a6e3-b40c32e374f8|1|SCRN|3|SCREENING|2021-11-14|2022-03-22|42|170
Study ID|SE|04820ebc-945e-4625-a6e3-b40c32e374f8|2|5|2|TREATMENT|2022-02-01|2022-04-11|121|190
Study ID|SE|04820ebc-945e-4625-a6e3-b40c32e374f8|3|REST|2|WASHOUT|2021-10-17|2021-11-15|14|43
Study ID|SE|04820ebc-945e-4625-a6e3-b40c32e374f8|4|P|1|TREATMENT|2021-11-20|2021-12-25|48|83
Study ID|SE|04820ebc-945e-4625-a6e3-b40c32e374f8|5|REST|4|WASHOUT|2021-11-20|2022-01-19|48|108
Study ID|SE|04820ebc-945e-4625-a6e3-b40c32e374f8|6|10|3|TREATMENT|2021-11-10|2022-01-18|38|107
Study ID|SE|04820ebc-945e-4625-a6e3-b40c32e374f8|7|FU|2|FOLLOW-UP|2021-10-12|2021-10-21|9|18
Study ID|SE|cf5c476b-1fa3-443b-b692-e1749ec1a311|1|SCRN|4|SCREENING|2021-10-10|2021-11-15|32|68
Study ID|SE|cf5c476b-1fa3-443b-b692-e1749ec1a311|2|P|4|TREATMENT|2021-10-09|2021-10-27|31|49
Study ID|SE|cf5c476b-1fa3-443b-b692-e1749ec1a311|3|REST|6|WASHOUT|2021-10-18|2022-03-05|40|178
Study ID|SE|cf5c476b-1fa3-443b-b692-e1749ec1a311|4|5|2|TREATMENT|2022-05-14|2022-06-23|248|288
Study ID|SE|cf5c476b-1fa3-443b-b692-e1749ec1a311|5|REST|1|WASHOUT|2021-12-31|2022-01-22|114|136
Study ID|SE|cf5c476b-1fa3-443b-b692-e1749ec1a311|6|10|5|TREATMENT|2021-12-03|2022-06-16|86|281
Study ID|SE|cf5c476b-1fa3-443b-b692-e1749ec1a311|7|FU|3|FOLLOW-UP|2021-09-12|2022-04-13|4|217
Study ID|SE|c472e3b9-65a2-4eff-a2f8-2795a8dcb69a|1|SCRN|5|SCREENING|2022-01-17|2022-01-26|104|113
Study ID|SE|c472e3b9-65a2-4eff-a2f8-2795a8dcb69a|2|5|7|TREATMENT|2021-12-16|2022-01-01|72|88
Study ID|SE|c472e3b9-65a2-4eff-a2f8-2795a8dcb69a|3|REST|7|WASHOUT|2022-03-27|2022-07-20|173|288
Study ID|SE|c472e3b9-65a2-4eff-a2f8-2795a8dcb69a|4|10|1|TREATMENT|2021-11-30|2022-05-16|56|223
Study ID|SE|c472e3b9-65a2-4eff-a2f8-2795a8dcb69a|5|REST|7|WASHOUT|2022-03-15|2022-05-23|161|230
Study ID|SE|c472e3b9-65a2-4eff-a2f8-2795a8dcb69a|6|P|7|TREATMENT|2021-11-11|2021-12-10|37|66
Study ID|SE|c472e3b9-65a2-4eff-a2f8-2795a8dcb69a|7|FU|5|FOLLOW-UP|2022-05-05|2022-06-10|212|248
Study ID|SE|318c96b9-51b5-46c7-ac4d-6bebe6060498|1|SCRN|1|SCREENING|2021-11-19|2022-01-02|35|79
Study ID|SE|318c96b9-51b5-46c7-ac4d-6bebe6060498|2|5|6|TREATMENT|2021-10-29|2021-11-06|14|22
Study ID|SE|318c96b9-51b5-46c7-ac4d-6bebe6060498|3|REST|4|WASHOUT|2021-12-26|2022-01-03|72|80
Study ID|SE|318c96b9-51b5-46c7-ac4d-6bebe6060498|4|P|4|TREATMENT|2022-02-01|2022-03-08|109|144
Study ID|SE|318c96b9-51b5-46c7-ac4d-6bebe6060498|5|REST|2|WASHOUT|2021-11-04|2022-04-21|20|188
Study ID|SE|318c96b9-51b5-46c7-ac4d-6bebe6060498|6|10|7|TREATMENT|2022-01-18|2022-01-29|95|106
Study ID|SE|318c96b9-51b5-46c7-ac4d-6bebe6060498|7|FU|1|FOLLOW-UP|2021-10-30|2022-07-04|15|262
Study ID|SE|7741ac05-c3df-49b6-bce4-593b34a9dd72|1|SCRN|2|SCREENING|2022-04-03|2022-06-08|183|249
Study ID|SE|7741ac05-c3df-49b6-bce4-593b34a9dd72|2|5|7|TREATMENT|2021-10-12|2021-10-14|10|12
Study ID|SE|7741ac05-c3df-49b6-bce4-593b34a9dd72|3|REST|5|WASHOUT|2021-10-15|2022-04-16|13|196
Study ID|SE|7741ac05-c3df-49b6-bce4-593b34a9dd72|4|10|3|TREATMENT|2022-06-20|2022-07-14|261|285
Study ID|SE|7741ac05-c3df-49b6-bce4-593b34a9dd72|5|REST|6|WASHOUT|2021-11-18|2021-12-29|47|88
Study ID|SE|7741ac05-c3df-49b6-bce4-593b34a9dd72|6|P|7|TREATMENT|2021-10-20|2021-11-14|18|43
Study ID|SE|7741ac05-c3df-49b6-bce4-593b34a9dd72|7|FU|5|FOLLOW-UP|2022-01-10|2022-02-05|100|126
Study ID|SE|17381173-41bd-4620-83dc-ab51611d807e|1|SCRN|3|SCREENING|2021-09-28|2022-06-27|15|287
Study ID|SE|17381173-41bd-4620-83dc-ab51611d807e|2|5|2|TREATMENT|2022-01-12|2022-05-26|121|255
Study ID|SE|17381173-41bd-4620-83dc-ab51611d807e|3|REST|1|WASHOUT|2021-10-09|2021-12-04|26|82
Study ID|SE|17381173-41bd-4620-83dc-ab51611d807e|4|10|2|TREATMENT|2022-03-23|2022-07-07|191|297
Study ID|SE|17381173-41bd-4620-83dc-ab51611d807e|5|REST|4|WASHOUT|2022-05-29|2022-06-29|258|289
Study ID|SE|17381173-41bd-4620-83dc-ab51611d807e|6|P|7|TREATMENT|2021-12-10|2022-03-13|88|181
Study ID|SE|17381173-41bd-4620-83dc-ab51611d807e|7|FU|4|FOLLOW-UP|2022-04-21|2022-04-23|220|222
Study ID|SE|99233170-3f1d-4cea-acca-6a9df5e53fb9|1|SCRN|1|SCREENING|2021-10-28|2022-01-20|73|157
Study ID|SE|99233170-3f1d-4cea-acca-6a9df5e53fb9|2|5|6|TREATMENT|2022-04-08|2022-04-16|235|243
Study ID|SE|99233170-3f1d-4cea-acca-6a9df5e53fb9|3|REST|7|WASHOUT|2022-02-05|2022-04-07|173|234
Study ID|SE|99233170-3f1d-4cea-acca-6a9df5e53fb9|4|10|5|TREATMENT|2022-01-08|2022-05-02|145|259
Study ID|SE|99233170-3f1d-4cea-acca-6a9df5e53fb9|5|REST|7|WASHOUT|2021-09-28|2022-01-23|43|160
Study ID|SE|99233170-3f1d-4cea-acca-6a9df5e53fb9|6|P|5|TREATMENT|2022-04-30|2022-05-06|257|263
Study ID|SE|99233170-3f1d-4cea-acca-6a9df5e53fb9|7|FU|4|FOLLOW-UP|2021-08-18|2021-09-15|2|30
Study ID|SE|e25f381b-35ad-4e0e-b68f-5064f975797c|1|SCRN|3|SCREENING|2022-02-14|2022-04-22|150|217
Study ID|SE|e25f381b-35ad-4e0e-b68f-5064f975797c|2|5|5|TREATMENT|2022-02-10|2022-05-01|146|226
Study ID|SE|e25f381b-35ad-4e0e-b68f-5064f975797c|3|REST|5|WASHOUT|2021-09-27|2021-11-02|10|46
Study ID|SE|e25f381b-35ad-4e0e-b68f-5064f975797c|4|P|5|TREATMENT|2022-01-07|2022-02-02|112|138
Study ID|SE|e25f381b-35ad-4e0e-b68f-5064f975797c|5|REST|7|WASHOUT|2021-10-09|2022-02-03|22|139
Study ID|SE|e25f381b-35ad-4e0e-b68f-5064f975797c|6|10|6|TREATMENT|2021-12-15|2021-12-23|89|97
Study ID|SE|e25f381b-35ad-4e0e-b68f-5064f975797c|7|FU|2|FOLLOW-UP|2021-09-30|2021-10-30|13|43
Study ID|SE|c01e42ba-3c20-4dc8-8275-973b23c7d24e|1|SCRN|6|SCREENING|2021-11-18|2022-01-01|63|107
Study ID|SE|c01e42ba-3c20-4dc8-8275-973b23c7d24e|2|P|3|TREATMENT|2021-09-24|2022-02-03|8|140
Study ID|SE|c01e42ba-3c20-4dc8-8275-973b23c7d24e|3|REST|2|WASHOUT|2022-02-16|2022-05-20|153|246
Study ID|SE|c01e42ba-3c20-4dc8-8275-973b23c7d24e|4|5|3|TREATMENT|2022-01-27|2022-03-14|133|179
Study ID|SE|c01e42ba-3c20-4dc8-8275-973b23c7d24e|5|REST|4|WASHOUT|2022-01-19|2022-01-27|125|133
Study ID|SE|c01e42ba-3c20-4dc8-8275-973b23c7d24e|6|10|3|TREATMENT|2021-11-02|2021-12-23|47|98
Study ID|SE|c01e42ba-3c20-4dc8-8275-973b23c7d24e|7|FU|2|FOLLOW-UP|2021-10-22|2022-04-08|36|204
Study ID|SE|1e88658b-be76-4197-a4ba-5e9e6ecf9510|1|SCRN|7|SCREENING|2022-01-25|2022-02-13|118|137
Study ID|SE|1e88658b-be76-4197-a4ba-5e9e6ecf9510|2|5|6|TREATMENT|2021-10-12|2022-01-14|13|107
Study ID|SE|1e88658b-be76-4197-a4ba-5e9e6ecf9510|3|REST|2|WASHOUT|2022-01-19|2022-03-29|112|181
Study ID|SE|1e88658b-be76-4197-a4ba-5e9e6ecf9510|4|10|2|TREATMENT|2021-12-26|2021-12-31|88|93
Study ID|SE|1e88658b-be76-4197-a4ba-5e9e6ecf9510|5|REST|2|WASHOUT|2021-11-11|2022-03-06|43|158
Study ID|SE|1e88658b-be76-4197-a4ba-5e9e6ecf9510|6|P|1|TREATMENT|2021-10-03|2021-11-16|4|48
Study ID|SE|1e88658b-be76-4197-a4ba-5e9e6ecf9510|7|FU|2|FOLLOW-UP|2021-12-04|2021-12-14|66|76
Study ID|SE|8f7bdef5-9a74-42d8-b249-33b99356ce97|1|SCRN|1|SCREENING|2021-09-16|2022-03-09|20|194
Study ID|SE|8f7bdef5-9a74-42d8-b249-33b99356ce97|2|5|1|TREATMENT|2021-10-03|2022-02-06|37|163
Study ID|SE|8f7bdef5-9a74-42d8-b249-33b99356ce97|3|REST|3|WASHOUT|2021-10-11|2022-02-28|45|185
Study ID|SE|8f7bdef5-9a74-42d8-b249-33b99356ce97|4|P|7|TREATMENT|2021-10-09|2021-10-12|43|46
Study ID|SE|8f7bdef5-9a74-42d8-b249-33b99356ce97|5|REST|4|WASHOUT|2022-01-13|2022-05-24|139|270
Study ID|SE|8f7bdef5-9a74-42d8-b249-33b99356ce97|6|10|3|TREATMENT|2021-09-21|2021-10-14|25|48
Study ID|SE|8f7bdef5-9a74-42d8-b249-33b99356ce97|7|FU|7|FOLLOW-UP|2021-10-29|2021-12-10|63|105
Study ID|SE|ff8bdf28-42ca-4c5b-ad57-231fb9e9eab8|1|SCRN|2|SCREENING|2021-10-24|2021-12-29|29|95
Study ID|SE|ff8bdf28-42ca-4c5b-ad57-231fb9e9eab8|2|5|3|TREATMENT|2021-11-14|2022-04-18|50|205
Study ID|SE|ff8bdf28-42ca-4c5b-ad57-231fb9e9eab8|3|REST|5|WASHOUT|2022-02-13|2022-05-26|141|243
Study ID|SE|ff8bdf28-42ca-4c5b-ad57-231fb9e9eab8|4|P|1|TREATMENT|2021-10-23|2021-10-31|28|36
Study ID|SE|ff8bdf28-42ca-4c5b-ad57-231fb9e9eab8|5|REST|1|WASHOUT|2022-01-23|2022-03-23|120|179
Study ID|SE|ff8bdf28-42ca-4c5b-ad57-231fb9e9eab8|6|10|7|TREATMENT|2022-02-20|2022-02-23|148|151
Study ID|SE|ff8bdf28-42ca-4c5b-ad57-231fb9e9eab8|7|FU|2|FOLLOW-UP|2021-11-10|2021-11-15|46|51
Study ID|SE|2b7f19fd-2b74-43af-96e6-d3277f9bfb16|1|SCRN|7|SCREENING|2022-03-07|2022-04-03|186|213
Study ID|SE|2b7f19fd-2b74-43af-96e6-d3277f9bfb16|2|5|4|TREATMENT|2022-03-08|2022-03-18|187|197
Study ID|SE|2b7f19fd-2b74-43af-96e6-d3277f9bfb16|3|REST|5|WASHOUT|2021-09-06|2021-09-07|4|5
Study ID|SE|2b7f19fd-2b74-43af-96e6-d3277f9bfb16|4|P|3|TREATMENT|2021-09-04|2021-09-04|2|2
Study ID|SE|2b7f19fd-2b74-43af-96e6-d3277f9bfb16|5|REST|4|WASHOUT|2022-01-08|2022-03-29|128|208
Study ID|SE|2b7f19fd-2b74-43af-96e6-d3277f9bfb16|6|10|3|TREATMENT|2022-01-17|2022-01-31|137|151
Study ID|SE|2b7f19fd-2b74-43af-96e6-d3277f9bfb16|7|FU|3|FOLLOW-UP|2022-04-04|2022-05-30|214|270
Study ID|SE|e8c495d0-b9c2-48a0-9846-f0cd24df8675|1|SCRN|6|SCREENING|2021-12-09|2022-02-11|68|132
Study ID|SE|e8c495d0-b9c2-48a0-9846-f0cd24df8675|2|P|1|TREATMENT|2022-02-28|2022-03-25|149|174
Study ID|SE|e8c495d0-b9c2-48a0-9846-f0cd24df8675|3|REST|1|WASHOUT|2022-01-22|2022-04-07|112|187
Study ID|SE|e8c495d0-b9c2-48a0-9846-f0cd24df8675|4|5|6|TREATMENT|2022-05-07|2022-05-09|217|219
Study ID|SE|e8c495d0-b9c2-48a0-9846-f0cd24df8675|5|REST|5|WASHOUT|2021-12-28|2022-01-28|87|118
Study ID|SE|e8c495d0-b9c2-48a0-9846-f0cd24df8675|6|10|4|TREATMENT|2022-01-21|2022-04-04|111|184
Study ID|SE|e8c495d0-b9c2-48a0-9846-f0cd24df8675|7|FU|4|FOLLOW-UP|2021-11-24|2021-12-23|53|82
Study ID|SE|102375bf-0d0d-4b6d-ad07-e82886eebd33|1|SCRN|3|SCREENING|2021-08-17|2021-09-08|9|31
Study ID|SE|102375bf-0d0d-4b6d-ad07-e82886eebd33|2|P|2|TREATMENT|2021-10-11|2021-12-26|64|140
Study ID|SE|102375bf-0d0d-4b6d-ad07-e82886eebd33|3|REST|1|WASHOUT|2021-08-16|2022-02-26|8|202
Study ID|SE|102375bf-0d0d-4b6d-ad07-e82886eebd33|4|5|3|TREATMENT|2022-01-17|2022-04-21|162|256
Study ID|SE|102375bf-0d0d-4b6d-ad07-e82886eebd33|5|REST|1|WASHOUT|2021-08-30|2021-10-05|22|58
Study ID|SE|102375bf-0d0d-4b6d-ad07-e82886eebd33|6|10|3|TREATMENT|2021-08-22|2021-10-23|14|76
Study ID|SE|102375bf-0d0d-4b6d-ad07-e82886eebd33|7|FU|2|FOLLOW-UP|2021-11-04|2022-03-22|88|226
Study ID|SE|2cbee9a8-b1ff-45d7-95e7-444c53088ec6|1|SCRN|1|SCREENING|2021-10-06|2021-10-31|43|68
Study ID|SE|2cbee9a8-b1ff-45d7-95e7-444c53088ec6|2|P|7|TREATMENT|2021-10-20|2022-03-28|57|216
Study ID|SE|2cbee9a8-b1ff-45d7-95e7-444c53088ec6|3|REST|4|WASHOUT|2021-12-12|2022-04-23|110|242
Study ID|SE|2cbee9a8-b1ff-45d7-95e7-444c53088ec6|4|5|4|TREATMENT|2021-11-01|2022-02-22|69|182
Study ID|SE|2cbee9a8-b1ff-45d7-95e7-444c53088ec6|5|REST|2|WASHOUT|2021-09-10|2022-01-27|17|156
Study ID|SE|2cbee9a8-b1ff-45d7-95e7-444c53088ec6|6|10|7|TREATMENT|2021-12-11|2022-03-26|109|214
Study ID|SE|2cbee9a8-b1ff-45d7-95e7-444c53088ec6|7|FU|7|FOLLOW-UP|2021-11-26|2022-02-15|94|175
Study ID|SE|d8fa5a4c-28f1-48ba-a463-83a0f2149944|1|SCRN|4|SCREENING|2021-10-26|2021-11-26|53|84
Study ID|SE|d8fa5a4c-28f1-48ba-a463-83a0f2149944|2|P|5|TREATMENT|2021-09-22|2021-10-23|19|50
Study ID|SE|d8fa5a4c-28f1-48ba-a463-83a0f2149944|3|REST|2|WASHOUT|2022-03-01|2022-03-23|179|201
Study ID|SE|d8fa5a4c-28f1-48ba-a463-83a0f2149944|4|5|4|TREATMENT|2021-09-29|2021-12-19|26|107
Study ID|SE|d8fa5a4c-28f1-48ba-a463-83a0f2149944|5|REST|1|WASHOUT|2021-10-15|2022-06-16|42|286
Study ID|SE|d8fa5a4c-28f1-48ba-a463-83a0f2149944|6|10|4|TREATMENT|2021-10-17|2022-01-10|44|129
Study ID|SE|d8fa5a4c-28f1-48ba-a463-83a0f2149944|7|FU|2|FOLLOW-UP|2021-12-22|2022-04-13|110|222
Study ID|SE|7a8957a1-9945-4a8b-84be-4f5c7b3f2f2d|1|SCRN|5|SCREENING|2021-10-18|2021-12-18|5|66
Study ID|SE|7a8957a1-9945-4a8b-84be-4f5c7b3f2f2d|2|P|6|TREATMENT|2022-03-17|2022-08-06|155|297
Study ID|SE|7a8957a1-9945-4a8b-84be-4f5c7b3f2f2d|3|REST|6|WASHOUT|2022-03-03|2022-04-29|141|198
Study ID|SE|7a8957a1-9945-4a8b-84be-4f5c7b3f2f2d|4|5|1|TREATMENT|2021-11-14|2022-04-07|32|176
Study ID|SE|7a8957a1-9945-4a8b-84be-4f5c7b3f2f2d|5|REST|2|WASHOUT|2022-02-21|2022-04-27|131|196
Study ID|SE|7a8957a1-9945-4a8b-84be-4f5c7b3f2f2d|6|10|6|TREATMENT|2021-12-18|2022-04-28|66|197
Study ID|SE|7a8957a1-9945-4a8b-84be-4f5c7b3f2f2d|7|FU|1|FOLLOW-UP|2021-10-29|2021-12-24|16|72
Study ID|SE|5df59b18-8e89-4f71-aa42-e67131bcca74|1|SCRN|2|SCREENING|2021-09-02|2022-02-23|9|183
Study ID|SE|5df59b18-8e89-4f71-aa42-e67131bcca74|2|5|5|TREATMENT|2021-09-11|2021-12-31|18|129
Study ID|SE|5df59b18-8e89-4f71-aa42-e67131bcca74|3|REST|1|WASHOUT|2022-05-17|2022-05-22|266|271
Study ID|SE|5df59b18-8e89-4f71-aa42-e67131bcca74|4|10|5|TREATMENT|2021-09-21|2022-06-16|28|296
Study ID|SE|5df59b18-8e89-4f71-aa42-e67131bcca74|5|REST|3|WASHOUT|2021-10-16|2022-02-01|53|161
Study ID|SE|5df59b18-8e89-4f71-aa42-e67131bcca74|6|P|1|TREATMENT|2021-10-07|2021-10-13|44|50
Study ID|SE|5df59b18-8e89-4f71-aa42-e67131bcca74|7|FU|5|FOLLOW-UP|2022-01-05|2022-03-31|134|219
Study ID|SE|33bc825d-2eef-4f45-92ad-9fa4a1041abc|1|SCRN|4|SCREENING|2021-09-09|2021-10-16|26|63
Study ID|SE|33bc825d-2eef-4f45-92ad-9fa4a1041abc|2|5|1|TREATMENT|2021-08-31|2021-09-01|17|18
Study ID|SE|33bc825d-2eef-4f45-92ad-9fa4a1041abc|3|REST|7|WASHOUT|2021-08-18|2021-08-27|4|13
Study ID|SE|33bc825d-2eef-4f45-92ad-9fa4a1041abc|4|P|3|TREATMENT|2021-08-17|2021-08-30|3|16
Study ID|SE|33bc825d-2eef-4f45-92ad-9fa4a1041abc|5|REST|2|WASHOUT|2021-11-04|2022-01-28|82|167
Study ID|SE|33bc825d-2eef-4f45-92ad-9fa4a1041abc|6|10|5|TREATMENT|2021-08-23|2021-10-09|9|56
Study ID|SE|33bc825d-2eef-4f45-92ad-9fa4a1041abc|7|FU|7|FOLLOW-UP|2021-08-30|2021-11-01|16|79
Study ID|SE|79aa6da6-c48b-465d-a8e3-8a70cc7fe0a0|1|SCRN|3|SCREENING|2021-09-12|2022-04-09|16|225
Study ID|SE|79aa6da6-c48b-465d-a8e3-8a70cc7fe0a0|2|P|1|TREATMENT|2021-09-04|2021-09-25|8|29
Study ID|SE|79aa6da6-c48b-465d-a8e3-8a70cc7fe0a0|3|REST|3|WASHOUT|2022-03-16|2022-04-22|201|238
Study ID|SE|79aa6da6-c48b-465d-a8e3-8a70cc7fe0a0|4|5|5|TREATMENT|2021-08-31|2021-09-02|4|6
Study ID|SE|79aa6da6-c48b-465d-a8e3-8a70cc7fe0a0|5|REST|7|WASHOUT|2021-10-15|2021-10-21|49|55
Study ID|SE|79aa6da6-c48b-465d-a8e3-8a70cc7fe0a0|6|10|2|TREATMENT|2021-10-08|2021-12-26|42|121
Study ID|SE|79aa6da6-c48b-465d-a8e3-8a70cc7fe0a0|7|FU|3|FOLLOW-UP|2022-04-01|2022-06-04|217|281
Study ID|SE|25a0f0de-927e-42b6-8806-8694ba57fdbe|1|SCRN|2|SCREENING|2021-12-19|2022-04-08|103|213
Study ID|SE|25a0f0de-927e-42b6-8806-8694ba57fdbe|2|5|7|TREATMENT|2021-09-18|2021-10-08|11|31
Study ID|SE|25a0f0de-927e-42b6-8806-8694ba57fdbe|3|REST|5|WASHOUT|2021-09-30|2021-10-29|23|52
Study ID|SE|25a0f0de-927e-42b6-8806-8694ba57fdbe|4|10|7|TREATMENT|2022-05-09|2022-05-16|244|251
Study ID|SE|25a0f0de-927e-42b6-8806-8694ba57fdbe|5|REST|7|WASHOUT|2021-09-16|2021-09-17|9|10
Study ID|SE|25a0f0de-927e-42b6-8806-8694ba57fdbe|6|P|3|TREATMENT|2021-10-15|2022-05-27|38|262
Study ID|SE|25a0f0de-927e-42b6-8806-8694ba57fdbe|7|FU|6|FOLLOW-UP|2021-09-09|2021-09-13|2|6
Study ID|SE|6a1315aa-839b-4b9e-b531-04697602c150|1|SCRN|7|SCREENING|2021-08-28|2021-10-11|11|55
Study ID|SE|6a1315aa-839b-4b9e-b531-04697602c150|2|P|3|TREATMENT|2021-09-23|2021-11-25|37|100
Study ID|SE|6a1315aa-839b-4b9e-b531-04697602c150|3|REST|1|WASHOUT|2021-08-19|2022-03-07|2|202
Study ID|SE|6a1315aa-839b-4b9e-b531-04697602c150|4|5|7|TREATMENT|2021-09-09|2021-11-25|23|100
Study ID|SE|6a1315aa-839b-4b9e-b531-04697602c150|5|REST|4|WASHOUT|2021-09-04|2021-09-07|18|21
Study ID|SE|6a1315aa-839b-4b9e-b531-04697602c150|6|10|4|TREATMENT|2021-08-22|2021-09-17|5|31
Study ID|SE|6a1315aa-839b-4b9e-b531-04697602c150|7|FU|7|FOLLOW-UP|2021-10-11|2022-02-07|55|174
Study ID|SE|0424f6df-1e7e-4656-8d05-94b93de045f0|1|SCRN|7|SCREENING|2021-10-02|2021-10-15|4|17
Study ID|SE|0424f6df-1e7e-4656-8d05-94b93de045f0|2|5|3|TREATMENT|2021-11-19|2022-04-21|52|205
Study ID|SE|0424f6df-1e7e-4656-8d05-94b93de045f0|3|REST|3|WASHOUT|2021-10-08|2021-10-10|10|12
Study ID|SE|0424f6df-1e7e-4656-8d05-94b93de045f0|4|10|2|TREATMENT|2021-11-02|2021-11-06|35|39
Study ID|SE|0424f6df-1e7e-4656-8d05-94b93de045f0|5|REST|2|WASHOUT|2021-11-14|2022-05-10|47|224
Study ID|SE|0424f6df-1e7e-4656-8d05-94b93de045f0|6|P|6|TREATMENT|2021-11-05|2022-06-07|38|252
Study ID|SE|0424f6df-1e7e-4656-8d05-94b93de045f0|7|FU|3|FOLLOW-UP|2022-01-09|2022-02-17|103|142
Study ID|SE|edc797eb-dcac-465a-90b3-7200364e4115|1|SCRN|2|SCREENING|2021-10-20|2021-10-24|42|46
Study ID|SE|edc797eb-dcac-465a-90b3-7200364e4115|2|P|4|TREATMENT|2022-04-29|2022-05-27|233|261
Study ID|SE|edc797eb-dcac-465a-90b3-7200364e4115|3|REST|1|WASHOUT|2021-10-16|2022-06-24|38|289
Study ID|SE|edc797eb-dcac-465a-90b3-7200364e4115|4|5|2|TREATMENT|2021-09-19|2021-10-16|11|38
Study ID|SE|edc797eb-dcac-465a-90b3-7200364e4115|5|REST|6|WASHOUT|2022-02-24|2022-04-21|169|225
Study ID|SE|edc797eb-dcac-465a-90b3-7200364e4115|6|10|4|TREATMENT|2021-09-28|2021-12-10|20|93
Study ID|SE|edc797eb-dcac-465a-90b3-7200364e4115|7|FU|5|FOLLOW-UP|2022-04-10|2022-06-13|214|278
Study ID|SE|d3c66bad-a6a4-4ab2-8ab9-16c6062f4e37|1|SCRN|4|SCREENING|2022-04-16|2022-05-27|209|250
Study ID|SE|d3c66bad-a6a4-4ab2-8ab9-16c6062f4e37|2|5|1|TREATMENT|2021-10-04|2021-11-20|15|62
Study ID|SE|d3c66bad-a6a4-4ab2-8ab9-16c6062f4e37|3|REST|3|WASHOUT|2022-01-24|2022-07-11|127|295
Study ID|SE|d3c66bad-a6a4-4ab2-8ab9-16c6062f4e37|4|10|5|TREATMENT|2021-09-29|2022-06-23|10|277
Study ID|SE|d3c66bad-a6a4-4ab2-8ab9-16c6062f4e37|5|REST|5|WASHOUT|2021-10-03|2021-11-17|14|59
Study ID|SE|d3c66bad-a6a4-4ab2-8ab9-16c6062f4e37|6|P|1|TREATMENT|2021-10-10|2022-05-12|21|235
Study ID|SE|d3c66bad-a6a4-4ab2-8ab9-16c6062f4e37|7|FU|7|FOLLOW-UP|2022-02-26|2022-07-11|160|295
Study ID|SE|ed11b631-0d04-44fe-8581-179d81848148|1|SCRN|5|SCREENING|2022-02-19|2022-06-19|132|252
Study ID|SE|ed11b631-0d04-44fe-8581-179d81848148|2|P|5|TREATMENT|2021-11-06|2022-06-14|27|247
Study ID|SE|ed11b631-0d04-44fe-8581-179d81848148|3|REST|7|WASHOUT|2021-11-03|2021-12-01|24|52
Study ID|SE|ed11b631-0d04-44fe-8581-179d81848148|4|5|5|TREATMENT|2021-12-30|2022-01-07|81|89
Study ID|SE|ed11b631-0d04-44fe-8581-179d81848148|5|REST|2|WASHOUT|2022-01-18|2022-03-31|100|172
Study ID|SE|ed11b631-0d04-44fe-8581-179d81848148|6|10|6|TREATMENT|2021-12-03|2022-08-04|54|298
Study ID|SE|ed11b631-0d04-44fe-8581-179d81848148|7|FU|7|FOLLOW-UP|2022-02-02|2022-03-12|115|153
Study ID|SE|5f46adb9-5194-4421-ba70-2f276b9e82c5|1|SCRN|1|SCREENING|2021-08-24|2021-10-03|10|50
Study ID|SE|5f46adb9-5194-4421-ba70-2f276b9e82c5|2|P|6|TREATMENT|2021-08-28|2021-12-28|14|136
Study ID|SE|5f46adb9-5194-4421-ba70-2f276b9e82c5|3|REST|4|WASHOUT|2022-02-03|2022-02-27|173|197
Study ID|SE|5f46adb9-5194-4421-ba70-2f276b9e82c5|4|5|4|TREATMENT|2021-08-18|2022-01-25|4|164
Study ID|SE|5f46adb9-5194-4421-ba70-2f276b9e82c5|5|REST|7|WASHOUT|2021-08-29|2021-11-14|15|92
Study ID|SE|5f46adb9-5194-4421-ba70-2f276b9e82c5|6|10|2|TREATMENT|2021-09-26|2021-11-29|43|107
Study ID|SE|5f46adb9-5194-4421-ba70-2f276b9e82c5|7|FU|6|FOLLOW-UP|2022-01-06|2022-03-25|145|223
Study ID|SE|02ce4273-a033-40ac-b8a0-aae023732aa9|1|SCRN|7|SCREENING|2021-09-08|2021-09-10|7|9
Study ID|SE|02ce4273-a033-40ac-b8a0-aae023732aa9|2|P|7|TREATMENT|2022-04-27|2022-06-26|238|298
Study ID|SE|02ce4273-a033-40ac-b8a0-aae023732aa9|3|REST|6|WASHOUT|2021-09-19|2022-06-26|18|298
Study ID|SE|02ce4273-a033-40ac-b8a0-aae023732aa9|4|5|4|TREATMENT|2021-09-15|2022-03-25|14|205
Study ID|SE|02ce4273-a033-40ac-b8a0-aae023732aa9|5|REST|7|WASHOUT|2021-10-27|2022-06-03|56|275
Study ID|SE|02ce4273-a033-40ac-b8a0-aae023732aa9|6|10|7|TREATMENT|2021-10-10|2022-04-24|39|235
Study ID|SE|02ce4273-a033-40ac-b8a0-aae023732aa9|7|FU|2|FOLLOW-UP|2021-10-13|2021-11-05|42|65
Study ID|SE|2725ff54-6e0c-4857-8749-13096a80eedb|1|SCRN|4|SCREENING|2021-09-28|2021-10-01|12|15
Study ID|SE|2725ff54-6e0c-4857-8749-13096a80eedb|2|5|3|TREATMENT|2022-02-05|2022-05-12|142|238
Study ID|SE|2725ff54-6e0c-4857-8749-13096a80eedb|3|REST|3|WASHOUT|2021-09-23|2021-10-14|7|28
Study ID|SE|2725ff54-6e0c-4857-8749-13096a80eedb|4|10|3|TREATMENT|2021-10-31|2022-02-19|45|156
Study ID|SE|2725ff54-6e0c-4857-8749-13096a80eedb|5|REST|3|WASHOUT|2021-09-27|2021-12-03|11|78
Study ID|SE|2725ff54-6e0c-4857-8749-13096a80eedb|6|P|1|TREATMENT|2022-04-23|2022-06-15|219|272
Study ID|SE|2725ff54-6e0c-4857-8749-13096a80eedb|7|FU|5|FOLLOW-UP|2021-09-20|2021-09-28|4|12
Study ID|SE|0b84fe7d-fea2-4025-a6e5-30d14d9669c2|1|SCRN|6|SCREENING|2021-10-29|2022-03-27|55|204
Study ID|SE|0b84fe7d-fea2-4025-a6e5-30d14d9669c2|2|P|2|TREATMENT|2022-04-10|2022-04-30|218|238
Study ID|SE|0b84fe7d-fea2-4025-a6e5-30d14d9669c2|3|REST|3|WASHOUT|2021-09-17|2021-10-04|13|30
Study ID|SE|0b84fe7d-fea2-4025-a6e5-30d14d9669c2|4|5|6|TREATMENT|2021-12-04|2021-12-07|91|94
Study ID|SE|0b84fe7d-fea2-4025-a6e5-30d14d9669c2|5|REST|3|WASHOUT|2022-01-10|2022-06-17|128|286
Study ID|SE|0b84fe7d-fea2-4025-a6e5-30d14d9669c2|6|10|4|TREATMENT|2022-02-02|2022-03-08|151|185
Study ID|SE|0b84fe7d-fea2-4025-a6e5-30d14d9669c2|7|FU|2|FOLLOW-UP|2021-09-19|2022-02-08|15|157
Study ID|SE|8d66f913-08d2-4c0e-b662-91e2ce0a7d1e|1|SCRN|1|SCREENING|2021-11-10|2022-05-31|34|236
Study ID|SE|8d66f913-08d2-4c0e-b662-91e2ce0a7d1e|2|5|5|TREATMENT|2022-06-11|2022-06-21|247|257
Study ID|SE|8d66f913-08d2-4c0e-b662-91e2ce0a7d1e|3|REST|3|WASHOUT|2021-11-10|2021-12-03|34|57
Study ID|SE|8d66f913-08d2-4c0e-b662-91e2ce0a7d1e|4|P|2|TREATMENT|2021-10-25|2021-10-27|18|20
Study ID|SE|8d66f913-08d2-4c0e-b662-91e2ce0a7d1e|5|REST|4|WASHOUT|2021-11-13|2021-11-17|37|41
Study ID|SE|8d66f913-08d2-4c0e-b662-91e2ce0a7d1e|6|10|4|TREATMENT|2022-01-16|2022-06-12|101|248
Study ID|SE|8d66f913-08d2-4c0e-b662-91e2ce0a7d1e|7|FU|7|FOLLOW-UP|2021-10-13|2022-03-26|6|170
Study ID|SE|2baf42c1-e2c2-46e7-b559-a4f27dde2a62|1|SCRN|6|SCREENING|2021-12-28|2022-02-10|111|155
Study ID|SE|2baf42c1-e2c2-46e7-b559-a4f27dde2a62|2|5|5|TREATMENT|2022-01-20|2022-01-30|134|144
Study ID|SE|2baf42c1-e2c2-46e7-b559-a4f27dde2a62|3|REST|1|WASHOUT|2021-09-13|2021-11-18|5|71
Study ID|SE|2baf42c1-e2c2-46e7-b559-a4f27dde2a62|4|P|6|TREATMENT|2022-01-31|2022-02-06|145|151
Study ID|SE|2baf42c1-e2c2-46e7-b559-a4f27dde2a62|5|REST|5|WASHOUT|2022-03-29|2022-05-08|202|242
Study ID|SE|2baf42c1-e2c2-46e7-b559-a4f27dde2a62|6|10|5|TREATMENT|2021-10-30|2022-01-02|52|116
Study ID|SE|2baf42c1-e2c2-46e7-b559-a4f27dde2a62|7|FU|2|FOLLOW-UP|2022-05-09|2022-06-12|243|277
Study ID|SE|3b938a08-d41a-4b13-8fca-02fdcea7459f|1|SCRN|4|SCREENING|2021-08-16|2021-08-16|2|2
Study ID|SE|3b938a08-d41a-4b13-8fca-02fdcea7459f|2|5|6|TREATMENT|2021-09-08|2022-01-11|25|150
Study ID|SE|3b938a08-d41a-4b13-8fca-02fdcea7459f|3|REST|6|WASHOUT|2021-12-11|2022-04-23|119|252
Study ID|SE|3b938a08-d41a-4b13-8fca-02fdcea7459f|4|P|2|TREATMENT|2021-12-07|2022-03-08|115|206
Study ID|SE|3b938a08-d41a-4b13-8fca-02fdcea7459f|5|REST|3|WASHOUT|2021-10-23|2021-11-13|70|91
Study ID|SE|3b938a08-d41a-4b13-8fca-02fdcea7459f|6|10|3|TREATMENT|2021-09-17|2021-09-18|34|35
Study ID|SE|3b938a08-d41a-4b13-8fca-02fdcea7459f|7|FU|6|FOLLOW-UP|2021-09-18|2021-12-18|35|126
Study ID|SE|24c2989c-3b77-401f-a162-b1dcfb9ba02a|1|SCRN|5|SCREENING|2022-05-08|2022-06-13|241|277
Study ID|SE|24c2989c-3b77-401f-a162-b1dcfb9ba02a|2|5|4|TREATMENT|2021-12-20|2022-04-30|102|233
Study ID|SE|24c2989c-3b77-401f-a162-b1dcfb9ba02a|3|REST|5|WASHOUT|2021-09-14|2021-10-10|5|31
Study ID|SE|24c2989c-3b77-401f-a162-b1dcfb9ba02a|4|10|3|TREATMENT|2021-09-23|2021-10-14|14|35
Study ID|SE|24c2989c-3b77-401f-a162-b1dcfb9ba02a|5|REST|7|WASHOUT|2021-09-16|2021-09-19|7|10
Study ID|SE|24c2989c-3b77-401f-a162-b1dcfb9ba02a|6|P|7|TREATMENT|2021-09-28|2021-10-05|19|26
Study ID|SE|24c2989c-3b77-401f-a162-b1dcfb9ba02a|7|FU|7|FOLLOW-UP|2021-10-11|2022-01-29|32|142
Study ID|SE|5b5dc815-e7bd-40d1-bf51-8c1f383eaac3|1|SCRN|6|SCREENING|2022-02-04|2022-03-03|108|135
Study ID|SE|5b5dc815-e7bd-40d1-bf51-8c1f383eaac3|2|5|1|TREATMENT|2021-10-31|2021-12-13|12|55
Study ID|SE|5b5dc815-e7bd-40d1-bf51-8c1f383eaac3|3|REST|3|WASHOUT|2021-11-13|2021-12-16|25|58
Study ID|SE|5b5dc815-e7bd-40d1-bf51-8c1f383eaac3|4|10|2|TREATMENT|2021-10-30|2021-11-08|11|20
Study ID|SE|5b5dc815-e7bd-40d1-bf51-8c1f383eaac3|5|REST|2|WASHOUT|2021-12-26|2022-02-10|68|114
Study ID|SE|5b5dc815-e7bd-40d1-bf51-8c1f383eaac3|6|P|1|TREATMENT|2021-11-10|2022-07-09|22|263
Study ID|SE|5b5dc815-e7bd-40d1-bf51-8c1f383eaac3|7|FU|1|FOLLOW-UP|2021-11-02|2021-11-06|14|18
Study ID|SE|3a612fb3-b197-437b-b1e2-2205114ebbe9|1|SCRN|2|SCREENING|2021-11-09|2021-12-27|29|77
Study ID|SE|3a612fb3-b197-437b-b1e2-2205114ebbe9|2|5|6|TREATMENT|2022-02-27|2022-05-16|139|217
Study ID|SE|3a612fb3-b197-437b-b1e2-2205114ebbe9|3|REST|6|WASHOUT|2021-11-18|2021-12-19|38|69
Study ID|SE|3a612fb3-b197-437b-b1e2-2205114ebbe9|4|P|2|TREATMENT|2021-10-23|2022-07-05|12|267
Study ID|SE|3a612fb3-b197-437b-b1e2-2205114ebbe9|5|REST|2|WASHOUT|2021-10-29|2021-12-15|18|65
Study ID|SE|3a612fb3-b197-437b-b1e2-2205114ebbe9|6|10|5|TREATMENT|2021-11-24|2021-12-05|44|55
Study ID|SE|3a612fb3-b197-437b-b1e2-2205114ebbe9|7|FU|6|FOLLOW-UP|2022-03-30|2022-05-21|170|222
Study ID|SE|0cfe074e-2d3d-4985-8187-30ccbf1327f7|1|SCRN|3|SCREENING|2022-05-22|2022-07-01|245|285
Study ID|SE|0cfe074e-2d3d-4985-8187-30ccbf1327f7|2|P|5|TREATMENT|2022-01-14|2022-07-03|117|287
Study ID|SE|0cfe074e-2d3d-4985-8187-30ccbf1327f7|3|REST|2|WASHOUT|2021-10-20|2021-11-10|31|52
Study ID|SE|0cfe074e-2d3d-4985-8187-30ccbf1327f7|4|5|6|TREATMENT|2021-12-08|2022-03-16|80|178
Study ID|SE|0cfe074e-2d3d-4985-8187-30ccbf1327f7|5|REST|7|WASHOUT|2021-10-08|2021-11-07|19|49
Study ID|SE|0cfe074e-2d3d-4985-8187-30ccbf1327f7|6|10|4|TREATMENT|2021-10-29|2022-01-19|40|122
Study ID|SE|0cfe074e-2d3d-4985-8187-30ccbf1327f7|7|FU|4|FOLLOW-UP|2021-09-26|2021-11-12|7|54
Study ID|SE|fd90b54e-45f0-4c57-8be7-ea03b4ba72bd|1|SCRN|5|SCREENING|2021-08-11|2021-09-11|5|36
Study ID|SE|fd90b54e-45f0-4c57-8be7-ea03b4ba72bd|2|5|1|TREATMENT|2021-10-01|2022-02-02|56|180
Study ID|SE|fd90b54e-45f0-4c57-8be7-ea03b4ba72bd|3|REST|7|WASHOUT|2022-01-10|2022-03-02|157|208
Study ID|SE|fd90b54e-45f0-4c57-8be7-ea03b4ba72bd|4|P|2|TREATMENT|2021-08-23|2021-09-25|17|50
Study ID|SE|fd90b54e-45f0-4c57-8be7-ea03b4ba72bd|5|REST|4|WASHOUT|2022-03-18|2022-04-02|224|239
Study ID|SE|fd90b54e-45f0-4c57-8be7-ea03b4ba72bd|6|10|7|TREATMENT|2021-09-09|2021-09-18|34|43
Study ID|SE|fd90b54e-45f0-4c57-8be7-ea03b4ba72bd|7|FU|3|FOLLOW-UP|2021-10-22|2021-11-11|77|97
Study ID|SE|d2ee9a68-accc-410b-afcd-465f50b2549e|1|SCRN|6|SCREENING|2022-01-07|2022-01-20|97|110
Study ID|SE|d2ee9a68-accc-410b-afcd-465f50b2549e|2|P|6|TREATMENT|2021-12-15|2022-01-04|74|94
Study ID|SE|d2ee9a68-accc-410b-afcd-465f50b2549e|3|REST|4|WASHOUT|2021-10-06|2021-10-09|4|7
Study ID|SE|d2ee9a68-accc-410b-afcd-465f50b2549e|4|5|3|TREATMENT|2021-10-12|2021-10-17|10|15
Study ID|SE|d2ee9a68-accc-410b-afcd-465f50b2549e|5|REST|3|WASHOUT|2022-06-03|2022-07-13|244|284
Study ID|SE|d2ee9a68-accc-410b-afcd-465f50b2549e|6|10|5|TREATMENT|2021-11-20|2022-01-10|49|100
Study ID|SE|d2ee9a68-accc-410b-afcd-465f50b2549e|7|FU|6|FOLLOW-UP|2021-10-11|2021-11-27|9|56
Study ID|SE|6115f166-0c52-4e50-bcd7-5077eb324052|1|SCRN|1|SCREENING|2021-09-02|2022-02-16|3|170
Study ID|SE|6115f166-0c52-4e50-bcd7-5077eb324052|2|5|3|TREATMENT|2022-03-17|2022-04-02|199|215
Study ID|SE|6115f166-0c52-4e50-bcd7-5077eb324052|3|REST|1|WASHOUT|2022-04-29|2022-05-01|242|244
Study ID|SE|6115f166-0c52-4e50-bcd7-5077eb324052|4|10|3|TREATMENT|2021-11-25|2022-01-02|87|125
Study ID|SE|6115f166-0c52-4e50-bcd7-5077eb324052|5|REST|3|WASHOUT|2021-09-01|2021-09-02|2|3
Study ID|SE|6115f166-0c52-4e50-bcd7-5077eb324052|6|P|4|TREATMENT|2021-10-30|2021-12-08|61|100
Study ID|SE|6115f166-0c52-4e50-bcd7-5077eb324052|7|FU|5|FOLLOW-UP|2021-09-07|2021-09-09|8|10
Study ID|SE|33cc84d6-d563-4122-9e12-2f5f4d108d3d|1|SCRN|5|SCREENING|2021-12-04|2022-02-04|40|102
Study ID|SE|33cc84d6-d563-4122-9e12-2f5f4d108d3d|2|P|4|TREATMENT|2022-03-09|2022-06-04|135|222
Study ID|SE|33cc84d6-d563-4122-9e12-2f5f4d108d3d|3|REST|3|WASHOUT|2022-06-01|2022-07-06|219|254
Study ID|SE|33cc84d6-d563-4122-9e12-2f5f4d108d3d|4|5|3|TREATMENT|2021-10-29|2021-10-31|4|6
Study ID|SE|33cc84d6-d563-4122-9e12-2f5f4d108d3d|5|REST|4|WASHOUT|2021-11-04|2021-11-05|10|11
Study ID|SE|33cc84d6-d563-4122-9e12-2f5f4d108d3d|6|10|5|TREATMENT|2022-01-02|2022-04-06|69|163
Study ID|SE|33cc84d6-d563-4122-9e12-2f5f4d108d3d|7|FU|2|FOLLOW-UP|2022-02-28|2022-03-06|126|132
Study ID|SE|a8e4d91e-ec8e-43b7-b6ae-6d6531a5d183|1|SCRN|2|SCREENING|2021-10-31|2021-12-05|69|104
Study ID|SE|a8e4d91e-ec8e-43b7-b6ae-6d6531a5d183|2|5|5|TREATMENT|2021-09-07|2022-03-23|15|212
Study ID|SE|a8e4d91e-ec8e-43b7-b6ae-6d6531a5d183|3|REST|3|WASHOUT|2021-10-03|2021-10-09|41|47
Study ID|SE|a8e4d91e-ec8e-43b7-b6ae-6d6531a5d183|4|P|5|TREATMENT|2021-10-21|2021-11-21|59|90
Study ID|SE|a8e4d91e-ec8e-43b7-b6ae-6d6531a5d183|5|REST|1|WASHOUT|2021-09-11|2021-12-16|19|115
Study ID|SE|a8e4d91e-ec8e-43b7-b6ae-6d6531a5d183|6|10|6|TREATMENT|2021-11-18|2021-11-24|87|93
Study ID|SE|a8e4d91e-ec8e-43b7-b6ae-6d6531a5d183|7|FU|3|FOLLOW-UP|2021-10-02|2022-01-12|40|142
Study ID|SE|39005f68-0383-4062-a43a-73af8fc6ed79|1|SCRN|2|SCREENING|2021-11-17|2021-12-04|75|92
Study ID|SE|39005f68-0383-4062-a43a-73af8fc6ed79|2|5|7|TREATMENT|2021-09-05|2022-06-03|2|273
Study ID|SE|39005f68-0383-4062-a43a-73af8fc6ed79|3|REST|1|WASHOUT|2021-12-10|2022-06-10|98|280
Study ID|SE|39005f68-0383-4062-a43a-73af8fc6ed79|4|10|6|TREATMENT|2021-09-09|2021-09-17|6|14
Study ID|SE|39005f68-0383-4062-a43a-73af8fc6ed79|5|REST|1|WASHOUT|2021-12-25|2022-01-13|113|132
Study ID|SE|39005f68-0383-4062-a43a-73af8fc6ed79|6|P|5|TREATMENT|2021-09-19|2022-03-02|16|180
Study ID|SE|39005f68-0383-4062-a43a-73af8fc6ed79|7|FU|5|FOLLOW-UP|2021-09-29|2022-03-02|26|180
Study ID|SE|07ad428b-af9a-4329-9020-edfc3510efb7|1|SCRN|4|SCREENING|2022-01-10|2022-04-20|141|241
Study ID|SE|07ad428b-af9a-4329-9020-edfc3510efb7|2|5|5|TREATMENT|2021-09-01|2021-11-27|10|97
Study ID|SE|07ad428b-af9a-4329-9020-edfc3510efb7|3|REST|3|WASHOUT|2022-01-03|2022-02-03|134|165
Study ID|SE|07ad428b-af9a-4329-9020-edfc3510efb7|4|P|5|TREATMENT|2021-10-02|2022-03-26|41|216
Study ID|SE|07ad428b-af9a-4329-9020-edfc3510efb7|5|REST|4|WASHOUT|2021-11-20|2021-12-19|90|119
Study ID|SE|07ad428b-af9a-4329-9020-edfc3510efb7|6|10|6|TREATMENT|2021-10-17|2022-03-16|56|206
Study ID|SE|07ad428b-af9a-4329-9020-edfc3510efb7|7|FU|4|FOLLOW-UP|2021-11-02|2022-01-02|72|133
Study ID|SE|6afbc143-c718-434e-b2c9-90fb94d15e5f|1|SCRN|5|SCREENING|2022-03-26|2022-04-03|174|182
Study ID|SE|6afbc143-c718-434e-b2c9-90fb94d15e5f|2|5|7|TREATMENT|2021-11-30|2022-05-04|58|213
Study ID|SE|6afbc143-c718-434e-b2c9-90fb94d15e5f|3|REST|3|WASHOUT|2021-12-15|2022-01-20|73|109
Study ID|SE|6afbc143-c718-434e-b2c9-90fb94d15e5f|4|10|5|TREATMENT|2022-01-22|2022-05-24|111|233
Study ID|SE|6afbc143-c718-434e-b2c9-90fb94d15e5f|5|REST|5|WASHOUT|2021-11-18|2022-04-03|46|182
Study ID|SE|6afbc143-c718-434e-b2c9-90fb94d15e5f|6|P|1|TREATMENT|2021-10-19|2022-07-17|16|287
Study ID|SE|6afbc143-c718-434e-b2c9-90fb94d15e5f|7|FU|7|FOLLOW-UP|2022-02-09|2022-04-07|129|186
Study ID|SE|9a2bf45c-ff6b-42d1-b37b-1d9227a57adb|1|SCRN|1|SCREENING|2021-12-01|2022-01-07|55|92
Study ID|SE|9a2bf45c-ff6b-42d1-b37b-1d9227a57adb|2|5|1|TREATMENT|2021-11-20|2022-03-01|44|145
Study ID|SE|9a2bf45c-ff6b-42d1-b37b-1d9227a57adb|3|REST|3|WASHOUT|2021-10-21|2022-01-26|14|111
Study ID|SE|9a2bf45c-ff6b-42d1-b37b-1d9227a57adb|4|10|3|TREATMENT|2021-12-17|2022-01-04|71|89
Study ID|SE|9a2bf45c-ff6b-42d1-b37b-1d9227a57adb|5|REST|1|WASHOUT|2021-12-10|2022-05-26|64|231
Study ID|SE|9a2bf45c-ff6b-42d1-b37b-1d9227a57adb|6|P|2|TREATMENT|2021-12-13|2022-01-03|67|88
Study ID|SE|9a2bf45c-ff6b-42d1-b37b-1d9227a57adb|7|FU|5|FOLLOW-UP|2021-10-27|2021-12-15|20|69
Study ID|SE|fc67788f-0782-4e37-ab27-87ed60178271|1|SCRN|1|SCREENING|2021-10-01|2021-10-12|11|22
Study ID|SE|fc67788f-0782-4e37-ab27-87ed60178271|2|5|6|TREATMENT|2022-03-10|2022-04-21|171|213
Study ID|SE|fc67788f-0782-4e37-ab27-87ed60178271|3|REST|7|WASHOUT|2022-01-01|2022-06-19|103|272
Study ID|SE|fc67788f-0782-4e37-ab27-87ed60178271|4|P|6|TREATMENT|2022-03-23|2022-06-15|184|268
Study ID|SE|fc67788f-0782-4e37-ab27-87ed60178271|5|REST|1|WASHOUT|2021-12-29|2022-05-27|100|249
Study ID|SE|fc67788f-0782-4e37-ab27-87ed60178271|6|10|4|TREATMENT|2022-04-20|2022-05-18|212|240
Study ID|SE|fc67788f-0782-4e37-ab27-87ed60178271|7|FU|2|FOLLOW-UP|2022-01-10|2022-05-11|112|233
Study ID|SE|934efb57-d68c-40b6-9677-2bf5af0f5afe|1|SCRN|7|SCREENING|2022-02-06|2022-05-23|113|219
Study ID|SE|934efb57-d68c-40b6-9677-2bf5af0f5afe|2|5|3|TREATMENT|2022-01-09|2022-03-25|85|160
Study ID|SE|934efb57-d68c-40b6-9677-2bf5af0f5afe|3|REST|3|WASHOUT|2022-06-09|2022-07-10|236|267
Study ID|SE|934efb57-d68c-40b6-9677-2bf5af0f5afe|4|P|7|TREATMENT|2022-03-06|2022-04-13|141|179
Study ID|SE|934efb57-d68c-40b6-9677-2bf5af0f5afe|5|REST|3|WASHOUT|2022-02-13|2022-05-27|120|223
Study ID|SE|934efb57-d68c-40b6-9677-2bf5af0f5afe|6|10|4|TREATMENT|2022-03-29|2022-04-01|164|167
Study ID|SE|934efb57-d68c-40b6-9677-2bf5af0f5afe|7|FU|7|FOLLOW-UP|2021-10-19|2021-11-30|3|45
Study ID|SE|3fb1940f-49e7-4d22-89c2-49fa8ba12b8e|1|SCRN|2|SCREENING|2022-03-05|2022-06-14|193|294
Study ID|SE|3fb1940f-49e7-4d22-89c2-49fa8ba12b8e|2|P|2|TREATMENT|2021-09-29|2022-05-28|36|277
Study ID|SE|3fb1940f-49e7-4d22-89c2-49fa8ba12b8e|3|REST|2|WASHOUT|2021-12-18|2022-01-07|116|136
Study ID|SE|3fb1940f-49e7-4d22-89c2-49fa8ba12b8e|4|5|5|TREATMENT|2021-09-15|2022-05-07|22|256
Study ID|SE|3fb1940f-49e7-4d22-89c2-49fa8ba12b8e|5|REST|5|WASHOUT|2021-10-03|2022-01-23|40|152
Study ID|SE|3fb1940f-49e7-4d22-89c2-49fa8ba12b8e|6|10|5|TREATMENT|2021-11-03|2022-06-14|71|294
Study ID|SE|3fb1940f-49e7-4d22-89c2-49fa8ba12b8e|7|FU|4|FOLLOW-UP|2021-11-09|2022-01-24|77|153
Study ID|SE|434b2cb0-e767-4f5d-97fb-c71c8624cb48|1|SCRN|1|SCREENING|2021-11-17|2021-12-27|101|141
Study ID|SE|434b2cb0-e767-4f5d-97fb-c71c8624cb48|2|P|7|TREATMENT|2022-03-07|2022-03-25|211|229
Study ID|SE|434b2cb0-e767-4f5d-97fb-c71c8624cb48|3|REST|6|WASHOUT|2021-09-04|2021-09-24|27|47
Study ID|SE|434b2cb0-e767-4f5d-97fb-c71c8624cb48|4|5|2|TREATMENT|2021-08-22|2022-05-10|14|275
Study ID|SE|434b2cb0-e767-4f5d-97fb-c71c8624cb48|5|REST|1|WASHOUT|2022-03-12|2022-05-18|216|283
Study ID|SE|434b2cb0-e767-4f5d-97fb-c71c8624cb48|6|10|3|TREATMENT|2022-03-15|2022-03-24|219|228
Study ID|SE|434b2cb0-e767-4f5d-97fb-c71c8624cb48|7|FU|5|FOLLOW-UP|2022-04-29|2022-05-24|264|289
Study ID|SE|bac51837-53f4-4785-98bd-a7fdeb04e309|1|SCRN|2|SCREENING|2022-05-26|2022-06-17|262|284
Study ID|SE|bac51837-53f4-4785-98bd-a7fdeb04e309|2|P|3|TREATMENT|2022-03-12|2022-05-18|187|254
Study ID|SE|bac51837-53f4-4785-98bd-a7fdeb04e309|3|REST|3|WASHOUT|2021-09-08|2021-09-20|2|14
Study ID|SE|bac51837-53f4-4785-98bd-a7fdeb04e309|4|5|6|TREATMENT|2021-10-03|2021-10-07|27|31
Study ID|SE|bac51837-53f4-4785-98bd-a7fdeb04e309|5|REST|5|WASHOUT|2021-09-19|2021-10-03|13|27
Study ID|SE|bac51837-53f4-4785-98bd-a7fdeb04e309|6|10|1|TREATMENT|2021-10-28|2022-02-12|52|159
Study ID|SE|bac51837-53f4-4785-98bd-a7fdeb04e309|7|FU|5|FOLLOW-UP|2021-10-06|2021-12-25|30|110
Study ID|SE|7978ecc6-c84e-4c79-bcec-9034523ed0ec|1|SCRN|7|SCREENING|2021-11-21|2021-12-01|61|71
Study ID|SE|7978ecc6-c84e-4c79-bcec-9034523ed0ec|2|5|6|TREATMENT|2021-11-08|2021-12-03|48|73
Study ID|SE|7978ecc6-c84e-4c79-bcec-9034523ed0ec|3|REST|6|WASHOUT|2021-10-25|2022-01-06|34|107
Study ID|SE|7978ecc6-c84e-4c79-bcec-9034523ed0ec|4|P|6|TREATMENT|2021-12-31|2022-03-20|101|180
Study ID|SE|7978ecc6-c84e-4c79-bcec-9034523ed0ec|5|REST|7|WASHOUT|2022-04-13|2022-06-06|204|258
Study ID|SE|7978ecc6-c84e-4c79-bcec-9034523ed0ec|6|10|2|TREATMENT|2022-05-04|2022-07-05|225|287
Study ID|SE|7978ecc6-c84e-4c79-bcec-9034523ed0ec|7|FU|5|FOLLOW-UP|2021-11-01|2021-11-09|41|49
Study ID|SE|41baa737-5c54-4341-97a5-39eba1110af5|1|SCRN|3|SCREENING|2021-09-16|2022-01-19|8|133
Study ID|SE|41baa737-5c54-4341-97a5-39eba1110af5|2|5|5|TREATMENT|2021-12-04|2021-12-08|87|91
Study ID|SE|41baa737-5c54-4341-97a5-39eba1110af5|3|REST|2|WASHOUT|2021-09-15|2022-01-20|7|134
Study ID|SE|41baa737-5c54-4341-97a5-39eba1110af5|4|P|3|TREATMENT|2021-11-06|2021-11-22|59|75
Study ID|SE|41baa737-5c54-4341-97a5-39eba1110af5|5|REST|1|WASHOUT|2021-11-24|2022-03-03|77|176
Study ID|SE|41baa737-5c54-4341-97a5-39eba1110af5|6|10|2|TREATMENT|2021-11-12|2021-11-15|65|68
Study ID|SE|41baa737-5c54-4341-97a5-39eba1110af5|7|FU|6|FOLLOW-UP|2021-10-27|2021-12-09|49|92
Study ID|SE|1639ffae-9892-4db3-bcf1-8ec410d02017|1|SCRN|6|SCREENING|2022-01-04|2022-05-01|91|208
Study ID|SE|1639ffae-9892-4db3-bcf1-8ec410d02017|2|5|6|TREATMENT|2022-02-11|2022-05-05|129|212
Study ID|SE|1639ffae-9892-4db3-bcf1-8ec410d02017|3|REST|3|WASHOUT|2021-12-31|2022-02-12|87|130
Study ID|SE|1639ffae-9892-4db3-bcf1-8ec410d02017|4|P|7|TREATMENT|2021-11-06|2021-12-04|32|60
Study ID|SE|1639ffae-9892-4db3-bcf1-8ec410d02017|5|REST|5|WASHOUT|2021-10-09|2021-10-27|4|22
Study ID|SE|1639ffae-9892-4db3-bcf1-8ec410d02017|6|10|3|TREATMENT|2021-11-17|2021-12-24|43|80
Study ID|SE|1639ffae-9892-4db3-bcf1-8ec410d02017|7|FU|1|FOLLOW-UP|2022-03-29|2022-06-02|175|240
Study ID|SE|9fba0a8e-3fe2-4f06-b4cf-7aa401e971a7|1|SCRN|5|SCREENING|2021-10-25|2022-01-01|26|94
Study ID|SE|9fba0a8e-3fe2-4f06-b4cf-7aa401e971a7|2|P|3|TREATMENT|2021-10-30|2022-04-20|31|203
Study ID|SE|9fba0a8e-3fe2-4f06-b4cf-7aa401e971a7|3|REST|6|WASHOUT|2021-12-30|2022-01-14|92|107
Study ID|SE|9fba0a8e-3fe2-4f06-b4cf-7aa401e971a7|4|5|4|TREATMENT|2021-10-02|2022-04-25|3|208
Study ID|SE|9fba0a8e-3fe2-4f06-b4cf-7aa401e971a7|5|REST|3|WASHOUT|2021-10-06|2021-10-24|7|25
Study ID|SE|9fba0a8e-3fe2-4f06-b4cf-7aa401e971a7|6|10|1|TREATMENT|2021-10-22|2021-11-14|23|46
Study ID|SE|9fba0a8e-3fe2-4f06-b4cf-7aa401e971a7|7|FU|2|FOLLOW-UP|2021-10-09|2021-11-25|10|57
Study ID|SE|1e40f81b-3d74-4582-9c8d-bd0f9c7a044d|1|SCRN|3|SCREENING|2021-11-08|2021-11-11|21|24
Study ID|SE|1e40f81b-3d74-4582-9c8d-bd0f9c7a044d|2|P|6|TREATMENT|2021-11-22|2022-02-01|35|106
Study ID|SE|1e40f81b-3d74-4582-9c8d-bd0f9c7a044d|3|REST|2|WASHOUT|2022-01-18|2022-06-08|92|233
Study ID|SE|1e40f81b-3d74-4582-9c8d-bd0f9c7a044d|4|5|2|TREATMENT|2022-02-05|2022-08-04|110|290
Study ID|SE|1e40f81b-3d74-4582-9c8d-bd0f9c7a044d|5|REST|6|WASHOUT|2022-06-26|2022-08-13|251|299
Study ID|SE|1e40f81b-3d74-4582-9c8d-bd0f9c7a044d|6|10|7|TREATMENT|2021-10-20|2022-03-02|2|135
Study ID|SE|1e40f81b-3d74-4582-9c8d-bd0f9c7a044d|7|FU|6|FOLLOW-UP|2022-02-24|2022-06-27|129|252
Study ID|SE|eb393899-029c-4066-b337-87c4543b422d|1|SCRN|3|SCREENING|2021-08-23|2021-08-25|15|17
Study ID|SE|eb393899-029c-4066-b337-87c4543b422d|2|P|4|TREATMENT|2021-09-14|2022-03-06|37|210
Study ID|SE|eb393899-029c-4066-b337-87c4543b422d|3|REST|7|WASHOUT|2021-10-22|2021-12-23|75|137
Study ID|SE|eb393899-029c-4066-b337-87c4543b422d|4|5|2|TREATMENT|2021-10-09|2022-02-09|62|185
Study ID|SE|eb393899-029c-4066-b337-87c4543b422d|5|REST|3|WASHOUT|2021-08-13|2021-08-19|5|11
Study ID|SE|eb393899-029c-4066-b337-87c4543b422d|6|10|5|TREATMENT|2021-10-16|2022-01-21|69|166
Study ID|SE|eb393899-029c-4066-b337-87c4543b422d|7|FU|4|FOLLOW-UP|2021-10-18|2022-02-17|71|193
Study ID|SE|2176468c-0dba-4e31-9fb0-2d8c58f0a96a|1|SCRN|7|SCREENING|2021-11-27|2022-02-12|109|186
Study ID|SE|2176468c-0dba-4e31-9fb0-2d8c58f0a96a|2|P|5|TREATMENT|2021-08-23|2021-12-02|13|114
Study ID|SE|2176468c-0dba-4e31-9fb0-2d8c58f0a96a|3|REST|6|WASHOUT|2021-09-19|2022-03-19|40|221
Study ID|SE|2176468c-0dba-4e31-9fb0-2d8c58f0a96a|4|5|5|TREATMENT|2021-11-02|2022-05-24|84|287
Study ID|SE|2176468c-0dba-4e31-9fb0-2d8c58f0a96a|5|REST|4|WASHOUT|2022-04-26|2022-04-30|259|263
Study ID|SE|2176468c-0dba-4e31-9fb0-2d8c58f0a96a|6|10|5|TREATMENT|2021-09-27|2021-10-21|48|72
Study ID|SE|2176468c-0dba-4e31-9fb0-2d8c58f0a96a|7|FU|1|FOLLOW-UP|2021-09-14|2021-10-08|35|59
Study ID|SE|dfd17f44-0437-45de-9c6e-7cf4559269eb|1|SCRN|4|SCREENING|2022-04-26|2022-04-27|206|207
Study ID|SE|dfd17f44-0437-45de-9c6e-7cf4559269eb|2|P|3|TREATMENT|2022-02-03|2022-05-10|124|220
Study ID|SE|dfd17f44-0437-45de-9c6e-7cf4559269eb|3|REST|7|WASHOUT|2022-02-03|2022-03-16|124|165
Study ID|SE|dfd17f44-0437-45de-9c6e-7cf4559269eb|4|5|6|TREATMENT|2022-07-19|2022-07-21|290|292
Study ID|SE|dfd17f44-0437-45de-9c6e-7cf4559269eb|5|REST|7|WASHOUT|2021-10-19|2021-11-29|17|58
Study ID|SE|dfd17f44-0437-45de-9c6e-7cf4559269eb|6|10|7|TREATMENT|2021-10-12|2022-06-06|10|247
Study ID|SE|dfd17f44-0437-45de-9c6e-7cf4559269eb|7|FU|1|FOLLOW-UP|2022-01-18|2022-03-03|108|152
Study ID|SE|b115ac47-1e2b-485b-8d75-936280817c9c|1|SCRN|5|SCREENING|2022-02-22|2022-04-09|147|193
Study ID|SE|b115ac47-1e2b-485b-8d75-936280817c9c|2|5|7|TREATMENT|2021-09-30|2021-10-07|2|9
Study ID|SE|b115ac47-1e2b-485b-8d75-936280817c9c|3|REST|1|WASHOUT|2021-11-02|2022-07-07|35|282
Study ID|SE|b115ac47-1e2b-485b-8d75-936280817c9c|4|P|6|TREATMENT|2022-01-23|2022-02-17|117|142
Study ID|SE|b115ac47-1e2b-485b-8d75-936280817c9c|5|REST|2|WASHOUT|2021-10-10|2022-06-10|12|255
Study ID|SE|b115ac47-1e2b-485b-8d75-936280817c9c|6|10|1|TREATMENT|2021-12-10|2022-06-17|73|262
Study ID|SE|b115ac47-1e2b-485b-8d75-936280817c9c|7|FU|5|FOLLOW-UP|2021-10-28|2022-01-14|30|108
Study ID|SE|f2e017c3-9709-44a0-9fc9-6fb67695b97d|1|SCRN|7|SCREENING|2021-10-31|2021-11-14|23|37
Study ID|SE|f2e017c3-9709-44a0-9fc9-6fb67695b97d|2|P|5|TREATMENT|2021-11-15|2022-04-02|38|176
Study ID|SE|f2e017c3-9709-44a0-9fc9-6fb67695b97d|3|REST|7|WASHOUT|2021-10-14|2021-11-22|6|45
Study ID|SE|f2e017c3-9709-44a0-9fc9-6fb67695b97d|4|5|2|TREATMENT|2022-01-09|2022-03-04|93|147
Study ID|SE|f2e017c3-9709-44a0-9fc9-6fb67695b97d|5|REST|7|WASHOUT|2022-04-25|2022-05-08|199|212
Study ID|SE|f2e017c3-9709-44a0-9fc9-6fb67695b97d|6|10|6|TREATMENT|2021-10-21|2022-03-23|13|166
Study ID|SE|f2e017c3-9709-44a0-9fc9-6fb67695b97d|7|FU|2|FOLLOW-UP|2021-11-01|2022-07-29|24|294
Study ID|SE|322efb1f-10c2-41cf-8b4a-d84ae00b9faa|1|SCRN|6|SCREENING|2022-01-02|2022-06-13|67|229
Study ID|SE|322efb1f-10c2-41cf-8b4a-d84ae00b9faa|2|5|3|TREATMENT|2021-11-23|2022-01-12|27|77
Study ID|SE|322efb1f-10c2-41cf-8b4a-d84ae00b9faa|3|REST|3|WASHOUT|2021-11-07|2021-11-16|11|20
Study ID|SE|322efb1f-10c2-41cf-8b4a-d84ae00b9faa|4|10|4|TREATMENT|2021-10-31|2021-12-12|4|46
Study ID|SE|322efb1f-10c2-41cf-8b4a-d84ae00b9faa|5|REST|2|WASHOUT|2021-11-03|2021-11-04|7|8
Study ID|SE|322efb1f-10c2-41cf-8b4a-d84ae00b9faa|6|P|1|TREATMENT|2021-10-29|2021-12-08|2|42
Study ID|SE|322efb1f-10c2-41cf-8b4a-d84ae00b9faa|7|FU|6|FOLLOW-UP|2022-04-07|2022-04-21|162|176
Study ID|SE|8c7d810e-4a9c-4df2-b1bd-585e3e0c29ee|1|SCRN|6|SCREENING|2022-04-08|2022-05-05|179|206
Study ID|SE|8c7d810e-4a9c-4df2-b1bd-585e3e0c29ee|2|5|2|TREATMENT|2021-10-15|2021-10-24|4|13
Study ID|SE|8c7d810e-4a9c-4df2-b1bd-585e3e0c29ee|3|REST|1|WASHOUT|2022-02-15|2022-02-20|127|132
Study ID|SE|8c7d810e-4a9c-4df2-b1bd-585e3e0c29ee|4|10|3|TREATMENT|2021-12-10|2021-12-24|60|74
Study ID|SE|8c7d810e-4a9c-4df2-b1bd-585e3e0c29ee|5|REST|1|WASHOUT|2022-03-14|2022-04-06|154|177
Study ID|SE|8c7d810e-4a9c-4df2-b1bd-585e3e0c29ee|6|P|6|TREATMENT|2022-06-22|2022-07-25|254|287
Study ID|SE|8c7d810e-4a9c-4df2-b1bd-585e3e0c29ee|7|FU|3|FOLLOW-UP|2021-11-23|2022-02-19|43|131
Study ID|SE|6ea38426-aa83-4704-ab5d-2874505f731a|1|SCRN|7|SCREENING|2021-12-13|2022-03-02|111|190
Study ID|SE|6ea38426-aa83-4704-ab5d-2874505f731a|2|P|7|TREATMENT|2021-12-19|2022-04-07|117|226
Study ID|SE|6ea38426-aa83-4704-ab5d-2874505f731a|3|REST|6|WASHOUT|2021-08-29|2021-09-13|5|20
Study ID|SE|6ea38426-aa83-4704-ab5d-2874505f731a|4|5|2|TREATMENT|2021-09-10|2021-10-08|17|45
Study ID|SE|6ea38426-aa83-4704-ab5d-2874505f731a|5|REST|2|WASHOUT|2021-09-21|2021-10-16|28|53
Study ID|SE|6ea38426-aa83-4704-ab5d-2874505f731a|6|10|5|TREATMENT|2022-01-21|2022-03-25|150|213
Study ID|SE|6ea38426-aa83-4704-ab5d-2874505f731a|7|FU|5|FOLLOW-UP|2021-11-23|2022-03-15|91|203
Study ID|SE|37741997-556e-4bb0-9a8b-dcba68aad5ef|1|SCRN|3|SCREENING|2021-12-26|2022-04-22|109|226
Study ID|SE|37741997-556e-4bb0-9a8b-dcba68aad5ef|2|5|6|TREATMENT|2021-11-12|2021-12-05|65|88
Study ID|SE|37741997-556e-4bb0-9a8b-dcba68aad5ef|3|REST|3|WASHOUT|2022-03-16|2022-04-09|189|213
Study ID|SE|37741997-556e-4bb0-9a8b-dcba68aad5ef|4|10|5|TREATMENT|2022-02-25|2022-05-25|170|259
Study ID|SE|37741997-556e-4bb0-9a8b-dcba68aad5ef|5|REST|4|WASHOUT|2021-09-20|2021-11-25|12|78
Study ID|SE|37741997-556e-4bb0-9a8b-dcba68aad5ef|6|P|7|TREATMENT|2022-06-01|2022-06-30|266|295
Study ID|SE|37741997-556e-4bb0-9a8b-dcba68aad5ef|7|FU|1|FOLLOW-UP|2021-09-14|2021-09-17|6|9
Study ID|SE|3cc095a9-7201-4ee1-9d97-935fe761fb61|1|SCRN|2|SCREENING|2021-09-16|2021-10-03|35|52
Study ID|SE|3cc095a9-7201-4ee1-9d97-935fe761fb61|2|5|7|TREATMENT|2021-08-31|2022-01-05|19|146
Study ID|SE|3cc095a9-7201-4ee1-9d97-935fe761fb61|3|REST|6|WASHOUT|2021-10-07|2021-11-15|56|95
Study ID|SE|3cc095a9-7201-4ee1-9d97-935fe761fb61|4|P|7|TREATMENT|2021-08-20|2022-02-07|8|179
Study ID|SE|3cc095a9-7201-4ee1-9d97-935fe761fb61|5|REST|4|WASHOUT|2021-08-15|2021-11-08|3|88
Study ID|SE|3cc095a9-7201-4ee1-9d97-935fe761fb61|6|10|5|TREATMENT|2021-11-16|2022-05-28|96|289
Study ID|SE|3cc095a9-7201-4ee1-9d97-935fe761fb61|7|FU|1|FOLLOW-UP|2022-01-25|2022-02-11|166|183
Study ID|SE|badb6da6-bea2-41f0-98fc-93ac3b8aed7c|1|SCRN|4|SCREENING|2021-12-10|2021-12-15|49|54
Study ID|SE|badb6da6-bea2-41f0-98fc-93ac3b8aed7c|2|P|4|TREATMENT|2022-01-13|2022-05-10|83|200
Study ID|SE|badb6da6-bea2-41f0-98fc-93ac3b8aed7c|3|REST|7|WASHOUT|2022-04-23|2022-08-17|183|299
Study ID|SE|badb6da6-bea2-41f0-98fc-93ac3b8aed7c|4|5|6|TREATMENT|2022-01-25|2022-05-03|95|193
Study ID|SE|badb6da6-bea2-41f0-98fc-93ac3b8aed7c|5|REST|6|WASHOUT|2022-01-23|2022-02-02|93|103
Study ID|SE|badb6da6-bea2-41f0-98fc-93ac3b8aed7c|6|10|3|TREATMENT|2021-11-19|2021-12-19|28|58
Study ID|SE|badb6da6-bea2-41f0-98fc-93ac3b8aed7c|7|FU|3|FOLLOW-UP|2021-11-12|2021-12-22|21|61
Study ID|SE|ea87a2bd-903c-423d-ad46-3c53656bf49c|1|SCRN|1|SCREENING|2021-11-24|2022-01-09|30|76
Study ID|SE|ea87a2bd-903c-423d-ad46-3c53656bf49c|2|5|6|TREATMENT|2022-02-14|2022-04-27|112|184
Study ID|SE|ea87a2bd-903c-423d-ad46-3c53656bf49c|3|REST|3|WASHOUT|2021-11-12|2021-12-01|18|37
Study ID|SE|ea87a2bd-903c-423d-ad46-3c53656bf49c|4|10|1|TREATMENT|2022-05-14|2022-07-20|201|268
Study ID|SE|ea87a2bd-903c-423d-ad46-3c53656bf49c|5|REST|5|WASHOUT|2022-03-02|2022-03-12|128|138
Study ID|SE|ea87a2bd-903c-423d-ad46-3c53656bf49c|6|P|4|TREATMENT|2022-01-05|2022-07-06|72|254
Study ID|SE|ea87a2bd-903c-423d-ad46-3c53656bf49c|7|FU|5|FOLLOW-UP|2021-10-31|2021-11-13|6|19
Study ID|SE|5f1ef0c5-2c53-43c1-8231-d68e65462800|1|SCRN|4|SCREENING|2022-02-15|2022-04-13|186|243
Study ID|SE|5f1ef0c5-2c53-43c1-8231-d68e65462800|2|5|5|TREATMENT|2022-05-20|2022-06-01|280|292
Study ID|SE|5f1ef0c5-2c53-43c1-8231-d68e65462800|3|REST|1|WASHOUT|2021-09-25|2021-11-18|43|97
Study ID|SE|5f1ef0c5-2c53-43c1-8231-d68e65462800|4|10|2|TREATMENT|2021-12-14|2022-02-27|123|198
Study ID|SE|5f1ef0c5-2c53-43c1-8231-d68e65462800|5|REST|4|WASHOUT|2021-08-23|2022-01-19|10|159
Study ID|SE|5f1ef0c5-2c53-43c1-8231-d68e65462800|6|P|1|TREATMENT|2022-01-16|2022-06-02|156|293
Study ID|SE|5f1ef0c5-2c53-43c1-8231-d68e65462800|7|FU|3|FOLLOW-UP|2022-02-09|2022-02-16|180|187
Study ID|SE|39e8e130-6965-4eac-8eba-3e4af7aeea6b|1|SCRN|1|SCREENING|2022-03-21|2022-04-16|198|224
Study ID|SE|39e8e130-6965-4eac-8eba-3e4af7aeea6b|2|5|5|TREATMENT|2021-09-19|2021-10-13|15|39
Study ID|SE|39e8e130-6965-4eac-8eba-3e4af7aeea6b|3|REST|4|WASHOUT|2022-04-01|2022-05-16|209|254
Study ID|SE|39e8e130-6965-4eac-8eba-3e4af7aeea6b|4|10|4|TREATMENT|2021-11-21|2022-05-17|78|255
Study ID|SE|39e8e130-6965-4eac-8eba-3e4af7aeea6b|5|REST|4|WASHOUT|2022-03-28|2022-05-18|205|256
Study ID|SE|39e8e130-6965-4eac-8eba-3e4af7aeea6b|6|P|5|TREATMENT|2021-09-30|2021-11-20|26|77
Study ID|SE|39e8e130-6965-4eac-8eba-3e4af7aeea6b|7|FU|6|FOLLOW-UP|2022-01-04|2022-06-15|122|284
Study ID|SE|b05aafad-12da-4c19-85aa-845cf6f6819b|1|SCRN|1|SCREENING|2022-01-13|2022-03-06|112|164
Study ID|SE|b05aafad-12da-4c19-85aa-845cf6f6819b|2|5|5|TREATMENT|2021-10-16|2021-11-03|23|41
Study ID|SE|b05aafad-12da-4c19-85aa-845cf6f6819b|3|REST|4|WASHOUT|2021-11-13|2021-12-28|51|96
Study ID|SE|b05aafad-12da-4c19-85aa-845cf6f6819b|4|P|2|TREATMENT|2022-01-02|2022-05-04|101|223
Study ID|SE|b05aafad-12da-4c19-85aa-845cf6f6819b|5|REST|6|WASHOUT|2022-04-28|2022-06-07|217|257
Study ID|SE|b05aafad-12da-4c19-85aa-845cf6f6819b|6|10|2|TREATMENT|2021-11-29|2022-01-06|67|105
Study ID|SE|b05aafad-12da-4c19-85aa-845cf6f6819b|7|FU|1|FOLLOW-UP|2022-05-28|2022-06-16|247|266
Study ID|SE|0c7eb347-7a5a-4be1-804e-9a51d1690b28|1|SCRN|3|SCREENING|2022-04-06|2022-04-08|214|216
Study ID|SE|0c7eb347-7a5a-4be1-804e-9a51d1690b28|2|5|2|TREATMENT|2022-04-08|2022-05-21|216|259
Study ID|SE|0c7eb347-7a5a-4be1-804e-9a51d1690b28|3|REST|7|WASHOUT|2021-10-01|2022-04-18|27|226
Study ID|SE|0c7eb347-7a5a-4be1-804e-9a51d1690b28|4|10|5|TREATMENT|2022-02-23|2022-03-02|172|179
Study ID|SE|0c7eb347-7a5a-4be1-804e-9a51d1690b28|5|REST|1|WASHOUT|2021-10-30|2022-04-19|56|227
Study ID|SE|0c7eb347-7a5a-4be1-804e-9a51d1690b28|6|P|2|TREATMENT|2022-02-06|2022-04-17|155|225
Study ID|SE|0c7eb347-7a5a-4be1-804e-9a51d1690b28|7|FU|3|FOLLOW-UP|2022-02-17|2022-03-06|166|183
Study ID|SE|f4eae613-6019-4f7f-b1db-223290b90a34|1|SCRN|3|SCREENING|2021-10-04|2021-10-28|26|50
Study ID|SE|f4eae613-6019-4f7f-b1db-223290b90a34|2|P|1|TREATMENT|2021-12-08|2022-05-07|91|241
Study ID|SE|f4eae613-6019-4f7f-b1db-223290b90a34|3|REST|2|WASHOUT|2022-05-02|2022-06-09|236|274
Study ID|SE|f4eae613-6019-4f7f-b1db-223290b90a34|4|5|3|TREATMENT|2021-11-06|2022-04-07|59|211
Study ID|SE|f4eae613-6019-4f7f-b1db-223290b90a34|5|REST|3|WASHOUT|2021-10-04|2022-01-25|26|139
Study ID|SE|f4eae613-6019-4f7f-b1db-223290b90a34|6|10|7|TREATMENT|2021-12-17|2022-01-19|100|133
Study ID|SE|f4eae613-6019-4f7f-b1db-223290b90a34|7|FU|5|FOLLOW-UP|2021-10-15|2021-10-23|37|45
Study ID|SE|fd9d14f6-9c92-45db-b709-633924577209|1|SCRN|5|SCREENING|2022-04-18|2022-06-23|232|298
Study ID|SE|fd9d14f6-9c92-45db-b709-633924577209|2|5|4|TREATMENT|2021-10-13|2022-01-26|45|150
Study ID|SE|fd9d14f6-9c92-45db-b709-633924577209|3|REST|3|WASHOUT|2022-01-09|2022-05-21|133|265
Study ID|SE|fd9d14f6-9c92-45db-b709-633924577209|4|10|7|TREATMENT|2021-11-04|2022-04-02|67|216
Study ID|SE|fd9d14f6-9c92-45db-b709-633924577209|5|REST|3|WASHOUT|2021-09-10|2022-03-24|12|207
Study ID|SE|fd9d14f6-9c92-45db-b709-633924577209|6|P|4|TREATMENT|2021-08-31|2022-02-05|2|160
Study ID|SE|fd9d14f6-9c92-45db-b709-633924577209|7|FU|4|FOLLOW-UP|2021-09-19|2021-10-15|21|47
Study ID|SE|3489f7bf-ab6e-4f96-a65b-f1748be4c4b8|1|SCRN|5|SCREENING|2021-09-30|2022-02-18|14|155
Study ID|SE|3489f7bf-ab6e-4f96-a65b-f1748be4c4b8|2|5|5|TREATMENT|2021-11-03|2021-11-25|48|70
Study ID|SE|3489f7bf-ab6e-4f96-a65b-f1748be4c4b8|3|REST|5|WASHOUT|2021-11-17|2022-04-25|62|221
Study ID|SE|3489f7bf-ab6e-4f96-a65b-f1748be4c4b8|4|10|1|TREATMENT|2021-12-09|2022-06-14|84|271
Study ID|SE|3489f7bf-ab6e-4f96-a65b-f1748be4c4b8|5|REST|7|WASHOUT|2022-01-08|2022-03-17|114|182
Study ID|SE|3489f7bf-ab6e-4f96-a65b-f1748be4c4b8|6|P|6|TREATMENT|2022-02-01|2022-03-13|138|178
Study ID|SE|3489f7bf-ab6e-4f96-a65b-f1748be4c4b8|7|FU|2|FOLLOW-UP|2021-12-03|2022-05-13|78|239
Study ID|SE|11c7db3b-f41f-49c7-9b23-abc30f90bfad|1|SCRN|4|SCREENING|2021-10-22|2021-11-23|73|105
Study ID|SE|11c7db3b-f41f-49c7-9b23-abc30f90bfad|2|5|3|TREATMENT|2021-11-02|2022-02-14|84|188
Study ID|SE|11c7db3b-f41f-49c7-9b23-abc30f90bfad|3|REST|5|WASHOUT|2021-10-12|2021-10-18|63|69
Study ID|SE|11c7db3b-f41f-49c7-9b23-abc30f90bfad|4|10|1|TREATMENT|2021-09-11|2021-09-18|32|39
Study ID|SE|11c7db3b-f41f-49c7-9b23-abc30f90bfad|5|REST|4|WASHOUT|2021-10-11|2022-03-15|62|217
Study ID|SE|11c7db3b-f41f-49c7-9b23-abc30f90bfad|6|P|5|TREATMENT|2021-12-28|2022-01-28|140|171
Study ID|SE|11c7db3b-f41f-49c7-9b23-abc30f90bfad|7|FU|3|FOLLOW-UP|2022-02-27|2022-05-26|201|289
Study ID|SE|b7a8e338-2d22-4b6d-b659-bb404a4501e0|1|SCRN|6|SCREENING|2022-03-22|2022-04-03|151|163
Study ID|SE|b7a8e338-2d22-4b6d-b659-bb404a4501e0|2|5|2|TREATMENT|2022-01-24|2022-03-27|94|156
Study ID|SE|b7a8e338-2d22-4b6d-b659-bb404a4501e0|3|REST|7|WASHOUT|2021-11-04|2021-12-04|13|43
Study ID|SE|b7a8e338-2d22-4b6d-b659-bb404a4501e0|4|P|6|TREATMENT|2021-10-29|2021-11-03|7|12
Study ID|SE|b7a8e338-2d22-4b6d-b659-bb404a4501e0|5|REST|3|WASHOUT|2021-11-06|2022-07-14|15|265
Study ID|SE|b7a8e338-2d22-4b6d-b659-bb404a4501e0|6|10|1|TREATMENT|2021-11-04|2021-12-24|13|63
Study ID|SE|b7a8e338-2d22-4b6d-b659-bb404a4501e0|7|FU|4|FOLLOW-UP|2021-12-27|2022-05-30|66|220
Study ID|SE|8fe35032-c39c-4344-8f02-b9fd301a42bb|1|SCRN|7|SCREENING|2021-11-10|2021-11-26|18|34
Study ID|SE|8fe35032-c39c-4344-8f02-b9fd301a42bb|2|P|3|TREATMENT|2021-11-04|2021-12-12|12|50
Study ID|SE|8fe35032-c39c-4344-8f02-b9fd301a42bb|3|REST|7|WASHOUT|2022-03-28|2022-05-13|156|202
Study ID|SE|8fe35032-c39c-4344-8f02-b9fd301a42bb|4|5|7|TREATMENT|2022-05-12|2022-05-26|201|215
Study ID|SE|8fe35032-c39c-4344-8f02-b9fd301a42bb|5|REST|1|WASHOUT|2021-10-25|2021-10-25|2|2
Study ID|SE|8fe35032-c39c-4344-8f02-b9fd301a42bb|6|10|1|TREATMENT|2021-12-06|2022-06-01|44|221
Study ID|SE|8fe35032-c39c-4344-8f02-b9fd301a42bb|7|FU|3|FOLLOW-UP|2021-11-30|2021-12-09|38|47
Study ID|SE|326c0467-89b9-4ca9-9869-45d895d9c833|1|SCRN|1|SCREENING|2021-11-24|2022-02-21|65|154
Study ID|SE|326c0467-89b9-4ca9-9869-45d895d9c833|2|P|2|TREATMENT|2021-12-09|2022-01-28|80|130
Study ID|SE|326c0467-89b9-4ca9-9869-45d895d9c833|3|REST|4|WASHOUT|2022-05-22|2022-06-28|244|281
Study ID|SE|326c0467-89b9-4ca9-9869-45d895d9c833|4|5|5|TREATMENT|2021-11-01|2021-12-01|42|72
Study ID|SE|326c0467-89b9-4ca9-9869-45d895d9c833|5|REST|5|WASHOUT|2021-12-05|2022-07-15|76|298
Study ID|SE|326c0467-89b9-4ca9-9869-45d895d9c833|6|10|7|TREATMENT|2021-09-29|2021-10-11|9|21
Study ID|SE|326c0467-89b9-4ca9-9869-45d895d9c833|7|FU|4|FOLLOW-UP|2021-10-31|2022-05-18|41|240
Study ID|SE|1891448d-dbbd-4154-a793-0f7498187060|1|SCRN|5|SCREENING|2022-05-31|2022-07-06|250|286
Study ID|SE|1891448d-dbbd-4154-a793-0f7498187060|2|5|3|TREATMENT|2021-11-09|2021-12-26|47|94
Study ID|SE|1891448d-dbbd-4154-a793-0f7498187060|3|REST|2|WASHOUT|2022-03-21|2022-05-06|179|225
Study ID|SE|1891448d-dbbd-4154-a793-0f7498187060|4|10|2|TREATMENT|2021-10-01|2022-01-15|8|114
Study ID|SE|1891448d-dbbd-4154-a793-0f7498187060|5|REST|7|WASHOUT|2021-10-06|2021-12-13|13|81
Study ID|SE|1891448d-dbbd-4154-a793-0f7498187060|6|P|5|TREATMENT|2021-11-06|2022-03-24|44|182
Study ID|SE|1891448d-dbbd-4154-a793-0f7498187060|7|FU|1|FOLLOW-UP|2022-03-07|2022-05-27|165|246
Study ID|SE|9eba0bdd-c6cb-4a39-b1c6-43af7281d383|1|SCRN|3|SCREENING|2021-11-26|2021-12-28|32|64
Study ID|SE|9eba0bdd-c6cb-4a39-b1c6-43af7281d383|2|5|2|TREATMENT|2022-02-08|2022-06-08|106|226
Study ID|SE|9eba0bdd-c6cb-4a39-b1c6-43af7281d383|3|REST|1|WASHOUT|2021-12-17|2022-01-20|53|87
Study ID|SE|9eba0bdd-c6cb-4a39-b1c6-43af7281d383|4|P|4|TREATMENT|2021-11-14|2021-11-15|20|21
Study ID|SE|9eba0bdd-c6cb-4a39-b1c6-43af7281d383|5|REST|2|WASHOUT|2022-01-27|2022-05-03|94|190
Study ID|SE|9eba0bdd-c6cb-4a39-b1c6-43af7281d383|6|10|6|TREATMENT|2021-11-02|2021-11-06|8|12
Study ID|SE|9eba0bdd-c6cb-4a39-b1c6-43af7281d383|7|FU|2|FOLLOW-UP|2022-07-16|2022-08-11|264|290
Study ID|SE|018e26b8-610c-4ffc-ab50-d2abddadfbd3|1|SCRN|5|SCREENING|2022-03-30|2022-07-03|155|250
Study ID|SE|018e26b8-610c-4ffc-ab50-d2abddadfbd3|2|5|4|TREATMENT|2021-11-07|2021-11-08|12|13
Study ID|SE|018e26b8-610c-4ffc-ab50-d2abddadfbd3|3|REST|3|WASHOUT|2021-12-14|2022-07-12|49|259
Study ID|SE|018e26b8-610c-4ffc-ab50-d2abddadfbd3|4|10|5|TREATMENT|2022-07-29|2022-08-21|276|299
Study ID|SE|018e26b8-610c-4ffc-ab50-d2abddadfbd3|5|REST|6|WASHOUT|2022-01-29|2022-02-01|95|98
Study ID|SE|018e26b8-610c-4ffc-ab50-d2abddadfbd3|6|P|6|TREATMENT|2022-01-30|2022-04-01|96|157
Study ID|SE|018e26b8-610c-4ffc-ab50-d2abddadfbd3|7|FU|5|FOLLOW-UP|2021-10-28|2021-10-29|2|3
Study ID|SE|d697be0b-c117-4262-8431-859e7641370b|1|SCRN|2|SCREENING|2021-12-07|2022-03-06|95|184
Study ID|SE|d697be0b-c117-4262-8431-859e7641370b|2|P|6|TREATMENT|2021-09-24|2021-10-29|21|56
Study ID|SE|d697be0b-c117-4262-8431-859e7641370b|3|REST|5|WASHOUT|2021-11-02|2022-01-18|60|137
Study ID|SE|d697be0b-c117-4262-8431-859e7641370b|4|5|3|TREATMENT|2021-09-16|2022-05-20|13|259
Study ID|SE|d697be0b-c117-4262-8431-859e7641370b|5|REST|1|WASHOUT|2021-09-08|2021-09-13|5|10
Study ID|SE|d697be0b-c117-4262-8431-859e7641370b|6|10|1|TREATMENT|2022-02-07|2022-03-04|157|182
Study ID|SE|d697be0b-c117-4262-8431-859e7641370b|7|FU|2|FOLLOW-UP|2021-10-07|2021-11-02|34|60
Study ID|SE|1325428d-d272-4950-9588-27dac0f58b2d|1|SCRN|7|SCREENING|2021-11-20|2022-01-10|23|74
Study ID|SE|1325428d-d272-4950-9588-27dac0f58b2d|2|5|4|TREATMENT|2022-01-24|2022-02-18|88|113
Study ID|SE|1325428d-d272-4950-9588-27dac0f58b2d|3|REST|3|WASHOUT|2021-11-02|2021-12-07|5|40
Study ID|SE|1325428d-d272-4950-9588-27dac0f58b2d|4|P|2|TREATMENT|2021-11-20|2022-03-05|23|128
Study ID|SE|1325428d-d272-4950-9588-27dac0f58b2d|5|REST|4|WASHOUT|2022-02-19|2022-08-18|114|294
Study ID|SE|1325428d-d272-4950-9588-27dac0f58b2d|6|10|4|TREATMENT|2021-11-11|2021-12-10|14|43
Study ID|SE|1325428d-d272-4950-9588-27dac0f58b2d|7|FU|4|FOLLOW-UP|2022-02-02|2022-03-10|97|133
Study ID|SE|090de1de-e936-4be2-a746-62fe121f7da8|1|SCRN|4|SCREENING|2021-11-30|2021-12-19|36|55
Study ID|SE|090de1de-e936-4be2-a746-62fe121f7da8|2|5|7|TREATMENT|2021-12-21|2022-02-19|57|117
Study ID|SE|090de1de-e936-4be2-a746-62fe121f7da8|3|REST|1|WASHOUT|2022-01-06|2022-02-26|73|124
Study ID|SE|090de1de-e936-4be2-a746-62fe121f7da8|4|P|6|TREATMENT|2021-11-01|2022-07-07|7|255
Study ID|SE|090de1de-e936-4be2-a746-62fe121f7da8|5|REST|7|WASHOUT|2021-11-02|2021-11-24|8|30
Study ID|SE|090de1de-e936-4be2-a746-62fe121f7da8|6|10|3|TREATMENT|2021-11-24|2021-12-04|30|40
Study ID|SE|090de1de-e936-4be2-a746-62fe121f7da8|7|FU|3|FOLLOW-UP|2022-01-09|2022-06-29|76|247
Study ID|SE|51e2b6a9-dabf-425b-8263-88ec0bc326df|1|SCRN|5|SCREENING|2022-04-27|2022-06-30|213|277
Study ID|SE|51e2b6a9-dabf-425b-8263-88ec0bc326df|2|P|7|TREATMENT|2021-12-01|2022-02-22|66|149
Study ID|SE|51e2b6a9-dabf-425b-8263-88ec0bc326df|3|REST|6|WASHOUT|2022-01-28|2022-05-01|124|217
Study ID|SE|51e2b6a9-dabf-425b-8263-88ec0bc326df|4|5|4|TREATMENT|2021-10-17|2021-11-18|21|53
Study ID|SE|51e2b6a9-dabf-425b-8263-88ec0bc326df|5|REST|3|WASHOUT|2021-10-07|2022-02-03|11|130
Study ID|SE|51e2b6a9-dabf-425b-8263-88ec0bc326df|6|10|2|TREATMENT|2021-10-15|2022-06-24|19|271
Study ID|SE|51e2b6a9-dabf-425b-8263-88ec0bc326df|7|FU|1|FOLLOW-UP|2021-09-29|2021-10-01|3|5
Study ID|SE|f6a7da73-f887-48fb-a8dd-dba1df8264ac|1|SCRN|2|SCREENING|2021-12-28|2022-05-06|122|251
Study ID|SE|f6a7da73-f887-48fb-a8dd-dba1df8264ac|2|5|2|TREATMENT|2021-09-12|2022-01-19|15|144
Study ID|SE|f6a7da73-f887-48fb-a8dd-dba1df8264ac|3|REST|5|WASHOUT|2022-01-25|2022-05-23|150|268
Study ID|SE|f6a7da73-f887-48fb-a8dd-dba1df8264ac|4|P|1|TREATMENT|2021-09-14|2021-09-28|17|31
Study ID|SE|f6a7da73-f887-48fb-a8dd-dba1df8264ac|5|REST|6|WASHOUT|2021-10-09|2022-04-22|42|237
Study ID|SE|f6a7da73-f887-48fb-a8dd-dba1df8264ac|6|10|6|TREATMENT|2021-09-28|2021-10-03|31|36
Study ID|SE|f6a7da73-f887-48fb-a8dd-dba1df8264ac|7|FU|5|FOLLOW-UP|2021-09-15|2021-10-04|18|37
Study ID|SE|e4d806f1-76f0-49ca-8bbb-8c23827c4cdc|1|SCRN|6|SCREENING|2021-11-07|2022-04-06|25|175
Study ID|SE|e4d806f1-76f0-49ca-8bbb-8c23827c4cdc|2|P|7|TREATMENT|2021-10-18|2021-11-19|5|37
Study ID|SE|e4d806f1-76f0-49ca-8bbb-8c23827c4cdc|3|REST|2|WASHOUT|2022-04-13|2022-04-28|182|197
Study ID|SE|e4d806f1-76f0-49ca-8bbb-8c23827c4cdc|4|5|7|TREATMENT|2021-12-13|2021-12-21|61|69
Study ID|SE|e4d806f1-76f0-49ca-8bbb-8c23827c4cdc|5|REST|6|WASHOUT|2021-12-12|2022-01-18|60|97
Study ID|SE|e4d806f1-76f0-49ca-8bbb-8c23827c4cdc|6|10|1|TREATMENT|2021-11-22|2022-07-07|40|267
Study ID|SE|e4d806f1-76f0-49ca-8bbb-8c23827c4cdc|7|FU|4|FOLLOW-UP|2022-02-27|2022-03-08|137|146
Study ID|SE|448187d1-4bec-472e-8cff-b945923aeb54|1|SCRN|2|SCREENING|2022-01-17|2022-03-29|106|177
Study ID|SE|448187d1-4bec-472e-8cff-b945923aeb54|2|P|7|TREATMENT|2022-02-17|2022-06-18|137|258
Study ID|SE|448187d1-4bec-472e-8cff-b945923aeb54|3|REST|3|WASHOUT|2021-12-09|2021-12-20|67|78
Study ID|SE|448187d1-4bec-472e-8cff-b945923aeb54|4|5|5|TREATMENT|2022-01-20|2022-05-09|109|218
Study ID|SE|448187d1-4bec-472e-8cff-b945923aeb54|5|REST|2|WASHOUT|2021-12-05|2022-01-23|63|112
Study ID|SE|448187d1-4bec-472e-8cff-b945923aeb54|6|10|6|TREATMENT|2021-12-20|2022-01-27|78|116
Study ID|SE|448187d1-4bec-472e-8cff-b945923aeb54|7|FU|2|FOLLOW-UP|2021-10-05|2021-10-05|2|2
Study ID|SE|6b89a0c6-7ba2-49b1-b8b4-98ee72a8d610|1|SCRN|4|SCREENING|2021-10-13|2021-10-23|2|12
Study ID|SE|6b89a0c6-7ba2-49b1-b8b4-98ee72a8d610|2|5|2|TREATMENT|2022-01-31|2022-03-21|112|161
Study ID|SE|6b89a0c6-7ba2-49b1-b8b4-98ee72a8d610|3|REST|5|WASHOUT|2022-03-22|2022-04-23|162|194
Study ID|SE|6b89a0c6-7ba2-49b1-b8b4-98ee72a8d610|4|10|4|TREATMENT|2021-11-14|2021-11-15|34|35
Study ID|SE|6b89a0c6-7ba2-49b1-b8b4-98ee72a8d610|5|REST|4|WASHOUT|2022-03-21|2022-05-03|161|204
Study ID|SE|6b89a0c6-7ba2-49b1-b8b4-98ee72a8d610|6|P|6|TREATMENT|2021-12-17|2022-03-30|67|170
Study ID|SE|6b89a0c6-7ba2-49b1-b8b4-98ee72a8d610|7|FU|7|FOLLOW-UP|2021-12-26|2022-06-17|76|249
Study ID|SE|48bd4478-8623-48a0-be65-6f1024caf526|1|SCRN|6|SCREENING|2021-10-30|2021-11-02|39|42
Study ID|SE|48bd4478-8623-48a0-be65-6f1024caf526|2|5|3|TREATMENT|2021-09-26|2021-11-28|5|68
Study ID|SE|48bd4478-8623-48a0-be65-6f1024caf526|3|REST|2|WASHOUT|2021-11-07|2022-03-17|47|177
Study ID|SE|48bd4478-8623-48a0-be65-6f1024caf526|4|P|3|TREATMENT|2021-09-29|2022-02-15|8|147
Study ID|SE|48bd4478-8623-48a0-be65-6f1024caf526|5|REST|7|WASHOUT|2022-02-25|2022-03-31|157|191
Study ID|SE|48bd4478-8623-48a0-be65-6f1024caf526|6|10|1|TREATMENT|2022-02-01|2022-06-10|133|262
Study ID|SE|48bd4478-8623-48a0-be65-6f1024caf526|7|FU|7|FOLLOW-UP|2021-10-15|2021-12-21|24|91
Study ID|SE|4aa4833b-07b3-4f10-be23-98d8449b562c|1|SCRN|6|SCREENING|2022-02-28|2022-07-19|150|291
Study ID|SE|4aa4833b-07b3-4f10-be23-98d8449b562c|2|P|7|TREATMENT|2022-03-22|2022-05-19|172|230
Study ID|SE|4aa4833b-07b3-4f10-be23-98d8449b562c|3|REST|3|WASHOUT|2021-12-10|2022-04-11|70|192
Study ID|SE|4aa4833b-07b3-4f10-be23-98d8449b562c|4|5|3|TREATMENT|2021-10-27|2022-01-12|26|103
Study ID|SE|4aa4833b-07b3-4f10-be23-98d8449b562c|5|REST|7|WASHOUT|2021-10-09|2021-10-21|8|20
Study ID|SE|4aa4833b-07b3-4f10-be23-98d8449b562c|6|10|7|TREATMENT|2022-02-13|2022-04-13|135|194
Study ID|SE|4aa4833b-07b3-4f10-be23-98d8449b562c|7|FU|6|FOLLOW-UP|2021-10-16|2021-10-23|15|22
Study ID|SE|bd0bf10f-4c49-457a-9d98-b7f007619beb|1|SCRN|7|SCREENING|2021-11-10|2021-11-14|42|46
Study ID|SE|bd0bf10f-4c49-457a-9d98-b7f007619beb|2|P|4|TREATMENT|2022-01-26|2022-07-15|119|289
Study ID|SE|bd0bf10f-4c49-457a-9d98-b7f007619beb|3|REST|7|WASHOUT|2021-11-20|2022-02-02|52|126
Study ID|SE|bd0bf10f-4c49-457a-9d98-b7f007619beb|4|5|1|TREATMENT|2021-10-21|2021-10-27|22|28
Study ID|SE|bd0bf10f-4c49-457a-9d98-b7f007619beb|5|REST|3|WASHOUT|2022-02-22|2022-03-01|146|153
Study ID|SE|bd0bf10f-4c49-457a-9d98-b7f007619beb|6|10|5|TREATMENT|2021-11-30|2022-07-09|62|283
Study ID|SE|bd0bf10f-4c49-457a-9d98-b7f007619beb|7|FU|5|FOLLOW-UP|2021-12-23|2022-03-17|85|169
Study ID|SE|d0fbd021-74a2-4c6c-9a37-88b11e02e00a|1|SCRN|5|SCREENING|2021-11-26|2022-01-01|28|64
Study ID|SE|d0fbd021-74a2-4c6c-9a37-88b11e02e00a|2|5|6|TREATMENT|2022-03-31|2022-04-29|153|182
Study ID|SE|d0fbd021-74a2-4c6c-9a37-88b11e02e00a|3|REST|4|WASHOUT|2022-05-10|2022-05-30|193|213
Study ID|SE|d0fbd021-74a2-4c6c-9a37-88b11e02e00a|4|P|7|TREATMENT|2021-11-18|2021-12-03|20|35
Study ID|SE|d0fbd021-74a2-4c6c-9a37-88b11e02e00a|5|REST|4|WASHOUT|2021-11-06|2022-04-11|8|164
Study ID|SE|d0fbd021-74a2-4c6c-9a37-88b11e02e00a|6|10|2|TREATMENT|2022-03-22|2022-04-16|144|169
Study ID|SE|d0fbd021-74a2-4c6c-9a37-88b11e02e00a|7|FU|3|FOLLOW-UP|2022-01-09|2022-05-14|72|197
Study ID|SE|70630273-d909-4fbf-b576-8dcb9788749e|1|SCRN|5|SCREENING|2021-09-11|2022-04-09|28|238
Study ID|SE|70630273-d909-4fbf-b576-8dcb9788749e|2|5|2|TREATMENT|2021-09-15|2022-03-15|32|213
Study ID|SE|70630273-d909-4fbf-b576-8dcb9788749e|3|REST|3|WASHOUT|2021-09-09|2021-09-18|26|35
Study ID|SE|70630273-d909-4fbf-b576-8dcb9788749e|4|P|1|TREATMENT|2022-04-01|2022-05-18|230|277
Study ID|SE|70630273-d909-4fbf-b576-8dcb9788749e|5|REST|4|WASHOUT|2021-09-25|2022-01-25|42|164
Study ID|SE|70630273-d909-4fbf-b576-8dcb9788749e|6|10|5|TREATMENT|2021-09-15|2021-10-04|32|51
Study ID|SE|70630273-d909-4fbf-b576-8dcb9788749e|7|FU|1|FOLLOW-UP|2021-09-25|2021-10-03|42|50
Study ID|SE|a7330018-d906-4045-863f-cdeee9d0404c|1|SCRN|6|SCREENING|2022-01-21|2022-03-19|157|214
Study ID|SE|a7330018-d906-4045-863f-cdeee9d0404c|2|5|4|TREATMENT|2021-09-22|2022-02-16|36|183
Study ID|SE|a7330018-d906-4045-863f-cdeee9d0404c|3|REST|3|WASHOUT|2021-08-27|2022-05-21|10|277
Study ID|SE|a7330018-d906-4045-863f-cdeee9d0404c|4|10|2|TREATMENT|2021-10-08|2021-11-18|52|93
Study ID|SE|a7330018-d906-4045-863f-cdeee9d0404c|5|REST|5|WASHOUT|2021-11-09|2021-12-18|84|123
Study ID|SE|a7330018-d906-4045-863f-cdeee9d0404c|6|P|3|TREATMENT|2021-10-23|2021-12-31|67|136
Study ID|SE|a7330018-d906-4045-863f-cdeee9d0404c|7|FU|1|FOLLOW-UP|2021-11-18|2022-03-09|93|204
Study ID|SE|28ef3051-2a9a-4935-8177-bb4ead0807f3|1|SCRN|1|SCREENING|2022-04-17|2022-05-19|237|269
Study ID|SE|28ef3051-2a9a-4935-8177-bb4ead0807f3|2|5|6|TREATMENT|2021-09-18|2022-01-20|26|150
Study ID|SE|28ef3051-2a9a-4935-8177-bb4ead0807f3|3|REST|6|WASHOUT|2021-08-28|2021-11-15|5|84
Study ID|SE|28ef3051-2a9a-4935-8177-bb4ead0807f3|4|10|5|TREATMENT|2022-05-20|2022-06-14|270|295
Study ID|SE|28ef3051-2a9a-4935-8177-bb4ead0807f3|5|REST|1|WASHOUT|2022-01-10|2022-04-18|140|238
Study ID|SE|28ef3051-2a9a-4935-8177-bb4ead0807f3|6|P|7|TREATMENT|2021-10-12|2021-10-30|50|68
Study ID|SE|28ef3051-2a9a-4935-8177-bb4ead0807f3|7|FU|1|FOLLOW-UP|2021-09-05|2021-09-09|13|17
Study ID|SE|30f1e4f7-89e3-47e9-a6bf-c456f77ae0ae|1|SCRN|6|SCREENING|2021-12-04|2021-12-31|36|63
Study ID|SE|30f1e4f7-89e3-47e9-a6bf-c456f77ae0ae|2|5|2|TREATMENT|2021-12-10|2021-12-31|42|63
Study ID|SE|30f1e4f7-89e3-47e9-a6bf-c456f77ae0ae|3|REST|6|WASHOUT|2021-11-03|2021-11-07|5|9
Study ID|SE|30f1e4f7-89e3-47e9-a6bf-c456f77ae0ae|4|P|1|TREATMENT|2021-11-04|2022-06-09|6|223
Study ID|SE|30f1e4f7-89e3-47e9-a6bf-c456f77ae0ae|5|REST|1|WASHOUT|2021-11-04|2021-11-10|6|12
Study ID|SE|30f1e4f7-89e3-47e9-a6bf-c456f77ae0ae|6|10|6|TREATMENT|2021-11-08|2021-11-29|10|31
Study ID|SE|30f1e4f7-89e3-47e9-a6bf-c456f77ae0ae|7|FU|6|FOLLOW-UP|2022-02-16|2022-05-08|110|191
Study ID|SE|b4a535cc-d816-4c2d-96af-08b3a11fd61f|1|SCRN|2|SCREENING|2021-11-06|2022-03-28|15|157
Study ID|SE|b4a535cc-d816-4c2d-96af-08b3a11fd61f|2|5|3|TREATMENT|2021-11-01|2021-11-07|10|16
Study ID|SE|b4a535cc-d816-4c2d-96af-08b3a11fd61f|3|REST|7|WASHOUT|2021-11-11|2021-12-30|20|69
Study ID|SE|b4a535cc-d816-4c2d-96af-08b3a11fd61f|4|P|5|TREATMENT|2021-12-08|2021-12-22|47|61
Study ID|SE|b4a535cc-d816-4c2d-96af-08b3a11fd61f|5|REST|3|WASHOUT|2021-11-06|2022-01-09|15|79
Study ID|SE|b4a535cc-d816-4c2d-96af-08b3a11fd61f|6|10|7|TREATMENT|2022-03-11|2022-04-21|140|181
Study ID|SE|b4a535cc-d816-4c2d-96af-08b3a11fd61f|7|FU|6|FOLLOW-UP|2022-03-07|2022-04-07|136|167
Study ID|SE|94ee6fa6-c06a-424c-af88-76e7d8e4cf17|1|SCRN|1|SCREENING|2021-11-07|2021-12-26|20|69
Study ID|SE|94ee6fa6-c06a-424c-af88-76e7d8e4cf17|2|P|4|TREATMENT|2021-10-21|2021-11-03|3|16
Study ID|SE|94ee6fa6-c06a-424c-af88-76e7d8e4cf17|3|REST|3|WASHOUT|2021-10-31|2021-11-04|13|17
Study ID|SE|94ee6fa6-c06a-424c-af88-76e7d8e4cf17|4|5|7|TREATMENT|2022-06-02|2022-08-13|227|299
Study ID|SE|94ee6fa6-c06a-424c-af88-76e7d8e4cf17|5|REST|2|WASHOUT|2022-01-22|2022-02-03|96|108
Study ID|SE|94ee6fa6-c06a-424c-af88-76e7d8e4cf17|6|10|5|TREATMENT|2022-04-10|2022-06-07|174|232
Study ID|SE|94ee6fa6-c06a-424c-af88-76e7d8e4cf17|7|FU|6|FOLLOW-UP|2021-11-27|2022-07-16|40|271
Study ID|SE|b38c5cd8-6c9b-4997-9657-261c705eb0f2|1|SCRN|5|SCREENING|2022-05-21|2022-06-20|209|239
Study ID|SE|b38c5cd8-6c9b-4997-9657-261c705eb0f2|2|5|7|TREATMENT|2022-01-26|2022-03-07|94|134
Study ID|SE|b38c5cd8-6c9b-4997-9657-261c705eb0f2|3|REST|5|WASHOUT|2021-11-07|2021-12-01|14|38
Study ID|SE|b38c5cd8-6c9b-4997-9657-261c705eb0f2|4|P|7|TREATMENT|2022-03-25|2022-06-28|152|247
Study ID|SE|b38c5cd8-6c9b-4997-9657-261c705eb0f2|5|REST|7|WASHOUT|2022-02-19|2022-04-14|118|172
Study ID|SE|b38c5cd8-6c9b-4997-9657-261c705eb0f2|6|10|3|TREATMENT|2021-11-18|2021-12-07|25|44
Study ID|SE|b38c5cd8-6c9b-4997-9657-261c705eb0f2|7|FU|2|FOLLOW-UP|2022-06-18|2022-07-19|237|268
Study ID|SE|39def9d8-a452-486b-b1e8-12bebd4c36da|1|SCRN|5|SCREENING|2022-01-07|2022-03-02|122|176
Study ID|SE|39def9d8-a452-486b-b1e8-12bebd4c36da|2|5|3|TREATMENT|2021-09-24|2021-12-28|17|112
Study ID|SE|39def9d8-a452-486b-b1e8-12bebd4c36da|3|REST|6|WASHOUT|2022-04-13|2022-04-23|218|228
Study ID|SE|39def9d8-a452-486b-b1e8-12bebd4c36da|4|10|1|TREATMENT|2021-09-27|2022-06-10|20|276
Study ID|SE|39def9d8-a452-486b-b1e8-12bebd4c36da|5|REST|4|WASHOUT|2022-01-18|2022-02-15|133|161
Study ID|SE|39def9d8-a452-486b-b1e8-12bebd4c36da|6|P|7|TREATMENT|2022-02-28|2022-04-12|174|217
Study ID|SE|39def9d8-a452-486b-b1e8-12bebd4c36da|7|FU|4|FOLLOW-UP|2021-09-13|2021-10-20|6|43
Study ID|SE|7d08a831-9e94-440e-828a-4ba3a85d5841|1|SCRN|4|SCREENING|2021-12-28|2022-04-28|76|197
Study ID|SE|7d08a831-9e94-440e-828a-4ba3a85d5841|2|P|7|TREATMENT|2022-05-22|2022-08-04|221|295
Study ID|SE|7d08a831-9e94-440e-828a-4ba3a85d5841|3|REST|6|WASHOUT|2021-10-25|2021-12-05|12|53
Study ID|SE|7d08a831-9e94-440e-828a-4ba3a85d5841|4|5|4|TREATMENT|2022-02-26|2022-07-15|136|275
Study ID|SE|7d08a831-9e94-440e-828a-4ba3a85d5841|5|REST|6|WASHOUT|2021-12-28|2022-03-31|76|169
Study ID|SE|7d08a831-9e94-440e-828a-4ba3a85d5841|6|10|6|TREATMENT|2022-01-14|2022-06-19|93|249
Study ID|SE|7d08a831-9e94-440e-828a-4ba3a85d5841|7|FU|6|FOLLOW-UP|2022-01-25|2022-02-17|104|127
Study ID|SE|59795f52-5ee4-4a72-8b03-87e04bb0e87e|1|SCRN|6|SCREENING|2021-12-14|2022-02-26|115|189
Study ID|SE|59795f52-5ee4-4a72-8b03-87e04bb0e87e|2|P|5|TREATMENT|2021-09-22|2021-12-18|32|119
Study ID|SE|59795f52-5ee4-4a72-8b03-87e04bb0e87e|3|REST|3|WASHOUT|2021-09-16|2021-10-12|26|52
Study ID|SE|59795f52-5ee4-4a72-8b03-87e04bb0e87e|4|5|3|TREATMENT|2021-09-06|2021-10-09|16|49
Study ID|SE|59795f52-5ee4-4a72-8b03-87e04bb0e87e|5|REST|5|WASHOUT|2022-02-04|2022-02-23|167|186
Study ID|SE|59795f52-5ee4-4a72-8b03-87e04bb0e87e|6|10|5|TREATMENT|2021-09-03|2021-09-08|13|18
Study ID|SE|59795f52-5ee4-4a72-8b03-87e04bb0e87e|7|FU|1|FOLLOW-UP|2021-12-17|2022-01-29|118|161
Study ID|SE|b1ebda49-a95a-4140-b833-154fe8ab3401|1|SCRN|7|SCREENING|2021-09-04|2022-03-07|24|208
Study ID|SE|b1ebda49-a95a-4140-b833-154fe8ab3401|2|P|1|TREATMENT|2021-09-04|2021-11-12|24|93
Study ID|SE|b1ebda49-a95a-4140-b833-154fe8ab3401|3|REST|1|WASHOUT|2021-10-13|2022-01-18|63|160
Study ID|SE|b1ebda49-a95a-4140-b833-154fe8ab3401|4|5|7|TREATMENT|2021-09-23|2021-12-29|43|140
Study ID|SE|b1ebda49-a95a-4140-b833-154fe8ab3401|5|REST|7|WASHOUT|2021-10-28|2021-11-16|78|97
Study ID|SE|b1ebda49-a95a-4140-b833-154fe8ab3401|6|10|4|TREATMENT|2021-09-16|2021-12-01|36|112
Study ID|SE|b1ebda49-a95a-4140-b833-154fe8ab3401|7|FU|5|FOLLOW-UP|2021-08-20|2021-08-24|9|13
Study ID|SE|fa311f24-630a-411a-a48f-3c3b07e213d2|1|SCRN|5|SCREENING|2021-10-21|2022-04-12|52|225
Study ID|SE|fa311f24-630a-411a-a48f-3c3b07e213d2|2|5|7|TREATMENT|2021-10-09|2021-11-01|40|63
Study ID|SE|fa311f24-630a-411a-a48f-3c3b07e213d2|3|REST|2|WASHOUT|2021-09-21|2021-12-31|22|123
Study ID|SE|fa311f24-630a-411a-a48f-3c3b07e213d2|4|10|6|TREATMENT|2021-12-01|2022-04-18|93|231
Study ID|SE|fa311f24-630a-411a-a48f-3c3b07e213d2|5|REST|2|WASHOUT|2022-04-07|2022-05-02|220|245
Study ID|SE|fa311f24-630a-411a-a48f-3c3b07e213d2|6|P|1|TREATMENT|2021-10-02|2021-12-29|33|121
Study ID|SE|fa311f24-630a-411a-a48f-3c3b07e213d2|7|FU|1|FOLLOW-UP|2021-11-21|2022-01-30|83|153
Study ID|SE|f12d0bcd-16ab-420a-ab4c-a8e688285fde|1|SCRN|5|SCREENING|2021-12-02|2022-03-24|47|159
Study ID|SE|f12d0bcd-16ab-420a-ab4c-a8e688285fde|2|P|5|TREATMENT|2021-12-30|2022-01-05|75|81
Study ID|SE|f12d0bcd-16ab-420a-ab4c-a8e688285fde|3|REST|7|WASHOUT|2022-02-22|2022-03-15|129|150
Study ID|SE|f12d0bcd-16ab-420a-ab4c-a8e688285fde|4|5|5|TREATMENT|2021-12-21|2022-05-01|66|197
Study ID|SE|f12d0bcd-16ab-420a-ab4c-a8e688285fde|5|REST|6|WASHOUT|2021-11-24|2021-12-14|39|59
Study ID|SE|f12d0bcd-16ab-420a-ab4c-a8e688285fde|6|10|3|TREATMENT|2022-07-11|2022-07-29|268|286
Study ID|SE|f12d0bcd-16ab-420a-ab4c-a8e688285fde|7|FU|2|FOLLOW-UP|2021-11-23|2021-12-05|38|50
Study ID|SE|c307f13b-c7fe-437b-a990-e00f4e1f104a|1|SCRN|3|SCREENING|2021-12-13|2022-05-19|119|276
Study ID|SE|c307f13b-c7fe-437b-a990-e00f4e1f104a|2|5|5|TREATMENT|2021-09-12|2021-10-02|27|47
Study ID|SE|c307f13b-c7fe-437b-a990-e00f4e1f104a|3|REST|6|WASHOUT|2021-09-05|2021-10-02|20|47
Study ID|SE|c307f13b-c7fe-437b-a990-e00f4e1f104a|4|P|3|TREATMENT|2021-09-05|2021-09-21|20|36
Study ID|SE|c307f13b-c7fe-437b-a990-e00f4e1f104a|5|REST|1|WASHOUT|2021-08-28|2021-12-14|12|120
Study ID|SE|c307f13b-c7fe-437b-a990-e00f4e1f104a|6|10|6|TREATMENT|2021-09-04|2021-11-03|19|79
Study ID|SE|c307f13b-c7fe-437b-a990-e00f4e1f104a|7|FU|6|FOLLOW-UP|2021-11-20|2022-01-07|96|144
Study ID|SE|6c12bd19-7c12-411e-ba09-c9a4dce7ffd8|1|SCRN|7|SCREENING|2022-03-09|2022-04-02|195|219
Study ID|SE|6c12bd19-7c12-411e-ba09-c9a4dce7ffd8|2|5|6|TREATMENT|2021-12-11|2022-04-21|107|238
Study ID|SE|6c12bd19-7c12-411e-ba09-c9a4dce7ffd8|3|REST|1|WASHOUT|2021-12-22|2022-03-05|118|191
Study ID|SE|6c12bd19-7c12-411e-ba09-c9a4dce7ffd8|4|P|6|TREATMENT|2021-08-29|2021-09-15|3|20
Study ID|SE|6c12bd19-7c12-411e-ba09-c9a4dce7ffd8|5|REST|2|WASHOUT|2021-12-18|2022-01-26|114|153
Study ID|SE|6c12bd19-7c12-411e-ba09-c9a4dce7ffd8|6|10|6|TREATMENT|2021-11-08|2022-03-10|74|196
Study ID|SE|6c12bd19-7c12-411e-ba09-c9a4dce7ffd8|7|FU|3|FOLLOW-UP|2022-01-01|2022-04-11|128|228
Study ID|SE|eb822c77-ec30-4c17-bb12-bfb773c9d3eb|1|SCRN|6|SCREENING|2021-11-23|2022-04-19|56|203
Study ID|SE|eb822c77-ec30-4c17-bb12-bfb773c9d3eb|2|P|1|TREATMENT|2021-10-28|2021-12-27|30|90
Study ID|SE|eb822c77-ec30-4c17-bb12-bfb773c9d3eb|3|REST|4|WASHOUT|2021-11-29|2022-03-18|62|171
Study ID|SE|eb822c77-ec30-4c17-bb12-bfb773c9d3eb|4|5|2|TREATMENT|2022-04-17|2022-07-08|201|283
Study ID|SE|eb822c77-ec30-4c17-bb12-bfb773c9d3eb|5|REST|7|WASHOUT|2021-10-12|2021-10-21|14|23
Study ID|SE|eb822c77-ec30-4c17-bb12-bfb773c9d3eb|6|10|3|TREATMENT|2021-12-25|2022-01-15|88|109
Study ID|SE|eb822c77-ec30-4c17-bb12-bfb773c9d3eb|7|FU|3|FOLLOW-UP|2022-01-16|2022-04-28|110|212
Study ID|SE|c13f95cc-1a44-4b19-a007-4e6db10f9d94|1|SCRN|7|SCREENING|2021-10-19|2021-11-18|17|47
Study ID|SE|c13f95cc-1a44-4b19-a007-4e6db10f9d94|2|P|7|TREATMENT|2021-11-18|2022-02-28|47|149
Study ID|SE|c13f95cc-1a44-4b19-a007-4e6db10f9d94|3|REST|6|WASHOUT|2021-11-16|2021-11-30|45|59
Study ID|SE|c13f95cc-1a44-4b19-a007-4e6db10f9d94|4|5|3|TREATMENT|2021-10-04|2022-03-01|2|150
Study ID|SE|c13f95cc-1a44-4b19-a007-4e6db10f9d94|5|REST|5|WASHOUT|2021-10-08|2021-12-15|6|74
Study ID|SE|c13f95cc-1a44-4b19-a007-4e6db10f9d94|6|10|4|TREATMENT|2021-10-04|2021-11-08|2|37
Study ID|SE|c13f95cc-1a44-4b19-a007-4e6db10f9d94|7|FU|7|FOLLOW-UP|2022-01-02|2022-01-13|92|103
Study ID|SE|d0c75130-9899-4931-8ab5-ab5f0811f9c1|1|SCRN|3|SCREENING|2021-10-30|2021-11-03|17|21
Study ID|SE|d0c75130-9899-4931-8ab5-ab5f0811f9c1|2|5|7|TREATMENT|2022-01-11|2022-06-28|90|258
Study ID|SE|d0c75130-9899-4931-8ab5-ab5f0811f9c1|3|REST|6|WASHOUT|2021-11-24|2022-01-25|42|104
Study ID|SE|d0c75130-9899-4931-8ab5-ab5f0811f9c1|4|10|6|TREATMENT|2021-10-26|2022-05-11|13|210
Study ID|SE|d0c75130-9899-4931-8ab5-ab5f0811f9c1|5|REST|6|WASHOUT|2022-03-24|2022-04-22|162|191
Study ID|SE|d0c75130-9899-4931-8ab5-ab5f0811f9c1|6|P|1|TREATMENT|2022-01-13|2022-03-22|92|160
Study ID|SE|d0c75130-9899-4931-8ab5-ab5f0811f9c1|7|FU|4|FOLLOW-UP|2022-02-02|2022-07-03|112|263
Study ID|SE|59bb2cf4-a255-40d4-9d73-6d1114e2b8a9|1|SCRN|4|SCREENING|2021-10-24|2022-05-17|57|262
Study ID|SE|59bb2cf4-a255-40d4-9d73-6d1114e2b8a9|2|5|6|TREATMENT|2021-11-17|2022-03-31|81|215
Study ID|SE|59bb2cf4-a255-40d4-9d73-6d1114e2b8a9|3|REST|6|WASHOUT|2022-01-08|2022-03-07|133|191
Study ID|SE|59bb2cf4-a255-40d4-9d73-6d1114e2b8a9|4|10|3|TREATMENT|2022-05-05|2022-05-26|250|271
Study ID|SE|59bb2cf4-a255-40d4-9d73-6d1114e2b8a9|5|REST|6|WASHOUT|2021-08-30|2021-10-05|2|38
Study ID|SE|59bb2cf4-a255-40d4-9d73-6d1114e2b8a9|6|P|5|TREATMENT|2021-11-30|2021-12-20|94|114
Study ID|SE|59bb2cf4-a255-40d4-9d73-6d1114e2b8a9|7|FU|5|FOLLOW-UP|2022-02-18|2022-02-22|174|178
Study ID|SE|9aa5a461-1f6e-4dd2-bb06-e01d71ab3cce|1|SCRN|6|SCREENING|2021-09-15|2021-11-02|33|81
Study ID|SE|9aa5a461-1f6e-4dd2-bb06-e01d71ab3cce|2|5|1|TREATMENT|2021-10-10|2021-10-14|58|62
Study ID|SE|9aa5a461-1f6e-4dd2-bb06-e01d71ab3cce|3|REST|5|WASHOUT|2021-08-15|2021-08-15|2|2
Study ID|SE|9aa5a461-1f6e-4dd2-bb06-e01d71ab3cce|4|P|7|TREATMENT|2021-12-18|2022-03-07|127|206
Study ID|SE|9aa5a461-1f6e-4dd2-bb06-e01d71ab3cce|5|REST|1|WASHOUT|2022-03-14|2022-05-31|213|291
Study ID|SE|9aa5a461-1f6e-4dd2-bb06-e01d71ab3cce|6|10|4|TREATMENT|2021-09-12|2022-04-10|30|240
Study ID|SE|9aa5a461-1f6e-4dd2-bb06-e01d71ab3cce|7|FU|7|FOLLOW-UP|2021-08-16|2022-05-05|3|265
Study ID|SE|ed9b7770-a013-48b1-bd83-3761f33c675f|1|SCRN|2|SCREENING|2022-02-09|2022-05-13|114|207
Study ID|SE|ed9b7770-a013-48b1-bd83-3761f33c675f|2|P|4|TREATMENT|2021-11-20|2022-07-21|33|276
Study ID|SE|ed9b7770-a013-48b1-bd83-3761f33c675f|3|REST|5|WASHOUT|2022-03-16|2022-05-02|149|196
Study ID|SE|ed9b7770-a013-48b1-bd83-3761f33c675f|4|5|7|TREATMENT|2021-12-03|2022-01-10|46|84
Study ID|SE|ed9b7770-a013-48b1-bd83-3761f33c675f|5|REST|4|WASHOUT|2022-03-30|2022-06-25|163|250
Study ID|SE|ed9b7770-a013-48b1-bd83-3761f33c675f|6|10|4|TREATMENT|2021-10-28|2022-05-03|10|197
Study ID|SE|ed9b7770-a013-48b1-bd83-3761f33c675f|7|FU|6|FOLLOW-UP|2022-01-12|2022-03-28|86|161
Study ID|SE|30f82443-3ada-472b-b68c-281db036c5b7|1|SCRN|6|SCREENING|2021-11-26|2022-01-03|37|75
Study ID|SE|30f82443-3ada-472b-b68c-281db036c5b7|2|P|2|TREATMENT|2021-11-04|2022-04-14|15|176
Study ID|SE|30f82443-3ada-472b-b68c-281db036c5b7|3|REST|2|WASHOUT|2022-01-09|2022-07-31|81|284
Study ID|SE|30f82443-3ada-472b-b68c-281db036c5b7|4|5|5|TREATMENT|2021-11-06|2021-11-26|17|37
Study ID|SE|30f82443-3ada-472b-b68c-281db036c5b7|5|REST|2|WASHOUT|2021-11-26|2022-03-27|37|158
Study ID|SE|30f82443-3ada-472b-b68c-281db036c5b7|6|10|3|TREATMENT|2022-02-27|2022-03-03|130|134
Study ID|SE|30f82443-3ada-472b-b68c-281db036c5b7|7|FU|6|FOLLOW-UP|2021-10-23|2021-10-28|3|8
Study ID|SE|572f79de-369d-40c4-9153-a1f25fbb7e8f|1|SCRN|6|SCREENING|2021-11-11|2022-03-14|40|163
Study ID|SE|572f79de-369d-40c4-9153-a1f25fbb7e8f|2|P|3|TREATMENT|2022-01-28|2022-02-20|118|141
Study ID|SE|572f79de-369d-40c4-9153-a1f25fbb7e8f|3|REST|6|WASHOUT|2021-11-06|2022-01-31|35|121
Study ID|SE|572f79de-369d-40c4-9153-a1f25fbb7e8f|4|5|7|TREATMENT|2021-12-01|2022-05-17|60|227
Study ID|SE|572f79de-369d-40c4-9153-a1f25fbb7e8f|5|REST|7|WASHOUT|2021-10-16|2021-12-09|14|68
Study ID|SE|572f79de-369d-40c4-9153-a1f25fbb7e8f|6|10|1|TREATMENT|2021-12-14|2021-12-28|73|87
Study ID|SE|572f79de-369d-40c4-9153-a1f25fbb7e8f|7|FU|5|FOLLOW-UP|2022-02-21|2022-05-18|142|228
Study ID|SE|ff46289d-51d9-4fe8-9709-39509630591a|1|SCRN|1|SCREENING|2022-04-05|2022-05-25|219|269
Study ID|SE|ff46289d-51d9-4fe8-9709-39509630591a|2|5|2|TREATMENT|2021-10-15|2021-11-19|47|82
Study ID|SE|ff46289d-51d9-4fe8-9709-39509630591a|3|REST|1|WASHOUT|2021-11-01|2022-01-24|64|148
Study ID|SE|ff46289d-51d9-4fe8-9709-39509630591a|4|P|7|TREATMENT|2021-12-23|2022-01-29|116|153
Study ID|SE|ff46289d-51d9-4fe8-9709-39509630591a|5|REST|6|WASHOUT|2021-10-16|2021-10-28|48|60
Study ID|SE|ff46289d-51d9-4fe8-9709-39509630591a|6|10|3|TREATMENT|2021-09-05|2022-02-22|7|177
Study ID|SE|ff46289d-51d9-4fe8-9709-39509630591a|7|FU|3|FOLLOW-UP|2021-11-12|2022-01-20|75|144
Study ID|SE|243f053d-22b2-4468-a717-af7f22b7be1a|1|SCRN|5|SCREENING|2021-10-08|2021-10-09|2|3
Study ID|SE|243f053d-22b2-4468-a717-af7f22b7be1a|2|5|1|TREATMENT|2022-03-28|2022-06-23|173|260
Study ID|SE|243f053d-22b2-4468-a717-af7f22b7be1a|3|REST|1|WASHOUT|2022-01-28|2022-03-24|114|169
Study ID|SE|243f053d-22b2-4468-a717-af7f22b7be1a|4|P|7|TREATMENT|2021-12-06|2022-01-22|61|108
Study ID|SE|243f053d-22b2-4468-a717-af7f22b7be1a|5|REST|7|WASHOUT|2022-01-18|2022-01-24|104|110
Study ID|SE|243f053d-22b2-4468-a717-af7f22b7be1a|6|10|6|TREATMENT|2021-12-19|2022-02-08|74|125
Study ID|SE|243f053d-22b2-4468-a717-af7f22b7be1a|7|FU|5|FOLLOW-UP|2021-11-22|2022-03-25|47|170
Study ID|SE|b93fe287-2430-4c53-a385-fabbf6ece60a|1|SCRN|6|SCREENING|2021-10-01|2021-10-05|44|48
Study ID|SE|b93fe287-2430-4c53-a385-fabbf6ece60a|2|P|4|TREATMENT|2022-01-06|2022-04-15|141|240
Study ID|SE|b93fe287-2430-4c53-a385-fabbf6ece60a|3|REST|1|WASHOUT|2021-09-08|2021-09-20|21|33
Study ID|SE|b93fe287-2430-4c53-a385-fabbf6ece60a|4|5|6|TREATMENT|2021-09-17|2022-01-10|30|145
Study ID|SE|b93fe287-2430-4c53-a385-fabbf6ece60a|5|REST|4|WASHOUT|2021-09-19|2021-11-08|32|82
Study ID|SE|b93fe287-2430-4c53-a385-fabbf6ece60a|6|10|6|TREATMENT|2022-02-17|2022-04-13|183|238
Study ID|SE|b93fe287-2430-4c53-a385-fabbf6ece60a|7|FU|5|FOLLOW-UP|2021-10-18|2022-04-15|61|240
Study ID|SE|303cbab3-0804-43b0-8a2a-97fef0d5272d|1|SCRN|3|SCREENING|2021-12-29|2022-02-26|131|190
Study ID|SE|303cbab3-0804-43b0-8a2a-97fef0d5272d|2|P|6|TREATMENT|2021-10-05|2022-05-10|46|263
Study ID|SE|303cbab3-0804-43b0-8a2a-97fef0d5272d|3|REST|6|WASHOUT|2021-09-30|2021-10-01|41|42
Study ID|SE|303cbab3-0804-43b0-8a2a-97fef0d5272d|4|5|5|TREATMENT|2021-09-20|2022-04-02|31|225
Study ID|SE|303cbab3-0804-43b0-8a2a-97fef0d5272d|5|REST|2|WASHOUT|2021-08-27|2022-01-01|7|134
Study ID|SE|303cbab3-0804-43b0-8a2a-97fef0d5272d|6|10|4|TREATMENT|2022-01-18|2022-03-10|151|202
Study ID|SE|303cbab3-0804-43b0-8a2a-97fef0d5272d|7|FU|5|FOLLOW-UP|2021-11-15|2021-11-24|87|96
Study ID|SE|a2cd90d1-73b8-47f3-bf1e-6662f47b7ad8|1|SCRN|6|SCREENING|2022-02-03|2022-05-30|140|256
Study ID|SE|a2cd90d1-73b8-47f3-bf1e-6662f47b7ad8|2|5|5|TREATMENT|2021-12-20|2022-01-02|95|108
Study ID|SE|a2cd90d1-73b8-47f3-bf1e-6662f47b7ad8|3|REST|1|WASHOUT|2022-05-06|2022-05-11|232|237
Study ID|SE|a2cd90d1-73b8-47f3-bf1e-6662f47b7ad8|4|10|7|TREATMENT|2021-09-20|2021-12-10|4|85
Study ID|SE|a2cd90d1-73b8-47f3-bf1e-6662f47b7ad8|5|REST|4|WASHOUT|2022-02-11|2022-04-21|148|217
Study ID|SE|a2cd90d1-73b8-47f3-bf1e-6662f47b7ad8|6|P|3|TREATMENT|2022-04-18|2022-06-02|214|259
Study ID|SE|a2cd90d1-73b8-47f3-bf1e-6662f47b7ad8|7|FU|4|FOLLOW-UP|2022-01-11|2022-02-17|117|154
Study ID|SE|9f0a9ed8-d47a-408a-9a60-ab92ee14317f|1|SCRN|6|SCREENING|2022-01-03|2022-03-09|116|181
Study ID|SE|9f0a9ed8-d47a-408a-9a60-ab92ee14317f|2|5|4|TREATMENT|2021-09-12|2021-09-16|3|7
Study ID|SE|9f0a9ed8-d47a-408a-9a60-ab92ee14317f|3|REST|6|WASHOUT|2021-09-21|2021-10-07|12|28
Study ID|SE|9f0a9ed8-d47a-408a-9a60-ab92ee14317f|4|10|6|TREATMENT|2021-12-07|2022-04-09|89|212
Study ID|SE|9f0a9ed8-d47a-408a-9a60-ab92ee14317f|5|REST|4|WASHOUT|2021-12-08|2022-04-06|90|209
Study ID|SE|9f0a9ed8-d47a-408a-9a60-ab92ee14317f|6|P|2|TREATMENT|2021-09-22|2021-09-25|13|16
Study ID|SE|9f0a9ed8-d47a-408a-9a60-ab92ee14317f|7|FU|5|FOLLOW-UP|2021-09-20|2021-11-01|11|53
Study ID|SE|5b922ca1-bf69-45e3-b16f-180ab68cfc8f|1|SCRN|4|SCREENING|2021-09-02|2021-09-16|10|24
Study ID|SE|5b922ca1-bf69-45e3-b16f-180ab68cfc8f|2|P|6|TREATMENT|2021-11-21|2022-03-13|90|202
Study ID|SE|5b922ca1-bf69-45e3-b16f-180ab68cfc8f|3|REST|6|WASHOUT|2021-12-22|2022-01-23|121|153
Study ID|SE|5b922ca1-bf69-45e3-b16f-180ab68cfc8f|4|5|2|TREATMENT|2021-10-18|2021-12-11|56|110
Study ID|SE|5b922ca1-bf69-45e3-b16f-180ab68cfc8f|5|REST|7|WASHOUT|2021-09-14|2021-10-21|22|59
Study ID|SE|5b922ca1-bf69-45e3-b16f-180ab68cfc8f|6|10|3|TREATMENT|2022-01-08|2022-03-23|138|212
Study ID|SE|5b922ca1-bf69-45e3-b16f-180ab68cfc8f|7|FU|1|FOLLOW-UP|2021-10-23|2021-12-06|61|105
Study ID|SE|164be186-dcce-4440-a795-1130b543f736|1|SCRN|5|SCREENING|2021-10-26|2021-12-11|13|59
Study ID|SE|164be186-dcce-4440-a795-1130b543f736|2|5|4|TREATMENT|2022-06-04|2022-07-14|234|274
Study ID|SE|164be186-dcce-4440-a795-1130b543f736|3|REST|3|WASHOUT|2021-11-22|2022-08-01|40|292
Study ID|SE|164be186-dcce-4440-a795-1130b543f736|4|P|1|TREATMENT|2021-11-20|2022-05-06|38|205
Study ID|SE|164be186-dcce-4440-a795-1130b543f736|5|REST|4|WASHOUT|2021-10-28|2021-12-15|15|63
Study ID|SE|164be186-dcce-4440-a795-1130b543f736|6|10|3|TREATMENT|2021-11-09|2022-01-29|27|108
Study ID|SE|164be186-dcce-4440-a795-1130b543f736|7|FU|6|FOLLOW-UP|2022-02-17|2022-04-29|127|198
Study ID|SE|655c7821-7058-486b-96bd-e0cb4e00d6ca|1|SCRN|7|SCREENING|2022-02-13|2022-06-02|126|235
Study ID|SE|655c7821-7058-486b-96bd-e0cb4e00d6ca|2|5|3|TREATMENT|2021-12-23|2022-08-04|74|298
Study ID|SE|655c7821-7058-486b-96bd-e0cb4e00d6ca|3|REST|3|WASHOUT|2021-10-21|2022-03-15|11|156
Study ID|SE|655c7821-7058-486b-96bd-e0cb4e00d6ca|4|10|5|TREATMENT|2022-03-10|2022-06-03|151|236
Study ID|SE|655c7821-7058-486b-96bd-e0cb4e00d6ca|5|REST|3|WASHOUT|2021-12-01|2021-12-10|52|61
Study ID|SE|655c7821-7058-486b-96bd-e0cb4e00d6ca|6|P|1|TREATMENT|2021-10-21|2022-04-19|11|191
Study ID|SE|655c7821-7058-486b-96bd-e0cb4e00d6ca|7|FU|2|FOLLOW-UP|2021-10-23|2022-06-01|13|234
Study ID|SE|a414ce50-a635-461a-a109-591cda1040ca|1|SCRN|6|SCREENING|2021-11-29|2022-04-02|32|156
Study ID|SE|a414ce50-a635-461a-a109-591cda1040ca|2|P|2|TREATMENT|2022-03-29|2022-04-12|152|166
Study ID|SE|a414ce50-a635-461a-a109-591cda1040ca|3|REST|1|WASHOUT|2021-12-19|2022-06-20|52|235
Study ID|SE|a414ce50-a635-461a-a109-591cda1040ca|4|5|3|TREATMENT|2022-01-12|2022-06-14|76|229
Study ID|SE|a414ce50-a635-461a-a109-591cda1040ca|5|REST|5|WASHOUT|2021-11-14|2021-11-30|17|33
Study ID|SE|a414ce50-a635-461a-a109-591cda1040ca|6|10|1|TREATMENT|2022-01-10|2022-02-22|74|117
Study ID|SE|a414ce50-a635-461a-a109-591cda1040ca|7|FU|4|FOLLOW-UP|2022-02-13|2022-02-17|108|112
Study ID|SE|e137040f-31fe-4c36-9fa2-d5917539d11d|1|SCRN|7|SCREENING|2022-05-10|2022-07-28|205|284
Study ID|SE|e137040f-31fe-4c36-9fa2-d5917539d11d|2|5|7|TREATMENT|2021-10-23|2021-10-29|6|12
Study ID|SE|e137040f-31fe-4c36-9fa2-d5917539d11d|3|REST|7|WASHOUT|2022-02-09|2022-03-05|115|139
Study ID|SE|e137040f-31fe-4c36-9fa2-d5917539d11d|4|10|6|TREATMENT|2021-11-15|2022-02-23|29|129
Study ID|SE|e137040f-31fe-4c36-9fa2-d5917539d11d|5|REST|6|WASHOUT|2021-11-09|2022-03-04|23|138
Study ID|SE|e137040f-31fe-4c36-9fa2-d5917539d11d|6|P|3|TREATMENT|2022-01-01|2022-02-27|76|133
Study ID|SE|e137040f-31fe-4c36-9fa2-d5917539d11d|7|FU|3|FOLLOW-UP|2022-01-02|2022-05-24|77|219
Study ID|SE|cb063824-7827-4ba8-860f-13ea6401bd33|1|SCRN|7|SCREENING|2021-10-05|2022-04-14|5|196
Study ID|SE|cb063824-7827-4ba8-860f-13ea6401bd33|2|5|5|TREATMENT|2022-04-10|2022-07-18|192|291
Study ID|SE|cb063824-7827-4ba8-860f-13ea6401bd33|3|REST|4|WASHOUT|2021-10-04|2022-02-12|4|135
Study ID|SE|cb063824-7827-4ba8-860f-13ea6401bd33|4|P|1|TREATMENT|2021-11-06|2021-11-15|37|46
Study ID|SE|cb063824-7827-4ba8-860f-13ea6401bd33|5|REST|7|WASHOUT|2022-03-19|2022-06-04|170|247
Study ID|SE|cb063824-7827-4ba8-860f-13ea6401bd33|6|10|1|TREATMENT|2022-01-03|2022-02-07|95|130
Study ID|SE|cb063824-7827-4ba8-860f-13ea6401bd33|7|FU|1|FOLLOW-UP|2022-03-04|2022-06-05|155|248
Study ID|SE|e89dc34b-13f6-40d2-86d7-a46fef07d855|1|SCRN|7|SCREENING|2021-10-16|2022-01-15|21|112
Study ID|SE|e89dc34b-13f6-40d2-86d7-a46fef07d855|2|P|3|TREATMENT|2022-04-05|2022-04-16|192|203
Study ID|SE|e89dc34b-13f6-40d2-86d7-a46fef07d855|3|REST|6|WASHOUT|2021-10-21|2021-11-05|26|41
Study ID|SE|e89dc34b-13f6-40d2-86d7-a46fef07d855|4|5|5|TREATMENT|2021-10-12|2022-06-25|17|273
Study ID|SE|e89dc34b-13f6-40d2-86d7-a46fef07d855|5|REST|7|WASHOUT|2021-10-20|2022-04-17|25|204
Study ID|SE|e89dc34b-13f6-40d2-86d7-a46fef07d855|6|10|2|TREATMENT|2021-10-04|2022-02-06|9|134
Study ID|SE|e89dc34b-13f6-40d2-86d7-a46fef07d855|7|FU|2|FOLLOW-UP|2022-04-08|2022-07-01|195|279
Study ID|SE|7737fac2-0749-41bc-8249-0388b2fd68ef|1|SCRN|2|SCREENING|2021-11-16|2021-11-29|98|111
Study ID|SE|7737fac2-0749-41bc-8249-0388b2fd68ef|2|5|6|TREATMENT|2021-09-04|2022-02-13|25|187
Study ID|SE|7737fac2-0749-41bc-8249-0388b2fd68ef|3|REST|5|WASHOUT|2021-10-07|2022-02-15|58|189
Study ID|SE|7737fac2-0749-41bc-8249-0388b2fd68ef|4|P|7|TREATMENT|2021-09-13|2022-01-04|34|147
Study ID|SE|7737fac2-0749-41bc-8249-0388b2fd68ef|5|REST|2|WASHOUT|2021-12-22|2022-04-01|134|234
Study ID|SE|7737fac2-0749-41bc-8249-0388b2fd68ef|6|10|3|TREATMENT|2021-09-07|2021-09-22|28|43
Study ID|SE|7737fac2-0749-41bc-8249-0388b2fd68ef|7|FU|6|FOLLOW-UP|2021-11-23|2021-12-05|105|117
Study ID|SE|ed838820-1c2a-4cb2-b2d1-a15a67a591e7|1|SCRN|6|SCREENING|2021-09-20|2021-09-30|12|22
Study ID|SE|ed838820-1c2a-4cb2-b2d1-a15a67a591e7|2|5|1|TREATMENT|2022-02-20|2022-06-26|165|291
Study ID|SE|ed838820-1c2a-4cb2-b2d1-a15a67a591e7|3|REST|4|WASHOUT|2022-01-30|2022-04-09|144|213
Study ID|SE|ed838820-1c2a-4cb2-b2d1-a15a67a591e7|4|P|1|TREATMENT|2021-09-15|2022-01-18|7|132
Study ID|SE|ed838820-1c2a-4cb2-b2d1-a15a67a591e7|5|REST|5|WASHOUT|2021-10-14|2022-02-13|36|158
Study ID|SE|ed838820-1c2a-4cb2-b2d1-a15a67a591e7|6|10|1|TREATMENT|2022-01-29|2022-04-06|143|210
Study ID|SE|ed838820-1c2a-4cb2-b2d1-a15a67a591e7|7|FU|4|FOLLOW-UP|2022-01-27|2022-02-22|141|167
Study ID|SE|0c6caab4-8a56-44dd-83dd-f100286b9e74|1|SCRN|4|SCREENING|2022-01-06|2022-08-08|81|295
Study ID|SE|0c6caab4-8a56-44dd-83dd-f100286b9e74|2|5|4|TREATMENT|2021-12-05|2022-03-16|49|150
Study ID|SE|0c6caab4-8a56-44dd-83dd-f100286b9e74|3|REST|4|WASHOUT|2022-03-06|2022-04-09|140|174
Study ID|SE|0c6caab4-8a56-44dd-83dd-f100286b9e74|4|10|7|TREATMENT|2021-11-14|2021-12-05|28|49
Study ID|SE|0c6caab4-8a56-44dd-83dd-f100286b9e74|5|REST|3|WASHOUT|2022-01-29|2022-02-12|104|118
Study ID|SE|0c6caab4-8a56-44dd-83dd-f100286b9e74|6|P|7|TREATMENT|2021-10-31|2021-12-02|14|46
Study ID|SE|0c6caab4-8a56-44dd-83dd-f100286b9e74|7|FU|7|FOLLOW-UP|2021-11-14|2021-11-19|28|33
Study ID|SE|2cace3eb-a9ed-4b42-9acf-3083596a70e0|1|SCRN|6|SCREENING|2021-10-27|2021-11-30|2|36
Study ID|SE|2cace3eb-a9ed-4b42-9acf-3083596a70e0|2|P|2|TREATMENT|2021-12-05|2021-12-17|41|53
Study ID|SE|2cace3eb-a9ed-4b42-9acf-3083596a70e0|3|REST|3|WASHOUT|2022-01-13|2022-02-18|80|116
Study ID|SE|2cace3eb-a9ed-4b42-9acf-3083596a70e0|4|5|7|TREATMENT|2021-11-07|2021-12-03|13|39
Study ID|SE|2cace3eb-a9ed-4b42-9acf-3083596a70e0|5|REST|4|WASHOUT|2022-01-12|2022-04-28|79|185
Study ID|SE|2cace3eb-a9ed-4b42-9acf-3083596a70e0|6|10|5|TREATMENT|2021-11-24|2022-04-03|30|160
Study ID|SE|2cace3eb-a9ed-4b42-9acf-3083596a70e0|7|FU|6|FOLLOW-UP|2022-01-20|2022-02-27|87|125
Study ID|SE|d3d357d9-0a5d-4ad3-8cb6-5976f71accb3|1|SCRN|4|SCREENING|2021-11-13|2022-03-20|39|166
Study ID|SE|d3d357d9-0a5d-4ad3-8cb6-5976f71accb3|2|P|2|TREATMENT|2021-10-16|2022-01-31|11|118
Study ID|SE|d3d357d9-0a5d-4ad3-8cb6-5976f71accb3|3|REST|7|WASHOUT|2021-10-21|2022-01-28|16|115
Study ID|SE|d3d357d9-0a5d-4ad3-8cb6-5976f71accb3|4|5|4|TREATMENT|2021-11-05|2022-06-09|31|247
Study ID|SE|d3d357d9-0a5d-4ad3-8cb6-5976f71accb3|5|REST|7|WASHOUT|2021-12-09|2022-07-12|65|280
Study ID|SE|d3d357d9-0a5d-4ad3-8cb6-5976f71accb3|6|10|3|TREATMENT|2022-04-10|2022-04-26|187|203
Study ID|SE|d3d357d9-0a5d-4ad3-8cb6-5976f71accb3|7|FU|4|FOLLOW-UP|2021-10-26|2022-04-24|21|201
Study ID|SE|14e47c8e-f157-4202-b16f-563957d7c7ca|1|SCRN|4|SCREENING|2021-12-25|2022-05-04|94|224
Study ID|SE|14e47c8e-f157-4202-b16f-563957d7c7ca|2|5|2|TREATMENT|2021-10-19|2021-12-25|27|94
Study ID|SE|14e47c8e-f157-4202-b16f-563957d7c7ca|3|REST|6|WASHOUT|2022-03-06|2022-04-04|165|194
Study ID|SE|14e47c8e-f157-4202-b16f-563957d7c7ca|4|10|6|TREATMENT|2022-05-04|2022-05-05|224|225
Study ID|SE|14e47c8e-f157-4202-b16f-563957d7c7ca|5|REST|1|WASHOUT|2021-11-02|2021-12-27|41|96
Study ID|SE|14e47c8e-f157-4202-b16f-563957d7c7ca|6|P|7|TREATMENT|2021-10-09|2021-11-10|17|49
Study ID|SE|14e47c8e-f157-4202-b16f-563957d7c7ca|7|FU|2|FOLLOW-UP|2022-04-17|2022-07-14|207|295
Study ID|SE|cb700cc0-92f5-4a8c-b5e5-64ba84d1b22d|1|SCRN|5|SCREENING|2021-12-15|2021-12-27|97|109
Study ID|SE|cb700cc0-92f5-4a8c-b5e5-64ba84d1b22d|2|P|7|TREATMENT|2021-10-26|2022-02-05|47|149
Study ID|SE|cb700cc0-92f5-4a8c-b5e5-64ba84d1b22d|3|REST|2|WASHOUT|2021-10-16|2022-06-05|37|269
Study ID|SE|cb700cc0-92f5-4a8c-b5e5-64ba84d1b22d|4|5|7|TREATMENT|2021-12-16|2022-02-07|98|151
Study ID|SE|cb700cc0-92f5-4a8c-b5e5-64ba84d1b22d|5|REST|1|WASHOUT|2022-01-02|2022-06-09|115|273
Study ID|SE|cb700cc0-92f5-4a8c-b5e5-64ba84d1b22d|6|10|7|TREATMENT|2021-10-30|2021-11-18|51|70
Study ID|SE|cb700cc0-92f5-4a8c-b5e5-64ba84d1b22d|7|FU|1|FOLLOW-UP|2021-11-24|2022-05-27|76|260
Study ID|SE|86d62168-ed8f-4583-9710-02d5f265e4d8|1|SCRN|5|SCREENING|2022-05-03|2022-06-08|243|279
Study ID|SE|86d62168-ed8f-4583-9710-02d5f265e4d8|2|5|2|TREATMENT|2021-10-26|2021-11-25|54|84
Study ID|SE|86d62168-ed8f-4583-9710-02d5f265e4d8|3|REST|2|WASHOUT|2021-09-30|2021-10-22|28|50
Study ID|SE|86d62168-ed8f-4583-9710-02d5f265e4d8|4|10|5|TREATMENT|2021-12-10|2022-03-09|99|188
Study ID|SE|86d62168-ed8f-4583-9710-02d5f265e4d8|5|REST|6|WASHOUT|2022-01-06|2022-04-30|126|240
Study ID|SE|86d62168-ed8f-4583-9710-02d5f265e4d8|6|P|3|TREATMENT|2021-12-27|2022-03-18|116|197
Study ID|SE|86d62168-ed8f-4583-9710-02d5f265e4d8|7|FU|5|FOLLOW-UP|2021-09-05|2022-01-17|3|137
Study ID|SE|8833f332-3d59-42b9-98cf-814501052dfd|1|SCRN|4|SCREENING|2021-08-22|2021-10-15|2|56
Study ID|SE|8833f332-3d59-42b9-98cf-814501052dfd|2|P|1|TREATMENT|2021-08-29|2021-09-12|9|23
Study ID|SE|8833f332-3d59-42b9-98cf-814501052dfd|3|REST|5|WASHOUT|2021-10-29|2022-01-19|70|152
Study ID|SE|8833f332-3d59-42b9-98cf-814501052dfd|4|5|3|TREATMENT|2021-09-09|2021-10-25|20|66
Study ID|SE|8833f332-3d59-42b9-98cf-814501052dfd|5|REST|4|WASHOUT|2021-09-02|2021-10-15|13|56
Study ID|SE|8833f332-3d59-42b9-98cf-814501052dfd|6|10|2|TREATMENT|2021-10-16|2022-04-04|57|227
Study ID|SE|8833f332-3d59-42b9-98cf-814501052dfd|7|FU|4|FOLLOW-UP|2021-09-26|2021-10-04|37|45
Study ID|SE|1549db45-529f-4d67-8deb-c44e5770fa42|1|SCRN|1|SCREENING|2021-10-26|2022-03-08|25|158
Study ID|SE|1549db45-529f-4d67-8deb-c44e5770fa42|2|5|5|TREATMENT|2021-12-05|2022-02-07|65|129
Study ID|SE|1549db45-529f-4d67-8deb-c44e5770fa42|3|REST|5|WASHOUT|2022-02-20|2022-04-22|142|203
Study ID|SE|1549db45-529f-4d67-8deb-c44e5770fa42|4|P|1|TREATMENT|2022-04-03|2022-06-07|184|249
Study ID|SE|1549db45-529f-4d67-8deb-c44e5770fa42|5|REST|2|WASHOUT|2021-12-16|2022-03-05|76|155
Study ID|SE|1549db45-529f-4d67-8deb-c44e5770fa42|6|10|2|TREATMENT|2022-05-13|2022-07-03|224|275
Study ID|SE|1549db45-529f-4d67-8deb-c44e5770fa42|7|FU|4|FOLLOW-UP|2021-11-24|2022-04-25|54|206
Study ID|SE|7001ef0f-72be-48a3-b427-56e8e43422cf|1|SCRN|1|SCREENING|2021-10-11|2021-10-23|52|64
Study ID|SE|7001ef0f-72be-48a3-b427-56e8e43422cf|2|5|6|TREATMENT|2021-10-19|2022-02-18|60|182
Study ID|SE|7001ef0f-72be-48a3-b427-56e8e43422cf|3|REST|5|WASHOUT|2021-09-17|2022-03-20|28|212
Study ID|SE|7001ef0f-72be-48a3-b427-56e8e43422cf|4|10|2|TREATMENT|2021-10-05|2022-05-02|46|255
Study ID|SE|7001ef0f-72be-48a3-b427-56e8e43422cf|5|REST|2|WASHOUT|2021-12-12|2022-04-24|114|247
Study ID|SE|7001ef0f-72be-48a3-b427-56e8e43422cf|6|P|7|TREATMENT|2022-01-19|2022-06-04|152|288
Study ID|SE|7001ef0f-72be-48a3-b427-56e8e43422cf|7|FU|3|FOLLOW-UP|2021-12-25|2022-01-19|127|152
Study ID|SE|12c6ab37-bc49-4067-9009-1e122459c621|1|SCRN|4|SCREENING|2021-10-13|2021-11-24|34|76
Study ID|SE|12c6ab37-bc49-4067-9009-1e122459c621|2|5|6|TREATMENT|2021-09-19|2021-10-16|10|37
Study ID|SE|12c6ab37-bc49-4067-9009-1e122459c621|3|REST|7|WASHOUT|2021-12-11|2022-01-07|93|120
Study ID|SE|12c6ab37-bc49-4067-9009-1e122459c621|4|10|6|TREATMENT|2022-01-24|2022-06-24|137|288
Study ID|SE|12c6ab37-bc49-4067-9009-1e122459c621|5|REST|3|WASHOUT|2021-09-12|2021-11-09|3|61
Study ID|SE|12c6ab37-bc49-4067-9009-1e122459c621|6|P|4|TREATMENT|2021-11-06|2022-03-29|58|201
Study ID|SE|12c6ab37-bc49-4067-9009-1e122459c621|7|FU|5|FOLLOW-UP|2022-02-22|2022-07-01|166|295
Study ID|SE|a5463071-7429-40f2-9e02-337ae889669d|1|SCRN|5|SCREENING|2022-03-02|2022-07-30|143|293
Study ID|SE|a5463071-7429-40f2-9e02-337ae889669d|2|5|3|TREATMENT|2022-03-04|2022-05-22|145|224
Study ID|SE|a5463071-7429-40f2-9e02-337ae889669d|3|REST|6|WASHOUT|2021-11-17|2022-01-01|38|83
Study ID|SE|a5463071-7429-40f2-9e02-337ae889669d|4|P|6|TREATMENT|2022-05-14|2022-06-03|216|236
Study ID|SE|a5463071-7429-40f2-9e02-337ae889669d|5|REST|7|WASHOUT|2021-12-04|2022-06-18|55|251
Study ID|SE|a5463071-7429-40f2-9e02-337ae889669d|6|10|3|TREATMENT|2021-12-31|2022-02-05|82|118
Study ID|SE|a5463071-7429-40f2-9e02-337ae889669d|7|FU|4|FOLLOW-UP|2021-11-30|2021-12-30|51|81
Study ID|SE|24169321-2355-409b-b819-e3a808ed24e9|1|SCRN|5|SCREENING|2022-03-27|2022-05-03|223|260
Study ID|SE|24169321-2355-409b-b819-e3a808ed24e9|2|5|5|TREATMENT|2021-12-27|2022-04-06|133|233
Study ID|SE|24169321-2355-409b-b819-e3a808ed24e9|3|REST|4|WASHOUT|2021-09-15|2022-02-03|30|171
Study ID|SE|24169321-2355-409b-b819-e3a808ed24e9|4|P|6|TREATMENT|2022-01-02|2022-05-25|139|282
Study ID|SE|24169321-2355-409b-b819-e3a808ed24e9|5|REST|3|WASHOUT|2021-08-18|2021-10-13|2|58
Study ID|SE|24169321-2355-409b-b819-e3a808ed24e9|6|10|5|TREATMENT|2021-12-21|2022-06-07|127|295
Study ID|SE|24169321-2355-409b-b819-e3a808ed24e9|7|FU|1|FOLLOW-UP|2021-09-17|2021-10-28|32|73
Study ID|SE|cdca79f6-2e7f-462f-9c1f-ab7b06fc1843|1|SCRN|5|SCREENING|2021-11-10|2021-12-30|49|99
Study ID|SE|cdca79f6-2e7f-462f-9c1f-ab7b06fc1843|2|5|1|TREATMENT|2022-01-07|2022-02-10|107|141
Study ID|SE|cdca79f6-2e7f-462f-9c1f-ab7b06fc1843|3|REST|3|WASHOUT|2021-12-01|2022-01-31|70|131
Study ID|SE|cdca79f6-2e7f-462f-9c1f-ab7b06fc1843|4|10|4|TREATMENT|2021-12-10|2021-12-12|79|81
Study ID|SE|cdca79f6-2e7f-462f-9c1f-ab7b06fc1843|5|REST|2|WASHOUT|2022-03-03|2022-05-29|162|249
Study ID|SE|cdca79f6-2e7f-462f-9c1f-ab7b06fc1843|6|P|1|TREATMENT|2022-01-16|2022-04-21|116|211
Study ID|SE|cdca79f6-2e7f-462f-9c1f-ab7b06fc1843|7|FU|2|FOLLOW-UP|2021-12-23|2022-05-08|92|228
Study ID|SE|8d9c886d-707d-40e3-8588-c6910dda733a|1|SCRN|5|SCREENING|2022-02-16|2022-02-26|121|131
Study ID|SE|8d9c886d-707d-40e3-8588-c6910dda733a|2|5|4|TREATMENT|2021-11-20|2021-12-24|33|67
Study ID|SE|8d9c886d-707d-40e3-8588-c6910dda733a|3|REST|3|WASHOUT|2021-12-11|2022-01-05|54|79
Study ID|SE|8d9c886d-707d-40e3-8588-c6910dda733a|4|P|5|TREATMENT|2021-11-02|2022-02-18|15|123
Study ID|SE|8d9c886d-707d-40e3-8588-c6910dda733a|5|REST|4|WASHOUT|2022-03-28|2022-04-21|161|185
Study ID|SE|8d9c886d-707d-40e3-8588-c6910dda733a|6|10|2|TREATMENT|2021-11-05|2022-01-02|18|76
Study ID|SE|8d9c886d-707d-40e3-8588-c6910dda733a|7|FU|2|FOLLOW-UP|2021-10-29|2022-03-27|11|160
Study ID|SE|cb2f7899-e727-42d2-804d-5a4a60216e27|1|SCRN|6|SCREENING|2021-11-23|2021-12-29|49|85
Study ID|SE|cb2f7899-e727-42d2-804d-5a4a60216e27|2|P|4|TREATMENT|2021-10-21|2022-03-01|16|147
Study ID|SE|cb2f7899-e727-42d2-804d-5a4a60216e27|3|REST|1|WASHOUT|2022-01-10|2022-05-05|97|212
Study ID|SE|cb2f7899-e727-42d2-804d-5a4a60216e27|4|5|6|TREATMENT|2021-12-01|2022-05-24|57|231
Study ID|SE|cb2f7899-e727-42d2-804d-5a4a60216e27|5|REST|2|WASHOUT|2021-11-02|2022-01-02|28|89
Study ID|SE|cb2f7899-e727-42d2-804d-5a4a60216e27|6|10|2|TREATMENT|2022-01-20|2022-04-13|107|190
Study ID|SE|cb2f7899-e727-42d2-804d-5a4a60216e27|7|FU|7|FOLLOW-UP|2021-12-19|2021-12-26|75|82
Study ID|SE|683c148f-7062-45e5-8292-a819f788d4ef|1|SCRN|2|SCREENING|2021-11-10|2021-11-13|60|63
Study ID|SE|683c148f-7062-45e5-8292-a819f788d4ef|2|P|5|TREATMENT|2021-12-21|2022-02-09|101|151
Study ID|SE|683c148f-7062-45e5-8292-a819f788d4ef|3|REST|2|WASHOUT|2021-09-30|2022-07-06|19|298
Study ID|SE|683c148f-7062-45e5-8292-a819f788d4ef|4|5|1|TREATMENT|2021-11-27|2022-03-16|77|186
Study ID|SE|683c148f-7062-45e5-8292-a819f788d4ef|5|REST|6|WASHOUT|2021-11-06|2021-11-07|56|57
Study ID|SE|683c148f-7062-45e5-8292-a819f788d4ef|6|10|3|TREATMENT|2021-09-22|2021-12-04|11|84
Study ID|SE|683c148f-7062-45e5-8292-a819f788d4ef|7|FU|4|FOLLOW-UP|2021-10-22|2021-12-18|41|98
Study ID|SE|0854edf0-d4c4-485b-a2a6-af120559f427|1|SCRN|6|SCREENING|2022-06-22|2022-06-26|273|277
Study ID|SE|0854edf0-d4c4-485b-a2a6-af120559f427|2|P|5|TREATMENT|2022-01-27|2022-05-25|127|245
Study ID|SE|0854edf0-d4c4-485b-a2a6-af120559f427|3|REST|6|WASHOUT|2022-03-13|2022-07-14|172|295
Study ID|SE|0854edf0-d4c4-485b-a2a6-af120559f427|4|5|2|TREATMENT|2021-09-28|2022-05-11|6|231
Study ID|SE|0854edf0-d4c4-485b-a2a6-af120559f427|5|REST|3|WASHOUT|2022-03-01|2022-06-23|160|274
Study ID|SE|0854edf0-d4c4-485b-a2a6-af120559f427|6|10|6|TREATMENT|2022-01-15|2022-05-16|115|236
Study ID|SE|0854edf0-d4c4-485b-a2a6-af120559f427|7|FU|1|FOLLOW-UP|2021-10-05|2021-12-03|13|72
Study ID|SE|d15128a8-f001-460b-a13d-b84c534549a5|1|SCRN|6|SCREENING|2021-11-04|2022-02-09|55|152
Study ID|SE|d15128a8-f001-460b-a13d-b84c534549a5|2|5|6|TREATMENT|2021-11-15|2022-01-20|66|132
Study ID|SE|d15128a8-f001-460b-a13d-b84c534549a5|3|REST|3|WASHOUT|2022-03-25|2022-05-04|196|236
Study ID|SE|d15128a8-f001-460b-a13d-b84c534549a5|4|P|3|TREATMENT|2021-09-20|2021-09-30|10|20
Study ID|SE|d15128a8-f001-460b-a13d-b84c534549a5|5|REST|4|WASHOUT|2021-09-26|2021-09-27|16|17
Study ID|SE|d15128a8-f001-460b-a13d-b84c534549a5|6|10|2|TREATMENT|2021-10-23|2021-12-12|43|93
Study ID|SE|d15128a8-f001-460b-a13d-b84c534549a5|7|FU|5|FOLLOW-UP|2021-10-27|2022-07-03|47|296
Study ID|SE|6db4143d-10c0-47c1-b285-0dce306a0332|1|SCRN|6|SCREENING|2021-10-22|2021-11-09|34|52
Study ID|SE|6db4143d-10c0-47c1-b285-0dce306a0332|2|5|2|TREATMENT|2021-12-10|2022-03-18|83|181
Study ID|SE|6db4143d-10c0-47c1-b285-0dce306a0332|3|REST|2|WASHOUT|2021-12-21|2022-05-12|94|236
Study ID|SE|6db4143d-10c0-47c1-b285-0dce306a0332|4|10|7|TREATMENT|2021-10-05|2021-10-06|17|18
Study ID|SE|6db4143d-10c0-47c1-b285-0dce306a0332|5|REST|1|WASHOUT|2021-10-16|2021-10-18|28|30
Study ID|SE|6db4143d-10c0-47c1-b285-0dce306a0332|6|P|3|TREATMENT|2021-11-30|2021-12-14|73|87
Study ID|SE|6db4143d-10c0-47c1-b285-0dce306a0332|7|FU|4|FOLLOW-UP|2022-01-30|2022-06-16|134|271
Study ID|SE|19bc0794-e5de-41d3-b963-023119d05010|1|SCRN|4|SCREENING|2021-12-11|2022-03-20|59|158
Study ID|SE|19bc0794-e5de-41d3-b963-023119d05010|2|5|3|TREATMENT|2022-03-04|2022-07-02|142|262
Study ID|SE|19bc0794-e5de-41d3-b963-023119d05010|3|REST|4|WASHOUT|2021-12-22|2022-02-26|70|136
Study ID|SE|19bc0794-e5de-41d3-b963-023119d05010|4|P|6|TREATMENT|2021-11-19|2022-02-18|37|128
Study ID|SE|19bc0794-e5de-41d3-b963-023119d05010|5|REST|3|WASHOUT|2022-05-27|2022-06-12|226|242
Study ID|SE|19bc0794-e5de-41d3-b963-023119d05010|6|10|1|TREATMENT|2021-12-04|2022-01-24|52|103
Study ID|SE|19bc0794-e5de-41d3-b963-023119d05010|7|FU|7|FOLLOW-UP|2021-10-15|2022-03-07|2|145
Study ID|SE|f8391173-3563-4fd2-aecc-bb1ecd64d577|1|SCRN|1|SCREENING|2021-11-01|2021-11-15|57|71
Study ID|SE|f8391173-3563-4fd2-aecc-bb1ecd64d577|2|5|2|TREATMENT|2021-10-12|2022-02-12|37|160
Study ID|SE|f8391173-3563-4fd2-aecc-bb1ecd64d577|3|REST|5|WASHOUT|2022-02-03|2022-02-19|151|167
Study ID|SE|f8391173-3563-4fd2-aecc-bb1ecd64d577|4|10|1|TREATMENT|2021-09-12|2021-11-05|7|61
Study ID|SE|f8391173-3563-4fd2-aecc-bb1ecd64d577|5|REST|2|WASHOUT|2021-09-11|2021-09-16|6|11
Study ID|SE|f8391173-3563-4fd2-aecc-bb1ecd64d577|6|P|3|TREATMENT|2021-10-23|2021-11-29|48|85
Study ID|SE|f8391173-3563-4fd2-aecc-bb1ecd64d577|7|FU|3|FOLLOW-UP|2021-11-04|2021-11-16|60|72
Study ID|SE|d1e5d6d9-4f78-41e1-b469-6566418bc856|1|SCRN|2|SCREENING|2021-12-01|2021-12-10|42|51
Study ID|SE|d1e5d6d9-4f78-41e1-b469-6566418bc856|2|P|3|TREATMENT|2021-11-27|2021-12-29|38|70
Study ID|SE|d1e5d6d9-4f78-41e1-b469-6566418bc856|3|REST|4|WASHOUT|2021-11-28|2021-12-02|39|43
Study ID|SE|d1e5d6d9-4f78-41e1-b469-6566418bc856|4|5|1|TREATMENT|2021-10-24|2021-10-29|4|9
Study ID|SE|d1e5d6d9-4f78-41e1-b469-6566418bc856|5|REST|5|WASHOUT|2022-01-18|2022-04-05|90|167
Study ID|SE|d1e5d6d9-4f78-41e1-b469-6566418bc856|6|10|4|TREATMENT|2021-11-02|2021-11-07|13|18
Study ID|SE|d1e5d6d9-4f78-41e1-b469-6566418bc856|7|FU|7|FOLLOW-UP|2021-12-04|2022-04-17|45|179
Study ID|SE|e0cfd275-64aa-4995-995a-fbc5b5a368b2|1|SCRN|1|SCREENING|2021-12-29|2022-07-30|79|292
Study ID|SE|e0cfd275-64aa-4995-995a-fbc5b5a368b2|2|5|2|TREATMENT|2021-10-29|2022-07-17|18|279
Study ID|SE|e0cfd275-64aa-4995-995a-fbc5b5a368b2|3|REST|5|WASHOUT|2022-02-05|2022-04-15|117|186
Study ID|SE|e0cfd275-64aa-4995-995a-fbc5b5a368b2|4|10|6|TREATMENT|2022-03-12|2022-04-03|152|174
Study ID|SE|e0cfd275-64aa-4995-995a-fbc5b5a368b2|5|REST|1|WASHOUT|2022-02-19|2022-07-09|131|271
Study ID|SE|e0cfd275-64aa-4995-995a-fbc5b5a368b2|6|P|5|TREATMENT|2021-12-22|2022-01-28|72|109
Study ID|SE|e0cfd275-64aa-4995-995a-fbc5b5a368b2|7|FU|6|FOLLOW-UP|2022-04-16|2022-05-18|187|219
Study ID|SE|93a5bacb-f220-45be-9329-5c73363ed53b|1|SCRN|1|SCREENING|2021-12-08|2022-03-10|47|139
Study ID|SE|93a5bacb-f220-45be-9329-5c73363ed53b|2|P|6|TREATMENT|2021-10-31|2022-03-03|9|132
Study ID|SE|93a5bacb-f220-45be-9329-5c73363ed53b|3|REST|6|WASHOUT|2022-01-04|2022-01-19|74|89
Study ID|SE|93a5bacb-f220-45be-9329-5c73363ed53b|4|5|5|TREATMENT|2021-12-22|2022-01-04|61|74
Study ID|SE|93a5bacb-f220-45be-9329-5c73363ed53b|5|REST|2|WASHOUT|2022-01-12|2022-02-05|82|106
Study ID|SE|93a5bacb-f220-45be-9329-5c73363ed53b|6|10|2|TREATMENT|2021-11-05|2022-07-28|14|279
Study ID|SE|93a5bacb-f220-45be-9329-5c73363ed53b|7|FU|4|FOLLOW-UP|2022-02-01|2022-05-11|102|201
Study ID|SE|d3f324e4-1ede-4f14-94d3-ffbbef10d646|1|SCRN|3|SCREENING|2022-01-16|2022-03-20|93|156
Study ID|SE|d3f324e4-1ede-4f14-94d3-ffbbef10d646|2|5|3|TREATMENT|2021-11-29|2022-02-27|45|135
Study ID|SE|d3f324e4-1ede-4f14-94d3-ffbbef10d646|3|REST|3|WASHOUT|2021-11-10|2022-01-04|26|81
Study ID|SE|d3f324e4-1ede-4f14-94d3-ffbbef10d646|4|P|5|TREATMENT|2022-02-28|2022-08-02|136|291
Study ID|SE|d3f324e4-1ede-4f14-94d3-ffbbef10d646|5|REST|4|WASHOUT|2022-01-05|2022-07-01|82|259
Study ID|SE|d3f324e4-1ede-4f14-94d3-ffbbef10d646|6|10|2|TREATMENT|2021-11-07|2021-12-31|23|77
Study ID|SE|d3f324e4-1ede-4f14-94d3-ffbbef10d646|7|FU|4|FOLLOW-UP|2021-12-03|2022-01-01|49|78
Study ID|SE|e5da9056-0005-4e1b-be83-cbc3d12764e5|1|SCRN|2|SCREENING|2021-12-27|2022-01-30|110|144
Study ID|SE|e5da9056-0005-4e1b-be83-cbc3d12764e5|2|5|5|TREATMENT|2022-06-11|2022-06-20|276|285
Study ID|SE|e5da9056-0005-4e1b-be83-cbc3d12764e5|3|REST|6|WASHOUT|2022-01-02|2022-02-24|116|169
Study ID|SE|e5da9056-0005-4e1b-be83-cbc3d12764e5|4|10|7|TREATMENT|2021-10-22|2021-12-25|44|108
Study ID|SE|e5da9056-0005-4e1b-be83-cbc3d12764e5|5|REST|6|WASHOUT|2021-09-20|2021-09-24|12|16
Study ID|SE|e5da9056-0005-4e1b-be83-cbc3d12764e5|6|P|3|TREATMENT|2021-09-16|2021-09-24|8|16
Study ID|SE|e5da9056-0005-4e1b-be83-cbc3d12764e5|7|FU|5|FOLLOW-UP|2022-03-29|2022-04-16|202|220
Study ID|SE|4845fb08-1d83-49e6-8ff9-653c3f3394f4|1|SCRN|2|SCREENING|2022-05-22|2022-07-21|228|288
Study ID|SE|4845fb08-1d83-49e6-8ff9-653c3f3394f4|2|5|1|TREATMENT|2021-12-21|2021-12-25|76|80
Study ID|SE|4845fb08-1d83-49e6-8ff9-653c3f3394f4|3|REST|6|WASHOUT|2021-10-24|2022-07-25|18|292
Study ID|SE|4845fb08-1d83-49e6-8ff9-653c3f3394f4|4|10|7|TREATMENT|2022-01-24|2022-05-24|110|230
Study ID|SE|4845fb08-1d83-49e6-8ff9-653c3f3394f4|5|REST|2|WASHOUT|2022-02-14|2022-02-21|131|138
Study ID|SE|4845fb08-1d83-49e6-8ff9-653c3f3394f4|6|P|4|TREATMENT|2022-04-28|2022-05-05|204|211
Study ID|SE|4845fb08-1d83-49e6-8ff9-653c3f3394f4|7|FU|6|FOLLOW-UP|2022-01-11|2022-01-31|97|117
Study ID|SE|b355f502-2f42-4dbd-aeba-23c83cc82261|1|SCRN|1|SCREENING|2022-02-04|2022-06-05|165|286
Study ID|SE|b355f502-2f42-4dbd-aeba-23c83cc82261|2|5|7|TREATMENT|2021-09-03|2022-02-28|11|189
Study ID|SE|b355f502-2f42-4dbd-aeba-23c83cc82261|3|REST|5|WASHOUT|2021-09-17|2021-10-27|25|65
Study ID|SE|b355f502-2f42-4dbd-aeba-23c83cc82261|4|P|7|TREATMENT|2022-03-06|2022-05-15|195|265
Study ID|SE|b355f502-2f42-4dbd-aeba-23c83cc82261|5|REST|6|WASHOUT|2021-09-17|2021-10-09|25|47
Study ID|SE|b355f502-2f42-4dbd-aeba-23c83cc82261|6|10|7|TREATMENT|2021-10-17|2022-01-21|55|151
Study ID|SE|b355f502-2f42-4dbd-aeba-23c83cc82261|7|FU|1|FOLLOW-UP|2022-03-03|2022-04-29|192|249
Study ID|SE|dbd8c5b1-6ac0-4a31-94b9-4073da7d09a2|1|SCRN|7|SCREENING|2021-09-16|2021-10-10|5|29
Study ID|SE|dbd8c5b1-6ac0-4a31-94b9-4073da7d09a2|2|5|1|TREATMENT|2021-12-16|2022-05-24|96|255
Study ID|SE|dbd8c5b1-6ac0-4a31-94b9-4073da7d09a2|3|REST|6|WASHOUT|2022-05-01|2022-07-02|232|294
Study ID|SE|dbd8c5b1-6ac0-4a31-94b9-4073da7d09a2|4|10|7|TREATMENT|2022-01-02|2022-04-23|113|224
Study ID|SE|dbd8c5b1-6ac0-4a31-94b9-4073da7d09a2|5|REST|6|WASHOUT|2021-09-29|2021-10-01|18|20
Study ID|SE|dbd8c5b1-6ac0-4a31-94b9-4073da7d09a2|6|P|7|TREATMENT|2021-09-27|2021-11-25|16|75
Study ID|SE|dbd8c5b1-6ac0-4a31-94b9-4073da7d09a2|7|FU|5|FOLLOW-UP|2021-10-01|2021-12-22|20|102
Study ID|SE|a670e73c-6a53-4f32-af2a-4a951d4a8ebc|1|SCRN|5|SCREENING|2021-11-14|2022-02-16|90|184
Study ID|SE|a670e73c-6a53-4f32-af2a-4a951d4a8ebc|2|5|7|TREATMENT|2022-01-18|2022-05-18|155|275
Study ID|SE|a670e73c-6a53-4f32-af2a-4a951d4a8ebc|3|REST|6|WASHOUT|2021-09-03|2021-12-22|18|128
Study ID|SE|a670e73c-6a53-4f32-af2a-4a951d4a8ebc|4|10|6|TREATMENT|2021-09-21|2022-01-23|36|160
Study ID|SE|a670e73c-6a53-4f32-af2a-4a951d4a8ebc|5|REST|2|WASHOUT|2021-11-12|2022-02-23|88|191
Study ID|SE|a670e73c-6a53-4f32-af2a-4a951d4a8ebc|6|P|6|TREATMENT|2021-08-28|2021-11-02|12|78
Study ID|SE|a670e73c-6a53-4f32-af2a-4a951d4a8ebc|7|FU|2|FOLLOW-UP|2022-02-01|2022-03-01|169|197
Study ID|SE|3f3bb1b8-f058-49be-a1c0-1599d5c6f61d|1|SCRN|2|SCREENING|2022-01-04|2022-03-25|86|166
Study ID|SE|3f3bb1b8-f058-49be-a1c0-1599d5c6f61d|2|5|2|TREATMENT|2022-02-23|2022-04-20|136|192
Study ID|SE|3f3bb1b8-f058-49be-a1c0-1599d5c6f61d|3|REST|4|WASHOUT|2021-11-08|2022-04-12|29|184
Study ID|SE|3f3bb1b8-f058-49be-a1c0-1599d5c6f61d|4|P|5|TREATMENT|2022-03-14|2022-04-20|155|192
Study ID|SE|3f3bb1b8-f058-49be-a1c0-1599d5c6f61d|5|REST|2|WASHOUT|2021-10-21|2022-02-08|11|121
Study ID|SE|3f3bb1b8-f058-49be-a1c0-1599d5c6f61d|6|10|6|TREATMENT|2021-11-05|2021-12-26|26|77
Study ID|SE|3f3bb1b8-f058-49be-a1c0-1599d5c6f61d|7|FU|4|FOLLOW-UP|2021-10-18|2021-11-03|8|24
Study ID|SE|11662041-2a09-422e-bea9-2439b4ec197f|1|SCRN|1|SCREENING|2021-10-13|2021-11-17|57|92
Study ID|SE|11662041-2a09-422e-bea9-2439b4ec197f|2|5|7|TREATMENT|2021-08-27|2021-10-12|10|56
Study ID|SE|11662041-2a09-422e-bea9-2439b4ec197f|3|REST|4|WASHOUT|2021-09-23|2021-09-26|37|40
Study ID|SE|11662041-2a09-422e-bea9-2439b4ec197f|4|P|7|TREATMENT|2021-11-08|2021-11-15|83|90
Study ID|SE|11662041-2a09-422e-bea9-2439b4ec197f|5|REST|5|WASHOUT|2021-10-01|2021-11-19|45|94
Study ID|SE|11662041-2a09-422e-bea9-2439b4ec197f|6|10|7|TREATMENT|2021-09-13|2021-09-21|27|35
Study ID|SE|11662041-2a09-422e-bea9-2439b4ec197f|7|FU|4|FOLLOW-UP|2021-10-29|2021-11-09|73|84
Study ID|SE|4844756a-975e-458c-906a-aa8810210a03|1|SCRN|5|SCREENING|2022-04-18|2022-07-03|202|278
Study ID|SE|4844756a-975e-458c-906a-aa8810210a03|2|5|5|TREATMENT|2021-10-11|2022-03-13|13|166
Study ID|SE|4844756a-975e-458c-906a-aa8810210a03|3|REST|4|WASHOUT|2022-01-13|2022-05-26|107|240
Study ID|SE|4844756a-975e-458c-906a-aa8810210a03|4|P|5|TREATMENT|2022-06-09|2022-06-22|254|267
Study ID|SE|4844756a-975e-458c-906a-aa8810210a03|5|REST|1|WASHOUT|2022-03-07|2022-03-28|160|181
Study ID|SE|4844756a-975e-458c-906a-aa8810210a03|6|10|4|TREATMENT|2022-01-08|2022-04-10|102|194
Study ID|SE|4844756a-975e-458c-906a-aa8810210a03|7|FU|1|FOLLOW-UP|2021-10-03|2021-11-15|5|48
Study ID|SE|ac6bb1a4-5711-4732-ab1e-ab8c7bcad0ef|1|SCRN|7|SCREENING|2022-04-01|2022-04-09|204|212
Study ID|SE|ac6bb1a4-5711-4732-ab1e-ab8c7bcad0ef|2|5|2|TREATMENT|2022-04-22|2022-05-28|225|261
Study ID|SE|ac6bb1a4-5711-4732-ab1e-ab8c7bcad0ef|3|REST|1|WASHOUT|2021-11-07|2021-12-03|59|85
Study ID|SE|ac6bb1a4-5711-4732-ab1e-ab8c7bcad0ef|4|P|5|TREATMENT|2022-02-28|2022-03-14|172|186
Study ID|SE|ac6bb1a4-5711-4732-ab1e-ab8c7bcad0ef|5|REST|2|WASHOUT|2021-10-17|2022-02-22|38|166
Study ID|SE|ac6bb1a4-5711-4732-ab1e-ab8c7bcad0ef|6|10|1|TREATMENT|2021-09-19|2021-10-01|10|22
Study ID|SE|ac6bb1a4-5711-4732-ab1e-ab8c7bcad0ef|7|FU|5|FOLLOW-UP|2021-10-26|2021-12-12|47|94
Study ID|SE|66d82444-1e96-4aa3-8a6f-213e1c91aff8|1|SCRN|3|SCREENING|2022-03-11|2022-06-15|165|261
Study ID|SE|66d82444-1e96-4aa3-8a6f-213e1c91aff8|2|P|3|TREATMENT|2021-10-23|2021-12-10|26|74
Study ID|SE|66d82444-1e96-4aa3-8a6f-213e1c91aff8|3|REST|1|WASHOUT|2022-01-21|2022-06-29|116|275
Study ID|SE|66d82444-1e96-4aa3-8a6f-213e1c91aff8|4|5|5|TREATMENT|2022-03-25|2022-05-25|179|240
Study ID|SE|66d82444-1e96-4aa3-8a6f-213e1c91aff8|5|REST|3|WASHOUT|2021-12-29|2022-03-20|93|174
Study ID|SE|66d82444-1e96-4aa3-8a6f-213e1c91aff8|6|10|2|TREATMENT|2021-10-15|2021-12-14|18|78
Study ID|SE|66d82444-1e96-4aa3-8a6f-213e1c91aff8|7|FU|3|FOLLOW-UP|2022-04-30|2022-06-21|215|267
Study ID|SE|85e322c1-c83f-4a50-a8b9-567f45aace35|1|SCRN|5|SCREENING|2021-12-23|2022-02-06|121|166
Study ID|SE|85e322c1-c83f-4a50-a8b9-567f45aace35|2|5|1|TREATMENT|2021-11-03|2021-12-05|71|103
Study ID|SE|85e322c1-c83f-4a50-a8b9-567f45aace35|3|REST|6|WASHOUT|2021-08-26|2021-08-26|2|2
Study ID|SE|85e322c1-c83f-4a50-a8b9-567f45aace35|4|10|3|TREATMENT|2021-09-10|2021-09-15|17|22
Study ID|SE|85e322c1-c83f-4a50-a8b9-567f45aace35|5|REST|3|WASHOUT|2021-08-30|2022-01-28|6|157
Study ID|SE|85e322c1-c83f-4a50-a8b9-567f45aace35|6|P|6|TREATMENT|2021-12-05|2022-02-13|103|173
Study ID|SE|85e322c1-c83f-4a50-a8b9-567f45aace35|7|FU|1|FOLLOW-UP|2021-12-22|2022-04-12|120|231
Study ID|SE|88f390b8-2e4a-4ec6-90c0-627fd2ea27f6|1|SCRN|1|SCREENING|2021-09-09|2021-12-15|3|100
Study ID|SE|88f390b8-2e4a-4ec6-90c0-627fd2ea27f6|2|5|1|TREATMENT|2021-12-16|2022-04-21|101|227
Study ID|SE|88f390b8-2e4a-4ec6-90c0-627fd2ea27f6|3|REST|7|WASHOUT|2021-09-23|2021-11-01|17|56
Study ID|SE|88f390b8-2e4a-4ec6-90c0-627fd2ea27f6|4|10|7|TREATMENT|2021-09-20|2022-07-01|14|298
Study ID|SE|88f390b8-2e4a-4ec6-90c0-627fd2ea27f6|5|REST|1|WASHOUT|2022-01-10|2022-01-29|126|145
Study ID|SE|88f390b8-2e4a-4ec6-90c0-627fd2ea27f6|6|P|6|TREATMENT|2021-11-23|2021-12-02|78|87
Study ID|SE|88f390b8-2e4a-4ec6-90c0-627fd2ea27f6|7|FU|2|FOLLOW-UP|2021-09-09|2021-11-13|3|68
Study ID|SE|9313ccd0-1f71-479f-976b-ff5182bf3fe9|1|SCRN|4|SCREENING|2022-01-01|2022-05-16|126|261
Study ID|SE|9313ccd0-1f71-479f-976b-ff5182bf3fe9|2|5|6|TREATMENT|2021-12-22|2022-03-23|116|207
Study ID|SE|9313ccd0-1f71-479f-976b-ff5182bf3fe9|3|REST|4|WASHOUT|2021-10-03|2021-12-08|36|102
Study ID|SE|9313ccd0-1f71-479f-976b-ff5182bf3fe9|4|10|7|TREATMENT|2022-01-17|2022-05-30|142|275
Study ID|SE|9313ccd0-1f71-479f-976b-ff5182bf3fe9|5|REST|3|WASHOUT|2021-09-11|2021-09-26|14|29
Study ID|SE|9313ccd0-1f71-479f-976b-ff5182bf3fe9|6|P|2|TREATMENT|2021-11-20|2022-06-06|84|282
Study ID|SE|9313ccd0-1f71-479f-976b-ff5182bf3fe9|7|FU|5|FOLLOW-UP|2022-01-08|2022-02-23|133|179
Study ID|SE|55e15a91-a192-44f5-b72f-d364eb6b8331|1|SCRN|2|SCREENING|2021-10-08|2022-01-09|4|97
Study ID|SE|55e15a91-a192-44f5-b72f-d364eb6b8331|2|5|3|TREATMENT|2022-01-15|2022-01-30|103|118
Study ID|SE|55e15a91-a192-44f5-b72f-d364eb6b8331|3|REST|3|WASHOUT|2021-10-09|2021-10-30|5|26
Study ID|SE|55e15a91-a192-44f5-b72f-d364eb6b8331|4|P|1|TREATMENT|2021-11-17|2021-11-19|44|46
Study ID|SE|55e15a91-a192-44f5-b72f-d364eb6b8331|5|REST|4|WASHOUT|2022-04-17|2022-05-02|195|210
Study ID|SE|55e15a91-a192-44f5-b72f-d364eb6b8331|6|10|1|TREATMENT|2021-11-10|2022-04-07|37|185
Study ID|SE|55e15a91-a192-44f5-b72f-d364eb6b8331|7|FU|6|FOLLOW-UP|2021-11-15|2022-06-03|42|242
Study ID|SE|325b6c89-ae9e-4463-8690-8a7c2a625467|1|SCRN|3|SCREENING|2021-12-04|2022-01-03|109|139
Study ID|SE|325b6c89-ae9e-4463-8690-8a7c2a625467|2|P|7|TREATMENT|2021-10-19|2022-04-05|63|231
Study ID|SE|325b6c89-ae9e-4463-8690-8a7c2a625467|3|REST|7|WASHOUT|2022-02-20|2022-06-12|187|299
Study ID|SE|325b6c89-ae9e-4463-8690-8a7c2a625467|4|5|2|TREATMENT|2022-01-01|2022-02-19|137|186
Study ID|SE|325b6c89-ae9e-4463-8690-8a7c2a625467|5|REST|3|WASHOUT|2022-02-13|2022-03-28|180|223
Study ID|SE|325b6c89-ae9e-4463-8690-8a7c2a625467|6|10|6|TREATMENT|2021-09-30|2022-06-07|44|294
Study ID|SE|325b6c89-ae9e-4463-8690-8a7c2a625467|7|FU|2|FOLLOW-UP|2021-09-07|2021-09-10|21|24
Study ID|SE|2e0e8646-d205-415b-8223-dd72aa5681ed|1|SCRN|7|SCREENING|2022-04-11|2022-05-02|223|244
Study ID|SE|2e0e8646-d205-415b-8223-dd72aa5681ed|2|P|4|TREATMENT|2021-10-31|2021-12-09|61|100
Study ID|SE|2e0e8646-d205-415b-8223-dd72aa5681ed|3|REST|7|WASHOUT|2021-10-26|2022-01-19|56|141
Study ID|SE|2e0e8646-d205-415b-8223-dd72aa5681ed|4|5|2|TREATMENT|2021-11-22|2021-11-27|83|88
Study ID|SE|2e0e8646-d205-415b-8223-dd72aa5681ed|5|REST|6|WASHOUT|2022-03-24|2022-04-05|205|217
Study ID|SE|2e0e8646-d205-415b-8223-dd72aa5681ed|6|10|6|TREATMENT|2021-12-05|2022-06-22|96|295
Study ID|SE|2e0e8646-d205-415b-8223-dd72aa5681ed|7|FU|5|FOLLOW-UP|2021-09-29|2021-12-04|29|95
Study ID|SE|664740e0-4da9-43fd-af07-1ec459ac3120|1|SCRN|1|SCREENING|2022-03-15|2022-05-24|154|224
Study ID|SE|664740e0-4da9-43fd-af07-1ec459ac3120|2|5|4|TREATMENT|2022-02-20|2022-03-12|131|151
Study ID|SE|664740e0-4da9-43fd-af07-1ec459ac3120|3|REST|3|WASHOUT|2021-12-09|2022-02-16|58|127
Study ID|SE|664740e0-4da9-43fd-af07-1ec459ac3120|4|10|7|TREATMENT|2022-01-09|2022-04-03|89|173
Study ID|SE|664740e0-4da9-43fd-af07-1ec459ac3120|5|REST|5|WASHOUT|2022-05-22|2022-06-28|222|259
Study ID|SE|664740e0-4da9-43fd-af07-1ec459ac3120|6|P|7|TREATMENT|2021-10-29|2021-11-27|17|46
Study ID|SE|664740e0-4da9-43fd-af07-1ec459ac3120|7|FU|2|FOLLOW-UP|2021-10-28|2022-01-02|16|82
Study ID|SE|e2bcd781-5145-401f-93a6-967394fa863d|1|SCRN|3|SCREENING|2021-09-18|2022-03-25|17|205
Study ID|SE|e2bcd781-5145-401f-93a6-967394fa863d|2|P|5|TREATMENT|2021-09-21|2021-10-21|20|50
Study ID|SE|e2bcd781-5145-401f-93a6-967394fa863d|3|REST|6|WASHOUT|2021-10-19|2022-05-13|48|254
Study ID|SE|e2bcd781-5145-401f-93a6-967394fa863d|4|5|6|TREATMENT|2022-02-08|2022-02-09|160|161
Study ID|SE|e2bcd781-5145-401f-93a6-967394fa863d|5|REST|7|WASHOUT|2022-05-06|2022-06-08|247|280
Study ID|SE|e2bcd781-5145-401f-93a6-967394fa863d|6|10|5|TREATMENT|2022-05-19|2022-06-26|260|298
Study ID|SE|e2bcd781-5145-401f-93a6-967394fa863d|7|FU|6|FOLLOW-UP|2021-11-16|2022-05-19|76|260
Study ID|SE|e6abc3f9-be68-415a-8eb6-868f74c2f238|1|SCRN|7|SCREENING|2021-10-20|2021-12-03|64|108
Study ID|SE|e6abc3f9-be68-415a-8eb6-868f74c2f238|2|5|2|TREATMENT|2021-08-21|2021-12-27|4|132
Study ID|SE|e6abc3f9-be68-415a-8eb6-868f74c2f238|3|REST|7|WASHOUT|2021-12-01|2022-04-06|106|232
Study ID|SE|e6abc3f9-be68-415a-8eb6-868f74c2f238|4|P|5|TREATMENT|2021-08-25|2021-08-28|8|11
Study ID|SE|e6abc3f9-be68-415a-8eb6-868f74c2f238|5|REST|5|WASHOUT|2021-09-19|2022-03-29|33|224
Study ID|SE|e6abc3f9-be68-415a-8eb6-868f74c2f238|6|10|6|TREATMENT|2021-11-10|2021-12-16|85|121
Study ID|SE|e6abc3f9-be68-415a-8eb6-868f74c2f238|7|FU|5|FOLLOW-UP|2021-08-27|2021-09-18|10|32
Study ID|SE|e977fe2e-6626-4c88-8a05-d37f88c10df4|1|SCRN|3|SCREENING|2022-01-30|2022-04-29|100|189
Study ID|SE|e977fe2e-6626-4c88-8a05-d37f88c10df4|2|5|6|TREATMENT|2021-11-21|2022-06-27|30|248
Study ID|SE|e977fe2e-6626-4c88-8a05-d37f88c10df4|3|REST|4|WASHOUT|2022-01-31|2022-02-01|101|102
Study ID|SE|e977fe2e-6626-4c88-8a05-d37f88c10df4|4|P|3|TREATMENT|2021-10-27|2021-12-19|5|58
Study ID|SE|e977fe2e-6626-4c88-8a05-d37f88c10df4|5|REST|6|WASHOUT|2021-11-07|2021-11-13|16|22
Study ID|SE|e977fe2e-6626-4c88-8a05-d37f88c10df4|6|10|6|TREATMENT|2022-06-17|2022-07-08|238|259
Study ID|SE|e977fe2e-6626-4c88-8a05-d37f88c10df4|7|FU|2|FOLLOW-UP|2021-10-27|2021-10-31|5|9
Study ID|SE|c403ce49-1286-4be1-b906-8ec089e4fffe|1|SCRN|4|SCREENING|2021-10-31|2022-01-30|39|130
Study ID|SE|c403ce49-1286-4be1-b906-8ec089e4fffe|2|5|1|TREATMENT|2021-12-24|2022-05-23|93|243
Study ID|SE|c403ce49-1286-4be1-b906-8ec089e4fffe|3|REST|3|WASHOUT|2022-01-08|2022-03-08|108|167
Study ID|SE|c403ce49-1286-4be1-b906-8ec089e4fffe|4|10|3|TREATMENT|2021-11-26|2022-01-18|65|118
Study ID|SE|c403ce49-1286-4be1-b906-8ec089e4fffe|5|REST|2|WASHOUT|2021-12-30|2022-03-15|99|174
Study ID|SE|c403ce49-1286-4be1-b906-8ec089e4fffe|6|P|4|TREATMENT|2021-09-27|2022-04-04|5|194
Study ID|SE|c403ce49-1286-4be1-b906-8ec089e4fffe|7|FU|3|FOLLOW-UP|2021-10-26|2022-06-28|34|279
Study ID|SE|7d519538-945d-49c6-be2d-a8b61f42b962|1|SCRN|6|SCREENING|2021-09-19|2021-10-12|17|40
Study ID|SE|7d519538-945d-49c6-be2d-a8b61f42b962|2|P|5|TREATMENT|2021-09-21|2022-02-06|19|157
Study ID|SE|7d519538-945d-49c6-be2d-a8b61f42b962|3|REST|5|WASHOUT|2022-01-07|2022-04-07|127|217
Study ID|SE|7d519538-945d-49c6-be2d-a8b61f42b962|4|5|5|TREATMENT|2021-11-07|2022-02-08|66|159
Study ID|SE|7d519538-945d-49c6-be2d-a8b61f42b962|5|REST|2|WASHOUT|2021-09-21|2021-11-07|19|66
Study ID|SE|7d519538-945d-49c6-be2d-a8b61f42b962|6|10|2|TREATMENT|2022-04-19|2022-05-17|229|257
Study ID|SE|7d519538-945d-49c6-be2d-a8b61f42b962|7|FU|3|FOLLOW-UP|2021-10-16|2022-01-07|44|127
Study ID|SE|0a2112c2-242b-40c1-bfc1-1db362eee1d6|1|SCRN|6|SCREENING|2021-08-21|2021-09-19|8|37
Study ID|SE|0a2112c2-242b-40c1-bfc1-1db362eee1d6|2|5|1|TREATMENT|2021-11-12|2022-02-27|91|198
Study ID|SE|0a2112c2-242b-40c1-bfc1-1db362eee1d6|3|REST|5|WASHOUT|2021-08-19|2022-01-17|6|157
Study ID|SE|0a2112c2-242b-40c1-bfc1-1db362eee1d6|4|10|5|TREATMENT|2021-11-16|2022-03-26|95|225
Study ID|SE|0a2112c2-242b-40c1-bfc1-1db362eee1d6|5|REST|4|WASHOUT|2021-11-10|2022-04-18|89|248
Study ID|SE|0a2112c2-242b-40c1-bfc1-1db362eee1d6|6|P|6|TREATMENT|2021-11-24|2022-01-05|103|145
Study ID|SE|0a2112c2-242b-40c1-bfc1-1db362eee1d6|7|FU|2|FOLLOW-UP|2021-08-16|2021-12-20|3|129
Study ID|SE|1323f04e-64a4-4fca-ad08-ce9f8877ad19|1|SCRN|2|SCREENING|2021-11-06|2022-02-17|9|112
Study ID|SE|1323f04e-64a4-4fca-ad08-ce9f8877ad19|2|P|6|TREATMENT|2022-05-09|2022-08-11|193|287
Study ID|SE|1323f04e-64a4-4fca-ad08-ce9f8877ad19|3|REST|4|WASHOUT|2022-05-03|2022-08-18|187|294
Study ID|SE|1323f04e-64a4-4fca-ad08-ce9f8877ad19|4|5|5|TREATMENT|2022-03-07|2022-04-30|130|184
Study ID|SE|1323f04e-64a4-4fca-ad08-ce9f8877ad19|5|REST|3|WASHOUT|2021-12-13|2022-01-17|46|81
Study ID|SE|1323f04e-64a4-4fca-ad08-ce9f8877ad19|6|10|6|TREATMENT|2021-12-13|2022-03-31|46|154
Study ID|SE|1323f04e-64a4-4fca-ad08-ce9f8877ad19|7|FU|2|FOLLOW-UP|2021-11-24|2022-01-30|27|94
Study ID|SE|debd39bf-afd2-4181-8dba-15969de2e52e|1|SCRN|6|SCREENING|2021-10-31|2022-03-07|20|147
Study ID|SE|debd39bf-afd2-4181-8dba-15969de2e52e|2|P|7|TREATMENT|2021-10-22|2022-02-19|11|131
Study ID|SE|debd39bf-afd2-4181-8dba-15969de2e52e|3|REST|4|WASHOUT|2021-12-21|2022-01-18|71|99
Study ID|SE|debd39bf-afd2-4181-8dba-15969de2e52e|4|5|1|TREATMENT|2021-11-14|2022-01-26|34|107
Study ID|SE|debd39bf-afd2-4181-8dba-15969de2e52e|5|REST|6|WASHOUT|2021-11-13|2021-11-24|33|44
Study ID|SE|debd39bf-afd2-4181-8dba-15969de2e52e|6|10|6|TREATMENT|2022-05-05|2022-06-05|206|237
Study ID|SE|debd39bf-afd2-4181-8dba-15969de2e52e|7|FU|7|FOLLOW-UP|2022-03-10|2022-07-17|150|279
Study ID|SE|fe53160f-1cf3-4e3d-86e9-f579dfe7c3e1|1|SCRN|3|SCREENING|2022-01-19|2022-01-26|116|123
Study ID|SE|fe53160f-1cf3-4e3d-86e9-f579dfe7c3e1|2|5|6|TREATMENT|2021-11-05|2022-04-07|41|194
Study ID|SE|fe53160f-1cf3-4e3d-86e9-f579dfe7c3e1|3|REST|3|WASHOUT|2022-03-22|2022-05-14|178|231
Study ID|SE|fe53160f-1cf3-4e3d-86e9-f579dfe7c3e1|4|P|4|TREATMENT|2021-10-19|2022-04-30|24|217
Study ID|SE|fe53160f-1cf3-4e3d-86e9-f579dfe7c3e1|5|REST|4|WASHOUT|2022-02-10|2022-03-19|138|175
Study ID|SE|fe53160f-1cf3-4e3d-86e9-f579dfe7c3e1|6|10|3|TREATMENT|2022-01-05|2022-06-01|102|249
Study ID|SE|fe53160f-1cf3-4e3d-86e9-f579dfe7c3e1|7|FU|4|FOLLOW-UP|2021-09-28|2022-01-13|3|110
Study ID|SE|1a37144b-9674-456f-9921-1cbad458c388|1|SCRN|7|SCREENING|2021-12-22|2022-07-03|63|256
Study ID|SE|1a37144b-9674-456f-9921-1cbad458c388|2|5|7|TREATMENT|2021-12-09|2022-02-18|50|121
Study ID|SE|1a37144b-9674-456f-9921-1cbad458c388|3|REST|4|WASHOUT|2022-02-07|2022-04-08|110|170
Study ID|SE|1a37144b-9674-456f-9921-1cbad458c388|4|P|5|TREATMENT|2022-03-25|2022-05-06|156|198
Study ID|SE|1a37144b-9674-456f-9921-1cbad458c388|5|REST|3|WASHOUT|2021-10-27|2022-06-24|7|247
Study ID|SE|1a37144b-9674-456f-9921-1cbad458c388|6|10|1|TREATMENT|2021-11-10|2022-03-09|21|140
Study ID|SE|1a37144b-9674-456f-9921-1cbad458c388|7|FU|7|FOLLOW-UP|2021-11-05|2022-04-10|16|172
Study ID|SE|ecb9c7f9-d76a-49fb-9ee9-087f7442349a|1|SCRN|3|SCREENING|2021-11-19|2021-12-01|66|78
Study ID|SE|ecb9c7f9-d76a-49fb-9ee9-087f7442349a|2|P|3|TREATMENT|2022-02-15|2022-04-20|154|218
Study ID|SE|ecb9c7f9-d76a-49fb-9ee9-087f7442349a|3|REST|6|WASHOUT|2022-03-22|2022-04-18|189|216
Study ID|SE|ecb9c7f9-d76a-49fb-9ee9-087f7442349a|4|5|3|TREATMENT|2021-12-23|2022-01-28|100|136
Study ID|SE|ecb9c7f9-d76a-49fb-9ee9-087f7442349a|5|REST|6|WASHOUT|2021-11-16|2021-12-30|63|107
Study ID|SE|ecb9c7f9-d76a-49fb-9ee9-087f7442349a|6|10|1|TREATMENT|2021-11-01|2022-05-08|48|236
Study ID|SE|ecb9c7f9-d76a-49fb-9ee9-087f7442349a|7|FU|6|FOLLOW-UP|2021-10-15|2021-12-07|31|84
Study ID|SE|8c57e3bc-53d5-4804-91a6-ad9cdb66f82b|1|SCRN|3|SCREENING|2021-10-14|2021-10-15|10|11
Study ID|SE|8c57e3bc-53d5-4804-91a6-ad9cdb66f82b|2|5|1|TREATMENT|2022-02-26|2022-07-03|145|272
Study ID|SE|8c57e3bc-53d5-4804-91a6-ad9cdb66f82b|3|REST|7|WASHOUT|2022-02-12|2022-03-08|131|155
Study ID|SE|8c57e3bc-53d5-4804-91a6-ad9cdb66f82b|4|P|7|TREATMENT|2021-10-09|2022-06-28|5|267
Study ID|SE|8c57e3bc-53d5-4804-91a6-ad9cdb66f82b|5|REST|1|WASHOUT|2022-07-05|2022-07-09|274|278
Study ID|SE|8c57e3bc-53d5-4804-91a6-ad9cdb66f82b|6|10|2|TREATMENT|2021-10-10|2022-03-04|6|151
Study ID|SE|8c57e3bc-53d5-4804-91a6-ad9cdb66f82b|7|FU|4|FOLLOW-UP|2021-10-18|2021-10-30|14|26
Study ID|SE|e5973012-f101-497e-97ac-31dca1010976|1|SCRN|4|SCREENING|2021-10-31|2021-12-16|18|64
Study ID|SE|e5973012-f101-497e-97ac-31dca1010976|2|5|2|TREATMENT|2022-05-07|2022-07-06|206|266
Study ID|SE|e5973012-f101-497e-97ac-31dca1010976|3|REST|6|WASHOUT|2022-02-01|2022-02-10|111|120
Study ID|SE|e5973012-f101-497e-97ac-31dca1010976|4|P|5|TREATMENT|2022-02-28|2022-03-12|138|150
Study ID|SE|e5973012-f101-497e-97ac-31dca1010976|5|REST|6|WASHOUT|2021-12-03|2021-12-15|51|63
Study ID|SE|e5973012-f101-497e-97ac-31dca1010976|6|10|1|TREATMENT|2021-12-11|2022-04-13|59|182
Study ID|SE|e5973012-f101-497e-97ac-31dca1010976|7|FU|7|FOLLOW-UP|2022-04-09|2022-04-10|178|179
Study ID|SE|69d3fc98-8093-4347-8d58-e32d75b8821d|1|SCRN|5|SCREENING|2021-10-27|2022-07-12|25|283
Study ID|SE|69d3fc98-8093-4347-8d58-e32d75b8821d|2|5|4|TREATMENT|2021-11-01|2022-06-09|30|250
Study ID|SE|69d3fc98-8093-4347-8d58-e32d75b8821d|3|REST|7|WASHOUT|2022-03-09|2022-03-13|158|162
Study ID|SE|69d3fc98-8093-4347-8d58-e32d75b8821d|4|10|7|TREATMENT|2021-10-04|2021-11-05|2|34
Study ID|SE|69d3fc98-8093-4347-8d58-e32d75b8821d|5|REST|2|WASHOUT|2021-10-27|2021-12-14|25|73
Study ID|SE|69d3fc98-8093-4347-8d58-e32d75b8821d|6|P|5|TREATMENT|2021-12-18|2022-06-07|77|248
Study ID|SE|69d3fc98-8093-4347-8d58-e32d75b8821d|7|FU|3|FOLLOW-UP|2022-03-18|2022-07-16|167|287
Study ID|SE|8bdbec73-69a4-48b9-8663-13ef32c9a40d|1|SCRN|3|SCREENING|2022-06-06|2022-06-11|268|273
Study ID|SE|8bdbec73-69a4-48b9-8663-13ef32c9a40d|2|5|6|TREATMENT|2021-09-19|2021-09-20|8|9
Study ID|SE|8bdbec73-69a4-48b9-8663-13ef32c9a40d|3|REST|2|WASHOUT|2021-10-30|2022-04-19|49|220
Study ID|SE|8bdbec73-69a4-48b9-8663-13ef32c9a40d|4|P|1|TREATMENT|2022-03-22|2022-05-07|192|238
Study ID|SE|8bdbec73-69a4-48b9-8663-13ef32c9a40d|5|REST|4|WASHOUT|2021-11-08|2022-02-27|58|169
Study ID|SE|8bdbec73-69a4-48b9-8663-13ef32c9a40d|6|10|2|TREATMENT|2022-03-02|2022-03-23|172|193
Study ID|SE|8bdbec73-69a4-48b9-8663-13ef32c9a40d|7|FU|5|FOLLOW-UP|2022-01-01|2022-01-26|112|137
Study ID|SE|3e9d07b3-f91b-4c6c-a9c7-7b97fdb9b0d2|1|SCRN|5|SCREENING|2021-10-05|2022-07-11|6|285
Study ID|SE|3e9d07b3-f91b-4c6c-a9c7-7b97fdb9b0d2|2|P|5|TREATMENT|2021-10-03|2021-11-05|4|37
Study ID|SE|3e9d07b3-f91b-4c6c-a9c7-7b97fdb9b0d2|3|REST|2|WASHOUT|2021-11-02|2022-03-08|34|160
Study ID|SE|3e9d07b3-f91b-4c6c-a9c7-7b97fdb9b0d2|4|5|6|TREATMENT|2021-11-16|2022-01-24|48|117
Study ID|SE|3e9d07b3-f91b-4c6c-a9c7-7b97fdb9b0d2|5|REST|6|WASHOUT|2022-01-09|2022-03-05|102|157
Study ID|SE|3e9d07b3-f91b-4c6c-a9c7-7b97fdb9b0d2|6|10|7|TREATMENT|2021-10-06|2021-10-13|7|14
Study ID|SE|3e9d07b3-f91b-4c6c-a9c7-7b97fdb9b0d2|7|FU|1|FOLLOW-UP|2021-11-05|2022-04-21|37|204
Study ID|SE|ef3d99d3-a644-4dd0-b0c6-8921899aa59e|1|SCRN|7|SCREENING|2021-12-27|2021-12-29|82|84
Study ID|SE|ef3d99d3-a644-4dd0-b0c6-8921899aa59e|2|5|2|TREATMENT|2022-05-27|2022-07-10|233|277
Study ID|SE|ef3d99d3-a644-4dd0-b0c6-8921899aa59e|3|REST|5|WASHOUT|2022-03-08|2022-07-29|153|296
Study ID|SE|ef3d99d3-a644-4dd0-b0c6-8921899aa59e|4|P|1|TREATMENT|2022-01-11|2022-07-23|97|290
Study ID|SE|ef3d99d3-a644-4dd0-b0c6-8921899aa59e|5|REST|6|WASHOUT|2021-11-13|2021-12-14|38|69
Study ID|SE|ef3d99d3-a644-4dd0-b0c6-8921899aa59e|6|10|5|TREATMENT|2021-12-20|2022-02-16|75|133
Study ID|SE|ef3d99d3-a644-4dd0-b0c6-8921899aa59e|7|FU|3|FOLLOW-UP|2022-03-29|2022-05-14|174|220
Study ID|SE|6c70f183-90ac-436e-b1b4-6c9d23b2dbc4|1|SCRN|7|SCREENING|2021-12-09|2022-05-01|91|234
Study ID|SE|6c70f183-90ac-436e-b1b4-6c9d23b2dbc4|2|P|5|TREATMENT|2021-10-07|2022-05-10|28|243
Study ID|SE|6c70f183-90ac-436e-b1b4-6c9d23b2dbc4|3|REST|3|WASHOUT|2021-09-25|2021-10-12|16|33
Study ID|SE|6c70f183-90ac-436e-b1b4-6c9d23b2dbc4|4|5|2|TREATMENT|2021-12-29|2022-03-15|111|187
Study ID|SE|6c70f183-90ac-436e-b1b4-6c9d23b2dbc4|5|REST|3|WASHOUT|2022-04-05|2022-05-03|208|236
Study ID|SE|6c70f183-90ac-436e-b1b4-6c9d23b2dbc4|6|10|7|TREATMENT|2022-01-29|2022-04-22|142|225
Study ID|SE|6c70f183-90ac-436e-b1b4-6c9d23b2dbc4|7|FU|3|FOLLOW-UP|2022-02-06|2022-06-30|150|294
Study ID|SE|85cf4495-2bfc-41e5-88f7-fccea156c124|1|SCRN|2|SCREENING|2021-11-07|2022-06-23|63|291
Study ID|SE|85cf4495-2bfc-41e5-88f7-fccea156c124|2|P|7|TREATMENT|2021-10-03|2022-01-24|28|141
Study ID|SE|85cf4495-2bfc-41e5-88f7-fccea156c124|3|REST|7|WASHOUT|2021-12-16|2022-05-17|102|254
Study ID|SE|85cf4495-2bfc-41e5-88f7-fccea156c124|4|5|7|TREATMENT|2022-01-13|2022-02-18|130|166
Study ID|SE|85cf4495-2bfc-41e5-88f7-fccea156c124|5|REST|1|WASHOUT|2021-09-29|2021-10-21|24|46
Study ID|SE|85cf4495-2bfc-41e5-88f7-fccea156c124|6|10|7|TREATMENT|2021-09-21|2021-10-19|16|44
Study ID|SE|85cf4495-2bfc-41e5-88f7-fccea156c124|7|FU|3|FOLLOW-UP|2022-05-03|2022-05-08|240|245
Study ID|SE|1330d021-2954-4531-a684-80f55b5a9644|1|SCRN|6|SCREENING|2021-09-09|2022-05-12|20|265
Study ID|SE|1330d021-2954-4531-a684-80f55b5a9644|2|5|2|TREATMENT|2021-09-26|2021-10-12|37|53
Study ID|SE|1330d021-2954-4531-a684-80f55b5a9644|3|REST|5|WASHOUT|2022-04-28|2022-05-27|251|280
Study ID|SE|1330d021-2954-4531-a684-80f55b5a9644|4|10|1|TREATMENT|2022-03-24|2022-05-26|216|279
Study ID|SE|1330d021-2954-4531-a684-80f55b5a9644|5|REST|2|WASHOUT|2021-09-11|2021-11-24|22|96
Study ID|SE|1330d021-2954-4531-a684-80f55b5a9644|6|P|2|TREATMENT|2021-10-22|2022-05-31|63|284
Study ID|SE|1330d021-2954-4531-a684-80f55b5a9644|7|FU|7|FOLLOW-UP|2021-11-15|2022-06-06|87|290
Study ID|SE|94f2f9da-dd24-4135-b61d-ee48c9dd801a|1|SCRN|4|SCREENING|2021-09-27|2022-05-18|2|235
Study ID|SE|94f2f9da-dd24-4135-b61d-ee48c9dd801a|2|P|5|TREATMENT|2021-11-26|2021-11-28|62|64
Study ID|SE|94f2f9da-dd24-4135-b61d-ee48c9dd801a|3|REST|4|WASHOUT|2021-10-13|2021-12-13|18|79
Study ID|SE|94f2f9da-dd24-4135-b61d-ee48c9dd801a|4|5|3|TREATMENT|2022-06-09|2022-07-20|257|298
Study ID|SE|94f2f9da-dd24-4135-b61d-ee48c9dd801a|5|REST|6|WASHOUT|2021-11-11|2022-02-01|47|129
Study ID|SE|94f2f9da-dd24-4135-b61d-ee48c9dd801a|6|10|5|TREATMENT|2021-10-18|2022-02-23|23|151
Study ID|SE|94f2f9da-dd24-4135-b61d-ee48c9dd801a|7|FU|7|FOLLOW-UP|2022-02-18|2022-07-11|146|289
Study ID|SE|cefcf4a6-bda8-4f39-8429-ccfaf2b815f2|1|SCRN|3|SCREENING|2021-08-30|2021-09-10|22|33
Study ID|SE|cefcf4a6-bda8-4f39-8429-ccfaf2b815f2|2|P|2|TREATMENT|2021-09-22|2022-01-01|45|146
Study ID|SE|cefcf4a6-bda8-4f39-8429-ccfaf2b815f2|3|REST|1|WASHOUT|2021-10-09|2022-02-21|62|197
Study ID|SE|cefcf4a6-bda8-4f39-8429-ccfaf2b815f2|4|5|1|TREATMENT|2021-12-12|2022-05-16|126|281
Study ID|SE|cefcf4a6-bda8-4f39-8429-ccfaf2b815f2|5|REST|1|WASHOUT|2021-09-14|2022-04-16|37|251
Study ID|SE|cefcf4a6-bda8-4f39-8429-ccfaf2b815f2|6|10|3|TREATMENT|2022-01-28|2022-02-09|173|185
Study ID|SE|cefcf4a6-bda8-4f39-8429-ccfaf2b815f2|7|FU|3|FOLLOW-UP|2021-08-14|2022-02-09|6|185
Study ID|SE|5fd47059-e6ae-4ae2-84df-d5d6b19de07c|1|SCRN|3|SCREENING|2022-03-27|2022-04-02|200|206
Study ID|SE|5fd47059-e6ae-4ae2-84df-d5d6b19de07c|2|P|6|TREATMENT|2021-12-13|2022-01-17|96|131
Study ID|SE|5fd47059-e6ae-4ae2-84df-d5d6b19de07c|3|REST|3|WASHOUT|2022-02-02|2022-06-22|147|287
Study ID|SE|5fd47059-e6ae-4ae2-84df-d5d6b19de07c|4|5|6|TREATMENT|2021-11-27|2022-01-30|80|144
Study ID|SE|5fd47059-e6ae-4ae2-84df-d5d6b19de07c|5|REST|4|WASHOUT|2021-11-17|2022-06-06|70|271
Study ID|SE|5fd47059-e6ae-4ae2-84df-d5d6b19de07c|6|10|6|TREATMENT|2021-11-09|2022-06-08|62|273
Study ID|SE|5fd47059-e6ae-4ae2-84df-d5d6b19de07c|7|FU|2|FOLLOW-UP|2021-09-28|2022-03-23|20|196
Study ID|SE|2b7029f5-5da5-4b3c-8b1c-190226b13524|1|SCRN|4|SCREENING|2022-02-06|2022-05-30|146|259
Study ID|SE|2b7029f5-5da5-4b3c-8b1c-190226b13524|2|5|1|TREATMENT|2022-02-23|2022-05-11|163|240
Study ID|SE|2b7029f5-5da5-4b3c-8b1c-190226b13524|3|REST|7|WASHOUT|2022-01-06|2022-02-13|115|153
Study ID|SE|2b7029f5-5da5-4b3c-8b1c-190226b13524|4|P|4|TREATMENT|2021-11-28|2021-12-06|76|84
Study ID|SE|2b7029f5-5da5-4b3c-8b1c-190226b13524|5|REST|7|WASHOUT|2021-12-31|2022-06-24|109|284
Study ID|SE|2b7029f5-5da5-4b3c-8b1c-190226b13524|6|10|7|TREATMENT|2022-01-07|2022-04-06|116|205
Study ID|SE|2b7029f5-5da5-4b3c-8b1c-190226b13524|7|FU|1|FOLLOW-UP|2021-10-30|2022-02-25|47|165
Study ID|SE|5d80cf62-78a8-44fc-81a9-044537f0436f|1|SCRN|7|SCREENING|2021-10-24|2021-12-17|36|90
Study ID|SE|5d80cf62-78a8-44fc-81a9-044537f0436f|2|5|6|TREATMENT|2021-12-13|2022-04-01|86|195
Study ID|SE|5d80cf62-78a8-44fc-81a9-044537f0436f|3|REST|3|WASHOUT|2021-10-25|2021-11-21|37|64
Study ID|SE|5d80cf62-78a8-44fc-81a9-044537f0436f|4|10|4|TREATMENT|2021-11-09|2022-02-19|52|154
Study ID|SE|5d80cf62-78a8-44fc-81a9-044537f0436f|5|REST|4|WASHOUT|2021-12-06|2022-01-18|79|122
Study ID|SE|5d80cf62-78a8-44fc-81a9-044537f0436f|6|P|7|TREATMENT|2021-10-28|2022-04-03|40|197
Study ID|SE|5d80cf62-78a8-44fc-81a9-044537f0436f|7|FU|6|FOLLOW-UP|2021-11-02|2022-03-06|45|169
Study ID|SE|6a24825b-2ccc-4905-aad4-4bbaf7d3ffef|1|SCRN|6|SCREENING|2022-01-07|2022-03-23|90|165
Study ID|SE|6a24825b-2ccc-4905-aad4-4bbaf7d3ffef|2|P|4|TREATMENT|2021-11-10|2021-12-04|32|56
Study ID|SE|6a24825b-2ccc-4905-aad4-4bbaf7d3ffef|3|REST|1|WASHOUT|2022-01-21|2022-03-14|104|156
Study ID|SE|6a24825b-2ccc-4905-aad4-4bbaf7d3ffef|4|5|7|TREATMENT|2022-03-28|2022-05-19|170|222
Study ID|SE|6a24825b-2ccc-4905-aad4-4bbaf7d3ffef|5|REST|2|WASHOUT|2021-11-26|2021-12-30|48|82
Study ID|SE|6a24825b-2ccc-4905-aad4-4bbaf7d3ffef|6|10|5|TREATMENT|2022-02-01|2022-02-17|115|131
Study ID|SE|6a24825b-2ccc-4905-aad4-4bbaf7d3ffef|7|FU|5|FOLLOW-UP|2021-11-22|2022-01-02|44|85
Study ID|SE|c68b6ff6-fba7-4e68-9e36-3242b1182910|1|SCRN|7|SCREENING|2021-09-23|2022-01-09|37|145
Study ID|SE|c68b6ff6-fba7-4e68-9e36-3242b1182910|2|5|1|TREATMENT|2021-08-26|2021-08-29|9|12
Study ID|SE|c68b6ff6-fba7-4e68-9e36-3242b1182910|3|REST|1|WASHOUT|2021-12-08|2022-04-02|113|228
Study ID|SE|c68b6ff6-fba7-4e68-9e36-3242b1182910|4|10|2|TREATMENT|2021-08-26|2021-10-24|9|68
Study ID|SE|c68b6ff6-fba7-4e68-9e36-3242b1182910|5|REST|1|WASHOUT|2021-08-27|2022-03-19|10|214
Study ID|SE|c68b6ff6-fba7-4e68-9e36-3242b1182910|6|P|6|TREATMENT|2021-11-14|2022-05-12|89|268
Study ID|SE|c68b6ff6-fba7-4e68-9e36-3242b1182910|7|FU|4|FOLLOW-UP|2022-04-15|2022-06-03|241|290
Study ID|SE|8e4a02c9-3671-49aa-99d9-5ff4a86b707d|1|SCRN|1|SCREENING|2021-11-14|2022-03-17|77|200
Study ID|SE|8e4a02c9-3671-49aa-99d9-5ff4a86b707d|2|P|6|TREATMENT|2021-11-04|2022-03-21|67|204
Study ID|SE|8e4a02c9-3671-49aa-99d9-5ff4a86b707d|3|REST|4|WASHOUT|2021-10-09|2021-12-10|41|103
Study ID|SE|8e4a02c9-3671-49aa-99d9-5ff4a86b707d|4|5|2|TREATMENT|2021-10-24|2022-06-01|56|276
Study ID|SE|8e4a02c9-3671-49aa-99d9-5ff4a86b707d|5|REST|5|WASHOUT|2021-11-06|2021-11-10|69|73
Study ID|SE|8e4a02c9-3671-49aa-99d9-5ff4a86b707d|6|10|7|TREATMENT|2022-04-02|2022-04-10|216|224
Study ID|SE|8e4a02c9-3671-49aa-99d9-5ff4a86b707d|7|FU|4|FOLLOW-UP|2021-10-20|2021-11-24|52|87
Study ID|SE|3e684a59-b5ac-4730-a2fe-13595dc2c8a6|1|SCRN|6|SCREENING|2021-12-03|2022-08-17|40|297
Study ID|SE|3e684a59-b5ac-4730-a2fe-13595dc2c8a6|2|5|4|TREATMENT|2021-11-09|2021-11-14|16|21
Study ID|SE|3e684a59-b5ac-4730-a2fe-13595dc2c8a6|3|REST|3|WASHOUT|2022-05-04|2022-08-12|192|292
Study ID|SE|3e684a59-b5ac-4730-a2fe-13595dc2c8a6|4|P|6|TREATMENT|2022-01-27|2022-05-13|95|201
Study ID|SE|3e684a59-b5ac-4730-a2fe-13595dc2c8a6|5|REST|3|WASHOUT|2021-11-28|2022-03-18|35|145
Study ID|SE|3e684a59-b5ac-4730-a2fe-13595dc2c8a6|6|10|2|TREATMENT|2021-11-11|2022-08-05|18|285
Study ID|SE|3e684a59-b5ac-4730-a2fe-13595dc2c8a6|7|FU|4|FOLLOW-UP|2022-01-28|2022-02-06|96|105
Study ID|SE|e38a9fd6-aee5-48b0-a13a-864415fe9728|1|SCRN|3|SCREENING|2022-05-17|2022-05-28|273|284
Study ID|SE|e38a9fd6-aee5-48b0-a13a-864415fe9728|2|5|4|TREATMENT|2021-08-24|2021-09-10|7|24
Study ID|SE|e38a9fd6-aee5-48b0-a13a-864415fe9728|3|REST|3|WASHOUT|2022-01-14|2022-02-23|150|190
Study ID|SE|e38a9fd6-aee5-48b0-a13a-864415fe9728|4|10|4|TREATMENT|2021-11-01|2021-12-29|76|134
Study ID|SE|e38a9fd6-aee5-48b0-a13a-864415fe9728|5|REST|5|WASHOUT|2021-08-30|2021-11-15|13|90
Study ID|SE|e38a9fd6-aee5-48b0-a13a-864415fe9728|6|P|2|TREATMENT|2021-11-22|2022-04-29|97|255
Study ID|SE|e38a9fd6-aee5-48b0-a13a-864415fe9728|7|FU|3|FOLLOW-UP|2021-09-28|2022-05-05|42|261
Study ID|SE|d751eafe-b68d-4494-9109-7f13e6b64234|1|SCRN|7|SCREENING|2022-05-03|2022-07-12|209|279
Study ID|SE|d751eafe-b68d-4494-9109-7f13e6b64234|2|P|6|TREATMENT|2021-11-11|2022-01-14|36|100
Study ID|SE|d751eafe-b68d-4494-9109-7f13e6b64234|3|REST|5|WASHOUT|2022-05-08|2022-07-23|214|290
Study ID|SE|d751eafe-b68d-4494-9109-7f13e6b64234|4|5|4|TREATMENT|2021-10-31|2021-11-04|25|29
Study ID|SE|d751eafe-b68d-4494-9109-7f13e6b64234|5|REST|2|WASHOUT|2021-10-08|2021-10-22|2|16
Study ID|SE|d751eafe-b68d-4494-9109-7f13e6b64234|6|10|2|TREATMENT|2021-10-20|2021-12-04|14|59
Study ID|SE|d751eafe-b68d-4494-9109-7f13e6b64234|7|FU|1|FOLLOW-UP|2022-05-25|2022-07-05|231|272
Study ID|SE|bf7ed2f3-70c6-4686-8bff-27fb4fab8c29|1|SCRN|1|SCREENING|2021-12-18|2022-01-31|100|144
Study ID|SE|bf7ed2f3-70c6-4686-8bff-27fb4fab8c29|2|P|1|TREATMENT|2021-10-02|2021-10-10|23|31
Study ID|SE|bf7ed2f3-70c6-4686-8bff-27fb4fab8c29|3|REST|4|WASHOUT|2021-10-13|2021-10-17|34|38
Study ID|SE|bf7ed2f3-70c6-4686-8bff-27fb4fab8c29|4|5|3|TREATMENT|2021-10-30|2021-12-19|51|101
Study ID|SE|bf7ed2f3-70c6-4686-8bff-27fb4fab8c29|5|REST|4|WASHOUT|2021-10-31|2022-05-03|52|236
Study ID|SE|bf7ed2f3-70c6-4686-8bff-27fb4fab8c29|6|10|2|TREATMENT|2021-10-10|2021-11-12|31|64
Study ID|SE|bf7ed2f3-70c6-4686-8bff-27fb4fab8c29|7|FU|4|FOLLOW-UP|2021-12-06|2021-12-13|88|95
Study ID|SE|b01188af-a822-4411-a34c-65922fa92047|1|SCRN|2|SCREENING|2021-11-23|2021-12-07|73|87
Study ID|SE|b01188af-a822-4411-a34c-65922fa92047|2|5|3|TREATMENT|2021-11-20|2021-12-12|70|92
Study ID|SE|b01188af-a822-4411-a34c-65922fa92047|3|REST|6|WASHOUT|2021-10-08|2021-12-19|27|99
Study ID|SE|b01188af-a822-4411-a34c-65922fa92047|4|P|3|TREATMENT|2021-11-29|2022-04-06|79|207
Study ID|SE|b01188af-a822-4411-a34c-65922fa92047|5|REST|7|WASHOUT|2022-03-14|2022-03-17|184|187
Study ID|SE|b01188af-a822-4411-a34c-65922fa92047|6|10|2|TREATMENT|2021-10-11|2022-02-07|30|149
Study ID|SE|b01188af-a822-4411-a34c-65922fa92047|7|FU|6|FOLLOW-UP|2021-10-14|2022-02-24|33|166
Study ID|SE|9b873e9b-37fa-4e3e-9068-a2b87fea1604|1|SCRN|2|SCREENING|2021-12-09|2022-06-08|92|273
Study ID|SE|9b873e9b-37fa-4e3e-9068-a2b87fea1604|2|5|2|TREATMENT|2021-11-27|2021-12-12|80|95
Study ID|SE|9b873e9b-37fa-4e3e-9068-a2b87fea1604|3|REST|4|WASHOUT|2021-10-24|2021-12-18|46|101
Study ID|SE|9b873e9b-37fa-4e3e-9068-a2b87fea1604|4|10|3|TREATMENT|2021-12-14|2021-12-18|97|101
Study ID|SE|9b873e9b-37fa-4e3e-9068-a2b87fea1604|5|REST|3|WASHOUT|2021-11-19|2022-02-28|72|173
Study ID|SE|9b873e9b-37fa-4e3e-9068-a2b87fea1604|6|P|7|TREATMENT|2021-09-25|2022-02-19|17|164
Study ID|SE|9b873e9b-37fa-4e3e-9068-a2b87fea1604|7|FU|4|FOLLOW-UP|2021-09-19|2021-10-17|11|39
Study ID|SE|0cf1fa7a-9450-41d2-8bad-790918f3ff0b|1|SCRN|7|SCREENING|2021-10-21|2021-12-03|3|46
Study ID|SE|0cf1fa7a-9450-41d2-8bad-790918f3ff0b|2|P|6|TREATMENT|2022-05-18|2022-07-23|212|278
Study ID|SE|0cf1fa7a-9450-41d2-8bad-790918f3ff0b|3|REST|2|WASHOUT|2022-02-01|2022-04-16|106|180
Study ID|SE|0cf1fa7a-9450-41d2-8bad-790918f3ff0b|4|5|5|TREATMENT|2022-02-18|2022-06-03|123|228
Study ID|SE|0cf1fa7a-9450-41d2-8bad-790918f3ff0b|5|REST|6|WASHOUT|2021-11-25|2021-12-05|38|48
Study ID|SE|0cf1fa7a-9450-41d2-8bad-790918f3ff0b|6|10|2|TREATMENT|2021-10-20|2021-10-20|2|2
Study ID|SE|0cf1fa7a-9450-41d2-8bad-790918f3ff0b|7|FU|7|FOLLOW-UP|2022-03-28|2022-05-26|161|220
Study ID|SE|217a3159-2d8d-40f8-9593-4730883a5f94|1|SCRN|4|SCREENING|2021-11-02|2022-06-03|18|231
Study ID|SE|217a3159-2d8d-40f8-9593-4730883a5f94|2|5|1|TREATMENT|2021-11-04|2021-11-29|20|45
Study ID|SE|217a3159-2d8d-40f8-9593-4730883a5f94|3|REST|7|WASHOUT|2022-03-05|2022-07-31|141|289
Study ID|SE|217a3159-2d8d-40f8-9593-4730883a5f94|4|10|2|TREATMENT|2022-01-27|2022-03-07|104|143
Study ID|SE|217a3159-2d8d-40f8-9593-4730883a5f94|5|REST|3|WASHOUT|2021-12-26|2022-03-27|72|163
Study ID|SE|217a3159-2d8d-40f8-9593-4730883a5f94|6|P|4|TREATMENT|2021-10-17|2021-10-19|2|4
Study ID|SE|217a3159-2d8d-40f8-9593-4730883a5f94|7|FU|1|FOLLOW-UP|2021-11-04|2021-12-06|20|52
Study ID|SE|0c713211-b021-4d3b-bca5-4a90d0731fa3|1|SCRN|5|SCREENING|2022-03-13|2022-04-03|215|236
Study ID|SE|0c713211-b021-4d3b-bca5-4a90d0731fa3|2|5|7|TREATMENT|2021-09-25|2021-12-01|46|113
Study ID|SE|0c713211-b021-4d3b-bca5-4a90d0731fa3|3|REST|2|WASHOUT|2021-11-19|2022-04-08|101|241
Study ID|SE|0c713211-b021-4d3b-bca5-4a90d0731fa3|4|10|4|TREATMENT|2022-01-15|2022-03-01|158|203
Study ID|SE|0c713211-b021-4d3b-bca5-4a90d0731fa3|5|REST|4|WASHOUT|2021-09-01|2021-10-06|22|57
Study ID|SE|0c713211-b021-4d3b-bca5-4a90d0731fa3|6|P|7|TREATMENT|2021-11-22|2021-12-29|104|141
Study ID|SE|0c713211-b021-4d3b-bca5-4a90d0731fa3|7|FU|2|FOLLOW-UP|2022-04-18|2022-05-31|251|294
Study ID|SE|324b1ffb-952e-40ae-b9d5-de801b0dd515|1|SCRN|3|SCREENING|2021-10-20|2022-06-19|45|287
Study ID|SE|324b1ffb-952e-40ae-b9d5-de801b0dd515|2|5|2|TREATMENT|2021-10-15|2021-12-21|40|107
Study ID|SE|324b1ffb-952e-40ae-b9d5-de801b0dd515|3|REST|7|WASHOUT|2021-09-07|2021-09-08|2|3
Study ID|SE|324b1ffb-952e-40ae-b9d5-de801b0dd515|4|P|3|TREATMENT|2021-10-14|2022-01-25|39|142
Study ID|SE|324b1ffb-952e-40ae-b9d5-de801b0dd515|5|REST|6|WASHOUT|2021-10-05|2021-10-06|30|31
Study ID|SE|324b1ffb-952e-40ae-b9d5-de801b0dd515|6|10|3|TREATMENT|2022-05-28|2022-06-25|265|293
Study ID|SE|324b1ffb-952e-40ae-b9d5-de801b0dd515|7|FU|4|FOLLOW-UP|2021-10-13|2022-05-09|38|246
Study ID|SE|229d8b75-df53-4cf4-b163-4338f51354ca|1|SCRN|2|SCREENING|2021-09-12|2021-10-02|24|44
Study ID|SE|229d8b75-df53-4cf4-b163-4338f51354ca|2|5|4|TREATMENT|2022-02-15|2022-03-08|180|201
Study ID|SE|229d8b75-df53-4cf4-b163-4338f51354ca|3|REST|4|WASHOUT|2021-12-20|2022-03-23|123|216
Study ID|SE|229d8b75-df53-4cf4-b163-4338f51354ca|4|10|2|TREATMENT|2021-08-26|2021-09-08|7|20
Study ID|SE|229d8b75-df53-4cf4-b163-4338f51354ca|5|REST|2|WASHOUT|2021-09-27|2021-10-30|39|72
Study ID|SE|229d8b75-df53-4cf4-b163-4338f51354ca|6|P|3|TREATMENT|2021-12-08|2022-02-09|111|174
Study ID|SE|229d8b75-df53-4cf4-b163-4338f51354ca|7|FU|4|FOLLOW-UP|2021-11-08|2022-01-31|81|165
Study ID|SE|36814c94-db9d-487c-81aa-22c2bfe89fb6|1|SCRN|6|SCREENING|2022-02-02|2022-04-11|103|171
Study ID|SE|36814c94-db9d-487c-81aa-22c2bfe89fb6|2|5|4|TREATMENT|2021-10-28|2022-02-07|6|108
Study ID|SE|36814c94-db9d-487c-81aa-22c2bfe89fb6|3|REST|4|WASHOUT|2021-12-15|2022-06-16|54|237
Study ID|SE|36814c94-db9d-487c-81aa-22c2bfe89fb6|4|10|1|TREATMENT|2021-10-25|2022-02-17|3|118
Study ID|SE|36814c94-db9d-487c-81aa-22c2bfe89fb6|5|REST|3|WASHOUT|2021-11-11|2022-04-12|20|172
Study ID|SE|36814c94-db9d-487c-81aa-22c2bfe89fb6|6|P|1|TREATMENT|2022-01-21|2022-04-14|91|174
Study ID|SE|36814c94-db9d-487c-81aa-22c2bfe89fb6|7|FU|1|FOLLOW-UP|2021-10-24|2021-11-19|2|28
Study ID|SE|99f42caa-8619-4864-b717-42594d2c1c4d|1|SCRN|3|SCREENING|2021-11-21|2022-02-13|27|111
Study ID|SE|99f42caa-8619-4864-b717-42594d2c1c4d|2|5|6|TREATMENT|2022-02-09|2022-07-29|107|277
Study ID|SE|99f42caa-8619-4864-b717-42594d2c1c4d|3|REST|6|WASHOUT|2021-11-11|2022-07-15|17|263
Study ID|SE|99f42caa-8619-4864-b717-42594d2c1c4d|4|10|5|TREATMENT|2022-01-23|2022-03-10|90|136
Study ID|SE|99f42caa-8619-4864-b717-42594d2c1c4d|5|REST|2|WASHOUT|2021-10-27|2021-10-29|2|4
Study ID|SE|99f42caa-8619-4864-b717-42594d2c1c4d|6|P|4|TREATMENT|2022-05-01|2022-05-02|188|189
Study ID|SE|99f42caa-8619-4864-b717-42594d2c1c4d|7|FU|2|FOLLOW-UP|2022-04-14|2022-05-27|171|214
Study ID|SE|fc9a7c4b-b2df-42d5-bafb-909b518df602|1|SCRN|3|SCREENING|2021-09-26|2021-11-23|11|69
Study ID|SE|fc9a7c4b-b2df-42d5-bafb-909b518df602|2|P|3|TREATMENT|2021-11-11|2022-07-07|57|295
Study ID|SE|fc9a7c4b-b2df-42d5-bafb-909b518df602|3|REST|4|WASHOUT|2021-09-28|2021-09-30|13|15
Study ID|SE|fc9a7c4b-b2df-42d5-bafb-909b518df602|4|5|2|TREATMENT|2021-09-18|2021-09-25|3|10
Study ID|SE|fc9a7c4b-b2df-42d5-bafb-909b518df602|5|REST|2|WASHOUT|2022-05-24|2022-07-01|251|289
Study ID|SE|fc9a7c4b-b2df-42d5-bafb-909b518df602|6|10|2|TREATMENT|2021-11-05|2021-12-30|51|106
Study ID|SE|fc9a7c4b-b2df-42d5-bafb-909b518df602|7|FU|4|FOLLOW-UP|2021-12-11|2022-02-28|87|166
Study ID|SE|b72d89cb-cbd0-4a2a-b2b6-73ab91370632|1|SCRN|3|SCREENING|2021-12-24|2022-05-28|72|227
Study ID|SE|b72d89cb-cbd0-4a2a-b2b6-73ab91370632|2|5|3|TREATMENT|2021-12-17|2022-02-18|65|128
Study ID|SE|b72d89cb-cbd0-4a2a-b2b6-73ab91370632|3|REST|3|WASHOUT|2022-02-15|2022-04-11|125|180
Study ID|SE|b72d89cb-cbd0-4a2a-b2b6-73ab91370632|4|P|3|TREATMENT|2021-10-16|2022-02-16|3|126
Study ID|SE|b72d89cb-cbd0-4a2a-b2b6-73ab91370632|5|REST|2|WASHOUT|2022-01-12|2022-03-08|91|146
Study ID|SE|b72d89cb-cbd0-4a2a-b2b6-73ab91370632|6|10|7|TREATMENT|2021-11-09|2021-11-14|27|32
Study ID|SE|b72d89cb-cbd0-4a2a-b2b6-73ab91370632|7|FU|7|FOLLOW-UP|2021-11-03|2021-12-06|21|54
Study ID|SE|60991758-1054-4201-9716-4b24ae56beaf|1|SCRN|3|SCREENING|2021-12-16|2022-02-18|129|193
Study ID|SE|60991758-1054-4201-9716-4b24ae56beaf|2|5|4|TREATMENT|2022-02-12|2022-03-27|187|230
Study ID|SE|60991758-1054-4201-9716-4b24ae56beaf|3|REST|7|WASHOUT|2021-11-17|2021-12-25|100|138
Study ID|SE|60991758-1054-4201-9716-4b24ae56beaf|4|P|5|TREATMENT|2021-08-11|2021-08-17|2|8
Study ID|SE|60991758-1054-4201-9716-4b24ae56beaf|5|REST|2|WASHOUT|2021-11-08|2022-05-24|91|288
Study ID|SE|60991758-1054-4201-9716-4b24ae56beaf|6|10|5|TREATMENT|2021-08-19|2021-09-22|10|44
Study ID|SE|60991758-1054-4201-9716-4b24ae56beaf|7|FU|6|FOLLOW-UP|2021-08-24|2021-10-08|15|60
Study ID|SE|3dbd06b5-5838-4494-ac8a-cad254dae8ae|1|SCRN|2|SCREENING|2022-03-28|2022-07-03|196|293
Study ID|SE|3dbd06b5-5838-4494-ac8a-cad254dae8ae|2|5|6|TREATMENT|2021-11-27|2022-01-17|75|126
Study ID|SE|3dbd06b5-5838-4494-ac8a-cad254dae8ae|3|REST|6|WASHOUT|2021-12-09|2022-04-23|87|222
Study ID|SE|3dbd06b5-5838-4494-ac8a-cad254dae8ae|4|P|1|TREATMENT|2021-10-07|2021-10-15|24|32
Study ID|SE|3dbd06b5-5838-4494-ac8a-cad254dae8ae|5|REST|3|WASHOUT|2022-04-19|2022-04-23|218|222
Study ID|SE|3dbd06b5-5838-4494-ac8a-cad254dae8ae|6|10|1|TREATMENT|2021-11-25|2021-12-15|73|93
Study ID|SE|3dbd06b5-5838-4494-ac8a-cad254dae8ae|7|FU|4|FOLLOW-UP|2022-04-02|2022-04-03|201|202
Study ID|SE|85fd26a5-3a3f-4fb7-adc2-000a24ec595b|1|SCRN|2|SCREENING|2021-10-06|2022-03-07|35|187
Study ID|SE|85fd26a5-3a3f-4fb7-adc2-000a24ec595b|2|P|2|TREATMENT|2022-01-09|2022-06-20|130|292
Study ID|SE|85fd26a5-3a3f-4fb7-adc2-000a24ec595b|3|REST|4|WASHOUT|2021-11-08|2022-02-16|68|168
Study ID|SE|85fd26a5-3a3f-4fb7-adc2-000a24ec595b|4|5|4|TREATMENT|2021-10-28|2022-06-11|57|283
Study ID|SE|85fd26a5-3a3f-4fb7-adc2-000a24ec595b|5|REST|4|WASHOUT|2021-09-23|2021-12-16|22|106
Study ID|SE|85fd26a5-3a3f-4fb7-adc2-000a24ec595b|6|10|2|TREATMENT|2021-09-11|2022-01-16|10|137
Study ID|SE|85fd26a5-3a3f-4fb7-adc2-000a24ec595b|7|FU|3|FOLLOW-UP|2021-10-27|2022-03-01|56|181
Study ID|SE|f6de105a-14b1-49d2-a1ef-273e4f0729b7|1|SCRN|7|SCREENING|2022-03-30|2022-04-22|203|226
Study ID|SE|f6de105a-14b1-49d2-a1ef-273e4f0729b7|2|5|7|TREATMENT|2021-12-29|2022-03-22|112|195
Study ID|SE|f6de105a-14b1-49d2-a1ef-273e4f0729b7|3|REST|3|WASHOUT|2022-04-09|2022-06-14|213|279
Study ID|SE|f6de105a-14b1-49d2-a1ef-273e4f0729b7|4|P|6|TREATMENT|2021-09-25|2021-10-24|17|46
Study ID|SE|f6de105a-14b1-49d2-a1ef-273e4f0729b7|5|REST|7|WASHOUT|2021-11-25|2022-02-11|78|156
Study ID|SE|f6de105a-14b1-49d2-a1ef-273e4f0729b7|6|10|4|TREATMENT|2021-10-03|2021-11-26|25|79
Study ID|SE|f6de105a-14b1-49d2-a1ef-273e4f0729b7|7|FU|1|FOLLOW-UP|2021-12-19|2022-05-11|102|245
Study ID|SE|09e91029-8b43-4d2f-a4e3-632be587394f|1|SCRN|6|SCREENING|2021-08-23|2021-08-29|14|20
Study ID|SE|09e91029-8b43-4d2f-a4e3-632be587394f|2|5|7|TREATMENT|2021-08-19|2021-10-07|10|59
Study ID|SE|09e91029-8b43-4d2f-a4e3-632be587394f|3|REST|1|WASHOUT|2021-08-11|2022-02-03|2|178
Study ID|SE|09e91029-8b43-4d2f-a4e3-632be587394f|4|10|3|TREATMENT|2021-11-28|2022-04-25|111|259
Study ID|SE|09e91029-8b43-4d2f-a4e3-632be587394f|5|REST|3|WASHOUT|2021-08-11|2021-08-13|2|4
Study ID|SE|09e91029-8b43-4d2f-a4e3-632be587394f|6|P|3|TREATMENT|2021-09-06|2021-11-21|28|104
Study ID|SE|09e91029-8b43-4d2f-a4e3-632be587394f|7|FU|6|FOLLOW-UP|2022-01-10|2022-05-21|154|285
Study ID|SE|5c00668d-44b0-4d1f-8da8-435da5b088f5|1|SCRN|4|SCREENING|2022-03-13|2022-04-19|155|192
Study ID|SE|5c00668d-44b0-4d1f-8da8-435da5b088f5|2|P|7|TREATMENT|2021-11-12|2022-01-08|34|91
Study ID|SE|5c00668d-44b0-4d1f-8da8-435da5b088f5|3|REST|3|WASHOUT|2022-02-15|2022-06-27|129|261
Study ID|SE|5c00668d-44b0-4d1f-8da8-435da5b088f5|4|5|7|TREATMENT|2021-11-28|2022-04-11|50|184
Study ID|SE|5c00668d-44b0-4d1f-8da8-435da5b088f5|5|REST|4|WASHOUT|2022-03-01|2022-05-30|143|233
Study ID|SE|5c00668d-44b0-4d1f-8da8-435da5b088f5|6|10|5|TREATMENT|2021-12-02|2022-07-22|54|286
Study ID|SE|5c00668d-44b0-4d1f-8da8-435da5b088f5|7|FU|1|FOLLOW-UP|2022-01-04|2022-01-07|87|90
Study ID|SE|09add726-3b75-472e-b0c3-6006a15380f5|1|SCRN|7|SCREENING|2022-03-11|2022-05-20|134|204
Study ID|SE|09add726-3b75-472e-b0c3-6006a15380f5|2|5|3|TREATMENT|2021-10-31|2021-11-14|3|17
Study ID|SE|09add726-3b75-472e-b0c3-6006a15380f5|3|REST|6|WASHOUT|2021-11-21|2022-02-04|24|99
Study ID|SE|09add726-3b75-472e-b0c3-6006a15380f5|4|P|6|TREATMENT|2022-04-01|2022-06-04|155|219
Study ID|SE|09add726-3b75-472e-b0c3-6006a15380f5|5|REST|4|WASHOUT|2021-12-12|2022-01-24|45|88
Study ID|SE|09add726-3b75-472e-b0c3-6006a15380f5|6|10|4|TREATMENT|2021-11-18|2022-04-02|21|156
Study ID|SE|09add726-3b75-472e-b0c3-6006a15380f5|7|FU|3|FOLLOW-UP|2022-03-11|2022-03-20|134|143
Study ID|SE|b51ef82f-586a-4ac9-a0d6-4f68875f3f82|1|SCRN|5|SCREENING|2022-05-11|2022-05-20|203|212
Study ID|SE|b51ef82f-586a-4ac9-a0d6-4f68875f3f82|2|5|2|TREATMENT|2021-12-26|2022-01-25|67|97
Study ID|SE|b51ef82f-586a-4ac9-a0d6-4f68875f3f82|3|REST|3|WASHOUT|2021-10-26|2022-02-05|6|108
Study ID|SE|b51ef82f-586a-4ac9-a0d6-4f68875f3f82|4|10|5|TREATMENT|2021-12-21|2022-03-05|62|136
Study ID|SE|b51ef82f-586a-4ac9-a0d6-4f68875f3f82|5|REST|7|WASHOUT|2021-11-27|2022-06-25|38|248
Study ID|SE|b51ef82f-586a-4ac9-a0d6-4f68875f3f82|6|P|1|TREATMENT|2021-11-03|2021-11-08|14|19
Study ID|SE|b51ef82f-586a-4ac9-a0d6-4f68875f3f82|7|FU|3|FOLLOW-UP|2021-10-24|2021-11-16|4|27
Study ID|SE|7bd4f72b-7c16-48f2-bc05-25e91e874731|1|SCRN|3|SCREENING|2021-12-03|2022-06-30|54|263
Study ID|SE|7bd4f72b-7c16-48f2-bc05-25e91e874731|2|5|4|TREATMENT|2021-12-30|2022-02-13|81|126
Study ID|SE|7bd4f72b-7c16-48f2-bc05-25e91e874731|3|REST|6|WASHOUT|2022-03-01|2022-03-19|142|160
Study ID|SE|7bd4f72b-7c16-48f2-bc05-25e91e874731|4|10|6|TREATMENT|2021-10-18|2021-11-26|8|47
Study ID|SE|7bd4f72b-7c16-48f2-bc05-25e91e874731|5|REST|2|WASHOUT|2021-12-23|2022-01-16|74|98
Study ID|SE|7bd4f72b-7c16-48f2-bc05-25e91e874731|6|P|2|TREATMENT|2022-01-14|2022-05-25|96|227
Study ID|SE|7bd4f72b-7c16-48f2-bc05-25e91e874731|7|FU|1|FOLLOW-UP|2021-11-03|2022-08-01|24|295
Study ID|SE|130f73ca-f82c-4811-a177-5f7b00d48419|1|SCRN|7|SCREENING|2021-11-23|2021-12-10|45|62
Study ID|SE|130f73ca-f82c-4811-a177-5f7b00d48419|2|5|3|TREATMENT|2021-11-13|2022-02-25|35|139
Study ID|SE|130f73ca-f82c-4811-a177-5f7b00d48419|3|REST|2|WASHOUT|2021-11-05|2022-05-25|27|228
Study ID|SE|130f73ca-f82c-4811-a177-5f7b00d48419|4|10|6|TREATMENT|2021-10-17|2021-10-27|8|18
Study ID|SE|130f73ca-f82c-4811-a177-5f7b00d48419|5|REST|3|WASHOUT|2021-10-19|2021-10-24|10|15
Study ID|SE|130f73ca-f82c-4811-a177-5f7b00d48419|6|P|2|TREATMENT|2021-12-18|2022-05-31|70|234
Study ID|SE|130f73ca-f82c-4811-a177-5f7b00d48419|7|FU|5|FOLLOW-UP|2021-10-15|2022-02-08|6|122
Study ID|SE|c54c8670-10d9-4405-9540-ae64c6af702c|1|SCRN|7|SCREENING|2021-11-16|2022-04-03|59|197
Study ID|SE|c54c8670-10d9-4405-9540-ae64c6af702c|2|5|1|TREATMENT|2021-10-26|2022-01-30|38|134
Study ID|SE|c54c8670-10d9-4405-9540-ae64c6af702c|3|REST|5|WASHOUT|2021-11-29|2021-12-26|72|99
Study ID|SE|c54c8670-10d9-4405-9540-ae64c6af702c|4|10|3|TREATMENT|2022-01-21|2022-06-04|125|259
Study ID|SE|c54c8670-10d9-4405-9540-ae64c6af702c|5|REST|3|WASHOUT|2021-11-04|2021-12-20|47|93
Study ID|SE|c54c8670-10d9-4405-9540-ae64c6af702c|6|P|7|TREATMENT|2021-10-25|2021-12-23|37|96
Study ID|SE|c54c8670-10d9-4405-9540-ae64c6af702c|7|FU|2|FOLLOW-UP|2021-10-22|2022-04-05|34|199
Study ID|SE|80a63cef-bcfc-4b49-80bc-7f6cf7e77a71|1|SCRN|2|SCREENING|2021-08-31|2021-09-29|15|44
Study ID|SE|80a63cef-bcfc-4b49-80bc-7f6cf7e77a71|2|5|6|TREATMENT|2021-09-16|2022-04-11|31|238
Study ID|SE|80a63cef-bcfc-4b49-80bc-7f6cf7e77a71|3|REST|5|WASHOUT|2021-09-22|2022-01-27|37|164
Study ID|SE|80a63cef-bcfc-4b49-80bc-7f6cf7e77a71|4|P|7|TREATMENT|2021-10-30|2022-04-27|75|254
Study ID|SE|80a63cef-bcfc-4b49-80bc-7f6cf7e77a71|5|REST|3|WASHOUT|2021-10-04|2021-10-22|49|67
Study ID|SE|80a63cef-bcfc-4b49-80bc-7f6cf7e77a71|6|10|5|TREATMENT|2022-03-25|2022-03-27|221|223
Study ID|SE|80a63cef-bcfc-4b49-80bc-7f6cf7e77a71|7|FU|3|FOLLOW-UP|2021-08-24|2021-12-08|8|114
Study ID|SE|2873c83e-0c3d-40b5-98ed-521ad0559370|1|SCRN|2|SCREENING|2022-05-09|2022-06-05|231|258
Study ID|SE|2873c83e-0c3d-40b5-98ed-521ad0559370|2|5|2|TREATMENT|2021-09-28|2021-12-28|8|99
Study ID|SE|2873c83e-0c3d-40b5-98ed-521ad0559370|3|REST|6|WASHOUT|2021-11-20|2021-12-10|61|81
Study ID|SE|2873c83e-0c3d-40b5-98ed-521ad0559370|4|10|7|TREATMENT|2022-01-10|2022-01-27|112|129
Study ID|SE|2873c83e-0c3d-40b5-98ed-521ad0559370|5|REST|6|WASHOUT|2022-02-03|2022-07-04|136|287
Study ID|SE|2873c83e-0c3d-40b5-98ed-521ad0559370|6|P|3|TREATMENT|2021-10-22|2022-02-23|32|156
Study ID|SE|2873c83e-0c3d-40b5-98ed-521ad0559370|7|FU|7|FOLLOW-UP|2022-04-02|2022-07-11|194|294
Study ID|SE|05988326-eade-4aba-bba3-1ae3a95cf672|1|SCRN|3|SCREENING|2021-11-21|2022-01-25|94|159
Study ID|SE|05988326-eade-4aba-bba3-1ae3a95cf672|2|5|2|TREATMENT|2021-08-26|2022-03-06|7|199
Study ID|SE|05988326-eade-4aba-bba3-1ae3a95cf672|3|REST|6|WASHOUT|2021-08-27|2021-09-12|8|24
Study ID|SE|05988326-eade-4aba-bba3-1ae3a95cf672|4|P|7|TREATMENT|2021-11-18|2022-05-03|91|257
Study ID|SE|05988326-eade-4aba-bba3-1ae3a95cf672|5|REST|2|WASHOUT|2021-11-23|2022-04-03|96|227
Study ID|SE|05988326-eade-4aba-bba3-1ae3a95cf672|6|10|3|TREATMENT|2021-10-02|2022-04-03|44|227
Study ID|SE|05988326-eade-4aba-bba3-1ae3a95cf672|7|FU|1|FOLLOW-UP|2021-11-01|2022-02-15|74|180
Study ID|SE|a2c5ff67-5280-4949-b01e-b6e148bfdf16|1|SCRN|6|SCREENING|2021-10-20|2021-10-21|52|53
Study ID|SE|a2c5ff67-5280-4949-b01e-b6e148bfdf16|2|5|7|TREATMENT|2021-08-31|2021-09-27|2|29
Study ID|SE|a2c5ff67-5280-4949-b01e-b6e148bfdf16|3|REST|7|WASHOUT|2022-01-03|2022-02-18|127|173
Study ID|SE|a2c5ff67-5280-4949-b01e-b6e148bfdf16|4|10|6|TREATMENT|2021-10-21|2022-03-13|53|196
Study ID|SE|a2c5ff67-5280-4949-b01e-b6e148bfdf16|5|REST|2|WASHOUT|2021-10-25|2021-11-02|57|65
Study ID|SE|a2c5ff67-5280-4949-b01e-b6e148bfdf16|6|P|3|TREATMENT|2021-10-09|2021-12-22|41|115
Study ID|SE|a2c5ff67-5280-4949-b01e-b6e148bfdf16|7|FU|7|FOLLOW-UP|2021-11-04|2022-05-11|67|255
Study ID|SE|58434e9b-ce78-4bb8-8c19-3edaffd41442|1|SCRN|2|SCREENING|2021-10-14|2021-11-01|5|23
Study ID|SE|58434e9b-ce78-4bb8-8c19-3edaffd41442|2|5|6|TREATMENT|2021-12-20|2022-06-16|72|250
Study ID|SE|58434e9b-ce78-4bb8-8c19-3edaffd41442|3|REST|5|WASHOUT|2021-10-23|2021-11-18|14|40
Study ID|SE|58434e9b-ce78-4bb8-8c19-3edaffd41442|4|P|2|TREATMENT|2021-10-23|2021-11-12|14|34
Study ID|SE|58434e9b-ce78-4bb8-8c19-3edaffd41442|5|REST|3|WASHOUT|2021-10-15|2021-10-16|6|7
Study ID|SE|58434e9b-ce78-4bb8-8c19-3edaffd41442|6|10|6|TREATMENT|2022-01-29|2022-07-10|112|274
Study ID|SE|58434e9b-ce78-4bb8-8c19-3edaffd41442|7|FU|3|FOLLOW-UP|2021-11-15|2021-12-22|37|74
Study ID|SE|29e2110f-69f6-47e7-b412-f1490d15855e|1|SCRN|6|SCREENING|2021-12-13|2022-02-01|68|118
Study ID|SE|29e2110f-69f6-47e7-b412-f1490d15855e|2|P|6|TREATMENT|2021-10-11|2022-02-14|5|131
Study ID|SE|29e2110f-69f6-47e7-b412-f1490d15855e|3|REST|1|WASHOUT|2021-11-13|2021-12-03|38|58
Study ID|SE|29e2110f-69f6-47e7-b412-f1490d15855e|4|5|4|TREATMENT|2021-10-14|2022-03-09|8|154
Study ID|SE|29e2110f-69f6-47e7-b412-f1490d15855e|5|REST|5|WASHOUT|2021-10-08|2021-10-08|2|2
Study ID|SE|29e2110f-69f6-47e7-b412-f1490d15855e|6|10|6|TREATMENT|2021-12-10|2021-12-29|65|84
Study ID|SE|29e2110f-69f6-47e7-b412-f1490d15855e|7|FU|4|FOLLOW-UP|2021-11-25|2021-12-25|50|80
Study ID|SE|60fcbb9e-b305-4e8f-8f51-ec65bccba7c0|1|SCRN|1|SCREENING|2021-09-24|2022-05-16|11|245
Study ID|SE|60fcbb9e-b305-4e8f-8f51-ec65bccba7c0|2|5|1|TREATMENT|2021-11-23|2022-02-04|71|144
Study ID|SE|60fcbb9e-b305-4e8f-8f51-ec65bccba7c0|3|REST|1|WASHOUT|2022-03-10|2022-06-24|178|284
Study ID|SE|60fcbb9e-b305-4e8f-8f51-ec65bccba7c0|4|P|7|TREATMENT|2021-10-10|2022-05-14|27|243
Study ID|SE|60fcbb9e-b305-4e8f-8f51-ec65bccba7c0|5|REST|1|WASHOUT|2022-04-05|2022-06-25|204|285
Study ID|SE|60fcbb9e-b305-4e8f-8f51-ec65bccba7c0|6|10|7|TREATMENT|2021-11-10|2022-01-01|58|110
Study ID|SE|60fcbb9e-b305-4e8f-8f51-ec65bccba7c0|7|FU|1|FOLLOW-UP|2021-11-01|2022-02-01|49|141
Study ID|SE|d54966ca-f53b-4ebe-80eb-43184a62a26c|1|SCRN|6|SCREENING|2021-11-03|2021-11-08|23|28
Study ID|SE|d54966ca-f53b-4ebe-80eb-43184a62a26c|2|P|1|TREATMENT|2021-11-15|2022-07-23|35|285
Study ID|SE|d54966ca-f53b-4ebe-80eb-43184a62a26c|3|REST|4|WASHOUT|2021-11-27|2022-01-24|47|105
Study ID|SE|d54966ca-f53b-4ebe-80eb-43184a62a26c|4|5|7|TREATMENT|2022-02-04|2022-07-24|116|286
Study ID|SE|d54966ca-f53b-4ebe-80eb-43184a62a26c|5|REST|2|WASHOUT|2022-03-25|2022-06-11|165|243
Study ID|SE|d54966ca-f53b-4ebe-80eb-43184a62a26c|6|10|3|TREATMENT|2021-10-18|2021-10-23|7|12
Study ID|SE|d54966ca-f53b-4ebe-80eb-43184a62a26c|7|FU|4|FOLLOW-UP|2021-10-16|2021-11-07|5|27
Study ID|SE|85e86c83-ac59-4eff-9919-bc373b99ec0a|1|SCRN|2|SCREENING|2021-10-12|2022-05-27|31|258
Study ID|SE|85e86c83-ac59-4eff-9919-bc373b99ec0a|2|P|1|TREATMENT|2021-10-26|2021-11-24|45|74
Study ID|SE|85e86c83-ac59-4eff-9919-bc373b99ec0a|3|REST|5|WASHOUT|2022-06-19|2022-06-26|281|288
Study ID|SE|85e86c83-ac59-4eff-9919-bc373b99ec0a|4|5|2|TREATMENT|2022-01-08|2022-02-01|119|143
Study ID|SE|85e86c83-ac59-4eff-9919-bc373b99ec0a|5|REST|5|WASHOUT|2022-02-10|2022-05-03|152|234
Study ID|SE|85e86c83-ac59-4eff-9919-bc373b99ec0a|6|10|2|TREATMENT|2022-01-12|2022-01-28|123|139
Study ID|SE|85e86c83-ac59-4eff-9919-bc373b99ec0a|7|FU|6|FOLLOW-UP|2021-11-27|2022-03-19|77|189
Study ID|SE|c5c66bf5-c3d4-4970-9aa8-aede675abbd1|1|SCRN|7|SCREENING|2022-04-03|2022-04-16|171|184
Study ID|SE|c5c66bf5-c3d4-4970-9aa8-aede675abbd1|2|5|6|TREATMENT|2021-10-27|2022-02-05|13|114
Study ID|SE|c5c66bf5-c3d4-4970-9aa8-aede675abbd1|3|REST|5|WASHOUT|2022-02-16|2022-04-12|125|180
Study ID|SE|c5c66bf5-c3d4-4970-9aa8-aede675abbd1|4|10|4|TREATMENT|2021-10-27|2022-05-07|13|205
Study ID|SE|c5c66bf5-c3d4-4970-9aa8-aede675abbd1|5|REST|6|WASHOUT|2022-02-24|2022-03-15|133|152
Study ID|SE|c5c66bf5-c3d4-4970-9aa8-aede675abbd1|6|P|2|TREATMENT|2021-10-27|2022-01-09|13|87
Study ID|SE|c5c66bf5-c3d4-4970-9aa8-aede675abbd1|7|FU|3|FOLLOW-UP|2022-02-01|2022-02-02|110|111
Study ID|SE|c8869166-757e-47e0-ab64-263a9d7656b6|1|SCRN|6|SCREENING|2021-12-31|2022-07-16|79|276
Study ID|SE|c8869166-757e-47e0-ab64-263a9d7656b6|2|5|5|TREATMENT|2021-10-16|2022-06-15|3|245
Study ID|SE|c8869166-757e-47e0-ab64-263a9d7656b6|3|REST|2|WASHOUT|2021-10-19|2021-11-20|6|38
Study ID|SE|c8869166-757e-47e0-ab64-263a9d7656b6|4|10|7|TREATMENT|2021-11-13|2021-11-25|31|43
Study ID|SE|c8869166-757e-47e0-ab64-263a9d7656b6|5|REST|1|WASHOUT|2022-03-27|2022-06-20|165|250
Study ID|SE|c8869166-757e-47e0-ab64-263a9d7656b6|6|P|2|TREATMENT|2022-02-10|2022-03-10|120|148
Study ID|SE|c8869166-757e-47e0-ab64-263a9d7656b6|7|FU|5|FOLLOW-UP|2022-03-01|2022-04-12|139|181
Study ID|SE|f86d76f1-768e-4e57-89b6-7aedc9354f06|1|SCRN|5|SCREENING|2022-01-31|2022-05-08|158|255
Study ID|SE|f86d76f1-768e-4e57-89b6-7aedc9354f06|2|5|6|TREATMENT|2021-09-13|2022-05-11|18|258
Study ID|SE|f86d76f1-768e-4e57-89b6-7aedc9354f06|3|REST|4|WASHOUT|2021-11-27|2022-04-04|93|221
Study ID|SE|f86d76f1-768e-4e57-89b6-7aedc9354f06|4|P|5|TREATMENT|2021-10-10|2021-11-09|45|75
Study ID|SE|f86d76f1-768e-4e57-89b6-7aedc9354f06|5|REST|1|WASHOUT|2021-09-02|2021-09-26|7|31
Study ID|SE|f86d76f1-768e-4e57-89b6-7aedc9354f06|6|10|5|TREATMENT|2021-10-13|2021-10-30|48|65
Study ID|SE|f86d76f1-768e-4e57-89b6-7aedc9354f06|7|FU|1|FOLLOW-UP|2022-02-12|2022-04-09|170|226
Study ID|SE|fce3efcc-0df4-45c3-8923-68a138d27d73|1|SCRN|4|SCREENING|2021-12-30|2022-01-18|84|103
Study ID|SE|fce3efcc-0df4-45c3-8923-68a138d27d73|2|5|6|TREATMENT|2021-10-25|2021-10-29|18|22
Study ID|SE|fce3efcc-0df4-45c3-8923-68a138d27d73|3|REST|1|WASHOUT|2022-04-06|2022-05-08|181|213
Study ID|SE|fce3efcc-0df4-45c3-8923-68a138d27d73|4|10|1|TREATMENT|2022-04-13|2022-05-09|188|214
Study ID|SE|fce3efcc-0df4-45c3-8923-68a138d27d73|5|REST|2|WASHOUT|2021-10-28|2021-11-13|21|37
Study ID|SE|fce3efcc-0df4-45c3-8923-68a138d27d73|6|P|7|TREATMENT|2021-10-10|2021-10-22|3|15
Study ID|SE|fce3efcc-0df4-45c3-8923-68a138d27d73|7|FU|6|FOLLOW-UP|2022-02-17|2022-04-07|133|182
Study ID|SE|ee0af298-ceb4-4439-8668-328d7b1f0b6a|1|SCRN|5|SCREENING|2022-03-20|2022-06-05|184|261
Study ID|SE|ee0af298-ceb4-4439-8668-328d7b1f0b6a|2|P|5|TREATMENT|2021-09-24|2021-11-29|7|73
Study ID|SE|ee0af298-ceb4-4439-8668-328d7b1f0b6a|3|REST|7|WASHOUT|2021-10-16|2021-11-23|29|67
Study ID|SE|ee0af298-ceb4-4439-8668-328d7b1f0b6a|4|5|3|TREATMENT|2021-10-10|2021-12-24|23|98
Study ID|SE|ee0af298-ceb4-4439-8668-328d7b1f0b6a|5|REST|2|WASHOUT|2022-01-30|2022-04-16|135|211
Study ID|SE|ee0af298-ceb4-4439-8668-328d7b1f0b6a|6|10|1|TREATMENT|2022-03-06|2022-04-07|170|202
Study ID|SE|ee0af298-ceb4-4439-8668-328d7b1f0b6a|7|FU|3|FOLLOW-UP|2022-02-27|2022-04-18|163|213
Study ID|SE|d06e8baf-1bbc-4d73-b527-34fd1b395292|1|SCRN|2|SCREENING|2022-04-05|2022-04-16|176|187
Study ID|SE|d06e8baf-1bbc-4d73-b527-34fd1b395292|2|5|5|TREATMENT|2021-10-30|2021-12-05|19|55
Study ID|SE|d06e8baf-1bbc-4d73-b527-34fd1b395292|3|REST|6|WASHOUT|2021-10-30|2021-10-31|19|20
Study ID|SE|d06e8baf-1bbc-4d73-b527-34fd1b395292|4|10|2|TREATMENT|2021-10-20|2021-11-26|9|46
Study ID|SE|d06e8baf-1bbc-4d73-b527-34fd1b395292|5|REST|4|WASHOUT|2022-02-04|2022-05-29|116|230
Study ID|SE|d06e8baf-1bbc-4d73-b527-34fd1b395292|6|P|2|TREATMENT|2021-10-19|2021-10-23|8|12
Study ID|SE|d06e8baf-1bbc-4d73-b527-34fd1b395292|7|FU|4|FOLLOW-UP|2021-11-03|2021-12-21|23|71
Study ID|SE|74717162-82c4-4d83-a77e-4f3078e4a004|1|SCRN|7|SCREENING|2022-03-17|2022-03-20|147|150
Study ID|SE|74717162-82c4-4d83-a77e-4f3078e4a004|2|5|5|TREATMENT|2021-10-23|2022-03-28|2|158
Study ID|SE|74717162-82c4-4d83-a77e-4f3078e4a004|3|REST|1|WASHOUT|2021-11-28|2022-01-12|38|83
Study ID|SE|74717162-82c4-4d83-a77e-4f3078e4a004|4|10|3|TREATMENT|2022-06-04|2022-06-28|226|250
Study ID|SE|74717162-82c4-4d83-a77e-4f3078e4a004|5|REST|6|WASHOUT|2021-11-09|2022-05-22|19|213
Study ID|SE|74717162-82c4-4d83-a77e-4f3078e4a004|6|P|4|TREATMENT|2022-04-14|2022-05-01|175|192
Study ID|SE|74717162-82c4-4d83-a77e-4f3078e4a004|7|FU|5|FOLLOW-UP|2022-02-25|2022-08-11|127|294
Study ID|SE|6f3b2913-194d-4844-80d5-70a3701f5cb8|1|SCRN|4|SCREENING|2021-09-26|2021-10-14|8|26
Study ID|SE|6f3b2913-194d-4844-80d5-70a3701f5cb8|2|5|1|TREATMENT|2021-10-11|2021-12-22|23|95
Study ID|SE|6f3b2913-194d-4844-80d5-70a3701f5cb8|3|REST|1|WASHOUT|2021-09-24|2021-10-04|6|16
Study ID|SE|6f3b2913-194d-4844-80d5-70a3701f5cb8|4|P|5|TREATMENT|2022-03-22|2022-05-01|185|225
Study ID|SE|6f3b2913-194d-4844-80d5-70a3701f5cb8|5|REST|1|WASHOUT|2021-11-03|2022-07-08|46|293
Study ID|SE|6f3b2913-194d-4844-80d5-70a3701f5cb8|6|10|4|TREATMENT|2022-03-19|2022-04-09|182|203
Study ID|SE|6f3b2913-194d-4844-80d5-70a3701f5cb8|7|FU|1|FOLLOW-UP|2022-01-06|2022-02-22|110|157
Study ID|SE|3b6b4fd0-0730-4398-8f67-9d8cbd4e8465|1|SCRN|5|SCREENING|2021-10-09|2022-05-26|53|282
Study ID|SE|3b6b4fd0-0730-4398-8f67-9d8cbd4e8465|2|P|6|TREATMENT|2021-09-09|2021-12-01|23|106
Study ID|SE|3b6b4fd0-0730-4398-8f67-9d8cbd4e8465|3|REST|5|WASHOUT|2021-09-22|2021-10-06|36|50
Study ID|SE|3b6b4fd0-0730-4398-8f67-9d8cbd4e8465|4|5|4|TREATMENT|2022-01-25|2022-03-03|161|198
Study ID|SE|3b6b4fd0-0730-4398-8f67-9d8cbd4e8465|5|REST|2|WASHOUT|2021-08-29|2022-03-09|12|204
Study ID|SE|3b6b4fd0-0730-4398-8f67-9d8cbd4e8465|6|10|3|TREATMENT|2022-03-30|2022-04-09|225|235
Study ID|SE|3b6b4fd0-0730-4398-8f67-9d8cbd4e8465|7|FU|1|FOLLOW-UP|2021-09-10|2021-10-15|24|59
Study ID|SE|c208988f-4212-4eb2-b348-24442f85af9b|1|SCRN|5|SCREENING|2021-08-30|2021-09-03|3|7
Study ID|SE|c208988f-4212-4eb2-b348-24442f85af9b|2|5|2|TREATMENT|2022-03-03|2022-03-26|188|211
Study ID|SE|c208988f-4212-4eb2-b348-24442f85af9b|3|REST|2|WASHOUT|2021-12-16|2021-12-24|111|119
Study ID|SE|c208988f-4212-4eb2-b348-24442f85af9b|4|P|6|TREATMENT|2021-09-22|2021-11-12|26|77
Study ID|SE|c208988f-4212-4eb2-b348-24442f85af9b|5|REST|6|WASHOUT|2021-12-02|2022-03-07|97|192
Study ID|SE|c208988f-4212-4eb2-b348-24442f85af9b|6|10|4|TREATMENT|2021-10-07|2022-06-02|41|279
Study ID|SE|c208988f-4212-4eb2-b348-24442f85af9b|7|FU|4|FOLLOW-UP|2021-11-15|2022-04-15|80|231
Study ID|SE|3791a6ab-a874-4b57-9611-26d8eb585711|1|SCRN|3|SCREENING|2021-12-11|2022-01-09|123|152
Study ID|SE|3791a6ab-a874-4b57-9611-26d8eb585711|2|P|2|TREATMENT|2021-09-09|2021-09-12|30|33
Study ID|SE|3791a6ab-a874-4b57-9611-26d8eb585711|3|REST|1|WASHOUT|2021-08-16|2021-10-10|6|61
Study ID|SE|3791a6ab-a874-4b57-9611-26d8eb585711|4|5|2|TREATMENT|2021-11-18|2022-01-11|100|154
Study ID|SE|3791a6ab-a874-4b57-9611-26d8eb585711|5|REST|2|WASHOUT|2021-10-10|2022-03-08|61|210
Study ID|SE|3791a6ab-a874-4b57-9611-26d8eb585711|6|10|1|TREATMENT|2021-08-20|2021-08-24|10|14
Study ID|SE|3791a6ab-a874-4b57-9611-26d8eb585711|7|FU|3|FOLLOW-UP|2021-10-25|2021-11-04|76|86
Study ID|SE|814f4185-6b93-45b3-a04f-bc65b47af956|1|SCRN|3|SCREENING|2022-04-27|2022-05-28|208|239
Study ID|SE|814f4185-6b93-45b3-a04f-bc65b47af956|2|5|2|TREATMENT|2021-10-27|2021-11-02|26|32
Study ID|SE|814f4185-6b93-45b3-a04f-bc65b47af956|3|REST|4|WASHOUT|2021-11-03|2022-05-02|33|213
Study ID|SE|814f4185-6b93-45b3-a04f-bc65b47af956|4|10|4|TREATMENT|2022-01-15|2022-01-24|106|115
Study ID|SE|814f4185-6b93-45b3-a04f-bc65b47af956|5|REST|5|WASHOUT|2021-12-05|2022-07-26|65|298
Study ID|SE|814f4185-6b93-45b3-a04f-bc65b47af956|6|P|7|TREATMENT|2022-04-19|2022-07-21|200|293
Study ID|SE|814f4185-6b93-45b3-a04f-bc65b47af956|7|FU|1|FOLLOW-UP|2022-03-15|2022-05-17|165|228
Study ID|SE|91b47cdc-d93b-415e-ac54-482a23e15c6c|1|SCRN|3|SCREENING|2021-11-26|2022-04-04|102|231
Study ID|SE|91b47cdc-d93b-415e-ac54-482a23e15c6c|2|5|6|TREATMENT|2021-09-13|2021-09-15|28|30
Study ID|SE|91b47cdc-d93b-415e-ac54-482a23e15c6c|3|REST|4|WASHOUT|2021-11-15|2021-11-25|91|101
Study ID|SE|91b47cdc-d93b-415e-ac54-482a23e15c6c|4|10|6|TREATMENT|2021-08-25|2021-09-10|9|25
Study ID|SE|91b47cdc-d93b-415e-ac54-482a23e15c6c|5|REST|5|WASHOUT|2022-01-11|2022-03-03|148|199
Study ID|SE|91b47cdc-d93b-415e-ac54-482a23e15c6c|6|P|2|TREATMENT|2021-08-26|2021-09-14|10|29
Study ID|SE|91b47cdc-d93b-415e-ac54-482a23e15c6c|7|FU|4|FOLLOW-UP|2021-09-05|2021-09-06|20|21
Study ID|SE|0a501dd0-6dca-47e4-9d7e-a773a9c5825c|1|SCRN|5|SCREENING|2022-05-13|2022-05-25|207|219
Study ID|SE|0a501dd0-6dca-47e4-9d7e-a773a9c5825c|2|5|3|TREATMENT|2022-05-19|2022-08-02|213|288
Study ID|SE|0a501dd0-6dca-47e4-9d7e-a773a9c5825c|3|REST|2|WASHOUT|2021-12-09|2022-01-24|52|98
Study ID|SE|0a501dd0-6dca-47e4-9d7e-a773a9c5825c|4|P|5|TREATMENT|2022-02-11|2022-03-24|116|157
Study ID|SE|0a501dd0-6dca-47e4-9d7e-a773a9c5825c|5|REST|6|WASHOUT|2021-12-09|2021-12-10|52|53
Study ID|SE|0a501dd0-6dca-47e4-9d7e-a773a9c5825c|6|10|4|TREATMENT|2022-01-30|2022-03-14|104|147
Study ID|SE|0a501dd0-6dca-47e4-9d7e-a773a9c5825c|7|FU|3|FOLLOW-UP|2021-10-21|2021-10-31|3|13
Study ID|SE|e929ba72-b74d-4c71-82f9-da766e17fd6f|1|SCRN|3|SCREENING|2022-02-21|2022-05-22|197|287
Study ID|SE|e929ba72-b74d-4c71-82f9-da766e17fd6f|2|P|2|TREATMENT|2021-08-11|2021-08-27|3|19
Study ID|SE|e929ba72-b74d-4c71-82f9-da766e17fd6f|3|REST|6|WASHOUT|2021-09-18|2021-10-05|41|58
Study ID|SE|e929ba72-b74d-4c71-82f9-da766e17fd6f|4|5|6|TREATMENT|2021-08-22|2021-09-08|14|31
Study ID|SE|e929ba72-b74d-4c71-82f9-da766e17fd6f|5|REST|6|WASHOUT|2021-10-17|2022-02-28|70|204
Study ID|SE|e929ba72-b74d-4c71-82f9-da766e17fd6f|6|10|4|TREATMENT|2021-08-11|2021-10-23|3|76
Study ID|SE|e929ba72-b74d-4c71-82f9-da766e17fd6f|7|FU|2|FOLLOW-UP|2021-10-25|2022-03-10|78|214
Study ID|SE|1f125b08-c7fb-4c6b-b64b-38ce4a50a74b|1|SCRN|3|SCREENING|2022-01-26|2022-07-04|91|250
Study ID|SE|1f125b08-c7fb-4c6b-b64b-38ce4a50a74b|2|5|2|TREATMENT|2021-12-26|2022-04-20|60|175
Study ID|SE|1f125b08-c7fb-4c6b-b64b-38ce4a50a74b|3|REST|2|WASHOUT|2022-01-24|2022-01-27|89|92
Study ID|SE|1f125b08-c7fb-4c6b-b64b-38ce4a50a74b|4|10|7|TREATMENT|2021-11-27|2022-06-16|31|232
Study ID|SE|1f125b08-c7fb-4c6b-b64b-38ce4a50a74b|5|REST|2|WASHOUT|2021-11-21|2022-05-22|25|207
Study ID|SE|1f125b08-c7fb-4c6b-b64b-38ce4a50a74b|6|P|7|TREATMENT|2021-11-05|2022-01-15|9|80
Study ID|SE|1f125b08-c7fb-4c6b-b64b-38ce4a50a74b|7|FU|4|FOLLOW-UP|2021-11-12|2022-02-06|16|102
Study ID|SE|f7ff7030-27e7-4d60-b511-2c6c2bd9eb4f|1|SCRN|5|SCREENING|2021-11-30|2022-01-16|100|147
Study ID|SE|f7ff7030-27e7-4d60-b511-2c6c2bd9eb4f|2|5|6|TREATMENT|2021-10-11|2021-10-17|50|56
Study ID|SE|f7ff7030-27e7-4d60-b511-2c6c2bd9eb4f|3|REST|7|WASHOUT|2022-02-18|2022-03-18|180|208
Study ID|SE|f7ff7030-27e7-4d60-b511-2c6c2bd9eb4f|4|10|1|TREATMENT|2021-11-01|2021-11-15|71|85
Study ID|SE|f7ff7030-27e7-4d60-b511-2c6c2bd9eb4f|5|REST|2|WASHOUT|2021-10-06|2021-10-20|45|59
Study ID|SE|f7ff7030-27e7-4d60-b511-2c6c2bd9eb4f|6|P|4|TREATMENT|2022-03-11|2022-05-02|201|253
Study ID|SE|f7ff7030-27e7-4d60-b511-2c6c2bd9eb4f|7|FU|7|FOLLOW-UP|2021-09-11|2021-10-08|20|47
Study ID|SE|3d436511-0dce-4437-b15b-932141264f50|1|SCRN|1|SCREENING|2021-11-13|2021-11-16|72|75
Study ID|SE|3d436511-0dce-4437-b15b-932141264f50|2|5|4|TREATMENT|2021-09-14|2021-10-08|12|36
Study ID|SE|3d436511-0dce-4437-b15b-932141264f50|3|REST|4|WASHOUT|2022-02-27|2022-03-09|178|188
Study ID|SE|3d436511-0dce-4437-b15b-932141264f50|4|10|5|TREATMENT|2021-10-03|2022-05-03|31|243
Study ID|SE|3d436511-0dce-4437-b15b-932141264f50|5|REST|2|WASHOUT|2022-04-08|2022-04-10|218|220
Study ID|SE|3d436511-0dce-4437-b15b-932141264f50|6|P|2|TREATMENT|2022-05-25|2022-05-26|265|266
Study ID|SE|3d436511-0dce-4437-b15b-932141264f50|7|FU|3|FOLLOW-UP|2021-09-27|2021-10-31|25|59
Study ID|SE|a0b6b2a4-910a-4c3c-87b6-48ee38dfa2f7|1|SCRN|3|SCREENING|2021-09-19|2022-02-07|31|172
Study ID|SE|a0b6b2a4-910a-4c3c-87b6-48ee38dfa2f7|2|P|6|TREATMENT|2021-08-25|2021-09-10|6|22
Study ID|SE|a0b6b2a4-910a-4c3c-87b6-48ee38dfa2f7|3|REST|4|WASHOUT|2021-10-01|2021-10-13|43|55
Study ID|SE|a0b6b2a4-910a-4c3c-87b6-48ee38dfa2f7|4|5|7|TREATMENT|2021-12-19|2021-12-31|122|134
Study ID|SE|a0b6b2a4-910a-4c3c-87b6-48ee38dfa2f7|5|REST|7|WASHOUT|2021-10-18|2021-10-19|60|61
Study ID|SE|a0b6b2a4-910a-4c3c-87b6-48ee38dfa2f7|6|10|7|TREATMENT|2022-03-24|2022-05-01|217|255
Study ID|SE|a0b6b2a4-910a-4c3c-87b6-48ee38dfa2f7|7|FU|2|FOLLOW-UP|2021-10-10|2021-10-19|52|61
Study ID|SE|eb0b2151-9ebc-44cb-8667-15fe2bfd4e46|1|SCRN|7|SCREENING|2021-12-14|2022-04-13|49|169
Study ID|SE|eb0b2151-9ebc-44cb-8667-15fe2bfd4e46|2|P|4|TREATMENT|2021-12-30|2022-01-30|65|96
Study ID|SE|eb0b2151-9ebc-44cb-8667-15fe2bfd4e46|3|REST|5|WASHOUT|2021-11-20|2021-12-01|25|36
Study ID|SE|eb0b2151-9ebc-44cb-8667-15fe2bfd4e46|4|5|7|TREATMENT|2021-12-12|2022-04-04|47|160
Study ID|SE|eb0b2151-9ebc-44cb-8667-15fe2bfd4e46|5|REST|3|WASHOUT|2022-06-18|2022-08-14|235|292
Study ID|SE|eb0b2151-9ebc-44cb-8667-15fe2bfd4e46|6|10|7|TREATMENT|2021-11-03|2021-12-08|8|43
Study ID|SE|eb0b2151-9ebc-44cb-8667-15fe2bfd4e46|7|FU|4|FOLLOW-UP|2022-05-19|2022-06-17|205|234
Study ID|SE|ab4630d3-b303-4abf-b74a-944ec3fdae75|1|SCRN|7|SCREENING|2021-12-08|2022-01-28|58|109
Study ID|SE|ab4630d3-b303-4abf-b74a-944ec3fdae75|2|P|5|TREATMENT|2022-02-17|2022-05-29|129|230
Study ID|SE|ab4630d3-b303-4abf-b74a-944ec3fdae75|3|REST|3|WASHOUT|2021-11-25|2022-03-02|45|142
Study ID|SE|ab4630d3-b303-4abf-b74a-944ec3fdae75|4|5|7|TREATMENT|2021-11-26|2022-03-21|46|161
Study ID|SE|ab4630d3-b303-4abf-b74a-944ec3fdae75|5|REST|1|WASHOUT|2021-11-20|2022-03-04|40|144
Study ID|SE|ab4630d3-b303-4abf-b74a-944ec3fdae75|6|10|1|TREATMENT|2021-12-30|2022-03-17|80|157
Study ID|SE|ab4630d3-b303-4abf-b74a-944ec3fdae75|7|FU|4|FOLLOW-UP|2021-12-04|2022-01-23|54|104
Study ID|SE|885d9228-b3dd-4c95-90be-6596c61a3b05|1|SCRN|1|SCREENING|2021-09-27|2022-06-01|34|281
Study ID|SE|885d9228-b3dd-4c95-90be-6596c61a3b05|2|5|5|TREATMENT|2021-08-27|2021-12-11|3|109
Study ID|SE|885d9228-b3dd-4c95-90be-6596c61a3b05|3|REST|5|WASHOUT|2021-09-04|2022-03-23|11|211
Study ID|SE|885d9228-b3dd-4c95-90be-6596c61a3b05|4|10|6|TREATMENT|2021-10-18|2022-05-15|55|264
Study ID|SE|885d9228-b3dd-4c95-90be-6596c61a3b05|5|REST|5|WASHOUT|2022-01-22|2022-03-04|151|192
Study ID|SE|885d9228-b3dd-4c95-90be-6596c61a3b05|6|P|4|TREATMENT|2021-09-17|2021-10-05|24|42
Study ID|SE|885d9228-b3dd-4c95-90be-6596c61a3b05|7|FU|3|FOLLOW-UP|2021-12-02|2022-01-28|100|157
Study ID|SE|01c22518-040f-41f9-ac4e-622da72ea8bb|1|SCRN|5|SCREENING|2021-10-24|2022-06-21|42|282
Study ID|SE|01c22518-040f-41f9-ac4e-622da72ea8bb|2|5|6|TREATMENT|2021-12-02|2022-02-18|81|159
Study ID|SE|01c22518-040f-41f9-ac4e-622da72ea8bb|3|REST|4|WASHOUT|2021-12-05|2021-12-21|84|100
Study ID|SE|01c22518-040f-41f9-ac4e-622da72ea8bb|4|P|3|TREATMENT|2021-11-04|2022-02-15|53|156
Study ID|SE|01c22518-040f-41f9-ac4e-622da72ea8bb|5|REST|4|WASHOUT|2021-09-28|2021-12-07|16|86
Study ID|SE|01c22518-040f-41f9-ac4e-622da72ea8bb|6|10|2|TREATMENT|2021-09-14|2021-09-17|2|5
Study ID|SE|01c22518-040f-41f9-ac4e-622da72ea8bb|7|FU|1|FOLLOW-UP|2021-11-02|2022-03-23|51|192
Study ID|SE|2a190ec9-08e6-4b07-ae4e-da7c896fb02d|1|SCRN|1|SCREENING|2021-09-07|2021-09-18|15|26
Study ID|SE|2a190ec9-08e6-4b07-ae4e-da7c896fb02d|2|5|4|TREATMENT|2021-09-19|2021-12-28|27|127
Study ID|SE|2a190ec9-08e6-4b07-ae4e-da7c896fb02d|3|REST|7|WASHOUT|2022-01-20|2022-02-01|150|162
Study ID|SE|2a190ec9-08e6-4b07-ae4e-da7c896fb02d|4|10|1|TREATMENT|2021-09-20|2021-10-31|28|69
Study ID|SE|2a190ec9-08e6-4b07-ae4e-da7c896fb02d|5|REST|2|WASHOUT|2021-09-04|2022-01-13|12|143
Study ID|SE|2a190ec9-08e6-4b07-ae4e-da7c896fb02d|6|P|6|TREATMENT|2022-02-07|2022-03-24|168|213
Study ID|SE|2a190ec9-08e6-4b07-ae4e-da7c896fb02d|7|FU|7|FOLLOW-UP|2021-12-08|2021-12-24|107|123
Study ID|SE|a90c7293-d8b1-4555-8b71-29e5d9707635|1|SCRN|2|SCREENING|2021-10-29|2022-03-17|82|221
Study ID|SE|a90c7293-d8b1-4555-8b71-29e5d9707635|2|P|3|TREATMENT|2021-08-27|2022-03-24|19|228
Study ID|SE|a90c7293-d8b1-4555-8b71-29e5d9707635|3|REST|7|WASHOUT|2021-10-08|2021-10-10|61|63
Study ID|SE|a90c7293-d8b1-4555-8b71-29e5d9707635|4|5|7|TREATMENT|2021-08-15|2021-08-26|7|18
Study ID|SE|a90c7293-d8b1-4555-8b71-29e5d9707635|5|REST|1|WASHOUT|2022-01-09|2022-03-31|154|235
Study ID|SE|a90c7293-d8b1-4555-8b71-29e5d9707635|6|10|3|TREATMENT|2021-08-16|2021-09-17|8|40
Study ID|SE|a90c7293-d8b1-4555-8b71-29e5d9707635|7|FU|2|FOLLOW-UP|2021-10-21|2022-03-12|74|216
Study ID|SE|2b963e8c-d7d4-4a5d-8371-3ea9273624bf|1|SCRN|6|SCREENING|2021-10-31|2021-11-06|2|8
Study ID|SE|2b963e8c-d7d4-4a5d-8371-3ea9273624bf|2|5|5|TREATMENT|2022-04-17|2022-05-26|170|209
Study ID|SE|2b963e8c-d7d4-4a5d-8371-3ea9273624bf|3|REST|4|WASHOUT|2022-06-20|2022-08-17|234|292
Study ID|SE|2b963e8c-d7d4-4a5d-8371-3ea9273624bf|4|10|3|TREATMENT|2021-11-16|2022-04-28|18|181
Study ID|SE|2b963e8c-d7d4-4a5d-8371-3ea9273624bf|5|REST|6|WASHOUT|2022-04-22|2022-07-23|175|267
Study ID|SE|2b963e8c-d7d4-4a5d-8371-3ea9273624bf|6|P|3|TREATMENT|2022-02-02|2022-03-10|96|132
Study ID|SE|2b963e8c-d7d4-4a5d-8371-3ea9273624bf|7|FU|4|FOLLOW-UP|2022-05-22|2022-08-15|205|290
Study ID|SE|64fdccee-e171-44be-b8a6-2cd692ac2a5d|1|SCRN|7|SCREENING|2021-11-06|2021-12-30|26|80
Study ID|SE|64fdccee-e171-44be-b8a6-2cd692ac2a5d|2|5|1|TREATMENT|2022-05-14|2022-05-17|215|218
Study ID|SE|64fdccee-e171-44be-b8a6-2cd692ac2a5d|3|REST|2|WASHOUT|2022-01-05|2022-01-18|86|99
Study ID|SE|64fdccee-e171-44be-b8a6-2cd692ac2a5d|4|P|5|TREATMENT|2021-12-04|2022-07-11|54|273
Study ID|SE|64fdccee-e171-44be-b8a6-2cd692ac2a5d|5|REST|7|WASHOUT|2022-01-27|2022-07-21|108|283
Study ID|SE|64fdccee-e171-44be-b8a6-2cd692ac2a5d|6|10|1|TREATMENT|2022-04-01|2022-04-07|172|178
Study ID|SE|64fdccee-e171-44be-b8a6-2cd692ac2a5d|7|FU|3|FOLLOW-UP|2022-01-02|2022-02-13|83|125
Study ID|SE|273f51b2-e379-40cd-9db2-6dc6b8e27d7c|1|SCRN|3|SCREENING|2021-08-17|2021-08-18|9|10
Study ID|SE|273f51b2-e379-40cd-9db2-6dc6b8e27d7c|2|5|4|TREATMENT|2021-11-26|2022-01-25|110|170
Study ID|SE|273f51b2-e379-40cd-9db2-6dc6b8e27d7c|3|REST|6|WASHOUT|2021-08-19|2021-09-24|11|47
Study ID|SE|273f51b2-e379-40cd-9db2-6dc6b8e27d7c|4|10|6|TREATMENT|2021-08-31|2021-09-07|23|30
Study ID|SE|273f51b2-e379-40cd-9db2-6dc6b8e27d7c|5|REST|4|WASHOUT|2021-08-15|2021-11-22|7|106
Study ID|SE|273f51b2-e379-40cd-9db2-6dc6b8e27d7c|6|P|5|TREATMENT|2021-11-25|2021-12-25|109|139
Study ID|SE|273f51b2-e379-40cd-9db2-6dc6b8e27d7c|7|FU|4|FOLLOW-UP|2021-12-14|2022-01-27|128|172
Study ID|SE|d5581a4d-39c5-4632-82e5-ac43f43641e9|1|SCRN|3|SCREENING|2021-12-05|2021-12-07|79|81
Study ID|SE|d5581a4d-39c5-4632-82e5-ac43f43641e9|2|5|2|TREATMENT|2021-11-21|2022-01-25|65|130
Study ID|SE|d5581a4d-39c5-4632-82e5-ac43f43641e9|3|REST|4|WASHOUT|2021-10-03|2021-10-09|16|22
Study ID|SE|d5581a4d-39c5-4632-82e5-ac43f43641e9|4|10|2|TREATMENT|2021-09-26|2021-10-05|9|18
Study ID|SE|d5581a4d-39c5-4632-82e5-ac43f43641e9|5|REST|5|WASHOUT|2022-05-11|2022-07-05|236|291
Study ID|SE|d5581a4d-39c5-4632-82e5-ac43f43641e9|6|P|5|TREATMENT|2021-09-19|2021-09-19|2|2
Study ID|SE|d5581a4d-39c5-4632-82e5-ac43f43641e9|7|FU|3|FOLLOW-UP|2021-10-29|2021-11-06|42|50
Study ID|SE|23e77b5d-4802-42d0-8dba-af4b45303337|1|SCRN|1|SCREENING|2021-11-21|2021-11-30|47|56
Study ID|SE|23e77b5d-4802-42d0-8dba-af4b45303337|2|5|2|TREATMENT|2021-11-23|2022-01-24|49|111
Study ID|SE|23e77b5d-4802-42d0-8dba-af4b45303337|3|REST|4|WASHOUT|2022-01-31|2022-02-21|118|139
Study ID|SE|23e77b5d-4802-42d0-8dba-af4b45303337|4|10|6|TREATMENT|2021-10-16|2021-10-24|11|19
Study ID|SE|23e77b5d-4802-42d0-8dba-af4b45303337|5|REST|3|WASHOUT|2021-10-07|2022-01-01|2|88
Study ID|SE|23e77b5d-4802-42d0-8dba-af4b45303337|6|P|3|TREATMENT|2021-10-11|2022-05-01|6|208
Study ID|SE|23e77b5d-4802-42d0-8dba-af4b45303337|7|FU|4|FOLLOW-UP|2021-10-25|2021-11-15|20|41
Study ID|SE|316f549c-6079-4363-a85b-e1e253be2f93|1|SCRN|5|SCREENING|2021-11-25|2021-11-30|85|90
Study ID|SE|316f549c-6079-4363-a85b-e1e253be2f93|2|P|7|TREATMENT|2021-11-22|2022-03-27|82|207
Study ID|SE|316f549c-6079-4363-a85b-e1e253be2f93|3|REST|3|WASHOUT|2021-10-03|2022-01-01|32|122
Study ID|SE|316f549c-6079-4363-a85b-e1e253be2f93|4|5|4|TREATMENT|2021-10-27|2022-06-19|56|291
Study ID|SE|316f549c-6079-4363-a85b-e1e253be2f93|5|REST|4|WASHOUT|2021-10-19|2022-01-25|48|146
Study ID|SE|316f549c-6079-4363-a85b-e1e253be2f93|6|10|3|TREATMENT|2021-09-14|2021-09-26|13|25
Study ID|SE|316f549c-6079-4363-a85b-e1e253be2f93|7|FU|7|FOLLOW-UP|2021-09-23|2021-09-25|22|24
Study ID|SE|a3abeeb6-eaf0-4eab-a899-30705e4d155a|1|SCRN|5|SCREENING|2021-12-15|2022-04-21|79|206
Study ID|SE|a3abeeb6-eaf0-4eab-a899-30705e4d155a|2|5|3|TREATMENT|2022-02-05|2022-04-09|131|194
Study ID|SE|a3abeeb6-eaf0-4eab-a899-30705e4d155a|3|REST|2|WASHOUT|2021-10-04|2021-11-14|7|48
Study ID|SE|a3abeeb6-eaf0-4eab-a899-30705e4d155a|4|10|6|TREATMENT|2021-11-14|2022-03-19|48|173
Study ID|SE|a3abeeb6-eaf0-4eab-a899-30705e4d155a|5|REST|7|WASHOUT|2021-12-23|2022-01-02|87|97
Study ID|SE|a3abeeb6-eaf0-4eab-a899-30705e4d155a|6|P|7|TREATMENT|2021-10-27|2022-03-30|30|184
Study ID|SE|a3abeeb6-eaf0-4eab-a899-30705e4d155a|7|FU|6|FOLLOW-UP|2021-11-28|2022-01-10|62|105
Study ID|SE|e08079a2-3221-4294-8448-fd50f847079c|1|SCRN|4|SCREENING|2021-09-23|2021-09-25|9|11
Study ID|SE|e08079a2-3221-4294-8448-fd50f847079c|2|5|4|TREATMENT|2022-01-30|2022-05-11|138|239
Study ID|SE|e08079a2-3221-4294-8448-fd50f847079c|3|REST|4|WASHOUT|2021-10-21|2021-10-24|37|40
Study ID|SE|e08079a2-3221-4294-8448-fd50f847079c|4|P|5|TREATMENT|2021-09-17|2021-10-16|3|32
Study ID|SE|e08079a2-3221-4294-8448-fd50f847079c|5|REST|1|WASHOUT|2022-02-13|2022-04-23|152|221
Study ID|SE|e08079a2-3221-4294-8448-fd50f847079c|6|10|7|TREATMENT|2021-12-10|2021-12-30|87|107
Study ID|SE|e08079a2-3221-4294-8448-fd50f847079c|7|FU|7|FOLLOW-UP|2021-11-17|2022-02-15|64|154
Study ID|SE|e19a993a-4c6c-4c81-8623-722d532297ca|1|SCRN|7|SCREENING|2021-11-12|2022-01-17|96|162
Study ID|SE|e19a993a-4c6c-4c81-8623-722d532297ca|2|5|6|TREATMENT|2021-09-17|2022-01-28|40|173
Study ID|SE|e19a993a-4c6c-4c81-8623-722d532297ca|3|REST|1|WASHOUT|2021-08-14|2021-08-27|6|19
Study ID|SE|e19a993a-4c6c-4c81-8623-722d532297ca|4|10|4|TREATMENT|2022-02-08|2022-03-25|184|229
Study ID|SE|e19a993a-4c6c-4c81-8623-722d532297ca|5|REST|5|WASHOUT|2021-09-24|2022-03-03|47|207
Study ID|SE|e19a993a-4c6c-4c81-8623-722d532297ca|6|P|2|TREATMENT|2022-02-27|2022-03-12|203|216
Study ID|SE|e19a993a-4c6c-4c81-8623-722d532297ca|7|FU|5|FOLLOW-UP|2022-02-04|2022-04-15|180|250
Study ID|SE|e0936e84-299e-451f-b8fa-ae8b6f9f83dc|1|SCRN|6|SCREENING|2021-09-28|2021-11-27|11|71
Study ID|SE|e0936e84-299e-451f-b8fa-ae8b6f9f83dc|2|P|6|TREATMENT|2022-01-31|2022-04-04|136|199
Study ID|SE|e0936e84-299e-451f-b8fa-ae8b6f9f83dc|3|REST|1|WASHOUT|2022-05-16|2022-06-21|241|277
Study ID|SE|e0936e84-299e-451f-b8fa-ae8b6f9f83dc|4|5|6|TREATMENT|2022-04-22|2022-07-01|217|287
Study ID|SE|e0936e84-299e-451f-b8fa-ae8b6f9f83dc|5|REST|5|WASHOUT|2021-11-01|2022-01-20|45|125
Study ID|SE|e0936e84-299e-451f-b8fa-ae8b6f9f83dc|6|10|1|TREATMENT|2021-09-22|2021-10-02|5|15
Study ID|SE|e0936e84-299e-451f-b8fa-ae8b6f9f83dc|7|FU|6|FOLLOW-UP|2021-10-13|2022-02-23|26|159
Study ID|SE|825caa22-c4b4-4d79-9ee7-86d8bb490e7a|1|SCRN|3|SCREENING|2021-12-02|2021-12-07|97|102
Study ID|SE|825caa22-c4b4-4d79-9ee7-86d8bb490e7a|2|5|3|TREATMENT|2021-09-14|2021-10-27|18|61
Study ID|SE|825caa22-c4b4-4d79-9ee7-86d8bb490e7a|3|REST|5|WASHOUT|2021-10-21|2021-12-16|55|111
Study ID|SE|825caa22-c4b4-4d79-9ee7-86d8bb490e7a|4|P|7|TREATMENT|2021-09-27|2021-11-23|31|88
Study ID|SE|825caa22-c4b4-4d79-9ee7-86d8bb490e7a|5|REST|4|WASHOUT|2021-12-02|2021-12-20|97|115
Study ID|SE|825caa22-c4b4-4d79-9ee7-86d8bb490e7a|6|10|4|TREATMENT|2022-02-06|2022-02-27|163|184
Study ID|SE|825caa22-c4b4-4d79-9ee7-86d8bb490e7a|7|FU|1|FOLLOW-UP|2022-01-01|2022-01-03|127|129
Study ID|SE|8fe536c8-85cf-4f2a-87d4-05764a9bc9ec|1|SCRN|7|SCREENING|2021-09-17|2021-11-21|33|98
Study ID|SE|8fe536c8-85cf-4f2a-87d4-05764a9bc9ec|2|5|6|TREATMENT|2021-08-28|2021-10-23|13|69
Study ID|SE|8fe536c8-85cf-4f2a-87d4-05764a9bc9ec|3|REST|6|WASHOUT|2021-09-19|2021-09-25|35|41
Study ID|SE|8fe536c8-85cf-4f2a-87d4-05764a9bc9ec|4|10|5|TREATMENT|2021-12-25|2022-04-12|132|240
Study ID|SE|8fe536c8-85cf-4f2a-87d4-05764a9bc9ec|5|REST|5|WASHOUT|2021-12-14|2022-01-16|121|154
Study ID|SE|8fe536c8-85cf-4f2a-87d4-05764a9bc9ec|6|P|4|TREATMENT|2021-08-21|2021-10-01|6|47
Study ID|SE|8fe536c8-85cf-4f2a-87d4-05764a9bc9ec|7|FU|4|FOLLOW-UP|2021-11-05|2021-11-07|82|84
Study ID|SE|1951f531-f305-4020-b2f5-1763a5caf825|1|SCRN|3|SCREENING|2022-04-19|2022-04-25|215|221
Study ID|SE|1951f531-f305-4020-b2f5-1763a5caf825|2|5|3|TREATMENT|2022-06-18|2022-06-21|275|278
Study ID|SE|1951f531-f305-4020-b2f5-1763a5caf825|3|REST|6|WASHOUT|2021-10-09|2022-01-08|23|114
Study ID|SE|1951f531-f305-4020-b2f5-1763a5caf825|4|P|6|TREATMENT|2021-11-26|2022-02-02|71|139
Study ID|SE|1951f531-f305-4020-b2f5-1763a5caf825|5|REST|5|WASHOUT|2021-11-01|2021-11-17|46|62
Study ID|SE|1951f531-f305-4020-b2f5-1763a5caf825|6|10|6|TREATMENT|2021-09-29|2022-01-08|13|114
Study ID|SE|1951f531-f305-4020-b2f5-1763a5caf825|7|FU|4|FOLLOW-UP|2022-02-14|2022-04-08|151|204
Study ID|SE|530b8498-6e55-433d-b9b8-0e439fbc2a76|1|SCRN|7|SCREENING|2021-08-25|2022-01-02|7|137
Study ID|SE|530b8498-6e55-433d-b9b8-0e439fbc2a76|2|P|1|TREATMENT|2021-11-22|2021-12-25|96|129
Study ID|SE|530b8498-6e55-433d-b9b8-0e439fbc2a76|3|REST|7|WASHOUT|2021-12-01|2022-03-11|105|205
Study ID|SE|530b8498-6e55-433d-b9b8-0e439fbc2a76|4|5|4|TREATMENT|2022-02-17|2022-06-07|183|293
Study ID|SE|530b8498-6e55-433d-b9b8-0e439fbc2a76|5|REST|5|WASHOUT|2021-11-19|2021-12-27|93|131
Study ID|SE|530b8498-6e55-433d-b9b8-0e439fbc2a76|6|10|4|TREATMENT|2022-02-07|2022-05-23|173|278
Study ID|SE|530b8498-6e55-433d-b9b8-0e439fbc2a76|7|FU|2|FOLLOW-UP|2021-12-05|2022-05-14|109|269
Study ID|SE|9e950611-579d-4c71-afff-2cd2d5dc37a5|1|SCRN|7|SCREENING|2022-03-19|2022-06-29|194|296
Study ID|SE|9e950611-579d-4c71-afff-2cd2d5dc37a5|2|5|4|TREATMENT|2021-10-23|2022-01-09|47|125
Study ID|SE|9e950611-579d-4c71-afff-2cd2d5dc37a5|3|REST|5|WASHOUT|2021-12-15|2022-02-24|100|171
Study ID|SE|9e950611-579d-4c71-afff-2cd2d5dc37a5|4|10|2|TREATMENT|2021-09-13|2021-10-28|7|52
Study ID|SE|9e950611-579d-4c71-afff-2cd2d5dc37a5|5|REST|6|WASHOUT|2021-12-03|2021-12-05|88|90
Study ID|SE|9e950611-579d-4c71-afff-2cd2d5dc37a5|6|P|2|TREATMENT|2021-11-27|2021-12-15|82|100
Study ID|SE|9e950611-579d-4c71-afff-2cd2d5dc37a5|7|FU|2|FOLLOW-UP|2021-09-29|2022-04-02|23|208
Study ID|SE|b44bf72e-cf3c-43ff-a9c0-68a7115fc254|1|SCRN|2|SCREENING|2022-01-17|2022-04-13|89|175
Study ID|SE|b44bf72e-cf3c-43ff-a9c0-68a7115fc254|2|P|2|TREATMENT|2021-12-02|2022-04-08|43|170
Study ID|SE|b44bf72e-cf3c-43ff-a9c0-68a7115fc254|3|REST|6|WASHOUT|2021-11-27|2022-03-09|38|140
Study ID|SE|b44bf72e-cf3c-43ff-a9c0-68a7115fc254|4|5|1|TREATMENT|2021-11-09|2022-03-05|20|136
Study ID|SE|b44bf72e-cf3c-43ff-a9c0-68a7115fc254|5|REST|7|WASHOUT|2022-01-29|2022-05-09|101|201
Study ID|SE|b44bf72e-cf3c-43ff-a9c0-68a7115fc254|6|10|5|TREATMENT|2021-10-24|2021-11-06|4|17
Study ID|SE|b44bf72e-cf3c-43ff-a9c0-68a7115fc254|7|FU|4|FOLLOW-UP|2022-03-02|2022-08-05|133|289
Study ID|SE|e1409bdb-3da1-43e3-bfd5-910e263b4451|1|SCRN|6|SCREENING|2021-11-04|2022-06-10|35|253
Study ID|SE|e1409bdb-3da1-43e3-bfd5-910e263b4451|2|5|3|TREATMENT|2021-10-29|2021-12-21|29|82
Study ID|SE|e1409bdb-3da1-43e3-bfd5-910e263b4451|3|REST|2|WASHOUT|2022-01-16|2022-05-01|108|213
Study ID|SE|e1409bdb-3da1-43e3-bfd5-910e263b4451|4|P|4|TREATMENT|2021-11-02|2022-03-12|33|163
Study ID|SE|e1409bdb-3da1-43e3-bfd5-910e263b4451|5|REST|6|WASHOUT|2021-10-09|2022-03-13|9|164
Study ID|SE|e1409bdb-3da1-43e3-bfd5-910e263b4451|6|10|6|TREATMENT|2021-11-09|2022-01-18|40|110
Study ID|SE|e1409bdb-3da1-43e3-bfd5-910e263b4451|7|FU|1|FOLLOW-UP|2021-10-05|2021-10-08|5|8
Study ID|SE|c814d769-4ae9-4330-9aa3-27726bcf47b1|1|SCRN|5|SCREENING|2021-11-20|2021-12-01|37|48
Study ID|SE|c814d769-4ae9-4330-9aa3-27726bcf47b1|2|P|4|TREATMENT|2021-11-16|2022-01-25|33|103
Study ID|SE|c814d769-4ae9-4330-9aa3-27726bcf47b1|3|REST|3|WASHOUT|2021-10-29|2022-04-07|15|175
Study ID|SE|c814d769-4ae9-4330-9aa3-27726bcf47b1|4|5|2|TREATMENT|2022-02-13|2022-03-08|122|145
Study ID|SE|c814d769-4ae9-4330-9aa3-27726bcf47b1|5|REST|5|WASHOUT|2022-07-04|2022-07-14|263|273
Study ID|SE|c814d769-4ae9-4330-9aa3-27726bcf47b1|6|10|6|TREATMENT|2022-04-08|2022-08-07|176|297
Study ID|SE|c814d769-4ae9-4330-9aa3-27726bcf47b1|7|FU|4|FOLLOW-UP|2021-11-08|2022-04-26|25|194
Study ID|SE|344de0e1-fade-42e7-a779-074a00dfafa0|1|SCRN|3|SCREENING|2021-09-21|2022-02-19|34|185
Study ID|SE|344de0e1-fade-42e7-a779-074a00dfafa0|2|5|1|TREATMENT|2022-02-28|2022-03-31|194|225
Study ID|SE|344de0e1-fade-42e7-a779-074a00dfafa0|3|REST|2|WASHOUT|2021-08-21|2021-12-01|3|105
Study ID|SE|344de0e1-fade-42e7-a779-074a00dfafa0|4|10|5|TREATMENT|2022-02-21|2022-04-09|187|234
Study ID|SE|344de0e1-fade-42e7-a779-074a00dfafa0|5|REST|2|WASHOUT|2021-12-29|2022-04-15|133|240
Study ID|SE|344de0e1-fade-42e7-a779-074a00dfafa0|6|P|5|TREATMENT|2022-03-30|2022-05-05|224|260
Study ID|SE|344de0e1-fade-42e7-a779-074a00dfafa0|7|FU|4|FOLLOW-UP|2021-09-02|2021-10-02|15|45
Study ID|SE|91e53c15-99c3-40da-82f6-cd2ee96ecee6|1|SCRN|2|SCREENING|2021-10-15|2022-04-01|51|219
Study ID|SE|91e53c15-99c3-40da-82f6-cd2ee96ecee6|2|5|7|TREATMENT|2022-01-26|2022-05-09|154|257
Study ID|SE|91e53c15-99c3-40da-82f6-cd2ee96ecee6|3|REST|1|WASHOUT|2021-08-31|2022-06-13|6|292
Study ID|SE|91e53c15-99c3-40da-82f6-cd2ee96ecee6|4|P|1|TREATMENT|2021-09-02|2021-09-22|8|28
Study ID|SE|91e53c15-99c3-40da-82f6-cd2ee96ecee6|5|REST|2|WASHOUT|2021-10-03|2022-03-30|39|217
Study ID|SE|91e53c15-99c3-40da-82f6-cd2ee96ecee6|6|10|1|TREATMENT|2021-09-19|2021-10-14|25|50
Study ID|SE|91e53c15-99c3-40da-82f6-cd2ee96ecee6|7|FU|1|FOLLOW-UP|2021-10-06|2022-03-18|42|205
Study ID|SE|cae377f3-e022-4abe-82a0-2ef6cb6c6b82|1|SCRN|2|SCREENING|2021-10-21|2021-10-30|6|15
Study ID|SE|cae377f3-e022-4abe-82a0-2ef6cb6c6b82|2|5|3|TREATMENT|2022-01-14|2022-04-02|91|169
Study ID|SE|cae377f3-e022-4abe-82a0-2ef6cb6c6b82|3|REST|2|WASHOUT|2021-10-30|2021-10-31|15|16
Study ID|SE|cae377f3-e022-4abe-82a0-2ef6cb6c6b82|4|10|2|TREATMENT|2022-01-20|2022-06-19|97|247
Study ID|SE|cae377f3-e022-4abe-82a0-2ef6cb6c6b82|5|REST|5|WASHOUT|2022-03-03|2022-05-02|139|199
Study ID|SE|cae377f3-e022-4abe-82a0-2ef6cb6c6b82|6|P|4|TREATMENT|2021-11-16|2021-11-26|32|42
Study ID|SE|cae377f3-e022-4abe-82a0-2ef6cb6c6b82|7|FU|1|FOLLOW-UP|2022-01-19|2022-05-18|96|215
Study ID|SE|a945ed2b-40ca-4142-a6d8-6e14451d8a4e|1|SCRN|7|SCREENING|2021-09-12|2021-09-14|4|6
Study ID|SE|a945ed2b-40ca-4142-a6d8-6e14451d8a4e|2|5|5|TREATMENT|2021-12-17|2022-01-28|100|142
Study ID|SE|a945ed2b-40ca-4142-a6d8-6e14451d8a4e|3|REST|2|WASHOUT|2022-05-16|2022-07-03|250|298
Study ID|SE|a945ed2b-40ca-4142-a6d8-6e14451d8a4e|4|10|1|TREATMENT|2021-10-07|2021-11-08|29|61
Study ID|SE|a945ed2b-40ca-4142-a6d8-6e14451d8a4e|5|REST|1|WASHOUT|2021-10-25|2022-02-07|47|152
Study ID|SE|a945ed2b-40ca-4142-a6d8-6e14451d8a4e|6|P|3|TREATMENT|2021-11-08|2022-01-31|61|145
Study ID|SE|a945ed2b-40ca-4142-a6d8-6e14451d8a4e|7|FU|4|FOLLOW-UP|2022-04-05|2022-05-14|209|248
Study ID|SE|d18fdc52-3a8c-4c0c-8839-0dbd23663dc9|1|SCRN|1|SCREENING|2021-11-05|2022-03-12|44|171
Study ID|SE|d18fdc52-3a8c-4c0c-8839-0dbd23663dc9|2|P|4|TREATMENT|2021-12-11|2021-12-17|80|86
Study ID|SE|d18fdc52-3a8c-4c0c-8839-0dbd23663dc9|3|REST|4|WASHOUT|2022-01-21|2022-05-21|121|241
Study ID|SE|d18fdc52-3a8c-4c0c-8839-0dbd23663dc9|4|5|2|TREATMENT|2021-10-03|2021-11-09|11|48
Study ID|SE|d18fdc52-3a8c-4c0c-8839-0dbd23663dc9|5|REST|6|WASHOUT|2021-11-06|2022-03-31|45|190
Study ID|SE|d18fdc52-3a8c-4c0c-8839-0dbd23663dc9|6|10|3|TREATMENT|2021-10-22|2022-01-06|30|106
Study ID|SE|d18fdc52-3a8c-4c0c-8839-0dbd23663dc9|7|FU|5|FOLLOW-UP|2022-03-14|2022-05-21|173|241
Study ID|SE|f97bb27a-15d6-4dea-b575-38574128e3e0|1|SCRN|6|SCREENING|2021-10-06|2022-02-03|28|148
Study ID|SE|f97bb27a-15d6-4dea-b575-38574128e3e0|2|P|6|TREATMENT|2022-03-06|2022-04-14|179|218
Study ID|SE|f97bb27a-15d6-4dea-b575-38574128e3e0|3|REST|5|WASHOUT|2021-09-14|2021-09-20|6|12
Study ID|SE|f97bb27a-15d6-4dea-b575-38574128e3e0|4|5|4|TREATMENT|2021-12-07|2022-06-14|90|279
Study ID|SE|f97bb27a-15d6-4dea-b575-38574128e3e0|5|REST|4|WASHOUT|2021-10-06|2022-04-25|28|229
Study ID|SE|f97bb27a-15d6-4dea-b575-38574128e3e0|6|10|4|TREATMENT|2021-10-09|2021-11-15|31|68
Study ID|SE|f97bb27a-15d6-4dea-b575-38574128e3e0|7|FU|2|FOLLOW-UP|2021-10-17|2021-11-22|39|75
Study ID|SE|7842c627-54d1-4afb-b863-3ef84d7b335a|1|SCRN|2|SCREENING|2021-10-26|2022-02-07|7|111
Study ID|SE|7842c627-54d1-4afb-b863-3ef84d7b335a|2|5|1|TREATMENT|2021-12-19|2022-07-15|61|269
Study ID|SE|7842c627-54d1-4afb-b863-3ef84d7b335a|3|REST|6|WASHOUT|2022-01-14|2022-08-08|87|293
Study ID|SE|7842c627-54d1-4afb-b863-3ef84d7b335a|4|P|3|TREATMENT|2021-10-21|2021-10-23|2|4
Study ID|SE|7842c627-54d1-4afb-b863-3ef84d7b335a|5|REST|1|WASHOUT|2021-10-28|2022-03-02|9|134
Study ID|SE|7842c627-54d1-4afb-b863-3ef84d7b335a|6|10|6|TREATMENT|2022-02-06|2022-04-27|110|190
Study ID|SE|7842c627-54d1-4afb-b863-3ef84d7b335a|7|FU|1|FOLLOW-UP|2021-12-25|2022-06-09|67|233
Study ID|SE|d1fe1ae9-17b7-40dc-8250-67515f6659b8|1|SCRN|7|SCREENING|2021-10-10|2022-02-01|4|118
Study ID|SE|d1fe1ae9-17b7-40dc-8250-67515f6659b8|2|P|4|TREATMENT|2021-12-13|2022-01-26|68|112
Study ID|SE|d1fe1ae9-17b7-40dc-8250-67515f6659b8|3|REST|4|WASHOUT|2022-05-15|2022-07-06|221|273
Study ID|SE|d1fe1ae9-17b7-40dc-8250-67515f6659b8|4|5|2|TREATMENT|2022-04-02|2022-04-15|178|191
Study ID|SE|d1fe1ae9-17b7-40dc-8250-67515f6659b8|5|REST|2|WASHOUT|2022-01-20|2022-03-01|106|146
Study ID|SE|d1fe1ae9-17b7-40dc-8250-67515f6659b8|6|10|5|TREATMENT|2022-04-06|2022-06-11|182|248
Study ID|SE|d1fe1ae9-17b7-40dc-8250-67515f6659b8|7|FU|4|FOLLOW-UP|2021-10-10|2021-10-24|4|18
Study ID|SE|1f438f27-e049-4f32-b59d-2acda0e39316|1|SCRN|1|SCREENING|2022-03-11|2022-06-19|144|244
Study ID|SE|1f438f27-e049-4f32-b59d-2acda0e39316|2|5|1|TREATMENT|2021-11-02|2021-11-26|15|39
Study ID|SE|1f438f27-e049-4f32-b59d-2acda0e39316|3|REST|4|WASHOUT|2022-07-03|2022-08-05|258|291
Study ID|SE|1f438f27-e049-4f32-b59d-2acda0e39316|4|P|6|TREATMENT|2021-12-13|2022-06-09|56|234
Study ID|SE|1f438f27-e049-4f32-b59d-2acda0e39316|5|REST|6|WASHOUT|2021-11-07|2021-11-23|20|36
Study ID|SE|1f438f27-e049-4f32-b59d-2acda0e39316|6|10|6|TREATMENT|2021-10-24|2021-10-29|6|11
Study ID|SE|1f438f27-e049-4f32-b59d-2acda0e39316|7|FU|5|FOLLOW-UP|2022-03-05|2022-04-26|138|190
Study ID|SE|20e1ef99-3101-4fc3-b6c6-f7b7d87f5585|1|SCRN|6|SCREENING|2021-12-11|2022-05-06|105|251
Study ID|SE|20e1ef99-3101-4fc3-b6c6-f7b7d87f5585|2|5|7|TREATMENT|2021-09-26|2022-01-10|29|135
Study ID|SE|20e1ef99-3101-4fc3-b6c6-f7b7d87f5585|3|REST|3|WASHOUT|2022-01-02|2022-05-07|127|252
Study ID|SE|20e1ef99-3101-4fc3-b6c6-f7b7d87f5585|4|P|2|TREATMENT|2022-03-04|2022-03-06|188|190
Study ID|SE|20e1ef99-3101-4fc3-b6c6-f7b7d87f5585|5|REST|6|WASHOUT|2021-10-01|2021-10-21|34|54
Study ID|SE|20e1ef99-3101-4fc3-b6c6-f7b7d87f5585|6|10|1|TREATMENT|2021-08-30|2021-08-30|2|2
Study ID|SE|20e1ef99-3101-4fc3-b6c6-f7b7d87f5585|7|FU|2|FOLLOW-UP|2021-10-16|2021-10-28|49|61
Study ID|SE|030ef2b4-fbd8-4b11-a8af-8d16f2b16007|1|SCRN|2|SCREENING|2021-11-04|2022-06-01|9|218
Study ID|SE|030ef2b4-fbd8-4b11-a8af-8d16f2b16007|2|5|3|TREATMENT|2022-01-23|2022-04-18|89|174
Study ID|SE|030ef2b4-fbd8-4b11-a8af-8d16f2b16007|3|REST|2|WASHOUT|2022-01-29|2022-02-09|95|106
Study ID|SE|030ef2b4-fbd8-4b11-a8af-8d16f2b16007|4|P|3|TREATMENT|2022-04-11|2022-05-06|167|192
Study ID|SE|030ef2b4-fbd8-4b11-a8af-8d16f2b16007|5|REST|6|WASHOUT|2021-10-31|2021-11-09|5|14
Study ID|SE|030ef2b4-fbd8-4b11-a8af-8d16f2b16007|6|10|6|TREATMENT|2022-04-11|2022-05-19|167|205
Study ID|SE|030ef2b4-fbd8-4b11-a8af-8d16f2b16007|7|FU|6|FOLLOW-UP|2021-11-06|2021-11-14|11|19
Study ID|SE|63336123-e50a-4ab9-b5e6-3cabc3743244|1|SCRN|6|SCREENING|2021-10-09|2021-11-08|44|74
Study ID|SE|63336123-e50a-4ab9-b5e6-3cabc3743244|2|5|1|TREATMENT|2021-10-08|2021-10-19|43|54
Study ID|SE|63336123-e50a-4ab9-b5e6-3cabc3743244|3|REST|2|WASHOUT|2021-12-07|2022-05-05|103|252
Study ID|SE|63336123-e50a-4ab9-b5e6-3cabc3743244|4|P|6|TREATMENT|2021-09-19|2022-01-28|24|155
Study ID|SE|63336123-e50a-4ab9-b5e6-3cabc3743244|5|REST|3|WASHOUT|2021-09-14|2022-04-06|19|223
Study ID|SE|63336123-e50a-4ab9-b5e6-3cabc3743244|6|10|5|TREATMENT|2022-02-21|2022-03-07|179|193
Study ID|SE|63336123-e50a-4ab9-b5e6-3cabc3743244|7|FU|1|FOLLOW-UP|2021-09-12|2022-04-09|17|226
Study ID|SE|34a1462e-fa46-4fe0-bcf8-9aec157ecc7e|1|SCRN|1|SCREENING|2022-02-04|2022-04-17|162|234
Study ID|SE|34a1462e-fa46-4fe0-bcf8-9aec157ecc7e|2|5|2|TREATMENT|2021-10-28|2022-01-03|63|130
Study ID|SE|34a1462e-fa46-4fe0-bcf8-9aec157ecc7e|3|REST|4|WASHOUT|2021-12-20|2022-01-29|116|156
Study ID|SE|34a1462e-fa46-4fe0-bcf8-9aec157ecc7e|4|10|2|TREATMENT|2022-01-12|2022-02-26|139|184
Study ID|SE|34a1462e-fa46-4fe0-bcf8-9aec157ecc7e|5|REST|6|WASHOUT|2021-09-01|2021-12-13|6|109
Study ID|SE|34a1462e-fa46-4fe0-bcf8-9aec157ecc7e|6|P|2|TREATMENT|2022-03-08|2022-03-22|194|208
Study ID|SE|34a1462e-fa46-4fe0-bcf8-9aec157ecc7e|7|FU|1|FOLLOW-UP|2021-10-05|2021-12-27|40|123
Study ID|SE|59ffc393-9862-4a7c-af96-c7c27375bc0c|1|SCRN|6|SCREENING|2021-09-12|2021-10-17|18|53
Study ID|SE|59ffc393-9862-4a7c-af96-c7c27375bc0c|2|5|5|TREATMENT|2021-11-07|2022-04-29|74|247
Study ID|SE|59ffc393-9862-4a7c-af96-c7c27375bc0c|3|REST|6|WASHOUT|2021-12-03|2022-05-07|100|255
Study ID|SE|59ffc393-9862-4a7c-af96-c7c27375bc0c|4|10|2|TREATMENT|2021-11-22|2022-02-28|89|187
Study ID|SE|59ffc393-9862-4a7c-af96-c7c27375bc0c|5|REST|5|WASHOUT|2021-10-20|2021-12-05|56|102
Study ID|SE|59ffc393-9862-4a7c-af96-c7c27375bc0c|6|P|7|TREATMENT|2022-03-11|2022-04-01|198|219
Study ID|SE|59ffc393-9862-4a7c-af96-c7c27375bc0c|7|FU|2|FOLLOW-UP|2022-04-12|2022-06-14|230|293
Study ID|SE|2784bbb9-6f8b-450c-97ee-0f05afc7a497|1|SCRN|1|SCREENING|2021-10-31|2022-03-16|34|170
Study ID|SE|2784bbb9-6f8b-450c-97ee-0f05afc7a497|2|P|6|TREATMENT|2021-09-30|2021-10-02|3|5
Study ID|SE|2784bbb9-6f8b-450c-97ee-0f05afc7a497|3|REST|7|WASHOUT|2021-10-14|2021-12-23|17|87
Study ID|SE|2784bbb9-6f8b-450c-97ee-0f05afc7a497|4|5|5|TREATMENT|2021-10-06|2021-10-16|9|19
Study ID|SE|2784bbb9-6f8b-450c-97ee-0f05afc7a497|5|REST|6|WASHOUT|2021-10-09|2021-10-20|12|23
Study ID|SE|2784bbb9-6f8b-450c-97ee-0f05afc7a497|6|10|6|TREATMENT|2021-10-13|2021-11-01|16|35
Study ID|SE|2784bbb9-6f8b-450c-97ee-0f05afc7a497|7|FU|3|FOLLOW-UP|2021-10-01|2021-10-05|4|8
Study ID|SE|e0f7f8f4-bc53-457a-b1e7-334d80be8ce5|1|SCRN|5|SCREENING|2021-11-26|2022-01-06|77|118
Study ID|SE|e0f7f8f4-bc53-457a-b1e7-334d80be8ce5|2|P|6|TREATMENT|2021-10-04|2021-10-08|24|28
Study ID|SE|e0f7f8f4-bc53-457a-b1e7-334d80be8ce5|3|REST|2|WASHOUT|2021-11-07|2022-04-22|58|224
Study ID|SE|e0f7f8f4-bc53-457a-b1e7-334d80be8ce5|4|5|6|TREATMENT|2021-09-15|2021-10-30|5|50
Study ID|SE|e0f7f8f4-bc53-457a-b1e7-334d80be8ce5|5|REST|2|WASHOUT|2021-09-23|2021-10-13|13|33
Study ID|SE|e0f7f8f4-bc53-457a-b1e7-334d80be8ce5|6|10|1|TREATMENT|2021-10-13|2021-11-01|33|52
Study ID|SE|e0f7f8f4-bc53-457a-b1e7-334d80be8ce5|7|FU|3|FOLLOW-UP|2021-11-04|2022-03-05|55|176
Study ID|SE|2e012a0a-8b8d-4c4b-93bc-9c4856d84648|1|SCRN|1|SCREENING|2022-03-04|2022-03-09|177|182
Study ID|SE|2e012a0a-8b8d-4c4b-93bc-9c4856d84648|2|5|6|TREATMENT|2021-12-24|2022-03-13|107|186
Study ID|SE|2e012a0a-8b8d-4c4b-93bc-9c4856d84648|3|REST|3|WASHOUT|2022-06-05|2022-06-07|270|272
Study ID|SE|2e012a0a-8b8d-4c4b-93bc-9c4856d84648|4|10|1|TREATMENT|2021-11-28|2021-12-19|81|102
Study ID|SE|2e012a0a-8b8d-4c4b-93bc-9c4856d84648|5|REST|1|WASHOUT|2022-02-06|2022-02-07|151|152
Study ID|SE|2e012a0a-8b8d-4c4b-93bc-9c4856d84648|6|P|7|TREATMENT|2021-09-10|2021-09-11|2|3
Study ID|SE|2e012a0a-8b8d-4c4b-93bc-9c4856d84648|7|FU|4|FOLLOW-UP|2022-04-27|2022-04-28|231|232
Study ID|SE|9c7788ce-b9c4-4410-8cd1-e3acb135fe30|1|SCRN|4|SCREENING|2021-10-11|2021-12-10|7|67
Study ID|SE|9c7788ce-b9c4-4410-8cd1-e3acb135fe30|2|5|5|TREATMENT|2021-10-07|2021-12-27|3|84
Study ID|SE|9c7788ce-b9c4-4410-8cd1-e3acb135fe30|3|REST|7|WASHOUT|2021-10-10|2022-06-30|6|269
Study ID|SE|9c7788ce-b9c4-4410-8cd1-e3acb135fe30|4|P|2|TREATMENT|2021-10-23|2021-10-25|19|21
Study ID|SE|9c7788ce-b9c4-4410-8cd1-e3acb135fe30|5|REST|3|WASHOUT|2022-04-02|2022-06-07|180|246
Study ID|SE|9c7788ce-b9c4-4410-8cd1-e3acb135fe30|6|10|1|TREATMENT|2022-02-12|2022-04-27|131|205
Study ID|SE|9c7788ce-b9c4-4410-8cd1-e3acb135fe30|7|FU|2|FOLLOW-UP|2021-11-15|2021-11-21|42|48
Study ID|SE|08a80286-6add-4dce-bbe6-b82cc0acc896|1|SCRN|1|SCREENING|2021-11-29|2022-01-04|44|80
Study ID|SE|08a80286-6add-4dce-bbe6-b82cc0acc896|2|5|1|TREATMENT|2022-02-15|2022-06-23|122|250
Study ID|SE|08a80286-6add-4dce-bbe6-b82cc0acc896|3|REST|6|WASHOUT|2021-10-24|2022-01-31|8|107
Study ID|SE|08a80286-6add-4dce-bbe6-b82cc0acc896|4|10|3|TREATMENT|2022-01-23|2022-01-28|99|104
Study ID|SE|08a80286-6add-4dce-bbe6-b82cc0acc896|5|REST|6|WASHOUT|2022-01-17|2022-03-07|93|142
Study ID|SE|08a80286-6add-4dce-bbe6-b82cc0acc896|6|P|3|TREATMENT|2022-03-01|2022-03-28|136|163
Study ID|SE|08a80286-6add-4dce-bbe6-b82cc0acc896|7|FU|4|FOLLOW-UP|2021-12-01|2022-05-15|46|211
Study ID|SE|6fbbc5b9-1a74-40d0-9448-41e909dd41a4|1|SCRN|6|SCREENING|2021-11-21|2022-07-11|32|264
Study ID|SE|6fbbc5b9-1a74-40d0-9448-41e909dd41a4|2|5|2|TREATMENT|2022-05-11|2022-06-20|203|243
Study ID|SE|6fbbc5b9-1a74-40d0-9448-41e909dd41a4|3|REST|5|WASHOUT|2021-10-24|2021-11-16|4|27
Study ID|SE|6fbbc5b9-1a74-40d0-9448-41e909dd41a4|4|P|7|TREATMENT|2022-06-08|2022-08-08|231|292
Study ID|SE|6fbbc5b9-1a74-40d0-9448-41e909dd41a4|5|REST|5|WASHOUT|2021-11-12|2022-05-25|23|217
Study ID|SE|6fbbc5b9-1a74-40d0-9448-41e909dd41a4|6|10|1|TREATMENT|2021-11-08|2022-06-29|19|252
Study ID|SE|6fbbc5b9-1a74-40d0-9448-41e909dd41a4|7|FU|2|FOLLOW-UP|2022-02-19|2022-04-23|122|185
Study ID|SE|ad425a12-3cf4-4946-8f9b-daae4296fa21|1|SCRN|2|SCREENING|2022-03-14|2022-05-22|141|210
Study ID|SE|ad425a12-3cf4-4946-8f9b-daae4296fa21|2|5|3|TREATMENT|2021-12-10|2022-03-20|47|147
Study ID|SE|ad425a12-3cf4-4946-8f9b-daae4296fa21|3|REST|5|WASHOUT|2021-10-26|2021-12-05|2|42
Study ID|SE|ad425a12-3cf4-4946-8f9b-daae4296fa21|4|P|7|TREATMENT|2021-11-17|2021-12-16|24|53
Study ID|SE|ad425a12-3cf4-4946-8f9b-daae4296fa21|5|REST|3|WASHOUT|2021-11-29|2021-12-08|36|45
Study ID|SE|ad425a12-3cf4-4946-8f9b-daae4296fa21|6|10|7|TREATMENT|2022-01-05|2022-07-16|73|265
Study ID|SE|ad425a12-3cf4-4946-8f9b-daae4296fa21|7|FU|4|FOLLOW-UP|2022-01-10|2022-05-03|78|191
Study ID|SE|bf793505-2348-407b-bcf6-813e5bcb71f3|1|SCRN|2|SCREENING|2021-11-01|2022-03-04|71|194
Study ID|SE|bf793505-2348-407b-bcf6-813e5bcb71f3|2|5|7|TREATMENT|2021-10-12|2022-04-04|51|225
Study ID|SE|bf793505-2348-407b-bcf6-813e5bcb71f3|3|REST|6|WASHOUT|2022-02-06|2022-03-24|168|214
Study ID|SE|bf793505-2348-407b-bcf6-813e5bcb71f3|4|10|6|TREATMENT|2021-09-30|2021-10-26|39|65
Study ID|SE|bf793505-2348-407b-bcf6-813e5bcb71f3|5|REST|1|WASHOUT|2021-12-29|2022-01-06|129|137
Study ID|SE|bf793505-2348-407b-bcf6-813e5bcb71f3|6|P|5|TREATMENT|2021-09-22|2021-10-25|31|64
Study ID|SE|bf793505-2348-407b-bcf6-813e5bcb71f3|7|FU|7|FOLLOW-UP|2021-09-06|2021-11-17|15|87
Study ID|SE|b2fc787c-4951-4884-b680-e7c57416c68d|1|SCRN|7|SCREENING|2022-02-18|2022-02-25|183|190
Study ID|SE|b2fc787c-4951-4884-b680-e7c57416c68d|2|5|5|TREATMENT|2021-09-23|2021-11-17|35|90
Study ID|SE|b2fc787c-4951-4884-b680-e7c57416c68d|3|REST|7|WASHOUT|2022-01-08|2022-05-25|142|279
Study ID|SE|b2fc787c-4951-4884-b680-e7c57416c68d|4|P|7|TREATMENT|2022-02-11|2022-03-31|176|224
Study ID|SE|b2fc787c-4951-4884-b680-e7c57416c68d|5|REST|3|WASHOUT|2021-12-02|2022-02-08|105|173
Study ID|SE|b2fc787c-4951-4884-b680-e7c57416c68d|6|10|7|TREATMENT|2022-03-09|2022-03-30|202|223
Study ID|SE|b2fc787c-4951-4884-b680-e7c57416c68d|7|FU|3|FOLLOW-UP|2021-08-30|2021-11-22|11|95
Study ID|SE|7587dc09-07b9-4d28-a07c-c173ee7f785f|1|SCRN|7|SCREENING|2022-03-26|2022-04-03|226|234
Study ID|SE|7587dc09-07b9-4d28-a07c-c173ee7f785f|2|P|6|TREATMENT|2021-09-13|2021-12-05|32|115
Study ID|SE|7587dc09-07b9-4d28-a07c-c173ee7f785f|3|REST|7|WASHOUT|2021-09-24|2021-11-04|43|84
Study ID|SE|7587dc09-07b9-4d28-a07c-c173ee7f785f|4|5|6|TREATMENT|2021-10-02|2021-11-15|51|95
Study ID|SE|7587dc09-07b9-4d28-a07c-c173ee7f785f|5|REST|7|WASHOUT|2021-08-15|2022-01-08|3|149
Study ID|SE|7587dc09-07b9-4d28-a07c-c173ee7f785f|6|10|6|TREATMENT|2021-09-01|2021-09-06|20|25
Study ID|SE|7587dc09-07b9-4d28-a07c-c173ee7f785f|7|FU|1|FOLLOW-UP|2022-01-19|2022-01-25|160|166
Study ID|SE|9bfee219-aaa1-48c3-a971-5cb6fe2f930e|1|SCRN|5|SCREENING|2022-03-07|2022-03-17|181|191
Study ID|SE|9bfee219-aaa1-48c3-a971-5cb6fe2f930e|2|P|2|TREATMENT|2021-09-13|2021-10-03|6|26
Study ID|SE|9bfee219-aaa1-48c3-a971-5cb6fe2f930e|3|REST|4|WASHOUT|2021-10-01|2021-12-04|24|88
Study ID|SE|9bfee219-aaa1-48c3-a971-5cb6fe2f930e|4|5|1|TREATMENT|2022-03-01|2022-03-22|175|196
Study ID|SE|9bfee219-aaa1-48c3-a971-5cb6fe2f930e|5|REST|7|WASHOUT|2021-11-29|2022-03-30|83|204
Study ID|SE|9bfee219-aaa1-48c3-a971-5cb6fe2f930e|6|10|1|TREATMENT|2021-11-13|2021-12-15|67|99
Study ID|SE|9bfee219-aaa1-48c3-a971-5cb6fe2f930e|7|FU|3|FOLLOW-UP|2021-11-09|2022-04-19|63|224
Study ID|SE|657a8fa7-8788-4993-bd8d-d2e86a4572b7|1|SCRN|3|SCREENING|2021-10-21|2021-12-06|45|91
Study ID|SE|657a8fa7-8788-4993-bd8d-d2e86a4572b7|2|5|3|TREATMENT|2021-11-25|2022-05-06|80|242
Study ID|SE|657a8fa7-8788-4993-bd8d-d2e86a4572b7|3|REST|2|WASHOUT|2021-10-28|2021-12-01|52|86
Study ID|SE|657a8fa7-8788-4993-bd8d-d2e86a4572b7|4|P|1|TREATMENT|2021-10-17|2021-10-27|41|51
Study ID|SE|657a8fa7-8788-4993-bd8d-d2e86a4572b7|5|REST|2|WASHOUT|2021-10-04|2022-01-02|28|118
Study ID|SE|657a8fa7-8788-4993-bd8d-d2e86a4572b7|6|10|7|TREATMENT|2021-09-28|2021-10-18|22|42
Study ID|SE|657a8fa7-8788-4993-bd8d-d2e86a4572b7|7|FU|6|FOLLOW-UP|2021-09-09|2021-09-11|3|5
Study ID|SE|f25b0eae-0a80-472f-94b8-c5d4f35ea9ee|1|SCRN|4|SCREENING|2021-08-29|2022-04-10|6|230
Study ID|SE|f25b0eae-0a80-472f-94b8-c5d4f35ea9ee|2|P|7|TREATMENT|2022-01-08|2022-06-12|138|293
Study ID|SE|f25b0eae-0a80-472f-94b8-c5d4f35ea9ee|3|REST|3|WASHOUT|2021-08-28|2021-08-30|5|7
Study ID|SE|f25b0eae-0a80-472f-94b8-c5d4f35ea9ee|4|5|2|TREATMENT|2021-09-29|2021-10-18|37|56
Study ID|SE|f25b0eae-0a80-472f-94b8-c5d4f35ea9ee|5|REST|7|WASHOUT|2021-10-17|2021-12-13|55|112
Study ID|SE|f25b0eae-0a80-472f-94b8-c5d4f35ea9ee|6|10|7|TREATMENT|2022-01-01|2022-01-15|131|145
Study ID|SE|f25b0eae-0a80-472f-94b8-c5d4f35ea9ee|7|FU|4|FOLLOW-UP|2021-12-25|2022-02-01|124|162
Study ID|SE|3b1ec433-5317-4320-a601-36e1c72db8c7|1|SCRN|1|SCREENING|2022-01-25|2022-02-11|111|128
Study ID|SE|3b1ec433-5317-4320-a601-36e1c72db8c7|2|5|6|TREATMENT|2021-12-21|2022-03-02|76|147
Study ID|SE|3b1ec433-5317-4320-a601-36e1c72db8c7|3|REST|6|WASHOUT|2021-12-31|2022-04-20|86|196
Study ID|SE|3b1ec433-5317-4320-a601-36e1c72db8c7|4|10|7|TREATMENT|2021-11-04|2022-07-01|29|268
Study ID|SE|3b1ec433-5317-4320-a601-36e1c72db8c7|5|REST|4|WASHOUT|2021-10-09|2022-04-29|3|205
Study ID|SE|3b1ec433-5317-4320-a601-36e1c72db8c7|6|P|7|TREATMENT|2022-03-04|2022-03-15|149|160
Study ID|SE|3b1ec433-5317-4320-a601-36e1c72db8c7|7|FU|4|FOLLOW-UP|2021-11-26|2022-02-21|51|138
Study ID|SE|fbadb011-97b4-4423-bf72-8bb4774381e4|1|SCRN|6|SCREENING|2021-11-13|2021-11-14|60|61
Study ID|SE|fbadb011-97b4-4423-bf72-8bb4774381e4|2|5|3|TREATMENT|2022-01-29|2022-03-24|137|191
Study ID|SE|fbadb011-97b4-4423-bf72-8bb4774381e4|3|REST|5|WASHOUT|2022-04-20|2022-05-13|218|241
Study ID|SE|fbadb011-97b4-4423-bf72-8bb4774381e4|4|10|5|TREATMENT|2021-10-01|2022-01-04|17|112
Study ID|SE|fbadb011-97b4-4423-bf72-8bb4774381e4|5|REST|4|WASHOUT|2021-09-18|2021-11-06|4|53
Study ID|SE|fbadb011-97b4-4423-bf72-8bb4774381e4|6|P|1|TREATMENT|2021-11-15|2021-12-09|62|86
Study ID|SE|fbadb011-97b4-4423-bf72-8bb4774381e4|7|FU|5|FOLLOW-UP|2021-11-30|2022-02-06|77|145
Study ID|SE|3ae6412f-08b1-4d32-97da-58e3176856b5|1|SCRN|6|SCREENING|2021-09-21|2021-10-03|44|56
Study ID|SE|3ae6412f-08b1-4d32-97da-58e3176856b5|2|P|3|TREATMENT|2021-12-25|2022-03-10|139|214
Study ID|SE|3ae6412f-08b1-4d32-97da-58e3176856b5|3|REST|3|WASHOUT|2021-08-10|2021-08-10|2|2
Study ID|SE|3ae6412f-08b1-4d32-97da-58e3176856b5|4|5|3|TREATMENT|2021-11-20|2021-12-06|104|120
Study ID|SE|3ae6412f-08b1-4d32-97da-58e3176856b5|5|REST|3|WASHOUT|2021-09-01|2021-09-03|24|26
Study ID|SE|3ae6412f-08b1-4d32-97da-58e3176856b5|6|10|2|TREATMENT|2021-09-09|2021-09-19|32|42
Study ID|SE|3ae6412f-08b1-4d32-97da-58e3176856b5|7|FU|1|FOLLOW-UP|2021-11-29|2022-01-31|113|176
Study ID|SE|c11083b3-523d-451c-9e98-4f4738c45b7a|1|SCRN|4|SCREENING|2021-11-18|2021-12-07|68|87
Study ID|SE|c11083b3-523d-451c-9e98-4f4738c45b7a|2|5|7|TREATMENT|2021-12-07|2021-12-23|87|103
Study ID|SE|c11083b3-523d-451c-9e98-4f4738c45b7a|3|REST|6|WASHOUT|2022-02-17|2022-04-26|159|227
Study ID|SE|c11083b3-523d-451c-9e98-4f4738c45b7a|4|10|6|TREATMENT|2022-03-17|2022-03-23|187|193
Study ID|SE|c11083b3-523d-451c-9e98-4f4738c45b7a|5|REST|5|WASHOUT|2021-11-07|2022-05-24|57|255
Study ID|SE|c11083b3-523d-451c-9e98-4f4738c45b7a|6|P|3|TREATMENT|2022-02-27|2022-07-05|169|297
Study ID|SE|c11083b3-523d-451c-9e98-4f4738c45b7a|7|FU|5|FOLLOW-UP|2022-02-10|2022-03-29|152|199
Study ID|SE|8c41ca81-05e8-42a1-86aa-fdf787ba5ba9|1|SCRN|7|SCREENING|2021-10-07|2021-10-10|25|28
Study ID|SE|8c41ca81-05e8-42a1-86aa-fdf787ba5ba9|2|5|6|TREATMENT|2022-01-10|2022-04-15|120|215
Study ID|SE|8c41ca81-05e8-42a1-86aa-fdf787ba5ba9|3|REST|1|WASHOUT|2022-01-31|2022-02-22|141|163
Study ID|SE|8c41ca81-05e8-42a1-86aa-fdf787ba5ba9|4|10|1|TREATMENT|2021-10-14|2021-10-20|32|38
Study ID|SE|8c41ca81-05e8-42a1-86aa-fdf787ba5ba9|5|REST|1|WASHOUT|2021-10-28|2022-05-06|46|236
Study ID|SE|8c41ca81-05e8-42a1-86aa-fdf787ba5ba9|6|P|6|TREATMENT|2021-11-14|2022-03-16|63|185
Study ID|SE|8c41ca81-05e8-42a1-86aa-fdf787ba5ba9|7|FU|6|FOLLOW-UP|2021-10-19|2022-04-19|37|219
Study ID|SE|409a8a8f-13e0-4929-a97e-14daef23bef6|1|SCRN|1|SCREENING|2021-11-01|2021-11-03|55|57
Study ID|SE|409a8a8f-13e0-4929-a97e-14daef23bef6|2|5|6|TREATMENT|2021-10-14|2021-11-20|37|74
Study ID|SE|409a8a8f-13e0-4929-a97e-14daef23bef6|3|REST|3|WASHOUT|2022-04-21|2022-05-30|226|265
Study ID|SE|409a8a8f-13e0-4929-a97e-14daef23bef6|4|P|7|TREATMENT|2021-11-08|2022-04-08|62|213
Study ID|SE|409a8a8f-13e0-4929-a97e-14daef23bef6|5|REST|2|WASHOUT|2021-09-09|2021-10-27|2|50
Study ID|SE|409a8a8f-13e0-4929-a97e-14daef23bef6|6|10|4|TREATMENT|2021-11-01|2022-03-29|55|203
Study ID|SE|409a8a8f-13e0-4929-a97e-14daef23bef6|7|FU|7|FOLLOW-UP|2021-10-10|2021-12-04|33|88
Study ID|SE|da4ebea3-ae83-4370-b62a-a96db1b12b94|1|SCRN|3|SCREENING|2021-11-22|2021-12-08|33|49
Study ID|SE|da4ebea3-ae83-4370-b62a-a96db1b12b94|2|5|2|TREATMENT|2021-11-19|2022-01-28|30|100
Study ID|SE|da4ebea3-ae83-4370-b62a-a96db1b12b94|3|REST|4|WASHOUT|2022-04-19|2022-04-23|181|185
Study ID|SE|da4ebea3-ae83-4370-b62a-a96db1b12b94|4|10|6|TREATMENT|2021-10-25|2022-06-20|5|243
Study ID|SE|da4ebea3-ae83-4370-b62a-a96db1b12b94|5|REST|1|WASHOUT|2022-04-29|2022-06-04|191|227
Study ID|SE|da4ebea3-ae83-4370-b62a-a96db1b12b94|6|P|6|TREATMENT|2021-11-17|2022-02-17|28|120
Study ID|SE|da4ebea3-ae83-4370-b62a-a96db1b12b94|7|FU|5|FOLLOW-UP|2021-11-19|2021-12-15|30|56
Study ID|SE|cf675c93-71a6-4e6d-bb9e-4cb880f39d0c|1|SCRN|1|SCREENING|2021-12-28|2022-02-26|134|194
Study ID|SE|cf675c93-71a6-4e6d-bb9e-4cb880f39d0c|2|5|1|TREATMENT|2021-08-28|2021-08-30|12|14
Study ID|SE|cf675c93-71a6-4e6d-bb9e-4cb880f39d0c|3|REST|4|WASHOUT|2021-10-06|2021-12-10|51|116
Study ID|SE|cf675c93-71a6-4e6d-bb9e-4cb880f39d0c|4|10|3|TREATMENT|2022-01-02|2022-02-01|139|169
Study ID|SE|cf675c93-71a6-4e6d-bb9e-4cb880f39d0c|5|REST|6|WASHOUT|2022-01-20|2022-04-23|157|250
Study ID|SE|cf675c93-71a6-4e6d-bb9e-4cb880f39d0c|6|P|5|TREATMENT|2021-12-18|2022-04-28|124|255
Study ID|SE|cf675c93-71a6-4e6d-bb9e-4cb880f39d0c|7|FU|1|FOLLOW-UP|2021-10-10|2022-04-16|55|243
Study ID|SE|2c2d051b-9dd9-4899-8ddb-b2f00f97c046|1|SCRN|3|SCREENING|2022-01-06|2022-01-20|74|88
Study ID|SE|2c2d051b-9dd9-4899-8ddb-b2f00f97c046|2|P|6|TREATMENT|2022-02-18|2022-05-22|117|210
Study ID|SE|2c2d051b-9dd9-4899-8ddb-b2f00f97c046|3|REST|2|WASHOUT|2021-10-30|2022-03-07|6|134
Study ID|SE|2c2d051b-9dd9-4899-8ddb-b2f00f97c046|4|5|6|TREATMENT|2022-01-20|2022-05-02|88|190
Study ID|SE|2c2d051b-9dd9-4899-8ddb-b2f00f97c046|5|REST|6|WASHOUT|2021-11-07|2021-11-14|14|21
Study ID|SE|2c2d051b-9dd9-4899-8ddb-b2f00f97c046|6|10|1|TREATMENT|2021-11-05|2021-11-07|12|14
Study ID|SE|2c2d051b-9dd9-4899-8ddb-b2f00f97c046|7|FU|7|FOLLOW-UP|2022-01-22|2022-05-05|90|193
Study ID|SE|fcac6ec4-f62f-48ef-9f90-5342ea4bcd5c|1|SCRN|4|SCREENING|2021-11-11|2022-01-11|54|115
Study ID|SE|fcac6ec4-f62f-48ef-9f90-5342ea4bcd5c|2|5|6|TREATMENT|2021-11-22|2022-06-06|65|261
Study ID|SE|fcac6ec4-f62f-48ef-9f90-5342ea4bcd5c|3|REST|2|WASHOUT|2021-10-30|2021-12-03|42|76
Study ID|SE|fcac6ec4-f62f-48ef-9f90-5342ea4bcd5c|4|10|1|TREATMENT|2021-10-23|2021-11-18|35|61
Study ID|SE|fcac6ec4-f62f-48ef-9f90-5342ea4bcd5c|5|REST|1|WASHOUT|2021-12-03|2022-03-17|76|180
Study ID|SE|fcac6ec4-f62f-48ef-9f90-5342ea4bcd5c|6|P|3|TREATMENT|2022-01-01|2022-01-16|105|120
Study ID|SE|fcac6ec4-f62f-48ef-9f90-5342ea4bcd5c|7|FU|7|FOLLOW-UP|2021-12-22|2022-01-26|95|130
Study ID|SE|4d8033a3-b04e-4f93-b644-75caca7d00bc|1|SCRN|1|SCREENING|2021-08-24|2021-09-14|6|27
Study ID|SE|4d8033a3-b04e-4f93-b644-75caca7d00bc|2|5|4|TREATMENT|2021-09-06|2021-11-19|19|93
Study ID|SE|4d8033a3-b04e-4f93-b644-75caca7d00bc|3|REST|1|WASHOUT|2021-10-08|2022-03-27|51|221
Study ID|SE|4d8033a3-b04e-4f93-b644-75caca7d00bc|4|10|1|TREATMENT|2021-08-20|2021-08-25|2|7
Study ID|SE|4d8033a3-b04e-4f93-b644-75caca7d00bc|5|REST|1|WASHOUT|2021-11-13|2021-11-15|87|89
Study ID|SE|4d8033a3-b04e-4f93-b644-75caca7d00bc|6|P|2|TREATMENT|2022-01-28|2022-05-20|163|275
Study ID|SE|4d8033a3-b04e-4f93-b644-75caca7d00bc|7|FU|7|FOLLOW-UP|2021-11-30|2022-02-04|104|170
Study ID|SE|febce16b-a7bd-4d15-8686-5d9c021c8062|1|SCRN|2|SCREENING|2021-11-07|2021-12-12|13|48
Study ID|SE|febce16b-a7bd-4d15-8686-5d9c021c8062|2|P|1|TREATMENT|2022-06-15|2022-08-03|233|282
Study ID|SE|febce16b-a7bd-4d15-8686-5d9c021c8062|3|REST|7|WASHOUT|2022-07-12|2022-08-20|260|299
Study ID|SE|febce16b-a7bd-4d15-8686-5d9c021c8062|4|5|4|TREATMENT|2021-10-31|2021-12-09|6|45
Study ID|SE|febce16b-a7bd-4d15-8686-5d9c021c8062|5|REST|6|WASHOUT|2022-02-28|2022-05-18|126|205
Study ID|SE|febce16b-a7bd-4d15-8686-5d9c021c8062|6|10|6|TREATMENT|2021-11-23|2022-05-05|29|192
Study ID|SE|febce16b-a7bd-4d15-8686-5d9c021c8062|7|FU|3|FOLLOW-UP|2021-11-03|2021-12-05|9|41
Study ID|SE|88704a8c-b2f9-4b83-ac37-be443121d27f|1|SCRN|4|SCREENING|2021-11-26|2022-01-29|81|145
Study ID|SE|88704a8c-b2f9-4b83-ac37-be443121d27f|2|5|4|TREATMENT|2021-09-24|2021-12-08|18|93
Study ID|SE|88704a8c-b2f9-4b83-ac37-be443121d27f|3|REST|3|WASHOUT|2021-10-09|2021-10-21|33|45
Study ID|SE|88704a8c-b2f9-4b83-ac37-be443121d27f|4|10|4|TREATMENT|2021-09-10|2022-04-30|4|236
Study ID|SE|88704a8c-b2f9-4b83-ac37-be443121d27f|5|REST|3|WASHOUT|2021-12-09|2022-04-23|94|229
Study ID|SE|88704a8c-b2f9-4b83-ac37-be443121d27f|6|P|3|TREATMENT|2021-09-30|2021-10-18|24|42
Study ID|SE|88704a8c-b2f9-4b83-ac37-be443121d27f|7|FU|4|FOLLOW-UP|2021-11-24|2021-11-29|79|84
Study ID|SE|ef5270fe-24e3-4df8-9e0a-b64a033828fe|1|SCRN|3|SCREENING|2022-04-30|2022-05-14|242|256
Study ID|SE|ef5270fe-24e3-4df8-9e0a-b64a033828fe|2|P|1|TREATMENT|2021-09-05|2021-09-07|5|7
Study ID|SE|ef5270fe-24e3-4df8-9e0a-b64a033828fe|3|REST|2|WASHOUT|2021-10-13|2021-11-02|43|63
Study ID|SE|ef5270fe-24e3-4df8-9e0a-b64a033828fe|4|5|6|TREATMENT|2021-12-10|2022-04-04|101|216
Study ID|SE|ef5270fe-24e3-4df8-9e0a-b64a033828fe|5|REST|6|WASHOUT|2021-09-12|2022-02-12|12|165
Study ID|SE|ef5270fe-24e3-4df8-9e0a-b64a033828fe|6|10|4|TREATMENT|2022-01-02|2022-03-28|124|209
Study ID|SE|ef5270fe-24e3-4df8-9e0a-b64a033828fe|7|FU|3|FOLLOW-UP|2022-01-29|2022-02-19|151|172
Study ID|SE|f9aa875f-6ddd-4fe9-80ca-e12ab3d12f45|1|SCRN|6|SCREENING|2021-09-02|2021-10-16|21|65
Study ID|SE|f9aa875f-6ddd-4fe9-80ca-e12ab3d12f45|2|5|3|TREATMENT|2021-10-12|2022-04-24|61|255
Study ID|SE|f9aa875f-6ddd-4fe9-80ca-e12ab3d12f45|3|REST|7|WASHOUT|2021-09-06|2021-10-19|25|68
Study ID|SE|f9aa875f-6ddd-4fe9-80ca-e12ab3d12f45|4|10|5|TREATMENT|2021-08-24|2022-02-17|12|189
Study ID|SE|f9aa875f-6ddd-4fe9-80ca-e12ab3d12f45|5|REST|7|WASHOUT|2021-09-02|2021-10-10|21|59
Study ID|SE|f9aa875f-6ddd-4fe9-80ca-e12ab3d12f45|6|P|6|TREATMENT|2022-04-26|2022-06-02|257|294
Study ID|SE|f9aa875f-6ddd-4fe9-80ca-e12ab3d12f45|7|FU|5|FOLLOW-UP|2021-09-29|2021-11-23|48|103
Study ID|SE|ffe35386-c166-44f6-8fdb-f1feae2b078e|1|SCRN|2|SCREENING|2021-08-12|2021-12-17|5|132
Study ID|SE|ffe35386-c166-44f6-8fdb-f1feae2b078e|2|P|1|TREATMENT|2021-08-11|2021-10-15|4|69
Study ID|SE|ffe35386-c166-44f6-8fdb-f1feae2b078e|3|REST|5|WASHOUT|2022-04-22|2022-05-26|258|292
Study ID|SE|ffe35386-c166-44f6-8fdb-f1feae2b078e|4|5|7|TREATMENT|2021-08-14|2021-11-10|7|95
Study ID|SE|ffe35386-c166-44f6-8fdb-f1feae2b078e|5|REST|5|WASHOUT|2021-08-09|2021-08-12|2|5
Study ID|SE|ffe35386-c166-44f6-8fdb-f1feae2b078e|6|10|6|TREATMENT|2021-11-16|2021-12-06|101|121
Study ID|SE|ffe35386-c166-44f6-8fdb-f1feae2b078e|7|FU|2|FOLLOW-UP|2021-10-25|2021-10-27|79|81
Study ID|SE|df12b0b6-0854-4fb9-8b90-f87021c31013|1|SCRN|5|SCREENING|2021-12-20|2022-03-14|69|153
Study ID|SE|df12b0b6-0854-4fb9-8b90-f87021c31013|2|5|7|TREATMENT|2021-10-24|2022-06-08|12|239
Study ID|SE|df12b0b6-0854-4fb9-8b90-f87021c31013|3|REST|1|WASHOUT|2022-03-31|2022-05-07|170|207
Study ID|SE|df12b0b6-0854-4fb9-8b90-f87021c31013|4|10|1|TREATMENT|2021-11-12|2022-02-17|31|128
Study ID|SE|df12b0b6-0854-4fb9-8b90-f87021c31013|5|REST|5|WASHOUT|2022-05-01|2022-05-27|201|227
Study ID|SE|df12b0b6-0854-4fb9-8b90-f87021c31013|6|P|5|TREATMENT|2022-02-02|2022-07-17|113|278
Study ID|SE|df12b0b6-0854-4fb9-8b90-f87021c31013|7|FU|7|FOLLOW-UP|2021-11-18|2021-11-22|37|41
Study ID|SE|1baa76bc-cc44-42cf-9585-0fda2afe6740|1|SCRN|6|SCREENING|2021-10-31|2021-12-11|45|86
Study ID|SE|1baa76bc-cc44-42cf-9585-0fda2afe6740|2|5|3|TREATMENT|2022-04-11|2022-04-29|207|225
Study ID|SE|1baa76bc-cc44-42cf-9585-0fda2afe6740|3|REST|3|WASHOUT|2021-09-18|2021-09-19|2|3
Study ID|SE|1baa76bc-cc44-42cf-9585-0fda2afe6740|4|10|2|TREATMENT|2021-09-20|2021-12-15|4|90
Study ID|SE|1baa76bc-cc44-42cf-9585-0fda2afe6740|5|REST|1|WASHOUT|2022-03-04|2022-06-19|169|276
Study ID|SE|1baa76bc-cc44-42cf-9585-0fda2afe6740|6|P|4|TREATMENT|2021-12-25|2021-12-31|100|106
Study ID|SE|1baa76bc-cc44-42cf-9585-0fda2afe6740|7|FU|4|FOLLOW-UP|2022-04-01|2022-07-07|197|294
Study ID|SE|46265849-9afc-4952-b01d-aa593948576f|1|SCRN|5|SCREENING|2021-10-28|2022-04-21|38|213
Study ID|SE|46265849-9afc-4952-b01d-aa593948576f|2|P|3|TREATMENT|2021-10-30|2021-12-04|40|75
Study ID|SE|46265849-9afc-4952-b01d-aa593948576f|3|REST|7|WASHOUT|2022-01-19|2022-01-24|121|126
Study ID|SE|46265849-9afc-4952-b01d-aa593948576f|4|5|2|TREATMENT|2022-02-17|2022-04-23|150|215
Study ID|SE|46265849-9afc-4952-b01d-aa593948576f|5|REST|1|WASHOUT|2021-12-30|2022-07-10|101|293
Study ID|SE|46265849-9afc-4952-b01d-aa593948576f|6|10|3|TREATMENT|2022-01-23|2022-02-26|125|159
Study ID|SE|46265849-9afc-4952-b01d-aa593948576f|7|FU|1|FOLLOW-UP|2021-12-07|2022-03-11|78|172
Study ID|SE|ed5681ef-04ae-4c9c-8af0-998801808ec0|1|SCRN|6|SCREENING|2021-09-03|2021-09-05|2|4
Study ID|SE|ed5681ef-04ae-4c9c-8af0-998801808ec0|2|P|6|TREATMENT|2021-11-08|2021-12-30|68|120
Study ID|SE|ed5681ef-04ae-4c9c-8af0-998801808ec0|3|REST|1|WASHOUT|2021-09-07|2021-09-24|6|23
Study ID|SE|ed5681ef-04ae-4c9c-8af0-998801808ec0|4|5|2|TREATMENT|2021-09-05|2021-09-06|4|5
Study ID|SE|ed5681ef-04ae-4c9c-8af0-998801808ec0|5|REST|7|WASHOUT|2021-10-24|2021-12-10|53|100
Study ID|SE|ed5681ef-04ae-4c9c-8af0-998801808ec0|6|10|2|TREATMENT|2022-05-06|2022-06-27|247|299
Study ID|SE|ed5681ef-04ae-4c9c-8af0-998801808ec0|7|FU|3|FOLLOW-UP|2021-09-24|2022-04-15|23|226
Study ID|SE|dc5e28e0-8e0f-4fea-9c63-170cb52a5514|1|SCRN|7|SCREENING|2021-11-20|2021-12-03|42|55
Study ID|SE|dc5e28e0-8e0f-4fea-9c63-170cb52a5514|2|5|2|TREATMENT|2022-03-21|2022-05-23|163|226
Study ID|SE|dc5e28e0-8e0f-4fea-9c63-170cb52a5514|3|REST|2|WASHOUT|2021-10-20|2021-11-26|11|48
Study ID|SE|dc5e28e0-8e0f-4fea-9c63-170cb52a5514|4|10|3|TREATMENT|2022-03-25|2022-05-25|167|228
Study ID|SE|dc5e28e0-8e0f-4fea-9c63-170cb52a5514|5|REST|7|WASHOUT|2021-12-30|2022-02-06|82|120
Study ID|SE|dc5e28e0-8e0f-4fea-9c63-170cb52a5514|6|P|5|TREATMENT|2021-11-23|2021-11-24|45|46
Study ID|SE|dc5e28e0-8e0f-4fea-9c63-170cb52a5514|7|FU|7|FOLLOW-UP|2021-10-14|2021-10-15|5|6
Study ID|SE|eeb49ee5-dca4-49c0-bc17-899504023412|1|SCRN|4|SCREENING|2021-10-29|2021-11-20|42|64
Study ID|SE|eeb49ee5-dca4-49c0-bc17-899504023412|2|P|1|TREATMENT|2021-09-23|2021-10-18|6|31
Study ID|SE|eeb49ee5-dca4-49c0-bc17-899504023412|3|REST|7|WASHOUT|2021-10-20|2022-04-21|33|216
Study ID|SE|eeb49ee5-dca4-49c0-bc17-899504023412|4|5|4|TREATMENT|2021-10-03|2022-01-11|16|116
Study ID|SE|eeb49ee5-dca4-49c0-bc17-899504023412|5|REST|5|WASHOUT|2021-10-23|2022-04-21|36|216
Study ID|SE|eeb49ee5-dca4-49c0-bc17-899504023412|6|10|1|TREATMENT|2022-05-27|2022-06-02|252|258
Study ID|SE|eeb49ee5-dca4-49c0-bc17-899504023412|7|FU|2|FOLLOW-UP|2022-02-11|2022-06-05|147|261
Study ID|SE|bdbcca7f-96e4-4ab3-a10c-433fb2f1b647|1|SCRN|6|SCREENING|2021-09-14|2021-09-17|2|5
Study ID|SE|bdbcca7f-96e4-4ab3-a10c-433fb2f1b647|2|5|5|TREATMENT|2021-10-06|2021-11-22|24|71
Study ID|SE|bdbcca7f-96e4-4ab3-a10c-433fb2f1b647|3|REST|3|WASHOUT|2021-09-24|2021-10-08|12|26
Study ID|SE|bdbcca7f-96e4-4ab3-a10c-433fb2f1b647|4|10|6|TREATMENT|2021-10-16|2022-05-10|34|240
Study ID|SE|bdbcca7f-96e4-4ab3-a10c-433fb2f1b647|5|REST|7|WASHOUT|2021-10-23|2022-01-04|41|114
Study ID|SE|bdbcca7f-96e4-4ab3-a10c-433fb2f1b647|6|P|1|TREATMENT|2021-11-07|2022-02-24|56|165
Study ID|SE|bdbcca7f-96e4-4ab3-a10c-433fb2f1b647|7|FU|5|FOLLOW-UP|2022-01-06|2022-06-12|116|273
Study ID|SE|b9309a9f-6f69-4d99-aab1-aed10a722e77|1|SCRN|5|SCREENING|2022-04-02|2022-06-11|205|275
Study ID|SE|b9309a9f-6f69-4d99-aab1-aed10a722e77|2|5|6|TREATMENT|2021-09-15|2021-10-05|6|26
Study ID|SE|b9309a9f-6f69-4d99-aab1-aed10a722e77|3|REST|6|WASHOUT|2022-02-18|2022-07-01|162|295
Study ID|SE|b9309a9f-6f69-4d99-aab1-aed10a722e77|4|P|3|TREATMENT|2022-01-18|2022-07-05|131|299
Study ID|SE|b9309a9f-6f69-4d99-aab1-aed10a722e77|5|REST|3|WASHOUT|2021-10-15|2022-01-16|36|129
Study ID|SE|b9309a9f-6f69-4d99-aab1-aed10a722e77|6|10|4|TREATMENT|2021-09-22|2021-10-05|13|26
Study ID|SE|b9309a9f-6f69-4d99-aab1-aed10a722e77|7|FU|6|FOLLOW-UP|2022-01-31|2022-03-13|144|185
Study ID|SE|3ca9e210-6f76-4881-b538-f8ce79ccfc57|1|SCRN|7|SCREENING|2021-12-02|2021-12-10|79|87
Study ID|SE|3ca9e210-6f76-4881-b538-f8ce79ccfc57|2|5|5|TREATMENT|2021-10-20|2021-10-23|36|39
Study ID|SE|3ca9e210-6f76-4881-b538-f8ce79ccfc57|3|REST|6|WASHOUT|2021-09-28|2021-12-26|14|103
Study ID|SE|3ca9e210-6f76-4881-b538-f8ce79ccfc57|4|10|7|TREATMENT|2021-10-01|2021-11-23|17|70
Study ID|SE|3ca9e210-6f76-4881-b538-f8ce79ccfc57|5|REST|2|WASHOUT|2022-02-18|2022-02-27|157|166
Study ID|SE|3ca9e210-6f76-4881-b538-f8ce79ccfc57|6|P|4|TREATMENT|2021-10-09|2022-01-26|25|134
Study ID|SE|3ca9e210-6f76-4881-b538-f8ce79ccfc57|7|FU|7|FOLLOW-UP|2021-10-06|2022-01-16|22|124
Study ID|SE|2821bf2d-e4d8-483c-8f7d-37d44889728d|1|SCRN|1|SCREENING|2021-11-06|2022-03-10|88|212
Study ID|SE|2821bf2d-e4d8-483c-8f7d-37d44889728d|2|5|3|TREATMENT|2021-08-27|2021-12-09|17|121
Study ID|SE|2821bf2d-e4d8-483c-8f7d-37d44889728d|3|REST|7|WASHOUT|2021-08-21|2022-03-22|11|224
Study ID|SE|2821bf2d-e4d8-483c-8f7d-37d44889728d|4|10|5|TREATMENT|2022-01-19|2022-01-22|162|165
Study ID|SE|2821bf2d-e4d8-483c-8f7d-37d44889728d|5|REST|7|WASHOUT|2021-12-11|2022-01-23|123|166
Study ID|SE|2821bf2d-e4d8-483c-8f7d-37d44889728d|6|P|2|TREATMENT|2021-11-14|2022-02-24|96|198
Study ID|SE|2821bf2d-e4d8-483c-8f7d-37d44889728d|7|FU|3|FOLLOW-UP|2021-10-29|2022-05-13|80|276
Study ID|SE|6d516ba5-96b3-4cfe-91a1-a350569866c6|1|SCRN|6|SCREENING|2022-03-19|2022-07-29|141|273
Study ID|SE|6d516ba5-96b3-4cfe-91a1-a350569866c6|2|5|5|TREATMENT|2021-11-06|2022-01-04|8|67
Study ID|SE|6d516ba5-96b3-4cfe-91a1-a350569866c6|3|REST|2|WASHOUT|2021-11-23|2021-12-15|25|47
Study ID|SE|6d516ba5-96b3-4cfe-91a1-a350569866c6|4|10|2|TREATMENT|2022-07-19|2022-08-23|263|298
Study ID|SE|6d516ba5-96b3-4cfe-91a1-a350569866c6|5|REST|2|WASHOUT|2021-11-09|2022-03-16|11|138
Study ID|SE|6d516ba5-96b3-4cfe-91a1-a350569866c6|6|P|4|TREATMENT|2021-12-13|2022-03-19|45|141
Study ID|SE|6d516ba5-96b3-4cfe-91a1-a350569866c6|7|FU|2|FOLLOW-UP|2021-12-03|2022-02-20|35|114
Study ID|SE|c217b3ca-addb-4c12-95f2-b58583bedcd8|1|SCRN|1|SCREENING|2021-12-21|2022-06-18|106|285
Study ID|SE|c217b3ca-addb-4c12-95f2-b58583bedcd8|2|P|5|TREATMENT|2021-12-25|2022-05-16|110|252
Study ID|SE|c217b3ca-addb-4c12-95f2-b58583bedcd8|3|REST|6|WASHOUT|2021-11-15|2022-05-01|70|237
Study ID|SE|c217b3ca-addb-4c12-95f2-b58583bedcd8|4|5|1|TREATMENT|2021-09-14|2021-11-01|8|56
Study ID|SE|c217b3ca-addb-4c12-95f2-b58583bedcd8|5|REST|1|WASHOUT|2021-09-18|2021-12-26|12|111
Study ID|SE|c217b3ca-addb-4c12-95f2-b58583bedcd8|6|10|3|TREATMENT|2021-09-30|2021-10-17|24|41
Study ID|SE|c217b3ca-addb-4c12-95f2-b58583bedcd8|7|FU|4|FOLLOW-UP|2022-05-29|2022-06-06|265|273
Study ID|SE|abb79778-ee30-4e6e-8da6-315ed44f1e86|1|SCRN|3|SCREENING|2022-07-28|2022-08-04|272|279
Study ID|SE|abb79778-ee30-4e6e-8da6-315ed44f1e86|2|5|1|TREATMENT|2022-01-04|2022-01-06|67|69
Study ID|SE|abb79778-ee30-4e6e-8da6-315ed44f1e86|3|REST|4|WASHOUT|2021-11-27|2021-12-02|29|34
Study ID|SE|abb79778-ee30-4e6e-8da6-315ed44f1e86|4|10|7|TREATMENT|2022-01-12|2022-07-13|75|257
Study ID|SE|abb79778-ee30-4e6e-8da6-315ed44f1e86|5|REST|1|WASHOUT|2022-04-19|2022-06-17|172|231
Study ID|SE|abb79778-ee30-4e6e-8da6-315ed44f1e86|6|P|5|TREATMENT|2021-10-31|2022-07-23|2|267
Study ID|SE|abb79778-ee30-4e6e-8da6-315ed44f1e86|7|FU|1|FOLLOW-UP|2022-03-09|2022-03-27|131|149
Study ID|SE|9e2c3174-5021-49a6-86c1-4a95ca7ea2dc|1|SCRN|2|SCREENING|2021-09-16|2021-12-14|11|100
Study ID|SE|9e2c3174-5021-49a6-86c1-4a95ca7ea2dc|2|P|1|TREATMENT|2021-11-09|2022-06-06|65|274
Study ID|SE|9e2c3174-5021-49a6-86c1-4a95ca7ea2dc|3|REST|7|WASHOUT|2021-10-21|2021-12-30|46|116
Study ID|SE|9e2c3174-5021-49a6-86c1-4a95ca7ea2dc|4|5|4|TREATMENT|2022-02-28|2022-06-12|176|280
Study ID|SE|9e2c3174-5021-49a6-86c1-4a95ca7ea2dc|5|REST|7|WASHOUT|2021-09-26|2021-12-20|21|106
Study ID|SE|9e2c3174-5021-49a6-86c1-4a95ca7ea2dc|6|10|7|TREATMENT|2021-12-06|2021-12-17|92|103
Study ID|SE|9e2c3174-5021-49a6-86c1-4a95ca7ea2dc|7|FU|1|FOLLOW-UP|2021-11-01|2021-12-09|57|95
Study ID|SE|8c1c8309-1e5d-4293-9657-3a1f4f1d4e4f|1|SCRN|4|SCREENING|2021-10-22|2022-05-30|20|240
Study ID|SE|8c1c8309-1e5d-4293-9657-3a1f4f1d4e4f|2|5|1|TREATMENT|2021-12-21|2022-03-03|80|152
Study ID|SE|8c1c8309-1e5d-4293-9657-3a1f4f1d4e4f|3|REST|5|WASHOUT|2021-12-01|2022-06-18|60|259
Study ID|SE|8c1c8309-1e5d-4293-9657-3a1f4f1d4e4f|4|10|2|TREATMENT|2021-10-29|2021-11-25|27|54
Study ID|SE|8c1c8309-1e5d-4293-9657-3a1f4f1d4e4f|5|REST|2|WASHOUT|2022-05-10|2022-06-11|220|252
Study ID|SE|8c1c8309-1e5d-4293-9657-3a1f4f1d4e4f|6|P|5|TREATMENT|2022-02-20|2022-06-05|141|246
Study ID|SE|8c1c8309-1e5d-4293-9657-3a1f4f1d4e4f|7|FU|2|FOLLOW-UP|2022-05-09|2022-05-15|219|225
Study ID|SE|c0e615c3-b9cb-469c-83e0-6e2e96b96e82|1|SCRN|4|SCREENING|2022-01-11|2022-04-30|85|194
Study ID|SE|c0e615c3-b9cb-469c-83e0-6e2e96b96e82|2|5|3|TREATMENT|2021-12-02|2022-01-05|45|79
Study ID|SE|c0e615c3-b9cb-469c-83e0-6e2e96b96e82|3|REST|6|WASHOUT|2021-11-20|2022-02-09|33|114
Study ID|SE|c0e615c3-b9cb-469c-83e0-6e2e96b96e82|4|P|6|TREATMENT|2022-05-08|2022-05-29|202|223
Study ID|SE|c0e615c3-b9cb-469c-83e0-6e2e96b96e82|5|REST|4|WASHOUT|2022-02-05|2022-06-06|110|231
Study ID|SE|c0e615c3-b9cb-469c-83e0-6e2e96b96e82|6|10|5|TREATMENT|2021-11-28|2022-02-07|41|112
Study ID|SE|c0e615c3-b9cb-469c-83e0-6e2e96b96e82|7|FU|7|FOLLOW-UP|2022-02-13|2022-08-07|118|293
Study ID|SE|980b659c-8a12-4dd9-b589-f3492331fc70|1|SCRN|5|SCREENING|2021-12-25|2022-01-26|139|171
Study ID|SE|980b659c-8a12-4dd9-b589-f3492331fc70|2|5|6|TREATMENT|2022-04-09|2022-05-02|244|267
Study ID|SE|980b659c-8a12-4dd9-b589-f3492331fc70|3|REST|6|WASHOUT|2022-01-21|2022-04-03|166|238
Study ID|SE|980b659c-8a12-4dd9-b589-f3492331fc70|4|10|1|TREATMENT|2021-09-22|2021-12-26|45|140
Study ID|SE|980b659c-8a12-4dd9-b589-f3492331fc70|5|REST|4|WASHOUT|2022-01-14|2022-01-26|159|171
Study ID|SE|980b659c-8a12-4dd9-b589-f3492331fc70|6|P|3|TREATMENT|2022-03-29|2022-04-14|233|249
Study ID|SE|980b659c-8a12-4dd9-b589-f3492331fc70|7|FU|1|FOLLOW-UP|2021-09-08|2022-02-09|31|185
Study ID|SE|c2f0ff14-ddad-46d2-a2cd-30ff2c6b6481|1|SCRN|6|SCREENING|2021-12-17|2022-03-03|126|202
Study ID|SE|c2f0ff14-ddad-46d2-a2cd-30ff2c6b6481|2|5|4|TREATMENT|2021-11-10|2021-12-26|89|135
Study ID|SE|c2f0ff14-ddad-46d2-a2cd-30ff2c6b6481|3|REST|3|WASHOUT|2021-08-28|2022-05-22|15|282
Study ID|SE|c2f0ff14-ddad-46d2-a2cd-30ff2c6b6481|4|P|2|TREATMENT|2021-11-17|2021-12-26|96|135
Study ID|SE|c2f0ff14-ddad-46d2-a2cd-30ff2c6b6481|5|REST|5|WASHOUT|2021-09-04|2021-09-19|22|37
Study ID|SE|c2f0ff14-ddad-46d2-a2cd-30ff2c6b6481|6|10|6|TREATMENT|2021-08-24|2021-10-02|11|50
Study ID|SE|c2f0ff14-ddad-46d2-a2cd-30ff2c6b6481|7|FU|4|FOLLOW-UP|2022-01-20|2022-06-05|160|296
Study ID|SE|0c97f3b3-9c2c-40a9-b101-c692977ceaef|1|SCRN|2|SCREENING|2021-11-15|2022-01-05|49|100
Study ID|SE|0c97f3b3-9c2c-40a9-b101-c692977ceaef|2|5|5|TREATMENT|2022-03-21|2022-06-06|175|252
Study ID|SE|0c97f3b3-9c2c-40a9-b101-c692977ceaef|3|REST|4|WASHOUT|2022-07-01|2022-07-09|277|285
Study ID|SE|0c97f3b3-9c2c-40a9-b101-c692977ceaef|4|10|4|TREATMENT|2021-10-26|2021-12-09|29|73
Study ID|SE|0c97f3b3-9c2c-40a9-b101-c692977ceaef|5|REST|6|WASHOUT|2021-09-29|2021-10-03|2|6
Study ID|SE|0c97f3b3-9c2c-40a9-b101-c692977ceaef|6|P|5|TREATMENT|2021-11-24|2022-04-10|58|195
Study ID|SE|0c97f3b3-9c2c-40a9-b101-c692977ceaef|7|FU|1|FOLLOW-UP|2021-11-20|2022-03-24|54|178
Study ID|SE|b02ce526-b4bb-49e3-ad64-7c3ccc43f4a5|1|SCRN|1|SCREENING|2021-11-15|2021-12-26|26|67
Study ID|SE|b02ce526-b4bb-49e3-ad64-7c3ccc43f4a5|2|5|1|TREATMENT|2022-01-26|2022-02-28|98|131
Study ID|SE|b02ce526-b4bb-49e3-ad64-7c3ccc43f4a5|3|REST|7|WASHOUT|2022-01-22|2022-05-13|94|205
Study ID|SE|b02ce526-b4bb-49e3-ad64-7c3ccc43f4a5|4|10|3|TREATMENT|2021-12-26|2022-02-02|67|105
Study ID|SE|b02ce526-b4bb-49e3-ad64-7c3ccc43f4a5|5|REST|6|WASHOUT|2021-12-31|2022-02-24|72|127
Study ID|SE|b02ce526-b4bb-49e3-ad64-7c3ccc43f4a5|6|P|7|TREATMENT|2021-12-04|2022-03-27|45|158
Study ID|SE|b02ce526-b4bb-49e3-ad64-7c3ccc43f4a5|7|FU|6|FOLLOW-UP|2022-01-21|2022-04-28|93|190
Study ID|SE|44d7d97c-25b9-4c6b-991b-2fed8b476263|1|SCRN|7|SCREENING|2022-01-09|2022-01-11|86|88
Study ID|SE|44d7d97c-25b9-4c6b-991b-2fed8b476263|2|5|6|TREATMENT|2022-02-07|2022-04-09|115|176
Study ID|SE|44d7d97c-25b9-4c6b-991b-2fed8b476263|3|REST|3|WASHOUT|2021-12-17|2021-12-26|63|72
Study ID|SE|44d7d97c-25b9-4c6b-991b-2fed8b476263|4|P|2|TREATMENT|2021-10-24|2021-10-25|9|10
Study ID|SE|44d7d97c-25b9-4c6b-991b-2fed8b476263|5|REST|6|WASHOUT|2021-12-07|2022-05-15|53|212
Study ID|SE|44d7d97c-25b9-4c6b-991b-2fed8b476263|6|10|3|TREATMENT|2022-02-12|2022-05-18|120|215
Study ID|SE|44d7d97c-25b9-4c6b-991b-2fed8b476263|7|FU|6|FOLLOW-UP|2022-02-04|2022-06-04|112|232
Study ID|SE|a81fca99-3517-4b04-ad22-6bfee2a1cc49|1|SCRN|3|SCREENING|2022-01-27|2022-03-12|154|198
Study ID|SE|a81fca99-3517-4b04-ad22-6bfee2a1cc49|2|5|7|TREATMENT|2021-09-03|2021-09-04|8|9
Study ID|SE|a81fca99-3517-4b04-ad22-6bfee2a1cc49|3|REST|3|WASHOUT|2022-02-10|2022-02-22|168|180
Study ID|SE|a81fca99-3517-4b04-ad22-6bfee2a1cc49|4|P|4|TREATMENT|2021-09-16|2021-10-03|21|38
Study ID|SE|a81fca99-3517-4b04-ad22-6bfee2a1cc49|5|REST|1|WASHOUT|2021-09-03|2021-11-18|8|84
Study ID|SE|a81fca99-3517-4b04-ad22-6bfee2a1cc49|6|10|3|TREATMENT|2021-09-07|2021-10-18|12|53
Study ID|SE|a81fca99-3517-4b04-ad22-6bfee2a1cc49|7|FU|4|FOLLOW-UP|2022-02-17|2022-04-06|175|223
Study ID|SE|cf2dc23d-bb37-49c1-9cab-a1b06cbda411|1|SCRN|6|SCREENING|2022-03-15|2022-06-28|152|257
Study ID|SE|cf2dc23d-bb37-49c1-9cab-a1b06cbda411|2|5|3|TREATMENT|2021-12-14|2022-04-03|61|171
Study ID|SE|cf2dc23d-bb37-49c1-9cab-a1b06cbda411|3|REST|2|WASHOUT|2022-04-15|2022-08-02|183|292
Study ID|SE|cf2dc23d-bb37-49c1-9cab-a1b06cbda411|4|10|2|TREATMENT|2021-12-19|2022-02-18|66|127
Study ID|SE|cf2dc23d-bb37-49c1-9cab-a1b06cbda411|5|REST|4|WASHOUT|2021-10-27|2021-11-12|13|29
Study ID|SE|cf2dc23d-bb37-49c1-9cab-a1b06cbda411|6|P|4|TREATMENT|2021-11-25|2021-11-29|42|46
Study ID|SE|cf2dc23d-bb37-49c1-9cab-a1b06cbda411|7|FU|5|FOLLOW-UP|2022-02-27|2022-03-16|136|153
Study ID|SE|8e034ca3-fc19-427a-82ff-f12581d19619|1|SCRN|5|SCREENING|2022-04-27|2022-07-11|211|286
Study ID|SE|8e034ca3-fc19-427a-82ff-f12581d19619|2|5|4|TREATMENT|2021-12-17|2022-02-22|80|147
Study ID|SE|8e034ca3-fc19-427a-82ff-f12581d19619|3|REST|6|WASHOUT|2022-01-29|2022-02-12|123|137
Study ID|SE|8e034ca3-fc19-427a-82ff-f12581d19619|4|P|5|TREATMENT|2021-11-02|2022-03-10|35|163
Study ID|SE|8e034ca3-fc19-427a-82ff-f12581d19619|5|REST|6|WASHOUT|2021-10-19|2022-03-05|21|158
Study ID|SE|8e034ca3-fc19-427a-82ff-f12581d19619|6|10|4|TREATMENT|2022-01-31|2022-04-24|125|208
Study ID|SE|8e034ca3-fc19-427a-82ff-f12581d19619|7|FU|1|FOLLOW-UP|2021-12-20|2022-03-26|83|179
Study ID|SE|9a0f0a03-746a-49bc-8ef6-a2b206506aa1|1|SCRN|4|SCREENING|2022-03-15|2022-05-18|200|264
Study ID|SE|9a0f0a03-746a-49bc-8ef6-a2b206506aa1|2|5|2|TREATMENT|2022-04-18|2022-05-03|234|249
Study ID|SE|9a0f0a03-746a-49bc-8ef6-a2b206506aa1|3|REST|6|WASHOUT|2021-08-30|2021-09-18|3|22
Study ID|SE|9a0f0a03-746a-49bc-8ef6-a2b206506aa1|4|10|1|TREATMENT|2021-09-30|2021-11-03|34|68
Study ID|SE|9a0f0a03-746a-49bc-8ef6-a2b206506aa1|5|REST|4|WASHOUT|2022-03-09|2022-06-14|194|291
Study ID|SE|9a0f0a03-746a-49bc-8ef6-a2b206506aa1|6|P|7|TREATMENT|2022-02-19|2022-05-07|176|253
Study ID|SE|9a0f0a03-746a-49bc-8ef6-a2b206506aa1|7|FU|7|FOLLOW-UP|2022-04-01|2022-05-16|217|262
Study ID|SE|2e11edef-2791-410b-8089-96bdfc9b73d7|1|SCRN|7|SCREENING|2021-10-20|2022-01-20|29|121
Study ID|SE|2e11edef-2791-410b-8089-96bdfc9b73d7|2|P|5|TREATMENT|2021-11-18|2021-12-03|58|73
Study ID|SE|2e11edef-2791-410b-8089-96bdfc9b73d7|3|REST|1|WASHOUT|2021-12-26|2022-04-19|96|210
Study ID|SE|2e11edef-2791-410b-8089-96bdfc9b73d7|4|5|6|TREATMENT|2022-02-07|2022-02-15|139|147
Study ID|SE|2e11edef-2791-410b-8089-96bdfc9b73d7|5|REST|4|WASHOUT|2022-02-03|2022-04-30|135|221
Study ID|SE|2e11edef-2791-410b-8089-96bdfc9b73d7|6|10|2|TREATMENT|2021-11-04|2022-05-31|44|252
Study ID|SE|2e11edef-2791-410b-8089-96bdfc9b73d7|7|FU|2|FOLLOW-UP|2022-02-12|2022-02-16|144|148
Study ID|SE|d232c4af-8771-45b6-8727-a5a00e2085d4|1|SCRN|5|SCREENING|2021-12-30|2022-04-26|101|218
Study ID|SE|d232c4af-8771-45b6-8727-a5a00e2085d4|2|5|5|TREATMENT|2021-09-23|2022-02-06|3|139
Study ID|SE|d232c4af-8771-45b6-8727-a5a00e2085d4|3|REST|1|WASHOUT|2021-12-09|2022-01-24|80|126
Study ID|SE|d232c4af-8771-45b6-8727-a5a00e2085d4|4|P|1|TREATMENT|2021-12-24|2022-07-01|95|284
Study ID|SE|d232c4af-8771-45b6-8727-a5a00e2085d4|5|REST|2|WASHOUT|2021-12-06|2022-01-09|77|111
Study ID|SE|d232c4af-8771-45b6-8727-a5a00e2085d4|6|10|5|TREATMENT|2021-11-23|2022-02-24|64|157
Study ID|SE|d232c4af-8771-45b6-8727-a5a00e2085d4|7|FU|6|FOLLOW-UP|2021-10-05|2021-11-24|15|65
Study ID|SE|4910eeaa-f945-4c7a-94ac-c7f1d9456ff8|1|SCRN|4|SCREENING|2022-01-02|2022-04-12|68|168
Study ID|SE|4910eeaa-f945-4c7a-94ac-c7f1d9456ff8|2|5|7|TREATMENT|2021-12-16|2022-02-11|51|108
Study ID|SE|4910eeaa-f945-4c7a-94ac-c7f1d9456ff8|3|REST|6|WASHOUT|2021-12-29|2022-03-25|64|150
Study ID|SE|4910eeaa-f945-4c7a-94ac-c7f1d9456ff8|4|10|6|TREATMENT|2021-11-19|2022-06-18|24|235
Study ID|SE|4910eeaa-f945-4c7a-94ac-c7f1d9456ff8|5|REST|3|WASHOUT|2021-12-14|2022-03-30|49|155
Study ID|SE|4910eeaa-f945-4c7a-94ac-c7f1d9456ff8|6|P|3|TREATMENT|2021-11-22|2022-02-01|27|98
Study ID|SE|4910eeaa-f945-4c7a-94ac-c7f1d9456ff8|7|FU|6|FOLLOW-UP|2022-04-03|2022-04-17|159|173
Study ID|SE|eaf2a5bb-519b-4d63-be7c-a33be121f5c7|1|SCRN|1|SCREENING|2021-08-17|2021-08-22|4|9
Study ID|SE|eaf2a5bb-519b-4d63-be7c-a33be121f5c7|2|5|6|TREATMENT|2021-11-24|2022-03-04|103|203
Study ID|SE|eaf2a5bb-519b-4d63-be7c-a33be121f5c7|3|REST|4|WASHOUT|2021-09-05|2021-10-23|23|71
Study ID|SE|eaf2a5bb-519b-4d63-be7c-a33be121f5c7|4|10|4|TREATMENT|2021-09-11|2021-09-22|29|40
Study ID|SE|eaf2a5bb-519b-4d63-be7c-a33be121f5c7|5|REST|1|WASHOUT|2021-08-17|2021-08-25|4|12
Study ID|SE|eaf2a5bb-519b-4d63-be7c-a33be121f5c7|6|P|3|TREATMENT|2021-09-03|2021-09-26|21|44
Study ID|SE|eaf2a5bb-519b-4d63-be7c-a33be121f5c7|7|FU|4|FOLLOW-UP|2022-03-05|2022-05-25|204|285
Study ID|SE|d131691d-6cc7-4fb9-92b8-e82d6c286389|1|SCRN|1|SCREENING|2021-10-13|2022-03-17|6|161
Study ID|SE|d131691d-6cc7-4fb9-92b8-e82d6c286389|2|5|4|TREATMENT|2022-02-11|2022-07-07|127|273
Study ID|SE|d131691d-6cc7-4fb9-92b8-e82d6c286389|3|REST|1|WASHOUT|2022-01-09|2022-01-21|94|106
Study ID|SE|d131691d-6cc7-4fb9-92b8-e82d6c286389|4|P|4|TREATMENT|2022-01-02|2022-07-13|87|279
Study ID|SE|d131691d-6cc7-4fb9-92b8-e82d6c286389|5|REST|5|WASHOUT|2022-02-17|2022-05-08|133|213
Study ID|SE|d131691d-6cc7-4fb9-92b8-e82d6c286389|6|10|6|TREATMENT|2022-02-10|2022-03-12|126|156
Study ID|SE|d131691d-6cc7-4fb9-92b8-e82d6c286389|7|FU|4|FOLLOW-UP|2022-01-03|2022-01-14|88|99
Study ID|SE|a2284a75-da2f-4157-bcc3-8c19d8aa91a2|1|SCRN|3|SCREENING|2021-10-31|2021-11-30|57|87
Study ID|SE|a2284a75-da2f-4157-bcc3-8c19d8aa91a2|2|5|2|TREATMENT|2021-11-29|2022-02-11|86|160
Study ID|SE|a2284a75-da2f-4157-bcc3-8c19d8aa91a2|3|REST|7|WASHOUT|2021-09-06|2021-11-16|2|73
Study ID|SE|a2284a75-da2f-4157-bcc3-8c19d8aa91a2|4|P|4|TREATMENT|2022-01-11|2022-01-30|129|148
Study ID|SE|a2284a75-da2f-4157-bcc3-8c19d8aa91a2|5|REST|6|WASHOUT|2022-02-26|2022-03-03|175|180
Study ID|SE|a2284a75-da2f-4157-bcc3-8c19d8aa91a2|6|10|5|TREATMENT|2022-01-14|2022-03-18|132|195
Study ID|SE|a2284a75-da2f-4157-bcc3-8c19d8aa91a2|7|FU|7|FOLLOW-UP|2022-01-26|2022-06-27|144|296
Study ID|SE|96690d2c-8ee6-4217-b728-4f3963e78c0f|1|SCRN|5|SCREENING|2021-09-23|2021-09-29|4|10
Study ID|SE|96690d2c-8ee6-4217-b728-4f3963e78c0f|2|5|3|TREATMENT|2021-09-22|2021-09-29|3|10
Study ID|SE|96690d2c-8ee6-4217-b728-4f3963e78c0f|3|REST|1|WASHOUT|2021-12-29|2022-07-05|101|289
Study ID|SE|96690d2c-8ee6-4217-b728-4f3963e78c0f|4|P|1|TREATMENT|2021-10-06|2022-01-22|17|125
Study ID|SE|96690d2c-8ee6-4217-b728-4f3963e78c0f|5|REST|6|WASHOUT|2021-10-03|2021-11-24|14|66
Study ID|SE|96690d2c-8ee6-4217-b728-4f3963e78c0f|6|10|5|TREATMENT|2022-06-05|2022-07-08|259|292
Study ID|SE|96690d2c-8ee6-4217-b728-4f3963e78c0f|7|FU|2|FOLLOW-UP|2022-03-04|2022-05-24|166|247
Study ID|SE|dc2d731e-5302-4b55-a0fd-126cac25413e|1|SCRN|3|SCREENING|2021-09-30|2021-11-21|2|54
Study ID|SE|dc2d731e-5302-4b55-a0fd-126cac25413e|2|P|7|TREATMENT|2022-01-12|2022-05-11|106|225
Study ID|SE|dc2d731e-5302-4b55-a0fd-126cac25413e|3|REST|6|WASHOUT|2022-03-09|2022-04-26|162|210
Study ID|SE|dc2d731e-5302-4b55-a0fd-126cac25413e|4|5|1|TREATMENT|2021-11-21|2022-04-20|54|204
Study ID|SE|dc2d731e-5302-4b55-a0fd-126cac25413e|5|REST|5|WASHOUT|2022-02-08|2022-02-15|133|140
Study ID|SE|dc2d731e-5302-4b55-a0fd-126cac25413e|6|10|1|TREATMENT|2022-04-12|2022-05-01|196|215
Study ID|SE|dc2d731e-5302-4b55-a0fd-126cac25413e|7|FU|3|FOLLOW-UP|2021-12-24|2022-07-17|87|292
Study ID|SE|baf33df4-7387-411e-8239-ecd5bc2aa3dc|1|SCRN|4|SCREENING|2021-11-25|2022-05-30|33|219
Study ID|SE|baf33df4-7387-411e-8239-ecd5bc2aa3dc|2|5|7|TREATMENT|2021-12-23|2022-06-20|61|240
Study ID|SE|baf33df4-7387-411e-8239-ecd5bc2aa3dc|3|REST|3|WASHOUT|2022-03-23|2022-06-12|151|232
Study ID|SE|baf33df4-7387-411e-8239-ecd5bc2aa3dc|4|10|7|TREATMENT|2021-10-26|2021-12-23|3|61
Study ID|SE|baf33df4-7387-411e-8239-ecd5bc2aa3dc|5|REST|1|WASHOUT|2021-11-16|2022-01-06|24|75
Study ID|SE|baf33df4-7387-411e-8239-ecd5bc2aa3dc|6|P|7|TREATMENT|2022-04-13|2022-05-14|172|203
Study ID|SE|baf33df4-7387-411e-8239-ecd5bc2aa3dc|7|FU|3|FOLLOW-UP|2022-01-05|2022-01-27|74|96
Study ID|SE|7d45c9cd-ad39-4c9a-8dcc-bc6087e0cf98|1|SCRN|4|SCREENING|2022-03-25|2022-06-18|157|242
Study ID|SE|7d45c9cd-ad39-4c9a-8dcc-bc6087e0cf98|2|5|1|TREATMENT|2022-05-14|2022-06-20|207|244
Study ID|SE|7d45c9cd-ad39-4c9a-8dcc-bc6087e0cf98|3|REST|2|WASHOUT|2021-12-03|2022-04-04|45|167
Study ID|SE|7d45c9cd-ad39-4c9a-8dcc-bc6087e0cf98|4|P|6|TREATMENT|2022-01-14|2022-03-16|87|148
Study ID|SE|7d45c9cd-ad39-4c9a-8dcc-bc6087e0cf98|5|REST|3|WASHOUT|2021-12-03|2022-05-04|45|197
Study ID|SE|7d45c9cd-ad39-4c9a-8dcc-bc6087e0cf98|6|10|4|TREATMENT|2021-11-07|2022-06-01|19|225
Study ID|SE|7d45c9cd-ad39-4c9a-8dcc-bc6087e0cf98|7|FU|6|FOLLOW-UP|2021-10-27|2021-11-03|8|15
Study ID|SE|f2742b1c-53d1-454b-ada5-bff2c2e7c755|1|SCRN|5|SCREENING|2021-09-30|2021-10-01|32|33
Study ID|SE|f2742b1c-53d1-454b-ada5-bff2c2e7c755|2|5|2|TREATMENT|2022-01-05|2022-03-18|129|201
Study ID|SE|f2742b1c-53d1-454b-ada5-bff2c2e7c755|3|REST|2|WASHOUT|2021-09-08|2021-09-12|10|14
Study ID|SE|f2742b1c-53d1-454b-ada5-bff2c2e7c755|4|10|1|TREATMENT|2021-11-20|2022-06-22|83|297
Study ID|SE|f2742b1c-53d1-454b-ada5-bff2c2e7c755|5|REST|5|WASHOUT|2022-02-16|2022-04-05|171|219
Study ID|SE|f2742b1c-53d1-454b-ada5-bff2c2e7c755|6|P|7|TREATMENT|2021-09-20|2022-04-02|22|216
Study ID|SE|f2742b1c-53d1-454b-ada5-bff2c2e7c755|7|FU|4|FOLLOW-UP|2021-09-12|2021-10-06|14|38
Study ID|SE|d8208864-fa0f-471a-a822-8cb606703cc2|1|SCRN|7|SCREENING|2021-11-04|2021-12-04|14|44
Study ID|SE|d8208864-fa0f-471a-a822-8cb606703cc2|2|P|1|TREATMENT|2021-12-31|2022-02-27|71|129
Study ID|SE|d8208864-fa0f-471a-a822-8cb606703cc2|3|REST|7|WASHOUT|2022-01-14|2022-03-19|85|149
Study ID|SE|d8208864-fa0f-471a-a822-8cb606703cc2|4|5|6|TREATMENT|2022-02-19|2022-08-12|121|295
Study ID|SE|d8208864-fa0f-471a-a822-8cb606703cc2|5|REST|5|WASHOUT|2022-01-21|2022-04-21|92|182
Study ID|SE|d8208864-fa0f-471a-a822-8cb606703cc2|6|10|6|TREATMENT|2022-03-06|2022-06-13|136|235
Study ID|SE|d8208864-fa0f-471a-a822-8cb606703cc2|7|FU|5|FOLLOW-UP|2022-05-16|2022-08-03|207|286
Study ID|SE|d4237095-7463-4f02-b85a-a073e859ddef|1|SCRN|5|SCREENING|2021-11-14|2022-04-03|43|183
Study ID|SE|d4237095-7463-4f02-b85a-a073e859ddef|2|5|1|TREATMENT|2021-10-09|2021-10-10|7|8
Study ID|SE|d4237095-7463-4f02-b85a-a073e859ddef|3|REST|6|WASHOUT|2021-12-03|2022-06-30|62|271
Study ID|SE|d4237095-7463-4f02-b85a-a073e859ddef|4|10|3|TREATMENT|2022-04-29|2022-06-18|209|259
Study ID|SE|d4237095-7463-4f02-b85a-a073e859ddef|5|REST|1|WASHOUT|2021-10-08|2022-03-21|6|170
Study ID|SE|d4237095-7463-4f02-b85a-a073e859ddef|6|P|1|TREATMENT|2021-10-10|2021-11-26|8|55
Study ID|SE|d4237095-7463-4f02-b85a-a073e859ddef|7|FU|5|FOLLOW-UP|2021-11-02|2021-11-08|31|37
Study ID|SE|3e507d13-a5be-4959-8f44-d057ead8d683|1|SCRN|2|SCREENING|2021-11-03|2022-04-16|82|246
Study ID|SE|3e507d13-a5be-4959-8f44-d057ead8d683|2|P|3|TREATMENT|2021-11-07|2022-05-20|86|280
Study ID|SE|3e507d13-a5be-4959-8f44-d057ead8d683|3|REST|4|WASHOUT|2021-08-15|2021-08-15|2|2
Study ID|SE|3e507d13-a5be-4959-8f44-d057ead8d683|4|5|7|TREATMENT|2021-11-07|2021-11-28|86|107
Study ID|SE|3e507d13-a5be-4959-8f44-d057ead8d683|5|REST|2|WASHOUT|2021-09-24|2021-12-08|42|117
Study ID|SE|3e507d13-a5be-4959-8f44-d057ead8d683|6|10|7|TREATMENT|2021-10-20|2022-01-17|68|157
Study ID|SE|3e507d13-a5be-4959-8f44-d057ead8d683|7|FU|5|FOLLOW-UP|2021-08-18|2022-01-18|5|158
Study ID|SE|15432e91-6157-450f-bb5c-024aeea0ea8a|1|SCRN|3|SCREENING|2022-03-09|2022-05-06|148|206
Study ID|SE|15432e91-6157-450f-bb5c-024aeea0ea8a|2|5|6|TREATMENT|2021-11-21|2022-06-30|40|261
Study ID|SE|15432e91-6157-450f-bb5c-024aeea0ea8a|3|REST|1|WASHOUT|2022-03-11|2022-03-21|150|160
Study ID|SE|15432e91-6157-450f-bb5c-024aeea0ea8a|4|10|3|TREATMENT|2021-11-04|2022-03-22|23|161
Study ID|SE|15432e91-6157-450f-bb5c-024aeea0ea8a|5|REST|1|WASHOUT|2021-11-16|2021-12-09|35|58
Study ID|SE|15432e91-6157-450f-bb5c-024aeea0ea8a|6|P|3|TREATMENT|2022-01-25|2022-06-06|105|237
Study ID|SE|15432e91-6157-450f-bb5c-024aeea0ea8a|7|FU|3|FOLLOW-UP|2021-10-24|2021-12-28|12|77
Study ID|SE|773a540c-2192-4d70-b1f4-c87a425ca0f5|1|SCRN|7|SCREENING|2022-01-08|2022-03-01|125|177
Study ID|SE|773a540c-2192-4d70-b1f4-c87a425ca0f5|2|5|5|TREATMENT|2021-10-05|2022-04-12|30|219
Study ID|SE|773a540c-2192-4d70-b1f4-c87a425ca0f5|3|REST|7|WASHOUT|2021-11-02|2022-04-22|58|229
Study ID|SE|773a540c-2192-4d70-b1f4-c87a425ca0f5|4|10|4|TREATMENT|2021-09-11|2022-02-05|6|153
Study ID|SE|773a540c-2192-4d70-b1f4-c87a425ca0f5|5|REST|2|WASHOUT|2021-09-12|2021-09-23|7|18
Study ID|SE|773a540c-2192-4d70-b1f4-c87a425ca0f5|6|P|5|TREATMENT|2021-10-25|2022-05-10|50|247
Study ID|SE|773a540c-2192-4d70-b1f4-c87a425ca0f5|7|FU|4|FOLLOW-UP|2021-09-21|2021-11-12|16|68
Study ID|SE|bfd02605-982e-4d42-8bbd-817e736cd501|1|SCRN|4|SCREENING|2022-02-12|2022-07-22|111|271
Study ID|SE|bfd02605-982e-4d42-8bbd-817e736cd501|2|5|2|TREATMENT|2021-10-28|2022-03-23|4|150
Study ID|SE|bfd02605-982e-4d42-8bbd-817e736cd501|3|REST|5|WASHOUT|2022-03-25|2022-08-19|152|299
Study ID|SE|bfd02605-982e-4d42-8bbd-817e736cd501|4|10|6|TREATMENT|2021-12-06|2022-02-15|43|114
Study ID|SE|bfd02605-982e-4d42-8bbd-817e736cd501|5|REST|4|WASHOUT|2021-11-11|2021-11-14|18|21
Study ID|SE|bfd02605-982e-4d42-8bbd-817e736cd501|6|P|1|TREATMENT|2022-01-08|2022-02-04|76|103
Study ID|SE|bfd02605-982e-4d42-8bbd-817e736cd501|7|FU|2|FOLLOW-UP|2021-12-26|2022-03-02|63|129
Study ID|SE|6bb46b4f-3727-41d0-91cc-fb7b4540b3af|1|SCRN|1|SCREENING|2021-10-30|2022-04-22|31|205
Study ID|SE|6bb46b4f-3727-41d0-91cc-fb7b4540b3af|2|5|4|TREATMENT|2021-10-25|2021-12-19|26|81
Study ID|SE|6bb46b4f-3727-41d0-91cc-fb7b4540b3af|3|REST|4|WASHOUT|2021-11-14|2022-02-05|46|129
Study ID|SE|6bb46b4f-3727-41d0-91cc-fb7b4540b3af|4|10|1|TREATMENT|2021-12-22|2022-01-30|84|123
Study ID|SE|6bb46b4f-3727-41d0-91cc-fb7b4540b3af|5|REST|7|WASHOUT|2021-10-28|2021-11-29|29|61
Study ID|SE|6bb46b4f-3727-41d0-91cc-fb7b4540b3af|6|P|4|TREATMENT|2022-01-04|2022-03-14|97|166
Study ID|SE|6bb46b4f-3727-41d0-91cc-fb7b4540b3af|7|FU|2|FOLLOW-UP|2021-11-08|2022-04-08|40|191
Study ID|SE|91250cab-9762-4c18-81b2-8d8d5fc8b193|1|SCRN|7|SCREENING|2021-10-05|2022-01-22|3|112
Study ID|SE|91250cab-9762-4c18-81b2-8d8d5fc8b193|2|5|7|TREATMENT|2021-10-18|2021-11-17|16|46
Study ID|SE|91250cab-9762-4c18-81b2-8d8d5fc8b193|3|REST|2|WASHOUT|2021-12-04|2022-05-04|63|214
Study ID|SE|91250cab-9762-4c18-81b2-8d8d5fc8b193|4|10|3|TREATMENT|2021-11-03|2021-12-31|32|90
Study ID|SE|91250cab-9762-4c18-81b2-8d8d5fc8b193|5|REST|3|WASHOUT|2021-10-24|2022-06-01|22|242
Study ID|SE|91250cab-9762-4c18-81b2-8d8d5fc8b193|6|P|2|TREATMENT|2021-12-26|2022-05-06|85|216
Study ID|SE|91250cab-9762-4c18-81b2-8d8d5fc8b193|7|FU|7|FOLLOW-UP|2022-02-13|2022-05-06|134|216
Study ID|SE|d80c7117-562a-4233-add0-d216c6d8ae62|1|SCRN|5|SCREENING|2021-09-08|2022-04-19|33|256
Study ID|SE|d80c7117-562a-4233-add0-d216c6d8ae62|2|P|5|TREATMENT|2021-08-30|2021-11-12|24|98
Study ID|SE|d80c7117-562a-4233-add0-d216c6d8ae62|3|REST|1|WASHOUT|2021-08-18|2021-10-14|12|69
Study ID|SE|d80c7117-562a-4233-add0-d216c6d8ae62|4|5|5|TREATMENT|2021-10-26|2022-01-10|81|157
Study ID|SE|d80c7117-562a-4233-add0-d216c6d8ae62|5|REST|6|WASHOUT|2021-12-15|2022-04-16|131|253
Study ID|SE|d80c7117-562a-4233-add0-d216c6d8ae62|6|10|1|TREATMENT|2021-09-25|2021-10-02|50|57
Study ID|SE|d80c7117-562a-4233-add0-d216c6d8ae62|7|FU|1|FOLLOW-UP|2021-08-31|2021-11-09|25|95
Study ID|SE|10b3ab23-8eea-409f-8b9a-22fc1a6b7e94|1|SCRN|2|SCREENING|2021-10-15|2022-03-21|17|174
Study ID|SE|10b3ab23-8eea-409f-8b9a-22fc1a6b7e94|2|5|4|TREATMENT|2021-11-12|2022-03-22|45|175
Study ID|SE|10b3ab23-8eea-409f-8b9a-22fc1a6b7e94|3|REST|3|WASHOUT|2021-12-16|2022-02-08|79|133
Study ID|SE|10b3ab23-8eea-409f-8b9a-22fc1a6b7e94|4|P|3|TREATMENT|2022-01-31|2022-03-28|125|181
Study ID|SE|10b3ab23-8eea-409f-8b9a-22fc1a6b7e94|5|REST|1|WASHOUT|2021-11-04|2022-01-09|37|103
Study ID|SE|10b3ab23-8eea-409f-8b9a-22fc1a6b7e94|6|10|6|TREATMENT|2021-12-22|2022-05-20|85|234
Study ID|SE|10b3ab23-8eea-409f-8b9a-22fc1a6b7e94|7|FU|3|FOLLOW-UP|2021-12-20|2022-06-15|83|260
Study ID|SE|848dd063-1b33-4487-8aaa-01757cb77046|1|SCRN|3|SCREENING|2021-11-25|2022-05-16|102|274
Study ID|SE|848dd063-1b33-4487-8aaa-01757cb77046|2|P|2|TREATMENT|2021-10-17|2021-10-20|63|66
Study ID|SE|848dd063-1b33-4487-8aaa-01757cb77046|3|REST|2|WASHOUT|2021-08-24|2021-12-08|9|115
Study ID|SE|848dd063-1b33-4487-8aaa-01757cb77046|4|5|5|TREATMENT|2021-08-19|2021-09-08|4|24
Study ID|SE|848dd063-1b33-4487-8aaa-01757cb77046|5|REST|6|WASHOUT|2021-10-25|2022-01-10|71|148
Study ID|SE|848dd063-1b33-4487-8aaa-01757cb77046|6|10|3|TREATMENT|2021-08-24|2021-12-16|9|123
Study ID|SE|848dd063-1b33-4487-8aaa-01757cb77046|7|FU|1|FOLLOW-UP|2021-11-07|2021-12-05|84|112
Study ID|SE|63a3bf0f-18a8-402b-bb40-d68bc96adc98|1|SCRN|1|SCREENING|2021-11-09|2021-12-12|12|45
Study ID|SE|63a3bf0f-18a8-402b-bb40-d68bc96adc98|2|5|1|TREATMENT|2022-01-16|2022-04-20|80|174
Study ID|SE|63a3bf0f-18a8-402b-bb40-d68bc96adc98|3|REST|4|WASHOUT|2021-11-16|2021-11-17|19|20
Study ID|SE|63a3bf0f-18a8-402b-bb40-d68bc96adc98|4|P|1|TREATMENT|2022-03-23|2022-04-14|146|168
Study ID|SE|63a3bf0f-18a8-402b-bb40-d68bc96adc98|5|REST|1|WASHOUT|2021-11-08|2022-02-06|11|101
Study ID|SE|63a3bf0f-18a8-402b-bb40-d68bc96adc98|6|10|2|TREATMENT|2022-04-30|2022-06-23|184|238
Study ID|SE|63a3bf0f-18a8-402b-bb40-d68bc96adc98|7|FU|6|FOLLOW-UP|2022-01-31|2022-02-19|95|114
Study ID|SE|06a270fe-45b6-406f-a543-4cb7240ebad5|1|SCRN|6|SCREENING|2021-10-26|2021-11-12|27|44
Study ID|SE|06a270fe-45b6-406f-a543-4cb7240ebad5|2|5|7|TREATMENT|2021-10-19|2022-05-24|20|237
Study ID|SE|06a270fe-45b6-406f-a543-4cb7240ebad5|3|REST|1|WASHOUT|2021-11-03|2022-02-14|35|138
Study ID|SE|06a270fe-45b6-406f-a543-4cb7240ebad5|4|P|4|TREATMENT|2022-04-21|2022-07-13|204|287
Study ID|SE|06a270fe-45b6-406f-a543-4cb7240ebad5|5|REST|1|WASHOUT|2022-01-21|2022-01-25|114|118
Study ID|SE|06a270fe-45b6-406f-a543-4cb7240ebad5|6|10|6|TREATMENT|2021-10-11|2022-05-02|12|215
Study ID|SE|06a270fe-45b6-406f-a543-4cb7240ebad5|7|FU|5|FOLLOW-UP|2021-10-26|2022-01-26|27|119
Study ID|SE|8ccf883c-fec1-41d8-87f4-3c8acea6dad4|1|SCRN|7|SCREENING|2021-10-05|2021-12-06|32|94
Study ID|SE|8ccf883c-fec1-41d8-87f4-3c8acea6dad4|2|5|4|TREATMENT|2021-09-07|2021-09-13|4|10
Study ID|SE|8ccf883c-fec1-41d8-87f4-3c8acea6dad4|3|REST|2|WASHOUT|2021-09-11|2021-09-28|8|25
Study ID|SE|8ccf883c-fec1-41d8-87f4-3c8acea6dad4|4|P|3|TREATMENT|2021-10-04|2022-04-15|31|224
Study ID|SE|8ccf883c-fec1-41d8-87f4-3c8acea6dad4|5|REST|4|WASHOUT|2021-11-04|2022-03-19|62|197
Study ID|SE|8ccf883c-fec1-41d8-87f4-3c8acea6dad4|6|10|4|TREATMENT|2021-09-13|2021-10-30|10|57
Study ID|SE|8ccf883c-fec1-41d8-87f4-3c8acea6dad4|7|FU|5|FOLLOW-UP|2022-02-14|2022-03-23|164|201
Study ID|SE|c4cd72ee-a69e-4918-b4ee-749907a13b09|1|SCRN|1|SCREENING|2021-12-03|2022-08-04|35|279
Study ID|SE|c4cd72ee-a69e-4918-b4ee-749907a13b09|2|5|3|TREATMENT|2021-10-31|2021-11-01|2|3
Study ID|SE|c4cd72ee-a69e-4918-b4ee-749907a13b09|3|REST|5|WASHOUT|2022-01-13|2022-03-17|76|139
Study ID|SE|c4cd72ee-a69e-4918-b4ee-749907a13b09|4|10|5|TREATMENT|2022-03-04|2022-04-26|126|179
Study ID|SE|c4cd72ee-a69e-4918-b4ee-749907a13b09|5|REST|6|WASHOUT|2021-11-08|2022-01-07|10|70
Study ID|SE|c4cd72ee-a69e-4918-b4ee-749907a13b09|6|P|1|TREATMENT|2022-02-10|2022-04-12|104|165
Study ID|SE|c4cd72ee-a69e-4918-b4ee-749907a13b09|7|FU|7|FOLLOW-UP|2021-10-31|2022-04-01|2|154
Study ID|SE|24d359a0-1b45-42df-bd8b-65856237b539|1|SCRN|7|SCREENING|2021-10-14|2021-11-02|31|50
Study ID|SE|24d359a0-1b45-42df-bd8b-65856237b539|2|P|2|TREATMENT|2022-05-30|2022-06-21|259|281
Study ID|SE|24d359a0-1b45-42df-bd8b-65856237b539|3|REST|5|WASHOUT|2021-10-16|2022-02-18|33|158
Study ID|SE|24d359a0-1b45-42df-bd8b-65856237b539|4|5|3|TREATMENT|2021-10-12|2021-10-16|29|33
Study ID|SE|24d359a0-1b45-42df-bd8b-65856237b539|5|REST|4|WASHOUT|2021-11-17|2022-02-18|65|158
Study ID|SE|24d359a0-1b45-42df-bd8b-65856237b539|6|10|1|TREATMENT|2021-10-28|2022-02-05|45|145
Study ID|SE|24d359a0-1b45-42df-bd8b-65856237b539|7|FU|3|FOLLOW-UP|2021-10-28|2022-04-20|45|219
Study ID|SE|6cc10a89-4636-45dc-a2b5-4722fe7b4f70|1|SCRN|7|SCREENING|2021-10-11|2021-11-13|16|49
Study ID|SE|6cc10a89-4636-45dc-a2b5-4722fe7b4f70|2|5|2|TREATMENT|2021-12-29|2022-03-23|95|179
Study ID|SE|6cc10a89-4636-45dc-a2b5-4722fe7b4f70|3|REST|4|WASHOUT|2021-12-17|2022-04-13|83|200
Study ID|SE|6cc10a89-4636-45dc-a2b5-4722fe7b4f70|4|10|5|TREATMENT|2021-10-05|2022-02-25|10|153
Study ID|SE|6cc10a89-4636-45dc-a2b5-4722fe7b4f70|5|REST|3|WASHOUT|2021-12-28|2022-05-14|94|231
Study ID|SE|6cc10a89-4636-45dc-a2b5-4722fe7b4f70|6|P|2|TREATMENT|2021-12-19|2022-05-13|85|230
Study ID|SE|6cc10a89-4636-45dc-a2b5-4722fe7b4f70|7|FU|5|FOLLOW-UP|2021-11-04|2022-04-25|40|212
Study ID|SE|136b774c-27d5-4513-ab9b-e359df78dc12|1|SCRN|3|SCREENING|2022-05-21|2022-07-11|227|278
Study ID|SE|136b774c-27d5-4513-ab9b-e359df78dc12|2|5|7|TREATMENT|2022-01-01|2022-02-11|87|128
Study ID|SE|136b774c-27d5-4513-ab9b-e359df78dc12|3|REST|2|WASHOUT|2021-10-15|2021-11-11|9|36
Study ID|SE|136b774c-27d5-4513-ab9b-e359df78dc12|4|10|3|TREATMENT|2022-01-17|2022-07-03|103|270
Study ID|SE|136b774c-27d5-4513-ab9b-e359df78dc12|5|REST|4|WASHOUT|2021-11-06|2022-02-19|31|136
Study ID|SE|136b774c-27d5-4513-ab9b-e359df78dc12|6|P|1|TREATMENT|2021-11-19|2021-11-27|44|52
Study ID|SE|136b774c-27d5-4513-ab9b-e359df78dc12|7|FU|5|FOLLOW-UP|2021-11-13|2022-06-28|38|265
Study ID|SE|0cd176fd-cf7d-4be6-ba63-d4e363bf3b40|1|SCRN|6|SCREENING|2021-09-03|2021-09-03|2|2
Study ID|SE|0cd176fd-cf7d-4be6-ba63-d4e363bf3b40|2|5|5|TREATMENT|2021-12-25|2022-05-17|115|258
Study ID|SE|0cd176fd-cf7d-4be6-ba63-d4e363bf3b40|3|REST|1|WASHOUT|2021-10-06|2021-10-13|35|42
Study ID|SE|0cd176fd-cf7d-4be6-ba63-d4e363bf3b40|4|P|7|TREATMENT|2022-03-03|2022-05-17|183|258
Study ID|SE|0cd176fd-cf7d-4be6-ba63-d4e363bf3b40|5|REST|5|WASHOUT|2022-03-05|2022-05-03|185|244
Study ID|SE|0cd176fd-cf7d-4be6-ba63-d4e363bf3b40|6|10|2|TREATMENT|2022-03-28|2022-04-07|208|218
Study ID|SE|0cd176fd-cf7d-4be6-ba63-d4e363bf3b40|7|FU|4|FOLLOW-UP|2021-11-23|2022-02-13|83|165
Study ID|SE|5fcad72b-cd2e-40ce-b2a4-f50768708c77|1|SCRN|2|SCREENING|2021-10-01|2021-12-25|27|112
Study ID|SE|5fcad72b-cd2e-40ce-b2a4-f50768708c77|2|5|3|TREATMENT|2022-03-19|2022-06-10|196|279
Study ID|SE|5fcad72b-cd2e-40ce-b2a4-f50768708c77|3|REST|2|WASHOUT|2021-09-14|2021-10-05|10|31
Study ID|SE|5fcad72b-cd2e-40ce-b2a4-f50768708c77|4|10|4|TREATMENT|2021-10-08|2022-06-07|34|276
Study ID|SE|5fcad72b-cd2e-40ce-b2a4-f50768708c77|5|REST|5|WASHOUT|2022-03-16|2022-04-07|193|215
Study ID|SE|5fcad72b-cd2e-40ce-b2a4-f50768708c77|6|P|4|TREATMENT|2021-09-09|2021-11-06|5|63
Study ID|SE|5fcad72b-cd2e-40ce-b2a4-f50768708c77|7|FU|7|FOLLOW-UP|2021-10-01|2021-12-18|27|105
Study ID|SE|133aa3a3-b051-4faa-b737-1851d7935fee|1|SCRN|6|SCREENING|2022-04-09|2022-06-12|215|279
Study ID|SE|133aa3a3-b051-4faa-b737-1851d7935fee|2|5|5|TREATMENT|2022-03-24|2022-06-23|199|290
Study ID|SE|133aa3a3-b051-4faa-b737-1851d7935fee|3|REST|1|WASHOUT|2021-12-10|2022-05-01|95|237
Study ID|SE|133aa3a3-b051-4faa-b737-1851d7935fee|4|P|6|TREATMENT|2022-02-14|2022-05-18|161|254
Study ID|SE|133aa3a3-b051-4faa-b737-1851d7935fee|5|REST|6|WASHOUT|2021-09-14|2021-09-15|8|9
Study ID|SE|133aa3a3-b051-4faa-b737-1851d7935fee|6|10|5|TREATMENT|2021-10-22|2021-10-24|46|48
Study ID|SE|133aa3a3-b051-4faa-b737-1851d7935fee|7|FU|1|FOLLOW-UP|2021-10-25|2022-03-19|49|194
Study ID|SE|a0293fb2-4ec2-48a8-be40-5936bc7cdde3|1|SCRN|4|SCREENING|2021-11-07|2021-12-03|21|47
Study ID|SE|a0293fb2-4ec2-48a8-be40-5936bc7cdde3|2|5|1|TREATMENT|2021-12-08|2022-07-01|52|257
Study ID|SE|a0293fb2-4ec2-48a8-be40-5936bc7cdde3|3|REST|2|WASHOUT|2021-11-06|2022-02-07|20|113
Study ID|SE|a0293fb2-4ec2-48a8-be40-5936bc7cdde3|4|10|3|TREATMENT|2022-04-09|2022-05-30|174|225
Study ID|SE|a0293fb2-4ec2-48a8-be40-5936bc7cdde3|5|REST|4|WASHOUT|2021-12-02|2022-01-29|46|104
Study ID|SE|a0293fb2-4ec2-48a8-be40-5936bc7cdde3|6|P|4|TREATMENT|2022-05-18|2022-06-22|213|248
Study ID|SE|a0293fb2-4ec2-48a8-be40-5936bc7cdde3|7|FU|6|FOLLOW-UP|2021-10-21|2021-10-24|4|7
Study ID|SE|1e612989-bd41-43fe-82bd-18b651c6c5ca|1|SCRN|5|SCREENING|2021-12-08|2022-03-04|80|166
Study ID|SE|1e612989-bd41-43fe-82bd-18b651c6c5ca|2|5|1|TREATMENT|2021-09-22|2021-10-24|3|35
Study ID|SE|1e612989-bd41-43fe-82bd-18b651c6c5ca|3|REST|3|WASHOUT|2021-09-26|2021-10-04|7|15
Study ID|SE|1e612989-bd41-43fe-82bd-18b651c6c5ca|4|10|5|TREATMENT|2021-12-13|2022-07-07|85|291
Study ID|SE|1e612989-bd41-43fe-82bd-18b651c6c5ca|5|REST|3|WASHOUT|2021-10-27|2021-12-07|38|79
Study ID|SE|1e612989-bd41-43fe-82bd-18b651c6c5ca|6|P|5|TREATMENT|2021-11-18|2022-02-24|60|158
Study ID|SE|1e612989-bd41-43fe-82bd-18b651c6c5ca|7|FU|2|FOLLOW-UP|2021-11-27|2021-11-29|69|71
Study ID|SE|91cbb9a1-c45e-471c-b09d-98de638b7a30|1|SCRN|6|SCREENING|2021-11-25|2022-04-21|63|210
Study ID|SE|91cbb9a1-c45e-471c-b09d-98de638b7a30|2|5|1|TREATMENT|2021-10-07|2021-10-20|14|27
Study ID|SE|91cbb9a1-c45e-471c-b09d-98de638b7a30|3|REST|4|WASHOUT|2021-10-29|2021-11-01|36|39
Study ID|SE|91cbb9a1-c45e-471c-b09d-98de638b7a30|4|P|7|TREATMENT|2021-12-06|2022-01-12|74|111
Study ID|SE|91cbb9a1-c45e-471c-b09d-98de638b7a30|5|REST|5|WASHOUT|2021-12-01|2022-02-16|69|146
Study ID|SE|91cbb9a1-c45e-471c-b09d-98de638b7a30|6|10|3|TREATMENT|2021-11-25|2022-05-17|63|236
Study ID|SE|91cbb9a1-c45e-471c-b09d-98de638b7a30|7|FU|6|FOLLOW-UP|2022-02-01|2022-05-13|131|232
Study ID|SE|fb2835ae-39a6-48dd-93f4-006b40dc947d|1|SCRN|6|SCREENING|2021-10-06|2021-11-26|14|65
Study ID|SE|fb2835ae-39a6-48dd-93f4-006b40dc947d|2|5|7|TREATMENT|2021-09-24|2021-09-25|2|3
Study ID|SE|fb2835ae-39a6-48dd-93f4-006b40dc947d|3|REST|1|WASHOUT|2021-09-27|2021-10-10|5|18
Study ID|SE|fb2835ae-39a6-48dd-93f4-006b40dc947d|4|P|1|TREATMENT|2021-11-12|2022-01-04|51|104
Study ID|SE|fb2835ae-39a6-48dd-93f4-006b40dc947d|5|REST|4|WASHOUT|2022-02-16|2022-05-21|147|241
Study ID|SE|fb2835ae-39a6-48dd-93f4-006b40dc947d|6|10|6|TREATMENT|2021-09-28|2021-10-19|6|27
Study ID|SE|fb2835ae-39a6-48dd-93f4-006b40dc947d|7|FU|2|FOLLOW-UP|2022-01-04|2022-06-11|104|262
Study ID|SE|fcc5702d-44d6-4ffc-b81c-b121c1b058a9|1|SCRN|7|SCREENING|2021-12-27|2022-04-01|95|190
Study ID|SE|fcc5702d-44d6-4ffc-b81c-b121c1b058a9|2|5|4|TREATMENT|2022-01-18|2022-06-29|117|279
Study ID|SE|fcc5702d-44d6-4ffc-b81c-b121c1b058a9|3|REST|2|WASHOUT|2022-02-12|2022-02-25|142|155
Study ID|SE|fcc5702d-44d6-4ffc-b81c-b121c1b058a9|4|P|4|TREATMENT|2021-09-25|2021-11-18|2|56
Study ID|SE|fcc5702d-44d6-4ffc-b81c-b121c1b058a9|5|REST|6|WASHOUT|2022-04-19|2022-07-04|208|284
Study ID|SE|fcc5702d-44d6-4ffc-b81c-b121c1b058a9|6|10|6|TREATMENT|2022-04-30|2022-07-11|219|291
Study ID|SE|fcc5702d-44d6-4ffc-b81c-b121c1b058a9|7|FU|2|FOLLOW-UP|2021-10-06|2021-10-22|13|29
Study ID|SE|df209108-bad2-4312-a372-1ca91d659760|1|SCRN|7|SCREENING|2022-05-07|2022-06-24|210|258
Study ID|SE|df209108-bad2-4312-a372-1ca91d659760|2|P|5|TREATMENT|2021-11-02|2022-03-28|24|170
Study ID|SE|df209108-bad2-4312-a372-1ca91d659760|3|REST|6|WASHOUT|2021-10-27|2021-11-02|18|24
Study ID|SE|df209108-bad2-4312-a372-1ca91d659760|4|5|5|TREATMENT|2022-02-06|2022-06-17|120|251
Study ID|SE|df209108-bad2-4312-a372-1ca91d659760|5|REST|1|WASHOUT|2021-10-30|2022-01-14|21|97
Study ID|SE|df209108-bad2-4312-a372-1ca91d659760|6|10|3|TREATMENT|2021-11-12|2022-03-12|34|154
Study ID|SE|df209108-bad2-4312-a372-1ca91d659760|7|FU|4|FOLLOW-UP|2021-12-15|2022-03-23|67|165
Study ID|SE|abca5aba-8fa2-4ecd-9416-42ea63ef1d63|1|SCRN|2|SCREENING|2021-12-07|2022-01-06|70|100
Study ID|SE|abca5aba-8fa2-4ecd-9416-42ea63ef1d63|2|5|5|TREATMENT|2021-11-04|2022-06-05|37|250
Study ID|SE|abca5aba-8fa2-4ecd-9416-42ea63ef1d63|3|REST|1|WASHOUT|2021-11-17|2021-12-19|50|82
Study ID|SE|abca5aba-8fa2-4ecd-9416-42ea63ef1d63|4|10|4|TREATMENT|2021-10-01|2021-10-02|3|4
Study ID|SE|abca5aba-8fa2-4ecd-9416-42ea63ef1d63|5|REST|6|WASHOUT|2021-10-05|2022-02-28|7|153
Study ID|SE|abca5aba-8fa2-4ecd-9416-42ea63ef1d63|6|P|3|TREATMENT|2021-10-12|2021-10-18|14|20
Study ID|SE|abca5aba-8fa2-4ecd-9416-42ea63ef1d63|7|FU|5|FOLLOW-UP|2021-11-06|2022-02-26|39|151
Study ID|SE|32683fbe-91aa-4e78-9cba-b9f507008b73|1|SCRN|3|SCREENING|2021-11-23|2022-06-08|50|247
Study ID|SE|32683fbe-91aa-4e78-9cba-b9f507008b73|2|5|7|TREATMENT|2021-12-06|2022-04-02|63|180
Study ID|SE|32683fbe-91aa-4e78-9cba-b9f507008b73|3|REST|5|WASHOUT|2021-10-12|2022-04-12|8|190
Study ID|SE|32683fbe-91aa-4e78-9cba-b9f507008b73|4|P|5|TREATMENT|2021-10-24|2022-02-17|20|136
Study ID|SE|32683fbe-91aa-4e78-9cba-b9f507008b73|5|REST|7|WASHOUT|2021-10-27|2022-01-03|23|91
Study ID|SE|32683fbe-91aa-4e78-9cba-b9f507008b73|6|10|4|TREATMENT|2021-12-22|2022-03-18|79|165
Study ID|SE|32683fbe-91aa-4e78-9cba-b9f507008b73|7|FU|3|FOLLOW-UP|2021-10-24|2021-10-25|20|21
Study ID|SE|118261a7-9740-4085-bfee-32fcdf7e2e73|1|SCRN|6|SCREENING|2021-10-25|2022-01-19|60|146
Study ID|SE|118261a7-9740-4085-bfee-32fcdf7e2e73|2|P|7|TREATMENT|2021-09-08|2021-10-31|13|66
Study ID|SE|118261a7-9740-4085-bfee-32fcdf7e2e73|3|REST|5|WASHOUT|2021-12-31|2022-04-15|127|232
Study ID|SE|118261a7-9740-4085-bfee-32fcdf7e2e73|4|5|6|TREATMENT|2021-11-23|2021-12-11|89|107
Study ID|SE|118261a7-9740-4085-bfee-32fcdf7e2e73|5|REST|6|WASHOUT|2021-10-13|2021-12-18|48|114
Study ID|SE|118261a7-9740-4085-bfee-32fcdf7e2e73|6|10|7|TREATMENT|2022-03-04|2022-04-29|190|246
Study ID|SE|118261a7-9740-4085-bfee-32fcdf7e2e73|7|FU|7|FOLLOW-UP|2021-10-09|2021-12-05|44|101
Study ID|SE|af31738e-c84d-4a27-b641-01ebc124fea2|1|SCRN|4|SCREENING|2021-11-24|2021-11-30|46|52
Study ID|SE|af31738e-c84d-4a27-b641-01ebc124fea2|2|5|3|TREATMENT|2021-11-24|2022-01-30|46|113
Study ID|SE|af31738e-c84d-4a27-b641-01ebc124fea2|3|REST|2|WASHOUT|2022-05-18|2022-07-31|221|295
Study ID|SE|af31738e-c84d-4a27-b641-01ebc124fea2|4|10|4|TREATMENT|2021-10-17|2021-10-31|8|22
Study ID|SE|af31738e-c84d-4a27-b641-01ebc124fea2|5|REST|7|WASHOUT|2021-10-18|2022-05-25|9|228
Study ID|SE|af31738e-c84d-4a27-b641-01ebc124fea2|6|P|2|TREATMENT|2021-11-23|2022-03-03|45|145
Study ID|SE|af31738e-c84d-4a27-b641-01ebc124fea2|7|FU|2|FOLLOW-UP|2021-10-25|2022-04-29|16|202
Study ID|SE|a92e4637-f1eb-4a92-8ebf-9cd094ac7e6e|1|SCRN|1|SCREENING|2021-12-14|2022-07-09|87|294
Study ID|SE|a92e4637-f1eb-4a92-8ebf-9cd094ac7e6e|2|5|1|TREATMENT|2021-09-23|2021-10-11|5|23
Study ID|SE|a92e4637-f1eb-4a92-8ebf-9cd094ac7e6e|3|REST|1|WASHOUT|2022-05-14|2022-05-31|238|255
Study ID|SE|a92e4637-f1eb-4a92-8ebf-9cd094ac7e6e|4|P|3|TREATMENT|2022-04-30|2022-06-09|224|264
Study ID|SE|a92e4637-f1eb-4a92-8ebf-9cd094ac7e6e|5|REST|1|WASHOUT|2021-12-04|2022-03-08|77|171
Study ID|SE|a92e4637-f1eb-4a92-8ebf-9cd094ac7e6e|6|10|5|TREATMENT|2021-09-26|2021-11-28|8|71
Study ID|SE|a92e4637-f1eb-4a92-8ebf-9cd094ac7e6e|7|FU|4|FOLLOW-UP|2021-09-22|2022-07-14|4|299
Study ID|SE|1347b170-a767-45a1-afd9-429d63fb750e|1|SCRN|4|SCREENING|2022-01-06|2022-04-26|84|194
Study ID|SE|1347b170-a767-45a1-afd9-429d63fb750e|2|5|2|TREATMENT|2022-03-04|2022-07-06|141|265
Study ID|SE|1347b170-a767-45a1-afd9-429d63fb750e|3|REST|1|WASHOUT|2021-10-16|2021-10-17|2|3
Study ID|SE|1347b170-a767-45a1-afd9-429d63fb750e|4|10|4|TREATMENT|2021-11-14|2022-07-30|31|289
Study ID|SE|1347b170-a767-45a1-afd9-429d63fb750e|5|REST|5|WASHOUT|2022-02-02|2022-03-29|111|166
Study ID|SE|1347b170-a767-45a1-afd9-429d63fb750e|6|P|6|TREATMENT|2021-12-17|2022-02-18|64|127
Study ID|SE|1347b170-a767-45a1-afd9-429d63fb750e|7|FU|5|FOLLOW-UP|2021-10-28|2022-03-27|14|164
Study ID|SE|8ece4da9-30d6-4c7a-8ad1-09234b4004cb|1|SCRN|3|SCREENING|2022-03-26|2022-08-16|149|292
Study ID|SE|8ece4da9-30d6-4c7a-8ad1-09234b4004cb|2|P|1|TREATMENT|2021-12-23|2022-05-13|56|197
Study ID|SE|8ece4da9-30d6-4c7a-8ad1-09234b4004cb|3|REST|3|WASHOUT|2022-05-10|2022-07-19|194|264
Study ID|SE|8ece4da9-30d6-4c7a-8ad1-09234b4004cb|4|5|2|TREATMENT|2021-11-11|2021-11-16|14|19
Study ID|SE|8ece4da9-30d6-4c7a-8ad1-09234b4004cb|5|REST|4|WASHOUT|2021-12-19|2022-03-10|52|133
Study ID|SE|8ece4da9-30d6-4c7a-8ad1-09234b4004cb|6|10|6|TREATMENT|2021-11-17|2022-02-25|20|120
Study ID|SE|8ece4da9-30d6-4c7a-8ad1-09234b4004cb|7|FU|5|FOLLOW-UP|2021-11-21|2021-12-29|24|62
Study ID|SE|5812af5b-fea6-408b-a4ec-5bcaf5664495|1|SCRN|2|SCREENING|2021-09-09|2021-09-10|9|10
Study ID|SE|5812af5b-fea6-408b-a4ec-5bcaf5664495|2|5|2|TREATMENT|2021-10-01|2022-02-17|31|170
Study ID|SE|5812af5b-fea6-408b-a4ec-5bcaf5664495|3|REST|2|WASHOUT|2022-03-21|2022-04-13|202|225
Study ID|SE|5812af5b-fea6-408b-a4ec-5bcaf5664495|4|P|5|TREATMENT|2021-09-09|2021-09-27|9|27
Study ID|SE|5812af5b-fea6-408b-a4ec-5bcaf5664495|5|REST|4|WASHOUT|2021-12-23|2022-06-08|114|281
Study ID|SE|5812af5b-fea6-408b-a4ec-5bcaf5664495|6|10|2|TREATMENT|2021-09-11|2021-10-07|11|37
Study ID|SE|5812af5b-fea6-408b-a4ec-5bcaf5664495|7|FU|3|FOLLOW-UP|2021-09-18|2021-10-18|18|48
Study ID|SE|c87f8dfc-095a-41d3-8cc6-69ac5c214f45|1|SCRN|2|SCREENING|2022-01-06|2022-03-18|87|158
Study ID|SE|c87f8dfc-095a-41d3-8cc6-69ac5c214f45|2|P|3|TREATMENT|2021-12-17|2021-12-22|67|72
Study ID|SE|c87f8dfc-095a-41d3-8cc6-69ac5c214f45|3|REST|7|WASHOUT|2022-02-06|2022-02-14|118|126
Study ID|SE|c87f8dfc-095a-41d3-8cc6-69ac5c214f45|4|5|5|TREATMENT|2022-01-04|2022-03-07|85|147
Study ID|SE|c87f8dfc-095a-41d3-8cc6-69ac5c214f45|5|REST|3|WASHOUT|2022-02-28|2022-05-14|140|215
Study ID|SE|c87f8dfc-095a-41d3-8cc6-69ac5c214f45|6|10|3|TREATMENT|2021-12-19|2022-03-01|69|141
Study ID|SE|c87f8dfc-095a-41d3-8cc6-69ac5c214f45|7|FU|7|FOLLOW-UP|2021-11-15|2022-03-30|35|170
Study ID|SE|fcecb8f0-b1c9-421f-b3e9-a29c4292ce89|1|SCRN|5|SCREENING|2022-01-08|2022-02-01|148|172
Study ID|SE|fcecb8f0-b1c9-421f-b3e9-a29c4292ce89|2|P|2|TREATMENT|2021-10-08|2021-11-30|56|109
Study ID|SE|fcecb8f0-b1c9-421f-b3e9-a29c4292ce89|3|REST|1|WASHOUT|2022-02-03|2022-02-10|174|181
Study ID|SE|fcecb8f0-b1c9-421f-b3e9-a29c4292ce89|4|5|3|TREATMENT|2021-08-15|2021-08-23|2|10
Study ID|SE|fcecb8f0-b1c9-421f-b3e9-a29c4292ce89|5|REST|2|WASHOUT|2021-08-20|2021-09-25|7|43
Study ID|SE|fcecb8f0-b1c9-421f-b3e9-a29c4292ce89|6|10|6|TREATMENT|2021-08-21|2021-09-26|8|44
Study ID|SE|fcecb8f0-b1c9-421f-b3e9-a29c4292ce89|7|FU|2|FOLLOW-UP|2021-10-12|2021-11-21|60|100
Study ID|SE|5601d848-0311-4526-8522-4b3028a88651|1|SCRN|5|SCREENING|2022-01-05|2022-01-26|130|151
Study ID|SE|5601d848-0311-4526-8522-4b3028a88651|2|5|3|TREATMENT|2021-10-04|2021-10-15|37|48
Study ID|SE|5601d848-0311-4526-8522-4b3028a88651|3|REST|3|WASHOUT|2021-12-05|2022-03-30|99|214
Study ID|SE|5601d848-0311-4526-8522-4b3028a88651|4|P|6|TREATMENT|2021-10-10|2021-10-17|43|50
Study ID|SE|5601d848-0311-4526-8522-4b3028a88651|5|REST|7|WASHOUT|2021-11-19|2022-03-31|83|215
Study ID|SE|5601d848-0311-4526-8522-4b3028a88651|6|10|7|TREATMENT|2021-11-17|2022-05-04|81|249
Study ID|SE|5601d848-0311-4526-8522-4b3028a88651|7|FU|3|FOLLOW-UP|2021-10-03|2022-05-19|36|264
Study ID|SE|cdcd8764-b9d7-4329-bf91-ea2571753b41|1|SCRN|3|SCREENING|2021-12-28|2022-03-19|139|220
Study ID|SE|cdcd8764-b9d7-4329-bf91-ea2571753b41|2|5|2|TREATMENT|2022-01-03|2022-05-03|145|265
Study ID|SE|cdcd8764-b9d7-4329-bf91-ea2571753b41|3|REST|4|WASHOUT|2021-08-26|2021-12-16|15|127
Study ID|SE|cdcd8764-b9d7-4329-bf91-ea2571753b41|4|10|2|TREATMENT|2021-08-14|2021-10-15|3|65
Study ID|SE|cdcd8764-b9d7-4329-bf91-ea2571753b41|5|REST|5|WASHOUT|2022-01-30|2022-03-18|172|219
Study ID|SE|cdcd8764-b9d7-4329-bf91-ea2571753b41|6|P|2|TREATMENT|2021-08-24|2022-01-07|13|149
Study ID|SE|cdcd8764-b9d7-4329-bf91-ea2571753b41|7|FU|4|FOLLOW-UP|2021-10-06|2021-12-22|56|133
Study ID|SE|69b001c0-9041-4e54-bfb2-fcfae2f12293|1|SCRN|6|SCREENING|2021-10-27|2022-02-16|20|132
Study ID|SE|69b001c0-9041-4e54-bfb2-fcfae2f12293|2|5|2|TREATMENT|2021-10-20|2021-10-23|13|16
Study ID|SE|69b001c0-9041-4e54-bfb2-fcfae2f12293|3|REST|4|WASHOUT|2022-01-22|2022-03-06|107|150
Study ID|SE|69b001c0-9041-4e54-bfb2-fcfae2f12293|4|P|7|TREATMENT|2021-10-17|2021-11-08|10|32
Study ID|SE|69b001c0-9041-4e54-bfb2-fcfae2f12293|5|REST|3|WASHOUT|2021-12-01|2022-01-10|55|95
Study ID|SE|69b001c0-9041-4e54-bfb2-fcfae2f12293|6|10|5|TREATMENT|2021-11-29|2022-04-22|53|197
Study ID|SE|69b001c0-9041-4e54-bfb2-fcfae2f12293|7|FU|3|FOLLOW-UP|2021-11-18|2022-02-12|42|128
Study ID|SE|4c9431ac-bd26-48a5-8303-86bf54f91e22|1|SCRN|6|SCREENING|2021-08-27|2021-10-08|11|53
Study ID|SE|4c9431ac-bd26-48a5-8303-86bf54f91e22|2|5|6|TREATMENT|2021-08-18|2021-08-27|2|11
Study ID|SE|4c9431ac-bd26-48a5-8303-86bf54f91e22|3|REST|7|WASHOUT|2021-08-18|2021-08-19|2|3
Study ID|SE|4c9431ac-bd26-48a5-8303-86bf54f91e22|4|P|2|TREATMENT|2021-08-31|2021-09-19|15|34
Study ID|SE|4c9431ac-bd26-48a5-8303-86bf54f91e22|5|REST|2|WASHOUT|2021-10-22|2022-01-30|67|167
Study ID|SE|4c9431ac-bd26-48a5-8303-86bf54f91e22|6|10|6|TREATMENT|2021-10-16|2022-01-20|61|157
Study ID|SE|4c9431ac-bd26-48a5-8303-86bf54f91e22|7|FU|1|FOLLOW-UP|2021-12-01|2021-12-05|107|111
Study ID|SE|364dde94-41af-4b6f-b984-192ee3ad71e1|1|SCRN|3|SCREENING|2021-09-08|2022-05-09|20|263
Study ID|SE|364dde94-41af-4b6f-b984-192ee3ad71e1|2|5|4|TREATMENT|2021-09-21|2022-06-06|33|291
Study ID|SE|364dde94-41af-4b6f-b984-192ee3ad71e1|3|REST|7|WASHOUT|2022-04-19|2022-06-04|243|289
Study ID|SE|364dde94-41af-4b6f-b984-192ee3ad71e1|4|P|1|TREATMENT|2021-09-30|2022-01-04|42|138
Study ID|SE|364dde94-41af-4b6f-b984-192ee3ad71e1|5|REST|7|WASHOUT|2021-09-19|2022-01-17|31|151
Study ID|SE|364dde94-41af-4b6f-b984-192ee3ad71e1|6|10|1|TREATMENT|2021-12-10|2022-03-19|113|212
Study ID|SE|364dde94-41af-4b6f-b984-192ee3ad71e1|7|FU|3|FOLLOW-UP|2021-11-02|2022-01-22|75|156
Study ID|SE|ddb801ce-53aa-4f8c-8ba1-c144c6c85d90|1|SCRN|5|SCREENING|2021-09-01|2021-09-07|15|21
Study ID|SE|ddb801ce-53aa-4f8c-8ba1-c144c6c85d90|2|5|3|TREATMENT|2021-08-25|2021-09-24|8|38
Study ID|SE|ddb801ce-53aa-4f8c-8ba1-c144c6c85d90|3|REST|1|WASHOUT|2022-01-09|2022-05-01|145|257
Study ID|SE|ddb801ce-53aa-4f8c-8ba1-c144c6c85d90|4|10|4|TREATMENT|2021-08-26|2022-02-19|9|186
Study ID|SE|ddb801ce-53aa-4f8c-8ba1-c144c6c85d90|5|REST|3|WASHOUT|2021-10-03|2021-10-05|47|49
Study ID|SE|ddb801ce-53aa-4f8c-8ba1-c144c6c85d90|6|P|1|TREATMENT|2021-12-29|2022-01-12|134|148
Study ID|SE|ddb801ce-53aa-4f8c-8ba1-c144c6c85d90|7|FU|4|FOLLOW-UP|2021-08-23|2021-08-30|6|13
Study ID|SE|1a584105-d14a-4717-9454-e2c3820381f8|1|SCRN|6|SCREENING|2021-11-11|2022-02-23|74|178
Study ID|SE|1a584105-d14a-4717-9454-e2c3820381f8|2|5|6|TREATMENT|2021-09-04|2022-02-02|6|157
Study ID|SE|1a584105-d14a-4717-9454-e2c3820381f8|3|REST|3|WASHOUT|2022-04-02|2022-05-13|216|257
Study ID|SE|1a584105-d14a-4717-9454-e2c3820381f8|4|10|6|TREATMENT|2021-10-20|2021-11-07|52|70
Study ID|SE|1a584105-d14a-4717-9454-e2c3820381f8|5|REST|3|WASHOUT|2021-10-17|2021-12-28|49|121
Study ID|SE|1a584105-d14a-4717-9454-e2c3820381f8|6|P|7|TREATMENT|2021-09-08|2021-10-10|10|42
Study ID|SE|1a584105-d14a-4717-9454-e2c3820381f8|7|FU|5|FOLLOW-UP|2021-10-11|2022-02-01|43|156
Study ID|SE|e43cdc5b-98d1-44d8-8d04-04711fad7f74|1|SCRN|4|SCREENING|2021-10-21|2022-03-04|27|161
Study ID|SE|e43cdc5b-98d1-44d8-8d04-04711fad7f74|2|5|7|TREATMENT|2021-10-07|2021-10-09|13|15
Study ID|SE|e43cdc5b-98d1-44d8-8d04-04711fad7f74|3|REST|4|WASHOUT|2021-10-04|2021-11-17|10|54
Study ID|SE|e43cdc5b-98d1-44d8-8d04-04711fad7f74|4|10|2|TREATMENT|2021-10-01|2021-11-05|7|42
Study ID|SE|e43cdc5b-98d1-44d8-8d04-04711fad7f74|5|REST|3|WASHOUT|2021-11-16|2021-11-20|53|57
Study ID|SE|e43cdc5b-98d1-44d8-8d04-04711fad7f74|6|P|1|TREATMENT|2021-12-20|2022-02-22|87|151
Study ID|SE|e43cdc5b-98d1-44d8-8d04-04711fad7f74|7|FU|6|FOLLOW-UP|2021-10-19|2022-02-16|25|145
Study ID|SE|046e07bb-a83a-4162-ae06-6a99ebf1b89e|1|SCRN|1|SCREENING|2021-10-28|2021-12-13|3|49
Study ID|SE|046e07bb-a83a-4162-ae06-6a99ebf1b89e|2|5|5|TREATMENT|2022-02-09|2022-03-05|107|131
Study ID|SE|046e07bb-a83a-4162-ae06-6a99ebf1b89e|3|REST|4|WASHOUT|2021-11-07|2022-04-29|13|186
Study ID|SE|046e07bb-a83a-4162-ae06-6a99ebf1b89e|4|P|6|TREATMENT|2021-11-24|2021-11-25|30|31
Study ID|SE|046e07bb-a83a-4162-ae06-6a99ebf1b89e|5|REST|2|WASHOUT|2021-11-30|2022-05-06|36|193
Study ID|SE|046e07bb-a83a-4162-ae06-6a99ebf1b89e|6|10|3|TREATMENT|2022-03-16|2022-04-22|142|179
Study ID|SE|046e07bb-a83a-4162-ae06-6a99ebf1b89e|7|FU|6|FOLLOW-UP|2021-12-20|2021-12-25|56|61
Study ID|SE|da8dfa1f-96a2-4d04-9d7d-3d38c38553fd|1|SCRN|5|SCREENING|2021-10-25|2022-03-08|50|184
Study ID|SE|da8dfa1f-96a2-4d04-9d7d-3d38c38553fd|2|P|1|TREATMENT|2021-09-22|2021-10-17|17|42
Study ID|SE|da8dfa1f-96a2-4d04-9d7d-3d38c38553fd|3|REST|6|WASHOUT|2021-10-15|2021-11-14|40|70
Study ID|SE|da8dfa1f-96a2-4d04-9d7d-3d38c38553fd|4|5|4|TREATMENT|2021-09-28|2021-10-19|23|44
Study ID|SE|da8dfa1f-96a2-4d04-9d7d-3d38c38553fd|5|REST|4|WASHOUT|2021-11-02|2022-06-20|58|288
Study ID|SE|da8dfa1f-96a2-4d04-9d7d-3d38c38553fd|6|10|7|TREATMENT|2021-10-16|2022-01-03|41|120
Study ID|SE|da8dfa1f-96a2-4d04-9d7d-3d38c38553fd|7|FU|2|FOLLOW-UP|2021-12-24|2022-02-14|110|162
Study ID|SE|83875d10-6b8d-4ee7-b603-b8def51a7461|1|SCRN|6|SCREENING|2021-10-28|2022-07-13|7|265
Study ID|SE|83875d10-6b8d-4ee7-b603-b8def51a7461|2|P|4|TREATMENT|2021-12-10|2022-01-19|50|90
Study ID|SE|83875d10-6b8d-4ee7-b603-b8def51a7461|3|REST|1|WASHOUT|2021-10-28|2021-10-29|7|8
Study ID|SE|83875d10-6b8d-4ee7-b603-b8def51a7461|4|5|6|TREATMENT|2021-11-14|2021-12-11|24|51
Study ID|SE|83875d10-6b8d-4ee7-b603-b8def51a7461|5|REST|2|WASHOUT|2022-05-14|2022-05-19|205|210
Study ID|SE|83875d10-6b8d-4ee7-b603-b8def51a7461|6|10|4|TREATMENT|2021-12-01|2021-12-18|41|58
Study ID|SE|83875d10-6b8d-4ee7-b603-b8def51a7461|7|FU|2|FOLLOW-UP|2022-03-23|2022-03-25|153|155
Study ID|SE|33e4bc92-e0fb-4067-bec6-91cb7a6a74f3|1|SCRN|1|SCREENING|2022-05-03|2022-07-03|202|263
Study ID|SE|33e4bc92-e0fb-4067-bec6-91cb7a6a74f3|2|5|1|TREATMENT|2022-01-05|2022-04-04|84|173
Study ID|SE|33e4bc92-e0fb-4067-bec6-91cb7a6a74f3|3|REST|4|WASHOUT|2021-11-14|2022-04-10|32|179
Study ID|SE|33e4bc92-e0fb-4067-bec6-91cb7a6a74f3|4|P|7|TREATMENT|2021-11-01|2021-11-07|19|25
Study ID|SE|33e4bc92-e0fb-4067-bec6-91cb7a6a74f3|5|REST|5|WASHOUT|2022-01-27|2022-03-23|106|161
Study ID|SE|33e4bc92-e0fb-4067-bec6-91cb7a6a74f3|6|10|1|TREATMENT|2021-11-12|2022-01-15|30|94
Study ID|SE|33e4bc92-e0fb-4067-bec6-91cb7a6a74f3|7|FU|7|FOLLOW-UP|2021-10-26|2022-01-14|13|93
Study ID|SE|32af130e-ded7-42b0-80d2-ef2ab8cb3716|1|SCRN|7|SCREENING|2021-09-22|2021-10-06|6|20
Study ID|SE|32af130e-ded7-42b0-80d2-ef2ab8cb3716|2|P|4|TREATMENT|2021-10-31|2022-05-05|45|231
Study ID|SE|32af130e-ded7-42b0-80d2-ef2ab8cb3716|3|REST|2|WASHOUT|2021-10-11|2021-11-08|25|53
Study ID|SE|32af130e-ded7-42b0-80d2-ef2ab8cb3716|4|5|5|TREATMENT|2022-03-24|2022-06-13|189|270
Study ID|SE|32af130e-ded7-42b0-80d2-ef2ab8cb3716|5|REST|3|WASHOUT|2021-10-30|2022-06-04|44|261
Study ID|SE|32af130e-ded7-42b0-80d2-ef2ab8cb3716|6|10|1|TREATMENT|2022-04-05|2022-04-26|201|222
Study ID|SE|32af130e-ded7-42b0-80d2-ef2ab8cb3716|7|FU|5|FOLLOW-UP|2021-12-15|2022-05-05|90|231
Study ID|SE|c5fb53bb-44b4-4b5c-b761-4162d98ebc17|1|SCRN|6|SCREENING|2022-03-06|2022-05-28|187|270
Study ID|SE|c5fb53bb-44b4-4b5c-b761-4162d98ebc17|2|5|1|TREATMENT|2021-09-02|2021-09-08|2|8
Study ID|SE|c5fb53bb-44b4-4b5c-b761-4162d98ebc17|3|REST|1|WASHOUT|2021-10-08|2022-05-11|38|253
Study ID|SE|c5fb53bb-44b4-4b5c-b761-4162d98ebc17|4|P|1|TREATMENT|2021-11-29|2021-12-07|90|98
Study ID|SE|c5fb53bb-44b4-4b5c-b761-4162d98ebc17|5|REST|5|WASHOUT|2022-03-15|2022-06-07|196|280
Study ID|SE|c5fb53bb-44b4-4b5c-b761-4162d98ebc17|6|10|4|TREATMENT|2022-04-30|2022-05-15|242|257
Study ID|SE|c5fb53bb-44b4-4b5c-b761-4162d98ebc17|7|FU|4|FOLLOW-UP|2021-12-03|2022-03-18|94|199
Study ID|SE|2a1a2992-8396-4304-8a92-9cd66a7369a1|1|SCRN|2|SCREENING|2021-09-07|2021-09-18|7|18
Study ID|SE|2a1a2992-8396-4304-8a92-9cd66a7369a1|2|P|3|TREATMENT|2021-10-10|2022-02-12|40|165
Study ID|SE|2a1a2992-8396-4304-8a92-9cd66a7369a1|3|REST|2|WASHOUT|2021-10-08|2021-11-13|38|74
Study ID|SE|2a1a2992-8396-4304-8a92-9cd66a7369a1|4|5|3|TREATMENT|2021-09-25|2022-04-23|25|235
Study ID|SE|2a1a2992-8396-4304-8a92-9cd66a7369a1|5|REST|7|WASHOUT|2021-11-12|2022-01-22|73|144
Study ID|SE|2a1a2992-8396-4304-8a92-9cd66a7369a1|6|10|3|TREATMENT|2021-10-12|2022-02-21|42|174
Study ID|SE|2a1a2992-8396-4304-8a92-9cd66a7369a1|7|FU|3|FOLLOW-UP|2022-02-24|2022-06-26|177|299
Study ID|SE|6ba2f713-f79c-4a47-bbd7-92621654749f|1|SCRN|4|SCREENING|2022-02-17|2022-04-15|119|176
Study ID|SE|6ba2f713-f79c-4a47-bbd7-92621654749f|2|5|3|TREATMENT|2021-12-12|2022-02-18|52|120
Study ID|SE|6ba2f713-f79c-4a47-bbd7-92621654749f|3|REST|5|WASHOUT|2022-03-15|2022-04-09|145|170
Study ID|SE|6ba2f713-f79c-4a47-bbd7-92621654749f|4|P|3|TREATMENT|2021-11-06|2021-11-20|16|30
Study ID|SE|6ba2f713-f79c-4a47-bbd7-92621654749f|5|REST|4|WASHOUT|2022-03-08|2022-03-12|138|142
Study ID|SE|6ba2f713-f79c-4a47-bbd7-92621654749f|6|10|7|TREATMENT|2021-11-12|2021-12-10|22|50
Study ID|SE|6ba2f713-f79c-4a47-bbd7-92621654749f|7|FU|3|FOLLOW-UP|2022-02-27|2022-03-30|129|160
Study ID|SE|0eda1b06-4864-40c9-9c20-9c925e1f783f|1|SCRN|3|SCREENING|2021-09-27|2022-01-05|17|117
Study ID|SE|0eda1b06-4864-40c9-9c20-9c925e1f783f|2|P|1|TREATMENT|2021-09-17|2021-10-11|7|31
Study ID|SE|0eda1b06-4864-40c9-9c20-9c925e1f783f|3|REST|1|WASHOUT|2022-01-17|2022-03-17|129|188
Study ID|SE|0eda1b06-4864-40c9-9c20-9c925e1f783f|4|5|1|TREATMENT|2021-12-31|2022-05-13|112|245
Study ID|SE|0eda1b06-4864-40c9-9c20-9c925e1f783f|5|REST|4|WASHOUT|2021-10-03|2021-11-18|23|69
Study ID|SE|0eda1b06-4864-40c9-9c20-9c925e1f783f|6|10|1|TREATMENT|2022-02-17|2022-05-29|160|261
Study ID|SE|0eda1b06-4864-40c9-9c20-9c925e1f783f|7|FU|7|FOLLOW-UP|2022-04-22|2022-05-21|224|253
Study ID|SE|03869e30-d967-4f76-9c9c-a36a7ac7d42a|1|SCRN|6|SCREENING|2021-12-03|2022-01-07|68|103
Study ID|SE|03869e30-d967-4f76-9c9c-a36a7ac7d42a|2|P|3|TREATMENT|2021-10-29|2021-11-10|33|45
Study ID|SE|03869e30-d967-4f76-9c9c-a36a7ac7d42a|3|REST|5|WASHOUT|2021-10-17|2021-12-15|21|80
Study ID|SE|03869e30-d967-4f76-9c9c-a36a7ac7d42a|4|5|6|TREATMENT|2021-12-28|2022-04-16|93|202
Study ID|SE|03869e30-d967-4f76-9c9c-a36a7ac7d42a|5|REST|7|WASHOUT|2022-01-07|2022-02-18|103|145
Study ID|SE|03869e30-d967-4f76-9c9c-a36a7ac7d42a|6|10|5|TREATMENT|2021-11-13|2022-03-25|48|180
Study ID|SE|03869e30-d967-4f76-9c9c-a36a7ac7d42a|7|FU|3|FOLLOW-UP|2021-11-27|2022-01-07|62|103
Study ID|SE|ad5bfc99-cd61-4bea-8df0-2755b2245233|1|SCRN|6|SCREENING|2022-04-27|2022-06-24|240|298
Study ID|SE|ad5bfc99-cd61-4bea-8df0-2755b2245233|2|P|1|TREATMENT|2021-10-13|2021-12-19|44|111
Study ID|SE|ad5bfc99-cd61-4bea-8df0-2755b2245233|3|REST|3|WASHOUT|2022-05-19|2022-06-04|262|278
Study ID|SE|ad5bfc99-cd61-4bea-8df0-2755b2245233|4|5|1|TREATMENT|2021-09-02|2021-09-12|3|13
Study ID|SE|ad5bfc99-cd61-4bea-8df0-2755b2245233|5|REST|3|WASHOUT|2022-01-07|2022-06-08|130|282
Study ID|SE|ad5bfc99-cd61-4bea-8df0-2755b2245233|6|10|1|TREATMENT|2021-09-12|2021-10-28|13|59
Study ID|SE|ad5bfc99-cd61-4bea-8df0-2755b2245233|7|FU|1|FOLLOW-UP|2022-01-09|2022-03-13|132|195
Study ID|SE|414d02ae-7812-4727-acb3-de9d06ea42b2|1|SCRN|5|SCREENING|2022-03-15|2022-04-07|192|215
Study ID|SE|414d02ae-7812-4727-acb3-de9d06ea42b2|2|5|1|TREATMENT|2021-11-05|2021-11-24|62|81
Study ID|SE|414d02ae-7812-4727-acb3-de9d06ea42b2|3|REST|2|WASHOUT|2021-11-01|2022-02-01|58|150
Study ID|SE|414d02ae-7812-4727-acb3-de9d06ea42b2|4|10|5|TREATMENT|2021-10-15|2021-10-23|41|49
Study ID|SE|414d02ae-7812-4727-acb3-de9d06ea42b2|5|REST|5|WASHOUT|2022-01-10|2022-03-12|128|189
Study ID|SE|414d02ae-7812-4727-acb3-de9d06ea42b2|6|P|2|TREATMENT|2021-11-27|2022-01-07|84|125
Study ID|SE|414d02ae-7812-4727-acb3-de9d06ea42b2|7|FU|5|FOLLOW-UP|2021-09-27|2021-10-16|23|42
Study ID|SE|d0ae8848-985b-4359-9bd1-ea5be3ccc25b|1|SCRN|7|SCREENING|2022-04-16|2022-06-18|218|281
Study ID|SE|d0ae8848-985b-4359-9bd1-ea5be3ccc25b|2|P|5|TREATMENT|2021-11-25|2021-12-04|76|85
Study ID|SE|d0ae8848-985b-4359-9bd1-ea5be3ccc25b|3|REST|1|WASHOUT|2021-11-05|2022-05-11|56|243
Study ID|SE|d0ae8848-985b-4359-9bd1-ea5be3ccc25b|4|5|3|TREATMENT|2022-06-15|2022-06-28|278|291
Study ID|SE|d0ae8848-985b-4359-9bd1-ea5be3ccc25b|5|REST|3|WASHOUT|2021-09-16|2021-09-20|6|10
Study ID|SE|d0ae8848-985b-4359-9bd1-ea5be3ccc25b|6|10|6|TREATMENT|2021-09-16|2022-04-24|6|226
Study ID|SE|d0ae8848-985b-4359-9bd1-ea5be3ccc25b|7|FU|5|FOLLOW-UP|2021-09-24|2021-10-04|14|24
Study ID|SE|b62294f9-8b23-4dec-90c8-a24950aa7d7a|1|SCRN|5|SCREENING|2022-03-27|2022-05-26|188|248
Study ID|SE|b62294f9-8b23-4dec-90c8-a24950aa7d7a|2|5|3|TREATMENT|2021-12-30|2022-02-24|101|157
Study ID|SE|b62294f9-8b23-4dec-90c8-a24950aa7d7a|3|REST|4|WASHOUT|2021-10-25|2021-12-14|35|85
Study ID|SE|b62294f9-8b23-4dec-90c8-a24950aa7d7a|4|10|4|TREATMENT|2021-11-19|2022-03-03|60|164
Study ID|SE|b62294f9-8b23-4dec-90c8-a24950aa7d7a|5|REST|3|WASHOUT|2021-09-26|2021-10-08|6|18
Study ID|SE|b62294f9-8b23-4dec-90c8-a24950aa7d7a|6|P|4|TREATMENT|2021-11-27|2022-07-06|68|289
Study ID|SE|b62294f9-8b23-4dec-90c8-a24950aa7d7a|7|FU|2|FOLLOW-UP|2021-10-05|2021-10-07|15|17
Study ID|SE|f17d2239-8ee6-4877-8505-755188fd7d8e|1|SCRN|6|SCREENING|2021-09-19|2021-10-18|29|58
Study ID|SE|f17d2239-8ee6-4877-8505-755188fd7d8e|2|5|4|TREATMENT|2021-08-29|2021-10-18|8|58
Study ID|SE|f17d2239-8ee6-4877-8505-755188fd7d8e|3|REST|7|WASHOUT|2021-09-15|2021-10-28|25|68
Study ID|SE|f17d2239-8ee6-4877-8505-755188fd7d8e|4|10|6|TREATMENT|2021-08-25|2021-08-27|4|6
Study ID|SE|f17d2239-8ee6-4877-8505-755188fd7d8e|5|REST|1|WASHOUT|2021-09-10|2021-10-25|20|65
Study ID|SE|f17d2239-8ee6-4877-8505-755188fd7d8e|6|P|3|TREATMENT|2021-09-26|2021-10-05|36|45
Study ID|SE|f17d2239-8ee6-4877-8505-755188fd7d8e|7|FU|7|FOLLOW-UP|2021-11-07|2022-01-08|78|140
Study ID|SE|a5012fe4-fb41-4745-9c68-35255d3fef81|1|SCRN|6|SCREENING|2022-03-25|2022-05-08|213|257
Study ID|SE|a5012fe4-fb41-4745-9c68-35255d3fef81|2|5|2|TREATMENT|2021-09-27|2022-05-30|34|279
Study ID|SE|a5012fe4-fb41-4745-9c68-35255d3fef81|3|REST|1|WASHOUT|2021-10-27|2022-04-29|64|248
Study ID|SE|a5012fe4-fb41-4745-9c68-35255d3fef81|4|10|3|TREATMENT|2021-08-29|2021-08-30|5|6
Study ID|SE|a5012fe4-fb41-4745-9c68-35255d3fef81|5|REST|4|WASHOUT|2022-03-25|2022-04-26|213|245
Study ID|SE|a5012fe4-fb41-4745-9c68-35255d3fef81|6|P|2|TREATMENT|2021-09-07|2021-10-05|14|42
Study ID|SE|a5012fe4-fb41-4745-9c68-35255d3fef81|7|FU|7|FOLLOW-UP|2021-12-20|2022-05-11|118|260
Study ID|SE|30957f3e-2568-43f7-988b-d7e8b8567bef|1|SCRN|1|SCREENING|2021-11-05|2021-11-22|23|40
Study ID|SE|30957f3e-2568-43f7-988b-d7e8b8567bef|2|P|2|TREATMENT|2021-11-17|2021-12-29|35|77
Study ID|SE|30957f3e-2568-43f7-988b-d7e8b8567bef|3|REST|7|WASHOUT|2021-12-16|2022-05-27|64|226
Study ID|SE|30957f3e-2568-43f7-988b-d7e8b8567bef|4|5|7|TREATMENT|2021-11-27|2022-01-04|45|83
Study ID|SE|30957f3e-2568-43f7-988b-d7e8b8567bef|5|REST|7|WASHOUT|2021-12-15|2022-08-04|63|295
Study ID|SE|30957f3e-2568-43f7-988b-d7e8b8567bef|6|10|6|TREATMENT|2021-10-27|2021-11-03|14|21
Study ID|SE|30957f3e-2568-43f7-988b-d7e8b8567bef|7|FU|5|FOLLOW-UP|2022-03-03|2022-04-03|141|172
Study ID|SE|6cff0c5a-e346-401c-b190-4357112f0917|1|SCRN|1|SCREENING|2021-08-29|2021-09-25|4|31
Study ID|SE|6cff0c5a-e346-401c-b190-4357112f0917|2|P|4|TREATMENT|2021-10-21|2022-02-02|57|161
Study ID|SE|6cff0c5a-e346-401c-b190-4357112f0917|3|REST|5|WASHOUT|2021-10-29|2022-04-03|65|221
Study ID|SE|6cff0c5a-e346-401c-b190-4357112f0917|4|5|1|TREATMENT|2021-09-06|2021-09-24|12|30
Study ID|SE|6cff0c5a-e346-401c-b190-4357112f0917|5|REST|3|WASHOUT|2022-01-19|2022-02-09|147|168
Study ID|SE|6cff0c5a-e346-401c-b190-4357112f0917|6|10|1|TREATMENT|2021-10-06|2022-03-21|42|208
Study ID|SE|6cff0c5a-e346-401c-b190-4357112f0917|7|FU|2|FOLLOW-UP|2021-09-14|2022-05-13|20|261
Study ID|SE|e1a36c62-1c14-42a2-bb96-4ab3c8b2649b|1|SCRN|3|SCREENING|2022-01-06|2022-05-31|107|252
Study ID|SE|e1a36c62-1c14-42a2-bb96-4ab3c8b2649b|2|P|1|TREATMENT|2022-02-07|2022-02-24|139|156
Study ID|SE|e1a36c62-1c14-42a2-bb96-4ab3c8b2649b|3|REST|3|WASHOUT|2022-03-25|2022-07-09|185|291
Study ID|SE|e1a36c62-1c14-42a2-bb96-4ab3c8b2649b|4|5|3|TREATMENT|2022-02-01|2022-04-14|133|205
Study ID|SE|e1a36c62-1c14-42a2-bb96-4ab3c8b2649b|5|REST|6|WASHOUT|2021-10-29|2022-02-02|38|134
Study ID|SE|e1a36c62-1c14-42a2-bb96-4ab3c8b2649b|6|10|3|TREATMENT|2022-03-01|2022-04-29|161|220
Study ID|SE|e1a36c62-1c14-42a2-bb96-4ab3c8b2649b|7|FU|6|FOLLOW-UP|2021-11-15|2022-03-10|55|170
Study ID|SE|10abfe98-d242-4549-8099-3c8d50bdbb31|1|SCRN|5|SCREENING|2021-11-28|2021-12-31|80|113
Study ID|SE|10abfe98-d242-4549-8099-3c8d50bdbb31|2|P|2|TREATMENT|2021-09-11|2022-02-26|2|170
Study ID|SE|10abfe98-d242-4549-8099-3c8d50bdbb31|3|REST|6|WASHOUT|2022-01-07|2022-05-03|120|236
Study ID|SE|10abfe98-d242-4549-8099-3c8d50bdbb31|4|5|1|TREATMENT|2022-05-18|2022-05-22|251|255
Study ID|SE|10abfe98-d242-4549-8099-3c8d50bdbb31|5|REST|7|WASHOUT|2021-10-31|2021-11-23|52|75
Study ID|SE|10abfe98-d242-4549-8099-3c8d50bdbb31|6|10|1|TREATMENT|2021-10-29|2021-12-09|50|91
Study ID|SE|10abfe98-d242-4549-8099-3c8d50bdbb31|7|FU|4|FOLLOW-UP|2021-09-16|2021-09-18|7|9
Study ID|SE|b85fe6ec-d44e-431a-ae48-22631d3da657|1|SCRN|6|SCREENING|2021-11-21|2022-07-15|34|270
Study ID|SE|b85fe6ec-d44e-431a-ae48-22631d3da657|2|5|7|TREATMENT|2021-12-17|2022-03-07|60|140
Study ID|SE|b85fe6ec-d44e-431a-ae48-22631d3da657|3|REST|7|WASHOUT|2021-12-22|2022-01-04|65|78
Study ID|SE|b85fe6ec-d44e-431a-ae48-22631d3da657|4|10|2|TREATMENT|2021-11-05|2022-04-10|18|174
Study ID|SE|b85fe6ec-d44e-431a-ae48-22631d3da657|5|REST|1|WASHOUT|2021-12-02|2022-06-09|45|234
Study ID|SE|b85fe6ec-d44e-431a-ae48-22631d3da657|6|P|2|TREATMENT|2021-12-25|2022-03-21|68|154
Study ID|SE|b85fe6ec-d44e-431a-ae48-22631d3da657|7|FU|7|FOLLOW-UP|2021-12-30|2021-12-31|73|74
Study ID|SE|5e715398-874e-49ab-b056-faad57de02ee|1|SCRN|4|SCREENING|2021-12-31|2022-01-20|118|138
Study ID|SE|5e715398-874e-49ab-b056-faad57de02ee|2|5|3|TREATMENT|2022-02-07|2022-02-23|156|172
Study ID|SE|5e715398-874e-49ab-b056-faad57de02ee|3|REST|2|WASHOUT|2021-09-09|2021-09-11|5|7
Study ID|SE|5e715398-874e-49ab-b056-faad57de02ee|4|P|2|TREATMENT|2022-04-13|2022-06-29|221|298
Study ID|SE|5e715398-874e-49ab-b056-faad57de02ee|5|REST|3|WASHOUT|2021-11-15|2021-12-04|72|91
Study ID|SE|5e715398-874e-49ab-b056-faad57de02ee|6|10|1|TREATMENT|2022-01-18|2022-06-25|136|294
Study ID|SE|5e715398-874e-49ab-b056-faad57de02ee|7|FU|3|FOLLOW-UP|2021-12-19|2022-03-11|106|188
Study ID|SE|20d29b93-4a30-4914-811a-84386d3e4f2d|1|SCRN|3|SCREENING|2021-12-16|2022-01-13|88|116
Study ID|SE|20d29b93-4a30-4914-811a-84386d3e4f2d|2|5|3|TREATMENT|2021-09-26|2022-03-14|7|176
Study ID|SE|20d29b93-4a30-4914-811a-84386d3e4f2d|3|REST|1|WASHOUT|2021-10-19|2021-11-28|30|70
Study ID|SE|20d29b93-4a30-4914-811a-84386d3e4f2d|4|P|7|TREATMENT|2021-10-18|2021-11-06|29|48
Study ID|SE|20d29b93-4a30-4914-811a-84386d3e4f2d|5|REST|6|WASHOUT|2021-09-30|2021-11-07|11|49
Study ID|SE|20d29b93-4a30-4914-811a-84386d3e4f2d|6|10|4|TREATMENT|2021-11-01|2021-11-14|43|56
Study ID|SE|20d29b93-4a30-4914-811a-84386d3e4f2d|7|FU|6|FOLLOW-UP|2021-12-16|2022-04-29|88|222
Study ID|SE|abf73edd-8476-43ac-8c86-b12ec46cc06f|1|SCRN|2|SCREENING|2021-10-11|2022-05-29|2|232
Study ID|SE|abf73edd-8476-43ac-8c86-b12ec46cc06f|2|5|4|TREATMENT|2021-10-30|2021-12-02|21|54
Study ID|SE|abf73edd-8476-43ac-8c86-b12ec46cc06f|3|REST|2|WASHOUT|2022-01-27|2022-03-03|110|145
Study ID|SE|abf73edd-8476-43ac-8c86-b12ec46cc06f|4|P|5|TREATMENT|2021-10-24|2021-11-10|15|32
Study ID|SE|abf73edd-8476-43ac-8c86-b12ec46cc06f|5|REST|1|WASHOUT|2022-03-26|2022-07-21|168|285
Study ID|SE|abf73edd-8476-43ac-8c86-b12ec46cc06f|6|10|6|TREATMENT|2022-02-12|2022-03-14|126|156
Study ID|SE|abf73edd-8476-43ac-8c86-b12ec46cc06f|7|FU|4|FOLLOW-UP|2021-10-20|2021-10-22|11|13
Study ID|SE|ed9b9e4e-49a2-47bc-bccb-2ae541395917|1|SCRN|2|SCREENING|2021-12-04|2022-06-20|101|299
Study ID|SE|ed9b9e4e-49a2-47bc-bccb-2ae541395917|2|5|2|TREATMENT|2021-09-30|2021-12-06|36|103
Study ID|SE|ed9b9e4e-49a2-47bc-bccb-2ae541395917|3|REST|5|WASHOUT|2022-01-27|2022-05-24|155|272
Study ID|SE|ed9b9e4e-49a2-47bc-bccb-2ae541395917|4|P|1|TREATMENT|2021-10-06|2021-11-11|42|78
Study ID|SE|ed9b9e4e-49a2-47bc-bccb-2ae541395917|5|REST|7|WASHOUT|2021-09-15|2021-10-30|21|66
Study ID|SE|ed9b9e4e-49a2-47bc-bccb-2ae541395917|6|10|2|TREATMENT|2021-09-10|2022-05-30|16|278
Study ID|SE|ed9b9e4e-49a2-47bc-bccb-2ae541395917|7|FU|5|FOLLOW-UP|2021-09-16|2022-01-02|22|130
Study ID|SE|14714bb0-b3c3-47c5-a26d-45a0c29a6b75|1|SCRN|6|SCREENING|2021-11-02|2022-01-19|4|82
Study ID|SE|14714bb0-b3c3-47c5-a26d-45a0c29a6b75|2|5|5|TREATMENT|2021-12-22|2022-04-04|54|157
Study ID|SE|14714bb0-b3c3-47c5-a26d-45a0c29a6b75|3|REST|1|WASHOUT|2021-12-01|2022-03-24|33|146
Study ID|SE|14714bb0-b3c3-47c5-a26d-45a0c29a6b75|4|10|1|TREATMENT|2021-12-16|2021-12-21|48|53
Study ID|SE|14714bb0-b3c3-47c5-a26d-45a0c29a6b75|5|REST|4|WASHOUT|2022-05-13|2022-06-03|196|217
Study ID|SE|14714bb0-b3c3-47c5-a26d-45a0c29a6b75|6|P|3|TREATMENT|2021-11-10|2022-01-12|12|75
Study ID|SE|14714bb0-b3c3-47c5-a26d-45a0c29a6b75|7|FU|1|FOLLOW-UP|2021-12-09|2022-01-21|41|84
Study ID|SE|8d12b4a9-3b4f-4bf8-9e44-1306a8fd2daa|1|SCRN|2|SCREENING|2022-01-16|2022-04-02|163|239
Study ID|SE|8d12b4a9-3b4f-4bf8-9e44-1306a8fd2daa|2|5|4|TREATMENT|2022-03-18|2022-05-12|224|279
Study ID|SE|8d12b4a9-3b4f-4bf8-9e44-1306a8fd2daa|3|REST|7|WASHOUT|2021-08-15|2021-08-25|9|19
Study ID|SE|8d12b4a9-3b4f-4bf8-9e44-1306a8fd2daa|4|10|1|TREATMENT|2021-12-20|2022-01-03|136|150
Study ID|SE|8d12b4a9-3b4f-4bf8-9e44-1306a8fd2daa|5|REST|2|WASHOUT|2021-08-20|2021-08-22|14|16
Study ID|SE|8d12b4a9-3b4f-4bf8-9e44-1306a8fd2daa|6|P|2|TREATMENT|2021-08-22|2021-09-10|16|35
Study ID|SE|8d12b4a9-3b4f-4bf8-9e44-1306a8fd2daa|7|FU|7|FOLLOW-UP|2021-10-24|2022-01-30|79|177
Study ID|SE|c8e04db6-28fa-4c0b-8611-8df28ec93013|1|SCRN|3|SCREENING|2021-08-18|2021-08-20|5|7
Study ID|SE|c8e04db6-28fa-4c0b-8611-8df28ec93013|2|5|6|TREATMENT|2021-10-13|2021-11-01|61|80
Study ID|SE|c8e04db6-28fa-4c0b-8611-8df28ec93013|3|REST|3|WASHOUT|2022-04-25|2022-05-17|255|277
Study ID|SE|c8e04db6-28fa-4c0b-8611-8df28ec93013|4|10|3|TREATMENT|2021-09-29|2022-02-03|47|174
Study ID|SE|c8e04db6-28fa-4c0b-8611-8df28ec93013|5|REST|7|WASHOUT|2022-02-06|2022-03-05|177|204
Study ID|SE|c8e04db6-28fa-4c0b-8611-8df28ec93013|6|P|3|TREATMENT|2021-10-15|2021-10-22|63|70
Study ID|SE|c8e04db6-28fa-4c0b-8611-8df28ec93013|7|FU|4|FOLLOW-UP|2021-08-22|2022-05-25|9|285
Study ID|SE|0e35ed14-e076-48cb-9f90-d559a4052575|1|SCRN|5|SCREENING|2022-03-25|2022-05-18|186|240
Study ID|SE|0e35ed14-e076-48cb-9f90-d559a4052575|2|5|3|TREATMENT|2021-09-30|2022-03-07|10|168
Study ID|SE|0e35ed14-e076-48cb-9f90-d559a4052575|3|REST|3|WASHOUT|2022-03-14|2022-04-28|175|220
Study ID|SE|0e35ed14-e076-48cb-9f90-d559a4052575|4|P|4|TREATMENT|2022-02-15|2022-03-25|148|186
Study ID|SE|0e35ed14-e076-48cb-9f90-d559a4052575|5|REST|3|WASHOUT|2021-12-12|2022-01-21|83|123
Study ID|SE|0e35ed14-e076-48cb-9f90-d559a4052575|6|10|5|TREATMENT|2021-12-05|2022-04-04|76|196
Study ID|SE|0e35ed14-e076-48cb-9f90-d559a4052575|7|FU|2|FOLLOW-UP|2021-09-26|2022-02-16|6|149
Study ID|SE|70433e05-ff36-402f-a3f4-b0427084c7d6|1|SCRN|2|SCREENING|2021-11-26|2022-05-29|68|252
Study ID|SE|70433e05-ff36-402f-a3f4-b0427084c7d6|2|P|4|TREATMENT|2021-09-21|2021-10-27|2|38
Study ID|SE|70433e05-ff36-402f-a3f4-b0427084c7d6|3|REST|6|WASHOUT|2022-01-12|2022-06-05|115|259
Study ID|SE|70433e05-ff36-402f-a3f4-b0427084c7d6|4|5|7|TREATMENT|2021-09-21|2022-02-06|2|140
Study ID|SE|70433e05-ff36-402f-a3f4-b0427084c7d6|5|REST|3|WASHOUT|2021-10-20|2022-03-17|31|179
Study ID|SE|70433e05-ff36-402f-a3f4-b0427084c7d6|6|10|7|TREATMENT|2021-09-21|2022-07-07|2|291
Study ID|SE|70433e05-ff36-402f-a3f4-b0427084c7d6|7|FU|3|FOLLOW-UP|2022-01-13|2022-04-06|116|199
Study ID|SE|07889b4d-b5c0-4609-b934-984dca657ea9|1|SCRN|1|SCREENING|2021-12-28|2021-12-30|96|98
Study ID|SE|07889b4d-b5c0-4609-b934-984dca657ea9|2|5|5|TREATMENT|2022-01-10|2022-03-26|109|184
Study ID|SE|07889b4d-b5c0-4609-b934-984dca657ea9|3|REST|3|WASHOUT|2022-05-15|2022-07-12|234|292
Study ID|SE|07889b4d-b5c0-4609-b934-984dca657ea9|4|P|4|TREATMENT|2021-11-13|2022-07-04|51|284
Study ID|SE|07889b4d-b5c0-4609-b934-984dca657ea9|5|REST|5|WASHOUT|2021-11-29|2022-06-12|67|262
Study ID|SE|07889b4d-b5c0-4609-b934-984dca657ea9|6|10|6|TREATMENT|2022-01-09|2022-03-29|108|187
Study ID|SE|07889b4d-b5c0-4609-b934-984dca657ea9|7|FU|1|FOLLOW-UP|2021-12-20|2022-04-06|88|195
Study ID|SE|89e46790-b0d5-4441-b36c-6a902e0cb5d5|1|SCRN|7|SCREENING|2022-05-25|2022-08-09|220|296
Study ID|SE|89e46790-b0d5-4441-b36c-6a902e0cb5d5|2|5|1|TREATMENT|2022-01-10|2022-03-29|85|163
Study ID|SE|89e46790-b0d5-4441-b36c-6a902e0cb5d5|3|REST|1|WASHOUT|2021-12-10|2021-12-15|54|59
Study ID|SE|89e46790-b0d5-4441-b36c-6a902e0cb5d5|4|P|7|TREATMENT|2021-11-21|2022-04-20|35|185
Study ID|SE|89e46790-b0d5-4441-b36c-6a902e0cb5d5|5|REST|2|WASHOUT|2022-01-12|2022-01-17|87|92
Study ID|SE|89e46790-b0d5-4441-b36c-6a902e0cb5d5|6|10|7|TREATMENT|2021-10-24|2021-10-25|7|8
Study ID|SE|89e46790-b0d5-4441-b36c-6a902e0cb5d5|7|FU|5|FOLLOW-UP|2022-03-01|2022-03-08|135|142
Study ID|SE|f3658539-a9d4-43c3-aac3-80276a70dfd6|1|SCRN|7|SCREENING|2021-11-26|2021-12-10|48|62
Study ID|SE|f3658539-a9d4-43c3-aac3-80276a70dfd6|2|P|4|TREATMENT|2022-03-19|2022-05-15|161|218
Study ID|SE|f3658539-a9d4-43c3-aac3-80276a70dfd6|3|REST|6|WASHOUT|2021-10-11|2021-12-01|2|53
Study ID|SE|f3658539-a9d4-43c3-aac3-80276a70dfd6|4|5|7|TREATMENT|2022-01-21|2022-02-17|104|131
Study ID|SE|f3658539-a9d4-43c3-aac3-80276a70dfd6|5|REST|2|WASHOUT|2021-11-16|2022-05-26|38|229
Study ID|SE|f3658539-a9d4-43c3-aac3-80276a70dfd6|6|10|7|TREATMENT|2022-02-23|2022-06-15|137|249
Study ID|SE|f3658539-a9d4-43c3-aac3-80276a70dfd6|7|FU|4|FOLLOW-UP|2022-01-26|2022-07-22|109|286
Study ID|SE|8d18e5f1-661a-4970-991b-6c80e12d2058|1|SCRN|1|SCREENING|2021-10-06|2021-10-08|2|4
Study ID|SE|8d18e5f1-661a-4970-991b-6c80e12d2058|2|P|3|TREATMENT|2022-03-01|2022-06-08|148|247
Study ID|SE|8d18e5f1-661a-4970-991b-6c80e12d2058|3|REST|2|WASHOUT|2021-12-15|2022-03-14|72|161
Study ID|SE|8d18e5f1-661a-4970-991b-6c80e12d2058|4|5|7|TREATMENT|2022-03-08|2022-04-28|155|206
Study ID|SE|8d18e5f1-661a-4970-991b-6c80e12d2058|5|REST|2|WASHOUT|2021-11-18|2021-12-17|45|74
Study ID|SE|8d18e5f1-661a-4970-991b-6c80e12d2058|6|10|3|TREATMENT|2022-05-06|2022-06-16|214|255
Study ID|SE|8d18e5f1-661a-4970-991b-6c80e12d2058|7|FU|3|FOLLOW-UP|2021-10-29|2022-03-01|25|148
Study ID|SE|58aeb7ff-d7ed-4c85-a6a6-69dcb56398e2|1|SCRN|6|SCREENING|2021-10-20|2022-03-14|41|186
Study ID|SE|58aeb7ff-d7ed-4c85-a6a6-69dcb56398e2|2|5|1|TREATMENT|2021-12-12|2022-03-11|94|183
Study ID|SE|58aeb7ff-d7ed-4c85-a6a6-69dcb56398e2|3|REST|7|WASHOUT|2021-12-25|2022-04-17|107|220
Study ID|SE|58aeb7ff-d7ed-4c85-a6a6-69dcb56398e2|4|10|1|TREATMENT|2021-09-29|2022-03-06|20|178
Study ID|SE|58aeb7ff-d7ed-4c85-a6a6-69dcb56398e2|5|REST|1|WASHOUT|2021-09-25|2021-11-04|16|56
Study ID|SE|58aeb7ff-d7ed-4c85-a6a6-69dcb56398e2|6|P|2|TREATMENT|2021-12-24|2022-03-01|106|173
Study ID|SE|58aeb7ff-d7ed-4c85-a6a6-69dcb56398e2|7|FU|4|FOLLOW-UP|2021-11-27|2021-12-22|79|104
Study ID|SE|232ddf92-f565-4f3e-9a4d-e114cea61631|1|SCRN|6|SCREENING|2021-12-31|2022-08-18|66|296
Study ID|SE|232ddf92-f565-4f3e-9a4d-e114cea61631|2|5|1|TREATMENT|2021-11-25|2021-12-24|30|59
Study ID|SE|232ddf92-f565-4f3e-9a4d-e114cea61631|3|REST|5|WASHOUT|2022-01-04|2022-07-26|70|273
Study ID|SE|232ddf92-f565-4f3e-9a4d-e114cea61631|4|10|6|TREATMENT|2021-10-29|2021-11-09|3|14
Study ID|SE|232ddf92-f565-4f3e-9a4d-e114cea61631|5|REST|2|WASHOUT|2021-10-28|2021-12-02|2|37
Study ID|SE|232ddf92-f565-4f3e-9a4d-e114cea61631|6|P|4|TREATMENT|2022-02-04|2022-03-11|101|136
Study ID|SE|232ddf92-f565-4f3e-9a4d-e114cea61631|7|FU|2|FOLLOW-UP|2022-01-05|2022-02-05|71|102
Study ID|SE|5007d0c9-4a11-4731-a110-f1864faf6854|1|SCRN|4|SCREENING|2021-09-16|2022-05-28|40|294
Study ID|SE|5007d0c9-4a11-4731-a110-f1864faf6854|2|P|5|TREATMENT|2021-11-18|2022-04-26|103|262
Study ID|SE|5007d0c9-4a11-4731-a110-f1864faf6854|3|REST|5|WASHOUT|2022-01-25|2022-04-17|171|253
Study ID|SE|5007d0c9-4a11-4731-a110-f1864faf6854|4|5|4|TREATMENT|2021-09-07|2021-12-23|31|138
Study ID|SE|5007d0c9-4a11-4731-a110-f1864faf6854|5|REST|3|WASHOUT|2021-11-08|2022-05-21|93|287
Study ID|SE|5007d0c9-4a11-4731-a110-f1864faf6854|6|10|6|TREATMENT|2021-12-05|2022-04-14|120|250
Study ID|SE|5007d0c9-4a11-4731-a110-f1864faf6854|7|FU|1|FOLLOW-UP|2021-08-15|2021-12-02|8|117
Study ID|SE|85b48279-6cdd-48c7-b7eb-bd6e595e0f8f|1|SCRN|2|SCREENING|2021-12-06|2022-01-01|49|75
Study ID|SE|85b48279-6cdd-48c7-b7eb-bd6e595e0f8f|2|5|4|TREATMENT|2022-04-23|2022-04-29|187|193
Study ID|SE|85b48279-6cdd-48c7-b7eb-bd6e595e0f8f|3|REST|3|WASHOUT|2021-12-03|2021-12-07|46|50
Study ID|SE|85b48279-6cdd-48c7-b7eb-bd6e595e0f8f|4|10|5|TREATMENT|2022-02-06|2022-04-21|111|185
Study ID|SE|85b48279-6cdd-48c7-b7eb-bd6e595e0f8f|5|REST|2|WASHOUT|2021-12-22|2022-05-14|65|208
Study ID|SE|85b48279-6cdd-48c7-b7eb-bd6e595e0f8f|6|P|7|TREATMENT|2021-10-27|2022-03-23|9|156
Study ID|SE|85b48279-6cdd-48c7-b7eb-bd6e595e0f8f|7|FU|6|FOLLOW-UP|2022-02-01|2022-04-09|106|173
Study ID|SE|581601c0-37e2-4ccf-9d24-55c599e44d84|1|SCRN|4|SCREENING|2021-10-25|2022-01-04|41|112
Study ID|SE|581601c0-37e2-4ccf-9d24-55c599e44d84|2|5|7|TREATMENT|2021-12-20|2022-02-02|97|141
Study ID|SE|581601c0-37e2-4ccf-9d24-55c599e44d84|3|REST|2|WASHOUT|2021-10-20|2021-10-26|36|42
Study ID|SE|581601c0-37e2-4ccf-9d24-55c599e44d84|4|P|1|TREATMENT|2022-02-14|2022-06-30|153|289
Study ID|SE|581601c0-37e2-4ccf-9d24-55c599e44d84|5|REST|2|WASHOUT|2021-09-24|2021-10-06|10|22
Study ID|SE|581601c0-37e2-4ccf-9d24-55c599e44d84|6|10|4|TREATMENT|2021-09-21|2022-05-27|7|255
Study ID|SE|581601c0-37e2-4ccf-9d24-55c599e44d84|7|FU|3|FOLLOW-UP|2022-04-12|2022-05-09|210|237
Study ID|SE|83f371a4-b017-4ccd-ae39-3ec0222a5ea2|1|SCRN|2|SCREENING|2021-10-20|2021-11-16|18|45
Study ID|SE|83f371a4-b017-4ccd-ae39-3ec0222a5ea2|2|5|2|TREATMENT|2021-10-18|2022-01-17|16|107
Study ID|SE|83f371a4-b017-4ccd-ae39-3ec0222a5ea2|3|REST|7|WASHOUT|2021-12-13|2022-03-04|72|153
Study ID|SE|83f371a4-b017-4ccd-ae39-3ec0222a5ea2|4|P|3|TREATMENT|2022-02-20|2022-03-02|141|151
Study ID|SE|83f371a4-b017-4ccd-ae39-3ec0222a5ea2|5|REST|6|WASHOUT|2022-01-07|2022-03-20|97|169
Study ID|SE|83f371a4-b017-4ccd-ae39-3ec0222a5ea2|6|10|5|TREATMENT|2021-10-05|2021-12-25|3|84
Study ID|SE|83f371a4-b017-4ccd-ae39-3ec0222a5ea2|7|FU|5|FOLLOW-UP|2021-10-04|2021-12-26|2|85
Study ID|SE|eb29f19c-b1ea-4618-bae9-a361b44ff63d|1|SCRN|7|SCREENING|2022-01-09|2022-03-27|90|167
Study ID|SE|eb29f19c-b1ea-4618-bae9-a361b44ff63d|2|5|7|TREATMENT|2021-10-24|2021-11-25|13|45
Study ID|SE|eb29f19c-b1ea-4618-bae9-a361b44ff63d|3|REST|7|WASHOUT|2022-02-19|2022-05-20|131|221
Study ID|SE|eb29f19c-b1ea-4618-bae9-a361b44ff63d|4|10|7|TREATMENT|2021-10-16|2022-05-03|5|204
Study ID|SE|eb29f19c-b1ea-4618-bae9-a361b44ff63d|5|REST|5|WASHOUT|2022-05-07|2022-07-21|208|283
Study ID|SE|eb29f19c-b1ea-4618-bae9-a361b44ff63d|6|P|6|TREATMENT|2021-10-17|2021-10-29|6|18
Study ID|SE|eb29f19c-b1ea-4618-bae9-a361b44ff63d|7|FU|7|FOLLOW-UP|2021-11-13|2022-05-22|33|223
Study ID|SE|6e271652-436d-49c6-b3a7-d66728d83df2|1|SCRN|2|SCREENING|2022-01-05|2022-04-05|101|191
Study ID|SE|6e271652-436d-49c6-b3a7-d66728d83df2|2|5|6|TREATMENT|2021-12-12|2022-01-02|77|98
Study ID|SE|6e271652-436d-49c6-b3a7-d66728d83df2|3|REST|4|WASHOUT|2021-11-19|2021-11-29|54|64
Study ID|SE|6e271652-436d-49c6-b3a7-d66728d83df2|4|10|5|TREATMENT|2022-01-07|2022-01-24|103|120
Study ID|SE|6e271652-436d-49c6-b3a7-d66728d83df2|5|REST|3|WASHOUT|2021-12-05|2022-05-28|70|244
Study ID|SE|6e271652-436d-49c6-b3a7-d66728d83df2|6|P|6|TREATMENT|2021-12-03|2022-03-07|68|162
Study ID|SE|6e271652-436d-49c6-b3a7-d66728d83df2|7|FU|2|FOLLOW-UP|2022-01-17|2022-05-26|113|242
Study ID|SE|d604ff11-f208-4ed0-8aaa-d9f2e6801a80|1|SCRN|5|SCREENING|2021-11-28|2021-12-01|46|49
Study ID|SE|d604ff11-f208-4ed0-8aaa-d9f2e6801a80|2|5|2|TREATMENT|2022-04-04|2022-07-04|173|264
Study ID|SE|d604ff11-f208-4ed0-8aaa-d9f2e6801a80|3|REST|2|WASHOUT|2021-12-11|2022-06-18|59|248
Study ID|SE|d604ff11-f208-4ed0-8aaa-d9f2e6801a80|4|P|3|TREATMENT|2021-12-24|2022-02-08|72|118
Study ID|SE|d604ff11-f208-4ed0-8aaa-d9f2e6801a80|5|REST|2|WASHOUT|2022-03-08|2022-06-11|146|241
Study ID|SE|d604ff11-f208-4ed0-8aaa-d9f2e6801a80|6|10|3|TREATMENT|2021-12-03|2022-04-05|51|174
Study ID|SE|d604ff11-f208-4ed0-8aaa-d9f2e6801a80|7|FU|2|FOLLOW-UP|2021-12-08|2022-04-04|56|173
Study ID|SE|49817fe6-5663-49b8-861e-79099a5c9798|1|SCRN|1|SCREENING|2022-05-22|2022-07-12|212|263
Study ID|SE|49817fe6-5663-49b8-861e-79099a5c9798|2|5|2|TREATMENT|2022-03-13|2022-08-11|142|293
Study ID|SE|49817fe6-5663-49b8-861e-79099a5c9798|3|REST|2|WASHOUT|2022-01-30|2022-04-05|100|165
Study ID|SE|49817fe6-5663-49b8-861e-79099a5c9798|4|10|5|TREATMENT|2021-11-13|2022-03-13|22|142
Study ID|SE|49817fe6-5663-49b8-861e-79099a5c9798|5|REST|7|WASHOUT|2022-01-11|2022-03-12|81|141
Study ID|SE|49817fe6-5663-49b8-861e-79099a5c9798|6|P|6|TREATMENT|2022-01-05|2022-01-31|75|101
Study ID|SE|49817fe6-5663-49b8-861e-79099a5c9798|7|FU|2|FOLLOW-UP|2021-10-27|2022-02-17|5|118
Study ID|SE|f0f58cb2-e314-4869-b28f-a143a705a667|1|SCRN|7|SCREENING|2022-02-27|2022-05-14|201|277
Study ID|SE|f0f58cb2-e314-4869-b28f-a143a705a667|2|P|1|TREATMENT|2021-08-18|2021-11-04|8|86
Study ID|SE|f0f58cb2-e314-4869-b28f-a143a705a667|3|REST|5|WASHOUT|2021-10-22|2021-11-04|73|86
Study ID|SE|f0f58cb2-e314-4869-b28f-a143a705a667|4|5|3|TREATMENT|2021-08-22|2021-08-25|12|15
Study ID|SE|f0f58cb2-e314-4869-b28f-a143a705a667|5|REST|4|WASHOUT|2021-09-11|2022-01-21|32|164
Study ID|SE|f0f58cb2-e314-4869-b28f-a143a705a667|6|10|4|TREATMENT|2021-09-11|2022-01-21|32|164
Study ID|SE|f0f58cb2-e314-4869-b28f-a143a705a667|7|FU|3|FOLLOW-UP|2021-08-30|2021-10-17|20|68
Study ID|SE|6b24c2d9-7aa1-4b21-b13b-11162e1bf375|1|SCRN|7|SCREENING|2021-10-01|2022-02-10|25|157
Study ID|SE|6b24c2d9-7aa1-4b21-b13b-11162e1bf375|2|5|4|TREATMENT|2021-11-05|2021-12-11|60|96
Study ID|SE|6b24c2d9-7aa1-4b21-b13b-11162e1bf375|3|REST|4|WASHOUT|2021-12-01|2022-06-29|86|296
Study ID|SE|6b24c2d9-7aa1-4b21-b13b-11162e1bf375|4|10|1|TREATMENT|2021-09-09|2021-09-10|3|4
Study ID|SE|6b24c2d9-7aa1-4b21-b13b-11162e1bf375|5|REST|3|WASHOUT|2021-09-30|2021-10-05|24|29
Study ID|SE|6b24c2d9-7aa1-4b21-b13b-11162e1bf375|6|P|2|TREATMENT|2021-10-25|2022-03-07|49|182
Study ID|SE|6b24c2d9-7aa1-4b21-b13b-11162e1bf375|7|FU|1|FOLLOW-UP|2022-04-12|2022-05-02|218|238
Study ID|SE|5a60ad4c-9966-47d1-9418-9f9cb058d026|1|SCRN|4|SCREENING|2022-05-24|2022-06-01|266|274
Study ID|SE|5a60ad4c-9966-47d1-9418-9f9cb058d026|2|P|3|TREATMENT|2022-02-10|2022-02-26|163|179
Study ID|SE|5a60ad4c-9966-47d1-9418-9f9cb058d026|3|REST|4|WASHOUT|2021-09-30|2022-02-13|30|166
Study ID|SE|5a60ad4c-9966-47d1-9418-9f9cb058d026|4|5|4|TREATMENT|2021-11-15|2021-12-06|76|97
Study ID|SE|5a60ad4c-9966-47d1-9418-9f9cb058d026|5|REST|5|WASHOUT|2022-03-06|2022-04-03|187|215
Study ID|SE|5a60ad4c-9966-47d1-9418-9f9cb058d026|6|10|3|TREATMENT|2021-10-13|2021-11-06|43|67
Study ID|SE|5a60ad4c-9966-47d1-9418-9f9cb058d026|7|FU|2|FOLLOW-UP|2021-09-21|2022-01-06|21|128
Study ID|SE|2f385096-51a8-4c83-8805-8bb8888a6b0e|1|SCRN|6|SCREENING|2022-02-18|2022-03-20|155|185
Study ID|SE|2f385096-51a8-4c83-8805-8bb8888a6b0e|2|5|2|TREATMENT|2021-10-24|2022-01-03|38|109
Study ID|SE|2f385096-51a8-4c83-8805-8bb8888a6b0e|3|REST|6|WASHOUT|2022-02-21|2022-04-04|158|200
Study ID|SE|2f385096-51a8-4c83-8805-8bb8888a6b0e|4|P|4|TREATMENT|2022-02-18|2022-02-22|155|159
Study ID|SE|2f385096-51a8-4c83-8805-8bb8888a6b0e|5|REST|2|WASHOUT|2022-02-25|2022-03-22|162|187
Study ID|SE|2f385096-51a8-4c83-8805-8bb8888a6b0e|6|10|4|TREATMENT|2021-09-22|2022-04-22|6|218
Study ID|SE|2f385096-51a8-4c83-8805-8bb8888a6b0e|7|FU|2|FOLLOW-UP|2021-11-12|2021-12-10|57|85
Study ID|SE|549a4864-34d9-4852-b90a-a4676ba46189|1|SCRN|4|SCREENING|2021-10-17|2021-10-19|3|5
Study ID|SE|549a4864-34d9-4852-b90a-a4676ba46189|2|5|4|TREATMENT|2022-02-19|2022-02-28|128|137
Study ID|SE|549a4864-34d9-4852-b90a-a4676ba46189|3|REST|5|WASHOUT|2022-03-17|2022-05-31|154|229
Study ID|SE|549a4864-34d9-4852-b90a-a4676ba46189|4|10|7|TREATMENT|2021-11-05|2021-11-19|22|36
Study ID|SE|549a4864-34d9-4852-b90a-a4676ba46189|5|REST|1|WASHOUT|2022-01-19|2022-05-09|97|207
Study ID|SE|549a4864-34d9-4852-b90a-a4676ba46189|6|P|6|TREATMENT|2021-11-01|2021-12-28|18|75
Study ID|SE|549a4864-34d9-4852-b90a-a4676ba46189|7|FU|6|FOLLOW-UP|2022-04-25|2022-05-09|193|207
Study ID|SE|ed891416-d5de-4985-9858-1ddeba0fb3de|1|SCRN|5|SCREENING|2021-10-11|2021-10-21|4|14
Study ID|SE|ed891416-d5de-4985-9858-1ddeba0fb3de|2|P|1|TREATMENT|2022-01-06|2022-01-29|91|114
Study ID|SE|ed891416-d5de-4985-9858-1ddeba0fb3de|3|REST|4|WASHOUT|2021-12-03|2022-01-24|57|109
Study ID|SE|ed891416-d5de-4985-9858-1ddeba0fb3de|4|5|6|TREATMENT|2021-11-13|2021-11-26|37|50
Study ID|SE|ed891416-d5de-4985-9858-1ddeba0fb3de|5|REST|6|WASHOUT|2021-11-07|2022-01-13|31|98
Study ID|SE|ed891416-d5de-4985-9858-1ddeba0fb3de|6|10|2|TREATMENT|2021-10-15|2021-11-13|8|37
Study ID|SE|ed891416-d5de-4985-9858-1ddeba0fb3de|7|FU|2|FOLLOW-UP|2022-06-11|2022-06-30|247|266
Study ID|SE|c594a6bc-d680-4e20-aff5-88a5ba520340|1|SCRN|1|SCREENING|2021-11-12|2022-01-06|26|81
Study ID|SE|c594a6bc-d680-4e20-aff5-88a5ba520340|2|5|5|TREATMENT|2021-11-11|2022-02-21|25|127
Study ID|SE|c594a6bc-d680-4e20-aff5-88a5ba520340|3|REST|5|WASHOUT|2021-11-22|2021-12-25|36|69
Study ID|SE|c594a6bc-d680-4e20-aff5-88a5ba520340|4|P|4|TREATMENT|2021-10-27|2021-10-30|10|13
Study ID|SE|c594a6bc-d680-4e20-aff5-88a5ba520340|5|REST|3|WASHOUT|2022-02-04|2022-04-25|110|190
Study ID|SE|c594a6bc-d680-4e20-aff5-88a5ba520340|6|10|2|TREATMENT|2022-04-10|2022-08-06|175|293
Study ID|SE|c594a6bc-d680-4e20-aff5-88a5ba520340|7|FU|4|FOLLOW-UP|2022-01-15|2022-04-22|90|187
Study ID|SE|89e24da4-3b14-4bb5-aad1-93988184ba42|1|SCRN|3|SCREENING|2022-03-03|2022-05-14|196|268
Study ID|SE|89e24da4-3b14-4bb5-aad1-93988184ba42|2|5|6|TREATMENT|2021-09-25|2022-04-02|37|226
Study ID|SE|89e24da4-3b14-4bb5-aad1-93988184ba42|3|REST|6|WASHOUT|2021-12-19|2022-05-31|122|285
Study ID|SE|89e24da4-3b14-4bb5-aad1-93988184ba42|4|P|2|TREATMENT|2021-12-19|2022-04-28|122|252
Study ID|SE|89e24da4-3b14-4bb5-aad1-93988184ba42|5|REST|3|WASHOUT|2021-10-12|2022-01-01|54|135
Study ID|SE|89e24da4-3b14-4bb5-aad1-93988184ba42|6|10|3|TREATMENT|2022-03-14|2022-05-05|207|259
Study ID|SE|89e24da4-3b14-4bb5-aad1-93988184ba42|7|FU|6|FOLLOW-UP|2021-10-27|2022-04-02|69|226
Study ID|SE|f7662580-466d-4a62-bb12-7074c0b93927|1|SCRN|2|SCREENING|2021-12-17|2022-03-21|69|163
Study ID|SE|f7662580-466d-4a62-bb12-7074c0b93927|2|5|1|TREATMENT|2021-10-20|2022-02-06|11|120
Study ID|SE|f7662580-466d-4a62-bb12-7074c0b93927|3|REST|2|WASHOUT|2021-10-12|2021-12-26|3|78
Study ID|SE|f7662580-466d-4a62-bb12-7074c0b93927|4|P|4|TREATMENT|2021-10-18|2022-01-12|9|95
Study ID|SE|f7662580-466d-4a62-bb12-7074c0b93927|5|REST|3|WASHOUT|2022-03-12|2022-03-13|154|155
Study ID|SE|f7662580-466d-4a62-bb12-7074c0b93927|6|10|6|TREATMENT|2021-11-10|2022-05-10|32|213
Study ID|SE|f7662580-466d-4a62-bb12-7074c0b93927|7|FU|3|FOLLOW-UP|2021-12-19|2022-02-22|71|136
Study ID|SE|7f931cc2-b6e7-4a31-a510-d7832b76b94a|1|SCRN|5|SCREENING|2022-01-22|2022-03-07|122|166
Study ID|SE|7f931cc2-b6e7-4a31-a510-d7832b76b94a|2|5|2|TREATMENT|2021-10-12|2021-12-19|20|88
Study ID|SE|7f931cc2-b6e7-4a31-a510-d7832b76b94a|3|REST|2|WASHOUT|2021-11-01|2021-11-18|40|57
Study ID|SE|7f931cc2-b6e7-4a31-a510-d7832b76b94a|4|10|2|TREATMENT|2021-10-20|2021-12-17|28|86
Study ID|SE|7f931cc2-b6e7-4a31-a510-d7832b76b94a|5|REST|6|WASHOUT|2021-11-10|2021-12-17|49|86
Study ID|SE|7f931cc2-b6e7-4a31-a510-d7832b76b94a|6|P|2|TREATMENT|2021-11-08|2022-06-03|47|254
Study ID|SE|7f931cc2-b6e7-4a31-a510-d7832b76b94a|7|FU|2|FOLLOW-UP|2022-04-14|2022-07-18|204|299
Study ID|SE|768fd6ff-701e-4fde-82e9-432fff3bc729|1|SCRN|7|SCREENING|2021-11-01|2021-11-12|75|86
Study ID|SE|768fd6ff-701e-4fde-82e9-432fff3bc729|2|5|2|TREATMENT|2021-11-12|2022-01-04|86|139
Study ID|SE|768fd6ff-701e-4fde-82e9-432fff3bc729|3|REST|3|WASHOUT|2021-10-09|2022-04-01|52|226
Study ID|SE|768fd6ff-701e-4fde-82e9-432fff3bc729|4|P|7|TREATMENT|2021-10-02|2021-10-17|45|60
Study ID|SE|768fd6ff-701e-4fde-82e9-432fff3bc729|5|REST|3|WASHOUT|2021-09-18|2022-03-28|31|222
Study ID|SE|768fd6ff-701e-4fde-82e9-432fff3bc729|6|10|2|TREATMENT|2022-01-09|2022-04-25|144|250
Study ID|SE|768fd6ff-701e-4fde-82e9-432fff3bc729|7|FU|5|FOLLOW-UP|2021-10-06|2022-06-01|49|287
Study ID|SE|cb48c1d0-24f7-4803-9a1a-d5a35e4b06cc|1|SCRN|6|SCREENING|2022-05-28|2022-05-31|245|248
Study ID|SE|cb48c1d0-24f7-4803-9a1a-d5a35e4b06cc|2|5|3|TREATMENT|2022-01-30|2022-07-20|127|298
Study ID|SE|cb48c1d0-24f7-4803-9a1a-d5a35e4b06cc|3|REST|2|WASHOUT|2021-11-18|2022-07-03|54|281
Study ID|SE|cb48c1d0-24f7-4803-9a1a-d5a35e4b06cc|4|P|2|TREATMENT|2022-01-27|2022-03-11|124|167
Study ID|SE|cb48c1d0-24f7-4803-9a1a-d5a35e4b06cc|5|REST|3|WASHOUT|2021-12-15|2022-04-10|81|197
Study ID|SE|cb48c1d0-24f7-4803-9a1a-d5a35e4b06cc|6|10|1|TREATMENT|2022-02-11|2022-03-09|139|165
Study ID|SE|cb48c1d0-24f7-4803-9a1a-d5a35e4b06cc|7|FU|6|FOLLOW-UP|2022-01-31|2022-05-17|128|234
Study ID|SE|060ee7f9-a05e-48df-ae4b-6ac2b8aea91c|1|SCRN|7|SCREENING|2021-12-09|2022-01-13|122|157
Study ID|SE|060ee7f9-a05e-48df-ae4b-6ac2b8aea91c|2|5|4|TREATMENT|2022-01-11|2022-02-14|155|189
Study ID|SE|060ee7f9-a05e-48df-ae4b-6ac2b8aea91c|3|REST|2|WASHOUT|2021-10-28|2022-03-25|80|228
Study ID|SE|060ee7f9-a05e-48df-ae4b-6ac2b8aea91c|4|10|3|TREATMENT|2021-11-19|2022-05-24|102|288
Study ID|SE|060ee7f9-a05e-48df-ae4b-6ac2b8aea91c|5|REST|5|WASHOUT|2021-11-09|2022-01-03|92|147
Study ID|SE|060ee7f9-a05e-48df-ae4b-6ac2b8aea91c|6|P|2|TREATMENT|2021-08-30|2021-10-13|21|65
Study ID|SE|060ee7f9-a05e-48df-ae4b-6ac2b8aea91c|7|FU|4|FOLLOW-UP|2021-08-21|2021-10-16|12|68
Study ID|SE|510a8ff9-0d06-412d-8de6-f88cf734d3f4|1|SCRN|1|SCREENING|2022-05-07|2022-05-12|250|255
Study ID|SE|510a8ff9-0d06-412d-8de6-f88cf734d3f4|2|5|4|TREATMENT|2022-02-20|2022-05-04|174|247
Study ID|SE|510a8ff9-0d06-412d-8de6-f88cf734d3f4|3|REST|1|WASHOUT|2021-09-14|2021-09-17|15|18
Study ID|SE|510a8ff9-0d06-412d-8de6-f88cf734d3f4|4|10|3|TREATMENT|2021-09-23|2022-02-28|24|182
Study ID|SE|510a8ff9-0d06-412d-8de6-f88cf734d3f4|5|REST|3|WASHOUT|2022-03-30|2022-05-27|212|270
Study ID|SE|510a8ff9-0d06-412d-8de6-f88cf734d3f4|6|P|6|TREATMENT|2021-10-22|2021-10-30|53|61
Study ID|SE|510a8ff9-0d06-412d-8de6-f88cf734d3f4|7|FU|6|FOLLOW-UP|2021-09-02|2021-09-29|3|30
Study ID|SE|c930bfa0-66b8-490b-a9fb-c6d0d98c79a7|1|SCRN|1|SCREENING|2022-01-28|2022-02-04|138|145
Study ID|SE|c930bfa0-66b8-490b-a9fb-c6d0d98c79a7|2|5|3|TREATMENT|2022-01-24|2022-04-25|134|225
Study ID|SE|c930bfa0-66b8-490b-a9fb-c6d0d98c79a7|3|REST|6|WASHOUT|2021-10-03|2021-11-13|21|62
Study ID|SE|c930bfa0-66b8-490b-a9fb-c6d0d98c79a7|4|P|1|TREATMENT|2021-12-15|2022-01-30|94|140
Study ID|SE|c930bfa0-66b8-490b-a9fb-c6d0d98c79a7|5|REST|7|WASHOUT|2021-12-11|2022-03-02|90|171
Study ID|SE|c930bfa0-66b8-490b-a9fb-c6d0d98c79a7|6|10|6|TREATMENT|2022-03-03|2022-04-03|172|203
Study ID|SE|c930bfa0-66b8-490b-a9fb-c6d0d98c79a7|7|FU|3|FOLLOW-UP|2021-09-16|2021-12-27|4|106
Study ID|SE|212370d6-958a-4f10-99fa-52a82dd9642f|1|SCRN|3|SCREENING|2021-11-28|2022-02-03|52|119
Study ID|SE|212370d6-958a-4f10-99fa-52a82dd9642f|2|5|4|TREATMENT|2022-01-24|2022-04-20|109|195
Study ID|SE|212370d6-958a-4f10-99fa-52a82dd9642f|3|REST|7|WASHOUT|2022-04-01|2022-07-05|176|271
Study ID|SE|212370d6-958a-4f10-99fa-52a82dd9642f|4|10|1|TREATMENT|2022-01-23|2022-03-20|108|164
Study ID|SE|212370d6-958a-4f10-99fa-52a82dd9642f|5|REST|4|WASHOUT|2021-10-30|2021-11-23|23|47
Study ID|SE|212370d6-958a-4f10-99fa-52a82dd9642f|6|P|4|TREATMENT|2021-12-15|2022-03-29|69|173
Study ID|SE|212370d6-958a-4f10-99fa-52a82dd9642f|7|FU|3|FOLLOW-UP|2022-02-23|2022-04-12|139|187
Study ID|SE|5b4d1030-da3a-4935-bad9-66f7f06a9011|1|SCRN|1|SCREENING|2021-10-18|2021-10-22|14|18
Study ID|SE|5b4d1030-da3a-4935-bad9-66f7f06a9011|2|5|2|TREATMENT|2022-03-10|2022-06-15|157|254
Study ID|SE|5b4d1030-da3a-4935-bad9-66f7f06a9011|3|REST|6|WASHOUT|2021-10-16|2021-12-15|12|72
Study ID|SE|5b4d1030-da3a-4935-bad9-66f7f06a9011|4|10|3|TREATMENT|2021-10-25|2022-04-23|21|201
Study ID|SE|5b4d1030-da3a-4935-bad9-66f7f06a9011|5|REST|6|WASHOUT|2022-02-01|2022-02-20|120|139
Study ID|SE|5b4d1030-da3a-4935-bad9-66f7f06a9011|6|P|5|TREATMENT|2021-12-25|2022-02-06|82|125
Study ID|SE|5b4d1030-da3a-4935-bad9-66f7f06a9011|7|FU|4|FOLLOW-UP|2022-02-16|2022-04-02|135|180
Study ID|SE|b57c8ca5-e2cf-43a9-945b-69356c428ea2|1|SCRN|2|SCREENING|2021-10-24|2022-06-10|44|273
Study ID|SE|b57c8ca5-e2cf-43a9-945b-69356c428ea2|2|5|2|TREATMENT|2021-10-22|2021-11-13|42|64
Study ID|SE|b57c8ca5-e2cf-43a9-945b-69356c428ea2|3|REST|5|WASHOUT|2021-10-24|2021-12-04|44|85
Study ID|SE|b57c8ca5-e2cf-43a9-945b-69356c428ea2|4|P|1|TREATMENT|2021-10-06|2021-10-18|26|38
Study ID|SE|b57c8ca5-e2cf-43a9-945b-69356c428ea2|5|REST|6|WASHOUT|2021-09-14|2021-10-29|4|49
Study ID|SE|b57c8ca5-e2cf-43a9-945b-69356c428ea2|6|10|5|TREATMENT|2021-12-31|2022-02-20|112|163
Study ID|SE|b57c8ca5-e2cf-43a9-945b-69356c428ea2|7|FU|6|FOLLOW-UP|2021-12-25|2022-05-04|106|236
Study ID|SE|ae30d67b-08bc-434f-a478-217b2c337bf1|1|SCRN|5|SCREENING|2021-11-12|2021-12-25|44|87
Study ID|SE|ae30d67b-08bc-434f-a478-217b2c337bf1|2|5|2|TREATMENT|2021-10-01|2021-10-01|2|2
Study ID|SE|ae30d67b-08bc-434f-a478-217b2c337bf1|3|REST|1|WASHOUT|2021-11-28|2022-06-18|60|262
Study ID|SE|ae30d67b-08bc-434f-a478-217b2c337bf1|4|10|1|TREATMENT|2021-10-19|2022-02-04|20|128
Study ID|SE|ae30d67b-08bc-434f-a478-217b2c337bf1|5|REST|3|WASHOUT|2021-10-12|2021-10-17|13|18
Study ID|SE|ae30d67b-08bc-434f-a478-217b2c337bf1|6|P|6|TREATMENT|2021-11-20|2021-12-13|52|75
Study ID|SE|ae30d67b-08bc-434f-a478-217b2c337bf1|7|FU|2|FOLLOW-UP|2021-10-13|2021-11-06|14|38
Study ID|SE|80e0a3ad-4614-45fa-b7da-4e3a75948dd8|1|SCRN|4|SCREENING|2022-01-05|2022-01-15|121|131
Study ID|SE|80e0a3ad-4614-45fa-b7da-4e3a75948dd8|2|P|4|TREATMENT|2021-11-29|2022-02-23|84|170
Study ID|SE|80e0a3ad-4614-45fa-b7da-4e3a75948dd8|3|REST|2|WASHOUT|2021-09-22|2021-10-13|16|37
Study ID|SE|80e0a3ad-4614-45fa-b7da-4e3a75948dd8|4|5|4|TREATMENT|2022-02-13|2022-05-10|160|246
Study ID|SE|80e0a3ad-4614-45fa-b7da-4e3a75948dd8|5|REST|7|WASHOUT|2021-11-15|2022-02-19|70|166
Study ID|SE|80e0a3ad-4614-45fa-b7da-4e3a75948dd8|6|10|3|TREATMENT|2021-09-25|2022-06-06|19|273
Study ID|SE|80e0a3ad-4614-45fa-b7da-4e3a75948dd8|7|FU|3|FOLLOW-UP|2021-10-13|2021-10-22|37|46
Study ID|SE|d2d84e70-17a5-426b-9950-eeb8400f3799|1|SCRN|2|SCREENING|2022-03-28|2022-05-03|225|261
Study ID|SE|d2d84e70-17a5-426b-9950-eeb8400f3799|2|P|4|TREATMENT|2021-09-14|2021-09-17|30|33
Study ID|SE|d2d84e70-17a5-426b-9950-eeb8400f3799|3|REST|2|WASHOUT|2022-03-24|2022-05-04|221|262
Study ID|SE|d2d84e70-17a5-426b-9950-eeb8400f3799|4|5|4|TREATMENT|2021-09-03|2021-11-09|19|86
Study ID|SE|d2d84e70-17a5-426b-9950-eeb8400f3799|5|REST|5|WASHOUT|2021-10-11|2022-02-14|57|183
Study ID|SE|d2d84e70-17a5-426b-9950-eeb8400f3799|6|10|6|TREATMENT|2021-11-23|2022-02-07|100|176
Study ID|SE|d2d84e70-17a5-426b-9950-eeb8400f3799|7|FU|3|FOLLOW-UP|2022-04-06|2022-04-21|234|249
Study ID|SE|ab29520f-676b-4f65-ac81-82304aef6428|1|SCRN|4|SCREENING|2021-08-26|2022-04-17|18|252
Study ID|SE|ab29520f-676b-4f65-ac81-82304aef6428|2|5|2|TREATMENT|2021-08-29|2021-11-07|21|91
Study ID|SE|ab29520f-676b-4f65-ac81-82304aef6428|3|REST|3|WASHOUT|2021-09-15|2022-02-20|38|196
Study ID|SE|ab29520f-676b-4f65-ac81-82304aef6428|4|10|7|TREATMENT|2021-09-01|2021-12-23|24|137
Study ID|SE|ab29520f-676b-4f65-ac81-82304aef6428|5|REST|7|WASHOUT|2021-11-26|2022-04-03|110|238
Study ID|SE|ab29520f-676b-4f65-ac81-82304aef6428|6|P|7|TREATMENT|2021-10-05|2021-12-05|58|119
Study ID|SE|ab29520f-676b-4f65-ac81-82304aef6428|7|FU|2|FOLLOW-UP|2021-08-15|2021-08-28|7|20
Study ID|SE|a2dd2ef8-c42f-4e17-aa79-72a1fcf94596|1|SCRN|7|SCREENING|2021-09-17|2021-10-12|21|46
Study ID|SE|a2dd2ef8-c42f-4e17-aa79-72a1fcf94596|2|P|5|TREATMENT|2021-10-16|2022-01-14|50|140
Study ID|SE|a2dd2ef8-c42f-4e17-aa79-72a1fcf94596|3|REST|6|WASHOUT|2021-09-21|2022-02-12|25|169
Study ID|SE|a2dd2ef8-c42f-4e17-aa79-72a1fcf94596|4|5|1|TREATMENT|2021-09-18|2022-02-19|22|176
Study ID|SE|a2dd2ef8-c42f-4e17-aa79-72a1fcf94596|5|REST|6|WASHOUT|2021-11-13|2021-12-28|78|123
Study ID|SE|a2dd2ef8-c42f-4e17-aa79-72a1fcf94596|6|10|3|TREATMENT|2022-04-28|2022-05-18|244|264
Study ID|SE|a2dd2ef8-c42f-4e17-aa79-72a1fcf94596|7|FU|4|FOLLOW-UP|2021-09-21|2021-12-20|25|115
Study ID|SE|6d740f8e-f7d4-40ec-b8d9-2ebbdcd7fb65|1|SCRN|1|SCREENING|2021-08-28|2021-09-07|12|22
Study ID|SE|6d740f8e-f7d4-40ec-b8d9-2ebbdcd7fb65|2|5|6|TREATMENT|2022-03-14|2022-05-26|210|283
Study ID|SE|6d740f8e-f7d4-40ec-b8d9-2ebbdcd7fb65|3|REST|7|WASHOUT|2022-04-20|2022-04-28|247|255
Study ID|SE|6d740f8e-f7d4-40ec-b8d9-2ebbdcd7fb65|4|P|4|TREATMENT|2022-02-04|2022-04-03|172|230
Study ID|SE|6d740f8e-f7d4-40ec-b8d9-2ebbdcd7fb65|5|REST|1|WASHOUT|2021-10-10|2021-11-10|55|86
Study ID|SE|6d740f8e-f7d4-40ec-b8d9-2ebbdcd7fb65|6|10|2|TREATMENT|2021-09-16|2021-11-22|31|98
Study ID|SE|6d740f8e-f7d4-40ec-b8d9-2ebbdcd7fb65|7|FU|7|FOLLOW-UP|2021-08-25|2021-11-17|9|93
Study ID|SE|55eeb8e7-c997-4f21-aa9a-92cfe57d6ade|1|SCRN|1|SCREENING|2021-09-07|2021-10-19|27|69
Study ID|SE|55eeb8e7-c997-4f21-aa9a-92cfe57d6ade|2|5|6|TREATMENT|2021-12-05|2022-05-26|116|288
Study ID|SE|55eeb8e7-c997-4f21-aa9a-92cfe57d6ade|3|REST|2|WASHOUT|2021-08-21|2021-08-23|10|12
Study ID|SE|55eeb8e7-c997-4f21-aa9a-92cfe57d6ade|4|P|7|TREATMENT|2021-10-06|2021-10-17|56|67
Study ID|SE|55eeb8e7-c997-4f21-aa9a-92cfe57d6ade|5|REST|6|WASHOUT|2021-08-28|2021-08-29|17|18
Study ID|SE|55eeb8e7-c997-4f21-aa9a-92cfe57d6ade|6|10|6|TREATMENT|2021-08-28|2021-08-30|17|19
Study ID|SE|55eeb8e7-c997-4f21-aa9a-92cfe57d6ade|7|FU|4|FOLLOW-UP|2021-12-20|2022-05-28|131|290
Study ID|SE|f02d68f6-149f-44f8-ae15-004b13f2447d|1|SCRN|6|SCREENING|2021-10-08|2021-10-17|6|15
Study ID|SE|f02d68f6-149f-44f8-ae15-004b13f2447d|2|P|2|TREATMENT|2021-11-12|2022-07-16|41|287
Study ID|SE|f02d68f6-149f-44f8-ae15-004b13f2447d|3|REST|1|WASHOUT|2022-01-22|2022-01-30|112|120
Study ID|SE|f02d68f6-149f-44f8-ae15-004b13f2447d|4|5|3|TREATMENT|2022-03-02|2022-04-28|151|208
Study ID|SE|f02d68f6-149f-44f8-ae15-004b13f2447d|5|REST|5|WASHOUT|2022-07-05|2022-07-15|276|286
Study ID|SE|f02d68f6-149f-44f8-ae15-004b13f2447d|6|10|7|TREATMENT|2021-11-23|2021-12-14|52|73
Study ID|SE|f02d68f6-149f-44f8-ae15-004b13f2447d|7|FU|7|FOLLOW-UP|2021-10-04|2021-10-07|2|5
Study ID|SE|0dc1253a-6f7b-4fb2-a008-832188c2baaf|1|SCRN|6|SCREENING|2022-02-13|2022-06-30|143|280
Study ID|SE|0dc1253a-6f7b-4fb2-a008-832188c2baaf|2|5|6|TREATMENT|2021-09-25|2021-09-25|2|2
Study ID|SE|0dc1253a-6f7b-4fb2-a008-832188c2baaf|3|REST|5|WASHOUT|2021-09-29|2021-11-06|6|44
Study ID|SE|0dc1253a-6f7b-4fb2-a008-832188c2baaf|4|10|3|TREATMENT|2021-11-05|2022-03-04|43|162
Study ID|SE|0dc1253a-6f7b-4fb2-a008-832188c2baaf|5|REST|3|WASHOUT|2022-01-14|2022-01-20|113|119
Study ID|SE|0dc1253a-6f7b-4fb2-a008-832188c2baaf|6|P|4|TREATMENT|2022-01-30|2022-03-10|129|168
Study ID|SE|0dc1253a-6f7b-4fb2-a008-832188c2baaf|7|FU|1|FOLLOW-UP|2021-10-06|2021-10-13|13|20
Study ID|SE|4335a7d8-78a7-43a5-891c-b9db8066e4b7|1|SCRN|2|SCREENING|2021-10-11|2021-11-14|12|46
Study ID|SE|4335a7d8-78a7-43a5-891c-b9db8066e4b7|2|P|5|TREATMENT|2021-10-01|2021-10-10|2|11
Study ID|SE|4335a7d8-78a7-43a5-891c-b9db8066e4b7|3|REST|4|WASHOUT|2021-10-22|2022-01-16|23|109
Study ID|SE|4335a7d8-78a7-43a5-891c-b9db8066e4b7|4|5|6|TREATMENT|2022-03-31|2022-05-06|183|219
Study ID|SE|4335a7d8-78a7-43a5-891c-b9db8066e4b7|5|REST|6|WASHOUT|2021-11-01|2022-04-15|33|198
Study ID|SE|4335a7d8-78a7-43a5-891c-b9db8066e4b7|6|10|5|TREATMENT|2021-10-01|2021-10-09|2|10
Study ID|SE|4335a7d8-78a7-43a5-891c-b9db8066e4b7|7|FU|1|FOLLOW-UP|2021-11-04|2021-12-07|36|69
Study ID|SE|34336761-a918-4570-bbb9-46fcf39cb60f|1|SCRN|7|SCREENING|2021-10-20|2022-01-12|61|145
Study ID|SE|34336761-a918-4570-bbb9-46fcf39cb60f|2|5|3|TREATMENT|2021-08-22|2021-08-23|2|3
Study ID|SE|34336761-a918-4570-bbb9-46fcf39cb60f|3|REST|4|WASHOUT|2021-10-17|2021-12-07|58|109
Study ID|SE|34336761-a918-4570-bbb9-46fcf39cb60f|4|10|2|TREATMENT|2021-09-26|2021-10-22|37|63
Study ID|SE|34336761-a918-4570-bbb9-46fcf39cb60f|5|REST|1|WASHOUT|2021-10-29|2022-04-05|70|228
Study ID|SE|34336761-a918-4570-bbb9-46fcf39cb60f|6|P|1|TREATMENT|2021-09-30|2021-10-22|41|63
Study ID|SE|34336761-a918-4570-bbb9-46fcf39cb60f|7|FU|6|FOLLOW-UP|2021-10-27|2021-12-09|68|111
Study ID|SE|9b20980a-c8fe-4d09-aa6c-2022eeeafdc1|1|SCRN|2|SCREENING|2021-10-27|2021-11-24|80|108
Study ID|SE|9b20980a-c8fe-4d09-aa6c-2022eeeafdc1|2|5|6|TREATMENT|2021-09-01|2021-11-18|24|102
Study ID|SE|9b20980a-c8fe-4d09-aa6c-2022eeeafdc1|3|REST|2|WASHOUT|2021-12-01|2022-05-18|115|283
Study ID|SE|9b20980a-c8fe-4d09-aa6c-2022eeeafdc1|4|P|6|TREATMENT|2021-08-15|2021-09-06|7|29
Study ID|SE|9b20980a-c8fe-4d09-aa6c-2022eeeafdc1|5|REST|7|WASHOUT|2022-05-04|2022-05-09|269|274
Study ID|SE|9b20980a-c8fe-4d09-aa6c-2022eeeafdc1|6|10|4|TREATMENT|2021-09-08|2021-11-28|31|112
Study ID|SE|9b20980a-c8fe-4d09-aa6c-2022eeeafdc1|7|FU|3|FOLLOW-UP|2021-08-29|2021-09-01|21|24
Study ID|SE|b8f38aeb-6f0c-42a9-b7ef-d054e379a0e2|1|SCRN|7|SCREENING|2022-01-16|2022-01-31|126|141
Study ID|SE|b8f38aeb-6f0c-42a9-b7ef-d054e379a0e2|2|5|7|TREATMENT|2021-09-14|2021-11-02|2|51
Study ID|SE|b8f38aeb-6f0c-42a9-b7ef-d054e379a0e2|3|REST|3|WASHOUT|2021-09-26|2022-04-08|14|208
Study ID|SE|b8f38aeb-6f0c-42a9-b7ef-d054e379a0e2|4|10|6|TREATMENT|2021-10-28|2022-06-21|46|282
Study ID|SE|b8f38aeb-6f0c-42a9-b7ef-d054e379a0e2|5|REST|5|WASHOUT|2021-10-30|2021-12-02|48|81
Study ID|SE|b8f38aeb-6f0c-42a9-b7ef-d054e379a0e2|6|P|2|TREATMENT|2021-12-12|2022-06-18|91|279
Study ID|SE|b8f38aeb-6f0c-42a9-b7ef-d054e379a0e2|7|FU|1|FOLLOW-UP|2021-11-23|2021-12-02|72|81
Study ID|SE|2288a9c2-c5cb-4517-91a9-6f329b6c074c|1|SCRN|6|SCREENING|2021-10-15|2021-12-31|27|104
Study ID|SE|2288a9c2-c5cb-4517-91a9-6f329b6c074c|2|5|1|TREATMENT|2022-05-18|2022-07-06|242|291
Study ID|SE|2288a9c2-c5cb-4517-91a9-6f329b6c074c|3|REST|4|WASHOUT|2021-10-07|2022-02-19|19|154
Study ID|SE|2288a9c2-c5cb-4517-91a9-6f329b6c074c|4|10|6|TREATMENT|2021-12-07|2022-05-22|80|246
Study ID|SE|2288a9c2-c5cb-4517-91a9-6f329b6c074c|5|REST|3|WASHOUT|2021-12-02|2022-06-08|75|263
Study ID|SE|2288a9c2-c5cb-4517-91a9-6f329b6c074c|6|P|4|TREATMENT|2022-01-05|2022-04-08|109|202
Study ID|SE|2288a9c2-c5cb-4517-91a9-6f329b6c074c|7|FU|1|FOLLOW-UP|2022-02-04|2022-04-09|139|203
Study ID|SE|a10ca8a1-71ac-4648-966c-a4fbe0ea9f6a|1|SCRN|6|SCREENING|2022-01-31|2022-06-11|127|258
Study ID|SE|a10ca8a1-71ac-4648-966c-a4fbe0ea9f6a|2|5|1|TREATMENT|2021-10-30|2021-11-05|34|40
Study ID|SE|a10ca8a1-71ac-4648-966c-a4fbe0ea9f6a|3|REST|7|WASHOUT|2022-02-24|2022-06-11|151|258
Study ID|SE|a10ca8a1-71ac-4648-966c-a4fbe0ea9f6a|4|10|5|TREATMENT|2022-01-13|2022-06-02|109|249
Study ID|SE|a10ca8a1-71ac-4648-966c-a4fbe0ea9f6a|5|REST|6|WASHOUT|2021-11-05|2021-11-13|40|48
Study ID|SE|a10ca8a1-71ac-4648-966c-a4fbe0ea9f6a|6|P|3|TREATMENT|2021-10-01|2021-10-05|5|9
Study ID|SE|a10ca8a1-71ac-4648-966c-a4fbe0ea9f6a|7|FU|2|FOLLOW-UP|2021-10-14|2021-10-19|18|23
Study ID|SE|10173319-d6ab-4249-a3a5-4e60f68cf5db|1|SCRN|2|SCREENING|2021-09-04|2021-09-08|12|16
Study ID|SE|10173319-d6ab-4249-a3a5-4e60f68cf5db|2|5|4|TREATMENT|2021-12-12|2022-05-10|111|260
Study ID|SE|10173319-d6ab-4249-a3a5-4e60f68cf5db|3|REST|5|WASHOUT|2021-12-28|2022-05-10|127|260
Study ID|SE|10173319-d6ab-4249-a3a5-4e60f68cf5db|4|10|6|TREATMENT|2021-09-06|2021-09-14|14|22
Study ID|SE|10173319-d6ab-4249-a3a5-4e60f68cf5db|5|REST|7|WASHOUT|2022-02-18|2022-03-01|179|190
Study ID|SE|10173319-d6ab-4249-a3a5-4e60f68cf5db|6|P|5|TREATMENT|2022-02-22|2022-05-06|183|256
Study ID|SE|10173319-d6ab-4249-a3a5-4e60f68cf5db|7|FU|1|FOLLOW-UP|2021-09-30|2021-10-23|38|61
Study ID|SE|9a049fca-bafc-4153-83b4-4dc70c68304c|1|SCRN|7|SCREENING|2021-08-19|2021-11-20|8|101
Study ID|SE|9a049fca-bafc-4153-83b4-4dc70c68304c|2|5|3|TREATMENT|2021-08-27|2022-02-25|16|198
Study ID|SE|9a049fca-bafc-4153-83b4-4dc70c68304c|3|REST|5|WASHOUT|2021-08-28|2021-12-23|17|134
Study ID|SE|9a049fca-bafc-4153-83b4-4dc70c68304c|4|P|1|TREATMENT|2021-08-14|2021-11-28|3|109
Study ID|SE|9a049fca-bafc-4153-83b4-4dc70c68304c|5|REST|6|WASHOUT|2021-10-08|2021-10-15|58|65
Study ID|SE|9a049fca-bafc-4153-83b4-4dc70c68304c|6|10|2|TREATMENT|2021-08-24|2021-09-11|13|31
Study ID|SE|9a049fca-bafc-4153-83b4-4dc70c68304c|7|FU|2|FOLLOW-UP|2021-09-09|2021-11-01|29|82
Study ID|SE|285df392-2e9c-494e-852f-54950a3dad0f|1|SCRN|4|SCREENING|2022-04-13|2022-05-10|185|212
Study ID|SE|285df392-2e9c-494e-852f-54950a3dad0f|2|5|2|TREATMENT|2022-01-02|2022-01-31|84|113
Study ID|SE|285df392-2e9c-494e-852f-54950a3dad0f|3|REST|6|WASHOUT|2021-12-06|2022-01-05|57|87
Study ID|SE|285df392-2e9c-494e-852f-54950a3dad0f|4|10|6|TREATMENT|2021-12-26|2022-04-23|77|195
Study ID|SE|285df392-2e9c-494e-852f-54950a3dad0f|5|REST|2|WASHOUT|2021-12-08|2022-01-10|59|92
Study ID|SE|285df392-2e9c-494e-852f-54950a3dad0f|6|P|6|TREATMENT|2021-10-21|2021-10-24|11|14
Study ID|SE|285df392-2e9c-494e-852f-54950a3dad0f|7|FU|1|FOLLOW-UP|2021-10-19|2022-03-20|9|161
Study ID|SE|b9c37acb-5ca8-40fd-8602-d0ad4482f2eb|1|SCRN|5|SCREENING|2022-01-08|2022-02-11|92|126
Study ID|SE|b9c37acb-5ca8-40fd-8602-d0ad4482f2eb|2|5|6|TREATMENT|2022-07-13|2022-07-31|278|296
Study ID|SE|b9c37acb-5ca8-40fd-8602-d0ad4482f2eb|3|REST|3|WASHOUT|2021-12-05|2021-12-13|58|66
Study ID|SE|b9c37acb-5ca8-40fd-8602-d0ad4482f2eb|4|P|6|TREATMENT|2021-10-13|2022-07-11|5|276
Study ID|SE|b9c37acb-5ca8-40fd-8602-d0ad4482f2eb|5|REST|7|WASHOUT|2021-10-14|2022-04-20|6|194
Study ID|SE|b9c37acb-5ca8-40fd-8602-d0ad4482f2eb|6|10|2|TREATMENT|2022-03-15|2022-05-27|158|231
Study ID|SE|b9c37acb-5ca8-40fd-8602-d0ad4482f2eb|7|FU|2|FOLLOW-UP|2022-02-18|2022-07-11|133|276
Study ID|SE|e7ce576e-012e-4632-ada0-59e2a592d408|1|SCRN|2|SCREENING|2021-11-28|2021-12-05|78|85
Study ID|SE|e7ce576e-012e-4632-ada0-59e2a592d408|2|5|1|TREATMENT|2021-10-16|2021-10-19|35|38
Study ID|SE|e7ce576e-012e-4632-ada0-59e2a592d408|3|REST|4|WASHOUT|2021-11-20|2022-04-10|70|211
Study ID|SE|e7ce576e-012e-4632-ada0-59e2a592d408|4|P|5|TREATMENT|2021-12-20|2022-04-07|100|208
Study ID|SE|e7ce576e-012e-4632-ada0-59e2a592d408|5|REST|7|WASHOUT|2021-10-08|2022-06-09|27|271
Study ID|SE|e7ce576e-012e-4632-ada0-59e2a592d408|6|10|3|TREATMENT|2022-02-14|2022-03-09|156|179
Study ID|SE|e7ce576e-012e-4632-ada0-59e2a592d408|7|FU|4|FOLLOW-UP|2021-09-17|2021-10-07|6|26
Study ID|SE|d8a4a180-a82d-4ddb-9274-5d83c70112a3|1|SCRN|6|SCREENING|2021-09-21|2021-10-11|14|34
Study ID|SE|d8a4a180-a82d-4ddb-9274-5d83c70112a3|2|P|2|TREATMENT|2022-01-07|2022-01-18|122|133
Study ID|SE|d8a4a180-a82d-4ddb-9274-5d83c70112a3|3|REST|1|WASHOUT|2021-09-17|2021-09-19|10|12
Study ID|SE|d8a4a180-a82d-4ddb-9274-5d83c70112a3|4|5|3|TREATMENT|2021-12-29|2022-05-05|113|240
Study ID|SE|d8a4a180-a82d-4ddb-9274-5d83c70112a3|5|REST|3|WASHOUT|2022-01-09|2022-04-08|124|213
Study ID|SE|d8a4a180-a82d-4ddb-9274-5d83c70112a3|6|10|6|TREATMENT|2022-03-25|2022-06-30|199|296
Study ID|SE|d8a4a180-a82d-4ddb-9274-5d83c70112a3|7|FU|2|FOLLOW-UP|2021-09-19|2022-02-15|12|161
Study ID|SE|63706db7-5cac-4126-a1ab-dca325988bf6|1|SCRN|6|SCREENING|2022-03-08|2022-04-23|133|179
Study ID|SE|63706db7-5cac-4126-a1ab-dca325988bf6|2|5|3|TREATMENT|2021-11-06|2021-11-20|11|25
Study ID|SE|63706db7-5cac-4126-a1ab-dca325988bf6|3|REST|5|WASHOUT|2022-06-09|2022-06-19|226|236
Study ID|SE|63706db7-5cac-4126-a1ab-dca325988bf6|4|P|6|TREATMENT|2021-11-17|2021-12-16|22|51
Study ID|SE|63706db7-5cac-4126-a1ab-dca325988bf6|5|REST|6|WASHOUT|2022-03-30|2022-08-13|155|291
Study ID|SE|63706db7-5cac-4126-a1ab-dca325988bf6|6|10|7|TREATMENT|2021-11-23|2021-12-28|28|63
Study ID|SE|63706db7-5cac-4126-a1ab-dca325988bf6|7|FU|5|FOLLOW-UP|2021-11-01|2022-04-05|6|161
Study ID|SE|9eed1701-6dbc-45c7-8ea7-4d5b686fb6ff|1|SCRN|7|SCREENING|2022-03-22|2022-05-31|215|285
Study ID|SE|9eed1701-6dbc-45c7-8ea7-4d5b686fb6ff|2|5|4|TREATMENT|2021-08-25|2022-05-17|6|271
Study ID|SE|9eed1701-6dbc-45c7-8ea7-4d5b686fb6ff|3|REST|4|WASHOUT|2021-09-08|2022-03-08|20|201
Study ID|SE|9eed1701-6dbc-45c7-8ea7-4d5b686fb6ff|4|P|1|TREATMENT|2021-10-29|2022-03-22|71|215
Study ID|SE|9eed1701-6dbc-45c7-8ea7-4d5b686fb6ff|5|REST|6|WASHOUT|2021-12-13|2022-04-17|116|241
Study ID|SE|9eed1701-6dbc-45c7-8ea7-4d5b686fb6ff|6|10|6|TREATMENT|2021-10-04|2022-04-04|46|228
Study ID|SE|9eed1701-6dbc-45c7-8ea7-4d5b686fb6ff|7|FU|4|FOLLOW-UP|2021-09-18|2021-09-25|30|37
Study ID|SE|74d84f4c-4566-4249-96a1-533de932dd89|1|SCRN|5|SCREENING|2021-11-29|2021-12-29|43|73
Study ID|SE|74d84f4c-4566-4249-96a1-533de932dd89|2|5|1|TREATMENT|2021-11-18|2022-03-22|32|156
Study ID|SE|74d84f4c-4566-4249-96a1-533de932dd89|3|REST|1|WASHOUT|2021-12-30|2022-06-22|74|248
Study ID|SE|74d84f4c-4566-4249-96a1-533de932dd89|4|10|5|TREATMENT|2022-01-31|2022-03-11|106|145
Study ID|SE|74d84f4c-4566-4249-96a1-533de932dd89|5|REST|7|WASHOUT|2022-02-11|2022-05-04|117|199
Study ID|SE|74d84f4c-4566-4249-96a1-533de932dd89|6|P|6|TREATMENT|2022-07-13|2022-07-23|269|279
Study ID|SE|74d84f4c-4566-4249-96a1-533de932dd89|7|FU|3|FOLLOW-UP|2022-04-06|2022-04-24|171|189
Study ID|SE|fe2e55ec-2e4c-4baa-9c92-60e7ed17c458|1|SCRN|3|SCREENING|2021-09-10|2022-05-09|23|264
Study ID|SE|fe2e55ec-2e4c-4baa-9c92-60e7ed17c458|2|P|3|TREATMENT|2021-09-21|2021-10-27|34|70
Study ID|SE|fe2e55ec-2e4c-4baa-9c92-60e7ed17c458|3|REST|3|WASHOUT|2022-01-10|2022-04-01|145|226
Study ID|SE|fe2e55ec-2e4c-4baa-9c92-60e7ed17c458|4|5|1|TREATMENT|2021-10-31|2022-02-10|74|176
Study ID|SE|fe2e55ec-2e4c-4baa-9c92-60e7ed17c458|5|REST|1|WASHOUT|2021-09-24|2021-11-01|37|75
Study ID|SE|fe2e55ec-2e4c-4baa-9c92-60e7ed17c458|6|10|6|TREATMENT|2021-09-19|2022-05-02|32|257
Study ID|SE|fe2e55ec-2e4c-4baa-9c92-60e7ed17c458|7|FU|3|FOLLOW-UP|2021-09-16|2022-01-02|29|137
Study ID|SE|86bb2bc8-a4ec-4965-af26-11f4979f99bb|1|SCRN|3|SCREENING|2021-08-30|2021-09-10|14|25
Study ID|SE|86bb2bc8-a4ec-4965-af26-11f4979f99bb|2|5|2|TREATMENT|2021-10-27|2022-02-19|72|187
Study ID|SE|86bb2bc8-a4ec-4965-af26-11f4979f99bb|3|REST|7|WASHOUT|2021-09-04|2022-03-06|19|202
Study ID|SE|86bb2bc8-a4ec-4965-af26-11f4979f99bb|4|P|4|TREATMENT|2021-08-22|2021-10-08|6|53
Study ID|SE|86bb2bc8-a4ec-4965-af26-11f4979f99bb|5|REST|5|WASHOUT|2021-10-05|2021-10-27|50|72
Study ID|SE|86bb2bc8-a4ec-4965-af26-11f4979f99bb|6|10|4|TREATMENT|2021-10-22|2022-02-24|67|192
Study ID|SE|86bb2bc8-a4ec-4965-af26-11f4979f99bb|7|FU|3|FOLLOW-UP|2021-10-09|2022-03-12|54|208
Study ID|SE|974ff09c-caf2-414a-ba3a-9b9471fbd620|1|SCRN|2|SCREENING|2021-12-09|2022-06-04|102|279
Study ID|SE|974ff09c-caf2-414a-ba3a-9b9471fbd620|2|5|6|TREATMENT|2021-10-11|2022-01-10|43|134
Study ID|SE|974ff09c-caf2-414a-ba3a-9b9471fbd620|3|REST|5|WASHOUT|2021-10-14|2021-11-04|46|67
Study ID|SE|974ff09c-caf2-414a-ba3a-9b9471fbd620|4|10|6|TREATMENT|2021-12-09|2022-02-08|102|163
Study ID|SE|974ff09c-caf2-414a-ba3a-9b9471fbd620|5|REST|6|WASHOUT|2022-03-08|2022-06-04|191|279
Study ID|SE|974ff09c-caf2-414a-ba3a-9b9471fbd620|6|P|3|TREATMENT|2021-09-21|2021-10-17|23|49
Study ID|SE|974ff09c-caf2-414a-ba3a-9b9471fbd620|7|FU|2|FOLLOW-UP|2022-04-18|2022-05-21|232|265
Study ID|SE|c9ec4c3f-144a-44b6-b5a8-83bb25599c0e|1|SCRN|6|SCREENING|2021-11-18|2022-01-03|99|145
Study ID|SE|c9ec4c3f-144a-44b6-b5a8-83bb25599c0e|2|5|4|TREATMENT|2022-04-07|2022-05-02|239|264
Study ID|SE|c9ec4c3f-144a-44b6-b5a8-83bb25599c0e|3|REST|4|WASHOUT|2021-08-21|2022-05-30|10|292
Study ID|SE|c9ec4c3f-144a-44b6-b5a8-83bb25599c0e|4|P|1|TREATMENT|2021-10-25|2022-02-23|75|196
Study ID|SE|c9ec4c3f-144a-44b6-b5a8-83bb25599c0e|5|REST|6|WASHOUT|2021-10-30|2022-02-20|80|193
Study ID|SE|c9ec4c3f-144a-44b6-b5a8-83bb25599c0e|6|10|7|TREATMENT|2021-12-30|2022-03-28|141|229
Study ID|SE|c9ec4c3f-144a-44b6-b5a8-83bb25599c0e|7|FU|2|FOLLOW-UP|2021-12-08|2022-02-24|119|197
Study ID|SE|713e69bd-2de6-434b-94ba-20b55da40e62|1|SCRN|2|SCREENING|2021-11-13|2022-02-11|94|184
Study ID|SE|713e69bd-2de6-434b-94ba-20b55da40e62|2|P|2|TREATMENT|2021-08-22|2021-11-30|11|111
Study ID|SE|713e69bd-2de6-434b-94ba-20b55da40e62|3|REST|5|WASHOUT|2021-10-16|2022-01-15|66|157
Study ID|SE|713e69bd-2de6-434b-94ba-20b55da40e62|4|5|2|TREATMENT|2021-11-13|2021-11-25|94|106
Study ID|SE|713e69bd-2de6-434b-94ba-20b55da40e62|5|REST|1|WASHOUT|2022-02-08|2022-04-07|181|239
Study ID|SE|713e69bd-2de6-434b-94ba-20b55da40e62|6|10|7|TREATMENT|2021-11-10|2021-11-17|91|98
Study ID|SE|713e69bd-2de6-434b-94ba-20b55da40e62|7|FU|2|FOLLOW-UP|2021-12-19|2022-04-30|130|262
Study ID|SE|7ab6fabe-0ef9-4661-9eec-f16834285435|1|SCRN|7|SCREENING|2022-05-17|2022-06-13|249|276
Study ID|SE|7ab6fabe-0ef9-4661-9eec-f16834285435|2|P|6|TREATMENT|2022-02-04|2022-05-16|147|248
Study ID|SE|7ab6fabe-0ef9-4661-9eec-f16834285435|3|REST|3|WASHOUT|2021-12-03|2022-05-23|84|255
Study ID|SE|7ab6fabe-0ef9-4661-9eec-f16834285435|4|5|1|TREATMENT|2021-12-03|2022-04-28|84|230
Study ID|SE|7ab6fabe-0ef9-4661-9eec-f16834285435|5|REST|3|WASHOUT|2021-10-03|2021-10-27|23|47
Study ID|SE|7ab6fabe-0ef9-4661-9eec-f16834285435|6|10|7|TREATMENT|2021-10-01|2021-12-07|21|88
Study ID|SE|7ab6fabe-0ef9-4661-9eec-f16834285435|7|FU|6|FOLLOW-UP|2021-09-14|2021-12-08|4|89
Study ID|SE|2d16c162-8f9f-4753-a06f-406c60f8bd9a|1|SCRN|1|SCREENING|2021-11-04|2021-12-17|19|62
Study ID|SE|2d16c162-8f9f-4753-a06f-406c60f8bd9a|2|5|2|TREATMENT|2021-11-21|2022-01-05|36|81
Study ID|SE|2d16c162-8f9f-4753-a06f-406c60f8bd9a|3|REST|7|WASHOUT|2022-03-28|2022-04-28|163|194
Study ID|SE|2d16c162-8f9f-4753-a06f-406c60f8bd9a|4|P|6|TREATMENT|2022-03-28|2022-07-29|163|286
Study ID|SE|2d16c162-8f9f-4753-a06f-406c60f8bd9a|5|REST|6|WASHOUT|2022-05-08|2022-05-12|204|208
Study ID|SE|2d16c162-8f9f-4753-a06f-406c60f8bd9a|6|10|5|TREATMENT|2022-02-07|2022-04-15|114|181
Study ID|SE|2d16c162-8f9f-4753-a06f-406c60f8bd9a|7|FU|1|FOLLOW-UP|2022-01-26|2022-03-09|102|144
Study ID|SE|4fc2b201-daad-42fb-b99c-63629135b9ce|1|SCRN|1|SCREENING|2022-06-14|2022-08-07|241|295
Study ID|SE|4fc2b201-daad-42fb-b99c-63629135b9ce|2|5|2|TREATMENT|2022-02-02|2022-06-08|109|235
Study ID|SE|4fc2b201-daad-42fb-b99c-63629135b9ce|3|REST|3|WASHOUT|2022-01-03|2022-04-15|79|181
Study ID|SE|4fc2b201-daad-42fb-b99c-63629135b9ce|4|P|6|TREATMENT|2021-10-28|2022-02-06|12|113
Study ID|SE|4fc2b201-daad-42fb-b99c-63629135b9ce|5|REST|2|WASHOUT|2021-10-27|2021-10-28|11|12
Study ID|SE|4fc2b201-daad-42fb-b99c-63629135b9ce|6|10|6|TREATMENT|2021-10-19|2021-10-21|3|5
Study ID|SE|4fc2b201-daad-42fb-b99c-63629135b9ce|7|FU|5|FOLLOW-UP|2022-01-29|2022-05-20|105|216
Study ID|SE|aaac8972-4d1a-45b2-ae50-57b398adf837|1|SCRN|6|SCREENING|2021-09-27|2021-10-05|2|10
Study ID|SE|aaac8972-4d1a-45b2-ae50-57b398adf837|2|P|4|TREATMENT|2021-10-20|2021-12-26|25|92
Study ID|SE|aaac8972-4d1a-45b2-ae50-57b398adf837|3|REST|5|WASHOUT|2021-12-19|2022-01-16|85|113
Study ID|SE|aaac8972-4d1a-45b2-ae50-57b398adf837|4|5|5|TREATMENT|2021-11-29|2022-02-18|65|146
Study ID|SE|aaac8972-4d1a-45b2-ae50-57b398adf837|5|REST|7|WASHOUT|2021-12-05|2022-02-06|71|134
Study ID|SE|aaac8972-4d1a-45b2-ae50-57b398adf837|6|10|2|TREATMENT|2021-12-19|2022-02-13|85|141
Study ID|SE|aaac8972-4d1a-45b2-ae50-57b398adf837|7|FU|1|FOLLOW-UP|2021-09-29|2022-01-18|4|115
Study ID|SE|5921f5c3-9900-4dba-a835-77dfc8c43637|1|SCRN|6|SCREENING|2021-10-27|2022-01-01|15|81
Study ID|SE|5921f5c3-9900-4dba-a835-77dfc8c43637|2|5|4|TREATMENT|2022-05-15|2022-05-28|215|228
Study ID|SE|5921f5c3-9900-4dba-a835-77dfc8c43637|3|REST|1|WASHOUT|2021-10-15|2021-10-19|3|7
Study ID|SE|5921f5c3-9900-4dba-a835-77dfc8c43637|4|P|2|TREATMENT|2022-03-11|2022-05-20|150|220
Study ID|SE|5921f5c3-9900-4dba-a835-77dfc8c43637|5|REST|1|WASHOUT|2022-03-13|2022-05-17|152|217
Study ID|SE|5921f5c3-9900-4dba-a835-77dfc8c43637|6|10|3|TREATMENT|2021-11-30|2021-12-30|49|79
Study ID|SE|5921f5c3-9900-4dba-a835-77dfc8c43637|7|FU|3|FOLLOW-UP|2022-03-19|2022-03-20|158|159
Study ID|SE|d4377c02-9a8e-4aca-a5b2-2669c963918c|1|SCRN|2|SCREENING|2021-09-15|2021-12-03|9|88
Study ID|SE|d4377c02-9a8e-4aca-a5b2-2669c963918c|2|5|2|TREATMENT|2022-04-26|2022-06-09|232|276
Study ID|SE|d4377c02-9a8e-4aca-a5b2-2669c963918c|3|REST|3|WASHOUT|2021-11-29|2022-06-08|84|275
Study ID|SE|d4377c02-9a8e-4aca-a5b2-2669c963918c|4|P|7|TREATMENT|2021-12-09|2022-06-09|94|276
Study ID|SE|d4377c02-9a8e-4aca-a5b2-2669c963918c|5|REST|1|WASHOUT|2021-09-09|2021-10-20|3|44
Study ID|SE|d4377c02-9a8e-4aca-a5b2-2669c963918c|6|10|7|TREATMENT|2022-02-03|2022-02-04|150|151
Study ID|SE|d4377c02-9a8e-4aca-a5b2-2669c963918c|7|FU|2|FOLLOW-UP|2021-09-11|2021-10-01|5|25
Study ID|SE|d84da97a-bd8d-4dba-8eb2-e545c8eac4e4|1|SCRN|6|SCREENING|2022-01-16|2022-08-03|100|299
Study ID|SE|d84da97a-bd8d-4dba-8eb2-e545c8eac4e4|2|P|1|TREATMENT|2021-11-25|2022-01-03|48|87
Study ID|SE|d84da97a-bd8d-4dba-8eb2-e545c8eac4e4|3|REST|3|WASHOUT|2021-10-28|2022-01-21|20|105
Study ID|SE|d84da97a-bd8d-4dba-8eb2-e545c8eac4e4|4|5|2|TREATMENT|2022-02-20|2022-06-25|135|260
Study ID|SE|d84da97a-bd8d-4dba-8eb2-e545c8eac4e4|5|REST|6|WASHOUT|2021-10-10|2021-10-14|2|6
Study ID|SE|d84da97a-bd8d-4dba-8eb2-e545c8eac4e4|6|10|7|TREATMENT|2021-11-17|2021-12-21|40|74
Study ID|SE|d84da97a-bd8d-4dba-8eb2-e545c8eac4e4|7|FU|6|FOLLOW-UP|2021-11-12|2021-11-27|35|50
Study ID|SE|9fc55af3-7317-40ed-bc56-1a89dd399808|1|SCRN|1|SCREENING|2022-02-26|2022-06-25|157|276
Study ID|SE|9fc55af3-7317-40ed-bc56-1a89dd399808|2|5|4|TREATMENT|2021-12-11|2021-12-22|80|91
Study ID|SE|9fc55af3-7317-40ed-bc56-1a89dd399808|3|REST|6|WASHOUT|2021-11-05|2022-03-06|44|165
Study ID|SE|9fc55af3-7317-40ed-bc56-1a89dd399808|4|P|1|TREATMENT|2021-10-29|2022-06-19|37|270
Study ID|SE|9fc55af3-7317-40ed-bc56-1a89dd399808|5|REST|1|WASHOUT|2022-01-31|2022-02-19|131|150
Study ID|SE|9fc55af3-7317-40ed-bc56-1a89dd399808|6|10|1|TREATMENT|2021-09-30|2021-10-02|8|10
Study ID|SE|9fc55af3-7317-40ed-bc56-1a89dd399808|7|FU|1|FOLLOW-UP|2021-11-15|2022-01-20|54|120
Study ID|SE|a68f4255-fc70-4b26-a0c0-d6de9b7369d0|1|SCRN|4|SCREENING|2021-12-06|2022-03-06|38|128
Study ID|SE|a68f4255-fc70-4b26-a0c0-d6de9b7369d0|2|P|2|TREATMENT|2021-10-31|2021-10-31|2|2
Study ID|SE|a68f4255-fc70-4b26-a0c0-d6de9b7369d0|3|REST|3|WASHOUT|2022-04-13|2022-05-27|166|210
Study ID|SE|a68f4255-fc70-4b26-a0c0-d6de9b7369d0|4|5|7|TREATMENT|2022-02-01|2022-08-01|95|276
Study ID|SE|a68f4255-fc70-4b26-a0c0-d6de9b7369d0|5|REST|7|WASHOUT|2021-11-26|2022-01-07|28|70
Study ID|SE|a68f4255-fc70-4b26-a0c0-d6de9b7369d0|6|10|5|TREATMENT|2021-11-22|2022-06-02|24|216
Study ID|SE|a68f4255-fc70-4b26-a0c0-d6de9b7369d0|7|FU|3|FOLLOW-UP|2021-11-16|2021-11-26|18|28
Study ID|SE|deae6b40-62c1-4064-bf0f-ab4f8fb92555|1|SCRN|5|SCREENING|2021-09-14|2021-09-15|9|10
Study ID|SE|deae6b40-62c1-4064-bf0f-ab4f8fb92555|2|5|5|TREATMENT|2021-12-11|2022-05-05|97|242
Study ID|SE|deae6b40-62c1-4064-bf0f-ab4f8fb92555|3|REST|1|WASHOUT|2021-09-07|2021-09-18|2|13
Study ID|SE|deae6b40-62c1-4064-bf0f-ab4f8fb92555|4|P|7|TREATMENT|2021-10-13|2021-10-28|38|53
Study ID|SE|deae6b40-62c1-4064-bf0f-ab4f8fb92555|5|REST|7|WASHOUT|2022-01-12|2022-05-13|129|250
Study ID|SE|deae6b40-62c1-4064-bf0f-ab4f8fb92555|6|10|4|TREATMENT|2022-04-27|2022-06-29|234|297
Study ID|SE|deae6b40-62c1-4064-bf0f-ab4f8fb92555|7|FU|7|FOLLOW-UP|2021-09-30|2021-10-18|25|43
Study ID|SE|a564a6ed-ebde-4d1d-a934-b54eb473a48f|1|SCRN|4|SCREENING|2022-05-02|2022-06-05|194|228
Study ID|SE|a564a6ed-ebde-4d1d-a934-b54eb473a48f|2|5|6|TREATMENT|2021-11-10|2021-11-11|21|22
Study ID|SE|a564a6ed-ebde-4d1d-a934-b54eb473a48f|3|REST|4|WASHOUT|2022-01-03|2022-01-20|75|92
Study ID|SE|a564a6ed-ebde-4d1d-a934-b54eb473a48f|4|10|5|TREATMENT|2021-11-23|2021-12-31|34|72
Study ID|SE|a564a6ed-ebde-4d1d-a934-b54eb473a48f|5|REST|3|WASHOUT|2022-04-11|2022-04-21|173|183
Study ID|SE|a564a6ed-ebde-4d1d-a934-b54eb473a48f|6|P|3|TREATMENT|2021-11-06|2022-06-15|17|238
Study ID|SE|a564a6ed-ebde-4d1d-a934-b54eb473a48f|7|FU|2|FOLLOW-UP|2021-11-08|2021-11-16|19|27
Study ID|SE|326438a0-7ab6-48c3-95d7-43bf8f86b14c|1|SCRN|2|SCREENING|2021-09-28|2021-11-29|44|106
Study ID|SE|326438a0-7ab6-48c3-95d7-43bf8f86b14c|2|P|3|TREATMENT|2021-08-17|2021-08-17|2|2
Study ID|SE|326438a0-7ab6-48c3-95d7-43bf8f86b14c|3|REST|4|WASHOUT|2021-08-22|2021-09-01|7|17
Study ID|SE|326438a0-7ab6-48c3-95d7-43bf8f86b14c|4|5|6|TREATMENT|2022-03-12|2022-05-21|209|279
Study ID|SE|326438a0-7ab6-48c3-95d7-43bf8f86b14c|5|REST|7|WASHOUT|2022-01-28|2022-06-04|166|293
Study ID|SE|326438a0-7ab6-48c3-95d7-43bf8f86b14c|6|10|3|TREATMENT|2021-11-22|2021-12-07|99|114
Study ID|SE|326438a0-7ab6-48c3-95d7-43bf8f86b14c|7|FU|1|FOLLOW-UP|2021-11-18|2022-03-10|95|207
Study ID|SE|85d8f88d-a898-4915-a9c3-caa158d0b213|1|SCRN|5|SCREENING|2022-02-14|2022-06-10|182|298
Study ID|SE|85d8f88d-a898-4915-a9c3-caa158d0b213|2|5|2|TREATMENT|2021-09-02|2021-11-14|17|90
Study ID|SE|85d8f88d-a898-4915-a9c3-caa158d0b213|3|REST|2|WASHOUT|2021-08-27|2022-04-08|11|235
Study ID|SE|85d8f88d-a898-4915-a9c3-caa158d0b213|4|10|3|TREATMENT|2021-12-01|2022-05-08|107|265
Study ID|SE|85d8f88d-a898-4915-a9c3-caa158d0b213|5|REST|2|WASHOUT|2021-09-08|2021-11-23|23|99
Study ID|SE|85d8f88d-a898-4915-a9c3-caa158d0b213|6|P|6|TREATMENT|2021-08-23|2021-08-26|7|10
Study ID|SE|85d8f88d-a898-4915-a9c3-caa158d0b213|7|FU|7|FOLLOW-UP|2021-08-18|2021-09-24|2|39
Study ID|SE|2d55e323-8719-4ffa-ab70-11adf033ce07|1|SCRN|3|SCREENING|2022-03-09|2022-08-20|134|298
Study ID|SE|2d55e323-8719-4ffa-ab70-11adf033ce07|2|5|4|TREATMENT|2022-01-08|2022-06-23|74|240
Study ID|SE|2d55e323-8719-4ffa-ab70-11adf033ce07|3|REST|3|WASHOUT|2021-11-09|2022-01-09|14|75
Study ID|SE|2d55e323-8719-4ffa-ab70-11adf033ce07|4|10|2|TREATMENT|2021-12-13|2022-01-06|48|72
Study ID|SE|2d55e323-8719-4ffa-ab70-11adf033ce07|5|REST|1|WASHOUT|2021-12-27|2022-04-12|62|168
Study ID|SE|2d55e323-8719-4ffa-ab70-11adf033ce07|6|P|2|TREATMENT|2021-11-05|2021-11-09|10|14
Study ID|SE|2d55e323-8719-4ffa-ab70-11adf033ce07|7|FU|1|FOLLOW-UP|2022-04-03|2022-05-14|159|200
Study ID|SE|0246f358-ce63-4bd6-a125-594ff357723e|1|SCRN|6|SCREENING|2021-12-09|2021-12-12|67|70
Study ID|SE|0246f358-ce63-4bd6-a125-594ff357723e|2|5|4|TREATMENT|2022-03-04|2022-06-04|152|244
Study ID|SE|0246f358-ce63-4bd6-a125-594ff357723e|3|REST|7|WASHOUT|2021-11-22|2022-01-28|50|117
Study ID|SE|0246f358-ce63-4bd6-a125-594ff357723e|4|10|1|TREATMENT|2021-11-08|2022-05-23|36|232
Study ID|SE|0246f358-ce63-4bd6-a125-594ff357723e|5|REST|1|WASHOUT|2022-02-23|2022-06-08|143|248
Study ID|SE|0246f358-ce63-4bd6-a125-594ff357723e|6|P|3|TREATMENT|2021-12-02|2022-04-09|60|188
Study ID|SE|0246f358-ce63-4bd6-a125-594ff357723e|7|FU|1|FOLLOW-UP|2021-10-21|2021-10-28|18|25
Study ID|SE|149e623e-b430-45e2-924e-46c437f3db59|1|SCRN|3|SCREENING|2021-12-21|2022-03-26|105|200
Study ID|SE|149e623e-b430-45e2-924e-46c437f3db59|2|5|7|TREATMENT|2022-04-22|2022-05-17|227|252
Study ID|SE|149e623e-b430-45e2-924e-46c437f3db59|3|REST|1|WASHOUT|2021-09-19|2021-09-27|12|20
Study ID|SE|149e623e-b430-45e2-924e-46c437f3db59|4|P|5|TREATMENT|2021-12-06|2022-02-19|90|165
Study ID|SE|149e623e-b430-45e2-924e-46c437f3db59|5|REST|4|WASHOUT|2021-12-03|2022-04-01|87|206
Study ID|SE|149e623e-b430-45e2-924e-46c437f3db59|6|10|6|TREATMENT|2021-09-27|2021-10-09|20|32
Study ID|SE|149e623e-b430-45e2-924e-46c437f3db59|7|FU|2|FOLLOW-UP|2021-12-13|2022-03-24|97|198
Study ID|SE|fcb09a08-0491-4bc4-a9b1-1fbd89586f71|1|SCRN|1|SCREENING|2021-10-03|2021-11-24|41|93
Study ID|SE|fcb09a08-0491-4bc4-a9b1-1fbd89586f71|2|5|1|TREATMENT|2021-10-24|2022-01-15|62|145
Study ID|SE|fcb09a08-0491-4bc4-a9b1-1fbd89586f71|3|REST|7|WASHOUT|2021-12-16|2021-12-30|115|129
Study ID|SE|fcb09a08-0491-4bc4-a9b1-1fbd89586f71|4|10|3|TREATMENT|2022-01-12|2022-06-14|142|295
Study ID|SE|fcb09a08-0491-4bc4-a9b1-1fbd89586f71|5|REST|7|WASHOUT|2021-09-21|2021-10-01|29|39
Study ID|SE|fcb09a08-0491-4bc4-a9b1-1fbd89586f71|6|P|7|TREATMENT|2022-01-02|2022-01-12|132|142
Study ID|SE|fcb09a08-0491-4bc4-a9b1-1fbd89586f71|7|FU|5|FOLLOW-UP|2021-09-01|2021-10-14|9|52
Study ID|SE|b5ad47f0-2842-430f-a0d9-aba11223ccfe|1|SCRN|3|SCREENING|2022-02-23|2022-05-22|164|252
Study ID|SE|b5ad47f0-2842-430f-a0d9-aba11223ccfe|2|5|1|TREATMENT|2021-12-12|2022-01-17|91|127
Study ID|SE|b5ad47f0-2842-430f-a0d9-aba11223ccfe|3|REST|4|WASHOUT|2022-03-15|2022-07-07|184|298
Study ID|SE|b5ad47f0-2842-430f-a0d9-aba11223ccfe|4|P|5|TREATMENT|2022-06-03|2022-06-20|264|281
Study ID|SE|b5ad47f0-2842-430f-a0d9-aba11223ccfe|5|REST|1|WASHOUT|2021-09-29|2021-11-17|17|66
Study ID|SE|b5ad47f0-2842-430f-a0d9-aba11223ccfe|6|10|7|TREATMENT|2021-10-07|2022-01-23|25|133
Study ID|SE|b5ad47f0-2842-430f-a0d9-aba11223ccfe|7|FU|5|FOLLOW-UP|2021-10-10|2021-11-04|28|53
Study ID|SE|1075bd3e-efcb-419d-8725-fab6f0c13f3a|1|SCRN|7|SCREENING|2021-09-24|2021-10-24|33|63
Study ID|SE|1075bd3e-efcb-419d-8725-fab6f0c13f3a|2|5|7|TREATMENT|2021-10-15|2021-11-12|54|82
Study ID|SE|1075bd3e-efcb-419d-8725-fab6f0c13f3a|3|REST|7|WASHOUT|2021-08-25|2021-08-31|3|9
Study ID|SE|1075bd3e-efcb-419d-8725-fab6f0c13f3a|4|P|1|TREATMENT|2021-11-09|2022-04-21|79|242
Study ID|SE|1075bd3e-efcb-419d-8725-fab6f0c13f3a|5|REST|7|WASHOUT|2022-01-26|2022-04-04|157|225
Study ID|SE|1075bd3e-efcb-419d-8725-fab6f0c13f3a|6|10|6|TREATMENT|2021-10-16|2021-11-24|55|94
Study ID|SE|1075bd3e-efcb-419d-8725-fab6f0c13f3a|7|FU|6|FOLLOW-UP|2022-02-27|2022-03-02|189|192
Study ID|SE|55a344d4-09b0-470b-9607-a19be9d5bd8d|1|SCRN|1|SCREENING|2021-12-08|2022-03-15|53|150
Study ID|SE|55a344d4-09b0-470b-9607-a19be9d5bd8d|2|5|5|TREATMENT|2021-10-30|2022-05-10|14|206
Study ID|SE|55a344d4-09b0-470b-9607-a19be9d5bd8d|3|REST|7|WASHOUT|2022-03-20|2022-07-27|155|284
Study ID|SE|55a344d4-09b0-470b-9607-a19be9d5bd8d|4|P|4|TREATMENT|2021-12-25|2022-04-06|70|172
Study ID|SE|55a344d4-09b0-470b-9607-a19be9d5bd8d|5|REST|6|WASHOUT|2022-01-19|2022-05-17|95|213
Study ID|SE|55a344d4-09b0-470b-9607-a19be9d5bd8d|6|10|4|TREATMENT|2021-11-20|2022-04-29|35|195
Study ID|SE|55a344d4-09b0-470b-9607-a19be9d5bd8d|7|FU|3|FOLLOW-UP|2021-11-28|2022-02-13|43|120
Study ID|SE|4fa27209-acde-4b73-852c-9124a6608f5a|1|SCRN|3|SCREENING|2021-11-30|2022-02-05|39|106
Study ID|SE|4fa27209-acde-4b73-852c-9124a6608f5a|2|5|3|TREATMENT|2021-12-01|2022-01-04|40|74
Study ID|SE|4fa27209-acde-4b73-852c-9124a6608f5a|3|REST|7|WASHOUT|2022-02-09|2022-04-29|110|189
Study ID|SE|4fa27209-acde-4b73-852c-9124a6608f5a|4|10|4|TREATMENT|2021-10-27|2022-02-16|5|117
Study ID|SE|4fa27209-acde-4b73-852c-9124a6608f5a|5|REST|1|WASHOUT|2021-10-26|2021-12-23|4|62
Study ID|SE|4fa27209-acde-4b73-852c-9124a6608f5a|6|P|1|TREATMENT|2021-10-24|2021-10-26|2|4
Study ID|SE|4fa27209-acde-4b73-852c-9124a6608f5a|7|FU|6|FOLLOW-UP|2021-12-07|2022-08-01|46|283
Study ID|SE|d692395a-1a30-4960-95f6-7e854c9f7ce4|1|SCRN|4|SCREENING|2022-01-17|2022-03-22|119|183
Study ID|SE|d692395a-1a30-4960-95f6-7e854c9f7ce4|2|5|3|TREATMENT|2022-02-13|2022-03-10|146|171
Study ID|SE|d692395a-1a30-4960-95f6-7e854c9f7ce4|3|REST|7|WASHOUT|2022-03-22|2022-04-01|183|193
Study ID|SE|d692395a-1a30-4960-95f6-7e854c9f7ce4|4|10|6|TREATMENT|2021-11-08|2022-02-27|49|160
Study ID|SE|d692395a-1a30-4960-95f6-7e854c9f7ce4|5|REST|4|WASHOUT|2021-11-06|2022-01-15|47|117
Study ID|SE|d692395a-1a30-4960-95f6-7e854c9f7ce4|6|P|6|TREATMENT|2021-10-17|2022-02-25|27|158
Study ID|SE|d692395a-1a30-4960-95f6-7e854c9f7ce4|7|FU|2|FOLLOW-UP|2021-10-04|2022-03-04|14|165
Study ID|SE|ac690278-07ba-4f47-ad36-f90640c4cac1|1|SCRN|4|SCREENING|2021-12-07|2022-01-20|74|118
Study ID|SE|ac690278-07ba-4f47-ad36-f90640c4cac1|2|5|6|TREATMENT|2021-10-29|2021-11-07|35|44
Study ID|SE|ac690278-07ba-4f47-ad36-f90640c4cac1|3|REST|5|WASHOUT|2022-02-15|2022-04-12|144|200
Study ID|SE|ac690278-07ba-4f47-ad36-f90640c4cac1|4|10|4|TREATMENT|2022-03-24|2022-06-20|181|269
Study ID|SE|ac690278-07ba-4f47-ad36-f90640c4cac1|5|REST|3|WASHOUT|2022-01-14|2022-05-07|112|225
Study ID|SE|ac690278-07ba-4f47-ad36-f90640c4cac1|6|P|1|TREATMENT|2021-09-26|2021-10-13|2|19
Study ID|SE|ac690278-07ba-4f47-ad36-f90640c4cac1|7|FU|6|FOLLOW-UP|2021-09-30|2021-10-04|6|10
Study ID|SE|3344cb70-4cee-4871-9e3c-ee86dc8c09b4|1|SCRN|4|SCREENING|2022-03-21|2022-06-30|143|244
Study ID|SE|3344cb70-4cee-4871-9e3c-ee86dc8c09b4|2|P|2|TREATMENT|2022-03-16|2022-07-13|138|257
Study ID|SE|3344cb70-4cee-4871-9e3c-ee86dc8c09b4|3|REST|2|WASHOUT|2021-11-24|2022-01-26|26|89
Study ID|SE|3344cb70-4cee-4871-9e3c-ee86dc8c09b4|4|5|5|TREATMENT|2021-11-24|2022-03-03|26|125
Study ID|SE|3344cb70-4cee-4871-9e3c-ee86dc8c09b4|5|REST|7|WASHOUT|2021-11-16|2021-11-22|18|24
Study ID|SE|3344cb70-4cee-4871-9e3c-ee86dc8c09b4|6|10|4|TREATMENT|2021-11-11|2021-11-12|13|14
Study ID|SE|3344cb70-4cee-4871-9e3c-ee86dc8c09b4|7|FU|1|FOLLOW-UP|2022-01-30|2022-02-23|93|117
Study ID|SE|0ed45504-ee29-4f01-9777-b71461c3f915|1|SCRN|4|SCREENING|2021-09-16|2022-01-11|11|128
Study ID|SE|0ed45504-ee29-4f01-9777-b71461c3f915|2|5|2|TREATMENT|2021-12-06|2022-01-16|92|133
Study ID|SE|0ed45504-ee29-4f01-9777-b71461c3f915|3|REST|6|WASHOUT|2021-09-07|2021-12-15|2|101
Study ID|SE|0ed45504-ee29-4f01-9777-b71461c3f915|4|P|6|TREATMENT|2022-01-01|2022-01-25|118|142
Study ID|SE|0ed45504-ee29-4f01-9777-b71461c3f915|5|REST|6|WASHOUT|2021-11-25|2021-12-04|81|90
Study ID|SE|0ed45504-ee29-4f01-9777-b71461c3f915|6|10|5|TREATMENT|2021-10-10|2022-04-12|35|219
Study ID|SE|0ed45504-ee29-4f01-9777-b71461c3f915|7|FU|3|FOLLOW-UP|2022-02-22|2022-04-25|170|232
Study ID|SE|9d5ab0d2-0ca8-4747-b374-5bc2ec812b53|1|SCRN|4|SCREENING|2021-10-19|2021-12-20|31|93
Study ID|SE|9d5ab0d2-0ca8-4747-b374-5bc2ec812b53|2|P|2|TREATMENT|2022-04-08|2022-05-16|202|240
Study ID|SE|9d5ab0d2-0ca8-4747-b374-5bc2ec812b53|3|REST|4|WASHOUT|2021-11-22|2022-01-10|65|114
Study ID|SE|9d5ab0d2-0ca8-4747-b374-5bc2ec812b53|4|5|1|TREATMENT|2021-10-05|2021-12-03|17|76
Study ID|SE|9d5ab0d2-0ca8-4747-b374-5bc2ec812b53|5|REST|2|WASHOUT|2022-01-14|2022-04-29|118|223
Study ID|SE|9d5ab0d2-0ca8-4747-b374-5bc2ec812b53|6|10|5|TREATMENT|2021-11-22|2022-02-03|65|138
Study ID|SE|9d5ab0d2-0ca8-4747-b374-5bc2ec812b53|7|FU|5|FOLLOW-UP|2021-11-18|2022-05-22|61|246
Study ID|SE|1dc9438c-e39c-4aa6-8d08-3702919ebe2e|1|SCRN|4|SCREENING|2021-12-22|2022-04-22|116|237
Study ID|SE|1dc9438c-e39c-4aa6-8d08-3702919ebe2e|2|5|6|TREATMENT|2021-09-24|2022-01-30|27|155
Study ID|SE|1dc9438c-e39c-4aa6-8d08-3702919ebe2e|3|REST|1|WASHOUT|2022-01-18|2022-05-03|143|248
Study ID|SE|1dc9438c-e39c-4aa6-8d08-3702919ebe2e|4|P|6|TREATMENT|2021-11-14|2022-04-13|78|228
Study ID|SE|1dc9438c-e39c-4aa6-8d08-3702919ebe2e|5|REST|2|WASHOUT|2021-12-13|2022-01-17|107|142
Study ID|SE|1dc9438c-e39c-4aa6-8d08-3702919ebe2e|6|10|1|TREATMENT|2021-10-04|2022-05-15|37|260
Study ID|SE|1dc9438c-e39c-4aa6-8d08-3702919ebe2e|7|FU|3|FOLLOW-UP|2022-01-15|2022-05-11|140|256
Study ID|SE|9492e29a-7a6a-46f2-aa3f-c751b4c2f77b|1|SCRN|2|SCREENING|2022-01-15|2022-02-06|85|107
Study ID|SE|9492e29a-7a6a-46f2-aa3f-c751b4c2f77b|2|P|2|TREATMENT|2022-02-12|2022-04-02|113|162
Study ID|SE|9492e29a-7a6a-46f2-aa3f-c751b4c2f77b|3|REST|6|WASHOUT|2021-11-02|2022-05-08|11|198
Study ID|SE|9492e29a-7a6a-46f2-aa3f-c751b4c2f77b|4|5|1|TREATMENT|2022-01-10|2022-04-27|80|187
Study ID|SE|9492e29a-7a6a-46f2-aa3f-c751b4c2f77b|5|REST|7|WASHOUT|2021-11-08|2021-12-05|17|44
Study ID|SE|9492e29a-7a6a-46f2-aa3f-c751b4c2f77b|6|10|2|TREATMENT|2022-05-06|2022-07-28|196|279
Study ID|SE|9492e29a-7a6a-46f2-aa3f-c751b4c2f77b|7|FU|2|FOLLOW-UP|2021-12-15|2022-02-20|54|121
Study ID|SE|82c7c099-b23e-4658-aca5-f51872352237|1|SCRN|2|SCREENING|2022-04-29|2022-05-09|245|255
Study ID|SE|82c7c099-b23e-4658-aca5-f51872352237|2|P|4|TREATMENT|2021-09-25|2021-10-19|29|53
Study ID|SE|82c7c099-b23e-4658-aca5-f51872352237|3|REST|5|WASHOUT|2021-09-07|2021-09-09|11|13
Study ID|SE|82c7c099-b23e-4658-aca5-f51872352237|4|5|6|TREATMENT|2021-09-18|2021-09-25|22|29
Study ID|SE|82c7c099-b23e-4658-aca5-f51872352237|5|REST|2|WASHOUT|2021-09-06|2022-01-07|10|133
Study ID|SE|82c7c099-b23e-4658-aca5-f51872352237|6|10|7|TREATMENT|2021-11-17|2022-05-27|82|273
Study ID|SE|82c7c099-b23e-4658-aca5-f51872352237|7|FU|1|FOLLOW-UP|2021-09-16|2021-10-10|20|44
Study ID|SE|3c34e10b-33bf-4e47-b2c6-4beaa9855655|1|SCRN|7|SCREENING|2021-09-30|2021-10-05|3|8
Study ID|SE|3c34e10b-33bf-4e47-b2c6-4beaa9855655|2|P|6|TREATMENT|2021-09-29|2021-10-03|2|6
Study ID|SE|3c34e10b-33bf-4e47-b2c6-4beaa9855655|3|REST|6|WASHOUT|2021-12-28|2022-06-18|92|264
Study ID|SE|3c34e10b-33bf-4e47-b2c6-4beaa9855655|4|5|6|TREATMENT|2022-05-07|2022-05-27|222|242
Study ID|SE|3c34e10b-33bf-4e47-b2c6-4beaa9855655|5|REST|6|WASHOUT|2021-10-05|2021-10-14|8|17
Study ID|SE|3c34e10b-33bf-4e47-b2c6-4beaa9855655|6|10|7|TREATMENT|2022-03-22|2022-06-24|176|270
Study ID|SE|3c34e10b-33bf-4e47-b2c6-4beaa9855655|7|FU|7|FOLLOW-UP|2022-01-21|2022-06-20|116|266
Study ID|SE|8bb18393-9df8-4a39-8fcd-46c740b3b0f2|1|SCRN|1|SCREENING|2021-12-27|2022-02-22|96|153
Study ID|SE|8bb18393-9df8-4a39-8fcd-46c740b3b0f2|2|P|4|TREATMENT|2022-03-07|2022-03-09|166|168
Study ID|SE|8bb18393-9df8-4a39-8fcd-46c740b3b0f2|3|REST|4|WASHOUT|2021-11-16|2021-12-27|55|96
Study ID|SE|8bb18393-9df8-4a39-8fcd-46c740b3b0f2|4|5|2|TREATMENT|2022-02-21|2022-02-24|152|155
Study ID|SE|8bb18393-9df8-4a39-8fcd-46c740b3b0f2|5|REST|5|WASHOUT|2021-12-11|2022-03-13|80|172
Study ID|SE|8bb18393-9df8-4a39-8fcd-46c740b3b0f2|6|10|1|TREATMENT|2021-11-27|2021-11-28|66|67
Study ID|SE|8bb18393-9df8-4a39-8fcd-46c740b3b0f2|7|FU|6|FOLLOW-UP|2021-10-02|2021-10-07|10|15
Study ID|SE|c332cb21-29a0-40a7-903a-cfc7e924cd3e|1|SCRN|6|SCREENING|2021-12-01|2022-01-04|100|134
Study ID|SE|c332cb21-29a0-40a7-903a-cfc7e924cd3e|2|5|5|TREATMENT|2021-10-01|2021-11-07|39|76
Study ID|SE|c332cb21-29a0-40a7-903a-cfc7e924cd3e|3|REST|7|WASHOUT|2021-09-25|2021-12-28|33|127
Study ID|SE|c332cb21-29a0-40a7-903a-cfc7e924cd3e|4|P|5|TREATMENT|2021-11-18|2022-02-22|87|183
Study ID|SE|c332cb21-29a0-40a7-903a-cfc7e924cd3e|5|REST|1|WASHOUT|2021-08-25|2021-08-30|2|7
Study ID|SE|c332cb21-29a0-40a7-903a-cfc7e924cd3e|6|10|1|TREATMENT|2022-01-10|2022-02-23|140|184
Study ID|SE|c332cb21-29a0-40a7-903a-cfc7e924cd3e|7|FU|1|FOLLOW-UP|2021-10-25|2022-02-23|63|184
Study ID|SE|12e20b79-d475-45d0-913b-692c4bd6b77c|1|SCRN|6|SCREENING|2021-10-12|2021-12-02|17|68
Study ID|SE|12e20b79-d475-45d0-913b-692c4bd6b77c|2|5|2|TREATMENT|2021-10-01|2021-12-12|6|78
Study ID|SE|12e20b79-d475-45d0-913b-692c4bd6b77c|3|REST|5|WASHOUT|2021-10-04|2021-10-31|9|36
Study ID|SE|12e20b79-d475-45d0-913b-692c4bd6b77c|4|10|4|TREATMENT|2021-10-21|2022-05-02|26|219
Study ID|SE|12e20b79-d475-45d0-913b-692c4bd6b77c|5|REST|3|WASHOUT|2021-12-27|2022-03-27|93|183
Study ID|SE|12e20b79-d475-45d0-913b-692c4bd6b77c|6|P|7|TREATMENT|2022-05-11|2022-05-30|228|247
Study ID|SE|12e20b79-d475-45d0-913b-692c4bd6b77c|7|FU|4|FOLLOW-UP|2022-02-22|2022-05-11|150|228
Study ID|SE|47ae4992-d9f2-41b8-b2bb-57b79f4d86a5|1|SCRN|4|SCREENING|2022-03-26|2022-04-08|212|225
Study ID|SE|47ae4992-d9f2-41b8-b2bb-57b79f4d86a5|2|5|2|TREATMENT|2022-04-23|2022-06-06|240|284
Study ID|SE|47ae4992-d9f2-41b8-b2bb-57b79f4d86a5|3|REST|1|WASHOUT|2021-10-12|2022-01-25|47|152
Study ID|SE|47ae4992-d9f2-41b8-b2bb-57b79f4d86a5|4|10|4|TREATMENT|2022-01-31|2022-03-30|158|216
Study ID|SE|47ae4992-d9f2-41b8-b2bb-57b79f4d86a5|5|REST|1|WASHOUT|2021-11-13|2022-02-27|79|185
Study ID|SE|47ae4992-d9f2-41b8-b2bb-57b79f4d86a5|6|P|5|TREATMENT|2021-10-19|2021-12-15|54|111
Study ID|SE|47ae4992-d9f2-41b8-b2bb-57b79f4d86a5|7|FU|6|FOLLOW-UP|2021-08-28|2021-08-28|2|2
Study ID|SE|b6f61fd5-1cae-4def-8da2-1155777dace4|1|SCRN|7|SCREENING|2021-10-30|2021-11-21|26|48
Study ID|SE|b6f61fd5-1cae-4def-8da2-1155777dace4|2|5|3|TREATMENT|2022-05-30|2022-07-23|238|292
Study ID|SE|b6f61fd5-1cae-4def-8da2-1155777dace4|3|REST|5|WASHOUT|2022-01-26|2022-01-27|114|115
Study ID|SE|b6f61fd5-1cae-4def-8da2-1155777dace4|4|10|1|TREATMENT|2021-10-13|2021-10-23|9|19
Study ID|SE|b6f61fd5-1cae-4def-8da2-1155777dace4|5|REST|4|WASHOUT|2021-12-09|2022-02-27|66|146
Study ID|SE|b6f61fd5-1cae-4def-8da2-1155777dace4|6|P|4|TREATMENT|2022-02-28|2022-05-06|147|214
Study ID|SE|b6f61fd5-1cae-4def-8da2-1155777dace4|7|FU|7|FOLLOW-UP|2021-10-06|2021-11-06|2|33
Study ID|SE|bf1aba67-4c57-4e5b-9c56-bad135c55428|1|SCRN|2|SCREENING|2021-09-29|2021-10-22|38|61
Study ID|SE|bf1aba67-4c57-4e5b-9c56-bad135c55428|2|5|4|TREATMENT|2022-03-06|2022-04-07|196|228
Study ID|SE|bf1aba67-4c57-4e5b-9c56-bad135c55428|3|REST|5|WASHOUT|2022-02-22|2022-05-08|184|259
Study ID|SE|bf1aba67-4c57-4e5b-9c56-bad135c55428|4|P|5|TREATMENT|2021-12-11|2022-01-19|111|150
Study ID|SE|bf1aba67-4c57-4e5b-9c56-bad135c55428|5|REST|5|WASHOUT|2021-08-30|2021-09-01|8|10
Study ID|SE|bf1aba67-4c57-4e5b-9c56-bad135c55428|6|10|6|TREATMENT|2021-10-26|2022-02-09|65|171
Study ID|SE|bf1aba67-4c57-4e5b-9c56-bad135c55428|7|FU|1|FOLLOW-UP|2021-09-16|2021-09-27|25|36
Study ID|SE|821b34a1-4785-41de-9af0-cd213b51f70e|1|SCRN|5|SCREENING|2022-03-01|2022-03-12|152|163
Study ID|SE|821b34a1-4785-41de-9af0-cd213b51f70e|2|5|4|TREATMENT|2021-12-20|2022-03-08|81|159
Study ID|SE|821b34a1-4785-41de-9af0-cd213b51f70e|3|REST|1|WASHOUT|2021-10-12|2021-11-22|12|53
Study ID|SE|821b34a1-4785-41de-9af0-cd213b51f70e|4|10|4|TREATMENT|2022-01-23|2022-03-07|115|158
Study ID|SE|821b34a1-4785-41de-9af0-cd213b51f70e|5|REST|1|WASHOUT|2021-11-10|2022-04-08|41|190
Study ID|SE|821b34a1-4785-41de-9af0-cd213b51f70e|6|P|4|TREATMENT|2021-10-09|2021-11-01|9|32
Study ID|SE|821b34a1-4785-41de-9af0-cd213b51f70e|7|FU|1|FOLLOW-UP|2021-11-15|2022-04-19|46|201
Study ID|SE|de9a8eef-40d1-46d0-ad17-0139e1ef6da7|1|SCRN|3|SCREENING|2021-10-06|2021-11-15|15|55
Study ID|SE|de9a8eef-40d1-46d0-ad17-0139e1ef6da7|2|5|7|TREATMENT|2021-09-24|2021-11-02|3|42
Study ID|SE|de9a8eef-40d1-46d0-ad17-0139e1ef6da7|3|REST|6|WASHOUT|2021-10-29|2022-03-25|38|185
Study ID|SE|de9a8eef-40d1-46d0-ad17-0139e1ef6da7|4|10|3|TREATMENT|2022-02-01|2022-05-02|133|223
Study ID|SE|de9a8eef-40d1-46d0-ad17-0139e1ef6da7|5|REST|2|WASHOUT|2021-09-29|2022-02-12|8|144
Study ID|SE|de9a8eef-40d1-46d0-ad17-0139e1ef6da7|6|P|6|TREATMENT|2021-12-16|2022-06-01|86|253
Study ID|SE|de9a8eef-40d1-46d0-ad17-0139e1ef6da7|7|FU|5|FOLLOW-UP|2021-09-26|2021-11-26|5|66
Study ID|SE|ebbee535-ce64-49fd-89ca-81b022838a8a|1|SCRN|7|SCREENING|2021-11-14|2022-02-23|16|117
Study ID|SE|ebbee535-ce64-49fd-89ca-81b022838a8a|2|P|7|TREATMENT|2021-12-12|2022-06-30|44|244
Study ID|SE|ebbee535-ce64-49fd-89ca-81b022838a8a|3|REST|6|WASHOUT|2022-01-27|2022-02-04|90|98
Study ID|SE|ebbee535-ce64-49fd-89ca-81b022838a8a|4|5|1|TREATMENT|2022-01-03|2022-05-25|66|208
Study ID|SE|ebbee535-ce64-49fd-89ca-81b022838a8a|5|REST|3|WASHOUT|2021-11-27|2021-12-12|29|44
Study ID|SE|ebbee535-ce64-49fd-89ca-81b022838a8a|6|10|3|TREATMENT|2021-12-20|2022-01-08|52|71
Study ID|SE|ebbee535-ce64-49fd-89ca-81b022838a8a|7|FU|2|FOLLOW-UP|2022-06-19|2022-08-21|233|296
Study ID|SE|86577261-79c9-40a0-90f6-341cc56dd879|1|SCRN|7|SCREENING|2021-11-13|2022-03-07|68|182
Study ID|SE|86577261-79c9-40a0-90f6-341cc56dd879|2|5|4|TREATMENT|2021-10-06|2022-04-24|30|230
Study ID|SE|86577261-79c9-40a0-90f6-341cc56dd879|3|REST|6|WASHOUT|2021-11-22|2021-12-04|77|89
Study ID|SE|86577261-79c9-40a0-90f6-341cc56dd879|4|P|4|TREATMENT|2021-11-26|2021-12-09|81|94
Study ID|SE|86577261-79c9-40a0-90f6-341cc56dd879|5|REST|4|WASHOUT|2022-02-07|2022-03-08|154|183
Study ID|SE|86577261-79c9-40a0-90f6-341cc56dd879|6|10|4|TREATMENT|2021-11-21|2022-03-06|76|181
Study ID|SE|86577261-79c9-40a0-90f6-341cc56dd879|7|FU|3|FOLLOW-UP|2021-09-14|2021-10-24|8|48
Study ID|SE|1af42d8c-ea33-447a-bc0e-7a5aef9f58a0|1|SCRN|7|SCREENING|2021-12-30|2022-04-02|78|171
Study ID|SE|1af42d8c-ea33-447a-bc0e-7a5aef9f58a0|2|5|7|TREATMENT|2021-11-10|2022-04-16|28|185
Study ID|SE|1af42d8c-ea33-447a-bc0e-7a5aef9f58a0|3|REST|5|WASHOUT|2021-11-03|2022-05-29|21|228
Study ID|SE|1af42d8c-ea33-447a-bc0e-7a5aef9f58a0|4|10|2|TREATMENT|2021-10-16|2021-10-19|3|6
Study ID|SE|1af42d8c-ea33-447a-bc0e-7a5aef9f58a0|5|REST|6|WASHOUT|2021-10-24|2021-10-26|11|13
Study ID|SE|1af42d8c-ea33-447a-bc0e-7a5aef9f58a0|6|P|4|TREATMENT|2021-12-24|2022-07-02|72|262
Study ID|SE|1af42d8c-ea33-447a-bc0e-7a5aef9f58a0|7|FU|3|FOLLOW-UP|2021-10-19|2021-11-05|6|23
Study ID|SE|59e4a43c-093a-47ec-af14-f59735ccce87|1|SCRN|6|SCREENING|2022-01-23|2022-06-17|116|261
Study ID|SE|59e4a43c-093a-47ec-af14-f59735ccce87|2|5|1|TREATMENT|2022-01-17|2022-07-20|110|294
Study ID|SE|59e4a43c-093a-47ec-af14-f59735ccce87|3|REST|7|WASHOUT|2021-10-16|2021-11-24|17|56
Study ID|SE|59e4a43c-093a-47ec-af14-f59735ccce87|4|10|5|TREATMENT|2021-12-31|2022-02-24|93|148
Study ID|SE|59e4a43c-093a-47ec-af14-f59735ccce87|5|REST|1|WASHOUT|2021-10-10|2021-10-13|11|14
Study ID|SE|59e4a43c-093a-47ec-af14-f59735ccce87|6|P|2|TREATMENT|2022-01-10|2022-05-11|103|224
Study ID|SE|59e4a43c-093a-47ec-af14-f59735ccce87|7|FU|6|FOLLOW-UP|2021-10-01|2022-03-22|2|174
Study ID|SE|5cb7a6b6-7e48-415c-a616-3db61858a2b9|1|SCRN|3|SCREENING|2021-10-11|2022-02-12|9|133
Study ID|SE|5cb7a6b6-7e48-415c-a616-3db61858a2b9|2|P|5|TREATMENT|2021-12-22|2022-04-10|81|190
Study ID|SE|5cb7a6b6-7e48-415c-a616-3db61858a2b9|3|REST|2|WASHOUT|2021-11-09|2021-12-25|38|84
Study ID|SE|5cb7a6b6-7e48-415c-a616-3db61858a2b9|4|5|1|TREATMENT|2021-10-04|2021-10-06|2|4
Study ID|SE|5cb7a6b6-7e48-415c-a616-3db61858a2b9|5|REST|2|WASHOUT|2021-10-30|2022-01-03|28|93
Study ID|SE|5cb7a6b6-7e48-415c-a616-3db61858a2b9|6|10|2|TREATMENT|2021-10-24|2022-02-23|22|144
Study ID|SE|5cb7a6b6-7e48-415c-a616-3db61858a2b9|7|FU|7|FOLLOW-UP|2022-01-10|2022-04-21|100|201
Study ID|SE|f3c49594-5c9e-4c45-9e0b-5c07b0f71596|1|SCRN|6|SCREENING|2021-10-04|2022-04-18|43|239
Study ID|SE|f3c49594-5c9e-4c45-9e0b-5c07b0f71596|2|5|5|TREATMENT|2021-09-24|2021-10-21|33|60
Study ID|SE|f3c49594-5c9e-4c45-9e0b-5c07b0f71596|3|REST|6|WASHOUT|2022-01-18|2022-06-04|149|286
Study ID|SE|f3c49594-5c9e-4c45-9e0b-5c07b0f71596|4|P|6|TREATMENT|2022-03-22|2022-05-24|212|275
Study ID|SE|f3c49594-5c9e-4c45-9e0b-5c07b0f71596|5|REST|6|WASHOUT|2021-10-17|2021-12-06|56|106
Study ID|SE|f3c49594-5c9e-4c45-9e0b-5c07b0f71596|6|10|7|TREATMENT|2021-09-24|2021-09-28|33|37
Study ID|SE|f3c49594-5c9e-4c45-9e0b-5c07b0f71596|7|FU|6|FOLLOW-UP|2021-09-19|2022-03-28|28|218
Study ID|SE|566b7b8c-95bf-43c8-b71f-4e3fab6d3fbe|1|SCRN|6|SCREENING|2021-11-27|2022-03-06|61|160
Study ID|SE|566b7b8c-95bf-43c8-b71f-4e3fab6d3fbe|2|5|3|TREATMENT|2021-10-11|2021-10-28|14|31
Study ID|SE|566b7b8c-95bf-43c8-b71f-4e3fab6d3fbe|3|REST|6|WASHOUT|2021-09-29|2021-10-01|2|4
Study ID|SE|566b7b8c-95bf-43c8-b71f-4e3fab6d3fbe|4|P|4|TREATMENT|2021-10-09|2021-10-15|12|18
Study ID|SE|566b7b8c-95bf-43c8-b71f-4e3fab6d3fbe|5|REST|6|WASHOUT|2022-02-25|2022-07-08|151|284
Study ID|SE|566b7b8c-95bf-43c8-b71f-4e3fab6d3fbe|6|10|2|TREATMENT|2021-10-06|2021-10-15|9|18
Study ID|SE|566b7b8c-95bf-43c8-b71f-4e3fab6d3fbe|7|FU|4|FOLLOW-UP|2021-10-27|2021-12-20|30|84
Study ID|SE|6e7b3388-f0fe-4867-9037-202cab925b1d|1|SCRN|2|SCREENING|2021-11-10|2021-11-23|25|38
Study ID|SE|6e7b3388-f0fe-4867-9037-202cab925b1d|2|5|5|TREATMENT|2021-12-20|2022-04-18|65|184
Study ID|SE|6e7b3388-f0fe-4867-9037-202cab925b1d|3|REST|1|WASHOUT|2021-10-23|2021-10-25|7|9
Study ID|SE|6e7b3388-f0fe-4867-9037-202cab925b1d|4|P|5|TREATMENT|2021-11-08|2022-06-17|23|244
Study ID|SE|6e7b3388-f0fe-4867-9037-202cab925b1d|5|REST|7|WASHOUT|2022-07-14|2022-08-09|271|297
Study ID|SE|6e7b3388-f0fe-4867-9037-202cab925b1d|6|10|5|TREATMENT|2021-11-21|2022-03-04|36|139
Study ID|SE|6e7b3388-f0fe-4867-9037-202cab925b1d|7|FU|4|FOLLOW-UP|2021-11-10|2021-12-17|25|62
Study ID|SE|1e595d68-b74a-499e-801b-5f6a708e39c3|1|SCRN|6|SCREENING|2022-02-19|2022-02-25|160|166
Study ID|SE|1e595d68-b74a-499e-801b-5f6a708e39c3|2|5|1|TREATMENT|2022-04-17|2022-05-19|217|249
Study ID|SE|1e595d68-b74a-499e-801b-5f6a708e39c3|3|REST|4|WASHOUT|2022-03-23|2022-05-01|192|231
Study ID|SE|1e595d68-b74a-499e-801b-5f6a708e39c3|4|P|7|TREATMENT|2022-01-31|2022-03-03|141|172
Study ID|SE|1e595d68-b74a-499e-801b-5f6a708e39c3|5|REST|3|WASHOUT|2021-09-17|2021-11-03|5|52
Study ID|SE|1e595d68-b74a-499e-801b-5f6a708e39c3|6|10|6|TREATMENT|2021-11-03|2021-11-09|52|58
Study ID|SE|1e595d68-b74a-499e-801b-5f6a708e39c3|7|FU|2|FOLLOW-UP|2022-02-05|2022-05-22|146|252
Study ID|SE|0dd22462-a34b-42ab-ad3d-2b4c029b9399|1|SCRN|4|SCREENING|2021-11-14|2022-07-17|54|299
Study ID|SE|0dd22462-a34b-42ab-ad3d-2b4c029b9399|2|5|1|TREATMENT|2021-10-18|2022-01-11|27|112
Study ID|SE|0dd22462-a34b-42ab-ad3d-2b4c029b9399|3|REST|7|WASHOUT|2021-11-07|2021-12-01|47|71
Study ID|SE|0dd22462-a34b-42ab-ad3d-2b4c029b9399|4|P|5|TREATMENT|2021-11-01|2022-04-17|41|208
Study ID|SE|0dd22462-a34b-42ab-ad3d-2b4c029b9399|5|REST|7|WASHOUT|2021-11-07|2022-04-18|47|209
Study ID|SE|0dd22462-a34b-42ab-ad3d-2b4c029b9399|6|10|6|TREATMENT|2022-01-19|2022-06-13|120|265
Study ID|SE|0dd22462-a34b-42ab-ad3d-2b4c029b9399|7|FU|2|FOLLOW-UP|2021-11-26|2022-02-10|66|142
Study ID|SE|e653c9e9-26ff-4b4e-80f1-464dc0995a42|1|SCRN|2|SCREENING|2021-09-10|2021-12-26|26|133
Study ID|SE|e653c9e9-26ff-4b4e-80f1-464dc0995a42|2|5|7|TREATMENT|2021-09-17|2021-10-01|33|47
Study ID|SE|e653c9e9-26ff-4b4e-80f1-464dc0995a42|3|REST|1|WASHOUT|2021-11-10|2022-03-27|87|224
Study ID|SE|e653c9e9-26ff-4b4e-80f1-464dc0995a42|4|10|3|TREATMENT|2021-08-26|2021-08-30|11|15
Study ID|SE|e653c9e9-26ff-4b4e-80f1-464dc0995a42|5|REST|7|WASHOUT|2021-11-28|2022-02-03|105|172
Study ID|SE|e653c9e9-26ff-4b4e-80f1-464dc0995a42|6|P|3|TREATMENT|2021-09-25|2021-10-24|41|70
Study ID|SE|e653c9e9-26ff-4b4e-80f1-464dc0995a42|7|FU|2|FOLLOW-UP|2021-12-29|2022-03-19|136|216
Study ID|SE|a3a8b4fb-1d7c-444f-9011-d037bfdec8a7|1|SCRN|6|SCREENING|2021-10-27|2021-10-28|77|78
Study ID|SE|a3a8b4fb-1d7c-444f-9011-d037bfdec8a7|2|5|2|TREATMENT|2022-01-13|2022-02-04|155|177
Study ID|SE|a3a8b4fb-1d7c-444f-9011-d037bfdec8a7|3|REST|6|WASHOUT|2021-10-11|2022-05-26|61|288
Study ID|SE|a3a8b4fb-1d7c-444f-9011-d037bfdec8a7|4|10|5|TREATMENT|2021-08-28|2021-09-24|17|44
Study ID|SE|a3a8b4fb-1d7c-444f-9011-d037bfdec8a7|5|REST|5|WASHOUT|2022-03-24|2022-05-07|225|269
Study ID|SE|a3a8b4fb-1d7c-444f-9011-d037bfdec8a7|6|P|2|TREATMENT|2021-09-20|2021-11-29|40|110
Study ID|SE|a3a8b4fb-1d7c-444f-9011-d037bfdec8a7|7|FU|5|FOLLOW-UP|2021-08-16|2021-08-29|5|18
Study ID|SE|379863fa-bfee-4e4d-befe-b8fd41c364ff|1|SCRN|2|SCREENING|2021-10-11|2022-01-17|47|145
Study ID|SE|379863fa-bfee-4e4d-befe-b8fd41c364ff|2|5|1|TREATMENT|2021-10-11|2022-05-30|47|278
Study ID|SE|379863fa-bfee-4e4d-befe-b8fd41c364ff|3|REST|5|WASHOUT|2021-11-04|2021-11-30|71|97
Study ID|SE|379863fa-bfee-4e4d-befe-b8fd41c364ff|4|P|1|TREATMENT|2021-09-04|2021-09-06|10|12
Study ID|SE|379863fa-bfee-4e4d-befe-b8fd41c364ff|5|REST|2|WASHOUT|2021-11-25|2021-12-07|92|104
Study ID|SE|379863fa-bfee-4e4d-befe-b8fd41c364ff|6|10|7|TREATMENT|2022-02-18|2022-04-12|177|230
Study ID|SE|379863fa-bfee-4e4d-befe-b8fd41c364ff|7|FU|2|FOLLOW-UP|2022-03-19|2022-04-02|206|220
Study ID|SE|b06186b7-1214-430a-bab2-df8236efd19f|1|SCRN|2|SCREENING|2022-02-25|2022-03-14|136|153
Study ID|SE|b06186b7-1214-430a-bab2-df8236efd19f|2|5|7|TREATMENT|2022-01-29|2022-03-13|109|152
Study ID|SE|b06186b7-1214-430a-bab2-df8236efd19f|3|REST|6|WASHOUT|2022-01-16|2022-07-22|96|283
Study ID|SE|b06186b7-1214-430a-bab2-df8236efd19f|4|P|5|TREATMENT|2021-10-25|2022-01-30|13|110
Study ID|SE|b06186b7-1214-430a-bab2-df8236efd19f|5|REST|1|WASHOUT|2021-11-24|2021-12-14|43|63
Study ID|SE|b06186b7-1214-430a-bab2-df8236efd19f|6|10|3|TREATMENT|2021-12-01|2021-12-04|50|53
Study ID|SE|b06186b7-1214-430a-bab2-df8236efd19f|7|FU|7|FOLLOW-UP|2022-01-28|2022-02-10|108|121
Study ID|SE|55195f1a-0df1-40b2-8c58-835ade2af55f|1|SCRN|7|SCREENING|2021-08-28|2022-03-22|6|212
Study ID|SE|55195f1a-0df1-40b2-8c58-835ade2af55f|2|5|6|TREATMENT|2021-09-11|2022-05-01|20|252
Study ID|SE|55195f1a-0df1-40b2-8c58-835ade2af55f|3|REST|6|WASHOUT|2021-08-30|2021-12-11|8|111
Study ID|SE|55195f1a-0df1-40b2-8c58-835ade2af55f|4|10|3|TREATMENT|2021-08-25|2021-08-27|3|5
Study ID|SE|55195f1a-0df1-40b2-8c58-835ade2af55f|5|REST|7|WASHOUT|2021-08-26|2022-03-26|4|216
Study ID|SE|55195f1a-0df1-40b2-8c58-835ade2af55f|6|P|5|TREATMENT|2021-09-15|2021-12-21|24|121
Study ID|SE|55195f1a-0df1-40b2-8c58-835ade2af55f|7|FU|2|FOLLOW-UP|2022-02-27|2022-03-25|189|215
Study ID|SE|eb79afb1-9c3a-454f-baa5-627758587ac7|1|SCRN|7|SCREENING|2021-11-06|2022-01-18|30|103
Study ID|SE|eb79afb1-9c3a-454f-baa5-627758587ac7|2|P|6|TREATMENT|2021-10-17|2021-11-13|10|37
Study ID|SE|eb79afb1-9c3a-454f-baa5-627758587ac7|3|REST|2|WASHOUT|2021-10-11|2022-01-18|4|103
Study ID|SE|eb79afb1-9c3a-454f-baa5-627758587ac7|4|5|5|TREATMENT|2021-11-11|2021-11-15|35|39
Study ID|SE|eb79afb1-9c3a-454f-baa5-627758587ac7|5|REST|3|WASHOUT|2021-11-20|2022-06-21|44|257
Study ID|SE|eb79afb1-9c3a-454f-baa5-627758587ac7|6|10|7|TREATMENT|2022-03-18|2022-05-11|162|216
Study ID|SE|eb79afb1-9c3a-454f-baa5-627758587ac7|7|FU|2|FOLLOW-UP|2022-02-01|2022-06-05|117|241
Study ID|SE|781798a9-20dd-4cc9-bb23-5794f2eb7336|1|SCRN|4|SCREENING|2021-12-06|2021-12-22|45|61
Study ID|SE|781798a9-20dd-4cc9-bb23-5794f2eb7336|2|5|1|TREATMENT|2021-12-31|2022-05-04|70|194
Study ID|SE|781798a9-20dd-4cc9-bb23-5794f2eb7336|3|REST|3|WASHOUT|2022-06-20|2022-07-12|241|263
Study ID|SE|781798a9-20dd-4cc9-bb23-5794f2eb7336|4|P|6|TREATMENT|2022-02-15|2022-03-03|116|132
Study ID|SE|781798a9-20dd-4cc9-bb23-5794f2eb7336|5|REST|7|WASHOUT|2021-11-27|2022-01-23|36|93
Study ID|SE|781798a9-20dd-4cc9-bb23-5794f2eb7336|6|10|6|TREATMENT|2021-11-16|2021-12-31|25|70
Study ID|SE|781798a9-20dd-4cc9-bb23-5794f2eb7336|7|FU|4|FOLLOW-UP|2021-11-19|2022-02-18|28|119
Study ID|SE|ade91982-0b4d-4d0d-b21f-d3abf6dc96f5|1|SCRN|6|SCREENING|2021-11-20|2022-03-01|75|176
Study ID|SE|ade91982-0b4d-4d0d-b21f-d3abf6dc96f5|2|P|6|TREATMENT|2021-10-02|2021-10-07|26|31
Study ID|SE|ade91982-0b4d-4d0d-b21f-d3abf6dc96f5|3|REST|1|WASHOUT|2021-09-16|2021-09-26|10|20
Study ID|SE|ade91982-0b4d-4d0d-b21f-d3abf6dc96f5|4|5|7|TREATMENT|2021-10-15|2021-11-05|39|60
Study ID|SE|ade91982-0b4d-4d0d-b21f-d3abf6dc96f5|5|REST|7|WASHOUT|2022-01-08|2022-02-05|124|152
Study ID|SE|ade91982-0b4d-4d0d-b21f-d3abf6dc96f5|6|10|6|TREATMENT|2021-09-17|2021-09-26|11|20
Study ID|SE|ade91982-0b4d-4d0d-b21f-d3abf6dc96f5|7|FU|1|FOLLOW-UP|2022-02-16|2022-05-01|163|237
Study ID|SE|00e59aa5-5211-459e-ac38-bbafb5ff3f24|1|SCRN|4|SCREENING|2021-11-09|2021-11-19|59|69
Study ID|SE|00e59aa5-5211-459e-ac38-bbafb5ff3f24|2|5|6|TREATMENT|2021-09-15|2021-09-16|4|5
Study ID|SE|00e59aa5-5211-459e-ac38-bbafb5ff3f24|3|REST|2|WASHOUT|2022-01-02|2022-06-14|113|276
Study ID|SE|00e59aa5-5211-459e-ac38-bbafb5ff3f24|4|P|1|TREATMENT|2021-09-17|2021-09-20|6|9
Study ID|SE|00e59aa5-5211-459e-ac38-bbafb5ff3f24|5|REST|5|WASHOUT|2021-09-28|2021-10-22|17|41
Study ID|SE|00e59aa5-5211-459e-ac38-bbafb5ff3f24|6|10|6|TREATMENT|2021-11-15|2021-11-27|65|77
Study ID|SE|00e59aa5-5211-459e-ac38-bbafb5ff3f24|7|FU|2|FOLLOW-UP|2021-09-16|2021-10-02|5|21
Study ID|SE|e99cb8c0-6dea-446a-b798-9c83a8d7e7a5|1|SCRN|4|SCREENING|2021-10-31|2022-07-01|42|285
Study ID|SE|e99cb8c0-6dea-446a-b798-9c83a8d7e7a5|2|5|3|TREATMENT|2021-12-18|2022-06-10|90|264
Study ID|SE|e99cb8c0-6dea-446a-b798-9c83a8d7e7a5|3|REST|7|WASHOUT|2021-12-14|2022-01-15|86|118
Study ID|SE|e99cb8c0-6dea-446a-b798-9c83a8d7e7a5|4|P|7|TREATMENT|2021-09-25|2021-10-12|6|23
Study ID|SE|e99cb8c0-6dea-446a-b798-9c83a8d7e7a5|5|REST|4|WASHOUT|2021-10-29|2022-03-24|40|186
Study ID|SE|e99cb8c0-6dea-446a-b798-9c83a8d7e7a5|6|10|5|TREATMENT|2021-09-30|2022-06-18|11|272
Study ID|SE|e99cb8c0-6dea-446a-b798-9c83a8d7e7a5|7|FU|5|FOLLOW-UP|2021-12-17|2022-02-02|89|136
Study ID|SE|58b27f5f-433c-4663-99f8-b05eaadebcf1|1|SCRN|5|SCREENING|2021-12-25|2022-04-16|141|253
Study ID|SE|58b27f5f-433c-4663-99f8-b05eaadebcf1|2|5|1|TREATMENT|2022-01-31|2022-05-19|178|286
Study ID|SE|58b27f5f-433c-4663-99f8-b05eaadebcf1|3|REST|4|WASHOUT|2021-12-02|2022-05-27|118|294
Study ID|SE|58b27f5f-433c-4663-99f8-b05eaadebcf1|4|10|6|TREATMENT|2021-08-09|2021-08-11|3|5
Study ID|SE|58b27f5f-433c-4663-99f8-b05eaadebcf1|5|REST|1|WASHOUT|2021-12-03|2022-05-25|119|292
Study ID|SE|58b27f5f-433c-4663-99f8-b05eaadebcf1|6|P|1|TREATMENT|2021-11-08|2021-12-16|94|132
Study ID|SE|58b27f5f-433c-4663-99f8-b05eaadebcf1|7|FU|4|FOLLOW-UP|2021-08-14|2021-08-15|8|9
Study ID|SE|05ad2b06-dee9-46de-bd5a-82370ab7619e|1|SCRN|6|SCREENING|2021-09-01|2021-09-02|7|8
Study ID|SE|05ad2b06-dee9-46de-bd5a-82370ab7619e|2|P|1|TREATMENT|2022-01-20|2022-03-03|148|190
Study ID|SE|05ad2b06-dee9-46de-bd5a-82370ab7619e|3|REST|3|WASHOUT|2022-02-10|2022-03-09|169|196
Study ID|SE|05ad2b06-dee9-46de-bd5a-82370ab7619e|4|5|6|TREATMENT|2021-10-17|2021-10-23|53|59
Study ID|SE|05ad2b06-dee9-46de-bd5a-82370ab7619e|5|REST|3|WASHOUT|2022-03-11|2022-05-29|198|277
Study ID|SE|05ad2b06-dee9-46de-bd5a-82370ab7619e|6|10|6|TREATMENT|2022-01-28|2022-05-03|156|251
Study ID|SE|05ad2b06-dee9-46de-bd5a-82370ab7619e|7|FU|6|FOLLOW-UP|2021-10-26|2021-11-30|62|97
Study ID|SE|fae01538-e100-4d2c-98ef-c3713d1d7081|1|SCRN|2|SCREENING|2021-12-01|2022-01-02|73|105
Study ID|SE|fae01538-e100-4d2c-98ef-c3713d1d7081|2|5|2|TREATMENT|2021-12-25|2022-03-08|97|170
Study ID|SE|fae01538-e100-4d2c-98ef-c3713d1d7081|3|REST|2|WASHOUT|2021-12-14|2021-12-17|86|89
Study ID|SE|fae01538-e100-4d2c-98ef-c3713d1d7081|4|10|7|TREATMENT|2021-10-20|2022-02-25|31|159
Study ID|SE|fae01538-e100-4d2c-98ef-c3713d1d7081|5|REST|4|WASHOUT|2022-03-30|2022-06-02|192|256
Study ID|SE|fae01538-e100-4d2c-98ef-c3713d1d7081|6|P|7|TREATMENT|2021-11-07|2021-12-04|49|76
Study ID|SE|fae01538-e100-4d2c-98ef-c3713d1d7081|7|FU|6|FOLLOW-UP|2021-12-08|2022-06-30|80|284
Study ID|SE|a510ec7d-0345-4e62-b40c-80c8cfa7cd20|1|SCRN|3|SCREENING|2022-04-18|2022-05-07|249|268
Study ID|SE|a510ec7d-0345-4e62-b40c-80c8cfa7cd20|2|5|4|TREATMENT|2021-10-08|2022-01-09|57|150
Study ID|SE|a510ec7d-0345-4e62-b40c-80c8cfa7cd20|3|REST|6|WASHOUT|2021-12-10|2022-01-15|120|156
Study ID|SE|a510ec7d-0345-4e62-b40c-80c8cfa7cd20|4|10|6|TREATMENT|2021-08-24|2021-09-19|12|38
Study ID|SE|a510ec7d-0345-4e62-b40c-80c8cfa7cd20|5|REST|7|WASHOUT|2021-12-09|2021-12-22|119|132
Study ID|SE|a510ec7d-0345-4e62-b40c-80c8cfa7cd20|6|P|6|TREATMENT|2021-10-28|2021-12-01|77|111
Study ID|SE|a510ec7d-0345-4e62-b40c-80c8cfa7cd20|7|FU|6|FOLLOW-UP|2021-12-04|2022-04-02|114|233
Study ID|SE|fea49005-0bfc-484e-98e6-ac47d64fbf56|1|SCRN|6|SCREENING|2022-05-17|2022-07-29|225|298
Study ID|SE|fea49005-0bfc-484e-98e6-ac47d64fbf56|2|5|2|TREATMENT|2021-10-10|2021-12-22|6|79
Study ID|SE|fea49005-0bfc-484e-98e6-ac47d64fbf56|3|REST|7|WASHOUT|2022-03-18|2022-03-24|165|171
Study ID|SE|fea49005-0bfc-484e-98e6-ac47d64fbf56|4|P|3|TREATMENT|2021-10-22|2021-11-12|18|39
Study ID|SE|fea49005-0bfc-484e-98e6-ac47d64fbf56|5|REST|2|WASHOUT|2021-10-08|2021-10-16|4|12
Study ID|SE|fea49005-0bfc-484e-98e6-ac47d64fbf56|6|10|1|TREATMENT|2021-10-20|2021-11-10|16|37
Study ID|SE|fea49005-0bfc-484e-98e6-ac47d64fbf56|7|FU|1|FOLLOW-UP|2021-12-10|2022-02-23|67|142
Study ID|SE|b2c1c740-dabb-4c35-9ec3-89fa8b631104|1|SCRN|5|SCREENING|2021-11-13|2022-03-31|50|188
Study ID|SE|b2c1c740-dabb-4c35-9ec3-89fa8b631104|2|P|7|TREATMENT|2022-03-31|2022-05-08|188|226
Study ID|SE|b2c1c740-dabb-4c35-9ec3-89fa8b631104|3|REST|3|WASHOUT|2021-10-24|2022-02-15|30|144
Study ID|SE|b2c1c740-dabb-4c35-9ec3-89fa8b631104|4|5|1|TREATMENT|2021-10-02|2021-11-18|8|55
Study ID|SE|b2c1c740-dabb-4c35-9ec3-89fa8b631104|5|REST|2|WASHOUT|2021-10-19|2021-10-24|25|30
Study ID|SE|b2c1c740-dabb-4c35-9ec3-89fa8b631104|6|10|1|TREATMENT|2021-12-13|2021-12-31|80|98
Study ID|SE|b2c1c740-dabb-4c35-9ec3-89fa8b631104|7|FU|4|FOLLOW-UP|2022-03-10|2022-05-03|167|221
Study ID|SE|66ae8b7c-4307-4873-8dc0-37d451513ade|1|SCRN|1|SCREENING|2021-12-21|2021-12-27|70|76
Study ID|SE|66ae8b7c-4307-4873-8dc0-37d451513ade|2|P|6|TREATMENT|2021-12-05|2022-06-24|54|255
Study ID|SE|66ae8b7c-4307-4873-8dc0-37d451513ade|3|REST|4|WASHOUT|2021-12-20|2021-12-22|69|71
Study ID|SE|66ae8b7c-4307-4873-8dc0-37d451513ade|4|5|4|TREATMENT|2021-12-29|2022-04-01|78|171
Study ID|SE|66ae8b7c-4307-4873-8dc0-37d451513ade|5|REST|4|WASHOUT|2022-01-06|2022-04-14|86|184
Study ID|SE|66ae8b7c-4307-4873-8dc0-37d451513ade|6|10|1|TREATMENT|2022-01-24|2022-05-18|104|218
Study ID|SE|66ae8b7c-4307-4873-8dc0-37d451513ade|7|FU|2|FOLLOW-UP|2021-11-30|2022-04-26|49|196
Study ID|SE|4f522ceb-0594-4d09-a8dc-ae62fc25b236|1|SCRN|6|SCREENING|2021-10-26|2021-11-22|36|63
Study ID|SE|4f522ceb-0594-4d09-a8dc-ae62fc25b236|2|5|7|TREATMENT|2021-10-17|2021-10-24|27|34
Study ID|SE|4f522ceb-0594-4d09-a8dc-ae62fc25b236|3|REST|1|WASHOUT|2022-01-12|2022-03-19|114|180
Study ID|SE|4f522ceb-0594-4d09-a8dc-ae62fc25b236|4|10|6|TREATMENT|2021-11-23|2022-03-04|64|165
Study ID|SE|4f522ceb-0594-4d09-a8dc-ae62fc25b236|5|REST|6|WASHOUT|2022-02-02|2022-03-07|135|168
Study ID|SE|4f522ceb-0594-4d09-a8dc-ae62fc25b236|6|P|7|TREATMENT|2021-12-25|2022-07-16|96|299
Study ID|SE|4f522ceb-0594-4d09-a8dc-ae62fc25b236|7|FU|1|FOLLOW-UP|2021-12-07|2021-12-08|78|79
Study ID|SE|38cc70be-90f8-4047-a6c3-202950fd7bf5|1|SCRN|2|SCREENING|2021-11-23|2022-03-28|36|161
Study ID|SE|38cc70be-90f8-4047-a6c3-202950fd7bf5|2|5|1|TREATMENT|2021-11-27|2021-12-10|40|53
Study ID|SE|38cc70be-90f8-4047-a6c3-202950fd7bf5|3|REST|1|WASHOUT|2021-12-23|2022-02-11|66|116
Study ID|SE|38cc70be-90f8-4047-a6c3-202950fd7bf5|4|P|5|TREATMENT|2022-05-20|2022-08-11|214|297
Study ID|SE|38cc70be-90f8-4047-a6c3-202950fd7bf5|5|REST|4|WASHOUT|2022-03-11|2022-04-14|144|178
Study ID|SE|38cc70be-90f8-4047-a6c3-202950fd7bf5|6|10|7|TREATMENT|2022-02-18|2022-03-25|123|158
Study ID|SE|38cc70be-90f8-4047-a6c3-202950fd7bf5|7|FU|7|FOLLOW-UP|2022-01-28|2022-01-30|102|104
Study ID|SE|19f9dd2b-c46c-4629-94dd-d38b92434e2b|1|SCRN|1|SCREENING|2021-10-23|2021-12-03|50|91
Study ID|SE|19f9dd2b-c46c-4629-94dd-d38b92434e2b|2|P|2|TREATMENT|2021-09-06|2021-09-17|3|14
Study ID|SE|19f9dd2b-c46c-4629-94dd-d38b92434e2b|3|REST|5|WASHOUT|2022-04-05|2022-06-22|214|292
Study ID|SE|19f9dd2b-c46c-4629-94dd-d38b92434e2b|4|5|3|TREATMENT|2022-01-23|2022-04-25|142|234
Study ID|SE|19f9dd2b-c46c-4629-94dd-d38b92434e2b|5|REST|1|WASHOUT|2021-12-20|2022-04-15|108|224
Study ID|SE|19f9dd2b-c46c-4629-94dd-d38b92434e2b|6|10|3|TREATMENT|2021-12-28|2022-02-24|116|174
Study ID|SE|19f9dd2b-c46c-4629-94dd-d38b92434e2b|7|FU|4|FOLLOW-UP|2022-03-10|2022-05-02|188|241
Study ID|SE|2edbba86-21c3-4d85-a985-b3a6916f9f97|1|SCRN|7|SCREENING|2022-01-03|2022-01-16|85|98
Study ID|SE|2edbba86-21c3-4d85-a985-b3a6916f9f97|2|5|1|TREATMENT|2021-12-31|2022-02-13|82|126
Study ID|SE|2edbba86-21c3-4d85-a985-b3a6916f9f97|3|REST|5|WASHOUT|2021-11-18|2021-11-26|39|47
Study ID|SE|2edbba86-21c3-4d85-a985-b3a6916f9f97|4|10|7|TREATMENT|2021-11-17|2021-12-12|38|63
Study ID|SE|2edbba86-21c3-4d85-a985-b3a6916f9f97|5|REST|6|WASHOUT|2021-12-10|2021-12-18|61|69
Study ID|SE|2edbba86-21c3-4d85-a985-b3a6916f9f97|6|P|1|TREATMENT|2021-11-06|2022-01-21|27|103
Study ID|SE|2edbba86-21c3-4d85-a985-b3a6916f9f97|7|FU|4|FOLLOW-UP|2021-11-13|2022-01-15|34|97
Study ID|SE|44914c1c-b117-4162-8da2-c1689a94b998|1|SCRN|2|SCREENING|2021-08-12|2021-11-29|5|114
Study ID|SE|44914c1c-b117-4162-8da2-c1689a94b998|2|5|4|TREATMENT|2021-09-18|2022-01-26|42|172
Study ID|SE|44914c1c-b117-4162-8da2-c1689a94b998|3|REST|1|WASHOUT|2021-08-18|2021-09-03|11|27
Study ID|SE|44914c1c-b117-4162-8da2-c1689a94b998|4|10|3|TREATMENT|2021-10-21|2021-12-11|75|126
Study ID|SE|44914c1c-b117-4162-8da2-c1689a94b998|5|REST|2|WASHOUT|2021-08-26|2021-09-19|19|43
Study ID|SE|44914c1c-b117-4162-8da2-c1689a94b998|6|P|3|TREATMENT|2021-10-05|2021-11-30|59|115
Study ID|SE|44914c1c-b117-4162-8da2-c1689a94b998|7|FU|3|FOLLOW-UP|2021-08-19|2021-09-01|12|25
Study ID|SE|e8e27076-473e-4293-b243-1bb94b3bf269|1|SCRN|3|SCREENING|2021-12-05|2022-01-25|78|129
Study ID|SE|e8e27076-473e-4293-b243-1bb94b3bf269|2|5|5|TREATMENT|2022-06-05|2022-06-07|260|262
Study ID|SE|e8e27076-473e-4293-b243-1bb94b3bf269|3|REST|5|WASHOUT|2021-12-05|2021-12-10|78|83
Study ID|SE|e8e27076-473e-4293-b243-1bb94b3bf269|4|10|4|TREATMENT|2022-02-20|2022-06-16|155|271
Study ID|SE|e8e27076-473e-4293-b243-1bb94b3bf269|5|REST|7|WASHOUT|2022-02-23|2022-03-07|158|170
Study ID|SE|e8e27076-473e-4293-b243-1bb94b3bf269|6|P|6|TREATMENT|2021-10-14|2021-10-28|26|40
Study ID|SE|e8e27076-473e-4293-b243-1bb94b3bf269|7|FU|7|FOLLOW-UP|2021-09-25|2021-10-07|7|19
Study ID|SE|cd33ac34-c57a-49c6-b847-59effff0d1c4|1|SCRN|4|SCREENING|2021-09-04|2022-04-03|9|220
Study ID|SE|cd33ac34-c57a-49c6-b847-59effff0d1c4|2|5|6|TREATMENT|2021-10-20|2022-03-17|55|203
Study ID|SE|cd33ac34-c57a-49c6-b847-59effff0d1c4|3|REST|1|WASHOUT|2021-09-07|2021-09-12|12|17
Study ID|SE|cd33ac34-c57a-49c6-b847-59effff0d1c4|4|P|6|TREATMENT|2022-02-12|2022-03-14|170|200
Study ID|SE|cd33ac34-c57a-49c6-b847-59effff0d1c4|5|REST|3|WASHOUT|2021-12-25|2022-03-21|121|207
Study ID|SE|cd33ac34-c57a-49c6-b847-59effff0d1c4|6|10|6|TREATMENT|2022-01-25|2022-06-01|152|279
Study ID|SE|cd33ac34-c57a-49c6-b847-59effff0d1c4|7|FU|6|FOLLOW-UP|2021-12-03|2022-04-26|99|243
Study ID|SE|2d6d1b14-f011-4f9c-810e-ea30fb92a74f|1|SCRN|6|SCREENING|2021-12-14|2022-02-05|94|147
Study ID|SE|2d6d1b14-f011-4f9c-810e-ea30fb92a74f|2|5|6|TREATMENT|2021-09-15|2021-09-27|4|16
Study ID|SE|2d6d1b14-f011-4f9c-810e-ea30fb92a74f|3|REST|5|WASHOUT|2021-12-20|2022-02-09|100|151
Study ID|SE|2d6d1b14-f011-4f9c-810e-ea30fb92a74f|4|P|3|TREATMENT|2021-09-16|2021-12-28|5|108
Study ID|SE|2d6d1b14-f011-4f9c-810e-ea30fb92a74f|5|REST|3|WASHOUT|2022-01-05|2022-06-09|116|271
Study ID|SE|2d6d1b14-f011-4f9c-810e-ea30fb92a74f|6|10|7|TREATMENT|2022-04-14|2022-05-11|215|242
Study ID|SE|2d6d1b14-f011-4f9c-810e-ea30fb92a74f|7|FU|3|FOLLOW-UP|2021-10-19|2022-03-24|38|194
Study ID|SE|d22fb880-8b73-4eee-8f7d-7ef0eecd8bd9|1|SCRN|7|SCREENING|2021-12-01|2021-12-20|34|53
Study ID|SE|d22fb880-8b73-4eee-8f7d-7ef0eecd8bd9|2|5|3|TREATMENT|2021-12-03|2021-12-15|36|48
Study ID|SE|d22fb880-8b73-4eee-8f7d-7ef0eecd8bd9|3|REST|3|WASHOUT|2021-12-21|2022-04-26|54|180
Study ID|SE|d22fb880-8b73-4eee-8f7d-7ef0eecd8bd9|4|P|6|TREATMENT|2022-01-06|2022-07-04|70|249
Study ID|SE|d22fb880-8b73-4eee-8f7d-7ef0eecd8bd9|5|REST|7|WASHOUT|2022-03-08|2022-08-17|131|293
Study ID|SE|d22fb880-8b73-4eee-8f7d-7ef0eecd8bd9|6|10|5|TREATMENT|2022-02-02|2022-08-11|97|287
Study ID|SE|d22fb880-8b73-4eee-8f7d-7ef0eecd8bd9|7|FU|6|FOLLOW-UP|2022-06-30|2022-08-10|245|286
Study ID|SE|09ee7713-76e0-4c7e-9b09-ed1e30338692|1|SCRN|7|SCREENING|2021-10-28|2021-12-06|24|63
Study ID|SE|09ee7713-76e0-4c7e-9b09-ed1e30338692|2|5|4|TREATMENT|2022-01-10|2022-02-07|98|126
Study ID|SE|09ee7713-76e0-4c7e-9b09-ed1e30338692|3|REST|7|WASHOUT|2021-10-27|2022-07-08|23|277
Study ID|SE|09ee7713-76e0-4c7e-9b09-ed1e30338692|4|10|2|TREATMENT|2022-03-25|2022-05-23|172|231
Study ID|SE|09ee7713-76e0-4c7e-9b09-ed1e30338692|5|REST|1|WASHOUT|2021-12-23|2021-12-27|80|84
Study ID|SE|09ee7713-76e0-4c7e-9b09-ed1e30338692|6|P|3|TREATMENT|2022-06-05|2022-06-22|244|261
Study ID|SE|09ee7713-76e0-4c7e-9b09-ed1e30338692|7|FU|3|FOLLOW-UP|2021-10-21|2021-12-30|17|87
Study ID|SE|4ba85b15-78bc-4434-9473-b728a29918e7|1|SCRN|5|SCREENING|2022-02-08|2022-02-21|114|127
Study ID|SE|4ba85b15-78bc-4434-9473-b728a29918e7|2|5|5|TREATMENT|2021-10-25|2022-06-18|8|244
Study ID|SE|4ba85b15-78bc-4434-9473-b728a29918e7|3|REST|2|WASHOUT|2021-11-12|2022-01-22|26|97
Study ID|SE|4ba85b15-78bc-4434-9473-b728a29918e7|4|P|3|TREATMENT|2021-11-29|2022-07-10|43|266
Study ID|SE|4ba85b15-78bc-4434-9473-b728a29918e7|5|REST|5|WASHOUT|2022-07-04|2022-08-05|260|292
Study ID|SE|4ba85b15-78bc-4434-9473-b728a29918e7|6|10|5|TREATMENT|2021-10-23|2021-11-12|6|26
Study ID|SE|4ba85b15-78bc-4434-9473-b728a29918e7|7|FU|1|FOLLOW-UP|2021-11-29|2022-07-19|43|275
Study ID|SE|ae3512e5-96ff-4ed1-8756-b279cb283132|1|SCRN|4|SCREENING|2022-01-15|2022-06-25|79|240
Study ID|SE|ae3512e5-96ff-4ed1-8756-b279cb283132|2|P|7|TREATMENT|2021-10-30|2021-11-16|2|19
Study ID|SE|ae3512e5-96ff-4ed1-8756-b279cb283132|3|REST|3|WASHOUT|2021-11-10|2022-07-06|13|251
Study ID|SE|ae3512e5-96ff-4ed1-8756-b279cb283132|4|5|4|TREATMENT|2021-11-25|2021-11-27|28|30
Study ID|SE|ae3512e5-96ff-4ed1-8756-b279cb283132|5|REST|7|WASHOUT|2022-06-10|2022-07-27|225|272
Study ID|SE|ae3512e5-96ff-4ed1-8756-b279cb283132|6|10|1|TREATMENT|2022-01-08|2022-01-13|72|77
Study ID|SE|ae3512e5-96ff-4ed1-8756-b279cb283132|7|FU|1|FOLLOW-UP|2021-11-04|2021-11-10|7|13
Study ID|SE|f6e6bd11-b4ef-4eb5-a21e-9a5406abb936|1|SCRN|7|SCREENING|2021-09-08|2021-09-15|2|9
Study ID|SE|f6e6bd11-b4ef-4eb5-a21e-9a5406abb936|2|5|4|TREATMENT|2021-10-11|2022-03-26|35|201
Study ID|SE|f6e6bd11-b4ef-4eb5-a21e-9a5406abb936|3|REST|4|WASHOUT|2021-09-23|2022-03-10|17|185
Study ID|SE|f6e6bd11-b4ef-4eb5-a21e-9a5406abb936|4|P|6|TREATMENT|2022-01-21|2022-02-16|137|163
Study ID|SE|f6e6bd11-b4ef-4eb5-a21e-9a5406abb936|5|REST|3|WASHOUT|2021-10-04|2021-12-16|28|101
Study ID|SE|f6e6bd11-b4ef-4eb5-a21e-9a5406abb936|6|10|2|TREATMENT|2021-10-08|2022-05-09|32|245
Study ID|SE|f6e6bd11-b4ef-4eb5-a21e-9a5406abb936|7|FU|7|FOLLOW-UP|2021-12-02|2022-03-20|87|195
Study ID|SE|59ed4050-4faa-4336-92bb-949fecdc4b00|1|SCRN|2|SCREENING|2022-04-07|2022-05-07|178|208
Study ID|SE|59ed4050-4faa-4336-92bb-949fecdc4b00|2|P|1|TREATMENT|2021-11-11|2022-01-23|31|104
Study ID|SE|59ed4050-4faa-4336-92bb-949fecdc4b00|3|REST|5|WASHOUT|2021-11-13|2022-05-30|33|231
Study ID|SE|59ed4050-4faa-4336-92bb-949fecdc4b00|4|5|5|TREATMENT|2022-07-08|2022-07-15|270|277
Study ID|SE|59ed4050-4faa-4336-92bb-949fecdc4b00|5|REST|7|WASHOUT|2022-01-04|2022-01-25|85|106
Study ID|SE|59ed4050-4faa-4336-92bb-949fecdc4b00|6|10|2|TREATMENT|2021-10-21|2021-10-31|10|20
Study ID|SE|59ed4050-4faa-4336-92bb-949fecdc4b00|7|FU|1|FOLLOW-UP|2021-10-20|2021-10-21|9|10
Study ID|SE|3c2d3684-0d5a-4808-be0c-0823d8cb9df8|1|SCRN|6|SCREENING|2022-05-26|2022-07-28|225|288
Study ID|SE|3c2d3684-0d5a-4808-be0c-0823d8cb9df8|2|P|1|TREATMENT|2021-12-07|2022-03-15|55|153
Study ID|SE|3c2d3684-0d5a-4808-be0c-0823d8cb9df8|3|REST|2|WASHOUT|2022-01-03|2022-04-17|82|186
Study ID|SE|3c2d3684-0d5a-4808-be0c-0823d8cb9df8|4|5|3|TREATMENT|2021-10-17|2021-10-24|4|11
Study ID|SE|3c2d3684-0d5a-4808-be0c-0823d8cb9df8|5|REST|1|WASHOUT|2021-10-27|2021-10-29|14|16
Study ID|SE|3c2d3684-0d5a-4808-be0c-0823d8cb9df8|6|10|4|TREATMENT|2022-05-21|2022-08-03|220|294
Study ID|SE|3c2d3684-0d5a-4808-be0c-0823d8cb9df8|7|FU|2|FOLLOW-UP|2022-01-09|2022-02-11|88|121
Study ID|SE|af4a272e-d496-4495-aeb3-385d991445cb|1|SCRN|2|SCREENING|2021-10-14|2021-10-23|63|72
Study ID|SE|af4a272e-d496-4495-aeb3-385d991445cb|2|P|2|TREATMENT|2022-02-19|2022-05-11|191|272
Study ID|SE|af4a272e-d496-4495-aeb3-385d991445cb|3|REST|6|WASHOUT|2022-04-19|2022-05-01|250|262
Study ID|SE|af4a272e-d496-4495-aeb3-385d991445cb|4|5|2|TREATMENT|2021-12-14|2022-01-18|124|159
Study ID|SE|af4a272e-d496-4495-aeb3-385d991445cb|5|REST|7|WASHOUT|2021-08-16|2022-04-01|4|232
Study ID|SE|af4a272e-d496-4495-aeb3-385d991445cb|6|10|2|TREATMENT|2021-09-12|2021-10-30|31|79
Study ID|SE|af4a272e-d496-4495-aeb3-385d991445cb|7|FU|5|FOLLOW-UP|2022-01-21|2022-01-24|162|165
Study ID|SE|3f08021d-f0ce-4ec8-8391-230f3f955f51|1|SCRN|7|SCREENING|2022-03-30|2022-05-30|155|216
Study ID|SE|3f08021d-f0ce-4ec8-8391-230f3f955f51|2|5|5|TREATMENT|2022-04-03|2022-07-16|159|263
Study ID|SE|3f08021d-f0ce-4ec8-8391-230f3f955f51|3|REST|2|WASHOUT|2021-11-11|2021-11-19|16|24
Study ID|SE|3f08021d-f0ce-4ec8-8391-230f3f955f51|4|10|3|TREATMENT|2021-10-28|2021-10-29|2|3
Study ID|SE|3f08021d-f0ce-4ec8-8391-230f3f955f51|5|REST|1|WASHOUT|2021-12-15|2022-04-14|50|170
Study ID|SE|3f08021d-f0ce-4ec8-8391-230f3f955f51|6|P|5|TREATMENT|2022-02-18|2022-03-03|115|128
Study ID|SE|3f08021d-f0ce-4ec8-8391-230f3f955f51|7|FU|7|FOLLOW-UP|2021-11-10|2022-01-07|15|73
Study ID|SE|a2e4b861-b070-4901-83c5-b00c4fd48d89|1|SCRN|7|SCREENING|2021-10-05|2022-02-05|57|180
Study ID|SE|a2e4b861-b070-4901-83c5-b00c4fd48d89|2|P|6|TREATMENT|2021-08-25|2021-11-17|16|100
Study ID|SE|a2e4b861-b070-4901-83c5-b00c4fd48d89|3|REST|7|WASHOUT|2022-04-15|2022-04-22|249|256
Study ID|SE|a2e4b861-b070-4901-83c5-b00c4fd48d89|4|5|1|TREATMENT|2022-04-19|2022-05-03|253|267
Study ID|SE|a2e4b861-b070-4901-83c5-b00c4fd48d89|5|REST|2|WASHOUT|2021-08-17|2021-08-25|8|16
Study ID|SE|a2e4b861-b070-4901-83c5-b00c4fd48d89|6|10|7|TREATMENT|2021-11-14|2022-01-05|97|149
Study ID|SE|a2e4b861-b070-4901-83c5-b00c4fd48d89|7|FU|3|FOLLOW-UP|2022-04-10|2022-04-27|244|261
Study ID|SE|0bbfbb9e-0acc-45c5-a49e-6172d899c8d7|1|SCRN|3|SCREENING|2022-04-07|2022-05-18|188|229
Study ID|SE|0bbfbb9e-0acc-45c5-a49e-6172d899c8d7|2|P|5|TREATMENT|2021-11-20|2021-11-24|50|54
Study ID|SE|0bbfbb9e-0acc-45c5-a49e-6172d899c8d7|3|REST|3|WASHOUT|2021-10-18|2021-12-30|17|90
Study ID|SE|0bbfbb9e-0acc-45c5-a49e-6172d899c8d7|4|5|1|TREATMENT|2021-10-14|2021-10-20|13|19
Study ID|SE|0bbfbb9e-0acc-45c5-a49e-6172d899c8d7|5|REST|7|WASHOUT|2022-01-04|2022-01-25|95|116
Study ID|SE|0bbfbb9e-0acc-45c5-a49e-6172d899c8d7|6|10|1|TREATMENT|2021-10-08|2022-07-17|7|289
Study ID|SE|0bbfbb9e-0acc-45c5-a49e-6172d899c8d7|7|FU|2|FOLLOW-UP|2021-11-09|2022-01-13|39|104
Study ID|SE|bd118e24-0744-4d61-8d3b-e39c8925765d|1|SCRN|2|SCREENING|2021-09-07|2021-12-06|10|100
Study ID|SE|bd118e24-0744-4d61-8d3b-e39c8925765d|2|5|5|TREATMENT|2021-10-10|2022-02-11|43|167
Study ID|SE|bd118e24-0744-4d61-8d3b-e39c8925765d|3|REST|4|WASHOUT|2021-11-07|2022-02-09|71|165
Study ID|SE|bd118e24-0744-4d61-8d3b-e39c8925765d|4|P|6|TREATMENT|2021-09-27|2021-10-16|30|49
Study ID|SE|bd118e24-0744-4d61-8d3b-e39c8925765d|5|REST|4|WASHOUT|2021-09-05|2021-12-07|8|101
Study ID|SE|bd118e24-0744-4d61-8d3b-e39c8925765d|6|10|2|TREATMENT|2021-10-31|2022-02-10|64|166
Study ID|SE|bd118e24-0744-4d61-8d3b-e39c8925765d|7|FU|2|FOLLOW-UP|2022-04-28|2022-04-29|243|244
Study ID|SE|90402180-9860-48b5-b39f-2853f61f798c|1|SCRN|7|SCREENING|2021-11-04|2022-05-13|88|278
Study ID|SE|90402180-9860-48b5-b39f-2853f61f798c|2|P|3|TREATMENT|2021-09-30|2021-10-22|53|75
Study ID|SE|90402180-9860-48b5-b39f-2853f61f798c|3|REST|6|WASHOUT|2021-08-10|2021-08-15|2|7
Study ID|SE|90402180-9860-48b5-b39f-2853f61f798c|4|5|4|TREATMENT|2021-08-14|2021-08-27|6|19
Study ID|SE|90402180-9860-48b5-b39f-2853f61f798c|5|REST|6|WASHOUT|2021-08-10|2021-08-10|2|2
Study ID|SE|90402180-9860-48b5-b39f-2853f61f798c|6|10|3|TREATMENT|2021-08-12|2021-12-22|4|136
Study ID|SE|90402180-9860-48b5-b39f-2853f61f798c|7|FU|5|FOLLOW-UP|2022-04-08|2022-05-17|243|282
Study ID|SE|a12d498c-5df4-49e4-9344-81dc0e85ae95|1|SCRN|7|SCREENING|2021-08-22|2021-08-25|16|19
Study ID|SE|a12d498c-5df4-49e4-9344-81dc0e85ae95|2|P|7|TREATMENT|2021-09-16|2021-10-01|41|56
Study ID|SE|a12d498c-5df4-49e4-9344-81dc0e85ae95|3|REST|6|WASHOUT|2021-08-23|2022-05-02|17|269
Study ID|SE|a12d498c-5df4-49e4-9344-81dc0e85ae95|4|5|7|TREATMENT|2021-10-06|2022-03-31|61|237
Study ID|SE|a12d498c-5df4-49e4-9344-81dc0e85ae95|5|REST|6|WASHOUT|2021-08-20|2022-03-02|14|208
Study ID|SE|a12d498c-5df4-49e4-9344-81dc0e85ae95|6|10|6|TREATMENT|2021-10-25|2021-11-30|80|116
Study ID|SE|a12d498c-5df4-49e4-9344-81dc0e85ae95|7|FU|2|FOLLOW-UP|2021-11-22|2022-04-21|108|258
Study ID|SE|02653a1e-e5bc-424d-8d16-878d950e6477|1|SCRN|1|SCREENING|2022-03-04|2022-07-26|129|273
Study ID|SE|02653a1e-e5bc-424d-8d16-878d950e6477|2|5|6|TREATMENT|2021-11-24|2022-06-26|29|243
Study ID|SE|02653a1e-e5bc-424d-8d16-878d950e6477|3|REST|6|WASHOUT|2022-01-18|2022-03-08|84|133
Study ID|SE|02653a1e-e5bc-424d-8d16-878d950e6477|4|P|5|TREATMENT|2022-01-02|2022-01-24|68|90
Study ID|SE|02653a1e-e5bc-424d-8d16-878d950e6477|5|REST|4|WASHOUT|2022-03-02|2022-04-25|127|181
Study ID|SE|02653a1e-e5bc-424d-8d16-878d950e6477|6|10|5|TREATMENT|2022-01-10|2022-04-19|76|175
Study ID|SE|02653a1e-e5bc-424d-8d16-878d950e6477|7|FU|5|FOLLOW-UP|2022-01-24|2022-07-12|90|259
Study ID|SE|1d2862be-1311-4934-8e2a-667a6b588468|1|SCRN|1|SCREENING|2021-11-21|2022-01-18|49|107
Study ID|SE|1d2862be-1311-4934-8e2a-667a6b588468|2|5|4|TREATMENT|2022-05-14|2022-05-16|223|225
Study ID|SE|1d2862be-1311-4934-8e2a-667a6b588468|3|REST|5|WASHOUT|2021-11-25|2021-12-14|53|72
Study ID|SE|1d2862be-1311-4934-8e2a-667a6b588468|4|P|2|TREATMENT|2022-05-01|2022-05-06|210|215
Study ID|SE|1d2862be-1311-4934-8e2a-667a6b588468|5|REST|2|WASHOUT|2022-01-17|2022-02-22|106|142
Study ID|SE|1d2862be-1311-4934-8e2a-667a6b588468|6|10|3|TREATMENT|2021-12-03|2022-03-14|61|162
Study ID|SE|1d2862be-1311-4934-8e2a-667a6b588468|7|FU|3|FOLLOW-UP|2021-11-28|2022-02-25|56|145
Study ID|SE|703313f4-61d3-41fe-acc9-c1167076306b|1|SCRN|5|SCREENING|2021-11-12|2022-03-22|83|213
Study ID|SE|703313f4-61d3-41fe-acc9-c1167076306b|2|5|2|TREATMENT|2022-01-22|2022-04-30|154|252
Study ID|SE|703313f4-61d3-41fe-acc9-c1167076306b|3|REST|2|WASHOUT|2021-09-06|2022-02-21|16|184
Study ID|SE|703313f4-61d3-41fe-acc9-c1167076306b|4|P|4|TREATMENT|2021-10-06|2021-12-28|46|129
Study ID|SE|703313f4-61d3-41fe-acc9-c1167076306b|5|REST|1|WASHOUT|2021-09-09|2021-11-02|19|73
Study ID|SE|703313f4-61d3-41fe-acc9-c1167076306b|6|10|4|TREATMENT|2021-09-04|2022-01-21|14|153
Study ID|SE|703313f4-61d3-41fe-acc9-c1167076306b|7|FU|2|FOLLOW-UP|2021-08-30|2022-03-25|9|216
Study ID|SE|9e662145-d0f9-4b10-acd0-8084041a5101|1|SCRN|5|SCREENING|2021-11-12|2022-02-05|39|124
Study ID|SE|9e662145-d0f9-4b10-acd0-8084041a5101|2|5|1|TREATMENT|2021-12-14|2022-04-11|71|189
Study ID|SE|9e662145-d0f9-4b10-acd0-8084041a5101|3|REST|7|WASHOUT|2022-02-18|2022-05-03|137|211
Study ID|SE|9e662145-d0f9-4b10-acd0-8084041a5101|4|P|7|TREATMENT|2021-10-13|2021-10-27|9|23
Study ID|SE|9e662145-d0f9-4b10-acd0-8084041a5101|5|REST|2|WASHOUT|2021-11-27|2022-02-21|54|140
Study ID|SE|9e662145-d0f9-4b10-acd0-8084041a5101|6|10|5|TREATMENT|2021-12-05|2021-12-30|62|87
Study ID|SE|9e662145-d0f9-4b10-acd0-8084041a5101|7|FU|1|FOLLOW-UP|2021-10-06|2021-10-07|2|3
Study ID|SE|5e99b934-db09-4b04-a001-8bcfd63b161e|1|SCRN|4|SCREENING|2021-10-29|2022-05-31|56|270
Study ID|SE|5e99b934-db09-4b04-a001-8bcfd63b161e|2|5|6|TREATMENT|2021-10-08|2021-11-14|35|72
Study ID|SE|5e99b934-db09-4b04-a001-8bcfd63b161e|3|REST|5|WASHOUT|2021-09-17|2021-09-27|14|24
Study ID|SE|5e99b934-db09-4b04-a001-8bcfd63b161e|4|10|7|TREATMENT|2021-09-21|2021-09-29|18|26
Study ID|SE|5e99b934-db09-4b04-a001-8bcfd63b161e|5|REST|2|WASHOUT|2021-09-13|2021-11-13|10|71
Study ID|SE|5e99b934-db09-4b04-a001-8bcfd63b161e|6|P|3|TREATMENT|2021-09-11|2022-05-16|8|255
Study ID|SE|5e99b934-db09-4b04-a001-8bcfd63b161e|7|FU|5|FOLLOW-UP|2022-03-11|2022-05-19|189|258
Study ID|SE|48356313-8821-4814-b386-1426007dc54c|1|SCRN|2|SCREENING|2021-09-19|2021-10-08|17|36
Study ID|SE|48356313-8821-4814-b386-1426007dc54c|2|P|2|TREATMENT|2022-05-13|2022-06-09|253|280
Study ID|SE|48356313-8821-4814-b386-1426007dc54c|3|REST|2|WASHOUT|2021-11-10|2022-04-10|69|220
Study ID|SE|48356313-8821-4814-b386-1426007dc54c|4|5|2|TREATMENT|2021-09-26|2021-12-12|24|101
Study ID|SE|48356313-8821-4814-b386-1426007dc54c|5|REST|1|WASHOUT|2021-10-02|2021-10-21|30|49
Study ID|SE|48356313-8821-4814-b386-1426007dc54c|6|10|6|TREATMENT|2021-11-28|2022-04-24|87|234
Study ID|SE|48356313-8821-4814-b386-1426007dc54c|7|FU|3|FOLLOW-UP|2022-04-07|2022-06-03|217|274
Study ID|SE|be84317a-930c-4f7c-bd68-c5a321eaabb0|1|SCRN|6|SCREENING|2021-10-20|2021-11-13|15|39
Study ID|SE|be84317a-930c-4f7c-bd68-c5a321eaabb0|2|5|2|TREATMENT|2021-10-22|2022-05-28|17|235
Study ID|SE|be84317a-930c-4f7c-bd68-c5a321eaabb0|3|REST|7|WASHOUT|2021-10-18|2021-11-11|13|37
Study ID|SE|be84317a-930c-4f7c-bd68-c5a321eaabb0|4|10|2|TREATMENT|2021-10-09|2021-11-04|4|30
Study ID|SE|be84317a-930c-4f7c-bd68-c5a321eaabb0|5|REST|7|WASHOUT|2022-01-19|2022-03-01|106|147
Study ID|SE|be84317a-930c-4f7c-bd68-c5a321eaabb0|6|P|4|TREATMENT|2021-12-19|2022-06-07|75|245
Study ID|SE|be84317a-930c-4f7c-bd68-c5a321eaabb0|7|FU|5|FOLLOW-UP|2021-10-15|2021-11-05|10|31
Study ID|SE|c42b2179-384c-43f6-a5c2-8cb461303738|1|SCRN|7|SCREENING|2022-05-01|2022-06-27|221|278
Study ID|SE|c42b2179-384c-43f6-a5c2-8cb461303738|2|P|1|TREATMENT|2021-11-30|2021-12-15|69|84
Study ID|SE|c42b2179-384c-43f6-a5c2-8cb461303738|3|REST|5|WASHOUT|2021-09-26|2022-04-07|4|197
Study ID|SE|c42b2179-384c-43f6-a5c2-8cb461303738|4|5|1|TREATMENT|2021-12-07|2022-06-05|76|256
Study ID|SE|c42b2179-384c-43f6-a5c2-8cb461303738|5|REST|7|WASHOUT|2021-11-12|2021-11-22|51|61
Study ID|SE|c42b2179-384c-43f6-a5c2-8cb461303738|6|10|7|TREATMENT|2021-10-12|2022-02-28|20|159
Study ID|SE|c42b2179-384c-43f6-a5c2-8cb461303738|7|FU|2|FOLLOW-UP|2021-11-19|2021-11-25|58|64
Study ID|SE|686be7c0-f49b-44ba-ba30-d1d9c00d0f4e|1|SCRN|6|SCREENING|2021-08-25|2021-08-29|18|22
Study ID|SE|686be7c0-f49b-44ba-ba30-d1d9c00d0f4e|2|P|6|TREATMENT|2022-02-18|2022-05-27|195|293
Study ID|SE|686be7c0-f49b-44ba-ba30-d1d9c00d0f4e|3|REST|1|WASHOUT|2021-10-22|2021-11-02|76|87
Study ID|SE|686be7c0-f49b-44ba-ba30-d1d9c00d0f4e|4|5|5|TREATMENT|2021-08-22|2021-12-21|15|136
Study ID|SE|686be7c0-f49b-44ba-ba30-d1d9c00d0f4e|5|REST|1|WASHOUT|2021-08-21|2021-11-18|14|103
Study ID|SE|686be7c0-f49b-44ba-ba30-d1d9c00d0f4e|6|10|2|TREATMENT|2021-09-12|2021-11-02|36|87
Study ID|SE|686be7c0-f49b-44ba-ba30-d1d9c00d0f4e|7|FU|2|FOLLOW-UP|2021-09-28|2022-06-02|52|299
Study ID|SE|8cb48d4c-1f19-4d4d-8604-8116b52e6ced|1|SCRN|4|SCREENING|2021-10-05|2022-05-05|42|254
Study ID|SE|8cb48d4c-1f19-4d4d-8604-8116b52e6ced|2|5|6|TREATMENT|2021-09-03|2022-03-16|10|204
Study ID|SE|8cb48d4c-1f19-4d4d-8604-8116b52e6ced|3|REST|4|WASHOUT|2021-08-27|2022-03-12|3|200
Study ID|SE|8cb48d4c-1f19-4d4d-8604-8116b52e6ced|4|P|4|TREATMENT|2022-01-06|2022-05-09|135|258
Study ID|SE|8cb48d4c-1f19-4d4d-8604-8116b52e6ced|5|REST|5|WASHOUT|2021-09-10|2022-02-26|17|186
Study ID|SE|8cb48d4c-1f19-4d4d-8604-8116b52e6ced|6|10|7|TREATMENT|2022-03-26|2022-06-13|214|293
Study ID|SE|8cb48d4c-1f19-4d4d-8604-8116b52e6ced|7|FU|7|FOLLOW-UP|2021-09-30|2022-04-30|37|249
Study ID|SE|a0123519-cc0c-4792-9644-b586d66cbee3|1|SCRN|4|SCREENING|2021-08-24|2022-06-06|7|293
Study ID|SE|a0123519-cc0c-4792-9644-b586d66cbee3|2|5|7|TREATMENT|2021-10-17|2022-04-14|61|240
Study ID|SE|a0123519-cc0c-4792-9644-b586d66cbee3|3|REST|6|WASHOUT|2021-09-30|2022-03-09|44|204
Study ID|SE|a0123519-cc0c-4792-9644-b586d66cbee3|4|P|4|TREATMENT|2021-10-21|2022-01-07|65|143
Study ID|SE|a0123519-cc0c-4792-9644-b586d66cbee3|5|REST|2|WASHOUT|2021-08-29|2021-12-17|12|122
Study ID|SE|a0123519-cc0c-4792-9644-b586d66cbee3|6|10|4|TREATMENT|2022-03-18|2022-04-10|213|236
Study ID|SE|a0123519-cc0c-4792-9644-b586d66cbee3|7|FU|7|FOLLOW-UP|2021-10-22|2022-02-22|66|189
Study ID|SE|5a318a1f-73aa-426d-a74f-51d34974bbdf|1|SCRN|1|SCREENING|2021-12-27|2022-05-29|81|234
Study ID|SE|5a318a1f-73aa-426d-a74f-51d34974bbdf|2|5|1|TREATMENT|2022-03-18|2022-05-26|162|231
Study ID|SE|5a318a1f-73aa-426d-a74f-51d34974bbdf|3|REST|3|WASHOUT|2022-01-20|2022-03-26|105|170
Study ID|SE|5a318a1f-73aa-426d-a74f-51d34974bbdf|4|10|7|TREATMENT|2022-01-18|2022-01-22|103|107
Study ID|SE|5a318a1f-73aa-426d-a74f-51d34974bbdf|5|REST|6|WASHOUT|2021-10-16|2021-10-17|9|10
Study ID|SE|5a318a1f-73aa-426d-a74f-51d34974bbdf|6|P|3|TREATMENT|2021-10-21|2022-01-17|14|102
Study ID|SE|5a318a1f-73aa-426d-a74f-51d34974bbdf|7|FU|2|FOLLOW-UP|2022-03-15|2022-04-08|159|183
Study ID|SE|fb6cd756-1ebc-46e5-9bf5-72190d6f9e5c|1|SCRN|2|SCREENING|2021-10-29|2021-11-17|14|33
Study ID|SE|fb6cd756-1ebc-46e5-9bf5-72190d6f9e5c|2|5|5|TREATMENT|2021-11-26|2021-12-02|42|48
Study ID|SE|fb6cd756-1ebc-46e5-9bf5-72190d6f9e5c|3|REST|5|WASHOUT|2021-12-09|2022-05-19|55|216
Study ID|SE|fb6cd756-1ebc-46e5-9bf5-72190d6f9e5c|4|10|6|TREATMENT|2021-11-20|2022-01-13|36|90
Study ID|SE|fb6cd756-1ebc-46e5-9bf5-72190d6f9e5c|5|REST|3|WASHOUT|2021-10-21|2021-11-25|6|41
Study ID|SE|fb6cd756-1ebc-46e5-9bf5-72190d6f9e5c|6|P|1|TREATMENT|2021-12-24|2022-02-15|70|123
Study ID|SE|fb6cd756-1ebc-46e5-9bf5-72190d6f9e5c|7|FU|6|FOLLOW-UP|2021-11-24|2022-01-19|40|96
Study ID|SE|251a673b-c882-4808-a1e0-37a01262b58a|1|SCRN|4|SCREENING|2021-08-21|2021-09-26|11|47
Study ID|SE|251a673b-c882-4808-a1e0-37a01262b58a|2|5|5|TREATMENT|2021-11-22|2021-11-29|104|111
Study ID|SE|251a673b-c882-4808-a1e0-37a01262b58a|3|REST|5|WASHOUT|2021-08-29|2021-11-23|19|105
Study ID|SE|251a673b-c882-4808-a1e0-37a01262b58a|4|10|4|TREATMENT|2021-09-02|2021-11-23|23|105
Study ID|SE|251a673b-c882-4808-a1e0-37a01262b58a|5|REST|4|WASHOUT|2021-10-25|2022-01-18|76|161
Study ID|SE|251a673b-c882-4808-a1e0-37a01262b58a|6|P|5|TREATMENT|2021-08-13|2021-11-29|3|111
Study ID|SE|251a673b-c882-4808-a1e0-37a01262b58a|7|FU|6|FOLLOW-UP|2021-08-25|2021-08-29|15|19
Study ID|SE|81479285-f19f-44b5-96c3-a23c08894e21|1|SCRN|3|SCREENING|2022-04-16|2022-05-28|186|228
Study ID|SE|81479285-f19f-44b5-96c3-a23c08894e21|2|5|1|TREATMENT|2021-11-17|2021-11-28|36|47
Study ID|SE|81479285-f19f-44b5-96c3-a23c08894e21|3|REST|3|WASHOUT|2021-12-14|2022-02-26|63|137
Study ID|SE|81479285-f19f-44b5-96c3-a23c08894e21|4|10|7|TREATMENT|2021-11-28|2021-12-09|47|58
Study ID|SE|81479285-f19f-44b5-96c3-a23c08894e21|5|REST|3|WASHOUT|2021-12-22|2022-01-01|71|81
Study ID|SE|81479285-f19f-44b5-96c3-a23c08894e21|6|P|7|TREATMENT|2021-10-27|2021-12-15|15|64
Study ID|SE|81479285-f19f-44b5-96c3-a23c08894e21|7|FU|1|FOLLOW-UP|2022-02-23|2022-03-03|134|142
Study ID|SE|8b72db84-3214-4393-9344-7b01ffd75a8f|1|SCRN|2|SCREENING|2022-03-27|2022-05-24|174|232
Study ID|SE|8b72db84-3214-4393-9344-7b01ffd75a8f|2|5|3|TREATMENT|2021-10-17|2022-03-24|13|171
Study ID|SE|8b72db84-3214-4393-9344-7b01ffd75a8f|3|REST|4|WASHOUT|2021-11-07|2021-12-24|34|81
Study ID|SE|8b72db84-3214-4393-9344-7b01ffd75a8f|4|10|7|TREATMENT|2022-04-15|2022-06-06|193|245
Study ID|SE|8b72db84-3214-4393-9344-7b01ffd75a8f|5|REST|2|WASHOUT|2021-10-15|2021-12-16|11|73
Study ID|SE|8b72db84-3214-4393-9344-7b01ffd75a8f|6|P|6|TREATMENT|2021-11-29|2022-02-18|56|137
Study ID|SE|8b72db84-3214-4393-9344-7b01ffd75a8f|7|FU|6|FOLLOW-UP|2021-12-09|2022-03-25|66|172
Study ID|SE|e137fe71-a123-4b88-a1b6-b49f510bebeb|1|SCRN|7|SCREENING|2021-11-10|2021-11-30|25|45
Study ID|SE|e137fe71-a123-4b88-a1b6-b49f510bebeb|2|P|7|TREATMENT|2022-04-14|2022-06-17|180|244
Study ID|SE|e137fe71-a123-4b88-a1b6-b49f510bebeb|3|REST|7|WASHOUT|2021-11-01|2021-11-20|16|35
Study ID|SE|e137fe71-a123-4b88-a1b6-b49f510bebeb|4|5|4|TREATMENT|2021-11-02|2021-11-04|17|19
Study ID|SE|e137fe71-a123-4b88-a1b6-b49f510bebeb|5|REST|6|WASHOUT|2021-12-21|2022-02-03|66|110
Study ID|SE|e137fe71-a123-4b88-a1b6-b49f510bebeb|6|10|6|TREATMENT|2021-11-21|2022-03-17|36|152
Study ID|SE|e137fe71-a123-4b88-a1b6-b49f510bebeb|7|FU|5|FOLLOW-UP|2022-05-04|2022-06-24|200|251
Study ID|SE|84980f4f-a492-4502-9779-5f0eb0a4c6a2|1|SCRN|1|SCREENING|2021-09-21|2021-12-10|2|82
Study ID|SE|84980f4f-a492-4502-9779-5f0eb0a4c6a2|2|5|7|TREATMENT|2021-09-23|2021-10-16|4|27
Study ID|SE|84980f4f-a492-4502-9779-5f0eb0a4c6a2|3|REST|3|WASHOUT|2022-01-24|2022-05-24|127|247
Study ID|SE|84980f4f-a492-4502-9779-5f0eb0a4c6a2|4|10|5|TREATMENT|2021-09-26|2022-01-25|7|128
Study ID|SE|84980f4f-a492-4502-9779-5f0eb0a4c6a2|5|REST|5|WASHOUT|2022-03-29|2022-04-24|191|217
Study ID|SE|84980f4f-a492-4502-9779-5f0eb0a4c6a2|6|P|1|TREATMENT|2022-05-28|2022-06-10|251|264
Study ID|SE|84980f4f-a492-4502-9779-5f0eb0a4c6a2|7|FU|5|FOLLOW-UP|2022-02-06|2022-07-07|140|291
Study ID|SE|602009f9-f365-4d39-a286-e781386731c8|1|SCRN|7|SCREENING|2022-02-28|2022-03-20|140|160
Study ID|SE|602009f9-f365-4d39-a286-e781386731c8|2|5|3|TREATMENT|2021-12-26|2022-02-19|76|131
Study ID|SE|602009f9-f365-4d39-a286-e781386731c8|3|REST|4|WASHOUT|2021-11-10|2021-12-19|30|69
Study ID|SE|602009f9-f365-4d39-a286-e781386731c8|4|10|4|TREATMENT|2022-01-01|2022-02-23|82|135
Study ID|SE|602009f9-f365-4d39-a286-e781386731c8|5|REST|4|WASHOUT|2022-03-17|2022-03-26|157|166
Study ID|SE|602009f9-f365-4d39-a286-e781386731c8|6|P|5|TREATMENT|2022-04-07|2022-06-06|178|238
Study ID|SE|602009f9-f365-4d39-a286-e781386731c8|7|FU|1|FOLLOW-UP|2021-10-19|2021-11-18|8|38
Study ID|SE|b2c2afea-6336-4b56-80e0-1d22ac07de48|1|SCRN|7|SCREENING|2021-11-08|2022-04-24|10|177
Study ID|SE|b2c2afea-6336-4b56-80e0-1d22ac07de48|2|5|7|TREATMENT|2021-12-04|2022-05-02|36|185
Study ID|SE|b2c2afea-6336-4b56-80e0-1d22ac07de48|3|REST|2|WASHOUT|2021-12-31|2022-02-21|63|115
Study ID|SE|b2c2afea-6336-4b56-80e0-1d22ac07de48|4|10|5|TREATMENT|2022-04-01|2022-07-30|154|274
Study ID|SE|b2c2afea-6336-4b56-80e0-1d22ac07de48|5|REST|7|WASHOUT|2022-02-15|2022-04-28|109|181
Study ID|SE|b2c2afea-6336-4b56-80e0-1d22ac07de48|6|P|7|TREATMENT|2021-11-29|2022-07-28|31|272
Study ID|SE|b2c2afea-6336-4b56-80e0-1d22ac07de48|7|FU|2|FOLLOW-UP|2021-12-18|2022-07-12|50|256
Study ID|SE|1044cde5-b270-498a-9e54-af607177b34c|1|SCRN|2|SCREENING|2022-02-03|2022-03-11|105|141
Study ID|SE|1044cde5-b270-498a-9e54-af607177b34c|2|P|2|TREATMENT|2022-01-31|2022-02-02|102|104
Study ID|SE|1044cde5-b270-498a-9e54-af607177b34c|3|REST|1|WASHOUT|2021-10-30|2021-11-17|9|27
Study ID|SE|1044cde5-b270-498a-9e54-af607177b34c|4|5|2|TREATMENT|2021-11-24|2022-08-14|34|297
Study ID|SE|1044cde5-b270-498a-9e54-af607177b34c|5|REST|7|WASHOUT|2021-11-04|2021-12-22|14|62
Study ID|SE|1044cde5-b270-498a-9e54-af607177b34c|6|10|4|TREATMENT|2021-10-24|2021-11-01|3|11
Study ID|SE|1044cde5-b270-498a-9e54-af607177b34c|7|FU|4|FOLLOW-UP|2022-03-30|2022-05-16|160|207
Study ID|SE|02eb41cd-6bea-4a56-b021-a3a8bb3930ca|1|SCRN|2|SCREENING|2021-11-28|2021-12-19|41|62
Study ID|SE|02eb41cd-6bea-4a56-b021-a3a8bb3930ca|2|5|1|TREATMENT|2022-03-21|2022-06-17|154|242
Study ID|SE|02eb41cd-6bea-4a56-b021-a3a8bb3930ca|3|REST|1|WASHOUT|2021-10-22|2021-12-28|4|71
Study ID|SE|02eb41cd-6bea-4a56-b021-a3a8bb3930ca|4|P|3|TREATMENT|2021-11-06|2022-01-05|19|79
Study ID|SE|02eb41cd-6bea-4a56-b021-a3a8bb3930ca|5|REST|2|WASHOUT|2022-02-02|2022-06-20|107|245
Study ID|SE|02eb41cd-6bea-4a56-b021-a3a8bb3930ca|6|10|1|TREATMENT|2021-10-28|2021-11-05|10|18
Study ID|SE|02eb41cd-6bea-4a56-b021-a3a8bb3930ca|7|FU|1|FOLLOW-UP|2021-11-17|2022-02-10|30|115
Study ID|SE|4913919b-0dc2-4fc1-a7ca-f282ce7249d3|1|SCRN|2|SCREENING|2022-04-08|2022-07-13|163|259
Study ID|SE|4913919b-0dc2-4fc1-a7ca-f282ce7249d3|2|5|3|TREATMENT|2021-11-04|2021-11-16|8|20
Study ID|SE|4913919b-0dc2-4fc1-a7ca-f282ce7249d3|3|REST|1|WASHOUT|2022-03-02|2022-03-21|126|145
Study ID|SE|4913919b-0dc2-4fc1-a7ca-f282ce7249d3|4|10|6|TREATMENT|2022-01-02|2022-01-20|67|85
Study ID|SE|4913919b-0dc2-4fc1-a7ca-f282ce7249d3|5|REST|3|WASHOUT|2021-10-29|2021-11-03|2|7
Study ID|SE|4913919b-0dc2-4fc1-a7ca-f282ce7249d3|6|P|2|TREATMENT|2022-02-09|2022-05-27|105|212
Study ID|SE|4913919b-0dc2-4fc1-a7ca-f282ce7249d3|7|FU|2|FOLLOW-UP|2021-10-31|2022-01-13|4|78
Study ID|SE|736c3d8e-42f5-4c39-89ef-42a7883f33c1|1|SCRN|7|SCREENING|2021-10-07|2021-12-06|22|82
Study ID|SE|736c3d8e-42f5-4c39-89ef-42a7883f33c1|2|5|6|TREATMENT|2022-01-20|2022-06-11|127|269
Study ID|SE|736c3d8e-42f5-4c39-89ef-42a7883f33c1|3|REST|3|WASHOUT|2022-03-15|2022-05-05|181|232
Study ID|SE|736c3d8e-42f5-4c39-89ef-42a7883f33c1|4|P|6|TREATMENT|2021-11-25|2022-06-30|71|288
Study ID|SE|736c3d8e-42f5-4c39-89ef-42a7883f33c1|5|REST|6|WASHOUT|2022-03-07|2022-05-14|173|241
Study ID|SE|736c3d8e-42f5-4c39-89ef-42a7883f33c1|6|10|6|TREATMENT|2021-10-13|2021-12-22|28|98
Study ID|SE|736c3d8e-42f5-4c39-89ef-42a7883f33c1|7|FU|1|FOLLOW-UP|2021-11-06|2021-11-21|52|67
Study ID|SE|9847eca9-c477-4a03-96ab-3ad77da580bf|1|SCRN|3|SCREENING|2021-11-27|2022-05-09|58|221
Study ID|SE|9847eca9-c477-4a03-96ab-3ad77da580bf|2|P|4|TREATMENT|2021-11-26|2022-02-24|57|147
Study ID|SE|9847eca9-c477-4a03-96ab-3ad77da580bf|3|REST|5|WASHOUT|2021-12-20|2022-01-28|81|120
Study ID|SE|9847eca9-c477-4a03-96ab-3ad77da580bf|4|5|2|TREATMENT|2022-05-21|2022-06-26|233|269
Study ID|SE|9847eca9-c477-4a03-96ab-3ad77da580bf|5|REST|2|WASHOUT|2021-11-14|2021-12-16|45|77
Study ID|SE|9847eca9-c477-4a03-96ab-3ad77da580bf|6|10|6|TREATMENT|2021-10-25|2022-04-17|25|199
Study ID|SE|9847eca9-c477-4a03-96ab-3ad77da580bf|7|FU|6|FOLLOW-UP|2022-03-20|2022-07-24|171|297
Study ID|SE|652a6c34-caae-455c-939b-de93c811b8e4|1|SCRN|4|SCREENING|2022-02-22|2022-03-16|116|138
Study ID|SE|652a6c34-caae-455c-939b-de93c811b8e4|2|P|4|TREATMENT|2022-01-26|2022-08-07|89|282
Study ID|SE|652a6c34-caae-455c-939b-de93c811b8e4|3|REST|6|WASHOUT|2022-02-23|2022-08-02|117|277
Study ID|SE|652a6c34-caae-455c-939b-de93c811b8e4|4|5|4|TREATMENT|2021-11-08|2021-11-12|10|14
Study ID|SE|652a6c34-caae-455c-939b-de93c811b8e4|5|REST|2|WASHOUT|2021-12-17|2022-01-19|49|82
Study ID|SE|652a6c34-caae-455c-939b-de93c811b8e4|6|10|6|TREATMENT|2022-07-25|2022-08-03|269|278
Study ID|SE|652a6c34-caae-455c-939b-de93c811b8e4|7|FU|6|FOLLOW-UP|2022-01-23|2022-05-24|86|207
Study ID|SE|7265965a-9dee-479e-91ff-99e4b3d38be5|1|SCRN|2|SCREENING|2022-01-17|2022-06-24|89|247
Study ID|SE|7265965a-9dee-479e-91ff-99e4b3d38be5|2|5|3|TREATMENT|2021-10-30|2021-11-04|10|15
Study ID|SE|7265965a-9dee-479e-91ff-99e4b3d38be5|3|REST|1|WASHOUT|2021-11-03|2021-12-28|14|69
Study ID|SE|7265965a-9dee-479e-91ff-99e4b3d38be5|4|10|2|TREATMENT|2021-12-02|2021-12-08|43|49
Study ID|SE|7265965a-9dee-479e-91ff-99e4b3d38be5|5|REST|4|WASHOUT|2022-01-10|2022-04-03|82|165
Study ID|SE|7265965a-9dee-479e-91ff-99e4b3d38be5|6|P|5|TREATMENT|2022-03-09|2022-03-17|140|148
Study ID|SE|7265965a-9dee-479e-91ff-99e4b3d38be5|7|FU|5|FOLLOW-UP|2021-12-12|2022-02-09|53|112
